PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Falkenberg, M; Gaspari, M; Rantanen, A; Trifunovic, A; Larsson, NG; Gustafsson, CM				Falkenberg, M; Gaspari, M; Rantanen, A; Trifunovic, A; Larsson, NG; Gustafsson, CM			Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA	NATURE GENETICS			English	Article							HMG-BOX PROTEIN; RNA-POLYMERASE; FACTOR-A; CRYSTAL-STRUCTURE; FACTOR-I; DNA; SEQUENCE; MOUSE; ORGANIZATION; PURIFICATION	Characterization of the basic transcription machinery of mammalian mitochondrial DNA (mtDNA)(1,2) is of fundamental biological interest and may also lead to therapeutic interventions for human diseases associated with mitochondrial dysfunction(3-6). Here we report that mitochondrial transcription factors B1 (TFB1M) and B2 (TFB2M) are necessary for basal transcription of mammalian mitochondrial DNA (mtDNA). Human TFB1M and TFB2M are expressed ubiquitously and can each support promoter-specific mtDNA transcription in a pure recombinant in vitro system containing mitochondrial RNA polymerase (POLRMT)(7) and mitochondrial transcription factor A(8,9). Both TFB1M and TFB2M interact directly with POLRMT, but TFB2M is at least one order of magnitude more active in promoting transcription than TFB1M. Both factors are highly homologous to bacterial rRNA dimethyltransferases, which suggests that an RNA-modifying enzyme has been recruited during evolution to function as a mitochondrial transcription factor. The presence of two proteins that interact with mammalian POLRMT may allow flexible regulation of mtDNA gene expression in response to the complex physiological demands of mammalian metabolism.	Huddinge Hosp, Karolinska Inst, Novum, Dept Med Nutr, S-14186 Huddinge, Sweden; Huddinge Hosp, Karolinska Inst, Novum, Dept Biosci, S-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet	Larsson, NG (corresponding author), Huddinge Hosp, Karolinska Inst, Novum, Dept Med Nutr, S-14186 Huddinge, Sweden.		Larsson, Nils-Göran/GVS-5578-2022	Larsson, Nils-Göran/0000-0001-5100-996X; Gustafsson, Claes/0000-0003-3531-8468				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANTOSHECHKIN I, 1995, MOL CELL BIOL, V15, P7032; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Bogenhagen DF, 1996, J BIOL CHEM, V271, P12036; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; Fernandez-Silva P, 1996, Methods Enzymol, V264, P129, DOI 10.1016/S0076-6879(96)64014-2; FISHER RP, 1985, J BIOL CHEM, V260, P1330; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 1996, NAT GENET, V13, P296, DOI 10.1038/ng0796-296; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Larsson NG, 1999, FEBS LETT, V455, P199, DOI 10.1016/S0014-5793(99)00854-6; Larsson NG, 1997, HUM MOL GENET, V6, P185, DOI 10.1093/hmg/6.2.185; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; SANYAL A, 1995, J BIOL CHEM, V270, P11970, DOI 10.1074/jbc.270.20.11970; SCHINKEL AH, 1987, J BIOL CHEM, V262, P12785; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yano M, 1997, J BIOL CHEM, V272, P8459, DOI 10.1074/jbc.272.13.8459	30	433	465	0	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					289	294		10.1038/ng909	http://dx.doi.org/10.1038/ng909			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12068295				2022-12-27	WOS:000176494100018
J	Cleary, JD; Nichol, K; Wang, YH; Pearson, CE				Cleary, JD; Nichol, K; Wang, YH; Pearson, CE			Evidence of cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; DNA-REPLICATION; SIMIAN VIRUS-40; TRANSGENIC MICE; HUMAN-DISEASE; CTG REPEATS; SOMATIC INSTABILITY; SECONDARY STRUCTURE; MUSCULAR-ATROPHY; CAG REPEAT	The mechanism of disease-associated trinucleotide repeat instability involves cis-acting factors (cis-elements) in the vicinity of the repeat, but the nature of these elements is unknown. One cis-element may be the location of the replication origin relative to the repeat. We have used an SV40 DNA replication system to investigate the effect of the location of replication initiation on (CTG)(n).(CAG)(n) stability in primate cells. Depending on the distance between the SV40 replication origin and the repeat tract, templates with 79 repeats yield predominantly expansions or predominantly deletions or remain intact. All templates with 17 repeats are stable. Thus, cis-elements that affect the sites of Okazaki fragment initiation relative to the repeat are crucial determinants of instability. This model system recapitulates the bias for expansions observed in many of the diseases associated with trinucleotide repeats. Our results might explain the variable amounts of CTG/CAG instability that are observed in different chromosomal contexts.	Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Rutgers State University New Brunswick; Rutgers State University Medical Center	Pearson, CE (corresponding author), Hosp Sick Children, Program Genet & Genom Biol, 555 Univ Ave,Elm Wing 11-135, Toronto, ON M5G 1X8, Canada.			Pearson, Christopher/0000-0001-9545-4205				ANDERSON S, 1979, J BIOL CHEM, V254, P1495; Ashizawa T, 1996, GENOMICS, V36, P47, DOI 10.1006/geno.1996.0424; ASHIZAWA T, 1994, AM J HUM GENET, V54, P414; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; Brock GJR, 1999, HUM MOL GENET, V8, P1061, DOI 10.1093/hmg/8.6.1061; BURHANS WC, 1990, CELL, V62, P955, DOI 10.1016/0092-8674(90)90270-O; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; DEPAMPHILIS ML, 1980, ANNU REV BIOCHEM, V49, P627, DOI 10.1146/annurev.bi.49.070180.003211; Freudenreich CH, 1997, MOL CELL BIOL, V17, P2090, DOI 10.1128/MCB.17.4.2090; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; GACY AM, 1995, CELL, V81, P533; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; Gourdon G, 1997, NAT GENET, V15, P190, DOI 10.1038/ng0297-190; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; HAY RT, 1982, CELL, V28, P767, DOI 10.1016/0092-8674(82)90056-3; HAY RT, 1984, J MOL BIOL, V175, P131, DOI 10.1016/0022-2836(84)90471-6; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; LaSpada AR, 1997, BRAIN PATHOL, V7, P943; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Martorell L, 1998, HUM MOL GENET, V7, P307, DOI 10.1093/hmg/7.2.307; Martorell L, 2001, NEUROLOGY, V56, P328, DOI 10.1212/WNL.56.3.328; Miret JJ, 1998, P NATL ACAD SCI USA, V95, P12438, DOI 10.1073/pnas.95.21.12438; Monckton DG, 1997, NAT GENET, V15, P193, DOI 10.1038/ng0297-193; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; NETHANEL T, 1988, J VIROL, V62, P2867, DOI 10.1128/JVI.62.8.2867-2873.1988; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pearson CE, 1997, HUM MOL GENET, V6, P1117, DOI 10.1093/hmg/6.7.1117; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Richard GF, 2000, EMBO J, V19, P2381, DOI 10.1093/emboj/19.10.2381; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; Richards RI, 1996, ANN HUM GENET, V60, P391, DOI 10.1111/j.1469-1809.1996.tb00437.x; ROBERTS JD, 1988, P NATL ACAD SCI USA, V85, P7064, DOI 10.1073/pnas.85.19.7064; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Spiegel R, 1996, HUM MUTAT, V8, P32, DOI 10.1002/(SICI)1098-1004(1996)8:1<32::AID-HUMU4>3.0.CO;2-R; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; TSENG BY, 1979, J MOL BIOL, V129, P531, DOI 10.1016/0022-2836(79)90467-4; VASSILEV L, 1988, NUCLEIC ACIDS RES, V16, P7742, DOI 10.1093/nar/16.15.7742; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WOHRLE D, 1995, HUM MOL GENET, V4, P1147, DOI 10.1093/hmg/4.7.1147; WONG LJC, 1995, AM J HUM GENET, V56, P114	50	153	158	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2002	31	1					37	46		10.1038/ng870	http://dx.doi.org/10.1038/ng870			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967533	Bronze			2022-12-27	WOS:000175362500012
J	Niederreither, K; Abu-Abed, S; Schuhbaur, B; Petkovich, M; Chambon, P; Dolle, P				Niederreither, K; Abu-Abed, S; Schuhbaur, B; Petkovich, M; Chambon, P; Dolle, P			Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development	NATURE GENETICS			English	Article							ENZYME; EXPRESSION; IDENTIFICATION; DEHYDROGENASE; 4-OXORETINOL; CYP26A1; DOMAINS; LIGAND; EMBRYO; CELLS	Retinoic acid, the active derivative of vitamin A (retinol), is a hormonal signaling molecule that acts in developing and adult tissues(1). The Cyp26a1 (cytochrome p450, 26) protein metabolizes retinoic acid into more polar hydroxylated and oxidized derivatives(2,3). Whether some of these derivatives are biologically active metabolites has been debated(4,5). Cyp26a1(-/-) mouse fetuses have lethal morphogenetic phenotypes mimicking those generated by excess retinoic acid administration, indicating that human CYP26A1 may be essential in controlling retinoic acid levels during development(6,7). This hypothesis suggests that the Cyp26a1(-/-) phenotype could be rescued under conditions in which embryonic retinoic acid levels are decreased. We show that Cyp26a1(-/-) mice are phenotypically rescued by heterozygous disruption of Aldh1a2 (also known as Raldh2), which encodes a retinaldehyde dehydrogenase responsible for the synthesis of retinoic acid during early embryonic development(8,9). Aldh1a2 haploinsufficiency prevents the appearance of spina bifida and rescues the development of posterior structures (sacral/caudal vertebrae, hindgut, urogenital tract), while partly preventing cervical vertebral transformations and hindbrain pattern alterations in Cyp26a1(-/-) mice. Thus, some of these double-mutant mice can reach adulthood. This study is the first report of a mutation acting as a dominant suppressor of a lethal morphogenetic mutation in mammals. We provide genetic evidence that ALDH1A2 and CYP26A1 activities concurrently establish local embryonic retinoic acid levels that must be finely tuned to allow posterior organ development and to prevent spina bifida.	Coll France, ULP, INSERM, CNRS,Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; Queens Univ, Dept Pathol, Canc Res Labs, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Biochem, Canc Res Labs, Kingston, ON K7L 3N6, Canada	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Queens University - Canada; Queens University - Canada	Dolle, P (corresponding author), Coll France, ULP, INSERM, CNRS,Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	dolle@igbmc.u-strasbg.fr	Dolle, Pascal/A-8037-2010	Dolle, Pascal/0000-0002-9294-9090				Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Achkar CC, 1996, P NATL ACAD SCI USA, V93, P4879, DOI 10.1073/pnas.93.10.4879; DECIMO D, 1995, GENE PROBES, V2, P182; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Haines N, 2000, GENETICS, V156, P1777; Hollemann T, 1998, EMBO J, V17, P7361, DOI 10.1093/emboj/17.24.7361; Lane MA, 1999, P NATL ACAD SCI USA, V96, P13524, DOI 10.1073/pnas.96.23.13524; Livrea M. A., 2000, VITAMIN A RETINOIDS; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Northrup H, 2000, Curr Probl Pediatr, V30, P313; PIJNAPPEL WWM, 1993, NATURE, V366, P340, DOI 10.1038/366340a0; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Sonneveld E, 1999, DEV BIOL, V213, P390, DOI 10.1006/dbio.1999.9381; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; Valenzano M, 1999, HUM REPROD UPDATE, V5, P82, DOI 10.1093/humupd/5.1.82; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x	22	181	186	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					84	88		10.1038/ng876	http://dx.doi.org/10.1038/ng876			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11953746				2022-12-27	WOS:000175362500020
J	Ozbudak, EM; Thattai, M; Kurtser, I; Grossman, AD; van Oudenaarden, A				Ozbudak, EM; Thattai, M; Kurtser, I; Grossman, AD; van Oudenaarden, A			Regulation of noise in the expression of a single gene	NATURE GENETICS			English	Article							ESCHERICHIA-COLI-CELLS; TRANSCRIPTIONAL REGULATION; NETWORKS; TRANSLATION; AUTOREGULATION; EFFICIENCY; ELEMENTS; LAMBDA	Stochastic mechanisms are ubiquitous in biological systems. Biochemical reactions that involve small numbers of molecules are intrinsically noisy, being dominated by large concentration fluctuations(1-3). This intrinsic noise has been implicated in the random lysis/lysogeny decision of bacteriophage-lambda4, in the loss of synchrony of circadian clocks(5,6) and in the decrease of precision of cell signals(7). We sought to quantitatively investigate the extent to which the occurrence of molecular fluctuations within single cells (biochemical noise) could explain the variation of gene expression levels between cells in a genetically identical population (phenotypic noise). We have isolated the biochemical contribution to phenotypic noise from that of other noise sources by carrying out a series of differential measurements. We varied independently the rates of transcription and translation of a single fluorescent reporter gene in the chromosome of Bacillus subtilis, and we quantitatively measured the resulting changes in the phenotypic noise characteristics. We report that of these two parameters, increased translational efficiency is the predominant source of increased phenotypic noise. This effect is consistent with a stochastic model of gene expression in which proteins are produced in random and sharp bursts. Our results thus provide the first direct experimental evidence of the biochemical origin of phenotypic noise, demonstrating that the level of phenotypic variation in an isogenic population can be regulated by genetic parameters.	MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.		van Oudenaarden, Alexander/AAA-1705-2019	Ozbudak, Ertugrul/0000-0003-2858-4696				Arkin A, 1998, GENETICS, V149, P1633; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; BAUMEISTER R, 1991, NUCLEIC ACIDS RES, V19, P4595, DOI 10.1093/nar/19.17.4595; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Berg OG, 2000, BIOPHYS J, V79, P1228, DOI 10.1016/S0006-3495(00)76377-6; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; CHAPON C, 1982, EMBO J, V1, P369, DOI 10.1002/j.1460-2075.1982.tb01176.x; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; KELLEY RL, 1982, P NATL ACAD SCI-BIOL, V79, P3120, DOI 10.1073/pnas.79.10.3120; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Levin MD, 1998, BIOPHYS J, V74, P175, DOI 10.1016/S0006-3495(98)77777-X; Lobner-Olesen A, 1999, EMBO J, V18, P1712, DOI 10.1093/emboj/18.6.1712; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Plumbridge J, 1996, J BACTERIOL, V178, P2629, DOI 10.1128/jb.178.9.2629-2636.1996; PTASHNE M, 1976, SCIENCE, V194, P156, DOI 10.1126/science.959843; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Trotot P, 1996, BIOCHIMIE, V78, P277, DOI 10.1016/0300-9084(96)82192-4; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; WEISS R, 1999, P DIMACS WORKSH EV C	28	1155	1171	2	118	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2002	31	1					69	73		10.1038/ng869	http://dx.doi.org/10.1038/ng869			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967532	Bronze			2022-12-27	WOS:000175362500017
J	Mao, JR; Taylor, G; Dean, WB; Wagner, DR; Afzal, V; Lotz, JC; Rubin, EM; Bristow, J				Mao, JR; Taylor, G; Dean, WB; Wagner, DR; Afzal, V; Lotz, JC; Rubin, EM; Bristow, J			Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition	NATURE GENETICS			English	Article							OSTEOGENESIS IMPERFECTA; I PROCOLLAGEN; COL5A1 GENE; GRAVIS FORM; PROPEPTIDE; MUTATIONS; FIBRILS; CHAINS	Tenascin-X is a large extracellular matrix protein of unknown function(1-3). Tenascin-X deficiency in humans is associated with Ehlers-Danlos syndrome(4,5), a generalized connective tissue disorder resulting from altered metabolism of the fibrillar collagens(6). Because TNXB is the first Ehlers-Danlos syndrome gene that does not encode a fibrillar collagen or collagen-modifying enzyme(7-14), we suggested that tenascin-X might regulate collagen synthesis or deposition(15). To test this hypothesis, we inactivated Tnxb in mice. Tnxb(-/-) mice showed progressive skin hyperextensibility, similar to individuals with Ehlers-Danlos syndrome. Biomechanical testing confirmed increased deformability and reduced tensile strength of their skin. The skin of Tnxb(-/-) mice was histologically normal, but its collagen content was significantly reduced. At the ultrastructural level, collagen fibrils of Tnxb(-/-) mice were of normal size and shape, but the density of fibrils in their skin was reduced, commensurate with the reduction in collagen content. Studies of cultured dermal fibroblasts showed that although synthesis of collagen I by Tnxb(-/-) and wildtype cells was similar, Tnxb(-/-) fibroblasts failed to deposit collagen I into cell-associated matrix. This study confirms a causative role for TNXB in human Ehlers-Danlos syndrome and suggests that tenascin-X is an essential regulator of collagen deposition by dermal fibroblasts.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94118 USA; Univ Calif San Francisco, Dept Orthoped Surg, San Francisco, CA 94118 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bristow, J (corresponding author), Univ Calif San Francisco, Dept Pediat, Laurel Hts Campus,3333 Calif St,Box 1245, San Francisco, CA 94118 USA.							BARSH GS, 1982, P NATL ACAD SCI-BIOL, V79, P3838, DOI 10.1073/pnas.79.12.3838; BATEMAN JF, 1986, BIOCHEM J, V240, P699, DOI 10.1042/bj2400699; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; Botas C, 1998, P NATL ACAD SCI USA, V95, P11869, DOI 10.1073/pnas.95.20.11869; BRISTOW J, 1993, J CELL BIOL, V122, P265, DOI 10.1083/jcb.122.1.265; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; BURCH GH, 1995, DEV DYNAM, V203, P491, DOI 10.1002/aja.1002030411; Burrows NP, 1998, AM J HUM GENET, V63, P390, DOI 10.1086/301948; Byers PH., 1995, METABOLIC MOL BASES, V7th ed, P4029; CHENG PTH, 1969, J INVEST DERMATOL, V53, P112, DOI 10.1038/jid.1969.116; Coats WD, 1996, J MOL CELL CARDIOL, V28, P441; DALY CH, 1982, J INVEST DERMATOL, V79, P17; DePaepe A, 1997, AM J HUM GENET, V60, P547; EYRE DR, 1985, J BIOL CHEM, V260, P1322; FUNG Y, 1990, BIOMECHANICS MECH PR, P259; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Lethias C, 1996, MATRIX BIOL, V15, P11, DOI 10.1016/S0945-053X(96)90122-5; Mao JR, 2001, J CLIN INVEST, V107, P1063, DOI 10.1172/JCI12881; MATSUMOTO K, 1994, J CELL BIOL, V125, P483, DOI 10.1083/jcb.125.2.483; Matsumoto K, 2001, GENES CELLS, V6, P1101, DOI 10.1046/j.1365-2443.2001.00482.x; MOREL Y, 1989, P NATL ACAD SCI USA, V86, P6582, DOI 10.1073/pnas.86.17.6582; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; SMITH LT, 1992, AM J HUM GENET, V51, P235; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; VOGEL A, 1979, LAB INVEST, V40, P201; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733	29	186	190	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					421	425		10.1038/ng850	http://dx.doi.org/10.1038/ng850			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11925569				2022-12-27	WOS:000174682000021
J	Broeckel, U; Hengstenberg, C; Mayer, B; Holmer, S; Martin, LJ; Comuzzie, AG; Blangero, J; Nurnberg, P; Reis, A; Riegger, GAJ; Jacob, HJ; Schunkert, H				Broeckel, U; Hengstenberg, C; Mayer, B; Holmer, S; Martin, LJ; Comuzzie, AG; Blangero, J; Nurnberg, P; Reis, A; Riegger, GAJ; Jacob, HJ; Schunkert, H			A comprehensive linkage analysis for myocardial infarction and its related risk factors	NATURE GENETICS			English	Article							CORONARY-HEART-DISEASE; SUSCEPTIBILITY LOCUS; GENETIC-LINKAGE; PAIR ANALYSIS; CHROMOSOME; HYPERTENSION; ASSOCIATION; MAPS	Coronary artery disease and myocardial infarction (MI) are leading causes of death in the western world. Numerous studies have shown that risk factors such as diabetes mellitus, arterial hypertension and hypercholesterolemia contribute to the development of the disease. Although each risk factor by itself is partly under genetic control, a positive family history is an independent predictor, which suggests that there are additional susceptibility genes(1). We have scanned the whole genome in 513 families to identify chromosomal regions linked to myocardial infarction and related risk factors that are known to be under genetic control. Here we show, by using variance component analysis and incorporating risk factors, that risk of myocardial infarction maps to a single region on chromosome 14 with a significant lod score of 3.9 (pointwise P=0.00015, genome-wide P<0.05), providing evidence of a principal MI locus. To characterize this locus we analyzed each risk factor by itself. Serum concentrations of lipoprotein (a) show linkage to both the apolipoprotein (a) locus (lod score 26.99) and a new locus on chromosome 1 (lod score 3.8). There is suggestive linkage for diabetes mellitus on chromosome 6 (lod score 2.96), for hypertension on chromosomes 1 and 6, for high-density and low-density lipoprotein cholesterol on chromosomes 1 and 17, and for triglyceride concentrations on chromosome 9. Although some of these risk factors overlap with previously identified loci, none overlaps with the newly identified susceptibility locus for myocardial infarction and coronary artery disease.	Univ Regensburg, Klin & Poliklin Innere Med 2, D-8400 Regensburg, Germany; Med Coll Wisconsin, Dept Cardiovasc Med, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Max Delbruck Ctr Mol Med, Zentrum Genkartierung, Berlin, Germany; Univ Erlangen Nurnberg, Inst Humangenet, D-8520 Erlangen, Germany; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	University of Regensburg; Medical College of Wisconsin; Medical College of Wisconsin; Texas Biomedical Research Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Erlangen Nuremberg; Medical College of Wisconsin	Schunkert, H (corresponding author), Univ Regensburg, Klin & Poliklin Innere Med 2, D-8400 Regensburg, Germany.	jacob@mcw.edu; heribert.schunkert@klinik.uni-regensburg.de	Blangero, John/ABA-7175-2021; Martin, Lisa/E-2425-2016; Hengstenberg, Christian/U-5485-2019; Reis, André/D-2309-2009	Martin, Lisa/0000-0001-8702-9946; Reis, André/0000-0002-6301-6363				Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Comuzzie AG, 1999, GENET EPIDEMIOL, V17, pS109; Dahlen GH, 1998, J INTERN MED, V244, P417; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; LOBEL H, 1993, CIRCULATION, V88, P2524; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; THOMPSON EA, 1993, 243 U WASH DEP STAT; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5	27	259	274	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					210	214		10.1038/ng827	http://dx.doi.org/10.1038/ng827			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11818963				2022-12-27	WOS:000173708700024
J	Peters, AHFM; Mermoud, JE; O'Carroll, D; Pagani, M; Schweizer, D; Brockdorff, N; Jenuwein, T				Peters, AHFM; Mermoud, JE; O'Carroll, D; Pagani, M; Schweizer, D; Brockdorff, N; Jenuwein, T			Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin	NATURE GENETICS			English	Article							INACTIVE X-CHROMOSOME; ACETYLATION; LOCALIZATION; FEMALE; RNA; PROTEINS; MACROH2A; GENE; SITE	Post-translational modifications of histone amino termini are an important regulatory mechanism that induce transitions in chromatin structure, thereby contributing to epigenetic gene control and the assembly of specialized chromosomal subdomains(1,2). Methylation of histone H3 at lysine 9 (H3-Lys9) by site-specific histone methyltransferases (Suv39h HMTaseS)(3) marks constitutive heterochromatin(4-6). Here, we show that H3-Lys9 methylation also occurs in facultative heterochromatin of the inactive X chromosome (X-i) in female mammals. H3-Lys9 methylation is retained through mitosis, indicating that it might provide an epigenetic imprint for the maintenance of the inactive state. Disruption of the two mouse Suv39h HMTases abolishes H3-Lys9 methylation of constitutive heterochromatin but not that of the X-i. In addition, HP1 proteins, which normally associate with heterochromatin, do not accumulate with the X-i. These observations suggest the existence of an Suv39h-HP1-independent pathway regulating H3-Lys9 methylation of facultative heterochromatin.	Res Inst Mol Pathol, Vienna Bioctr, A-1030 Vienna, Austria; Hammersmith Hosp, ISCM, MRC, Ctr Clin Sci, London W12 0NN, England; Univ Vienna, Inst Bot, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Imperial College London; University of Vienna	Jenuwein, T (corresponding author), Res Inst Mol Pathol, Vienna Bioctr, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	jenuwein@nt.imp.univie.ac.at		O'Carroll, Donal/0000-0002-8626-2217; Mermoud, Jacqueline/0000-0002-7718-646X; Brockdorff, Neil/0000-0003-4838-2653; Peters, Antoine/0000-0002-0311-1887				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Boggs BA, 1996, CHROMOSOMA, V105, P303, DOI 10.1007/BF02524648; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	30	388	404	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					77	80		10.1038/ng789	http://dx.doi.org/10.1038/ng789			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11740497				2022-12-27	WOS:000173105600017
J	Tartaglia, M; Mehler, EL; Goldberg, R; Zampino, G; Brunner, HG; Kremer, H; van der Burgt, I; Crosby, AH; Ion, A; Jeffery, S; Kalidas, K; Patton, MA; Kucherlapati, RS; Gelb, BD				Tartaglia, M; Mehler, EL; Goldberg, R; Zampino, G; Brunner, HG; Kremer, H; van der Burgt, I; Crosby, AH; Ion, A; Jeffery, S; Kalidas, K; Patton, MA; Kucherlapati, RS; Gelb, BD			Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome	NATURE GENETICS			English	Article							SH-PTP2; MUTANT; KINASE; MICE; CONFORMATIONS; ACTIVATION; CELL; SYP	Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy)(1,2). Webbed neck, chest deformity, cryptorchidism, mental retardation and bleeding diatheses also are frequently associated with this disease. This syndrome is relatively common, with an estimated incidence of 1 in 1,000-2,500 live births. it has been mapped to a 5-cM region (N-SH2) on chromosome 12q24.1, and genetic heterogeneity has also been documented(3-6). Here we show that missense mutations in PTPN11 (MIM 176876)-a gene encoding the nonreceptor protein tyrosine phosphatase SHP-2, which contains two Src homology 2 (SH2) domains-cause Noonan syndrome and account for more than 50% of the cases that we examined. All PTPN11 missense mutations cluster in interacting portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved in switching the protein between its inactive and active conformations. An energetics-based structural analysis of two N-SH2 mutants indicates that in these mutants there may be a significant shift of the equilibrium favoring the active conformation. This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.	Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Ist Super Sanita, Lab Metab & Biochim Patol, I-00161 Rome, Italy; Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Univ Cattolica Sacro Cuore, Ist Clin Pediat, Rome, Italy; Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Univ London St Georges Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Istituto Superiore di Sanita (ISS); Yeshiva University; Albert Einstein College of Medicine; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Radboud University Nijmegen; St Georges University London	Tartaglia, M (corresponding author), Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA.	tartam02@doc.mssm.edu	Zampino, Giuseppe/AAC-2152-2019; Tartaglia, Marco/K-2955-2018; Brunner, Han/C-9928-2013; Kremer, Hannie/F-5126-2010; Crosby, Andrew H/E-2218-2015; Kucherlapati, Raju/ABC-8807-2021	Tartaglia, Marco/0000-0001-7736-9672; Kremer, Hannie/0000-0002-0841-8693; Crosby, Andrew H/0000-0003-3667-9054; 				ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; Allen M., 2017, COMPUTER SIMULATIONS, V2nd; Arrandale JM, 1996, J BIOL CHEM, V271, P21353, DOI 10.1074/jbc.271.35.21353; Bradford T, 1997, ART CRITICISM, V12, P5; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; DECHERT U, 1995, HUM GENET, V96, P609; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Hassan SA, 2000, J PHYS CHEM B, V104, P6478, DOI 10.1021/jp993895e; HASSAN SA, IN PRESS LECT NOTES; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; JAMIESON CR, 1994, NAT GENET, V8, P357, DOI 10.1038/ng1294-357; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Legius E, 1998, EUR J HUM GENET, V6, P32, DOI 10.1038/sj.ejhg.5200150; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; NOGUTI T, 1985, BIOPOLYMERS, V24, P527, DOI 10.1002/bip.360240308; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Saxton TM, 2000, NAT GENET, V24, P420, DOI 10.1038/74279; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; SHENKIN PS, 1994, J COMPUT CHEM, V15, P899, DOI 10.1002/jcc.540150811; Shi ZQ, 1998, J BIOL CHEM, V273, P4904, DOI 10.1074/jbc.273.9.4904; Steinberg DL, 1998, WORK EMPLOY SOC, V12, P559; Tamir I, 2000, CURR OPIN IMMUNOL, V12, P307, DOI 10.1016/S0952-7915(00)00092-3; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; van der Burgt I, 2000, AM J MED GENET, V94, P46, DOI 10.1002/1096-8628(20000904)94:1<46::AID-AJMG10>3.0.CO;2-I; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101	32	1173	1241	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2001	29	4					465	468		10.1038/ng772	http://dx.doi.org/10.1038/ng772			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11704759				2022-12-27	WOS:000172507500024
J	Herceg, Z; Hulla, W; Gell, D; Cuenin, C; Lleonart, M; Jackson, S; Wang, ZQ				Herceg, Z; Hulla, W; Gell, D; Cuenin, C; Lleonart, M; Jackson, S; Wang, ZQ			Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression	NATURE GENETICS			English	Article							HISTONE ACETYLTRANSFERASE; SPINDLE CHECKPOINT; ESSENTIAL COFACTOR; HUMAN CANCERS; C-MYC; COMPLEX; LACKING; EMBRYOGENESIS; APOPTOSIS; COMPONENT		Int Agcy Res Canc, F-69008 Lyon, France; Univ Cambridge, Inst Canc & Dev Biol, Wellcome Trust, Canc Res Campaign, Cambridge, England	World Health Organization; International Agency for Research on Cancer (IARC); CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute	Wang, ZQ (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69008 Lyon, France.		Jackson, Stephen Philip/R-4548-2019; LLeonart, Matilde E./Q-2662-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; LLeonart, Matilde E./0000-0002-6196-7405; Gell, David/0000-0003-0382-1181				Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chen HW, 2001, CURR OPIN CELL BIOL, V13, P218, DOI 10.1016/S0955-0674(00)00200-3; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; Di Leonardo A, 1997, CANCER RES, V57, P1013; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Grant PA, 1998, MOL CELL, V2, P863, DOI 10.1016/S1097-2765(00)80300-7; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Stewart ZA, 1999, MOL CELL BIOL, V19, P205; Vassilev A, 1998, MOL CELL, V2, P869, DOI 10.1016/S1097-2765(00)80301-9; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303	30	102	105	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					206	211		10.1038/ng725	http://dx.doi.org/10.1038/ng725			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11544477				2022-12-27	WOS:000171374100029
J	Jeffreys, AJ; Kauppi, L; Neumann, R				Jeffreys, AJ; Kauppi, L; Neumann, R			Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; SACCHAROMYCES-CEREVISIAE; CHROMATIN STRUCTURE; DISEASE GENES; YEAST; HOTSPOTS; MEIOSIS; SITES; DNA; AMPLIFICATION	There is considerable interest in understanding patterns of linkage disequilibrium (LD) in the human genome, to aid investigations of human evolution and facilitate association studies in complex disease(1-5). The relative influences of meiotic crossover distribution and population history on LD remain unclear, however(5). In particular, it is uncertain to what extent crossovers are clustered into 'hot SpotS,(6-8) that might influence LID patterns. As a first step to investigating the relationship between LD and recombination, we have analyzed a 216-kb segment of the class II region of the major histocompatibility complex (MHC) already characterized for familial crossovers(9). High-resolution LD analysis shows the existence of extended domains of strong association interrupted by patchwork areas of LD breakdown. Sperm typing shows that these areas correspond precisely to meiotic crossover hot spots. All six hot spots defined share a remarkably similar symmetrical morphology but vary considerably in intensity, and are not obviously associated with any primary DNA sequence determinants of hot-spot activity. These hot spots occur in clusters and together account for almost all crossovers in this region of the MHC. These data show that, within the MHC at least, crossovers are far from randomly distributed at the molecular level and that recombination hot spots can profoundly affect LD patterns.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Jeffreys, AJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	ajj@1e.ac.uk	Peng, Bo/A-6920-2009; Kauppi, Liisa/H-5845-2012	Peng, Bo/0000-0001-8225-2284; Kauppi, Liisa/0000-0002-6759-8997				Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BORTS RH, 1987, SCIENCE, V237, P1459, DOI 10.1126/science.2820060; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; CULLEN M, 1995, AM J HUM GENET, V56, P1350; Cullen M, 1997, AM J HUM GENET, V60, P397; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Fan QQ, 1996, MOL CELL BIOL, V16, P2037; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEDRICK PW, 1988, HEREDITY, V60, P435, DOI 10.1038/hdy.1988.61; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LEWONTIN RC, 1964, GENETICS, V49, P49; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Morton N. E., 1982, OUTLINE GENETIC EPID; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; Ott J, 2000, P NATL ACAD SCI USA, V97, P2, DOI 10.1073/pnas.97.1.2; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SHIROISHI T, 1995, ADV BIOPHYS, V31, P119, DOI 10.1016/0065-227X(95)99387-5; Snoek M, 1998, J IMMUNOL, V160, P266; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; SVED J A, 1971, Theoretical Population Biology, V2, P125; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959	34	625	656	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2001	29	2					217	222		10.1038/ng1001-217	http://dx.doi.org/10.1038/ng1001-217			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586303				2022-12-27	WOS:000171374100031
J	MacDonald, TJ; Brown, KM; LaFleur, B; Peterson, K; Lawlor, C; Chen, YD; Packer, RJ; Cogen, P; Stephan, DA				MacDonald, TJ; Brown, KM; LaFleur, B; Peterson, K; Lawlor, C; Chen, YD; Packer, RJ; Cogen, P; Stephan, DA			Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease	NATURE GENETICS			English	Article							CHROMOSOME 17P DELETIONS; DNA-POLYMERASE-DELTA; GENE-EXPRESSION; GROWTH-FACTOR; CHILDHOOD MEDULLOBLASTOMA; MOLECULAR CLASSIFICATION; PROGNOSTIC-SIGNIFICANCE; BRAIN-TUMORS; RECEPTOR; CANCER	Little is known about the genetic regulation of medulloblastoma dissemination, but metastatic medulloblastoma is highly associated with poor outcome. We obtained expression profiles of 23 primary medulloblastomas clinically designated as either metastatic (M+) or non-metastatic (M0) and identified 85 genes whose expression differed significantly between classes. Using a class prediction algorithm based on these genes and a leave-one-out approach, we assigned sample class to these tumors (M+ or M0) with 72% accuracy and to four additional independent tumors with 100% accuracy. We also assigned the metastatic medulloblastoma cell line Daoy to the metastatic class. Notably, platelet-derived growth factor receptor alpha (PDGFRA) and members of the downstream RAS/mitogen-activated protein kinase (MAPK) signal transduction pathway are upregulated in M+ tumors. Immunohistochemical validation on an independent set of tumors shows significant overexpression of PDGFRA in M+ tumors compared to MO tumors. Using in vitro assays, we show that platelet-derived growth factor alpha (PDGFA) enhances medulloblastoma migration and increases downstream MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK1 (p42 MAPK) and MAPK3 (p44 MAPK) phosphorylation in a dose-dependent manner. Neutralizing antibodies to PDGFRA blocks MAP2K1, MAP2K2 and MAPK1/3 phosphorylation, whereas U0126, a highly specific inhibitor of MAP2K1 and MAP2K2, also blocks MAPK1/3. Both inhibit migration and prevent PDGFA-stimulated migration. These results provide the first insight into the genetic regulation of medulloblastoma metastasis and are the first to suggest a role for PDGFRA and the RAS/MAPK signaling pathway in medulloblastoma metastasis. Inhibitors of PDGFRA and RAS proteins should therefore be considered for investigation as possible novel therapeutic strategies against medulloblastoma.	Childrens Natl Med Ctr, Res Ctr Genet Med, Washington, DC 20010 USA; Childrens Natl Med Ctr, Ctr Canc & Transplantat Biol, Washington, DC 20010 USA; George Washington Univ, Dept Genet, Washington, DC USA; Vanderbilt Univ, Dept Prevent Med, Div Biostat, Nashville, TN USA; NHGRI, NIH, Bethesda, MD 20892 USA; Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Neurosurg, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA	Children's National Health System; Children's National Health System; George Washington University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Children's National Health System; Children's National Health System; Children's National Health System	MacDonald, TJ (corresponding author), Childrens Natl Med Ctr, Res Ctr Genet Med, 111 Michigan Ave NW, Washington, DC 20010 USA.		MacDonald, Tobey/D-4554-2013; LaFleur, Bonnie J/GPJ-9592-2022	LaFleur, Bonnie J/0000-0002-4939-9337				Adesina AM, 1999, J CHILD NEUROL, V14, P411, DOI 10.1177/088307389901400701; BATRA SK, 1995, J NEURO-ONCOL, V24, P39, DOI 10.1007/BF01052657; BENDOR A, 2000, AGL200012 AG LABS; Biegel JA, 1997, CLIN CANCER RES, V3, P473; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brown HG, 2000, J NEUROPATH EXP NEUR, V59, P857, DOI 10.1093/jnen/59.10.857; Cillo C, 1996, INT J CANCER, V66, P692, DOI 10.1002/(SICI)1097-0215(19960529)66:5<692::AID-IJC18>3.0.CO;2-6; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELLISON JA, 1994, J NEUROSCI RES, V37, P116, DOI 10.1002/jnr.490370116; Emadian SM, 1996, CLIN CANCER RES, V2, P1559; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; GARSON JA, 1989, BRIT J CANCER, V59, P889, DOI 10.1038/bjc.1989.188; Genda T, 2000, LAB INVEST, V80, P387, DOI 10.1038/labinvest.3780043; GILBERTSON RJ, 1995, BRIT J CANCER, V71, P473, DOI 10.1038/bjc.1995.96; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grotzer MA, 2000, J CLIN ONCOL, V18, P1027, DOI 10.1200/JCO.2000.18.5.1027; Herms J, 2000, INT J CANCER, V89, P395; Huang HT, 2000, CANCER RES, V60, P6868; Khan J, 1999, BIOCHIM BIOPHYS ACTA, V1423, P17; Kim JYH, 1999, CANCER RES, V59, P711; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Markert JM, 2001, PHYSIOL GENOMICS, V5, P21, DOI 10.1152/physiolgenomics.2001.5.1.21; McCarthy MJ, 1998, FEBS LETT, V423, P334, DOI 10.1016/S0014-5793(98)00122-7; Packer RJ, 1999, J CLIN ONCOL, V17, P2127, DOI 10.1200/JCO.1999.17.7.2127; Packer RJ, 1999, ARCH NEUROL-CHICAGO, V56, P421, DOI 10.1001/archneur.56.4.421; Packer RJ, 1999, BRAIN DEV-JPN, V21, P75, DOI 10.1016/S0387-7604(98)00085-0; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Remacle A, 2000, INT J CANCER, V89, P118, DOI 10.1002/(SICI)1097-0215(20000320)89:2<118::AID-IJC3>3.0.CO;2-8; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sunshine C, 2000, EXP CELL RES, V257, P1, DOI 10.1006/excr.2000.4855; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Yao RJ, 1997, J BIOL CHEM, V272, P18261, DOI 10.1074/jbc.272.29.18261; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620; Yu JH, 2000, J BIOL CHEM, V275, P19076, DOI 10.1074/jbc.M910329199; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; ZEITZER PM, 1999, J CLIN ONCOL, V17, P832; Zurawel RH, 2000, GENE CHROMOSOME CANC, V27, P44, DOI 10.1002/(SICI)1098-2264(200001)27:1<44::AID-GCC6>3.0.CO;2-V	38	349	370	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					143	152		10.1038/ng731	http://dx.doi.org/10.1038/ng731			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11544480				2022-12-27	WOS:000171374100019
J	Walley, AJ; Chavanas, S; Moffatt, ME; Esnouf, RM; Ubhi, B; Lawrence, R; Wong, K; Abecasis, GR; Jones, EY; Harper, JL; Hovnanian, A; Cookson, WOCM				Walley, AJ; Chavanas, S; Moffatt, ME; Esnouf, RM; Ubhi, B; Lawrence, R; Wong, K; Abecasis, GR; Jones, EY; Harper, JL; Hovnanian, A; Cookson, WOCM			Gene polymorphism in Netherton and common atopic disease	NATURE GENETICS			English	Article							PARTY DIAGNOSTIC-CRITERIA; GENOME-WIDE SEARCH; SERUM IGE LEVELS; UNDERLYING ASTHMA; LINKAGE; DERMATITIS; CHROMOSOME-11Q; ASSOCIATION; INHIBITOR; RECEPTOR	Atopic dermatitis (AD) and asthma are characterized by IgE-mediated atopic (allergic) responses to common proteins (allergens), many of which are proteinases. Loci influencing atopy have been localized to a number of chromosomal regions', including the chromosome 5q31 cytokine cluster(2-4). Netherton disease is a rare recessive skin disorder in which atopy is a universal accompaniment(5). The gene underlying Netherton disease (SPINK5)(6) encodes a 15-domain serine proteinase inhibitor (LEKTI) which is expressed in epithelial and mucosal surfaces and in the thymus(6,7). We have identified six coding polymorphisms in SPINK5 (Table 1) and found that a Glu420 --> Lys variant shows significant association with atopy and AD in two independent panels of families. Our results implicate a previously unrecognized pathway for the development of common allergic illnesses.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Great Ormond St Hosp Sick Children, Dept Paediat Dermatol, London WC1N 3JH, England	University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Cookson, WOCM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	wocc@well.ox.ac.uk	Hovnanian, Alain/I-4711-2017; Jones, Yvonne/N-8111-2019; Abecasis, Goncalo R/B-7840-2010; Cookson, William/HHC-1790-2022; Walley, Andrew J/D-2573-2009; Chavanas, stephane/K-1183-2014; Jones, Yvonne/J-2293-2016	Hovnanian, Alain/0000-0003-3412-7512; Jones, Yvonne/0000-0002-3834-1893; Walley, Andrew J/0000-0001-7707-7549; Jones, Yvonne/0000-0002-3834-1893; chavanas, stephane/0000-0003-4323-2656; Abecasis, Goncalo/0000-0003-1509-1825				Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; COOKSON WOCM, 1988, LANCET, V1, P86; COOKSON WOCM, 1992, LANCET, V340, P381, DOI 10.1016/0140-6736(92)91468-N; COOKSON WOCM, 1989, LANCET, V1, P1292; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Cox HE, 1998, BRIT J DERMATOL, V138, P182; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Deichmann KA, 1998, CLIN EXP ALLERGY, V28, P151; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; HOLFORDSTREVENS V, 1984, J ALLERGY CLIN IMMUN, V73, P516, DOI 10.1016/0091-6749(84)90363-4; JUDGE MR, 1994, BRIT J DERMATOL, V131, P615, DOI 10.1111/j.1365-2133.1994.tb04971.x; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Martinati LC, 1996, AM J RESP CRIT CARE, V153, P1682, DOI 10.1164/ajrccm.153.5.8630620; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; RAJKA G, 1989, ACTA DERM-VENEREOL, P13; Rosenwasser LJ, 1997, INT ARCH ALLERGY IMM, V113, P61, DOI 10.1159/000237509; Schechter NM, 1998, J CELL PHYSIOL, V176, P365, DOI 10.1002/(SICI)1097-4652(199808)176:2<365::AID-JCP15>3.0.CO;2-2; SHIRAKAWA T, 1994, CLIN GENET, V46, P228; THOMAS WR, 1993, CLIN EXP ALLERGY, V23, P350, DOI 10.1111/j.1365-2222.1993.tb00338.x; Tobe VO, 1996, NUCLEIC ACIDS RES, V24, P3728, DOI 10.1093/nar/24.19.3728; Vorechovsky I, 1999, AM J HUM GENET, V64, P1096, DOI 10.1086/302326; Walley AJ, 2001, GENOMICS, V72, P15, DOI 10.1006/geno.2000.6435; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x	31	283	298	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2001	29	2					175	178		10.1038/ng728	http://dx.doi.org/10.1038/ng728			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11544479				2022-12-27	WOS:000171374100023
J	Podani, J; Oltvai, ZN; Jeong, H; Tombor, B; Barabasi, AL; Szathmary, E				Podani, J; Oltvai, ZN; Jeong, H; Tombor, B; Barabasi, AL; Szathmary, E			Comparable system-level organization of Archaea and Eukaryotes	NATURE GENETICS			English	Article							METABOLIC NETWORKS; DEFINITION; HYPOTHESIS; PATHWAYS; GENES	A central and long-standing issue in evolutionary theory is the origin of the biological variation upon which natural selection acts'. Some hypotheses suggest that evolutionary change represents an adaptation to the surrounding environment within the constraints of an organism's innate characteristics(1-3). Elucidation of the origin and evolutionary relationship of species has been complemented by nucleotide sequence(4) and gene content(5) analyses, with profound implications for recognizing life's major domains(4). Understanding of evolutionary relationships may be further expanded by comparing systemic higher-level organization among species. Here we employ multivariate analyses to evaluate the biochemical reaction pathways characterizing 43 species. Comparison of the information transfer pathways of Archaea and Eukaryotes indicates a close relationship between these domains. In addition, whereas, eukaryotic metabolic enzymes are primarily of bacterial origin(6), the pathway-level organization of archaeal and eukaryotic metabolic networks is more closely related. Our analyses therefore suggest that during the symbiotic evolution of eukaryotes,(7-9) incorporation of bacterial metabolic enzymes into the proto-archaeal proteome was constrained by the host's pre-existing metabolic architecture.	Collegium Budapest, Inst Adv Study, H-1014 Budapest, Hungary; Eotvos Lorand Univ, Dept Plant Taxon & Ecol, H-1117 Budapest, Hungary; Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	Eotvos Lorand University; Northwestern University; University of Notre Dame	Oltvai, ZN (corresponding author), Collegium Budapest, Inst Adv Study, H-1014 Budapest, Hungary.	zno008@northwestern.edu; szathmary@zeus.colbud.hu	Jeong, Hawoong/A-2469-2009; Jeong, Hawoong/C-1587-2011; Szathmary, Eors/AAS-1202-2021; Szathmáry, Eörs/A-5007-2011; Jeong, Hawoong/AAR-2524-2021; Barabasi, Albert-Laszlo/S-6474-2017; Podani, Janos/G-3074-2014	Jeong, Hawoong/0000-0002-2491-8620; Szathmary, Eors/0000-0001-5227-2997; Jeong, Hawoong/0000-0002-2491-8620; Podani, Janos/0000-0002-1452-1486; Barabasi, Albert/0000-0002-4028-3522				Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Brooks DR, 2000, ANN NY ACAD SCI, V901, P257; Darwin C, 1872, ORIGIN SPECIES; Doolittle WE, 1998, TRENDS GENET, V14, P307; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Lawrence JG, 1996, GENETICS, V143, P1843; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MIYATA T, 1991, EVOLUTION OF LIFE, P337; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Penny D, 1999, CURR OPIN GENET DEV, V9, P672, DOI 10.1016/S0959-437X(99)00020-9; Podani J., 2001, SYN TAX 2000 COMPUTE; Podani J., 2000, INTRO EXPLORATION MU; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Sokal R. R., 1973, NUMERICAL TAXONOMY; Szathmary E, 1995, MAJOR TRANSITIONS EV; Tourasse NJ, 1999, MOL PHYLOGENET EVOL, V13, P159, DOI 10.1006/mpev.1999.0675; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; [No title captured]	24	57	61	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					54	56		10.1038/ng708	http://dx.doi.org/10.1038/ng708			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528391	Green Submitted			2022-12-27	WOS:000170781300016
J	Duffy, D; Montgomery, G; Treloar, S; Birley, A; Kirk, K; Boomsma, D; Beem, L; de Geus, E; Slagboom, E; Knighton, J; Reed, P; Martin, N				Duffy, D; Montgomery, G; Treloar, S; Birley, A; Kirk, K; Boomsma, D; Beem, L; de Geus, E; Slagboom, E; Knighton, J; Reed, P; Martin, N			IBD sharing around the PPARG locus is not increased in dizygotic twins or their mothers	NATURE GENETICS			English	Article									Queensland Inst Med Res, Brisbane, Qld 4006, Australia; Free Univ Amsterdam, Amsterdam, Netherlands; TNO, PG, Gaubius Lab, Leiden, Netherlands; Gemini Genom, Cambridge, England	QIMR Berghofer Medical Research Institute; Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research	Duffy, D (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.		Boomsma, Dorret I/AAX-4470-2020; Montgomery, Grant W/B-7148-2008; de Geus, Eco J.C./M-9318-2015; Duffy, David L/B-7392-2013; Slagboom, P. Eline/R-4790-2016	Montgomery, Grant W/0000-0002-4140-8139; de Geus, Eco J.C./0000-0001-6022-2666; Duffy, David L/0000-0001-7227-632X; Slagboom, P. Eline/0000-0002-2875-4723; Martin, Nicholas/0000-0003-4069-8020				Boomsma D I, 2000, Twin Res, V3, P323, DOI 10.1375/136905200320565300; Busjahn A, 2000, NAT GENET, V26, P398, DOI 10.1038/82515; Duffy DL, 1998, AM J RESP CRIT CARE, V157, P840, DOI 10.1164/ajrccm.157.3.9702070; Kirk K M, 2000, Twin Res, V3, P299, DOI 10.1375/136905200320565274; Montgomery GW, 2000, J CLIN ENDOCR METAB, V85, P3391, DOI 10.1210/jc.85.9.3391; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494	6	9	9	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					315	315		10.1038/91074	http://dx.doi.org/10.1038/91074			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479591	Bronze, Green Published			2022-12-27	WOS:000170174800010
J	Kang, YK; Koo, DB; Park, JS; Choi, YH; Chung, AS; Lee, KK; Han, YM				Kang, YK; Koo, DB; Park, JS; Choi, YH; Chung, AS; Lee, KK; Han, YM			Aberrant methylation of donor genome in cloned bovine embryos	NATURE GENETICS			English	Letter							DNA METHYLTRANSFERASE; FETAL FIBROBLASTS; NUCLEAR TRANSFER; PATERNAL GENOME; GERM-CELLS; IN-VITRO; MOUSE; CALVES; DEMETHYLATION; CULTURE	Despite recent successes in cloning various animal species, the use of somatic cells as the source of donor nuclei has raised many practically relevant questions such as increased abortion rates, high birth weight and perinatal death(1-3). These anomalies may be caused by incomplete epigenetic reprogramming of donor DNA. Genome-wide demethylation occurs during early development, 'erasing' gamete-specific methylation patterns inherited from the parents(4-8). This process may be a prerequisite for the formation of pluripotent stem cells that are important for the later development(9), Here, we provide evidence that cloned bovine embryos may have impaired epigenetic reprogramming capabilities. We found highly aberrant methylation patterns in various genomic regions of cloned embryos. Cloned blastocysts closely resembled donor cells in their overall genomic methylation status, which was very different from that of normal blastocysts produced in vitro or in vivo. We found demethylation of the Bov-B long interspersed nuclear element sequence in normal embryos, hut not in cloned embryos, in which the donor-type methylation was simply maintained during preimplantation development. There were also significant variations in the degree of methylation among individual cloned blastocysts. Our findings indicate that the developmental anomalies of cloned embryos could be due to incomplete epigenetic reprogramming of donor genomic DNA.	KRIBB, Anim Dev Biotechnol Lab, Taejon 305600, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST)	Han, YM (corresponding author), KRIBB, Anim Dev Biotechnol Lab, POB 115, Taejon 305600, South Korea.		Han, Yong-Mahn/C-1652-2011					Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; CARLSON LL, 1992, GENE DEV, V6, P2536, DOI 10.1101/gad.6.12b.2536; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Gonzalgo ML, 1997, CANCER RES, V57, P594; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mertineit C, 1998, DEVELOPMENT, V125, P889; MONK M, 1987, DEVELOPMENT, V99, P371; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; RELK W, 1997, GENOMIC INPRINTING; ROSENKRANS CF, 1993, BIOL REPROD, V49, P459, DOI 10.1095/biolreprod49.3.459; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2823, DOI 10.1093/nar/12.6.2823; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Shiga K, 1999, THERIOGENOLOGY, V52, P527, DOI 10.1016/S0093-691X(99)00149-1; Thompson JG, 1998, THERIOGENOLOGY, V49, P1239, DOI 10.1016/S0093-691X(98)00071-5; TSUNODA Y, 1986, J EXP ZOOL, V240, P119, DOI 10.1002/jez.1402400115; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zakhartchenko V, 1999, MOL REPROD DEV, V54, P264, DOI 10.1002/(SICI)1098-2795(199911)54:3&lt;264::AID-MRD7&gt;3.0.CO;2-Y; Zakhartchenko V, 1999, J REPROD FERTIL, V115, P325, DOI 10.1530/jrf.0.1150325	24	423	466	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					173	177		10.1038/88903	http://dx.doi.org/10.1038/88903			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381267				2022-12-27	WOS:000169011800022
J	Arikawa-Hirasawa, E; Wilcox, WR; Le, AH; Silverman, N; Govindraj, P; Hassell, JR; Yamada, Y				Arikawa-Hirasawa, E; Wilcox, WR; Le, AH; Silverman, N; Govindraj, P; Hassell, JR; Yamada, Y			Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene	NATURE GENETICS			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; DENSITY-LIPOPROTEIN-RECEPTOR; ATELOSTEOGENESIS TYPE-II; BASEMENT-MEMBRANES; SPLICING DEFECTS; TRANSPORTER GENE; GROWTH-FACTOR; CORE PROTEIN; CARTILAGE; EXPRESSION	Perlecan is a large heparan sulfate (HS) proteoglycan present in all basement membranes and in some other tissues such as cartilage(1,2), and is implicated in cell growth and differentiation(3-5). Mice lacking the perlecan gene(6,7) (Hspg2) have a severe chondrodysplasia with dyssegmental ossification of the spine and show radiographic, clinical and chondro-osseous morphology similar to a lethal autosomal recessive disorder in humans termed dyssegmental dysplasia, Silverman-Handmaker type (DDSH; MIM 224410). Here we report. a homozygous, 89-bp duplication in exon 34 of HSPG2 in a pair of siblings with DDSH born to consanguineous parents, and heterozygous point mutations in the 5' donor site of intron 52 and in the middle of exon 73 in a third, unrelated patient, causing skipping of the entire exons 52 and 73 of the HSPG2 transcript, respectively. These mutations are predicted to cause a frameshift, resulting in a truncated protein core. The cartilage matrix from these patients stained poorly with antibody specific for perlecan, but there was staining of intracellular inclusion bodies. Biochemically, truncated perlecan was not secreted by the patient fibroblasts, but was degraded to smaller fragments within the cells. Thus, DDSH is caused by a functional null mutation of HSPG2. Our findings demonstrate the critical role of perlecan in cartilage development.	Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Sch Med,Cedars Sinai Burns & Allen Res Inst, Ctr Med Genet Birth Defects, Steven Spielberg Pediat Res Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Dept Obstet & Gynecol,Div Maternal Fetal Med, Los Angeles, CA USA; Shriners Hosp Children, Tampa, FL USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yamada, Y (corresponding author), Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NICHD NIH HHS [5P01 HD22657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALECK KA, 1987, AM J MED GENET, V27, P295, DOI 10.1002/ajmg.1320270208; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Brodie SG, 1998, AM J MED GENET, V80, P247; Brodie SG, 1999, AM J MED GENET, V83, P372, DOI 10.1002/(SICI)1096-8628(19990423)83:5<372::AID-AJMG6>3.0.CO;2-J; Celebi JT, 2000, HUM GENET, V107, P234; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Delot E, 1998, J BIOL CHEM, V273, P26692, DOI 10.1074/jbc.273.41.26692; DODGE GR, 1991, GENOMICS, V10, P673, DOI 10.1016/0888-7543(91)90451-J; GRUBER HE, 1990, SCANNING MICROSCOPY, V4, P775; Hastbacka J, 1996, AM J HUM GENET, V58, P255; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; KALLUNKI P, 1992, J CELL BIOL, V116, P559, DOI 10.1083/jcb.116.2.559; KALLUNKI P, 1991, GENOMICS, V11, P389, DOI 10.1016/0888-7543(91)90147-7; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; Kurima K, 1998, P NATL ACAD SCI USA, V95, P12071; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; SUNDARRAJ N, 1995, J CELL SCI, V108, P2663; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; Westvik J, 1998, PEDIATR RADIOL, V28, P764, DOI 10.1007/s002470050462	29	163	168	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					431	434		10.1038/86941	http://dx.doi.org/10.1038/86941			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279527				2022-12-27	WOS:000167811200020
J	Reboul, J; Vaglio, P; Tzellas, N; Thierry-Mieg, N; Moore, T; Jackson, C; Shin-i, T; Kohara, Y; Thierry-Mieg, D; Thierry-Mieg, J; Lee, H; Hitti, J; Doucette-Stamm, L; Hartley, JL; Temple, GF; Brasch, MA; Vandenhaute, J; Lamesch, PE; Hill, DE; Vidal, M				Reboul, J; Vaglio, P; Tzellas, N; Thierry-Mieg, N; Moore, T; Jackson, C; Shin-i, T; Kohara, Y; Thierry-Mieg, D; Thierry-Mieg, J; Lee, H; Hitti, J; Doucette-Stamm, L; Hartley, JL; Temple, GF; Brasch, MA; Vandenhaute, J; Lamesch, PE; Hill, DE; Vidal, M			Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C-elegans	NATURE GENETICS			English	Letter							CLONING	The genome sequences of Caenorhabditis elegans. Drosophila melanogaster and Arabidopsis thaliana have been predicted to contain 19,000, 13,600 and 25,500 genes, respectively(1-3). Before this information can be fully used for evolutionary and functional studies, several issues need to be addressed. First, the gene number estimates obtained in silico and not yet supported by any experimental data need to be verified. For example, it seems biologically paradoxical that C.elegans would have 50% more genes than Drosophilia. Second, intron/exon predictions need to be tested experimentally. Third, complete sets of open reading frames (ORFs). or "ORFeomes."(4) need to be cloned into various expression vectors. To address these issues simultaneously, we have designed and applied to C. elegans the following strategy. Predicted ORFs are amplified by PCR from a highly representative cDNA library(4) using ORF-specific primers, cloned by Gateway recombination cloning(4-6) and then sequenced to generate ORF sequence tags (OSTs) as a way to verify identity and splicing. In a sample (n=1,222) of the nearly 10,000 genes predicted ab initio (that is, for which no expressed sequence tag (EST) is available so far), at least 70% were verified by OSTs. We also observed that 27% of these experimentally confirmed genes have a structure different from that predicted by GeneFinder. We now have experimental evidence that supports the existence of at least 17,300 genes in C. elegans. Hence we suggest that gene counts based primarily on ESTs may underestimate the number of genes in human and in other organisms.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; IMAG, Lab LSR, St Martin Dheres, France; Res Genet Huntsville, Huntsville, AL USA; Natl Inst Genet, Genome Biol Lab, Mishima, Shizuoka 411, Japan; NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Genome Therapeut Corp, Waltham, MA USA; Life Technol Inc, Rockville, MD USA; Fac Univ Notre Dame Paix, Dept Biol, B-5000 Namur, Belgium	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Thermo Fisher Scientific; University of Namur	Vidal, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	marc_vidal@dfci.harvard.edu	Reboul, Jerome/P-9103-2016; Hill, David E/B-6617-2011; Thierry-Mieg, Nicolas/M-6007-2014; THIERRY-MIEG, Jean/F-1975-2017	Reboul, Jerome/0000-0002-5513-4546; Thierry-Mieg, Nicolas/0000-0002-7667-2853; THIERRY-MIEG, Jean/0000-0002-0396-6789; Vaglio, Philippe/0000-0003-2900-5596; Thierry-Mieg, Danielle/0000-0001-9568-4211	NCI NIH HHS [R21 CA81658 A 01] Funding Source: Medline; NHGRI NIH HHS [R01 HG01715-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA081658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Gopal S, 2001, NAT GENET, V27, P337, DOI 10.1038/85922; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Liang F, 2000, NAT GENET, V26, P501; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X	13	129	129	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					332	336		10.1038/85913	http://dx.doi.org/10.1038/85913			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242119				2022-12-27	WOS:000167304200029
J	Adorini, L				Adorini, L			Interleukin 12 and autoimmune diabetes	NATURE GENETICS			English	Editorial Material							NOD MICE; CYTOKINE; CELLS	Interleukin 12 (IL-12) has been implicated in the pathogenesis of type 1 diabetes in the non-obese diabetic (NOD) mouse. Following this lead, a new locus associated with human type 1 diabetes, IDDM18 has been identified near the gene encoding the p40 subunit of interleukin 12 (IL12B). This finding has potential implications for the prediction of at-risk individuals and, perhaps, for the implementation of prevention strategies relevant to several autoimmune diseases.	Roche Milano Ric, I-20132 Milan, Italy	Roche Holding	Adorini, L (corresponding author), Roche Milano Ric, I-20132 Milan, Italy.		Adorini, Luciano/AAE-5149-2020					Adorini L, 1997, CHEM IMMUNOL, V68, P175; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Benoist C, 1997, CELL, V89, P1, DOI 10.1016/S0092-8674(00)80174-9; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Hultgren B, 1996, DIABETES, V45, P812, DOI 10.2337/diabetes.45.6.812; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Rothe H, 1997, DIABETOLOGIA, V40, P641, DOI 10.1007/s001250050728; Szelachowska M, 1997, HORM METAB RES, V29, P168, DOI 10.1055/s-2007-979014; TREMBLEAU, 2000, J IMMUNOL, V165, P6748; Trembleau S, 1999, J IMMUNOL, V163, P2960; TREMBLEAU S, 1995, J EXP MED, V181, P817, DOI 10.1084/jem.181.2.817; TREMBLEAU S, 1997, EUR J IMMUNOL, V27, P2230; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251	15	40	42	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					131	132		10.1038/84732	http://dx.doi.org/10.1038/84732			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175771				2022-12-27	WOS:000166839200003
J	Zhang, K; Kniazeva, M; Han, M; Li, W; Yu, ZY; Yang, ZL; Li, Y; Metzker, ML; Allikmets, R; Zack, DJ; Kakuk, LE; Lagali, PS; Wong, PW; MacDonald, IM; Sieving, PA; Figueroa, DJ; Austin, CP; Gould, RJ; Ayyagari, R; Petrukhin, K				Zhang, K; Kniazeva, M; Han, M; Li, W; Yu, ZY; Yang, ZL; Li, Y; Metzker, ML; Allikmets, R; Zack, DJ; Kakuk, LE; Lagali, PS; Wong, PW; MacDonald, IM; Sieving, PA; Figueroa, DJ; Austin, CP; Gould, RJ; Ayyagari, R; Petrukhin, K			A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; DISEASE GENE; ABCR; IDENTIFICATION; MEMBRANE; ACID; BIOSYNTHESIS; ELONGATION; MUTATIONS	Stargardt-like macular dystrophy (STGD3, MIM 600110) and autosomal dominant macular dystrophy (adMD) are inherited forms of macular degeneration characterized by decreased visual acuity, macular atrophy and extensive fundus flecks(1-3). Genetic mapping data suggest that mutations in a single gene may be responsible for both conditions, already known to bear clinical resemblance(1-3). Here we limit the minimum genetic region for STGD3 and adMD to a 0.6-cM interval by recombination breakpoint mapping and identify a single 5-bp deletion within the protein-coding region of a new retinal photoreceptor-specific gene, ELOVL4, in all affected members of STGD3 and adMD families. Bioinformatic analysis of ELOVL4 revealed that it has homology to a group of yeast proteins that function in the biosynthesis of Very long chain fatty acids. Our results are therefore the first to implicate the biosynthesis of fatty acids in the pathogenesis of inherited macular degeneration.	Merck Res Labs, Dept Pharmacol, W Point, PA USA; Merck Res Labs, Dept Human Genet, W Point, PA USA; Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA; Univ Colorado, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Columbia Univ, Dept Ophthalmol, New York, NY USA; Columbia Univ, Dept Pathol, New York, NY USA; Univ Michigan, WK Kellogg Eye Ctr, Ann Arbor, MI 48109 USA; Univ Alberta, Dept Sci Biol, Edmonton, AB, Canada; Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada; Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	Merck & Company; Merck & Company; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Columbia University; Columbia University; University of Michigan System; University of Michigan; University of Alberta; University of Alberta; University of Alberta	Petrukhin, K (corresponding author), Merck Res Labs, Dept Pharmacol, W Point, PA USA.		Allikmets, Rando/ABD-4533-2021; Kniazeva, Marina/D-4085-2012; Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697; Petrukhin, Konstantin/0000-0002-5545-6924; MacDonald, Ian/0000-0001-7472-8385; Zack, Don/0000-0002-7966-1973	NEI NIH HHS [EY00401] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Allikmets R, 1999, HUM GENET, V104, P449, DOI 10.1007/s004390050986; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; CINTI DL, 1992, PROG LIPID RES, V31, P1, DOI 10.1016/0163-7827(92)90014-A; Edwards AO, 1999, AM J OPHTHALMOL, V127, P426, DOI 10.1016/S0002-9394(98)00331-6; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Griesinger IB, 2000, INVEST OPHTH VIS SCI, V41, P248; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lagali PS, 2000, CAN J OPHTHALMOL, V35, P315, DOI 10.1016/S0008-4182(00)80059-9; Luthria DL, 1996, J BIOL CHEM, V271, P16020, DOI 10.1074/jbc.271.27.16020; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895; Shah AB, 1997, AM J HUM GENET, V61, P317, DOI 10.1086/514864; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sprecher H, 1995, J LIPID RES, V36, P2471; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; ZHANG K, 1994, ARCH OPHTHALMOL-CHIC, V112, P759, DOI 10.1001/archopht.1994.01090180057035	30	331	348	2	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					89	93		10.1038/83817	http://dx.doi.org/10.1038/83817			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138005				2022-12-27	WOS:000166187900022
J	Kmita, M; Kondo, T; Duboule, D				Kmita, M; Kondo, T; Duboule, D			Targeted inversion of a polar silencer within the HoxD complex re-allocates domains of enhancer sharing	NATURE GENETICS			English	Article							GENE-EXPRESSION; REGULATORY CONTROLS; COLINEARITY; MOUSE; LIMBS; MICE	Mammalian Hox genes are clustered at four genomic loci. During development, neighbouring genes are coordinately regulated by global enhancer sequences, which control multiple genes at once, as exemplified by the expression of series of contiguous Hoxd genes in either limbs or gut. The link between vertebrate Hox gene transcription and their clustered distribution is poorly understood. Experimental and comparative approaches have revealed that various mechanisms, such as gene clustering or global enhancer sequences, might have constrained this genomic organization and stabilized it throughout evolution(1-3) To understand what restricts the effect of a particular enhancer to a precise set of genes, we generated a loxP/Cre-mediated targeted inversion within the HoxD cluster. Mice carrying the inversion showed a reciprocal re-assignment of the limb versus gut regulatory specificities, suggesting the presence of a silencer element with a unidirectional property. This polar silencer appears to limit the number of genes that respond to one type of regulation and thus indicates how separate regulatory domains may be implemented within intricate gene clusters.	Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland	University of Geneva	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland.		kmita, marie/AAU-9620-2020	Kmita, Marie/0000-0003-4021-0478; duboule, denis/0000-0001-9961-2960; jin teng, long/0000-0002-1948-9331				Davis AP, 1996, DEVELOPMENT, V122, P1175; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; Duboule D, 1998, CURR OPIN GENET DEV, V8, P514, DOI 10.1016/S0959-437X(98)80004-X; Dupe V, 1997, DEVELOPMENT, V124, P399; Gerard M, 1996, GENE DEV, V10, P2326, DOI 10.1101/gad.10.18.2326; Goff DJ, 1997, DEVELOPMENT, V124, P627; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; Kmita M, 2000, GENE DEV, V14, P198; Kondo T, 1998, MOL CELL, V1, P289, DOI 10.1016/S1097-2765(00)80029-5; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Mann RS, 1997, BIOESSAYS, V19, P661, DOI 10.1002/bies.950190804; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Peichel CL, 1997, DEVELOPMENT, V124, P3481; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Zakany J, 1999, NATURE, V401, P761, DOI 10.1038/44511; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0	19	59	62	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					451	454		10.1038/82593	http://dx.doi.org/10.1038/82593			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101844				2022-12-27	WOS:000165671700019
J	De Fusco, M; Becchetti, A; Patrignani, A; Annesi, G; Gambardella, A; Quattrone, A; Ballabio, A; Wanke, E; Casari, G				De Fusco, M; Becchetti, A; Patrignani, A; Annesi, G; Gambardella, A; Quattrone, A; Ballabio, A; Wanke, E; Casari, G			The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy	NATURE GENETICS			English	Article							ACETYLCHOLINE-RECEPTOR; CHRNA4 GENE; MUTATION; BETA-2-SUBUNIT; MOUSE		TIGEM, Telethon Inst Genet & Med, Milan, Italy; Univ Milan, Dept Biosci & Biotechnol, Milan, Italy; Natl Res Council, Inst Expt Med & Biotechnol, Cosenza, Italy; Sch Med, Inst Neurol, Catanzaro, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Milan	Casari, G (corresponding author), TIGEM, Telethon Inst Genet & Med, San Raffaele Biomed Sci Pk, Milan, Italy.		Annesi, Grazia/AAX-5732-2020; De Fusco, Maurizio/AAN-7358-2020; Becchetti, Andrea/AAF-7821-2020; Gambardella, Antonio/F-5295-2012; CASARI, Giorgio/J-3070-2018; QUATTRONE, Aldo/A-6734-2016	Becchetti, Andrea/0000-0002-9297-0527; Gambardella, Antonio/0000-0001-7384-3074; CASARI, Giorgio/0000-0002-0115-8980; QUATTRONE, Aldo/0000-0003-2001-957X; BALLABIO, Andrea/0000-0003-1381-4604; Partigiani, Andrea/0000-0001-8019-3911	Telethon [1046, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Buisson B, 1996, J NEUROSCI, V16, P7880; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FLORES CM, 1992, MOL PHARMACOL, V41, P31; GAMBARDELLA A, IN PRESS NEUROLOGY; Hirose S, 1999, NEUROLOGY, V53, P1749, DOI 10.1212/WNL.53.8.1749; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; Phillips HA, 1998, AM J HUM GENET, V63, P1108, DOI 10.1086/302047; Rempel N, 1998, HUM GENET, V103, P645, DOI 10.1007/s004390050885; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Tenchini ML, 1999, SLEEP, V22, P637, DOI 10.1093/sleep/22.5.637	15	333	341	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					275	276						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062464				2022-12-27	WOS:000165176500013
J	Tullio-Pelet, A; Salomon, R; Hadj-Rabia, S; Mugnier, C; de Laet, MH; Chaouachi, B; Bakiri, F; Brottier, P; Cattolico, L; Penet, C; Begeot, M; Naville, D; Nicolino, M; Chaussain, JL; Weissenbach, J; Munnich, R; Lyonnet, S				Tullio-Pelet, A; Salomon, R; Hadj-Rabia, S; Mugnier, C; de Laet, MH; Chaouachi, B; Bakiri, F; Brottier, P; Cattolico, L; Penet, C; Begeot, M; Naville, D; Nicolino, M; Chaussain, JL; Weissenbach, J; Munnich, R; Lyonnet, S			Mutant WD-repeat protein in triple-A syndrome	NATURE GENETICS			English	Article							FAMILIAL GLUCOCORTICOID DEFICIENCY; ALLGROVE SYNDROME; ACHALASIA; GENE; ALACRIMA; MUTATIONS; CARDIA	Triple-A syndrome (MIM 231550; also known as Allgrove syndrome) is an autosomal recessive disorder characterized by adrenocorticotropin hormone (ACTH)-resistant adrenal insufficiency, achalasia of the oesophageal cardia and alacrima(1-3) Whereas several lines of evidence indicate that triple-A syndrome results from the abnormal development of the autonomic nervous system(4-6), late-onset progressive neurological symptoms (including cerebellar ataxia, peripheral neuropathy and mild dementia) suggest that the central nervous system may be involved in the disease as well(7,8). Using fine-mapping based on linkage disequilibrium in North African inbred families, we identified a short ancestral haplotype on chromosome 12q23 (<1 cM), sequenced a BAC contig encompassing the triple-a minimal region and identified a novel gene (AAAS) encoding a protein of 547 amino acids that is mutant in affected individuals. We found five homozygous truncating mutations in unrelated patients and ascribed the founder effect in North African families to a single splice-donor site mutation that occurred more than 2,400 years ago. The predicted product of AAAS, ALADIN (for alacrima-achalasia-adrenal insufficiency neurologic disorder), belongs to the WD-repeat family of regulatory proteins, indicating a new disease mechanism involved in triple-A syndrome. The expression of the gene in both neuroendocrine and cerebral structures points to a role in the normal development of the peripheral and central nervous systems.	Hop Necker Enfants Malad, INSERM U393, Unite Rech Handicaps Genet Enfant, Paris, France; Hop Necker Enfants Malad, Dept Genet, Paris, France; Hop Enfants, Serv Chirurg Pediat, Brussels, Belgium; Hop Enfants, Serv Chirurg Pediat B, Tunis, Tunisia; Hop Bologhine, Serv Endocrinol, Alger, Algeria; Genoscope, Evry, France; CNRS FRE 2231, Evry, France; Hop Debrousse, Serv Endocrinol Infantile, Lyon, France; Hop St Vincent de Paul, Serv Endocrinol Pediat, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Tunis-El-Manar; Hopital d'Enfants; Centre National de la Recherche Scientifique (CNRS); CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Lyonnet, S (corresponding author), Hop Necker Enfants Malad, INSERM U393, Unite Rech Handicaps Genet Enfant, Paris, France.		Naville, Danielle/N-1200-2017; Lyonnet, Stanislas/H-5483-2017	Naville, Danielle/0000-0003-2615-6161; Lyonnet, Stanislas/0000-0001-5426-9417; Hadj-Rabia, Smail/0000-0001-6801-7106				ALLGROVE J, 1978, LANCET, V1, P1284; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; BITTLES AH, 1991, SCIENCE, V252, P789, DOI 10.1126/science.2028254; Burke D T, 1991, Curr Opin Genet Dev, V1, P69, DOI 10.1016/0959-437X(91)80044-M; Chu ML, 1996, J PEDIATR-US, V129, P156, DOI 10.1016/S0022-3476(96)70205-6; CHUMAKOV IM, 1995, NATURE, V377, P175; Clark JS, 1998, HOLOCENE, V8, P19, DOI 10.1191/095968398672501165; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EHRLICH E, 1987, AM J MED GENET, V26, P637; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; GAZARIAN M, 1995, EUR J PEDIATR, V154, P18, DOI 10.1007/BF01972967; GRANT DB, 1992, EUR J PEDIATR, V151, P85, DOI 10.1007/BF01958948; Hadj-Rabia S, 2000, EUR J HUM GENET, V8, P613, DOI 10.1038/sj.ejhg.5200508; HEINRICHS C, 1995, EUR J PEDIATR, V154, P191, DOI 10.1007/BF01954269; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; MOORE PSJ, 1991, CLIN ENDOCRINOL, V34, P107, DOI 10.1111/j.1365-2265.1991.tb00279.x; Naville D, 1996, J CLIN ENDOCR METAB, V81, P1442, DOI 10.1210/jc.81.4.1442; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; Piccolo F, 1996, HUM MOL GENET, V5, P2019, DOI 10.1093/hmg/5.12.2019; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stratakis CA, 1997, P ASSOC AM PHYSICIAN, V109, P478; WEBER A, 1995, HORM RES S1, V44, P5; Weber S, 1996, VIRUS GENES, V12, P5, DOI 10.1007/BF00369995	24	227	243	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					332	335		10.1038/81642	http://dx.doi.org/10.1038/81642			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062474				2022-12-27	WOS:000165176500023
J	Zhu, H; Klemic, JF; Chang, S; Bertone, P; Casamayor, A; Klemic, KG; Smith, D; Gerstein, M; Reed, MA; Snyder, M				Zhu, H; Klemic, JF; Chang, S; Bertone, P; Casamayor, A; Klemic, KG; Smith, D; Gerstein, M; Reed, MA; Snyder, M			Analysis of yeast protein kinases using protein chips	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; SEQUENCE DATABASE; CATALYTIC DOMAIN; GENE; EXPRESSION; COMPLEX; ORGANIZATION; CHECKPOINT; REQUIRES	We have developed a novel protein chip technology that allows the high-throughput analysis of biochemical activities, and used this approach to analyse nearly all of the protein kinases from Saccharomyces cerevisiae. Protein chips are disposable arrays of microwells in silicone elastomer sheets placed on top of microscope slides. The high density and small size of the wells allows for high-throughput batch processing and simultaneous analysis of many individual samples. Only small amounts of protein are required. Of 122 known and predicted yeast protein kinases, 119 were overexpressed and analysed using 17 different substrates and protein chips. We found many novel activities and that a large number of protein kinases are capable of phosphorylating tyrosine. The tyrosine phosphorylating enzymes often share common amino acid residues that lie near the catalytic region. Thus, our study identified a number of novel features of protein kinases and demonstrates that protein chip technology is useful for high-throughput screening of protein biochemical activity.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Elect Engn, New Haven, CT USA; Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	michael.snyder@yale.edu	Casamayor, Antonio/A-3190-2012; Bertone, Paul/A-6600-2013; Bertone, Paul/Z-3734-2019; Reed, Mark/A-9970-2011; Casamayor, Antonio/C-2509-2017	Casamayor, Antonio/0000-0003-2788-7329; Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Reed, Mark/0000-0001-6479-7256; Snyder, Michael/0000-0003-0784-7987				Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; Barker WC, 1999, NUCLEIC ACIDS RES, V27, P39, DOI 10.1093/nar/27.1.39; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Dayhoff M, 1978, ATLAS PROTEIN SEQ ST, P345; de los Santos T, 1999, J BIOL CHEM, V274, P1783, DOI 10.1074/jbc.274.3.1783; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Fields S, 1999, P NATL ACAD SCI USA, V96, P8825, DOI 10.1073/pnas.96.16.8825; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heyman JA, 1999, GENOME RES, V9, P383; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; Holly SP, 1999, J CELL BIOL, V147, P845, DOI 10.1083/jcb.147.4.845; Hudson JR, 1997, GENOME RES, V7, P1169, DOI 10.1101/gr.7.12.1169; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Hunter T., 1991, METHOD ENZYMOL, V200, P33, DOI 10.1016/0076-6879(91)00125-G; Jackman RJ, 1999, LANGMUIR, V15, P2973, DOI 10.1021/la981591y; Jaquenoud M, 1998, EMBO J, V17, P5360, DOI 10.1093/emboj/17.18.5360; Kaouass M, 1997, MOL CELL BIOL, V17, P2994, DOI 10.1128/MCB.17.6.2994; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Malathi K, 1999, GENETICS, V153, P1145; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; MENEES TM, 1992, MOL CELL BIOL, V12, P1340, DOI 10.1128/MCB.12.3.1340; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; MYLIN LM, 1990, METHOD ENZYMOL, V185, P297; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Richman TJ, 1999, J BIOL CHEM, V274, P16861, DOI 10.1074/jbc.274.24.16861; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; Rogers YH, 1999, ANAL BIOCHEM, V266, P23, DOI 10.1006/abio.1998.2857; Sobel SG, 1995, J CELL BIOL, V131, P1775, DOI 10.1083/jcb.131.6.1775; STERN DF, 1991, MOL CELL BIOL, V11, P987, DOI 10.1128/MCB.11.2.987; WEINERT TA, 1993, GENETICS, V134, P63; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347	43	651	745	0	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					283	289		10.1038/81576	http://dx.doi.org/10.1038/81576			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062466				2022-12-27	WOS:000165176500015
J	Lamartine, J; Essenfelder, GM; Kibar, Z; Lanneluc, I; Callouet, E; Laoudj, D; Lemaitre, G; Hand, C; Hayflick, SJ; Zonana, J; Antonarakis, S; Radhakrishna, U; Kelsell, DP; Christianson, AL; Pitaval, A; Der Kaloustian, V; Fraser, C; Blanchet-Bardon, C; Rouleau, GA; Waksman, G				Lamartine, J; Essenfelder, GM; Kibar, Z; Lanneluc, I; Callouet, E; Laoudj, D; Lemaitre, G; Hand, C; Hayflick, SJ; Zonana, J; Antonarakis, S; Radhakrishna, U; Kelsell, DP; Christianson, AL; Pitaval, A; Der Kaloustian, V; Fraser, C; Blanchet-Bardon, C; Rouleau, GA; Waksman, G			Mutations in GJB6 cause hidrotic ectodermal dysplasia	NATURE GENETICS			English	Article							SENSORINEURAL DEAFNESS; DOMINANT DEAFNESS; GENE		Univ Evry, CEA, Lab Genom & Radiobiol Keratinocyte, Serv Genom Fonct,Dept Radiobiol & Radiopathol, Evry, France; McGill Univ, Ctr Res Neurosci, Montreal, PQ H3A 2T5, Canada; Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; Genethon, Evry, France; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Geneva, Switzerland; St Bartholomews & Royal London Hosp, Ctr Cutaneous Res, London, England; Univ Pretoria, Fac Med, Dept Human Genet & Dev Biol, ZA-0002 Pretoria, South Africa; Montreal Childrens Hosp, Div Med Genet, F Clarke Fraser Clin Genet Unit, Montreal, PQ H3H 1P3, Canada; Hop St Louis, Inst Rech Peau, Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; McGill University; McGill University; Oregon Health & Science University; University of Geneva; University of Geneva; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of Pretoria; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Waksman, G (corresponding author), Univ Evry, CEA, Lab Genom & Radiobiol Keratinocyte, Serv Genom Fonct,Dept Radiobiol & Radiopathol, EA 2541, Evry, France.		Kelsell, David P/F-8767-2011; Hand, Collette/GRY-7269-2022; Antonarakis, Stylianos E/N-8866-2014; Lemaître, Gilles/AAL-5889-2021; Lanneluc, Isabelle/N-6646-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; PITAVAL, Amandine/0000-0002-0279-2553; Kelsell, David/0000-0002-9910-7144; Hand, Collette/0000-0003-2348-5058; Lemaitre, Gilles/0000-0002-0898-1582; Lanneluc, Isabelle/0000-0002-7268-3950; Lamartine, Jerome/0000-0003-2322-1618				ANDO Y, 1988, DERMATOLOGICA, V176, P205, DOI 10.1159/000248705; Clouston HR, 1929, CAN MED ASSOC J, V21, P18; Dahl E, 1996, J BIOL CHEM, V271, P17903, DOI 10.1074/jbc.271.30.17903; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kibar Z, 2000, EUR J HUM GENET, V8, P372, DOI 10.1038/sj.ejhg.5200471; Kibar Z, 1996, HUM MOL GENET, V5, P543, DOI 10.1093/hmg/5.4.543; Lamartine J, 2000, BRIT J DERMATOL, V142, P248, DOI 10.1046/j.1365-2133.2000.03292.x; Lamartine J, 2000, GENOMICS, V67, P232, DOI 10.1006/geno.2000.6202; Maestrini E, 1999, HUM MOL GENET, V8, P1237, DOI 10.1093/hmg/8.7.1237; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; WOROBECVICTOR SM, 1988, PEDIAT DERMATOLOGY, P328; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	15	177	192	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					142	144		10.1038/79851	http://dx.doi.org/10.1038/79851			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017065				2022-12-27	WOS:000089638800007
J	Cossette, P; Liu, LD; Brisebois, K; Dong, HH; Lortie, A; Vanasse, M; Saint-Hilaire, JM; Carmant, L; Verner, A; Lu, WY; Wang, YT; Rouleau, GA				Cossette, P; Liu, LD; Brisebois, K; Dong, HH; Lortie, A; Vanasse, M; Saint-Hilaire, JM; Carmant, L; Verner, A; Lu, WY; Wang, YT; Rouleau, GA			Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy	NATURE GENETICS			English	Article							NEURONAL SODIUM-CHANNEL; FEBRILE SEIZURES PLUS; GENERALIZED EPILEPSY; GABA(A) RECEPTORS; SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; CHROMOSOME-6; CHILDHOOD; GENE; GAMMA-2-SUBUNIT	Although many genes that predispose for epilepsy in humans have been determined, those that underlie the classical syndromes of idiopathic generalized epilepsy (IGE) have yet to be identified. We report that an Ala322Asp mutation in GABRA1, encoding the alpha1 subunit of the gamma-aminobutyric acid receptor subtype A (GABA(A)), is found in affected individuals of a large French Canadian family with juvenile myoclonic epilepsy. Compared with wildtype receptors, GABA(A) receptors that contain the mutant subunit show a lesser amplitude of GABA-activated currents in vitro, indicating that seizures may result from loss of function of this inhibitory ligand-gated channel. Our results confirm that mutation of GABRA1 predisposes towards a common idiopathic generalized epilepsy syndrome in humans.	McGill Univ, Ctr Hlth, Inst Res, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada; Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ British Columbia, Vancouver Hosp, Res Ctr, Dept Med & Brain, Vancouver, BC, Canada; Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada; Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; Univ Toronto, Dept Physiol, Toronto, ON, Canada; Hop St Justine, Neurol Serv, Montreal, PQ, Canada; Univ Montreal, Ctr Hosp, Hop Notre Dame, Serv Neurol, Montreal, PQ, Canada; McGill Univ, Montreal Gen Hosp, Montreal Genome Ctr, Montreal, PQ, Canada	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Universite de Montreal; Universite de Montreal; McGill University	Rouleau, GA (corresponding author), McGill Univ, Ctr Hlth, Inst Res, Neurosci Res Ctr, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.		Wang, Yu Tian/J-8255-2015; Wang, Yu Tian/A-4729-2008; Lu, Wei-Yang/K-4404-2013	Liu, Lidong/0000-0002-7026-690X				ANNEGERS JF, 1982, NEUROLOGY, V32, P174, DOI 10.1212/WNL.32.2.174; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Berkovic SF, 1998, ANN NEUROL, V43, P435, DOI 10.1002/ana.410430405; BERKOVIC SF, 1987, NEUROLOGY, V37, P993, DOI 10.1212/WNL.37.6.993; DOOSE H, 1973, NEUROPADIATRIE, V4, P162, DOI 10.1055/s-0028-1091737; EEGOLOFSSON O, 1971, NEUROPADIATRIE, V2, P375, DOI 10.1055/s-0028-1091791; Elmslie FV, 1996, AM J HUM GENET, V59, P653; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; GENTON P, 1994, IDIOPATHIC GEN EPILE, pCH22; Greenberg DA, 2000, AM J HUM GENET, V66, P508, DOI 10.1086/302763; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; JANZ D, 1997, EPILEPSY COMPREHENSI, V3, pCH228; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lu WY, 1998, J PHYSIOL-LONDON, V512, P29, DOI 10.1111/j.1469-7793.1998.029bf.x; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; PANAYIOTOPOULOS CP, 1989, ANN NEUROL, V25, P440, DOI 10.1002/ana.410250504; Picard F, 2000, BRAIN, V123, P1247, DOI 10.1093/brain/123.6.1247; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; Wolfe B. E., 1992, J PSYCHOTHERAPY INTE, V2, P29; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs	30	443	466	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					184	189		10.1038/ng885	http://dx.doi.org/10.1038/ng885			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	11992121				2022-12-27	WOS:000175903500016
J	Bamforth, SD; Braganca, J; Eloranta, JJ; Murdoch, JN; Marques, FIR; Kranc, KR; Farza, H; Henderson, DJ; Hurst, HC; Bhattacharya, S				Bamforth, SD; Braganca, J; Eloranta, JJ; Murdoch, JN; Marques, FIR; Kranc, KR; Farza, H; Henderson, DJ; Hurst, HC; Bhattacharya, S			Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR AP-2; RUBINSTEIN-TAYBI-SYNDROME; GENE-EXPRESSION; MOUSE EMBRYOGENESIS; BINDING-PROTEIN; MUTATIONS; ERBB3; MRG1; TUBE; CBP	The protein EP300 and its paralog CREBBP (CREB-binding protein) are ubiquitously expressed transcriptional co-activators and histone acetyl transferases'. The gene EP300 is essential for normal cardiac and neural development, whereas CREBBP is essential for neurulation, hematopoietic differentiation, angiogenesis and skeletal and cardiac development(2-5). Mutations in CREBBP cause Rubinstein-Taybi syndrome, which is characterized by mental retardation, skeletal abnormalities and congenital cardiac defects(6,7). The CBP/p300-interacting transactivator with ED-rich tail 2 (CITED2) binds EP300 and CREBBP with high affinity(8) and regulates gene transcription(8-10). Here we show that Cited2(-/-) embryos die with cardiac malformations, adrenal agenesis, abnormal cranial ganglia and exencephaly. The cardiac defects include atrial and ventricular septal defects, overriding aorta, double-outlet right ventricle, persistent truncus arteriosus and right-sided aortic arches. We find increased apoptosis in the midbrain region and a marked reduction in ErbB3-expressing neural crest cells in mid-embryogenesis. We show that CITED2 interacts with and co-activates all isoforms of transcription factor AP-2 (TFAP2). Transactivation by TFAP2 isoforms is defective in Cited2(-/-) embryonic fibroblasts and is rescued by ectopically expressed CITED2. As certain Tfap2 isoforms are essential in neural crest, neural tube and cardiac development(11-13), we propose that abnormal embryogenesis in mice lacking Cited2 results, at least in part, from its role as a Tfap2 co-activator.	Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX3 7BN, England; Hammersmith Hosp, Imperial Canc Res Fund, Mol Oncol Unit, London, England; Inst Child Hlth, Neural Dev Unit, London, England	University of Oxford; Wellcome Centre for Human Genetics; Cancer Research UK; Imperial College London; University of London; University College London	Bhattacharya, S (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Roosevelt Dr, Oxford OX3 7BN, England.		Braganca, Jose/F-4410-2012; Kranc, Kamil/B-3449-2009; Bamforth, Simon David/I-1277-2019; Bhattacharya, Shoumo/F-4127-2010	Braganca, Jose/0000-0001-9566-400X; Bamforth, Simon David/0000-0002-5666-4485; Bhattacharya, Shoumo/0000-0002-5571-0478; Henderson, Deborah/0000-0002-2705-5998				Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bosher JM, 1996, ONCOGENE, V13, P1701; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Glenn DJ, 1999, J BIOL CHEM, V274, P36159, DOI 10.1074/jbc.274.51.36159; Goodman RH, 2000, GENE DEV, V14, P1553; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Kung AL, 2000, GENE DEV, V14, P272; Le Douarin NM, 1999, NEURAL CREST, V2; LOO DT, 1989, CELL GROWTH CELL DIV, P17; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Moser M, 1997, DEV DYNAM, V208, P115, DOI 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5; Oike Y, 1999, BLOOD, V93, P2771; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Shioda T, 1997, GENE, V204, P235, DOI 10.1016/S0378-1119(97)00551-9; SKINNER A, 1993, ONCOGENE, V8, P3393; STEVENS CA, 1995, AM J MED GENET, V59, P346, DOI 10.1002/ajmg.1320590313; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	30	253	268	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					469	474		10.1038/ng768	http://dx.doi.org/10.1038/ng768			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11694877				2022-12-27	WOS:000172507500025
J	Leegwater, PAJ; Vermeulen, G; Konst, AAM; Naidu, S; Mulders, J; Visser, A; Kersbergen, P; Mobach, D; Fonds, D; van Berkel, CGM; Lemmers, RJLF; Frants, RR; Oudejans, CBM; Schutgens, RBH; Pronk, JC; van der Knaap, MS				Leegwater, PAJ; Vermeulen, G; Konst, AAM; Naidu, S; Mulders, J; Visser, A; Kersbergen, P; Mobach, D; Fonds, D; van Berkel, CGM; Lemmers, RJLF; Frants, RR; Oudejans, CBM; Schutgens, RBH; Pronk, JC; van der Knaap, MS			Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter	NATURE GENETICS			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; GLYCOGEN-SYNTHASE KINASE-3; SIGNAL-TRANSDUCTION; EPSILON-SUBUNIT; IDENTIFICATION; EIF2B-EPSILON; INACTIVATION; DOMAINS; INSULIN; YEAST	Leukoencephalopathy with vanishing white matter (VWM) is an inherited brain disease that occurs mainly in children. The course is chronic-progressive with additional episodes of rapid deterioration following febrile infection or minor head trauma. We have identified mutations in EIF2B5 and EIF2B2, encoding the epsilon- and beta -subunits of the translation initiation factor eIF2B and located on chromosomes 3q27 and 14q24, respectively, as causing VWM. We found 16 different mutations in EIF2B5 in 29 patients from 23 families. We also found two distantly related individuals who were homozygous with respect to a missense mutation in EIF2B2, affecting a conserved amino acid. Three other patients also had mutations in EIF2B2. As eIF2B has an essential role in the regulation of translation under different conditions, including stress, this may explain the rapid deterioration of people with VWM under stress. Mutant translation initiation factors have not previously been implicated in disease.	Free Univ Amsterdam, Med Ctr, Dept Human Genet, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Clin Chem, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1081 BT Amsterdam, Netherlands; Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA; Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Kennedy Krieger Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Pronk, JC (corresponding author), Free Univ Amsterdam, Med Ctr, Dept Human Genet, Van Der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.			Leegwater, Peter/0000-0002-4100-015X; Oudejans, Cees/0000-0003-0717-4946				Anthony TG, 2000, BBA-GENE STRUCT EXPR, V1492, P56, DOI 10.1016/S0167-4781(00)00062-2; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; Clemens MJ, 1996, TRANSLATIONAL CONTRO, P139; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; HANEFELD F, 1993, NEUROPEDIATRICS, V24, P244, DOI 10.1055/s-2008-1071551; HINNEBUSCH AG, 1996, TRANSLATIONAL CONTRO, P194; Kleijn M, 1998, EUR J BIOCHEM, V253, P531, DOI 10.1046/j.1432-1327.1998.2530531.x; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Price NT, 1996, BIOCHEM J, V318, P637, DOI 10.1042/bj3180637; Quevedo C, 2000, J BIOL CHEM, V275, P19192, DOI 10.1074/jbc.M000238200; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Scheper GC, 1997, J BIOL CHEM, V272, P26850, DOI 10.1074/jbc.272.43.26850; Scheper GC, 1998, BIOCHEM J, V334, P463, DOI 10.1042/bj3340463; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Singh LP, 1996, BIOCHEMISTRY-US, V35, P3206, DOI 10.1021/bi9522099; van der Knaap MS, 1998, NEUROLOGY, V51, P540, DOI 10.1212/WNL.51.2.540; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2	23	285	303	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					383	388		10.1038/ng764	http://dx.doi.org/10.1038/ng764			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11704758				2022-12-27	WOS:000172507500012
J	Ando, H; Furuta, T; Tsien, RY; Okamoto, H				Ando, H; Furuta, T; Tsien, RY; Okamoto, H			Photo-mediated gene activation using caged RNA/DNA in zebrafish embryos	NATURE GENETICS			English	Article							TRANSGENIC ZEBRAFISH; EXPRESSION; BOUNDARY; BRAIN	We report a new and simple technique for photo-mediated temporal and spatial control of gene activation in zebrafish embryos as an alternative to the gene 'knockdown' approach using antisense, morpholino-modified oligonucleotides (morpholinos). The synthetic compound 6-bromo-4-diazomethyl-7-hydroxycoumarin (Bhc-diazo) forms a covalent bond with the phosphate moiety of the sugar-phosphate backbone of RNA, a process known as caging. The 6-bromo-7-hydroxycoumarin-4-ylmethyl (Bhc) group binds to approximately 30 sites on the phosphate moieties per 1 kb of RNA sequence. Bhc-caged mRNA undergoes photolysis (uncaging) when exposed to long-wave ultraviolet light (350 to 365 nm). We show that Bhc-caged green fluorescent protein (Gfp) mRNA has severely reduced translational activity in vitro, whereas illumination of Bhc-caged mRNA with ultraviolet light leads to partial recovery of translational activity. Bhc-caged mRNA is highly stable in zebrafish embryos. in embryos injected with Bhc-caged Gfp mRNA at the one-cell stage, GFP protein expression and fluorescence is specifically induced by ultraviolet light. We also show that, consistent with results obtained using other methods, uncaging eng2a (which encodes the, transcription factor Engrailed2a) in the head region during early development causes a severe reduction in the size of the eye and enhanced development of the midbrain and the midbrain-hindbrain boundary at the expense of the forebrain.	RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Dev Gene Regulat, Wako, Saitama 3510198, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Chuo Ku, Tokyo 1030027, Japan; Toho Univ, Dept Biomol Sci, Chiba 2748510, Japan; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	RIKEN; Japan Science & Technology Agency (JST); Toho University; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Okamoto, H (corresponding author), RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Dev Gene Regulat, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hitoshi@brain.riken.go.jp	Furuta, Toshiaki/F-1363-2011; Okamoto, Hitoshi/P-9767-2015	Furuta, Toshiaki/0000-0001-8532-1775; Okamoto, Hitoshi/0000-0002-7512-8549	NINDS NIH HHS [NS27177] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araki I, 1999, DEVELOPMENT, V126, P5127; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Cambridge SB, 1997, SCIENCE, V277, P825, DOI 10.1126/science.277.5327.825; Chaulk SG, 1998, NUCLEIC ACIDS RES, V26, P3173, DOI 10.1093/nar/26.13.3173; Cruz FG, 2000, J AM CHEM SOC, V122, P8777, DOI 10.1021/ja001804h; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; DRIEVER W, 1994, TRENDS GENET, V10, P152, DOI 10.1016/0168-9525(94)90091-4; EKKER M, 1992, DEVELOPMENT, V116, P1001; FJOSE A, 1992, MECH DEVELOP, V39, P51, DOI 10.1016/0925-4773(92)90025-F; Furuta T, 1998, Methods Enzymol, V291, P50; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Furuta T., 2000, USA Patent, Patent No. [0031588, WO/00/31588]; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; ITO K, 1983, CHEM PHARM BULL, V31, P3014; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kikuchi Y, 1997, NEURON, V18, P369, DOI 10.1016/S0896-6273(00)81239-8; KIMMEL CB, 1993, ANNU REV NEUROSCI, V16, P707, DOI 10.1146/annurev.ne.16.030193.003423; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; MARCH J, 1992, ADV ORG CHEM, P385; Miller JH., 1972, EXPT MOL GENETICS; Monroe WT, 1999, J BIOL CHEM, V274, P20895, DOI 10.1074/jbc.274.30.20895; MORI H, 1994, MOL BRAIN RES, V27, P221, DOI 10.1016/0169-328X(94)90004-3; MORITA T, 1995, NEUROSCI LETT, V198, P131, DOI 10.1016/0304-3940(95)11988-9; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Reifers F, 1998, DEVELOPMENT, V125, P2381; Ristoratore F, 1999, DEVELOPMENT, V126, P3769; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; SCHULTEMERKER S, 1995, ZEBRAFISH BOOK GUIDE; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; WALKER JW, 1989, METHOD ENZYMOL, V172, P288; Wilson Stephen W., 1992, Current Opinion in Neurobiology, V2, P9, DOI 10.1016/0959-4388(92)90154-D; Wulfman D.S., 1978, CHEM ISTRY DIAZONIUM, P821	39	295	308	1	85	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					317	325		10.1038/ng583	http://dx.doi.org/10.1038/ng583			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479592				2022-12-27	WOS:000170174800011
J	Shao, CS; Stambrook, PJ; Tischfield, JA				Shao, CS; Stambrook, PJ; Tischfield, JA			Mitotic recombination is suppressed by chromosomal divergence in hybrids of distantly related mouse strains	NATURE GENETICS			English	Letter							IN-VIVO LOSS; NEUROFIBROMATOSIS TYPE-1; HETEROZYGOUS MICE; ESCHERICHIA-COLI; CANCER; MAP; PREDISPOSITION; POLYMORPHISMS; DEPENDENCE; HOMOLOGY	Mitotic recombination occurs with high frequency in humans(1,2) and mice(3). It leads to loss of heterozygosity (LOH) at important gene loci and can cause disease(4-7). However, the genetic modulators of mitotic recombination are not well understood. As recombination depends on a high level of nucleotide sequence homology(8-12), we postulate that the frequency of somatic variants derived from mitotic recombination should be diminished in progeny from crosses between strains of mice in which nucleotide sequences have diverged. Here we report that mitotic recombination is suppressed, to various degrees in different tissues, in hybrids of distantly related mouse strains. Reintroduction of greater chromosomal homology by backcrossing restores mitotic recombination in offspring. Thus, chromosomal divergence inhibits mitotic recombination and, consequently, may act as a modifier of cancer susceptibility by limiting the rate of LOH. The suppression of mitotic recombination in some F-1 hybrids in which meiotic recombination persists indicates that these processes are differentially affected by chromosomal divergence.	Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA	Rutgers State University New Brunswick; University System of Ohio; University of Cincinnati	Shao, CS (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA.		Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342; Tischfield, Jay/0000-0003-3217-8287	NIDDK NIH HHS [R01DK38185] Funding Source: Medline; NIEHS NIH HHS [P01ES05652] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005652] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Chen WL, 1999, GENETICS, V151, P1299; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; Datta A, 1997, P NATL ACAD SCI USA, V94, P9757, DOI 10.1073/pnas.94.18.9757; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Engle SJ, 1996, P NATL ACAD SCI USA, V93, P5307, DOI 10.1073/pnas.93.11.5307; Gupta PK, 1997, CANCER RES, V57, P1188; Hagstrom SA, 1999, P NATL ACAD SCI USA, V96, P2952, DOI 10.1073/pnas.96.6.2952; Holt D, 1999, AM J HUM GENET, V65, P1423, DOI 10.1086/302614; LASKO D, 1991, ANNU REV GENET, V25, P281, DOI 10.1146/annurev.ge.25.120191.001433; Liang L, 2000, ENVIRON MOL MUTAGEN, V35, P150, DOI 10.1002/(SICI)1098-2280(2000)35:2<150::AID-EM10>3.3.CO;2-S; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Qian F, 1997, AM J HUM GENET, V61, P1000, DOI 10.1086/301618; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; Shao CS, 2000, P NATL ACAD SCI USA, V97, P7405, DOI 10.1073/pnas.97.13.7405; Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230; SHEN P, 1986, GENETICS, V112, P441; Van Sloun PPH, 1998, NUCLEIC ACIDS RES, V26, P4888, DOI 10.1093/nar/26.21.4888; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350	24	54	55	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					169	172		10.1038/88897	http://dx.doi.org/10.1038/88897			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381266				2022-12-27	WOS:000169011800021
J	Wallace, RH; Marini, C; Petrou, S; Harkin, LA; Bowser, DN; Panchal, RG; Williams, DA; Sutherland, GR; Mulley, JC; Scheffer, IE; Berkovic, SF				Wallace, RH; Marini, C; Petrou, S; Harkin, LA; Bowser, DN; Panchal, RG; Williams, DA; Sutherland, GR; Mulley, JC; Scheffer, IE; Berkovic, SF			Mutant GABA(A) receptor gamma 2-subunit in childhood absence epilepsy and febrile seizures	NATURE GENETICS			English	Article							IDIOPATHIC GENERALIZED EPILEPSIES; POTASSIUM CHANNEL GENE; SUBUNIT; LINKAGE; MUTATION; ASSOCIATION; CLUSTER	Epilepsies affect at least 2% of the population at some time in life, and many forms have genetic determinants(1,2). We have found a mutation in a gene encoding a GABA, receptor subunit in a large family with epilepsy. The two main phenotypes were childhood absence epilepsy (CAE) and febrile seizures (FS), There is a recognized genetic: relationship between FS and CAE, yet the two syndromes have different ages of onset, and the physiology of absences and convulsions is distinct. This suggests the mutation has age-dependent effects on different neuronal networks that influence the expression of these clinically distinct, but genetically related, epilepsy phenotypes. We found that the mutation in GABRG2 (encoding the gamma2-subunit) abolished in vitro sensitivity to diazepam, raising the possibility that endozepines do in fact exist and have a physiological role in preventing seizures.	Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, Adelaide, SA, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Univ Adelaide, Dept Genet, Adelaide, SA, Australia; Univ Melbourne, Austin & Repatriat Med Ctr, Epilepsy Res Inst, Heidelberg, Vic, Australia; Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med Neurol, Heidelberg, Vic, Australia; Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia	Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne	Wallace, RH (corresponding author), Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, Adelaide, SA, Australia.	rwallace@wch.bionomics.com.au	Scheffer, Ingrid E/G-1668-2013; jiang, yu/HGU-0029-2022; Sutherland, Grant Robert/D-2606-2012; Marini, Carla/AAC-2413-2022; Petrou, Steven/M-8332-2013; Panchal, Rekha/None	Scheffer, Ingrid E/0000-0002-2311-2174; Marini, Carla/0000-0002-9212-2691; Berkovic, Samuel/0000-0003-4580-841X; Petrou, Steven/0000-0002-4960-6375; Bowser, David/0000-0002-8974-9442; Wallace, Robyn/0000-0001-6141-3317; Panchal, Rekha/0000-0001-8621-9078				[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BIANCHI A, 1993, EPILEPSIA, V34, P819; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BROOKSKAYAL AR, 1993, ANN NEUROL, V34, P687, DOI 10.1002/ana.410340511; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; De Fusco M, 2000, NAT GENET, V26, P275; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Feucht M, 1999, BIOL PSYCHIAT, V46, P997, DOI 10.1016/S0006-3223(99)00039-6; Fong GCY, 1998, AM J HUM GENET, V63, P1117, DOI 10.1086/302066; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Knudsen FU, 2000, EPILEPSIA, V41, P2, DOI 10.1111/j.1528-1157.2000.tb01497.x; Kucken AM, 2000, MOL PHARMACOL, V57, P932; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Olsen RW, 1997, EPILEPSIA, V38, P399, DOI 10.1111/j.1528-1157.1997.tb01728.x; Sander T, 1999, AM J MED GENET, V88, P305, DOI 10.1002/(SICI)1096-8628(19990820)88:4<305::AID-AJMG5>3.0.CO;2-X; Sander T, 1997, ACTA NEUROL SCAND, V96, P1; Sander T, 1996, EPILEPSY RES, V23, P235, DOI 10.1016/0920-1211(95)00098-4; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Scheffer IE, 2000, CURR OPIN PEDIATR, V12, P536, DOI 10.1097/00008480-200012000-00004; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Snead O C 3rd, 1999, Adv Neurol, V79, P253; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252	27	622	664	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					49	52		10.1038/ng0501-49	http://dx.doi.org/10.1038/ng0501-49			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326275				2022-12-27	WOS:000168413300015
J	Wakamatsu, N; Yamada, Y; Yamada, K; Ono, T; Nomura, N; Taniguchi, H; Kitoh, H; Mutoh, N; Yamanaka, T; Mushiake, K; Kato, K; Sonta, S; Nagaya, M				Wakamatsu, N; Yamada, Y; Yamada, K; Ono, T; Nomura, N; Taniguchi, H; Kitoh, H; Mutoh, N; Yamanaka, T; Mushiake, K; Kato, K; Sonta, S; Nagaya, M			Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease	NATURE GENETICS			English	Article							GOLDBERG-SHPRINTZEN-SYNDROME; MENTAL-RETARDATION; UNUSUAL FACE; FAMILY	Hirschsprung disease (HSCR) is sometimes associated with a set of characteristics including mental retardation, microcephaly, and distinct facial features(1-3), but the gene mutated in this condition has not yet been identified. Here we report that mutations in SIP1, encoding Smad interacting protein-1, cause disease in a series of cases. SIP1 is located in the deleted segment at 2q22 from a patient with a de novo t(2;13)(q22;q22) translocation, SIP1 seems to have crucial roles in normal embryonic neural and neural crest development.	Aichi Human Serv Ctr, Cent Hosp, Dept Genet, Inst Dev Res, Aichi, Japan; Aichi Human Serv Ctr, Cent Hosp, Dept Biochem, Inst Dev Res, Aichi, Japan; Aichi Human Serv Ctr, Cent Hosp, Dept Pediat, Aichi, Japan; Aichi Human Serv Ctr, Cent Hosp, Dept Pediat Surg, Aichi, Japan; Toki Gen Hosp, Dept Pediat, Gifu, Japan		Wakamatsu, N (corresponding author), Aichi Human Serv Ctr, Cent Hosp, Dept Genet, Inst Dev Res, Aichi, Japan.		Kitoh, Hiroshi/AAC-2093-2021; KITOH, Hiroshi/I-7256-2014; Ono, Takao/C-6065-2017	Ono, Takao/0000-0002-0498-8293; Nobuaki, Wakamatsu/0000-0003-1956-8977; Yamada, Kenichiro/0000-0003-0486-284X; Wakamatsu, Nobuaki/0000-0001-5693-2227				Brooks AS, 1999, J MED GENET, V36, P485; Eisaki A, 2000, BIOCHEM BIOPH RES CO, V271, P151, DOI 10.1006/bbrc.2000.2545; Fryer AE, 1998, CLIN DYSMORPHOL, V7, P97, DOI 10.1097/00019605-199804000-00003; GOLDBERG RB, 1981, J CRAN GENET DEV BIO, V1, P185; HALAL F, 1990, AM J MED GENET, V37, P106, DOI 10.1002/ajmg.1320370125; Hofstra RMW, 1999, AM J HUM GENET, V64, P304, DOI 10.1086/302184; HURST JA, 1988, J MED GENET, V25, P494, DOI 10.1136/jmg.25.7.494; KUMASAKA K, 1988, AM J MED GENET, V31, P465, DOI 10.1002/ajmg.1320310227; Lurie I. W., 1994, Genetic Counseling, V5, P11; Mowat DR, 1998, J MED GENET, V35, P617, DOI 10.1136/jmg.35.8.617; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; TANAKA H, 1993, PEDIATR NEUROL, V9, P479, DOI 10.1016/0887-8994(93)90029-C; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; YOMO A, 1991, AM J MED GENET, V41, P188, DOI 10.1002/ajmg.1320410211	15	235	243	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					369	370		10.1038/86860	http://dx.doi.org/10.1038/86860			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279515				2022-12-27	WOS:000167811200008
J	Bejaoui, K; Wu, CY; Sheffler, MD; Haan, G; Ashby, P; Wu, LC; de Jong, P; Brown, RH				Bejaoui, K; Wu, CY; Sheffler, MD; Haan, G; Ashby, P; Wu, LC; de Jong, P; Brown, RH			SPTLC1 is mutated in hereditary sensory neuropathy, type 1	NATURE GENETICS			English	Letter							SPHINGOLIPID SYNTHESIS; AUTONOMIC NEUROPATHY; GENE; FAMILY; LINKAGE; ENZYME; MOTOR	Hereditary sensory neuropathy type 1 (HSN1, MIM 162400; ref. 1) genetically maps to chromosome 9q22 (refs. 2-4). We report here that the gene encoding a sub-unit of serine palmitoyltransferase is located within the HSN1 locus, expressed in dorsal root ganglia (DRG) and mutated in HSN1.	Massachusetts Gen Hosp E, CB Day Lab Neuromuscular Res, Charlestown, MA USA; Toronto Western Hosp, Neuromuscular Clin, Toronto, ON M5T 2S8, Canada; Pfizer Lab Mol Genet, Alameda, CA USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Pfizer	Brown, RH (corresponding author), Massachusetts Gen Hosp E, CB Day Lab Neuromuscular Res, Charlestown, MA USA.							Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Auer-Grumbach M, 2000, NEUROLOGY, V54, P45, DOI 10.1212/WNL.54.1.45; Bejaoui K, 1999, NEUROLOGY, V52, P510, DOI 10.1212/WNL.52.3.510; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Dubourg O, 2000, MUSCLE NERVE, V23, P1508, DOI 10.1002/1097-4598(200010)23:10<1508::AID-MUS6>3.0.CO;2-D; Dyck P. J., 1993, PERIPHERAL NEUROPATH, V3rd, P1065; Ferdinandusse S, 2000, NAT GENET, V24, P188, DOI 10.1038/72861; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; JESTICO JV, 1985, J NEUROL NEUROSUR PS, V48, P1259, DOI 10.1136/jnnp.48.12.1259; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; KWON JM, 1995, AM J HUM GENET, V57, P853; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Nicholson GA, 1996, NAT GENET, V13, P101, DOI 10.1038/ng0596-101; SARAIVA MJM, 1983, T ASSOC AM PHYSICIAN, V96, P261; Shivji ZM, 1999, MUSCLE NERVE, V22, P1283, DOI 10.1002/(SICI)1097-4598(199909)22:9<1283::AID-MUS19>3.0.CO;2-#; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x	18	211	220	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					261	262		10.1038/85817	http://dx.doi.org/10.1038/85817			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242106				2022-12-27	WOS:000167304200016
J	Kaessmann, H; Wiebe, V; Weiss, G; Paabo, S				Kaessmann, H; Wiebe, V; Weiss, G; Paabo, S			Great ape DNA sequences reveal a reduced diversity and an expansion in humans	NATURE GENETICS			English	Article							MITOCHONDRIAL; RECOMBINATION; CHIMPANZEES; EVOLUTION; REGION	The extent of DNA sequence Variation of chimpanzees is several-fold greater than that of humans'. It is unclear, however, if humans or chimpanzees are exceptional among primates in having low and high amounts of DNA sequence diversity, respectively. To address this, we have determined approximately 10,000 bp of noncoding DNA sequences at Xq13.3 (which has been extensively studied in both humans and chimpanzees(1,2)) from 10 western lowland gorillas (Gorilla gorilla gorilla) and 1 mountain gorilla (Gorilla gorilla beringei; that is, from 2 of the 3 currently recognized gorilla subspecies'), as well as 8 Bornean (Pongo pygmaeus pygmaeus) and 6 Sumatran (Pongo pygmaeus abelii) orang-utans. representing both currently recognized orangutan subspecies(4). We show that humans differ from the great apes in having a low level of genetic Variation and a signal of population expansion.	Max Planck Inst Evolut Anthropol, Leipzig, Germany	Max Planck Society	Paabo, S (corresponding author), Max Planck Inst Evolut Anthropol, Leipzig, Germany.		Kaessmann, Henrik/B-4989-2013	Kaessmann, Henrik/0000-0001-7563-839X				Deinard A, 1999, J HUM EVOL, V36, P687, DOI 10.1006/jhev.1999.0298; Deinard AS, 2000, AM J PHYS ANTHROPOL, V111, P25, DOI 10.1002/(SICI)1096-8644(200001)111:1<25::AID-AJPA3>3.0.CO;2-R; DEINARD AS, 2000, AM J PHYS ANTHROPOL, V25, P44; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P6319, DOI 10.1073/pnas.78.10.6319; FU YX, 1993, GENETICS, V133, P693; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; GROVES CP, 1970, J ZOOL, V161, P287; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; STONEKING M, 1994, J BIOENERG BIOMEMBR, V26, P251, DOI 10.1007/BF00763097; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; STRINGER C, 1999, HUMAN INHERITANCE, P33; Tavare S, 1997, GENETICS, V145, P505; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weiss G, 1998, GENETICS, V149, P1539; YU N, IN PRESS MOL BIOL EV; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197; Zhi L, 1996, CURR BIOL, V6, P1326, DOI 10.1016/S0960-9822(02)70719-7	22	152	154	2	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					155	156		10.1038/84773	http://dx.doi.org/10.1038/84773			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175781				2022-12-27	WOS:000166839200014
J	Wu, LZ; Aster, JC; Blacklow, SC; Lake, R; Artavanis-Tsakonas, S; Griffin, JD				Wu, LZ; Aster, JC; Blacklow, SC; Lake, R; Artavanis-Tsakonas, S; Griffin, JD			MAML1, a human homologue of Drosophila Mastermind, is a transcriptional co-activator for NOTCH receptors	NATURE GENETICS			English	Article							NEUROGENIC LOCUS MASTERMIND; CREB BINDING-PROTEIN; SIGNAL-TRANSDUCTION; PATHWAY; LOCALIZATION; MELANOGASTER; REGULATOR; COMPLEX; DOMAIN; DELTEX	Notch receptors are involved in cell-fate determination in organisms as diverse as flies, frogs and humans'. In Drosophila melanogaster, loss-of-function mutations of Notch produce a 'neurogenic' phenotype in which cells destined to become epidermis switch fate and differentiate to neural cells. Upon ligand activation, the intracellular domain of Notch (ICN) translocates to the nucleus', and interacts directly with the DNA-binding protein Suppressor of hairless (Su(H)) in flies, or recombination signal binding protein J kappa (RBP-J kappa) in mammals(3), to activate gene transcription(4). But the precise mechanisms of Notch-induced gene expression are not completely understood. The gene mastermind has been identified in multiple genetic screens for modifiers of Notch mutations in Drosophila(5-8). Here we clone MAML1, a human homologue of the Drosophila gene Mastermind, and show that it encodes a protein of 130 kD localizing to nuclear bodies. MAML1 binds to the ankyrin repeat domain of all four mammalian NOTCH receptors, forms a DNA-binding complex with ICN and RBP-J kappa and amplifies NOTCH-induced transcription of HES1. These studies provide a molecular mechanism to explain the genetic links between mastermind and Notch in Drosophila and indicate that MAML1 functions as a transcriptional co-activator for NOTCH signalling.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Griffin, JD (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA.	james_griffin@dfci.harvard.edu			NCI NIH HHS [CA82308, CA09362] Funding Source: Medline; NHLBI NIH HHS [HL61001] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082308, T32CA009362] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061001] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ASTER J, 1994, COLD SPRING HARB SYM, V59, P125, DOI 10.1101/SQB.1994.059.01.016; Aster JC, 1997, J BIOL CHEM, V272, P11336; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; Go MJ, 1998, GENETICS, V150, P211; HAWLEY RG, 1994, GENE THER, V1, P136; Helms W, 1999, DEV BIOL, V215, P358, DOI 10.1006/dbio.1999.9477; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; PETTIT GR, 1996, J CHEM SOC P1, V8, P859; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Rebay Ilaria, 1993, Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie, V316, P1097; Roehl H, 1996, EMBO J, V15, P7002, DOI 10.1002/j.1460-2075.1996.tb01092.x; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; YEDVOBNICK B, 1988, GENETICS, V118, P483; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	28	444	477	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2000	26	4					484	489		10.1038/82644	http://dx.doi.org/10.1038/82644			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101851				2022-12-27	WOS:000165671700026
J	Vermeulen, W; Bergmann, E; Auriol, J; Rademakers, S; Frit, P; Appeldoorn, E; Hoeijmakers, JHJ; Egly, JM				Vermeulen, W; Bergmann, E; Auriol, J; Rademakers, S; Frit, P; Appeldoorn, E; Hoeijmakers, JHJ; Egly, JM			Sublimiting concentration of TFIIH transcription/DNA repair factor causes TTD-A trichothiodystrophy disorder	NATURE GENETICS			English	Article							NUCLEOTIDE-EXCISION-REPAIR; RNA-POLYMERASE-II; DNA-REPAIR; XERODERMA-PIGMENTOSUM; GENE; MUTATIONS; HELICASE; SUBUNIT; XPD; COMPLEX	The repair-deficient form of trichothiodystrophy (TTD) most often results from mutations in the genes XPB or XPD. encoding helicases of the transcription/repair factor TFIIH. The genetic defect in a third group, TTD-A, is unknown, but is also caused by dysfunctioning TFIIH. None of the TFIIH subunits carry a mutation and TFIIH from fro-A cells is active in both transcription and repair. Instead, immunoblot and immunofluorescence analyses reveal a strong reduction in the TFIIH concentration. Thus, the phenotype of TTD-A appears to result from sublimiting amounts of TFIIH, probably due to a mutation in a gene determining the complex stability. The reduction of TFIIH mainly affects its repair function and hardly influences transcription.	Erasmus Univ, Ctr Med Genet, Dept Cell Biol & Genet, Rotterdam, Netherlands; Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Strasbourg, France	Erasmus University Rotterdam; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Ctr Med Genet, Dept Cell Biol & Genet, Rotterdam, Netherlands.		Vermeulen, Wim/W-8708-2019; Hoeijmakers, Jan/AAX-6972-2021	Vermeulen, Wim/0000-0003-3616-734X; 				Araujo SJ, 2000, GENE DEV, V14, P349; BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; BOOTSMA D, 1998, NUCLEOTIDE EXCISION, P245; Bradsher J, 2000, J BIOL CHEM, V275, P2532, DOI 10.1074/jbc.275.4.2532; BROUGHTON BC, 1995, AM J HUM GENET, V56, P167; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; de Boer J, 1999, CANCER RES, V59, P3489; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Evans E, 1997, EMBO J, V16, P625, DOI 10.1093/emboj/16.3.625; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; GERARD M, 1991, J BIOL CHEM, V266, P20940; Hanawalt PC, 2000, NATURE, V405, P415, DOI 10.1038/35013197; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Hwang BJ, 1996, MUTAT RES-DNA REPAIR, V362, P105, DOI 10.1016/0921-8777(95)00040-2; Lehmann AR, 1998, BIOESSAYS, V20, P146, DOI 10.1002/(SICI)1521-1878(199802)20:2<146::AID-BIES7>3.3.CO;2-5; Marinoni JC, 1997, EMBO J, V16, P1093, DOI 10.1093/emboj/16.5.1093; Moreland RJ, 1999, J BIOL CHEM, V274, P22127, DOI 10.1074/jbc.274.32.22127; ROY R, 1994, J BIOL CHEM, V269, P9826; Sambrook J., 2002, MOL CLONING LAB MANU; Satoh MS, 1996, NUCLEIC ACIDS RES, V24, P3576, DOI 10.1093/nar/24.18.3576; Satoh MS, 1997, BBA-GENE STRUCT EXPR, V1354, P241, DOI 10.1016/S0167-4781(97)00102-4; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; STEFANINI M, 1993, AM J HUM GENET, V53, P817; Sung P, 1996, J BIOL CHEM, V271, P10821, DOI 10.1074/jbc.271.18.10821; SVEJSTRUP JQ, 1995, CELL, V80, P21, DOI 10.1016/0092-8674(95)90447-6; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; van Oosterwijk MF, 1998, J BIOL CHEM, V273, P13599, DOI 10.1074/jbc.273.22.13599; VERMEULEN W, 1994, AM J HUM GENET, V54, P191; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Weeda G, 1997, AM J HUM GENET, V60, P320; Weeda G, 1997, NUCLEIC ACIDS RES, V25, P2274, DOI 10.1093/nar/25.12.2274; Winkler GS, 1998, J BIOL CHEM, V273, P1092, DOI 10.1074/jbc.273.2.1092; Winkler GS, 2000, J BIOL CHEM, V275, P4258, DOI 10.1074/jbc.275.6.4258	41	101	101	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					307	313		10.1038/81603	http://dx.doi.org/10.1038/81603			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062469				2022-12-27	WOS:000165176500018
J	Cartegni, L; Krainer, AR				Cartegni, L; Krainer, AR			Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1	NATURE GENETICS			English	Article							MOTOR-NEURON GENE; MESSENGER-RNA; SINGLE NUCLEOTIDE; SR PROTEINS; SURVIVAL; IDENTIFICATION; MOUSE; MUTATIONS; NONSENSE; DEFINITION	Alteration of correct splicing patterns by disruption of an exonic splicing enhancer may be a frequent mechanism by which point mutations cause genetic diseases. Spinal muscular atrophy results from the lack of functional survival of motor neuron 1 gene (SMN1), even though all affected individuals carry a nearly identical, normal SMN2 gene. SMN2 is only partially active because a translationally silent, single-nucleotide difference in exon 7 causes exon skipping. Using ESE motif-prediction tools, mutational analysis and in vivo and in vitro splicing assays, we show that this single-nucleotide change occurs within a heptamer motif of an exonic splicing enhancer, which in SMN1 is recognized directly by SF2/ASF. The abrogation of the SF2/ASF-dependent ESE is the basis for inefficient inclusion of exon 7 in SMN2, resulting in the spinal muscular atrophy phenotype.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	krainer@cshl.org		Krainer, Adrian/0000-0001-9024-9501				Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Burge CB, 1999, RNA WORLD, P525; CACERES JF, 1997, EUKARYOTIC MRNA PROC, P174; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Graveley BR, 1998, EMBO J, V17, P6747, DOI 10.1093/emboj/17.22.6747; Graveley BR, 1999, CURR BIOL, V9, pR6, DOI 10.1016/S0960-9822(99)80032-3; Hastings ML, 2001, RNA, V7, P471, DOI 10.1017/S1355838201002552; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Jablonka S, 2000, J NEUROL, V247, P37, DOI 10.1007/s004150050555; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lefebvre S, 1998, HUM MOL GENET, V7, P1531, DOI 10.1093/hmg/7.10.1531; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Mayeda A, 1999, METH MOL B, V118, P315; Mayeda A, 1999, METH MOL B, V118, P309; Mazoyer S, 1998, AM J HUM GENET, V62, P713, DOI 10.1086/301768; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Monani UR, 2000, HUM MOL GENET, V9, P2451, DOI 10.1093/hmg/9.16.2451; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Muro AF, 1999, MOL CELL BIOL, V19, P2657; Newman AJ, 1997, EMBO J, V16, P5797, DOI 10.1093/emboj/16.19.5797; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Penalva LOF, 2001, MOL CELL BIOL, V21, P1986, DOI 10.1128/MCB.21.6.1986-1996.2001; Reed R, 1999, METHODS, V18, P3, DOI 10.1006/meth.1999.0751; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Rochette CF, 2001, HUM GENET, V108, P255, DOI 10.1007/s004390100473; SAITO I, 1990, PHOTOCHEMISTRY NUCL, V2, P317; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; TACKE R, 1992, NUCLEIC ACIDS RES, V20, P5482, DOI 10.1093/nar/20.20.5482; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500	50	553	587	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2002	30	4					377	384		10.1038/ng854	http://dx.doi.org/10.1038/ng854			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11925564				2022-12-27	WOS:000174682000014
J	Kim, SK; Selleri, L; Lee, JS; Zhang, AY; Gu, XY; Jacobs, Y; Cleary, ML				Kim, SK; Selleri, L; Lee, JS; Zhang, AY; Gu, XY; Jacobs, Y; Cleary, ML			Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus	NATURE GENETICS			English	Article							HOMEODOMAIN PROTEINS; GENE; HOX; MUTATIONS; NOTOCHORD; EXOCRINE; IPF1	Pbx1 is a member of the TALE (three-amino acid loop extension) class of homeodomain transcription factors(1,2), which are components of hetero-oligomeric protein complexes thought to regulate developmental gene expression and to maintain differentiated cell states(3). In vitro studies(4,5) have shown that Pbx1 regulates the activity of Ipf1 (also known as Pdx1), a Para-Hox homeodomain transcription factor(6,7) required for the development and function of the pancreas in mice and humans(8-10). To investigate in vivo roles of Pbx1 in pancreatic development and function, we examined pancreatic Pbx1 expression, and morphogenesis, cell differentiation and function in mice deficient(11,12) for Pbx1. Pbx1(-/-) embryos had pancreatic hypoplasia and marked defects in exocrine and endocrine cell differentiation prior to death at embryonic day (E) 15 or E16. In these embryos, expression of IsI1 and Atoh5, essential regulators of pancreatic morphogenesis and differentiation, was severely reduced. Pbx1(+/-) adults had pancreatic islet malformations, impaired glucose tolerance and hypoinsulinemia. Thus, Pbx1 is essential for normal pancreatic development and function. Analysis of trans-heterozygous Pbx1(+/-) Ipf1(+/-) mice revealed in vivo genetic interactions between Pbx1 and Ipf1 that are essential for postnatal pancreatic function; these mice developed age-dependent overt diabetes mellitus, unlike Pbx1(+/-) or Ipf1(+/-) mice. Mutations affecting the Ipf1 protein may promote diabetes mellitus in mice and humans(13-16). This study suggests that perturbation of Pbx1 activity may also promote susceptibility to diabetes mellitus.	Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol,Div Oncol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Dept Med,Div Oncol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol,Div Oncol, Stanford, CA 94305 USA.			Zhang, Andrew/0000-0002-6309-9947; Kim, Seung/0000-0001-6135-7810				Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; Coulier F, 2000, INT J ONCOL, V17, P439; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Dutta S, 2001, P NATL ACAD SCI USA, V98, P1065, DOI 10.1073/pnas.031561298; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kim SK, 2000, GENE DEV, V14, P1866; Kim SK, 1997, DEVELOPMENT, V124, P4243; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Macfarlane WM, 1999, J CLIN INVEST, V104, pR33, DOI 10.1172/JCI7449; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Offield MF, 1996, DEVELOPMENT, V122, P983; PEERS B, 1995, MOL CELL BIOL, V15, P7091; Schnabel CA, 2001, MECH DEVELOP, V100, P131, DOI 10.1016/S0925-4773(00)00516-5; Selleri L, 2001, DEVELOPMENT, V128, P3543; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Swift GH, 1998, MOL CELL BIOL, V18, P5109, DOI 10.1128/MCB.18.9.5109	30	138	143	1	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					430	435		10.1038/ng860	http://dx.doi.org/10.1038/ng860			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11912494				2022-12-27	WOS:000174682000023
J	Jonkers, J; Meuwissen, R; van der Gulden, H; Peterse, H; van der Valk, M; Berns, A				Jonkers, J; Meuwissen, R; van der Gulden, H; Peterse, H; van der Valk, M; Berns, A			Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer	NATURE GENETICS			English	Article							SUSCEPTIBILITY GENE; P53-DEFICIENT MICE; TRANSGENIC MICE; DNA-REPAIR; STEM-CELLS; MUTATION; RAD51; SPECTRUM; DELETION; TUMORIGENESIS	Inheritance of one defective BRCA2 allele predisposes humans to breast cancer, To establish a mouse model for BRCA2-associated breast cancer, we generated mouse conditional mutants with BRCA2 and/or p53 inactivated in various epithelial tissues, including mammary-gland epithelium. Although no tumors arose in mice carrying conditional Brca2 alleles, mammary and skin tumors developed frequently in females carrying conditional Brca2 and Trp53 alleles. The presence of one wildtype Brca2 allele resulted in a markedly delayed tumor formation; loss of the wildtype Brca2 allele occurred in a subset of these tumors. Our results show that inactivation of BRCA2 and of p53 combine to mediate mammary tumorigenesis, and indicate that disruption of the p53 pathway is pivotal in BRCA2-associated breast cancer.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.		Jonkers, Jos/AAG-3246-2019	Jonkers, Jos/0000-0002-9264-9792				Berneburg M, 2001, ADV GENET, V43, P71, DOI 10.1016/S0065-2660(01)43004-5; Bogliolo M, 2000, ONCOGENE, V19, P5781, DOI 10.1038/sj.onc.1203951; Brugarolas J, 1997, NAT MED, V3, P721, DOI 10.1038/nm0797-721; Cavalieri E, 2000, J Natl Cancer Inst Monogr, P75; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Crook T, 1998, ONCOGENE, V17, P1681, DOI 10.1038/sj.onc.1202106; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Friedman LS, 1998, CANCER RES, V58, P1338; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hogan B, 1994, MANIPULATING MOUSE E; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PURDIE CA, 1994, ONCOGENE, V9, P603; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Ramus SJ, 1999, GENE CHROMOSOME CANC, V25, P91, DOI 10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5; Rasmussen S. B., 2000, METHODS MAMMARY GLAN, P75; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Sambrook J., 2002, MOL CLONING LAB MANU; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; VANDERPUTTEN H, 1979, CELL, V18, P109, DOI 10.1016/0092-8674(79)90359-3; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Venkitaraman AR, 2000, PHILOS T R SOC B, V355, P191, DOI 10.1098/rstb.2000.0558; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yu VPCC, 2000, GENE DEV, V14, P1400; 1999, J NATL CANC I, V91, P1310	50	779	798	1	42	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					418	425		10.1038/ng747	http://dx.doi.org/10.1038/ng747			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11694875				2022-12-27	WOS:000172507500017
J	Waters, VL				Waters, VL			Conjugation between bacterial and mammalian cells	NATURE GENETICS			English	Article							DNA TRANSFER; AGROBACTERIUM-TUMEFACIENS; TI PLASMIDS; INCP; YEAST; TRANSFORMATION	Bacterial conjugation, in which DNA is transferred from one bacterium to another, was first reported in 1946 and found to be mediated by the F factor(1). Although the F and RK2/RP4 prototypic plasmids can mediate the transfer of DNA from bacteria to yeast(2), there has been no evidence of classical bacterial conjugation to higher eukaryotes. Here, I present evidence of such transfer, using Escherichia coli, the RK2 plasmid system and Chinese hamster ovary CHO K1 cells.	Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Waters, VL (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.	vwaters@ucsd.edu						BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Haase J, 1997, J BACTERIOL, V179, P5728, DOI 10.1128/jb.179.18.5728-5735.1997; HEINEMANN JA, 1993, MOL MICROBIOL, V10, P57, DOI 10.1111/j.1365-2958.1993.tb00903.x; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; INOMATA K, 1994, J BACTERIOL, V176, P4770, DOI 10.1128/JB.176.15.4770-4773.1994; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; Piers KL, 1996, P NATL ACAD SCI USA, V93, P1613, DOI 10.1073/pnas.93.4.1613; Schubbert R, 1998, MOL GEN GENET, V259, P569, DOI 10.1007/s004380050850; SIA EA, 1995, J BACTERIOL, V177, P2789, DOI 10.1128/jb.177.10.2789-2797.1995; SIZEMORE DR, 1995, SCIENCE, V270, P299, DOI 10.1126/science.270.5234.299; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; WATERS VL, 1992, J BACTERIOL, V174, P6666, DOI 10.1128/JB.174.20.6666-6673.1992; WATERS VL, 1991, P NATL ACAD SCI USA, V88, P1456, DOI 10.1073/pnas.88.4.1456	15	117	136	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					375	376		10.1038/ng779	http://dx.doi.org/10.1038/ng779			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726922				2022-12-27	WOS:000172507500008
J	Rovio, AT; Marchington, DR; Donat, S; Schuppe, HC; Abe, J; Fritsche, E; Elliott, DJ; Laippala, P; Ahola, AL; McNay, D; Harrison, RF; Hughes, B; Barrett, T; Bailey, DMD; Mehmet, D; Jequier, AM; Hargreave, TB; Kao, SH; Cummins, JM; Barton, DE; Cooke, HJ; Wei, YH; Wichmann, L; Poulton, J; Jacobs, HT				Rovio, AT; Marchington, DR; Donat, S; Schuppe, HC; Abe, J; Fritsche, E; Elliott, DJ; Laippala, P; Ahola, AL; McNay, D; Harrison, RF; Hughes, B; Barrett, T; Bailey, DMD; Mehmet, D; Jequier, AM; Hargreave, TB; Kao, SH; Cummins, JM; Barton, DE; Cooke, HJ; Wei, YH; Wichmann, L; Poulton, J; Jacobs, HT			Mutations at the mitochondrial DNA polymerase (POLG) locus associated with male infertility	NATURE GENETICS			English	Article							MOTILITY; SPERMATOZOA; CELLS	Human mitochondrial DNA polymerase, encoded by POLG, contains a polyglutamine tract encoded by a CAG microsatellite repeat(1,2). Analysis of POLG genotypes in different populations identified an association between absence of the common, ten-repeat allele and male infertility typified by a range of sperm quality defects but excluding azoospermia.	Ancobio Ltd, Glasgow, Lanark, Scotland; Tampere Univ, Inst Med Technol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; Tampere Univ, Dept Anat, FIN-33101 Tampere, Finland; Tampere Univ, Sch Publ Hlth, Biometry Unit, FIN-33101 Tampere, Finland; Univ Oxford, Dept Paediat, Oxford OX1 2JD, England; Univ Dusseldorf, Med Inst Environm Hyg, Dept Expt Toxicol, D-4000 Dusseldorf, Germany; Univ Giessen, Ctr Dermatol & Androl, Giessen, Germany; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; Rotunda Hosp, Human Assisted Reprod Ireland, Dublin, Ireland; Univ Coll Dublin, Natl Ctr Med Genet, Dublin 2, Ireland; Murdoch Univ, Div Vet & Biomed Sci, Murdoch, WA 6150, Australia; Joondalup Hlth Campus, Perth, WA, Australia; Western Gen Hosp, Dept Urol, Edinburgh EH4 2XU, Midlothian, Scotland; Natl Yang Ming Univ, Dept Biochem, Taipei 112, Taiwan; Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland	Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University; University of Oxford; Heinrich Heine University Dusseldorf; Justus Liebig University Giessen; University of Edinburgh; University College Dublin; Murdoch University; University of Edinburgh; National Yang Ming Chiao Tung University; University of Glasgow	Jacobs, HT (corresponding author), Ancobio Ltd, Glasgow, Lanark, Scotland.	howy.jacobs@uta.fi	Poulton, Joanna/AAB-4828-2021; Barton, David E/I-1795-2019; Barton, David E/B-9460-2008; Wei, Yau-Huei/ABA-6841-2021; Jacobs, Howard T/G-2434-2011	Barton, David E/0000-0002-2031-9719; Wei, Yau-Huei/0000-0002-6429-2546; Jacobs, Howard/0000-0003-1895-6003; Kao, Shu-Huei/0000-0003-4618-0898; Poulton, Joanna/0000-0002-2460-5587; Elliott, David/0000-0002-6930-0699; McNay, David/0000-0002-4747-0136				CUMMINS JM, 1994, MOL REPROD DEV, V37, P345, DOI 10.1002/mrd.1080370314; Hargreave TB, 2000, BRIT MED BULL, V56, P650, DOI 10.1258/0007142001903454; John JCS, 1997, NAT MED, V3, P124, DOI 10.1038/nm0297-124c; Kao SH, 1998, MOL HUM REPROD, V4, P657, DOI 10.1093/molehr/4.7.657; Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4; Lestienne P, 1997, MOL HUM REPROD, V3, P811, DOI 10.1093/molehr/3.9.811; Mifsud A, 2001, FERTIL STERIL, V75, P275, DOI 10.1016/S0015-0282(00)01693-9; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; Rovio A, 1999, EUR J HUM GENET, V7, P140, DOI 10.1038/sj.ejhg.5200244; Ruiz-Pesini E, 2000, CLIN CHIM ACTA, V300, P97, DOI 10.1016/S0009-8981(00)00305-3; Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; SOKOL RZ, 1995, CURR OPIN OBSTET GYN, V7, P177, DOI 10.1097/00001703-199506000-00004; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Troiano L, 1998, EXP CELL RES, V241, P384, DOI 10.1006/excr.1998.4064	15	142	147	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					261	262		10.1038/ng759	http://dx.doi.org/10.1038/ng759			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687794				2022-12-27	WOS:000171911000009
J	Snijders, AM; Nowak, N; Segraves, R; Blackwood, S; Brown, N; Conroy, J; Hamilton, G; Hindle, AK; Huey, B; Kimura, K; Law, S; Myambo, K; Palmer, J; Ylstra, B; Yue, JP; Gray, JW; Jain, AN; Pinkel, D; Albertson, DG				Snijders, AM; Nowak, N; Segraves, R; Blackwood, S; Brown, N; Conroy, J; Hamilton, G; Hindle, AK; Huey, B; Kimura, K; Law, S; Myambo, K; Palmer, J; Ylstra, B; Yue, JP; Gray, JW; Jain, AN; Pinkel, D; Albertson, DG			Assembly of microarrays for genome-wide measurement of DNA copy number.	NATURE GENETICS			English	Article							HYBRIDIZATION; CELLS	We have assembled arrays of approximately 2,400 BAC clones for measurement of DNA copy number across the human genome. The arrays provide precise measurement (s.d. of log(2) ratios=0.05-0.10) in cell lines and clinical material, so that we can reliably detect and quantify high-level amplifications and single-copy alterations in diploid, polyploid and heterogeneous backgrounds.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; New York State Dept Hlth, Roswell Pk Canc Inst, Buffalo, NY 14263 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roswell Park Cancer Institute	Albertson, DG (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA.		Ylstra, Bauke/D-2906-2012	Ylstra, Bauke/0000-0001-9479-3010	NCI NIH HHS [CA58207, CA84118, CA83040, CA80314] Funding Source: Medline; NICHD NIH HHS [HD17665] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA083040, R01CA080314, U01CA084118, P50CA058207] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Geschwind DH, 1998, DEV GENET, V23, P215, DOI 10.1002/(SICI)1520-6408(1998)23:3<215::AID-DVG7>3.0.CO;2-X; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Lucito R, 2000, GENOME RES, V10, P1726, DOI 10.1101/gr.138300; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524	7	691	791	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					263	264		10.1038/ng754	http://dx.doi.org/10.1038/ng754			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687795				2022-12-27	WOS:000171911000010
J	Johnson, GCL; Esposito, L; Barratt, BJ; Smith, AN; Heward, J; Di Genova, G; Ueda, H; Cordell, HJ; Eaves, IA; Dudbridge, F; Twells, RCJ; Payne, F; Hughes, W; Nutland, S; Stevens, H; Carr, P; Tuomilehto-Wolf, E; Tuomilehto, J; Gough, SCL; Clayton, DG; Todd, JA				Johnson, GCL; Esposito, L; Barratt, BJ; Smith, AN; Heward, J; Di Genova, G; Ueda, H; Cordell, HJ; Eaves, IA; Dudbridge, F; Twells, RCJ; Payne, F; Hughes, W; Nutland, S; Stevens, H; Carr, P; Tuomilehto-Wolf, E; Tuomilehto, J; Gough, SCL; Clayton, DG; Todd, JA			Haplotype tagging for the identification of common disease genes	NATURE GENETICS			English	Article							HUMAN LIPOPROTEIN-LIPASE; DEPENDENT DIABETES-MELLITUS; LINKAGE DISEQUILIBRIUM; SEQUENCE VARIATION; DIVERSITY; REGION; SUSCEPTIBILITY; POLYMORPHISM; LOCUS	Genome-wide linkage disequilibrium (LD) mapping of common disease genes could be more powerful than linkage analysis if the appropriate density of polymorphic markers were known and if the genotyping effort and cost of producing such an LD map could be reduced. Although different metrics that measure the extent of LD have been evaluated(1-3), even the most recent studies(2,4) have not placed significant emphasis on the most informative and cost-effective method of LD mapping-that based on haplotypes. We have scanned 135 kb of DNA from nine genes, genotyped 122 single-nucleotide polymorphisms (SNPs; approximately 184,000 genotypes) and determined the common haplotypes in a minimum of 384 European individuals for each gene. Here we show how knowledge of the common haplotypes and the SNPs that tag them can be used to (i) explain the often complex patterns of LD between adjacent markers, (ii) reduce genotyping significantly (in this case from 122 to 34 SNPs), (iii) scan the common variation of a gene sensitively and comprehensively and (iv) provide key fine-mapping data within regions of strong LD. Our results also indicate that, at least for the genes studied here, the current version of dbSNP would have been of limited utility for LD mapping because many common haplotypes could not be defined. A directed re-sequencing effort of the approximately 10% of the genome in or near genes in the major ethnic groups would aid the systematic evaluation of the common variant model of common disease.	Univ Cambridge, Cambridge Inst Med Res, JDRF WT Diabet & Inflammat Lab, Cambridge, England; Univ Birmingham, Dept Med, Birmingham, W Midlands, England; Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England; Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland	University of Cambridge; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham; University of Birmingham; Finland National Institute for Health & Welfare; University of Helsinki	Todd, JA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, JDRF WT Diabet & Inflammat Lab, Wellcome Trust Med Res Council Bldg,Hills Rd, Cambridge, England.		Payne, Felicity/GKF-2573-2022; Todd, John A/A-3542-2010	Payne, Felicity/0000-0003-4228-581X; Todd, John A/0000-0003-2740-8148; Dudbridge, Frank/0000-0002-8817-8908; Barratt, Bryan/0000-0002-5598-2422; Cordell, Heather/0000-0002-1879-5572				Bonnen PE, 2000, AM J HUM GENET, V67, P1437, DOI 10.1086/316908; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V36, P345; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Farrall M, 1999, NAT GENET, V23, P270, DOI 10.1038/15449; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Joosten PHLJ, 2001, NAT GENET, V27, P215, DOI 10.1038/84867; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Longmate JA, 2001, AM J HUM GENET, V68, P1229, DOI 10.1086/320106; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; Marth G, 2001, NAT GENET, V27, P371, DOI 10.1038/86864; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Morton NE, 2001, P NATL ACAD SCI USA, V98, P5217, DOI 10.1073/pnas.091062198; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Templeton AR, 2000, GENETICS, V156, P1259; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0	32	918	982	1	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					233	237		10.1038/ng1001-233	http://dx.doi.org/10.1038/ng1001-233			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586306				2022-12-27	WOS:000171374100034
J	Thompson, DA; Li, Y; McHenry, CL; Carlson, TJ; Ding, X; Sieving, PA; Apfelstedt-Sylla, E; Gal, A				Thompson, DA; Li, Y; McHenry, CL; Carlson, TJ; Ding, X; Sieving, PA; Apfelstedt-Sylla, E; Gal, A			Mutations in the gene encoding lecithin retinol acyltransferase are associated with early-onset severe retinal dystrophy	NATURE GENETICS			English	Article							VITAMIN-A; RPE65; PIGMENT; MOUSE	The chromophore of the visual pigments, 11-cis retinal, is derived from vitamin A tall-trans retinol) through a series of reactions that take place in retinal pigment epithelium (RPE); (ref. 1), The first of these reactions is catalyzed by lecithin retinol acyltransferase (LRAT): (ref. 2). We screened 267 retinal dystrophy patients for mutations in LRAT and identified disease-associated mutations (S175R and 396delAA) in three individuals with severe, early-onset disease. We showed that the S175R mutant has no acyltransferase activity in transfected COS-7 cells. Our findings highlight the importance of genetic defects in vitamin A metabolism as causes of retinal dystrophies and extend prospects for retinoid replacement therapy in this group of diseases.	Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI USA; Univ Hamburg, Hosp Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; Dupont Exptl Stn, Wilmington, DE USA; Univ Tubingen, Hosp Eye, Dept 2, Tubingen, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Hamburg; Eberhard Karls University of Tubingen	Thompson, DA (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	dathom@umich.edu		Thompson, Debra/0000-0003-3485-0794	NATIONAL EYE INSTITUTE [R01EY012298] Funding Source: NIH RePORTER; NEI NIH HHS [EY06094, EY07003, EY12298] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BUNGE S, 1996, METH MOL G, V8, P26; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Mondal MS, 2000, BIOCHEMISTRY-US, V39, P5215, DOI 10.1021/bi9929554; NICOLETTI A, 1995, HUM MOL GENET, V4, P641, DOI 10.1093/hmg/4.4.641; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ruiz A, 2001, INVEST OPHTH VIS SCI, V42, P31; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; SHI YQ, 1993, BIOCHEMISTRY-US, V32, P1257, DOI 10.1021/bi00056a009; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Zolfaghari R, 2000, J LIPID RES, V41, P2024	15	146	158	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2001	28	2					123	124		10.1038/88828	http://dx.doi.org/10.1038/88828			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381255				2022-12-27	WOS:000169011800010
J	Acland, GM; Aguirre, GD; Ray, J; Zhang, Q; Aleman, TS; Cideciyan, AV; Pearce-Kelling, SE; Anand, V; Zeng, Y; Maguire, AM; Jacobson, SG; Hauswirth, WW; Bennett, J				Acland, GM; Aguirre, GD; Ray, J; Zhang, Q; Aleman, TS; Cideciyan, AV; Pearce-Kelling, SE; Anand, V; Zeng, Y; Maguire, AM; Jacobson, SG; Hauswirth, WW; Bennett, J			Gene therapy restores vision in a canine model of childhood blindness	NATURE GENETICS			English	Article							VISUAL PIGMENT; RPE65; EXPRESSION; MUTATIONS	The relationship between the neurosensory photoreceptors and the adjacent retinal pigment epithelium (RPE) controls not only normal retinal function, but also the pathogenesis of hereditary retinal degenerations. The molecular bases for both primary photoreceptor(1) and RPE diseases(2-4) that cause blindness have been identified. Gene therapy has been used successfully to slow degeneration in rodent models of primary photoreceptor diseases(5,6), but efficacy of gene therapy directed at photoreceptors and RPE in a large-animal model of human disease has not been reported. Here we study one of the most clinically severe retinal degenerations, Leber congenital amaurosis (LCA). LCA causes near total blindness in infancy and can result from mutations in RPE65 (LCA. type II; MIM 180069 and 204100). A naturally occurring animal model, the RPE65(-/-) dog, suffers from early and severe visual impairment similar to that seen in human LCA. We used a recombinant adeno-associated virus (AAV) carrying wild-type RPE65 (AAV-RPE65) to test the efficacy of gene therapy in this model. Our results indicate that visual function was restored in this large animal model of childhood blindness.	Univ Penn, Scheie Eye Inst, FM Kirby Ctr, Philadelphia, PA 19104 USA; Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; Univ Florida, Dept Ophthalmol, Gainesville, FL USA; Univ Florida, Powell Gene Therapy Ctr, Gainesville, FL USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bennett, J (corresponding author), Univ Penn, Scheie Eye Inst, FM Kirby Ctr, Philadelphia, PA 19104 USA.	jebennet@mail.med.upenn.edu	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Jacobson, Samuel/0000-0003-2122-169X	NATIONAL EYE INSTITUTE [U01EY006855, R01EY011123, R01EY006855, R01EY010820, R01EY013132, R01EY011142] Funding Source: NIH RePORTER; NEI NIH HHS [EY11142, EY13132, EY06855, EY10820, EY11123] Funding Source: Medline; NINDS NIH HHS [NS36202] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguirre G D, 1998, Mol Vis, V4, P23; Banin E, 1999, NEURON, V23, P549, DOI 10.1016/S0896-6273(00)80807-7; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; Bennett J, 2000, MOL THER, V1, P501, DOI 10.1006/mthe.2000.0080; Bennett J, 1999, P NATL ACAD SCI USA, V96, P9920, DOI 10.1073/pnas.96.17.9920; Dudus L, 1999, VISION RES, V39, P2545, DOI 10.1016/S0042-6989(98)00308-3; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hauswirth WW, 2000, INVEST OPHTH VIS SCI, V41, P2821; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Ma JX, 1998, BBA-GENE STRUCT EXPR, V1443, P255, DOI 10.1016/S0167-4781(98)00221-8; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Phelan JK, 2000, MOL VIS, V6, P116; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2000, METHOD ENZYMOL, V316, P705; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Wrigstad A, 1994, THESIS LINKOPING U	20	914	985	3	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					92	95		10.1038/88327	http://dx.doi.org/10.1038/88327			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326284				2022-12-27	WOS:000168413300024
J	Kuramochi, M; Fukuhara, H; Nobukuni, T; Kanbe, T; Maruyama, T; Ghosh, HP; Pletcher, M; Isomura, M; Onizuka, M; Kitamura, T; Sekiya, T; Reeves, RH; Murakami, Y				Kuramochi, M; Fukuhara, H; Nobukuni, T; Kanbe, T; Maruyama, T; Ghosh, HP; Pletcher, M; Isomura, M; Onizuka, M; Kitamura, T; Sekiya, T; Reeves, RH; Murakami, Y			TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer	NATURE GENETICS			English	Article							NUDE-MICE; LINES; METHYLATION; HMLH1; HETEROZYGOSITY; ADENOCARCINOMA; TUMORIGENICITY; LOCALIZATION; CISPLATIN; FRAGMENTS	The existence of tumor-suppressor genes was originally demonstrated by functional complementation through whole-cell and microcell fusion(1,2). Transfer of chromosome 11 into a human non-small-cell lung cancer (NSCLC) cell line, A549, suppresses tumorigenicity(3). Loss of heterozygosity (LOH) on the long arm of chromosome 11 has been reported in NSCLC and other cancers(4-6). Several independent studies indicate that multiple tumor-suppressor genes are found in this region, including the gene PPP2R1B at 11q23-24 (ref. 7). Linkage studies of NSCLC are precluded because no hereditary forms are known(8,9). We previously identified a region of 700 kb on 11q23.2 that completely suppresses tumorigenicity of A549 human NSCLC cells(10). Most of this tumor-suppressor activity localizes to a 100-kb segment by functional complementation. Here we report that this region contains a single confirmed gene, TSLC1, whose expression is reduced or absent in A549 and several other NSCLC, hepatocellular carcinoma (HCC) and pancreatic cancer (PaC) cell lines. TSLC1 expression or suppression is correlated with promoter methylation state in these cell lines. Restoration of TSLC1 expression to normal or higher levels suppresses tumor formation by A549 cells in nude mice. Only 2 inactivating mutations of TSLC1 were discovered in 161 tumors and tumor cell lines, both among the 20 primary tumors with LOH for 11q23.2. Promoter methylation was observed in 15 of the other 18 primary NSCLC, HCC and Pac tumors with LOH for 11q23.2. Thus, attenuation of TSLC1 expression occurred in 85% of primary tumors with LOH. Hypermethylation of the TSLC1 promoter would seem to represent the 'second hit' in NSCLC with LOH.	Natl Canc Ctr, Res Inst, Tumor Suppress & Funct Genom Project, Tokyo 104, Japan; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; Univ Tsukuba, Inst Clin Med, Dept Surg, Ibaraki, Osaka, Japan; Univ Tokyo, Fac Med, Dept Urol, Tokyo 113, Japan	National Cancer Center - Japan; Johns Hopkins University; University of Tokyo; University of Tsukuba; University of Tokyo	Murakami, Y (corresponding author), Natl Canc Ctr, Res Inst, Tumor Suppress & Funct Genom Project, Tokyo 104, Japan.		Kitamura, Toshio/AAA-2071-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024605] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-24605] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aoe K, 1999, ANTICANCER RES, V19, P291; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Ghosh K, 1999, BIOCHEM CELL BIOL, V77, P165; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; HARRIS H, 1969, NATURE, V223, P363, DOI 10.1038/223363a0; HIRAI KI, 1991, CLIN EXP METASTAS, V9, P517, DOI 10.1007/BF01768580; IHDE DC, 1991, CURR PROB CANCER, V15, P61; IIZUKA M, 1995, GENE CHROMOSOME CANC, V13, P40; Kanamori M, 2000, ONCOGENE, V19, P1564, DOI 10.1038/sj.onc.1203454; Kane MF, 1997, CANCER RES, V57, P808; Kukita Y, 1997, HUM MUTAT, V10, P400, DOI 10.1002/(SICI)1098-1004(1997)10:5<400::AID-HUMU11>3.3.CO;2-1; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Murakami Y, 1998, P NATL ACAD SCI USA, V95, P8153, DOI 10.1073/pnas.95.14.8153; Murakami Y, 1998, MUTAT RES-FUND MOL M, V400, P421, DOI 10.1016/S0027-5107(98)00031-1; MURAKAMI YS, 1995, CANCER RES, V55, P3389; Ohsaki Y, 1996, ONCOLOGY, V53, P327; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RASIO D, 1995, CANCER RES, V55, P3988; SAKAI T, 1991, AM J HUM GENET, V48, P880; SANTON JB, 1986, CANCER RES, V46, P4701; SATOH H, 1993, MOL CARCINOGEN, V7, P157, DOI 10.1002/mc.2940070306; Schutte M, 1997, CANCER RES, V57, P3126; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wang SSQ, 1999, GENE CHROMOSOME CANC, V25, P154, DOI 10.1002/(SICI)1098-2264(199906)25:2<154::AID-GCC11>3.3.CO;2-N; WEISBERG LA, 1987, COMPUT RADIOL, V11, P175, DOI 10.1016/0730-4862(87)90047-3; Yamori T, 1997, JPN J CANCER RES, V88, P1205, DOI 10.1111/j.1349-7006.1997.tb00350.x	29	367	402	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					427	430		10.1038/86934	http://dx.doi.org/10.1038/86934			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279526	Green Submitted			2022-12-27	WOS:000167811200019
J	Siddiqui, MR; Meisner, S; Tosh, K; Balakrishnan, K; Ghei, S; Fisher, SE; Golding, M; Narayan, NPS; Sitaraman, T; Sengupta, U; Pitchappan, R; Hill, AVS				Siddiqui, MR; Meisner, S; Tosh, K; Balakrishnan, K; Ghei, S; Fisher, SE; Golding, M; Narayan, NPS; Sitaraman, T; Sengupta, U; Pitchappan, R; Hill, AVS			A major susceptibility locus for leprosy in India maps to chromosome 10p13	NATURE GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; AFFECTED RELATIVE PAIRS; GENOME-WIDE SEARCH; SCHISTOSOMA-MANSONI; LINKAGE STRATEGIES; INFECTION; EPIDEMIOLOGY; INTENSITY; 5Q31-Q33; DISEASE	Leprosy, a chronic infectious disease caused by Mycobacterium leprae, is prevalent in India, where about half of the world's estimated 800,000 cases occur(1). A role for the genetics of the host in variable susceptibility to leprosy has been indicated by familial clustering, twin studies, complex segregation analyses and human leukocyte antigen (HLA) association studies. We report here a genetic linkage scan of the genomes of 224 families from South India, containing 245 independent affected sibpairs with leprosy, mainly of the paucibacillary type. In a two-stage genome screen using 396 microsatellite markers, we found significant linkage (maximum lod score (MLS)=4.09, P<2x10(-5)) on chromosome 10p13 for a series of neighboring microsatellite markers, providing evidence for a major locus for this prevalent infectious disease. Thus, despite the polygenic nature of infectious disease susceptibility, some major, non-HLA-linked loci exist that may be mapped through obtainable numbers of affected sibling pairs.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Madurai Kamaraj Univ, Madurai 625021, Tamil Nadu, India; JALMA Inst, Agra, Uttar Pradesh, India; Leprosy Project, Sakthi Nagar, India; Hindu Mission Hosp, Kumbakonam, India	University of Oxford; Wellcome Centre for Human Genetics; Madurai Kamaraj University; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra	Hill, AVS (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.		Peng, Bo/A-6920-2009; Fisher, Simon E./E-9130-2012; HILL, Adrian V>S>/C-1306-2008	Peng, Bo/0000-0001-8225-2284; Fisher, Simon E./0000-0002-3132-1996; Karuppiah, Balakrishnan/0000-0002-7494-5010; Siddiqui, Ruby/0000-0002-9638-594X				Abel L, 1998, J INFECT DIS, V177, P133, DOI 10.1086/513830; ABEL L, 1988, AM J HUM GENET, V42, P256; ALI PM, 1966, INT J LEPROSY, V34, P405; Aredath S P, 1984, Lepr Rev, V55, P47; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Chakravartti MR, 1973, TOPICS HUMAN GENETIC, P1; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FEITOSA MF, 1995, AM J HUM GENET, V56, P1179; HAILE RWC, 1985, HUM HERED, V35, P43, DOI 10.1159/000153514; HOLMANS P, 1993, AM J HUM GENET, V52, P362; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1987, AM J HUM GENET, V40, P1; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; TODD JR, 1990, REV INFECT DIS, V12, P63; *WHO, 1998, WKLY EPIDEMIOL REC, V73, P308	24	143	151	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					439	441		10.1038/86958	http://dx.doi.org/10.1038/86958			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279529				2022-12-27	WOS:000167811200022
J	Morello, R; Zhou, G; Dreyer, SD; Harvey, SJ; Ninomiya, Y; Thorner, PS; Miner, JH; Cole, W; Winterpacht, A; Zabel, B; Oberg, KC; Lee, B				Morello, R; Zhou, G; Dreyer, SD; Harvey, SJ; Ninomiya, Y; Thorner, PS; Miner, JH; Cole, W; Winterpacht, A; Zabel, B; Oberg, KC; Lee, B			Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome	NATURE GENETICS			English	Article							ALPORT-SYNDROME; IV COLLAGEN; MONOCLONAL-ANTIBODIES; GENE; ALPHA-3(IV); MUTATIONS; IDENTIFICATION; ORGANIZATION; DROSOPHILA; ENHANCER	Basement membrane (BM) morphogenesis is critical for normal kidney function(1). Heterotrimeric type IV collagen, composed of different combinations of six ct-chains lid), is a major matrix component of all BMs (ref. 2). Unlike in other BMs, glomerular BM (CBM) contains primarily the alpha3(IV) and alpha4(IV) chains, together with the alpha5(IV) chain(3,4). A poorly understood, coordinated temporal and spatial switch in gene expression from ubiquitously expressed alpha1(IV) and alpha2(IV) collagen to the alpha3(IV), alpha4(IV) and alpha5(IV) chains occurs during nqrmat embryogenesis of CBM (ref. 4). Structural abnormalities of type IV collagen have been associated with diverse biological processes including defects in molecular filtration in Alport syndrome(5,6), cell differentiation in hereditary leiomyomatosis(7), and autoimmunity in Goodpasture syndrome(7); however, the transcriptional and developmental regulation of type IV collagen expression is unknown. Nail patella syndrome (NPS) is caused by mutations in LMX1B, encoding a LIM homeodomain transcription factor. Some patients have nephrosis-associated renal disease characterized by typical ultrastructural abnormalities of GEM (refs. 8,9). In Lmx1b(-/-) mice, expression of both alpha (3)IV and alpha (4)IV collagen is strongly diminished in GEM, whereas that of alpha1, alpha2 and alpha5(IV) collagen is unchanged. Moreover, LMX1B binds specifically to a putative enhancer sequence in intron 1 of both mouse and human COL4A4 and upregulates reporter constructs containing this enhancer-like sequence. These data indicate that LMX1B directly regulates the coordinated expression of alpha3(IV) and alpha (IV) collagen required for normal CBM morphogenesis and that its dysregulation in CBM contributes to the renal pathology and nephrosis in NPS.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Mainz, Dept Pediat, D-6500 Mainz, Germany; Univ Toronto, Dept Pathobiol, Toronto, ON, Canada; Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; Okayama Univ, Sch Med, Dept Mol Biol & Biochem, Okayama 700, Japan; Washington Univ, Sch Med, Dept Med, Div Renal, St Louis, MO USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO USA; Hosp Sick Children, Div Orthoped, Toronto, ON M5G 1X8, Canada; Univ Hamburg, Inst Human Genet, D-2000 Hamburg, Germany; Loma Linda Univ, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA	Baylor College of Medicine; Johannes Gutenberg University of Mainz; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Okayama University; Washington University (WUSTL); Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Hamburg; Loma Linda University	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.		Harvey, Scott/C-8938-2011	Harvey, Scott/0000-0001-6007-785X; Oberg, Kerby/0000-0002-1241-4273	NIAMS NIH HHS [AR44738] Funding Source: Medline; NIDDK NIH HHS [DK53196, DK53763] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044738, R01AR044738, R55AR044738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053196, P01DK053763] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albrecht U., 1998, HUMAN GENOME METHODS, P93; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; DESJARDINS M, 1991, J CELL BIOL, V113, P689, DOI 10.1083/jcb.113.3.689; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; Dreyer SD, 2000, HUM MOL GENET, V9, P1067, DOI 10.1093/hmg/9.7.1067; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Haerry TE, 1997, DEV BIOL, V186, P1, DOI 10.1006/dbio.1997.8582; Harvey SJ, 1998, KIDNEY INT, V54, P1857, DOI 10.1046/j.1523-1755.1998.00188.x; HEIKKILA P, 1993, J BIOL CHEM, V268, P24677; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Kalluri R, 2000, J BIOL CHEM, V275, P12719, DOI 10.1074/jbc.275.17.12719; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Lu W, 1999, GENOMICS, V61, P113, DOI 10.1006/geno.1999.5943; McIntosh I, 1998, AM J HUM GENET, V63, P1651, DOI 10.1086/302165; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Momota R, 1998, FEBS LETT, V424, P11, DOI 10.1016/S0014-5793(98)00128-8; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; Sado Y, 1998, J BIOCHEM-TOKYO, V123, P767; SUTCLIFFE NP, 1989, NEPHROL DIAL TRANSPL, V4, P262, DOI 10.1093/oxfordjournals.ndt.a091869; TAGUCHI T, 1988, ULTRASTRUCT PATHOL, V12, P175, DOI 10.3109/01913128809058216; VALNIO S, 1997, CELL, V90, P975	30	144	147	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					205	208		10.1038/84853	http://dx.doi.org/10.1038/84853			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175791				2022-12-27	WOS:000166839200024
J	Constancia, M; Dean, W; Lopes, S; Moore, T; Kelsey, G; Reik, W				Constancia, M; Dean, W; Lopes, S; Moore, T; Kelsey, G; Reik, W			Deletion of a silencer element in lgf2 results in loss of imprinting independent of H19	NATURE GENETICS			English	Letter							BECKWITH-WIEDEMANN-SYNDROME; GROWTH-FACTOR-II; DEVELOPMENTAL CONTROL; WILMS-TUMOR; MOUSE IGF2; METHYLATION; GENE; EXPRESSION; CHROMATIN; PATTERN	Igf2 and H19 are closely linked, reciprocally imprinted genes on mouse distal chromosome 7. The paternally expressed Igf2 encodes a potent fetal growth factor and the maternally expressed H19 encodes a non-coding RNA (refs 1,2). Shared endoderm-specific enhancers 3' to H19 are necessary for transcription of the maternal copy of H19 and the paternal copy of Igf2 (ref. 3), a chromatin boundary upstream of H19 preventing access of the enhancers to the maternal Igf2 promoters(4-8). Mesoderm-specific control elements have not been identified, and the role of differentially methylated regions (DMRs) in Igf2 has not been addressed. Two DMRs in Igf2 are methylated on the active paternal allele, suggesting that they contain silencers(9-12). Here we have deleted the DMR1 region in Igf2. Maternal transmission of the deletion results in biallelic expression of Igf2 in most mesodermally derived tissues without altering H19 imprinting or expression. Paternal or maternal transmission leads to continued postnatal transcription of Igf2, in contrast to the wild-type allele, which is silenced soon after birth. These results reveal a mesodermal silencer, which may be regulated by methylation and which has a major role in H19-independent expression and imprinting control of Igf2. Our results establish a new mechanistic principle for imprinted genes whereby epigenetically regulated silencers interact with enhancers to control expression, and suggest a new mechanism for loss of imprinting (LOI) of Igf2, which may be important in a number of diseases.	Babraham Inst, Dev Genet Programme, Lab Dev Genet & Imprinting, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Reik, W (corresponding author), Babraham Inst, Dev Genet Programme, Lab Dev Genet & Imprinting, Cambridge, England.	wolf.reik@bbsrc.ac.uk	Constancia, Miguel/F-6654-2013; Reik, Wolf/I-6794-2012	Moore, Tom/0000-0001-9712-9625; Constancia, Miguel/0000-0002-8976-1679; Dean, Wendy/0000-0001-9441-5044; Reik, Wolf/0000-0003-0216-9881; Kelsey, Gavin/0000-0002-9762-5634				Ainscough JFX, 2000, DEVELOPMENT, V127, P3923; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; Brown LS, 1996, WOMEN THER, V19, P5, DOI 10.1300/J015v19n01_02; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; Dean W, 1998, DEVELOPMENT, V125, P2273; Drewell RA, 2000, DEVELOPMENT, V127, P3419; FEIL R, 1995, DEV GENET, V17, P240, DOI 10.1002/dvg.1020170309; FEIL R, 1994, DEVELOPMENT, V120, P2933; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hu JF, 1997, J BIOL CHEM, V272, P20715, DOI 10.1074/jbc.272.33.20715; Ishihara K, 2000, GENOME RES, V10, P664, DOI 10.1101/gr.10.5.664; Joyce JA, 1997, HUM MOL GENET, V6, P1543, DOI 10.1093/hmg/6.9.1543; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; RAINIER S, 1995, CANCER RES, V55, P1836; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Ward Andrew, 1997, Genes and Function, V1, P25	31	165	173	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2000	26	2					203	206		10.1038/79930	http://dx.doi.org/10.1038/79930			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017078				2022-12-27	WOS:000089638800019
J	Walder, RY; Landau, D; Meyer, P; Shalev, H; Tsolia, M; Borochowitz, Z; Boettger, MB; Beck, GE; Englehardt, RK; Carmi, R; Sheffield, VC				Walder, RY; Landau, D; Meyer, P; Shalev, H; Tsolia, M; Borochowitz, Z; Boettger, MB; Beck, GE; Englehardt, RK; Carmi, R; Sheffield, VC			Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia	NATURE GENETICS			English	Article							PROTEIN-KINASES; MAGNESIUM; PARACELLIN-1; TRANSPORT	Familial hypomagnesemia with secondary hypocalcemia (OMIM 602014) is an autosomal recessive disease that results in electrolyte abnormalities shortly after birth(1-6). Affected individuals show severe hypomagnesemia and hypocalcemia. which lead to seizures and tetany. The disorder has been thought to be caused by a defect in the intestinal absorption of magnesium, rather than by abnormal renal loss of magnesium. Restoring the concentrations of serum magnesium to normal values by high-dose magnesium supplementation can overcome the apparent defect in magnesium absorption and in serum concentrations of calcium. Life-long magnesium supplementation is required to overcome the defect in magnesium handling by these individuals(1,3,4). We previously mapped the gene locus to chromosome 9q in three large inbred kindreds from israel(2). Here we report that mutation of TRPM6 causes hypomagnesemia with secondary hypocalcemia and show that individuals carrying mutations in this gene have abnormal renal magnesium excretion.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Ben Gurion Univ Negev, Dept Pediat, Beer Sheva, Israel; Univ Heidelberg, INF 328, Inst Human Genet, D-69120 Heidelberg, Germany; Univ Athens, Dept Pediat, P A Kyriakou Childrens Hosp, Athens, Greece; Bnai Zion Med Ctr, Simon Winter Inst Human Genet, Haifa, Israel	University of Iowa; Howard Hughes Medical Institute; University of Iowa; Ben Gurion University; Ruprecht Karls University Heidelberg; National & Kapodistrian University of Athens; Bnai Zion Medical Center	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.			Sheffield, Val/0000-0002-6282-0835				ABDULRAZZAQ YM, 1989, EUR J PEDIATR, V148, P459, DOI 10.1007/BF00595914; ALGHAMDI SMG, 1994, AM J KIDNEY DIS, V24, P737, DOI 10.1016/S0272-6386(12)80667-6; Blanchard A, 2001, KIDNEY INT, V59, P2206, DOI 10.1046/j.1523-1755.2001.00736.x; CHALLA A, 1995, ACTA PAEDIATR, V84, P1075, DOI 10.1111/j.1651-2227.1995.tb13830.x; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Meyer P, 2001, J INHERIT METAB DIS, V24, P875, DOI 10.1023/A:1013952510698; MILLA PJ, 1979, GUT, V20, P1028, DOI 10.1136/gut.20.11.1028; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; PRAGA M, 1995, KIDNEY INT, V47, P1419, DOI 10.1038/ki.1995.199; PRONICKA E, 1991, J INHERIT METAB DIS, V14, P397, DOI 10.1007/BF01811713; RODRIGUEZSORIANO J, 1987, PEDIATR NEPHROL, V1, P465, DOI 10.1007/BF00849255; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; RYZEN E, 1985, Magnesium, V4, P137; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Shalev H, 1998, ARCH DIS CHILD, V78, P127, DOI 10.1136/adc.78.2.127; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; STAPLETON FB, 1983, J PEDIATR-US, V102, P88, DOI 10.1016/S0022-3476(83)80297-2; Walder RY, 1997, HUM MOL GENET, V6, P1491, DOI 10.1093/hmg/6.9.1491; YAMAMOTO T, 1985, Magnesium, V4, P153	22	387	413	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					171	174		10.1038/ng901	http://dx.doi.org/10.1038/ng901			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12032570				2022-12-27	WOS:000175903500013
J	Abecasis, GR; Cherny, SS; Cookson, WO; Cardon, LR				Abecasis, GR; Cherny, SS; Cookson, WO; Cardon, LR			Merlin-rapid analysis of dense genetic maps using sparse gene flow trees	NATURE GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; SNP MAP; MULTIPOINT; SEGREGATION; ALGORITHM; FASTER; ERRORS; HUMANS; MODEL	Efforts to find disease genes using high-density single-nucleotide polymorphism (SNP) maps will produce data sets that exceed the limitations of current computational tools. Here we describe a new, efficient method for the analysis of dense genetic maps in pedigree data that provides extremely fast solutions to common problems such as allele-sharing analyses and haplotyping. We show that sparse binary trees represent patterns of gene flow in general pedigrees in a parsimonious manner, and derive a family of related algorithms for pedigree traversal. With these trees, exact likelihood calculations can be carried out efficiently for single markers or for multiple linked markers. Using an approximate multipoint calculation that ignores the unlikely possibility of a large number of recombinants further improves speed and provides accurate solutions in dense maps with thousands of markers. our multipoint engine for rapid likelihood inference (Merlin) is a computer program that uses sparse inheritance trees for pedigree analysis; it performs rapid haplotyping, genotype error detection and affected pair linkage analyses and can handle more markers than other pedigree analysis packages.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Abecasis, GR (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, 1420 Washington Hts, Ann Arbor, MI 48109 USA.		Cherny, Stacey S/B-3315-2008; Cookson, William/HHC-1790-2022; Abecasis, Goncalo R/B-7840-2010	Cherny, Stacey S/0000-0002-0269-3352; Abecasis, Goncalo/0000-0003-1509-1825				Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gordon D, 1999, HUM HERED, V49, P65, DOI 10.1159/000022846; Gray F., 1953, U. S. Patent, Patent No. [2,632,058, 2632058, 2 632 058]; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; GUO SW, 1992, AM J HUM GENET, V51, P1111; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Idury RM, 1997, HUM HERED, V47, P197, DOI 10.1159/000154413; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Press W. H., 1992, ART SCI COMPUTING; Sobel E, 1996, AM J HUM GENET, V58, P1323	21	2721	2755	3	101	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					97	101		10.1038/ng786	http://dx.doi.org/10.1038/ng786			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11731797				2022-12-27	WOS:000173105600021
J	Yoon, BJ; Herman, H; Sikora, A; Smith, LT; Plass, C; Soloway, PD				Yoon, BJ; Herman, H; Sikora, A; Smith, LT; Plass, C; Soloway, PD			Regulation of DNA methylation of Rasgrf1	NATURE GENETICS			English	Article							HMLH1 PROMOTER HYPERMETHYLATION; TUMOR-SUPPRESSOR GENE; IMPRINTED EXPRESSION; CPG METHYLATION; H19 GENE; LOCUS; IGF2; REPEAT; CTCF; INACTIVATION	In mammals, DNA is methylated at cytosines within CpG dinucleoticles. Properly regulated methylation is crucial for normal development(1,2). Inappropriate methylation may contribute to tumorigenesis by silencing tumor-suppressor genes(3-10) or by activating growth-stimulating genes(11-13). Although many genes have been identified that acquire methylation and whose expression is methylation-sensitive(14,15), little is known about how DNA methylation is controlled(16). We have identified a DNA sequence that regulates establishment of DNA methylation in the male germ line at Rasgrf1. In mice, the imprinted Rasgrf1 locus is methylated on the paternal allele within a differentially methylated domain (DMD) 30 kbp 5' of the promoter. Expression is exclusively from the paternal allele in neonatal brain(17). Methylation is regulated by a repeated sequence, consisting of a 41-mer repeated 40 times, found immediately 3' of the DMD. This sequence is present in organisms in which Rasgrf1 is imprinted(18). In addition, DMD methylation is required for imprinted Rasgrf1 expression. Together the DMD and repeat element constitute a binary switch that regulates imprinting at the locus.	Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Ohio State Univ, Div Human Canc Genet, Columbus, OH 43210 USA	Roswell Park Cancer Institute; University System of Ohio; Ohio State University	Soloway, PD (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA.		Reever, Larson/H-9685-2019; Soloway, Paul/T-8243-2019; Yoon, Bong June/L-7126-2017; Plass, Christoph/H-7192-2014	Reever, Larson/0000-0002-5692-4793; Soloway, Paul/0000-0003-1967-0437	NCI NIH HHS [R01 CA098597, R01 CA098597-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098597] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baylin SB, 1998, ADV CANCER RES, V72, P141; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Esteller M, 1999, AM J PATHOL, V155, P1767, DOI 10.1016/S0002-9440(10)65492-2; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Goyon C, 1996, MOL CELL BIOL, V16, P3054; GRAFF JR, 1995, CANCER RES, V55, P5195; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Herman JG, 1996, CANCER RES, V56, P722; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jones BK, 1998, GENE DEV, V12, P2200, DOI 10.1101/gad.12.14.2200; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LINN F, 1990, MOL GEN GENET, V222, P329, DOI 10.1007/BF00633837; OHTANIFUJITA N, 1993, ONCOGENE, V8, P1063; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Shibata H, 1998, GENOMICS, V49, P30, DOI 10.1006/geno.1998.5218; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416	30	133	137	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					92	96		10.1038/ng795	http://dx.doi.org/10.1038/ng795			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11753386	Green Accepted			2022-12-27	WOS:000173105600020
J	Hughes, JF; Coffin, JM				Hughes, JF; Coffin, JM			Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution	NATURE GENETICS			English	Article							INTRACHROMOSOMAL RECOMBINATION; GENES; SEQUENCES	Human endogenous retroviruses (HERVs), which are remnants of past retroviral infections of the germline cells of our ancestors(1), make up as much as 8% of the human genome and may even outnumber genes(2,3). Most HERVs seem to have entered the genome between 10 and 50 million years ago, and they comprise over 200 distinct groups and subgroups(1,4). Although repeated sequence elements such as HERVs have the potential to lead to chromosomal rearrangement through homologous recombination between distant loci, evidence for the generality of this process is lacking. To gain insight into the expansion of these elements in the genome during the course of primate evolution, we have identified 23 new members of the HERV-K (HML-2) group, which is thought to contain the most recently active members. Here we show, by phylogenetic and sequence analysis, that at least 16% of these elements have undergone apparent rearrangements that may have resulted in large-scale deletions, duplications and chromosome reshuffling during the evolution of the human genome.	Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA	Tufts University; Tufts University	Coffin, JM (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, 136 Harrison Ave, Boston, MA 02111 USA.	jcoffin_par@opal.tufts.edu			NCI NIH HHS [CA5441, R01 CA 89441, R35 CA 44385] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089441, R35CA044385] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Boeke J. D., 1997, P343; Costas J, 2001, J MOL EVOL, V53, P237, DOI 10.1007/s002390010213; Johnson WE, 1999, P NATL ACAD SCI USA, V96, P10254, DOI 10.1073/pnas.96.18.10254; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kulski JK, 1999, J MOL EVOL, V49, P84, DOI 10.1007/PL00006537; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; ONO M, 1986, J VIROL, V58, P937, DOI 10.1128/JVI.58.3.937-944.1986; REARDEN A, 1993, J BIOL CHEM, V268, P2260; Reus K, 2001, J VIROL, V75, P8917, DOI 10.1128/JVI.75.19.8917-8926.2001; Schwartz A, 1998, HUM MOL GENET, V7, P1, DOI 10.1093/hmg/7.1.1; Sugimoto J, 2001, GENOMICS, V72, P137, DOI 10.1006/geno.2001.6473; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389	16	162	167	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					487	489		10.1038/ng775	http://dx.doi.org/10.1038/ng775			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11704760				2022-12-27	WOS:000172507500028
J	Zhang, ZQ; Wang, Y; Vikis, HG; Johnson, L; Liu, GJ; Li, J; Anderson, MW; Sills, RC; Hong, HL; Devereux, TR; Jacks, T; Guan, KL; You, M				Zhang, ZQ; Wang, Y; Vikis, HG; Johnson, L; Liu, GJ; Li, J; Anderson, MW; Sills, RC; Hong, HL; Devereux, TR; Jacks, T; Guan, KL; You, M			Wildtype Kras2 can inhibit lung carcinogenesis in mice	NATURE GENETICS			English	Article							NEGATIVE RAS MUTANT; C-KI-RAS; GENE AMPLIFICATION; MALIGNANT TRANSFORMATION; PHEOCHROMOCYTOMA CELLS; TUMOR PROGRESSION; SARCOMA-VIRUSES; POINT MUTATION; N-RAS; MOUSE	Although the ras genes have long been established as proto-oncogenes, the dominant role of activated ras in cell transformation has been questioned. Previous studies have shown frequent loss of the wildtype Kras2 allele in both mouse and human lung adenocarcinomas. To address the possible tumor suppressor role of wildtype Kras2 in lung tumorigenesis, we have carried out a lung tumor bioassay in heterozygous Kras2-deficient mice. Mice with a heterozygous Kras2 deficiency were highly susceptible to the chemical induction of lung tumors when compared to wildtype mice. Activating Kras2 mutations were detected in all chemically induced lung tumors obtained from both wildtype and heterozygous Kras2-deficient mice. Furthermore, wildtype Kras2 inhibited colony formation and tumor development by transformed NIH/3T3 cells and a mouse lung tumor cell line containing an activated Kras2 allele. Allelic loss of wildtype Kras2 was found in 67% to 100% of chemically induced mouse lung adenocarcinomas that harbor a mutant Kras2 allele. Finally, an inverse correlation between the level of wildtype Kras2 expression and extracellular signal-regulated kinase (ERK) activity was observed in these cells. These data strongly suggest that wildtype Kras2 has tumor suppressor activity and is frequently lost during lung tumor progression.	Ohio State Univ, Ctr Comprehens Canc, Div Human Canc Genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Sch Publ Hlth, Columbus, OH USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; MIT, Dept Biol, Cambridge, MA USA; MIT, Howard Hughes Med Inst, Cambridge, MA USA; Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wang, Y (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Div Human Canc Genet, 420 W 12th Ave, Columbus, OH 43210 USA.				NATIONAL CANCER INSTITUTE [R01CA078797, R01CA058554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES021219, Z01ES023006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062694] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA58554, R01CA78797] Funding Source: Medline; NIGMS NIH HHS [R01GM62694] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON M, 1992, ENV HLTH PERSPECT, V98, P12; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BORASIO GD, 1989, NEURON, V2, P1087; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; BRISON O, 1993, BIOCHIM BIOPHYS ACTA, V1155, P25, DOI 10.1016/0304-419X(93)90020-D; BUCHMANN A, 1991, CANCER RES, V51, P4097; CHANG EH, 1982, NATURE, V297, P479, DOI 10.1038/297479a0; CHEN B, 1994, P NATL ACAD SCI USA, V91, P1589, DOI 10.1073/pnas.91.4.1589; CICHUTEK K, 1989, J VIROL, V63, P1377, DOI 10.1128/JVI.63.3.1377-1383.1989; COHEN JB, 1988, NATURE, V334, P119, DOI 10.1038/334119a0; COROMINAS M, 1991, CANCER RES, V51, P5129; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; De Gregorio L, 1998, INT J CANCER, V79, P269, DOI 10.1002/(SICI)1097-0215(19980619)79:3<269::AID-IJC10>3.3.CO;2-J; Esteller M, 1997, EUR J CANCER, V33, P1572, DOI 10.1016/S0959-8049(97)00154-8; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FIELD JK, 1990, ANTICANCER RES, V10, P1; FINNEY RE, 1993, SCIENCE, V260, P1524, DOI 10.1126/science.8502998; GEORGE DL, 1985, EMBO J, V4, P1199, DOI 10.1002/j.1460-2075.1985.tb03760.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; GUERRERO I, 1984, P NATL ACAD SCI-BIOL, V81, P202, DOI 10.1073/pnas.81.1.202; HEGI ME, 1994, CANCER RES, V54, P6257; HEIGHWAY J, 1986, BRIT J CANCER, V53, P285, DOI 10.1038/bjc.1986.47; HERRICK CL, 1995, MINN GEOL NAT HIST S, V2, P1; Heumann Rolf, 1994, Current Opinion in Neurobiology, V4, P668, DOI 10.1016/0959-4388(94)90008-6; Hua VY, 1997, P NATL ACAD SCI USA, V94, P9614, DOI 10.1073/pnas.94.18.9614; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; LOWRY DR, 1993, ANNU REV BIOCHEM, V62, P851; Manenti G, 1999, GENOME RES, V9, P639; MARSHALL CJ, 1991, TRENDS GENET, V7, P91, DOI 10.1016/0168-9525(91)90063-V; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; McDoniels-Silvers AL, 2001, EXP LUNG RES, V27, P297, DOI 10.1080/019021401300054064; National Toxicology Program, 1996, NIH PUBL; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; SARANATH D, 1989, JPN J CANCER RES, V80, P430, DOI 10.1111/j.1349-7006.1989.tb02332.x; SCHWAB M, 1983, NATURE, V303, P497, DOI 10.1038/303497a0; Shichinohe T, 1996, J SURG RES, V66, P125, DOI 10.1006/jsre.1996.0383; Shimkin M B, 1975, Adv Cancer Res, V21, P1, DOI 10.1016/S0065-230X(08)60970-7; SHIRAISHI M, 1989, CANCER RES, V49, P6474; Sills RC, 1999, CARCINOGENESIS, V20, P657, DOI 10.1093/carcin/20.4.657; SLEBOS RJC, 1989, BRIT J CANCER, V59, P76, DOI 10.1038/bjc.1989.14; SORRENTINO V, 1988, ONCOGENE RES, V2, P189; SPANDIDOS DA, 1984, NATURE, V310, P469, DOI 10.1038/310469a0; Stewart S, 2000, J BIOL CHEM, V275, P8854, DOI 10.1074/jbc.275.12.8854; Takeuchi S, 1996, CANCER RES, V56, P738; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070	50	239	240	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					25	33		10.1038/ng721	http://dx.doi.org/10.1038/ng721			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528387				2022-12-27	WOS:000170781300012
J	Sisodiya, SM; Free, SL; Williamson, KA; Mitchell, TN; Willis, C; Stevens, JM; Kendall, BE; Shorvon, SD; Hanson, IM; Moore, AT; van Heyningen, V				Sisodiya, SM; Free, SL; Williamson, KA; Mitchell, TN; Willis, C; Stevens, JM; Kendall, BE; Shorvon, SD; Hanson, IM; Moore, AT; van Heyningen, V			PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans	NATURE GENETICS			English	Article							SMALL-EYE SEY; GENE DOSAGE; DEFECTS; DIFFERENTIATION; FOREBRAIN; ANIRIDIA; CORTEX; MOUSE; MICE	PAX6 is widely expressed in the central nervous system. Heterozygous PAX6 mutations in human aniridia cause defects that would seem to be confined to the eye(1). Magnetic resonance imaging (MRI) and smell testing reveal the absence or hypoplasia of the anterior commissure and reduced olfaction in a large proportion of aniridia cases, which shows that PAX6 haploinsuffiency causes more widespread human neuro developmental anomalies.	UCL, Inst Neurol, Dept Clin Neurol, Epilepsy Res Grp, London WC1N 3BG, England; Natl Soc Epilepsy, Gerrards Cross SL9 0RJ, Bucks, England; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Moorfields Eye Hosp, London EC1V 2PD, England; Addenbrookes Hosp, Cambridge CB2 2QQ, England	University of London; University College London; University of Edinburgh; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Sisodiya, SM (corresponding author), UCL, Inst Neurol, Dept Clin Neurol, Epilepsy Res Grp, Queen Sq, London WC1N 3BG, England.	sisodiya@ion.ucl.ac.uk	VAN HEYNINGEN, Veronica/GYE-0531-2022; van Heyningen, Veronica/B-8039-2008; Shorvon, Simon D/A-2019-2009	van Heyningen, Veronica/0000-0003-0359-0141; Hanson, Isabel/0000-0002-1878-0530	Medical Research Council [MC_U127527199] Funding Source: Medline; MRC [MC_U127527199] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Dellovade TL, 1998, J COMP NEUROL, V402, P402; Di Virgilio G, 1999, EXP BRAIN RES, V124, P1, DOI 10.1007/s002210050593; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; HANSON I, 1995, TRENDS GENET, V11, P268, DOI 10.1016/S0168-9525(00)89073-3; MARTHA A, 1995, HUM MUTAT, V6, P44, DOI 10.1002/humu.1380060109; Mastick GS, 1997, DEVELOPMENT, V124, P1985; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Sisodiya S, 1996, J ANAT, V188, P425; Stoykova A, 1996, DEVELOPMENT, V122, P3453; Warren N, 1999, CEREB CORTEX, V9, P627, DOI 10.1093/cercor/9.6.627	14	179	185	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					214	216		10.1038/90042	http://dx.doi.org/10.1038/90042			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431688				2022-12-27	WOS:000169656400010
J	Xu, X; Leo, C; Jang, YJ; Chan, E; Padilla, D; Huang, BCB; Lin, T; Gururaja, T; Hitoshi, Y; Lorens, JB; Anderson, DC; Sikic, B; Luo, Y; Payan, DG; Nolan, GP				Xu, X; Leo, C; Jang, YJ; Chan, E; Padilla, D; Huang, BCB; Lin, T; Gururaja, T; Hitoshi, Y; Lorens, JB; Anderson, DC; Sikic, B; Luo, Y; Payan, DG; Nolan, GP			Dominant effector genetics in mammalian cells	NATURE GENETICS			English	Article							HEAT-SHOCK-FACTOR; VIRUS-X PROTEIN; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; PROTEASOME INHIBITORS; SUPPRESSOR ELEMENTS; PHAGE DISPLAY; SUBUNIT-ZETA; EXPRESSION; ACTIVATION	We have expressed libraries of peptides in mammalian cells to select for trans-dominant effects on intracellular signaling systems. As an example-and to reveal pharmacologically relevant points in pathways that lead to Taxol resistance-we selected for peptide motifs that confer resistance to Taxol-induced cell death. Of several peptides selected, one, termed RGP8.5, was linked to upregulation of expression of the gene ABCB1 (also known as MDR1, for multiple drug resistance) in HeLa cells. Our data indicate that trans-dominant effector peptides can point to potential mechanisms by which signaling systems operate. Such tools may be useful in functional genomic analysis of signaling pathways in mammalian disease processes.	Rigel Inc, San Francisco, CA USA; Stanford Univ, Dept Microbiol & Immunol, Dept Mol Pharmacol, Palo Alto, CA 94304 USA; Stanford Univ, Dept Med Oncol, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Xu, X (corresponding author), Rigel Inc, San Francisco, CA USA.		Nolan, Garry/AAE-7903-2019; Lorens, James/B-9737-2017	Lorens, James/0000-0002-6782-3349; Nolan, Garry/0000-0002-8862-9043				Ausubel F.M., 1994, CURRENT PROTOCOLS MO, V1; BELLOREUSS E, 1994, AM J PHYSIOL-CELL PH, V267, pC1351, DOI 10.1152/ajpcell.1994.267.5.C1351; Blum JH, 2000, P NATL ACAD SCI USA, V97, P2241, DOI 10.1073/pnas.040573397; BODENMULLER H, 1986, EMBO J, V5, P1825, DOI 10.1002/j.1460-2075.1986.tb04433.x; Cabilly S, 1999, MOL BIOTECHNOL, V12, P143, DOI 10.1385/MB:12:2:143; Caponigro G, 1998, P NATL ACAD SCI USA, V95, P7508, DOI 10.1073/pnas.95.13.7508; CASTRO B, 1975, TETRAHEDRON LETT, V14, P1219; Chen G, 1997, J BIOL CHEM, V272, P5974, DOI 10.1074/jbc.272.9.5974; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Colas P, 1996, NATURE, V380, P548, DOI 10.1038/380548a0; Doong SL, 1998, J HEPATOL, V29, P872, DOI 10.1016/S0168-8278(98)80113-X; Dumontet C, 1996, CANCER RES, V56, P1091; Gallagher WM, 1997, ONCOGENE, V14, P185; Gao YH, 2000, J CLIN INVEST, V106, P439, DOI 10.1172/JCI9826; Groettrup M, 1999, DRUG DISCOV TODAY, V4, P63, DOI 10.1016/S1359-6446(98)01292-6; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Gururaja TL, 1996, PEPTIDE RES, V9, P283; Gururaja TL, 2000, CHEM BIOL, V7, P515, DOI 10.1016/S1074-5521(00)00137-X; HART SM, 1993, LEUKEMIA LYMPHOMA, V11, P239, DOI 10.3109/10428199309087001; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; Hu ZY, 1999, J VIROL, V73, P7231, DOI 10.1128/JVI.73.9.7231-7240.1999; Huang JK, 1996, J VIROL, V70, P5582, DOI 10.1128/JVI.70.8.5582-5591.1996; Huang Y, 1997, LEUKEMIA, V11, P253, DOI 10.1038/sj.leu.2400557; Jorgensen L, 1999, MOL BIOL REP, V26, P119, DOI 10.1023/A:1006965602142; Kania MA, 1996, EUR J BIOCHEM, V236, P510, DOI 10.1111/j.1432-1033.1996.00510.x; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kaye Stanley B., 1998, Current Opinion in Oncology, V10, pS15; Kim SH, 1997, CANCER LETT, V115, P9, DOI 10.1016/S0304-3835(97)04725-3; Klimka A, 1999, BRIT J CANCER, V80, P1214, DOI 10.1038/sj.bjc.6690488; Kundu B, 1999, Prog Drug Res, V53, P89; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LEE JS, 1994, MOL PHARMACOL, V46, P627; Leith C, 1998, Curr Opin Hematol, V5, P287; Lorens JB, 2000, MOL THER, V1, P438, DOI 10.1006/mthe.2000.0063; Mechetner E, 1998, CLIN CANCER RES, V4, P389; MIYAZAKI M, 1992, BIOCHEM BIOPH RES CO, V187, P677, DOI 10.1016/0006-291X(92)91248-O; Norman TC, 1999, SCIENCE, V285, P591, DOI 10.1126/science.285.5427.591; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Petit F, 1997, BIOCHEM J, V326, P93, DOI 10.1042/bj3260093; Schaffitzel C, 1999, J IMMUNOL METHODS, V231, P119, DOI 10.1016/S0022-1759(99)00149-0; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; Tsurumi C, 1996, Nihon Rinsho, V54, P861; Volm M, 1998, ANTICANCER RES, V18, P2905; Wong DWS, 1998, ANN NY ACAD SCI, V864, P555, DOI 10.1111/j.1749-6632.1998.tb10379.x; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; YAMAGUCHI M, 1995, CANCER, V76, P2351, DOI 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1	47	82	91	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					23	29		10.1038/83717	http://dx.doi.org/10.1038/83717			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137994				2022-12-27	WOS:000166187900011
J	Riazuddin, S; Castelein, CM; Ahmed, ZM; Lalwani, AK; Mastroianni, MA; Naz, S; Smith, TN; Liburd, NA; Friedman, TB; Griffith, AJ; Riazuddin, S; Wilcox, ER				Riazuddin, S; Castelein, CM; Ahmed, ZM; Lalwani, AK; Mastroianni, MA; Naz, S; Smith, TN; Liburd, NA; Friedman, TB; Griffith, AJ; Riazuddin, S; Wilcox, ER			Dominant modifier DFNM1 suppresses recessive deafness DFNB26	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCUS; HEARING IMPAIRMENT; GENE; MUTATION; EXISTENCE; PROTEIN; FORM	More than 50% of severe childhood deafness is genetically determined, approximately 70% of which occurs without other abnormalities and is thus termed nonsyndromic(1,2). So far, 30 nonsyndromic recessive deafness loci have been mapped and the defective genes at 6 loci, DFNB1, DFNB2, DFNB3, DFNB4, DFNB9 and DFNB21, have been identified, encoding connexin-26 (ref. 3), myosin VIIA (ref. 4), myosin XV (ref. 5), pendrin(6) otoferlin(7) and alpha -tectorin(8), respectively. Here we map a new recessive nonsyndromic deafness locus, DFNB26, to a 1.5-cM interval of chromosome 4q31 in a consanguineous Pakistani family. A maximum rod score of 8.10 at theta =0 was obtained with D4S1610 when only the 8 affected individuals in this family were included in the calculation. There are seven unaffected family members who are also homozygous for the DFNB26-linked haplotype and thus are non-penetrant. A dominant modifier, DFNM1. that suppresses deafness in the 7 nonpenetrant individuals was mapped to a 5.6-cM region on chromosome 1q24 with a rod score of 4.31 at theta =0 for D1S2815.	NIDCD, Genet Mol Lab, NIH, Rockville, MD 20852 USA; Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan; Univ Calif San Francisco, Dept Otolaryngol, Lab Mol Otol, San Francisco, CA 94143 USA; NIDCD, Neurootol Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Punjab; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Wilcox, ER (corresponding author), NIDCD, Genet Mol Lab, NIH, Rockville, MD 20852 USA.	wilcoxe@nidcd.nih.gov	Naz, Sadaf/C-3911-2019	Naz, Sadaf/0000-0002-1912-0235	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000035, Z01DC000039, Z01DC000048] Funding Source: NIH RePORTER; NIDCD NIH HHS [Z01DC00035] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aihara T, 1998, CYTOGENET CELL GENET, V81, P191, DOI 10.1159/000015027; Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367; BORK JM, IN PRESS AM J HUM GE; Bridges CB, 1919, J EXP ZOOL, V28, P337, DOI 10.1002/jez.1400280302; Bykhovskaya Y, 2000, AM J HUM GENET, V66, P1905, DOI 10.1086/302914; Cheng NC, 1996, HUM MOL GENET, V5, P309, DOI 10.1093/hmg/5.3.309; Fagerheim T, 1996, HUM MOL GENET, V5, P1187, DOI 10.1093/hmg/5.8.1187; Friedman T, 2000, CURR OPIN NEUROBIOL, V10, P487, DOI 10.1016/S0959-4388(00)00120-3; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Ikeda A, 1999, HUM MOL GENET, V8, P1761, DOI 10.1093/hmg/8.9.1761; KEISELL DP, 1997, NATURE, V387, P80; KERN MJ, 1994, GENOMICS, V19, P334, DOI 10.1006/geno.1994.1066; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sertie AL, 1999, AM J HUM GENET, V65, P433, DOI 10.1086/302491; SLYNN G, 1990, NUCLEIC ACIDS RES, V18, P681, DOI 10.1093/nar/18.3.681; TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421; Verhoeven K, 1999, EUR J HUM GENET, V7, P45, DOI 10.1038/sj.ejhg.5200247; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zielenski J, 1999, NAT GENET, V22, P128, DOI 10.1038/9635	31	95	99	1	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2000	26	4					431	434		10.1038/82558	http://dx.doi.org/10.1038/82558			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101839				2022-12-27	WOS:000165671700014
J	Weiss, KM; Terwilliger, JD				Weiss, KM; Terwilliger, JD			How many diseases does it take to map a gene with SNPs?	NATURE GENETICS			English	Editorial Material							SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN LIPOPROTEIN-LIPASE; TRANSCRIPTIONAL ACTIVITY; DROSOPHILA-MELANOGASTER; FUNCTIONAL GENOMICS; ALZHEIMER-DISEASE; CANDIDATE GENES; SEQUENCE; IDENTIFICATION; POPULATION		Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Columbia Univ, Dept Psychiat, Columbia Genome Ctr, New York, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Columbia University	Weiss, KM (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	kmw4@psu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058239] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 58239] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Artiga MJ, 1998, HUM MOL GENET, V7, P1887, DOI 10.1093/hmg/7.12.1887; Beckwith J. R., 1970, LACTOSE OPERON; BJERREGARD P, 1998, CIRCUMPOLAR INUIT HL; Bojko E R, 1997, Int J Circumpolar Health, V56, P134; Bojko E R, 1999, Int J Circumpolar Health, V58, P170; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Brent R, 1999, CURR BIOL, V9, pR338, DOI 10.1016/S0960-9822(99)80208-5; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Cole KA, 1999, NAT GENET, V21, P38, DOI 10.1038/4466; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Collins FS, 1999, ANN NY ACAD SCI, V882, P42, DOI 10.1111/j.1749-6632.1999.tb08532.x; Collins FS, 1999, GERIATRICS, V54, P41; Eaves IA, 2000, NAT GENET, V25, P320; EWENS WJ, 1978, AM J HUM GENET, V30, P328; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Garg K, 1999, GENOME RES, V9, P1087, DOI 10.1101/gr.9.11.1087; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Gragnoli C, 1997, DIABETES, V46, P1648, DOI 10.2337/diabetes.46.10.1648; Hall S, 1997, ARTERIOSCL THROM VAS, V17, P1969, DOI 10.1161/01.ATV.17.10.1969; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hatfield Frederick., 1993, HARDCORE BODYBUILDIN; HECKENLIVELY JR, 1996, EMORY RIMOINS PRINCI, P2555; HENDRICH BD, 1995, HUM MOL GENET, V4, P1765, DOI 10.1093/hmg/4.suppl_1.1765; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Irizarry K, 2000, NAT GENET, V26, P233, DOI 10.1038/79981; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Long AD, 1998, GENETICS, V149, P999; Mackay TFC, 1996, BIOESSAYS, V18, P113, DOI 10.1002/bies.950180207; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Martin ER, 2000, GENOMICS, V63, P7, DOI 10.1006/geno.1999.6057; McKusick V.A., 1998, MENDELIAN INHERITANC; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; NIKALI K, 1995, AM J HUM GENET, V56, P1088; Ott J, 2000, P NATL ACAD SCI USA, V97, P2, DOI 10.1073/pnas.97.1.2; Pastinen T, 1998, HUM MOL GENET, V7, P1453, DOI 10.1093/hmg/7.9.1453; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roberts L, 2000, SCIENCE, V287, P1898, DOI 10.1126/science.287.5460.1898; Rowell L, 1993, HUMAN CARDIOVASCULAR; RUSSO E, 2000, SCIENTIST, V14, P1; Sander C, 2000, SCIENCE, V287, P1977, DOI 10.1126/science.287.5460.1977; Sarkar S., 1998, GENETICS REDUCTIONIS; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; SCHLIEF R, 1986, GENETICS MOL BIOL; Scholtz CL, 1999, HUM MOL GENET, V8, P2025, DOI 10.1093/hmg/8.11.2025; Schork NJ, 1998, TRENDS GENET, V14, P266, DOI 10.1016/S0168-9525(98)01497-8; Shephard R.J., 1996, HLTH CONSEQUENCES MO, DOI [10.1017/CBO9780511983726, DOI 10.1017/CBO9780511983726]; Sing C, 1999, AM J HUM GENET, V65, pA14; Stam LF, 1996, GENETICS, V144, P1559; STEEL CM, 1996, EMORY RIMOINS PRINCI, P1501; TANG M, 1998, JAMA-J AM MED ASSOC, V2789, P751; Tang MX, 1996, AM J HUM GENET, V58, P574; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Terwilliger JD, 2000, HUM BIOL, V72, P63; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; TERWILLIGER JD, 2000, GENETIC DISSECTION C; TERWILLIGER JD, IN PRESS EUR J HUM G; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Trowell H. C., 1981, W DIS THEIR EMERGENC; Varilo T, 2000, EUR J HUM GENET, V8, P604, DOI 10.1038/sj.ejhg.5200482; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; WEISS K, IN PRESS THEOR POPUL; Weiss KM, 1996, MOL PHYLOGENET EVOL, V5, P259, DOI 10.1006/mpev.1996.0019; Weiss KM, 1998, GENOME RES, V8, P691, DOI 10.1101/gr.8.7.691; WEISS KM, 1999, GENETIC VARIATION HU; Woychik RP, 1998, MUTAT RES-FUND MOL M, V400, P3, DOI 10.1016/S0027-5107(98)00023-2; Zollner S, 2000, AM J HUM GENET, V66, P615, DOI 10.1086/302766	76	354	372	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2000	26	2					151	157		10.1038/79866	http://dx.doi.org/10.1038/79866			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017069				2022-12-27	WOS:000089638800010
J	Taylor, MD; Liu, L; Raffel, C; Hui, CC; Mainprize, TG; Zhang, XY; Agatep, R; Chiappa, S; Gao, LZ; Lowrance, A; Hao, AH; Goldstein, AM; Stavrou, T; Scherer, SW; Dura, WT; Wainwright, B; Squire, JA; Rutka, JT; Hogg, D				Taylor, MD; Liu, L; Raffel, C; Hui, CC; Mainprize, TG; Zhang, XY; Agatep, R; Chiappa, S; Gao, LZ; Lowrance, A; Hao, AH; Goldstein, AM; Stavrou, T; Scherer, SW; Dura, WT; Wainwright, B; Squire, JA; Rutka, JT; Hogg, D			Mutations in SUFU predispose to medulloblastoma	NATURE GENETICS			English	Article							BASAL-CELL CARCINOMAS; PRIMITIVE NEUROECTODERMAL TUMORS; CENTRAL-NERVOUS-SYSTEM; HUMAN HOMOLOG; SONIC HEDGEHOG; GORLIN SYNDROME; PATCHED PTCH; GENE; SUPPRESSOR; SKIN	The sonic hedgehog (SHH) signaling pathway directs the embryonic development of diverse organisms and is disrupted in a variety of malignancies. Pathway activation is triggered by binding of hedgehog proteins to the multipass Patched-1 (PTCH) receptor, which in the absence of hedgehog suppresses the activity of the seven-pass membrane protein Smoothened (SMOH). De-repression of SMOH culminates in the activation of one or more of the GLI transcription factors that regulate the transcription of downstream targets. Individuals with germline mutations of the SHH receptor gene PTCH are at high risk of developmental anomalies and of basal-cell carcinomas, medulloblastomas and other cancers (a pattern consistent with nevoid basal-cell carcinoma syndrome, NBCCS). In keeping with the role of PTCH as a tumor-suppressor gene, somatic mutations of this gene occur in sporadic basal-cell carcinomas and medulloblastomas. We report here that a subset of children with medulloblastoma carry germline and somatic mutations in SUFU (encoding the human suppressor of fused) of the SHH pathway, accompanied by loss of heterozygosity of the wildtype allele. Several of these mutations encode truncated proteins that are unable to export the GLI transcription factor from nucleus to cytoplasm, resulting in the activation of SHH signaling. SUFU is a newly identified tumor-suppressor gene that predisposes individuals to medulloblastoma by modulating the SHH signaling pathway through a newly identified mechanism.	Univ Toronto, Div Clin Sci, Toronto, ON, Canada; Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Mayo Clin, Dept Neurosurg, Rochester, MN USA; NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Childrens Natl Med Ctr, Dept Hematol Oncol, Washington, DC 20010 USA; Univ Warsaw, Dept Pathol, Warsaw, Poland; Univ Queensland, Ritchie Res Labs, St Lucia, Qld, Australia; Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Children's National Health System; University of Warsaw; University of Queensland; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Rutka, JT (corresponding author), Univ Toronto, Div Clin Sci, Toronto, ON, Canada.		Squire, Jeremy A/F-4437-2012; Squire, Jeremy A/A-9352-2012; Scherer, Stephen W./B-3785-2013	Squire, Jeremy A/0000-0002-9863-468X; Scherer, Stephen W./0000-0002-8326-1999; Taylor, Michael/0000-0001-7009-3466; Wainwright, Brandon/0000-0003-0406-2092				Bayani J, 2000, J NEUROSURG, V93, P437, DOI 10.3171/jns.2000.93.3.0437; Chidambaram A, 1996, CANCER RES, V56, P4599; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; LOBO S, 1992, AM J MED GENET, V43, P701, DOI 10.1002/ajmg.1320430410; Meng XW, 2001, J BIOL CHEM, V276, P40113, DOI 10.1074/jbc.M105317200; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Raffel C, 1997, CANCER RES, V57, P842; Raffel C, 1999, CLIN CANCER RES, V5, P4085; Reifenberger J, 1998, CANCER RES, V58, P1798; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Taylor MD, 2000, NEUROSURGERY, V47, P888, DOI 10.1097/00006123-200010000-00020; Unden AB, 1996, CANCER RES, V56, P4562; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wicking C, 1997, AM J HUM GENET, V60, P21; Wolter M, 1997, CANCER RES, V57, P2581; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zurawel RH, 1998, CANCER RES, V58, P896; Zurawel RH, 2000, GENE CHROMOSOME CANC, V27, P44, DOI 10.1002/(SICI)1098-2264(200001)27:1<44::AID-GCC6>3.0.CO;2-V	31	595	622	1	42	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					306	310		10.1038/ng916	http://dx.doi.org/10.1038/ng916			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12068298				2022-12-27	WOS:000176494100021
J	Bulavin, DV; Demidov, ON; Saito, S; Kauraniemi, P; Phillips, C; Amundson, SA; Ambrosino, C; Sauter, G; Nebreda, AR; Anderson, CW; Kallioniemi, A; Fornace, AJ; Appella, E				Bulavin, DV; Demidov, ON; Saito, S; Kauraniemi, P; Phillips, C; Amundson, SA; Ambrosino, C; Sauter, G; Nebreda, AR; Anderson, CW; Kallioniemi, A; Fornace, AJ; Appella, E			Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity	NATURE GENETICS			English	Article							POSTTRANSLATIONAL MODIFICATIONS; PREMATURE SENESCENCE; GENETIC ALTERATIONS; HUMAN FIBROBLASTS; BREAST-CANCER; UV-RADIATION; P38 KINASE; PATHWAY; PROTEIN; PHOSPHATASE	Expression of oncogenic Ras in primary human cells activates p53, thereby protecting cells from transformation. We show that in Ras-expressing IMR-90 cells, p53 is phosphorylated at Ser33 and Ser46 by the p38 mitogen-activated protein kinase (MAPK). Activity of p38 MAPK is regulated by the p53-inducible phosphatase PPM1D, creating a potential feedback loop. Expression of oncogenic Ras suppresses PPM1D mRNA induction, leaving p53 phosphorylated at Ser33 and Ser46 and in an active state. Retrovirus-mediated overexpression of PPM1D reduced p53 phosphorylation at these sites, abrogated Ras-induced apoptosis and partially rescued cells from cell-cycle arrest. Inactivation of p38 MAPK (the product of Mapk14) in vivo by gene targeting or by PPM1D overexpression expedited tumor formation after injection of mouse embryo fibroblasts (MEFs) expressing E1A+Ras into nude mice. The gene encoding PPM1D (PPM1D, at 17q22/q23) is amplified in human breast-tumor cell lines and in approximately 11% of primary breast tumors, most of which harbor wildtype p53. These findings suggest that inactivation of the p38 MAPK through PPM1D overexpression resulting from PPM1D amplification contributes to the development of human cancers by suppressing p53 activation.	NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NIH, Gene Response Sect, Bethesda, MD 20892 USA; NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; Tampere Univ, Inst Med Technol, Canc Genet Lab, Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; European Mol Biol Lab, Heidelberg, Germany; Univ Basel, Inst Pathol, Basel, Switzerland; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Tampere University; Tampere University; Tampere University Hospital; European Molecular Biology Laboratory (EMBL); University of Basel; United States Department of Energy (DOE); Brookhaven National Laboratory	Appella, E (corresponding author), NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.		Nebreda, Angel Rodriguez/R-9594-2019; Demidov, Oleg/U-2050-2017; Fornace, Albert J/A-7407-2008; Demidov, Oleg/AAC-4462-2021; ambrosino, concetta/AAB-3452-2019	Demidov, Oleg/0000-0003-4323-7174; Fornace, Albert J/0000-0001-9695-085X; Demidov, Oleg/0000-0003-4323-7174; Kallioniemi, Anne/0000-0003-3552-8158; Dudgeon, Crissy/0000-0001-9010-2569				Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; Bulavin DV, 1999, ONCOGENE, V18, P5611, DOI 10.1038/sj.onc.1202945; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Esteller M, 2000, CANCER RES, V60, P129; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Ho GH, 2001, BREAST CANCER RES TR, V65, P225, DOI 10.1023/A:1010686518990; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LI J, 2002, NATURE GENET, V31; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; OConnor PM, 1997, CANCER RES, V57, P4285; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Oster SK, 2000, MOL CELL BIOL, V20, P6768, DOI 10.1128/MCB.20.18.6768-6778.2000; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.3.CO;2-C; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	31	342	364	1	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					210	215		10.1038/ng894	http://dx.doi.org/10.1038/ng894			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12021785				2022-12-27	WOS:000175903500021
J	Verpy, E; Masmoudi, S; Zwaenepoel, I; Leibovici, M; Hutchin, TP; Del Castillo, I; Nouaille, S; Blanchard, S; Laine, S; Popot, JL; Moreno, F; Mueller, RF; Petit, C				Verpy, E; Masmoudi, S; Zwaenepoel, I; Leibovici, M; Hutchin, TP; Del Castillo, I; Nouaille, S; Blanchard, S; Laine, S; Popot, JL; Moreno, F; Mueller, RF; Petit, C			Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus	NATURE GENETICS			English	Article							INNER-EAR; ACELLULAR MEMBRANES; MYOSIN-VIIA; SEQUENCES; OTOGELIN; INSIGHTS; CELLS; CDNA	Hearing impairment affects about 1 in 1,000 children at birth. Approximately 70 loci implicated in non-syndromic forms of deafness have been reported in humans and 24 causative genes have been identified(1) (see also http://www.uia.ac.be/dnalab/hhh). We report a mouse transcript, isolated by a candidate deafness gene approach, that is expressed almost exclusively in the inner ear. Genomic analysis shows that the human ortholog STRC (so called owing to the name we have given its protein-stereocilin), which is located on chromosome 15q15, contains 29 exons encompassing approximately 19 kb. STRC is tandemly duplicated, with the coding sequence of the second copy interrupted by a stop codon in exon 20. We have identified two frameshift mutations and a large deletion in the copy containing 29 coding exons in two families affected by autosomal recessive non-syndromal sensorineural deafness linked to the DFNB16 locus. Stereocilin is made up of 1,809 amino acids, and contains a putative signal petide and several hydrophobic segments. Using immunohistolabeling, we demonstrate that, in the mouse inner ear,stereocilin is expressed only in the sensory hair cells and is associated with the stereocilia, the stiff microvilli forming the structure for mechanoreception of sound stimulation.	Inst Pasteur, CNRS URA 1968, Unite Genet Deficits Sensoriels, F-75724 Paris 15, France; Fac Med Sfax, Lab Genet Mol Humaine, Sfax, Tunisia; St James Hosp, Dept Mol Med, Leeds LS9 7TF, W Yorkshire, England; St James Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Hosp Ramon y Cajal, Unidad Genet Mol, E-28034 Madrid, Spain; Inst Biol Physicochim, CNRS UPR9052, Unite Physico Chim Mol Membranes Biol, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Sfax; Saint James's University Hospital; Saint James's University Hospital; Hospital Universitario Ramon y Cajal	Petit, C (corresponding author), Inst Pasteur, CNRS URA 1968, Unite Genet Deficits Sensoriels, 25 Rue Dr Roux, F-75724 Paris 15, France.		Masmoudi, Saber/W-1478-2019; del Castillo, Ignacio/B-4314-2013; Leibovici, Michel/ABB-6745-2020	del Castillo, Ignacio/0000-0003-1188-3665; Saber, Masmoudi/0000-0002-1076-5256; Petit, Christine/0000-0002-9069-002X	RNID [G6] Funding Source: Medline	RNID		Campbell DA, 1997, J MED GENET, V34, P1015, DOI 10.1136/jmg.34.12.1015; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; PETIT C, IN PRESS ANN REV GEN; POPOT JL, 1990, ANNU REV BIOPHYS BIO, V19, P369; Simmler MC, 2000, MAMM GENOME, V11, P961, DOI 10.1007/s003350010197; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Villamar M, 1999, AM J HUM GENET, V64, P1238, DOI 10.1086/302321; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zine A, 1996, BRAIN RES, V721, P49, DOI 10.1016/0006-8993(96)00147-3	19	114	123	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					345	349		10.1038/ng726	http://dx.doi.org/10.1038/ng726			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687802				2022-12-27	WOS:000171911000025
J	Moreira, MC; Barbot, C; Tachi, N; Kozuka, N; Uchida, E; Gibson, T; Mendonca, P; Costa, M; Barros, J; Yanagisawa, T; Watanabe, M; Ikeda, Y; Aoki, M; Nagata, T; Coutinho, P; Sequeiros, J; Koenig, M				Moreira, MC; Barbot, C; Tachi, N; Kozuka, N; Uchida, E; Gibson, T; Mendonca, P; Costa, M; Barros, J; Yanagisawa, T; Watanabe, M; Ikeda, Y; Aoki, M; Nagata, T; Coutinho, P; Sequeiros, J; Koenig, M			The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin	NATURE GENETICS			English	Article							CEREBELLAR ATROPHY HMSNCA; DNA STRAND BREAKS; POLY(ADP-RIBOSE) POLYMERASE; HEREDITARY MOTOR; LIGASE-III; NEUROPATHY; TELANGIECTASIA; KINASE; ATM	The newly recognized ataxia-ocular apraxia 1 (AOA1; MIM 208920)(1-4) is the most frequent cause of autosomal recessive ataxia in Japan(2,4-9) and is second only to Friedreich ataxia in Portugal(10). It shares several neurological features with ataxia-telanglectasia, including early onset ataxia, oculomotor apraxia and cerebellar atrophy, but does not share its extraneurological features (immune deficiency, chromosomal instability and hypersensitivity to X-rays). AOA1 is also characterized by axonal motor neuropathy(3,5,9) and the later decrease of serum albumin levels and elevation of total cholesterol(2,4,5,9). We have identified the gene causing AOA1 and the major Portuguese and Japanese mutations. This gene encodes a new, ubiquitously expressed protein that we named aprataxin. This protein is composed of three domains that share distant homology with the amino-terminal domain of polynucleotide kinase 3'-phosphatase (PNKP), with histidine-triad (HIT) proteins and with DNA-binding C2H2 zinc-finger proteins, respectively. PNKP is involved in DNA single-strand break repair (SSBR)(11) following exposure to ionizing radiation and reactive oxygen species. Fragile-HIT proteins (FHIT) cleave diadenosine tetraphosphate, which is potentially produced during activation of the SSBR complex(12). The results suggest that aprataxin is a nuclear protein with a role in DNA repair reminiscent of the function of the protein defective in ataxia-telangiectasia, but that would cause a phenotype restricted to neurological signs when mutant.	Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; Univ Porto, IBMC, UnIGENe, Oporto, Portugal; Univ Porto, ICBAS, Oporto, Portugal; Hosp Maria Pia, Dept Neurol, Oporto, Portugal; Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido, Japan; European Mol Biol Lab, Heidelberg, Germany; Hosp Divino Espirito Santo, Dept Hematol, Azores, Portugal; Hosp Pedro Hispano, Dept Neurol, Matosinhos, Portugal; Hosp Geral Sto Antonio, Dept Neurol, Oporto, Portugal; Isesaki Fukushima Hosp, Dept Neurol, Iseaki, Japan; Gunma Univ, Sch Med, Dept Neurol, Maebashi, Gumma, Japan; Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; Hosp S Sebastiao, Div Neurol, Santa Maria da Feira, Portugal	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade do Porto; Universidade do Porto; Sapporo Medical University; European Molecular Biology Laboratory (EMBL); Gunma University; Tohoku University	Koenig, M (corresponding author), Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, CU Strasbourg, Illkirch Graffenstaden, France.		Barbot, Clara/K-6378-2013; Coutinho, Paula/K-6053-2013	Barbot, Clara/0000-0002-5597-107X; Sequeiros, Jorge/0000-0002-9846-1037; Barros, Jose/0000-0001-6183-5050; Franco Mendonca, Pedro/0000-0002-3850-2909; Gibson, Toby James/0000-0003-0657-5166; Coutinho, Paula/0000-0002-3461-230X				AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; Barbot C, 2001, ARCH NEUROL-CHICAGO, V58, P201, DOI 10.1001/archneur.58.2.201; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; FUKUHARA N, 1995, J NEUROL SCI, V133, P140, DOI 10.1016/0022-510X(95)00176-3; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; GIBSON TJ, 1988, PROTEIN ENG, V2, P209, DOI 10.1093/protein/2.3.209; Hanihara T, 1995, Rinsho Shinkeigaku, V35, P83; Hawley RS, 1996, GENE DEV, V10, P2383, DOI 10.1101/gad.10.19.2383; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kubota H, 1995, No To Shinkei, V47, P289; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; McLennan AG, 2000, PHARMACOL THERAPEUT, V87, P73, DOI 10.1016/S0163-7258(00)00041-3; MOREIRA MC, 1999, ARQ MED, V13, P39; Moreira MD, 2001, AM J HUM GENET, V68, P501, DOI 10.1086/318191; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Sekijima Y, 1998, J NEUROL SCI, V158, P30, DOI 10.1016/S0022-510X(98)00103-8; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Tachi N, 2000, EUR NEUROL, V43, P82, DOI 10.1159/000008140; UEKAWA K, 1992, CLIN NEUROL, V32, P1067; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; YOSHIHARA K, 1981, J BIOL CHEM, V256, P6756	26	317	329	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					189	193		10.1038/ng1001-189	http://dx.doi.org/10.1038/ng1001-189			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586300				2022-12-27	WOS:000171374100026
J	Filippova, GN; Thienes, CP; Penn, BH; Cho, DH; Hu, YJ; Moore, JM; Klesert, T; Lobanenkov, VV; Tapscott, SJ				Filippova, GN; Thienes, CP; Penn, BH; Cho, DH; Hu, YJ; Moore, JM; Klesert, T; Lobanenkov, VV; Tapscott, SJ			CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus	NATURE GENETICS			English	Article							C-MYC GENE; ENHANCER-BLOCKING ACTIVITY; MYOTONIC-DYSTROPHY GENE; CTG REPEAT; MESSENGER-RNA; TRANSCRIPTIONAL ACTIVATION; REDUCES EXPRESSION; TRIPLET REPEATS; DNA-SEQUENCE; PROTEIN CTCF	An expansion of a CTG repeat at the DM1 locus causes myotonic dystrophy (DM) by altering the expression of the two adjacent genes, DMPK and SIX5, and through a toxic effect of the repeat-containing RNA. Here we identify two CTCF-binding sites that flank the CTG repeat and form an insulator element between DMPK and SIX5. Methylation of these sites prevents binding of CTCF, indicating that the DM1 locus methylation in congenital DM would disrupt insulator function. Furthermore, CTCF-binding sites are associated with CTG/CAG repeats at several other loci. We suggest a general role for CTG/CAG repeats as components of insulator elements at multiple sites in the human genome.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98109 USA; NIAID, Mol Pathol Sect, Immunopathol Lab, NIH, Bethesda, MD 20892 USA; Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle	Lobanenkov, VV (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.		Lobanenkov, Victor/ABD-5710-2021; Lobanenkov, Victor V./AGQ-8903-2022	Tapscott, Stephen/0000-0002-0319-0968; Thienes, Cortlandt/0000-0002-1715-7835; Lobanenkov, Victor/0000-0001-6665-3635	NATIONAL CANCER INSTITUTE [R01CA068360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045203] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA68360] Funding Source: Medline; NIAMS NIH HHS [R01-AR45203] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alwazzan M, 1998, MAMM GENOME, V9, P485, DOI 10.1007/s003359900804; Awad TA, 1999, J BIOL CHEM, V274, P27092, DOI 10.1074/jbc.274.38.27092; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 1998, GENE CHROMOSOME CANC, V22, P26, DOI 10.1002/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Godde JS, 1996, J BIOL CHEM, V271, P15222, DOI 10.1074/jbc.271.25.15222; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Klesert TR, 2000, NAT GENET, V25, P105, DOI 10.1038/75490; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; LOBANENKOV VV, 1986, EUR J BIOCHEM, V159, P181, DOI 10.1111/j.1432-1033.1986.tb09850.x; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; NOVELLI G, 1993, BIOCHEM MOL BIOL INT, V29, P291; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; Sarkar PS, 2000, NAT GENET, V25, P110, DOI 10.1038/75500; Steinbach P, 1998, AM J HUM GENET, V62, P278, DOI 10.1086/301711; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tapscott SJ, 2000, SCIENCE, V289, P1701, DOI 10.1126/science.289.5485.1701; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; WANG YH, 1995, GENOMICS, V25, P570, DOI 10.1016/0888-7543(95)80061-P; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; Wang YH, 1996, J MOL BIOL, V263, P511, DOI 10.1006/jmbi.1996.0593; Wolffe AP, 2000, CURR BIOL, V10, pR463, DOI 10.1016/S0960-9822(00)00534-0	45	245	256	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					335	343		10.1038/ng570	http://dx.doi.org/10.1038/ng570			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479593				2022-12-27	WOS:000170174800013
J	Serra, E; Rosenbaum, T; Nadal, M; Winner, U; Ars, E; Estivill, X; Lazaro, C				Serra, E; Rosenbaum, T; Nadal, M; Winner, U; Ars, E; Estivill, X; Lazaro, C			Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas	NATURE GENETICS			English	Letter							BENIGN NEUROFIBROMAS; GENE; HETEROZYGOSITY; TYPE-1; CELLS; TUMORS; DNA	Pure populations of neurofibroma-derived Schwann cells bearing both NF1 mutated alleles (NF1(-/-)) have been isolated from different neurofibromas' showing loss of heterozygosity of nearly the entire 17q chromosome. By comparing molecular and fluorescent in site hybridization analysis of these cells, we demonstrate mitotic recombination is the mechanism underlying this type of loss of heterozygosity leading to reduction to homozygosity of NF1 germline mutation.	Hosp Duran & Reynals, IRO, Med & Mol Genet Ctr, Barcelona 08907, Spain; Univ Dusseldorf, Childrens Hosp, Dept Neuropediat, D-40225 Dusseldorf, Germany	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Heinrich Heine University Dusseldorf	Lazaro, C (corresponding author), Hosp Duran & Reynals, IRO, Med & Mol Genet Ctr, Autovia Castelldefels Km 2-7, Barcelona 08907, Spain.	clazaro@iro.es	GARCIA, CONXI LAZARO/Q-2410-2016; Ars, Elisabet/AAM-8454-2021; Serra, Eduard/K-1332-2013; Estivill, Xavier/E-2957-2012; Estivill, Xavier/A-3125-2013	GARCIA, CONXI LAZARO/0000-0002-7198-5906; Ars, Elisabet/0000-0002-4118-4358; Serra, Eduard/0000-0003-2895-9857; Estivill, Xavier/0000-0002-0723-2256; Nadal, Marga/0000-0002-5739-1693				Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; Cooper LJN, 2000, BLOOD, V96, P2310; Correa CL, 2000, AM J HUM GENET, V66, P1969, DOI 10.1086/302920; Daschner K, 1997, BIOCHEM BIOPH RES CO, V234, P346, DOI 10.1006/bbrc.1997.6645; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; EASTGATE AR, 1993, J ANAL ATOM SPECTROM, V8, P305, DOI 10.1039/ja9930800305; Eisenbarth I, 2000, AM J HUM GENET, V66, P393, DOI 10.1086/302747; Gupta PK, 1997, CANCER RES, V57, P1188; Holt D, 1999, AM J HUM GENET, V65, P1423, DOI 10.1086/302614; John AM, 2000, J MED GENET, V37, P44, DOI 10.1136/jmg.37.1.44; Kluwe L, 1999, CANCER GENET CYTOGEN, V113, P65, DOI 10.1016/S0165-4608(99)00006-0; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nadal M, 1997, J MED GENET, V34, P50, DOI 10.1136/jmg.34.1.50; Rasmussen SA, 2000, GENE CHROMOSOME CANC, V28, P425, DOI 10.1002/1098-2264(200008)28:4<425::AID-GCC8>3.0.CO;2-E; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; Serra E, 1997, AM J HUM GENET, V61, P512, DOI 10.1086/515504; Serra E, 2001, HUM GENET, V108, P416; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; STEPHENS K, 1998, AM J HUM GENET, V63, pA39; Tischfield JA, 1997, AM J HUM GENET, V61, P995, DOI 10.1086/301617; Wallace MR, 2000, GENE CHROMOSOME CANC, V27, P117, DOI 10.1002/(SICI)1098-2264(200002)27:2<117::AID-GCC1>3.0.CO;2-H; Wu Q, 1995, NUCLEIC ACIDS RES, V23, P5087, DOI 10.1093/nar/23.24.5087	25	55	57	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					294	296		10.1038/90148	http://dx.doi.org/10.1038/90148			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431704				2022-12-27	WOS:000169656400026
J	Coller, HA; Khrapko, K; Bodyak, ND; Nekhaeva, E; Herrero-Jimenez, P; Thilly, WG				Coller, HA; Khrapko, K; Bodyak, ND; Nekhaeva, E; Herrero-Jimenez, P; Thilly, WG			High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection	NATURE GENETICS			English	Letter							MICROSATELLITE INSTABILITY; SOMATIC MUTATIONS; POINT MUTATIONS; CONTROL REGION; UNITED-STATES; COLON-CANCER; GENOME; SEGREGATION; ADVANTAGE; SEQUENCE	Researchers in several laboratories have reported a high frequency of homoplasmic mitochondrial DNA (mtDNA) mutations in human tumors(1-6). This observation has been interpreted to reflect a replicative advantage for mutated mtDNA copies(1,2,6), a growth advantage for a cell containing certain mtDNA mutations(1,6), and/or tumorigenic properties of mtDNA mutations(2). We consider another possibility-that the observed homoplasmy arose entirely by chance in tumor progenitor cells, without any physiological advantage or tumorigenic requirement. Through extensive computer modeling, we demonstrate that there is sufficient opportunity for a tumor progenitor cell to achieve homoplasmy through unbiased mtDNA replication and sorting during cell division. To test our model in vivo, we analyzed mtDNA homoplasmy in healthy human epithelial tissues and discovered that the model correctly predicts the considerable observed frequency of homoplasmic cells. Based on the available data on mitochondrial mutant fractions and cell division kinetics, we show that the predicted frequency of homoplasmy in tumor progenitor cells in the absence of selection is similar to the reported frequency of homoplasmic mutations in tumors. Although a role for other mechanisms is not excluded, random processes are sufficient to explain the incidence of homoplasmic mtDNA mutations in human tumors.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98119 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; MIT, Div Bioengn & Environm Hlth, Environm Hlth Sci Ctr, Cambridge, MA 02139 USA	Fred Hutchinson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Coller, HA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98119 USA.		Khrapko, Konstantin/A-3244-2009		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES007168, P30ES002109, P42ES004675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000251, R03AG018536] Funding Source: NIH RePORTER; NIA NIH HHS [R03-AG18536, T32-AG18388, T32-AG00251] Funding Source: Medline; NIEHS NIH HHS [P01-ES07168, P30 ES002109, P42-ES04675, P30-ES02109] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alonso A, 1997, ELECTROPHORESIS, V18, P682, DOI 10.1002/elps.1150180504; ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BODENTEICH A, 1991, GENE, V108, P305, DOI 10.1016/0378-1119(91)90451-G; Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17; Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949; Coller HA, 1998, CANCER RES, V58, P1268; COOK PJ, 1969, INT J CANCER, V4, P93, DOI 10.1002/ijc.2910040113; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Habano W, 1998, ONCOGENE, V17, P1931, DOI 10.1038/sj.onc.1202112; Habano W, 2000, GASTROENTEROLOGY, V118, P835, DOI 10.1016/S0016-5085(00)70169-7; HEERDT BG, 1994, CANCER RES, V54, P3912; Herrero-Jimenez P, 2000, MUTAT RES-FUND MOL M, V447, P73, DOI 10.1016/S0027-5107(99)00201-8; Herrero-Jimenez P, 1998, MUTAT RES-FUND MOL M, V400, P553, DOI 10.1016/S0027-5107(98)00067-0; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; Pallotti F, 1996, AM J HUM GENET, V59, P591; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Richard SM, 2000, CANCER RES, V60, P4231; SHAY JW, 1990, ANTICANCER RES, V10, P279; SHAY JW, 1987, MUTAT RES, V186, P149, DOI 10.1016/0165-1110(87)90028-5; Shibata D, 1996, NAT MED, V2, P676, DOI 10.1038/nm0696-676; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	25	222	232	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					147	150		10.1038/88859	http://dx.doi.org/10.1038/88859			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381261				2022-12-27	WOS:000169011800016
J	Marth, G; Yeh, R; Minton, M; Donaldson, R; Li, Q; Duan, SG; Davenport, R; Miller, RD; Kwok, PY				Marth, G; Yeh, R; Minton, M; Donaldson, R; Li, Q; Duan, SG; Davenport, R; Miller, RD; Kwok, PY			Single-nucleotide polymorphisms in the public domain: how useful are they?	NATURE GENETICS			English	Article								There is a concerted effort by a number of public and private groups to identify a large set of human single-nucleotide polymorphisms(1,2) (SNPs). As of March 2001, 2.84 million SNPs have been deposited in the public database, dbSNP, at the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/SNP/). The 2.84 million SNPs can he grouped into 1.65 million non-redundant SNPs. As part of the International SNP Map Working Group, we recently published a high-density SNP map of the human genome consisting of 1.42 million SNPs (ref. 3). In addition, numerous SNPs are maintained in proprietary databases. Our survey of more than 1,200 SNPs indicates that more than 80% of TSC and Washington University candidate SNPs are polymorphic and that approximately 50% of the candidate SNPs from these two sources are common SNPs (with minor allele frequency of greater than or equal to 20%) in any given population.	Washington Univ, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Div Dermatol, St Louis, MO 63130 USA; Natl Ctr Biotechnol Informat, Bethesda, MD USA	Washington University (WUSTL); Washington University (WUSTL)	Kwok, PY (corresponding author), Washington Univ, Div Dermatol, St Louis, MO 63130 USA.		Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059	NHGRI NIH HHS [HG01720] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001720] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000158] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; KWOK PY, 1994, GENOMICS, V23, P138, DOI 10.1006/geno.1994.1469; Marshall E, 1999, SCIENCE, V284, P406, DOI 10.1126/science.284.5413.406; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Rozen S, 2000, Methods Mol Biol, V132, P365; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Taillon-Miller P, 1999, GENOME RES, V9, P499; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Taillon-Miller P, 1998, GENOME RES, V8, P748, DOI 10.1101/gr.8.7.748	10	120	130	1	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					371	372		10.1038/86864	http://dx.doi.org/10.1038/86864			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279516				2022-12-27	WOS:000167811200009
J	Tavtigian, SV; Simard, J; Teng, DHF; Abtin, V; Baumgard, M; Beck, A; Camp, NJ; Carillo, AR; Chen, Y; Dayananth, P; Desrochers, M; Dumont, M; Farnham, JM; Frank, D; Frye, C; Ghaffari, S; Gupte, JS; Hu, R; Iliev, D; Janecki, T; Kort, EN; Laity, KE; Leavitt, A; Leblanc, G; McArthur-Morrison, J; Pederson, A; Penn, B; Peterson, KT; Reid, JE; Richards, S; Schroeder, M; Smith, R; Snyder, SC; Swedlund, B; Swensen, J; Thomas, A; Tranchant, M; Woodland, AM; Labrie, F; Skolnick, MH; Neuhausen, S; Rommens, J; Cannon-Albright, LA				Tavtigian, SV; Simard, J; Teng, DHF; Abtin, V; Baumgard, M; Beck, A; Camp, NJ; Carillo, AR; Chen, Y; Dayananth, P; Desrochers, M; Dumont, M; Farnham, JM; Frank, D; Frye, C; Ghaffari, S; Gupte, JS; Hu, R; Iliev, D; Janecki, T; Kort, EN; Laity, KE; Leavitt, A; Leblanc, G; McArthur-Morrison, J; Pederson, A; Penn, B; Peterson, KT; Reid, JE; Richards, S; Schroeder, M; Smith, R; Snyder, SC; Swedlund, B; Swensen, J; Thomas, A; Tranchant, M; Woodland, AM; Labrie, F; Skolnick, MH; Neuhausen, S; Rommens, J; Cannon-Albright, LA			A candidate prostate cancer susceptibility gene at chromosome 17p	NATURE GENETICS			English	Article							POLYADENYLATION SPECIFICITY FACTOR; ANDROGEN RECEPTOR GENE; LINKAGE ANALYSIS; BETA-LACTAMASE; PROTEIN; LOCUS; RISK; SUBSTITUTION; INHERITANCE; SIMILARITY	It is difficult to identify genes that predispose to prostate cancer due to late age at diagnosis, presence of phenocopies within high-risk pedigrees and genetic complexity. A genome-wide scan of large, high-risk pedigrees from Utah has provided evidence for linkage to a locus on chromosome 17p. We carried out positional cloning and mutation screening within the refined interval, identifying a gene, ELAC2, harboring mutations (including a frameshift and a nonconservative missense change) that segregate with prostate cancer in two pedigrees. In addition, two common missense variants in the gene are associated with the occurrence of prostate cancer. ELAC2 is a member of an uncharacterized gene family predicted to encode a metal-dependent hydrolase domain that is conserved among eukaryotes, archaebacteria and eubacteria. The gene product bears amino acid sequence similarity to two better understood protein families, namely the PSO2 (SNM1) DNA interstrand crosslink repair proteins and the 73-kD subunit of mRNA 3' end cleavage and polyadenylation specificity factor (CPSF73).	Myriad Genet Inc, Salt Lake City, UT 84108 USA; Univ Laval, Med Ctr, Oncol & Mol Endocrinol Res Ctr, CHUL, Quebec City, PQ, Canada; Univ Utah, Sch Med, Dept Med Informat, Genet Epidemiol Grp, Salt Lake City, UT USA; LDS Hosp, Intermt Hlth Care, Salt Lake City, UT USA; Univ Toronto, Hosp Sick Children, Program Genet & Genomic Biol, Toronto, ON M5G 1X8, Canada	Myriad Genetics, Inc; Laval University; Utah System of Higher Education; University of Utah; Intermountain Healthcare; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Tavtigian, SV (corresponding author), Myriad Genet Inc, Salt Lake City, UT 84108 USA.	seant@myriad.com		Durocher, Francine/0000-0001-8012-4641; Simard, Jacques/0000-0001-6906-3390; Smith, Richard/0000-0003-1201-6731; Farnham, James/0000-0002-8213-949X; albright, lisa/0000-0003-2602-3668; Thomas, Alun/0000-0001-5650-7044	NCI NIH HHS [CA62154, N01-PC-67000, CA64477] Funding Source: Medline; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067000] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA062154, R01CA064477] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; BARBEYRON T, 1995, MICROBIOL-UK, V141, P2897, DOI 10.1099/13500872-141-11-2897; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P47, DOI 10.1107/S090744499700927X; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chanfreau G, 1996, SCIENCE, V274, P1511, DOI 10.1126/science.274.5292.1511; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Gibbs M, 2000, AM J HUM GENET, V67, P100, DOI 10.1086/302969; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; GLOVANNUCCI E, 1997, P NATL ACAD SCI USA, V94, P3320; HAASE E, 1989, MOL GEN GENET, V218, P64, DOI 10.1007/BF00330566; Jaffe JM, 2000, CANCER RES, V60, P1626; JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183; Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514; JORDE LB, 1981, SCI HUMAINES, V56, P105; Jorde LB, 1981, INFORMATION SCI HUMA, V56, P105; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Makridakis N, 1997, CANCER RES, V57, P1020; Makridakis NM, 1999, LANCET, V354, P975, DOI 10.1016/S0140-6736(98)11282-5; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; Melino S, 1998, TRENDS BIOCHEM SCI, V23, P381, DOI 10.1016/S0968-0004(98)01264-X; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Neuhausen SL, 1999, HUM MOL GENET, V8, P2437, DOI 10.1093/hmg/8.13.2437; Nevill-Manning CG, 1998, P NATL ACAD SCI USA, V95, P5865, DOI 10.1073/pnas.95.11.5865; NIEGEMANN E, 1994, MUTAT RES-DNA REPAIR, V315, P275, DOI 10.1016/0921-8777(94)90038-8; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; OTT J, 1986, GENET EPIDEMIOL, P251; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Skolnick M, 1980, BANBURY REPORT, P285; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Stanford JL, 1997, CANCER RES, V57, P1194; Suarez BK, 2000, AM J HUM GENET, V66, P933, DOI 10.1086/302818; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thomas A, 2000, STAT COMPUT, V10, P259, DOI 10.1023/A:1008947712763; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807	52	436	466	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2001	27	2					172	180		10.1038/84808	http://dx.doi.org/10.1038/84808			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175785				2022-12-27	WOS:000166839200018
J	Weil, CF; Kunze, R				Weil, CF; Kunze, R			Transposition of maize Ac/Ds transposable elements in the yeast Saccharomyces cerevisiae	NATURE GENETICS			English	Article							ACTIVATOR AC TRANSPOSASE; DNA TRANSPOSITION; IN-VIVO; EXCISION; EXPRESSION; GENE; ARABIDOPSIS; TOBACCO; RECOMBINATION; DISSOCIATION	Excision by transposons is associated with chromosome breaks; generally, host-cell proteins repair this damage, often introducing mutations. Many transposons also use host proteins in the transposition mechanism or in regulation(1-4). Transposition in systems lacking host factors that influence the behaviour of these transpositions is useful in determining what those factors are and how they work. In addition, features of transposition and regulation intrinsic to the element itself can be determined. Maize Activator/Dissociation (Ac/Ds) elements transpose in a wide variety of heterologous plants, but their characteristics in these other systems differ from those in maize, including their response to increasing genetic dosage(5,6) and the types of repair products recovered following excision(7). Two Arabidopsis thaliana mutants (iae1 and iae2) show increased Ac transposition frequencies(8). These mutants, and the differences mentioned above, suggest the involvement of host proteins in Ac/Ds activity and potential differences between these proteins among plant species. Here we report that Ac/Ds elements, members of the hAT (hobo, Ac, Tam3) superfamily, transpose in the yeast Saccharomyces cerevisiae, an organism lacking class II ('cut and paste') transposons. This demonstrates that plant-specific proteins are not essential for Ac/Ds transposition. The yeast system is valuable for dissecting the Ac/Ds transposition mechanism and identifying host factors that can influence transposition and the repair of DNA damage induced by Ac/Ds. Mutations caused by Ds excision in yeast suggest formation of a DNA-hairpin intermediate, and reinsertions occur throughout the genome with a frequency similar to that in plants. The high proportion of Ac/Ds reinsertions also makes this system an in vivo mutagenesis and reverse genetics tool in yeast and, presumably, other eukaryotic systems.	Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; Univ Munich, Inst Genet & Mikrobiol, D-8000 Munich, Germany	Idaho; University of Idaho; University of Munich	Kunze, R (corresponding author), Univ Cologne, Bot Inst 2, Cologne, Germany.			Kunze, Reinhard/0000-0002-3304-5550				Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; ATKINSON PW, 1993, P NATL ACAD SCI USA, V90, P9693, DOI 10.1073/pnas.90.20.9693; Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921; COEN ES, 1989, MOBILE DNA; Colot V, 1998, MOL CELL BIOL, V18, P4337, DOI 10.1128/MCB.18.7.4337; DABOUSSI MJ, 1994, GENETICA, V93, P1; ESSER SL, 2000, PLANT CELL, V12, P211; FELDMAR S, 1991, EMBO J, V10, P4003, DOI 10.1002/j.1460-2075.1991.tb04975.x; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; HEINLEIN M, 1994, PLANT J, V5, P705, DOI 10.1111/j.1365-313X.1994.00705.x; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; HOUBAHERIN N, 1990, MOL GEN GENET, V224, P17, DOI 10.1007/BF00259446; Jarvis P, 1997, PLANT J, V11, P907; KELLER J, 1993, PLANT MOL BIOL, V21, P157, DOI 10.1007/BF00039626; Kempken F, 1996, MOL CELL BIOL, V16, P6563; Kunze R, 1997, ADV BOT RES, V27, P331; KUNZE R, 1995, PLANT J, V8, P45, DOI 10.1046/j.1365-313X.1995.08010045.x; KUNZE R, 1993, P NATL ACAD SCI USA, V90, P7094, DOI 10.1073/pnas.90.15.7094; LAUFS J, 1990, P NATL ACAD SCI USA, V87, P7752, DOI 10.1073/pnas.87.19.7752; MAKRIS JC, 1990, J BACTERIOL, V172, P1368, DOI 10.1128/jb.172.3.1368-1373.1990; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Rinehart TA, 1997, PLANT J, V12, P1419, DOI 10.1046/j.1365-313x.1997.12061419.x; SCOFIELD SR, 1993, CELL, V75, P507, DOI 10.1016/0092-8674(93)90385-4; SIGNON L, 1995, GENE DEV, V9, P1123, DOI 10.1101/gad.9.9.1123; SURETTE MG, 1989, EMBO J, V8, P3483, DOI 10.1002/j.1460-2075.1989.tb08513.x; SWINBURNE J, 1992, PLANT CELL, V4, P583, DOI 10.1105/tpc.4.5.583; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C	28	71	79	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					187	190		10.1038/82827	http://dx.doi.org/10.1038/82827			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017074				2022-12-27	WOS:000089638800015
J	Anand, N; Murthy, S; Amann, G; Wernick, M; Porter, LA; Cukier, IH; Collins, C; Gray, JW; Diebold, J; Demetrick, DJ; Lee, JM				Anand, N; Murthy, S; Amann, G; Wernick, M; Porter, LA; Cukier, IH; Collins, C; Gray, JW; Diebold, J; Demetrick, DJ; Lee, JM			Gene encoding protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer	NATURE GENETICS			English	Article							IN-SITU HYBRIDIZATION; FACTOR 1-ALPHA; BREAST-CARCINOMA; CELL-LINES; EXPRESSION; TRANSLATION; 20Q13; IDENTIFICATION; CLONING; DISPLAY	We have found that EEF1A2, the gene encoding protein elongation factor EEF1A2 (also known as eEF-1alpha2), is amplified in 25% of primary ovarian tumors and is highly expressed in approximately 30% of ovarian tumors and established cell lines. We have also demonstrated that EEF1A2 has oncogenic properties: it enhances focus formation, allows anchorage-independent growth and decreases the doubling time of rodent fibroblasts. In addition, EEF1A2 expression made NIH3T3 fibroblasts tumorigenic and increased the growth rate of ES-2 ovarian carcinoma cells xenografted in nude mice. Thus, EEF1A2 and the process of protein elongation are likely to be critical in the development of ovarian cancer.	Hamilton Reg Canc Ctr, Hamilton, ON L8V 5C2, Canada; Univ Calgary, Dept Pathol, Calgary, AB, Canada; Univ Calgary, Dept Oncol, Calgary, AB, Canada; Univ Calgary, Dept Med Biochem, Calgary, AB, Canada; Univ Munich, Inst Pathol, D-8000 Munich, Germany; Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; University of Calgary; University of Calgary; University of Calgary; University of Munich; University of California System; University of California San Francisco; McMaster University	Lee, JM (corresponding author), Hamilton Reg Canc Ctr, Room 450,699 Concess St, Hamilton, ON L8V 5C2, Canada.		ANAND, NOOPUR/GWR-1598-2022	Porter, Lisa A./0000-0002-9234-1712				Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Anthony B, 1996, INT J CANCER, V65, P858, DOI 10.1002/(SICI)1097-0215(19960315)65:6<858::AID-IJC25>3.0.CO;2-Z; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Courjal F, 1996, BRIT J CANCER, V74, P1984, DOI 10.1038/bjc.1996.664; Demetrick DJ, 1996, MODERN PATHOL, V9, P133; Diebold J, 2000, J PATHOL, V190, P564, DOI 10.1002/(SICI)1096-9896(200004)190:5<564::AID-PATH569>3.0.CO;2-L; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; KEREKATTE V, 1995, INT J CANCER, V64, P27, DOI 10.1002/ijc.2910640107; Kjaer S, 2001, EUR J BIOCHEM, V268, P3407, DOI 10.1046/j.1432-1327.2001.02240.x; KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEE S, 1992, J BIOL CHEM, V267, P24064; Lund A, 1996, GENOMICS, V36, P359, DOI 10.1006/geno.1996.0475; Nonet GH, 2001, CANCER RES, V61, P1250; Potter M, 1998, CELL IMMUNOL, V188, P111, DOI 10.1006/cimm.1998.1346; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; SHEN RQ, 1995, P NATL ACAD SCI USA, V92, P6778, DOI 10.1073/pnas.92.15.6778; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; SHULTZ LD, 1982, NATURE, V297, P402, DOI 10.1038/297402a0; Sonenberg N, 1993, CURR OPIN CELL BIOL, V5, P955, DOI 10.1016/0955-0674(93)90076-3; Sonoda G, 1997, GENE CHROMOSOME CANC, V20, P320; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0	27	181	212	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					301	305		10.1038/ng904	http://dx.doi.org/10.1038/ng904			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12053177				2022-12-27	WOS:000176494100020
J	Schlingmann, KP; Weber, S; Peters, M; Nejsum, LN; Vitzthum, H; Klingel, K; Kratz, M; Haddad, E; Ristoff, E; Dinour, D; Syrrou, M; Nielsen, S; Sassen, M; Waldegger, S; Seyberth, HW; Konrad, M				Schlingmann, KP; Weber, S; Peters, M; Nejsum, LN; Vitzthum, H; Klingel, K; Kratz, M; Haddad, E; Ristoff, E; Dinour, D; Syrrou, M; Nielsen, S; Sassen, M; Waldegger, S; Seyberth, HW; Konrad, M			Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family	NATURE GENETICS			English	Article							MAGNESIUM; EXPRESSION; PROTEIN; CHANNELS; KINASE; PARACELLIN-1; ABSORPTION; RESORPTION; TRANSPORT; CDNA	Magnesium is an essential ion involved in many biochemical and physiological processes. Homeostasis of magnesium levels is tightly regulated and depends on the balance between intestinal absorption and renal excretion. However, little is known about specific proteins mediating transepithelial magnesium transport. Using a positional candidate gene approach, we identified mutations in TRPM6 (also known as CHAK2), encoding TRPM6, in autosomal-recessive hypomagnesemia with secondary hypocalcemia (HSH, OMIM 602014)(1,2), previously mapped to chromosome 9q22 (ref. 3). The TRPM6 protein is a new member of the long transient receptor potential channel (TRPM) family 4 and is highly similar to TRPM7 (also known as TRP-PLIK), a bifunctional protein that combines calcium- and magnesium-permeable cation channel properties with protein kinase activity(5-7). TRPM6 is expressed in intestinal epithelia and kidney tubules. These findings indicate that TRPM6 is crucial for magnesium homeostasis and implicate a TRPM family member in human disease.	Univ Marburg, Dept Pediat, D-35037 Marburg, Germany; Aarhus Univ, Inst Anat, Water & Salt Res Ctr, DK-8000 Aarhus C, Denmark; Univ Regensburg, Dept Physiol 1, D-8400 Regensburg, Germany; Univ Hosp, Dept Mol Pathol, Tubingen, Germany; Univ Childrens Hosp, Mannheim, Germany; Robert Debre Hosp, Paris, France; Huddinge Univ, Karolinska Inst, Dept Pediat, Stockholm, Sweden; Chaim Sheba Med Ctr, Dept Nephrol, Ramat Gan, Israel; Univ Ioannina, Lab Gen Biol Genet, GR-45110 Ioannina, Greece	Philipps University Marburg; Aarhus University; University of Regensburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Chaim Sheba Medical Center; University of Ioannina	Konrad, M (corresponding author), Univ Marburg, Dept Pediat, Deutschhausstr 12, D-35037 Marburg, Germany.	konradm@mailer.uni-marburg.de	Haddad, Elie/AAQ-4971-2020	Haddad, Elie/0000-0003-2446-6879; Nejsum, Lene Niemann/0000-0003-4368-8821; SYRROU, MARIA/0000-0002-5748-5008				ANAST CS, 1972, SCIENCE, V177, P606, DOI 10.1126/science.177.4049.606; Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Cahalan MD, 2001, NATURE, V411, P542, DOI 10.1038/35079231; CHALLA A, 1995, ACTA PAEDIATR, V84, P1075, DOI 10.1111/j.1651-2227.1995.tb13830.x; Cole DEC, 2000, J AM SOC NEPHROL, V11, P1937, DOI 10.1681/ASN.V11101937; Duncan LM, 2001, J CLIN ONCOL, V19, P568, DOI 10.1200/JCO.2001.19.2.568; FINE KD, 1991, J CLIN INVEST, V88, P396, DOI 10.1172/JCI115317; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; KAYNE LH, 1993, MINER ELECTROL METAB, V19, P210; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Koizumi K, 2001, INT J MOL MED, V8, P273; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; MATZKIN H, 1989, NEPHRON, V52, P83, DOI 10.1159/000185588; Meij IC, 2000, NAT GENET, V26, P265, DOI 10.1038/81543; MILLA PJ, 1979, GUT, V20, P1028, DOI 10.1136/gut.20.11.1028; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; PAUNIER L, 1968, PEDIATRICS, V41, P385; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; Reddy S, 1998, J CELL PHYSIOL, V177, P636, DOI 10.1002/(SICI)1097-4652(199812)177:4<636::AID-JCP14>3.3.CO;2-8; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Ryazanova LV, 2001, MOL BIOL+, V35, P271, DOI 10.1023/A:1010499720185; Shalev H, 1998, ARCH DIS CHILD, V78, P127, DOI 10.1136/adc.78.2.127; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Walder RY, 1999, AM J HUM GENET, V65, pA451; Walder RY, 1997, HUM MOL GENET, V6, P1491, DOI 10.1093/hmg/6.9.1491; Weber S, 2001, J AM SOC NEPHROL, V12, P2664, DOI 10.1681/ASN.V12122664	30	541	577	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2002	31	2					166	170		10.1038/ng889	http://dx.doi.org/10.1038/ng889			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12032568				2022-12-27	WOS:000175903500012
J	Ward, CJ; Hogan, MC; Rossetti, S; Walker, D; Sneddon, T; Wang, XF; Kubly, V; Cunningham, JM; Bacallao, R; Ishibashi, M; Milliner, DS; Torres, VE; Harris, PC				Ward, CJ; Hogan, MC; Rossetti, S; Walker, D; Sneddon, T; Wang, XF; Kubly, V; Cunningham, JM; Bacallao, R; Ishibashi, M; Milliner, DS; Torres, VE; Harris, PC			The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein	NATURE GENETICS			English	Article							PRENATAL-DIAGNOSIS; PHYSICAL MAP; FAMILY; ARPKD; PKHD1; IDENTIFICATION; TRANSMEMBRANE; 6P21.1-P12; PREDICTION; EXCLUSION	Autosomal recessive polycystic kidney disease (ARPKD) is characterized by dilation of collecting ducts and by biliary dysgenesis and is an important cause of renal- and liver-related morbidity and mortality. Genetic analysis of a rat with recessive polycystic kidney disease revealed an orthologous relationship between the rat locus and the ARPKD region in humans; a candidate gene was identified. A mutation was characterized in the rat and screening the 66 coding exons of the human ortholog (PKHD1) in 14 probands with ARPKD revealed 6 truncating and 12 missense mutations; 8 of the affected individuals were compound heterozygotes. The PKHD1 transcript, approximately 16 kb long, is expressed in adult and fetal kidney, liver and pancreas and is predicted to encode a large novel protein, fibrocystin, with multiple copies of a domain shared with plexins and transcription factors. Fibrocystin may be a receptor protein that acts in collecting-duct and biliary differentiation.	Mayo Clin, Div Nephrol, Rochester, MN 55905 USA; Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Indiana Univ, Med Ctr, Dept Med, Indianapolis, IN 46202 USA; Azabu Univ, Sagamihara, Kanagawa, Japan	Mayo Clinic; Mayo Clinic; Indiana University System; Indiana University-Purdue University Indianapolis; Azabu University		harris.peter@mayo.edu		Sneddon, Tam Paterson/0000-0003-1137-8992; Torres, Vicente/0000-0003-2008-1576				Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BERNSTEIN J, 1992, PEDIATRIC KIDNEY DIS, V2, P1139; BLICKMAN JG, 1995, AM J ROENTGENOL, V164, P1247, DOI 10.2214/ajr.164.5.7717240; BLYTH H, 1971, J MED GENET, V8, P257, DOI 10.1136/jmg.8.3.257; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; CALVET JP, 1993, KIDNEY INT, V43, P101, DOI 10.1038/ki.1993.17; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; COLE BR, 1987, J PEDIATR-US, V111, P693, DOI 10.1016/S0022-3476(87)80244-5; DEGET F, 1995, CLIN GENET, V47, P248, DOI 10.1111/j.1399-0004.1995.tb04305.x; DELL KMM, 2001, GENEREVIEWS GENETIC; DESMET VJ, 1992, HEPATOLOGY, V16, P1069, DOI 10.1002/hep.1840160434; GUAYWOODFORD LM, 1995, AM J HUM GENET, V56, P1101; GUAYWOODFORD LM, 1996, POLYCYSTIC KIDNEY DI, P237; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; Hofmann Y, 2000, EUR J HUM GENET, V8, P163, DOI 10.1038/sj.ejhg.5200426; Jorgensen M J, 1977, Acta Pathol Microbiol Scand Suppl, P1; KAARIAINEN H, 1988, PEDIATR NEPHROL, V2, P296; KAPLAN BS, 1989, PEDIATR NEPHROL, V3, P43, DOI 10.1007/BF00859625; KAPLAN BS, 1988, AM J MED GENET, V29, P639, DOI 10.1002/ajmg.1320290323; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lager DJ, 2001, KIDNEY INT, V59, P126, DOI 10.1046/j.1523-1755.2001.00473.x; Lens XM, 1997, GENOMICS, V41, P463, DOI 10.1006/geno.1997.4671; MACKAY K, 1988, KIDNEY INT, V33, P677, DOI 10.1038/ki.1988.53; McDonald R, 1999, PEDIAT NEPHROLOGY, P459; MCDONALD RA, 1996, POLYCYSTIC KIDNEY DI, P63; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Mucher G, 1998, GENOMICS, V48, P40, DOI 10.1006/geno.1997.5145; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Onuchic LF, 1999, MAMM GENOME, V10, P1175, DOI 10.1007/s003359901186; OSATHANONDH V, 1964, ARCH PATHOL, V77, P466; Park JH, 1999, GENOMICS, V57, P249, DOI 10.1006/geno.1999.5777; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; ROSSETTI S, 2002, IN PRESS KIDNEY INT; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Roy S, 1997, PEDIATR NEPHROL, V11, P302, DOI 10.1007/s004670050281; Sanzen T, 2001, AM J PATHOL, V158, P1605, DOI 10.1016/S0002-9440(10)64116-8; Scott DA, 2000, GENE, V246, P265, DOI 10.1016/S0378-1119(00)00090-1; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; UHARI M, 1979, ACTA PAEDIATR SCAND, V68, P443, DOI 10.1111/j.1651-2227.1979.tb05035.x; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Zerres K, 1996, ACTA PAEDIATR, V85, P437, DOI 10.1111/j.1651-2227.1996.tb14056.x; Zerres K, 1998, J MOL MED, V76, P303, DOI 10.1007/s001090050221; ZERRES K, 1994, NAT GENET, V7, P429, DOI 10.1038/ng0794-429; ZERRES K, 1984, HUM GENET, V68, P104, DOI 10.1007/BF00279301; Zerres K, 1998, AM J MED GENET, V76, P137, DOI 10.1002/(SICI)1096-8628(19980305)76:2<137::AID-AJMG6>3.0.CO;2-Q	50	516	552	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2002	30	3					259	269		10.1038/ng833	http://dx.doi.org/10.1038/ng833			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11919560				2022-12-27	WOS:000174157600009
J	Trockenbacher, A; Suckow, V; Foerster, J; Winter, J; Krauss, S; Ropers, HH; Schneider, R; Schweiger, S				Trockenbacher, A; Suckow, V; Foerster, J; Winter, J; Krauss, S; Ropers, HH; Schneider, R; Schweiger, S			MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation	NATURE GENETICS			English	Article							SYNDROME GENE-PRODUCT; CELL-CYCLE; PROTEIN PHOSPHATASE-2A; G/BBB SYNDROME; FG-SYNDROME; IN-VIVO; PHOSPHORYLATION; MICROTUBULES; EXPRESSION; XP22	The gene MID1, the mutation of which causes X-linked Opitz G/BBB syndrome (OS, MIM 300000), encodes a microtubule-associated protein (MAP). We show that mutation of MID1 leads to a marked accumulation of the catalytic subunit of protein phosphatase 2A (PP2Ac), a central cellular regulator. PP2Ac accumulation is caused by an impairment of a newly identified E3 ubiquitin ligase activity of the MID1 protein that normally targets PP2Ac for degradation through binding to its alpha4 regulatory subunit in an embryonic fibroblast line derived from a fetus with OS. Elevated PP2Ac causes hypophosphorylation of MAPs, a pathological mechanism that is consistent with the OS phenotype.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Inst Biochem, A-6020 Innsbruck, Austria; Charite, Dept Dermatol, D-10117 Berlin, Germany	Max Planck Society; University of Innsbruck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schweiger, S (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	schweiger@molgen.mpg.de	Krauss, Sybille/L-5328-2016	Krauss, Sybille/0000-0002-5653-9289				AVILA J, 1994, INT J DEV BIOL, V38, P13; Baharians Z, 1999, MOL CARCINOGEN, V24, P246, DOI 10.1002/(SICI)1098-2744(199904)24:4<246::AID-MC2>3.0.CO;2-H; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Borden KLB, 1996, P NATL ACAD SCI USA, V93, P1601, DOI 10.1073/pnas.93.4.1601; Briault S, 1997, AM J MED GENET, V73, P87; Buchner G, 1999, HUM MOL GENET, V8, P1397, DOI 10.1093/hmg/8.8.1397; Cainarca S, 1999, HUM MOL GENET, V8, P1387, DOI 10.1093/hmg/8.8.1387; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Deng XM, 1998, J BIOL CHEM, V273, P34157, DOI 10.1074/jbc.273.51.34157; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Gong CX, 2000, BRAIN RES, V853, P299, DOI 10.1016/S0006-8993(99)02294-5; Graham JM, 1998, AM J MED GENET, V80, P145; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; INUI S, 1995, J IMMUNOL, V154, P2714; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kawabe T, 1997, NATURE, V385, P454, DOI 10.1038/385454a0; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Kobayashi N, 2001, HISTOCHEM CELL BIOL, V115, P255; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; MAIER GD, 1995, INT J CANCER, V61, P54, DOI 10.1002/ijc.2910610110; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; OPITZ JM, 1974, Z KINDERHEILKD, V117, P1, DOI 10.1007/BF00439020; Price NE, 1999, MOL BRAIN RES, V73, P68, DOI 10.1016/S0169-328X(99)00237-5; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Robin NH, 1996, AM J MED GENET, V62, P305, DOI 10.1002/(SICI)1096-8628(19960329)62:3<305::AID-AJMG20>3.0.CO;2-N; ROBIN NH, 1995, NAT GENET, V11, P459, DOI 10.1038/ng1295-459; Santoro MF, 1998, J BIOL CHEM, V273, P13119, DOI 10.1074/jbc.273.21.13119; Sapir T, 1999, EUR J BIOCHEM, V265, P181, DOI 10.1046/j.1432-1327.1999.00711.x; Schweiger S, 1999, P NATL ACAD SCI USA, V96, P2794, DOI 10.1073/pnas.96.6.2794; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Trojanowski JQ, 1995, FASEB J, V9, P1570, DOI 10.1096/fasebj.9.15.8529836; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; UEMURA T, 1993, GENE DEV, V7, P429, DOI 10.1101/gad.7.3.429; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; ZOINIEROWSICZ S, 2000, BIOCHEM PHARMACOL, V60, P1225	48	235	240	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					287	294		10.1038/ng762	http://dx.doi.org/10.1038/ng762			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11685209				2022-12-27	WOS:000171911000014
J	Sozen, MA; Suzuki, K; Tolarova, MM; Bustos, T; Iglesias, JEF; Spritz, RA				Sozen, MA; Suzuki, K; Tolarova, MM; Bustos, T; Iglesias, JEF; Spritz, RA			Mutation of PVRL1 is associated with sporadic, non-syndromic cleft lip/palate in northern Venezuela	NATURE GENETICS			English	Article							ECTODERMAL DYSPLASIA; PALATE; LIP; GENE	Non-syndromic cleft lip with or without cleft palate (CL/P, MIM 119530) is among the most common of major birth defects. Homozygosity for a nonsense mutation of PVRL1, W185X, results in an autosomal recessive CL/P syndrome on Margarita Island, CLPED1 (ref. 1). Here we demonstrate highly significant association between heterozygosity for this mutation and sporadic, non-syndromic CL/P in northern Venezuela.	Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA; Univ Pacific, Dept Orthodont, San Francisco, CA USA; Cent Univ Venezuela, Ctr Nacl Genet Humana & Expt, Caracas, Venezuela; Ctr Diagnost Odontol, Porlamar, Isla Margarita, Venezuela	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of the Pacific; University of Central Venezuela	Spritz, RA (corresponding author), Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA.	richard.spritz@uchsc.edu			NIDCR NIH HHS [DE13571] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013571] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Braybrook C, 2001, NAT GENET, V29, P179, DOI 10.1038/ng730; BUSTOS T, 1991, AM J MED GENET, V41, P398, DOI 10.1002/ajmg.1320410403; Juriloff DM, 2001, MAMM GENOME, V12, P426, DOI 10.1007/s003350010284; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; Mitchell LE, 1997, EPIDEMIOL REV, V19, P61, DOI 10.1093/oxfordjournals.epirev.a017947; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; Schutte BC, 1999, HUM MOL GENET, V8, P1853, DOI 10.1093/hmg/8.10.1853; SPRITZ RA, 2001, IN PRESS CURRENT OPI, V13; Suzuki K, 1998, AM J HUM GENET, V63, P1102, DOI 10.1086/302072; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; TOLAROVA M, 1987, SCAND J PLAST RECONS, V21, P19, DOI 10.3109/02844318709083574; Tolarova MM, 1998, AM J MED GENET, V75, P126; Young DL, 2000, CRIT REV ORAL BIOL M, V11, P304, DOI 10.1177/10454411000110030201	13	146	150	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2001	29	2					141	142		10.1038/ng740	http://dx.doi.org/10.1038/ng740			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11559849				2022-12-27	WOS:000171374100018
J	Sprecher, E; Bergman, R; Richard, G; Lurie, R; Shalev, S; Petronius, D; Shalata, A; Anbinder, Y; Leibu, R; Perlman, I; Cohen, N; Szargel, R				Sprecher, E; Bergman, R; Richard, G; Lurie, R; Shalev, S; Petronius, D; Shalata, A; Anbinder, Y; Leibu, R; Perlman, I; Cohen, N; Szargel, R			Hypotrichosis with juvenile macular dystrophy is caused by a mutation in CDH3, encoding P-cadherin	NATURE GENETICS			English	Article							HAIR FOLLICLE MORPHOGENESIS; BETA-CATENIN; IN-VITRO; EXPRESSION; MICE	Congenital hypotrichosis associated with juvenile macular dystrophy (HJMD; MIM601553) is an autosomal recessive disorder of unknown etiology, characterized by hair loss heralding progressive macular degeneration and early blindness(1,2). We used homozygosity mapping in four consanguineous families to localize the gene defective in HJMD to 16q22.1. This region contains CDH3, encoding P-cadherin, which is expressed in the retinal pigment epithelium and hair follicles. Mutation analysis shows in all families a common homozygous deletion in exon 8 of CDH3. These results establish the molecular etiology of HJMD and implicate for the first time a cadherin molecule in the pathogenesis of a human hair and retinal disorder.	Rambam Med Ctr, Dept Dermatol, IL-31096 Haifa, Israel; Rambam Med Ctr, Dept Pediat Surg, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Human Genet, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Physiol & Biophys, IL-31096 Haifa, Israel; Thomas Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA USA; Thomas Jefferson Med Coll, Thomas Jefferson Inst Mol Med, Philadelphia, PA USA; Schneider Childrens Hosp, Pediat Dermatol Unit, Petah Tiqwa, Israel; Haemek Med Ctr, Inst Human Genet, Afula, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Jefferson University; Jefferson University; Emek Medical Center	Sprecher, E (corresponding author), Rambam Med Ctr, Dept Dermatol, IL-31096 Haifa, Israel.							Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Burke JM, 1999, INVEST OPHTH VIS SCI, V40, P2963; Chen GTC, 1998, ENDOCRINE, V9, P263, DOI 10.1385/ENDO:9:3:263; Da Cruz L, 2001, BRIT J OPHTHALMOL, V85, P239; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LEWIS JE, 1994, J INVEST DERMATOL, V102, P870, DOI 10.1111/1523-1747.ep12382690; Muller-Rover S, 1999, EXP DERMATOL, V8, P237; QUMSIYEH MB, 1997, GENETIC DISORDERS AR, P232; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; SOUIED E, 1995, OPHTHALMIC GENET, V16, P11, DOI 10.3109/13816819509057848; Yagi T, 2000, GENE DEV, V14, P1169	15	126	132	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					134	136		10.1038/ng716	http://dx.doi.org/10.1038/ng716			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11544476				2022-12-27	WOS:000171374100015
J	Moghadaszadeh, B; Petit, N; Jaillard, C; Brockington, M; Roy, SQ; Merlini, L; Romero, N; Estournet, B; Desguerre, I; Chaigne, D; Muntoni, F; Topaloglu, H; Guicheney, P				Moghadaszadeh, B; Petit, N; Jaillard, C; Brockington, M; Roy, SQ; Merlini, L; Romero, N; Estournet, B; Desguerre, I; Chaigne, D; Muntoni, F; Topaloglu, H; Guicheney, P			Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome	NATURE GENETICS			English	Article							RNA STRUCTURAL MOTIF; SELENOCYSTEINE INSERTION; SECIS ELEMENTS; SELENOPROTEINS; SELENIUM; SEQUENCE	One form of congenital muscular dystrophy, rigid spine syndrome (MIM 602771), is a rare neuromuscular disorder characterized by early rigidity of the spine and respiratory insufficiency. A locus on 1p35-36 (RSMD1) was recently found to segregate with rigid spine muscular dystrophy 1 (ref. 1). Here we refine the locus and find evidence of linkage disequilibrium associated with SEPN1, which encodes the recently described selenoprotein N (ref. 2). Our identification and analysis of mutations in SEPN1 is the first description of a selenoprotein implicated in a human disease.	Grp Hosp Pitie Salpetriere, Inst Myol, INSERM, U523, F-75651 Paris 13, France; Hammersmith Hosp, Imperial Coll Sch Med, Dept Paediat & Neonatal Med, London, England; Hop Ray Poincare, Garches, France; Rizzoli Orthoped Inst, Bologna, Italy; Hop St Vincent de Paul, Serv Neuropediat, F-75674 Paris, France; Clin St Odile, Strasbourg, France; Hacettepe Childrens Hosp Med Ctr, Dept Paediat Neurol, Ankara, Turkey	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; IRCCS Istituto Ortopedico Rizzoli; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Hacettepe University	Guicheney, P (corresponding author), Grp Hosp Pitie Salpetriere, Inst Myol, INSERM, U523, 47 Blvd Hop, F-75651 Paris 13, France.		Merlini, Luciano/N-6478-2019; Guicheney, Pascale/D-1034-2017; TOPALOGLU, HALUK AYDIN/I-9318-2013	Merlini, Luciano/0000-0002-1108-1198; Guicheney, Pascale/0000-0002-7663-2050; Moghadaszadeh, Behzad/0000-0001-9787-0106				BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; Flanigan KM, 2000, ANN NEUROL, V47, P152, DOI 10.1002/1531-8249(200002)47:2<152::AID-ANA4>3.3.CO;2-L; Flohe L, 2000, IUBMB LIFE, V49, P411; GE KY, 1983, VIRCHOWS ARCH A, V401, P1, DOI 10.1007/BF00644785; Gu QP, 1997, GENE, V193, P187, DOI 10.1016/S0378-1119(97)00113-3; Holben DH, 1999, J AM DIET ASSOC, V99, P836, DOI 10.1016/S0002-8223(99)00198-4; LAMAND MCR, 1970, ACAD SCI HEBD SCI D, V270, P417; Lescure A, 1999, J BIOL CHEM, V274, P38147, DOI 10.1074/jbc.274.53.38147; MERLINI L, 1989, J CHILD NEUROL, V4, P274, DOI 10.1177/088307388900400405; Moghadaszadeh B, 1998, AM J HUM GENET, V62, P1439, DOI 10.1086/301882; Moghadaszadeh B, 1999, NEUROMUSCULAR DISORD, V9, P376, DOI 10.1016/S0960-8966(99)00051-6; OLDFIELD JE, 1989, BIOL TRACE ELEM RES, V20, P23, DOI 10.1007/BF02919095; TOME FMS, 1998, NEUROMUSCULAR DISORD, P21; Walczak R, 1996, RNA, V2, P367; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	15	236	242	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					17	18		10.1038/ng713	http://dx.doi.org/10.1038/ng713			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528383				2022-12-27	WOS:000170781300007
J	Mitchell, KJ; Pinson, KI; Kelly, OG; Brennan, J; Zupicich, L; Scherz, P; Leighton, PA; Goodrich, LV; Lu, XW; Avery, BJ; Tate, P; Dill, K; Pangilinan, E; Wakenight, P; Tessier-Lavigne, M; Skarnes, WC				Mitchell, KJ; Pinson, KI; Kelly, OG; Brennan, J; Zupicich, L; Scherz, P; Leighton, PA; Goodrich, LV; Lu, XW; Avery, BJ; Tate, P; Dill, K; Pangilinan, E; Wakenight, P; Tessier-Lavigne, M; Skarnes, WC			Functional analysis of secreted and transmembrane proteins critical to mouse development	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; GENE TRAP INTEGRATIONS; INSERTIONAL MUTATIONS; REGULATED GENES; GROWTH-FACTOR; MUTANT MICE; GENOME-WIDE; TOUT-VELU; DISRUPTION; IDENTIFICATION	We describe the successful application of a modified gene-trap approach, the secretory trap, to systematically analyze the functions in vivo of large numbers of genes encoding secreted and membrane proteins. Secretory-trap insertions in embryonic stem cells can be transmitted to the germ line of mice with high efficiency and effectively mutate the target gene. Of 60 insertions analyzed in mice, one-third cause recessive lethal phenotypes affecting various stages of embryonic and postnatal development. Thus, secretory-trap mutagenesis can be used for a genome-wide functional analysis of cell signaling pathways that are critical for normal mammalian development and physiology.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Skarnes, WC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	skarnes@socrates.berkeley.edu	Schick, Joel/ABA-3728-2021	Schick, Joel/0000-0002-8623-4910; Mitchell, Kevin/0000-0002-3433-4530; Brennan, Jane/0000-0003-3222-5485				AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Brennan J, 1999, METH MOL B, V97, P123, DOI 10.1385/1-59259-270-8:123; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Cal S, 2000, MOL BIOL CELL, V11, P1457, DOI 10.1091/mbc.11.4.1457; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; CHEN CC, 1993, ASIA PAC J PHARMACOL, V8, P1; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CORMICK C, 1998, NAT GENET, V19, P158; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; DEGREGORI J, 1994, GENE DEV, V8, P265, DOI 10.1101/gad.8.3.265; Forrester LM, 1996, P NATL ACAD SCI USA, V93, P1677, DOI 10.1073/pnas.93.4.1677; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Hicks GG, 1997, NAT GENET, V16, P338, DOI 10.1038/ng0897-338; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; McClive P, 1998, DEV DYNAM, V212, P267, DOI 10.1002/(SICI)1097-0177(199806)212:2<267::AID-AJA11>3.0.CO;2-1; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Paine-Saunders S, 2000, DEV BIOL, V225, P179, DOI 10.1006/dbio.2000.9831; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Sagane K, 1999, GENE, V236, P79, DOI 10.1016/S0378-1119(99)00253-X; Sam M, 1998, DEV DYNAM, V212, P304, DOI 10.1002/(SICI)1097-0177(199806)212:2<304::AID-AJA15>3.0.CO;2-3; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Tate P, 1998, J CELL SCI, V111, P2575; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; VONMELCHNER H, 1992, GENE DEV, V6, P919, DOI 10.1101/gad.6.6.919; Voss AK, 1998, DEV DYNAM, V212, P258; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WURST W, 1995, GENETICS, V139, P889; Yeo TT, 1997, J NEUROSCI RES, V47, P348, DOI 10.1002/(SICI)1097-4547(19970201)47:3<348::AID-JNR13>3.0.CO;2-Y; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	55	329	344	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					241	249		10.1038/90074	http://dx.doi.org/10.1038/90074			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431694				2022-12-27	WOS:000169656400016
J	Wicks, SR; Yeh, RT; Gish, WR; Waterston, RH; Plasterk, RHA				Wicks, SR; Yeh, RT; Gish, WR; Waterston, RH; Plasterk, RHA			Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map	NATURE GENETICS			English	Letter							SINGLE-NUCLEOTIDE POLYMORPHISMS; BULKED SEGREGANT ANALYSIS; NATURAL VARIATION; RESISTANCE GENES; C-ELEGANS; MARKERS; GENOME; IDENTIFICATION; PATTERNS; NEURONS	Single nucleotide polymorphisms (SNPs) are valuable genetic markers of human disease(1-3). They also comprise the highest potential density marker set available for mapping experimentally derived mutations in model organisms such as Caenorhabditis elegans. To facilitate the positional cloning of mutations we have identified polymorphisms in CB4856, an isolate from a Hawaiian island that shows a uniformly high density of polymorphisms compared with the reference Bristol N2 strain. Based on 5.4 Mbp of aligned sequences, we predicted 6.222 polymorphisms. Furthermore, 3,457 of these markers modify restriction enzyme recognition sites ('snip-SNPs') and are therefore easily detected as RFLPs. Of these, 493 were experimentally confirmed by restriction digest to produce a snip-SNP map of the worm genome. A mapping strategy using snip-SNPs and bulked segregant analysis(4) (BSA) is outlined. CB4856 is crossed into a mutant strain, and exclusion of CB4856 alleles of a subset of snip-SNPs in mutant progeny is assesed with BSA. The proximity of a linked marker to the mutation is estimated by the relative proportion of each form of the biallelic marker in populations of wildtype and mutant genomes. The usefulness of this approach is illustrated by the rapid mapping of the dyf-5 gene.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Netherlands Inst Dev Biol, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; Washington Univ, Dept Genet, St Louis, MO 63108 USA; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Washington University (WUSTL); Washington University (WUSTL)	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Gish, Warren/C-8123-2012; Wicks, Stephen/AAJ-7470-2020	Wicks, Stephen/0000-0003-3908-1891				ARRATIA R, 1991, GENOMICS, V11, P806, DOI 10.1016/0888-7543(91)90004-X; Bedell JA, 2000, BIOINFORMATICS, V16, P1040, DOI 10.1093/bioinformatics/16.11.1040; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; De Tomaso AW, 1998, GENETICS, V149, P277; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gilles PN, 1999, NAT BIOTECHNOL, V17, P365, DOI 10.1038/7921; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hodgkin J, 1997, GENETICS, V146, P149; Jakubowski J, 1999, GENETICS, V153, P743; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Kolchinsky A, 1997, MOL GEN GENET, V254, P29, DOI 10.1007/s004380050387; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kurian KM, 1999, J PATHOL, V187, P267; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Petrov DA, 1999, P NATL ACAD SCI USA, V96, P1475, DOI 10.1073/pnas.96.4.1475; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Severson DW, 1999, GENET RES, V73, P217, DOI 10.1017/S0016672399003791; STARICH TA, 1995, GENETICS, V139, P171; Villar M, 1996, GENETICS, V143, P531; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	27	488	497	1	41	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					160	164		10.1038/88878	http://dx.doi.org/10.1038/88878			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381264				2022-12-27	WOS:000169011800019
J	Jenssen, TK; Laegreid, A; Komorowski, J; Hovig, E				Jenssen, TK; Laegreid, A; Komorowski, J; Hovig, E			A literature network of human genes for high-throughput analysis of gene expression	NATURE GENETICS			English	Article							INSIGHTS	We have carried out automated extraction of explicit and implicit biomedical knowledge from publicly available gene and text databases to create a gene-to-gene co-citation network for 13,712 named human genes by automated analysis of titles and abstracts in over 10 million MEDLINE records. The associations between genes have been annotated by linking genes to terms from the medical subject heading (MeSH) index and terms from the gene ontology (CO) database. The extracted database and accompanying web tools for gene-expression analysis have collectively been named 'PubGene'. We validated the extracted networks by three large-scale experiments showing that co-occurrence reflects biologically meaningful relationships, thus providing an approach to extract and structure known biology. We validated the applicability of the tools by analyzing two publicly available microarray data sets.	Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; Norwegian Univ Sci & Technol, Dept Physiol & Biomed Engn, N-7034 Trondheim, Norway; Linkoping Univ, Dept Comp & Informat Sci, S-58183 Linkoping, Sweden; Norwegian Univ Sci & Technol, Dept Comp & Informat Sci, N-7034 Trondheim, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU); Linkoping University; Norwegian University of Science & Technology (NTNU)	Hovig, E (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway.	ehovig@radium.uio.no	Komorowski, Jan/A-9175-2010; Komorowski, Jan/M-2667-2013; Komorowski, Jan/AAP-1685-2020; Hovig, Eivind/H-2474-2011	Komorowski, Jan/0000-0002-0766-8789; Komorowski, Jan/0000-0002-0766-8789; Hovig, Eivind/0000-0002-9103-1077				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andrade MA, 2000, FEBS LETT, V476, P12, DOI 10.1016/S0014-5793(00)01661-6; Andrade MA, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P25; ARONSON AR, 1994, P 6 APPL NAT LANG PR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blaschke C, 1999, Proc Int Conf Intell Syst Mol Biol, P60; BRAVO R, 1990, CELL GROWTH DIFFER, V1, P305; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cormen T. H, 1990, INTRO ALGORITHMS, P1028; Craven M, 1999, Proc Int Conf Intell Syst Mol Biol, P77; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fukuda K., 1998, PAC S BIOCOMPUT, P705; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; Humphreys K, 2000, Pac Symp Biocomput, P505; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; JENSSEN TK, 2000, CURRENTS COMPUTATION, P48; Lossos IS, 2000, P NATL ACAD SCI USA, V97, P10209, DOI 10.1073/pnas.180316097; Parsons-Wingerter P, 2000, ARTERIOSCL THROM VAS, V20, P1250, DOI 10.1161/01.ATV.20.5.1250; Proux D., 1998, GENOME INFORMAT, V9, P72; Rindflesch T C, 2000, Pac Symp Biocomput, P517; Rindflesch TC, 2000, 6TH APPLIED NATURAL LANGUAGE PROCESSING CONFERENCE/1ST MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE AND PROCEEDINGS OF THE ANLP-NAACL 2000 STUDENT RESEARCH WORKSHOP, P188; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SEKIMIZU T, 1998, GENOME INFORMATICS, P62; SHATKAY H, 2000, INTELLIGENT SYSTEMS, P317; Stamatopoulos K, 2000, IMMUNOL TODAY, V21, P298, DOI 10.1016/S0167-5699(00)01650-9; Stapley B J, 2000, Pac Symp Biocomput, P529; Thomas J, 2000, Pac Symp Biocomput, P541; White JA, 1997, GENOMICS, V45, P468, DOI 10.1006/geno.1997.4979	31	570	627	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					21	+		10.1038/88213	http://dx.doi.org/10.1038/88213			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326270				2022-12-27	WOS:000168413300010
J	Reik, W; Walter, J				Reik, W; Walter, J			Evolution of imprinting mechanisms: the battle of the sexes begins in the zygote	NATURE GENETICS			English	Letter							DNA METHYLATION; PATERNAL GENOME; EMBRYOGENESIS; DEMETHYLATION; DISRUPTION; GENE		Babraham Inst, Lab Dev Genet & Imprinting, Cambridge, England; Max Planck Inst Mol Genet, Berlin, Germany; Univ Saarlandes, D-6600 Saarbrucken, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Max Planck Society; Saarland University	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge, England.		Reik, Wolf/I-6794-2012	Reik, Wolf/0000-0003-0216-9881				Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Kato Y, 1999, DEVELOPMENT, V126, P1823; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Macleod D, 1999, NAT GENET, V23, P139, DOI 10.1038/13767; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Moore T, 1996, Rev Reprod, V1, P73, DOI 10.1530/ror.0.0010073; Obata Y, 1998, DEVELOPMENT, V125, P1553; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3	13	172	178	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					255	256		10.1038/85804	http://dx.doi.org/10.1038/85804			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242103				2022-12-27	WOS:000167304200013
J	de la Serna, IL; Carlson, KA; Imbalzano, AN				de la Serna, IL; Carlson, KA; Imbalzano, AN			Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation	NATURE GENETICS			English	Article							SWI-SNF COMPLEX; RETINOBLASTOMA PROTEIN; GENE-EXPRESSION; CELL-CYCLE; CHROMATIN; TRANSCRIPTION; BINDING; BRG1; FIBROBLASTS; ACETYLATION	Mammalian SWI/SNF complexes are ATP-dependent chromatin remodeling enzymes that have been implicated in the regulation of gene expression, cell-cycle control and oncogenesis(1-4) MyoD is a muscle-specific regulator able to induce myogenesis in numerous cell types(5). To ascertain the requirement for chromatin remodeling enzymes in cellular differentiation processes, we examined MyoD-mediated induction of muscle differentiation in fibroblasts expressing dominant-negative versions of the human brahma-related gene-1 (BRG1) or human brahma (BRM), the ATPase subunits of two distinct SWI/SNF enzymes. We find that induction of the myogenic phenotype is completely abrogated in the presence of the mutant enzymes. We further demonstrate that failure to induce muscle-specific gene expression correlates with inhibition of chromatin remodeling in the promoter region of an endogenous muscle-specific gene. Our results demonstrate that SWI/SNF enzymes promote MyoD-mediated muscle differentiation and indicate that these enzymes function by altering chromatin structure in promoter regions of endogenous, differentiation-specific loci.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Imbalzano, AN (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.				NIGMS NIH HHS [R01 GM056244] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown SA, 1997, GENE DEV, V11, P3116, DOI 10.1101/gad.11.23.3116; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Imbalzano AN, 1998, CRIT REV EUKAR GENE, V8, P225, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.10; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Javed A, 1999, MOL CELL BIOL, V19, P7491; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Muchardt C, 1999, SEMIN CELL DEV BIOL, V10, P189, DOI 10.1006/scdb.1999.0300; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X	30	254	257	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					187	190		10.1038/84826	http://dx.doi.org/10.1038/84826			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175787				2022-12-27	WOS:000166839200020
J	Dragatsis, I; Levine, MS; Zeitlin, S				Dragatsis, I; Levine, MS; Zeitlin, S			Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice	NATURE GENETICS			English	Article							HUNTINGTONS-DISEASE GENE; CAG REPEAT; NEURONAL DEGENERATION; WIDESPREAD EXPRESSION; TARGETED DISRUPTION; EMBRYONIC LETHALITY; BASAL GANGLIA; WILD-TYPE; PROTEIN; CELL	Inactivation of the mouse homologue of the Huntington disease gene (Hdh) results in early embryonic lethality. To investigate the normal function of Hdh in the adult and to evaluate current models for Huntington disease (HD), we have used the Cre/IoxP site-specific recombination strategy to inactivate Hdh expression in the forebrain and testis, resulting in a progressive degenerative neuronal phenotype and sterility. On the basis of these results, we propose that huntingtin is required for neuronal function and survival in the brain and that a loss-of-function mechanism may contribute to HD pathogenesis.	Columbia Univ, Dept Pathol, New York, NY USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Mental Retardat Res Ctr, Los Angeles, CA 90024 USA; Columbia Univ, Dept Genet & Dev, New York, NY USA	Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University	Zeitlin, S (corresponding author), Univ Virginia, Dept Neurosci, Charlottesville, VA 22903 USA.		Zeitlin, Scott/P-5787-2019					BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Bordelon YM, 1999, NEUROSCIENCE, V93, P843, DOI 10.1016/S0306-4522(99)00239-0; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Dragatsis I, 2000, NEUROSCI LETT, V282, P37, DOI 10.1016/S0304-3940(00)00872-7; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Ferrante RJ, 1997, J NEUROSCI, V17, P3052; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LALONDE R, 1987, EXP BRAIN RES, V65, P479; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; MacDonald ME, 1996, CURR OPIN NEUROBIOL, V6, P638, DOI 10.1016/S0959-4388(96)80097-3; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matsuoka Y, 1997, EXP NEUROL, V146, P57, DOI 10.1006/exnr.1997.6488; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Metzler M, 1999, J NEUROCHEM, V72, P1009, DOI 10.1046/j.1471-4159.1999.0721009.x; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; O'Kusky JR, 1999, BRAIN RES, V818, P468, DOI 10.1016/S0006-8993(98)01312-2; PERSICHETTI F, 1995, MOL MED, V1, P374, DOI 10.1007/BF03401575; Reddy PH, 1999, TRENDS NEUROSCI, V22, P248, DOI 10.1016/S0166-2236(99)01415-0; Rich T, 1999, HUM MOL GENET, V8, P2451, DOI 10.1093/hmg/8.13.2451; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; SANTAROSA R, 1994, LAB INVEST, V70, P503; Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; Sittler A, 1998, MOL CELL, V2, P427, DOI 10.1016/S1097-2765(00)80142-2; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; van den Akker E, 1999, MECH DEVELOP, V89, P103, DOI 10.1016/S0925-4773(99)00212-9; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	46	405	423	1	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					300	306		10.1038/81593	http://dx.doi.org/10.1038/81593			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062468				2022-12-27	WOS:000165176500017
J	Bargal, R; Avidan, N; Ben-Asher, E; Olender, Z; Zeigler, M; Frumkin, A; Raas-Rothschild, A; Glusman, G; Lancet, D; Bach, G				Bargal, R; Avidan, N; Ben-Asher, E; Olender, Z; Zeigler, M; Frumkin, A; Raas-Rothschild, A; Glusman, G; Lancet, D; Bach, G			Identification of the gene causing mucolipidosis type IV	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; NATURAL-HISTORY; PROTEIN; PREDICTION; DATABASE; DNA	Mucolipidosis type IV (MLIV) is an autosomal recessive, neurodegenerative, lysosomal storage disorder(1) characterized by psychomotor retardation and ophthalmological abnormalities including corneal opacities, retinal degeneration and strabismus. Most patients reach a maximal developmental level of 12-15 months(2). The disease was classified as a mucolipidosis following observations by electron microscopy indicating the lysosomal storage of lipids together with water-soluble, granulated substances(1,3-6). Over 80% of the MLIV patients diagnosed are Ashkenazi Jews, including severely affected and mildly affected patients(3,4). The gene causing MLIV was previously mapped to human chromosome 19p13.2-13.3 in a region of approximately 1 cM (ref. 7). Haplotype analysis in the MLIV gene region of over 70 MLIV Ashkenazi chromosomes indicated the existence of two founder chromosomes among 95% of the Ashkenazi MLIV families: a major haplotype in 72% and a minor haplotype in 23% of the MLIV chromosomes (ref. 7, and G.B., unpublished data). The remaining 5% are distinct haplotypes found only in single patients. The basic metabolic defect causing the lysosomal storage in MLIV has not yet been identified. Thus. positional cloning was an alternative to identify the MLIV gene. We report here the identification of a new gene in this human chromosomal region in which MLIV-specific mutations were identified.	Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel; Weizmann Inst Sci, Dept Mol Genet, Crown Human Genome Ctr, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Weizmann Institute of Science	Bach, G (corresponding author), Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel.							Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMIR N, 1987, PEDIATRICS, V79, P953; BACH G, 1992, GENETIC DIVERSITY AMONG JEWS, P301; BERMAN ER, 1974, J PEDIATR-US, V84, P519, DOI 10.1016/S0022-3476(74)80671-2; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CHITAYAT D, 1991, AM J MED GENET, V41, P313, DOI 10.1002/ajmg.1320410310; Glusman G, 2000, BIOINFORMATICS, V16, P482, DOI 10.1093/bioinformatics/16.5.482; GOEBEL HH, 1982, CLIN NEUROPATHOL, V1, P73; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Harris PC, 1999, HUM MOL GENET, V8, P1861, DOI 10.1093/hmg/8.10.1861; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MERIN S, 1975, INVEST OPHTH VISUAL, V14, P437; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; REIS S, 1993, AM J MED GENET, V47, P392; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; Sessa A, 1997, J NEPHROL, V10, P295; Slaugenhaupt SA, 1999, AM J HUM GENET, V65, P773, DOI 10.1086/302549; SOLOVYEV V, 1997, ISMB, V5, P294	21	274	282	1	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					118	121		10.1038/79095	http://dx.doi.org/10.1038/79095			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973263				2022-12-27	WOS:000089078000032
J	Lincoln, AJ; Wickramasinghe, D; Stein, P; Schultz, RM; Palko, ME; De Miguel, MP; Tessarollo, L; Donovan, PJ				Lincoln, AJ; Wickramasinghe, D; Stein, P; Schultz, RM; Palko, ME; De Miguel, MP; Tessarollo, L; Donovan, PJ			Cdc25b phosphatase is required for resumption of meiosis during oocyte maturation	NATURE GENETICS			English	Article							MEIOTIC COMPETENCE; MOUSE OOCYTES; CELL-CYCLE; PROTEIN; YEAST; HOMOLOG; DEPHOSPHORYLATION; ACTIVATION; MITOSIS; ACQUISITION	In a wide variety of animal species, oocyte maturation is arrested temporarily at prophase of meiosis I (ref. 1). Resumption of meiosis requires activation of cyclin-dependent kinase-1 (CDK1, p34cdc2), one component of maturation-promoting factor (MPF)(2,3). The dual specificity phosphatases Cdc25a, Cdc25b and Cdc25c are activators of cyclin-dependent kinases(4-8); consequently, they are postulated to regulate cell-cycle progression in meiosis and mitosis as well as the DNA-damage response(9-12). We generated Cdc25b-deficient (Cdc25b(-/-)) mice and found that they are viable. As compared with wildtype cells, fibroblasts from Cdc25b(-/-) mice grew vigorously in culture and arrested normally in response to DNA damage. Female Cdc25b(-/-) mice were sterile, and Cdc25b(-/-) oocytes remained arrested at prophase with low MPF activity. Microinjection of wildtype Cdc25b mRNA into Cdc25b(-/-) oocytes caused activation of MPF and resumption of meiosis. Thus, Cdc25b(-/-) female mice are sterile because of permanent meiotic arrest resulting from the inability to activate MPF. Cdc25b is therefore essential for meiotic resumption in female mice. Mice lacking Cdc25b provide the first genetic model for studying the mechanisms regulating prophase arrest in vertebrates.	NCI, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Pennsylvania	Donovan, PJ (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.		Stein, Paula/ABE-9388-2020; Holt, Janet E/B-2415-2013	Stein, Paula/0000-0002-2040-4593; 				Chen MS, 2001, MOL CELL BIOL, V21, P3853, DOI 10.1128/MCB.21.12.3853-3861.2001; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; Eckstein J., 1997, BIOCHIM BIOPHYS ACTA, V1332, P53; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; Gopalan G, 1997, J CELL BIOL, V138, P643, DOI 10.1083/jcb.138.3.643; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Jessus C, 1995, Prog Cell Cycle Res, V1, P215; KAKIZUKA A, 1992, GENE DEV, V6, P578, DOI 10.1101/gad.6.4.578; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Masui Y, 1979, Int Rev Cytol, V57, P185, DOI 10.1016/S0074-7696(08)61464-3; Mitra J, 1996, J CELL SCI, V109, P2407; NAGATA A, 1991, NEW BIOL, V3, P959; NARGI JL, 1994, IMMUNOGENETICS, V39, P99, DOI 10.1007/BF00188612; Nurse P, 1997, CELL, V91, P865, DOI 10.1016/S0092-8674(00)80476-6; SADHU K, 1990, P NATL ACAD SCI USA, V87, P5139, DOI 10.1073/pnas.87.13.5139; SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Svoboda P, 2000, DEVELOPMENT, V127, P4147; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; Weinert T, 1997, SCIENCE, V277, P1450, DOI 10.1126/science.277.5331.1450; WICKRAMASINGHE D, 1991, DEV BIOL, V143, P162, DOI 10.1016/0012-1606(91)90063-9; WICKRAMASINGHE D, 1995, DEVELOPMENT, V121, P2047; WU S, 1995, DEV BIOL, V170, P195, DOI 10.1006/dbio.1995.1207	26	203	219	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					446	449		10.1038/ng856	http://dx.doi.org/10.1038/ng856			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11912493				2022-12-27	WOS:000174682000026
J	Coghill, EL; Hugill, A; Parkinson, N; Davison, C; Glenister, P; Clements, S; Hunter, J; Cox, RD; Brown, SDM				Coghill, EL; Hugill, A; Parkinson, N; Davison, C; Glenister, P; Clements, S; Hunter, J; Cox, RD; Brown, SDM			A gene-driven approach to the identification of ENU mutants in the mouse	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; SENSORINEURAL DEAFNESS; CONNEXIN-26 MUTATIONS; GENOME-WIDE; MICE; MUTAGENESIS	The construction of parallel archives of DNA and sperm from mice mutagenized with ethylnitrosurea (ENU) represents a potentially powerful and rapid approach for identifying point mutations in any gene in the mouse genome. We provide support for this approach and report the identification of mutations in the gene (Gjb2) encoding connexin 26, using archives established from the UK ENU mutagenesis program.	MRC, Mammalian Genet Unit, Harwell OX11 0RD, Berks, England; UK Mouse Genome Ctr, Harwell OX11 0RD, Berks, England; GlaxoSmithKline, Harlow CM19 5AW, Essex, England	GlaxoSmithKline	Brown, SDM (corresponding author), MRC, Mammalian Genet Unit, Harwell OX11 0RD, Berks, England.			Cox, Roger/0000-0001-7170-5014				Beier DR, 2000, MAMM GENOME, V11, P594, DOI 10.1007/s003350010113; Chen YJ, 2000, NAT GENET, V24, P314, DOI 10.1038/73557; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; Dobson-Stone C, 2000, EUR J HUM GENET, V8, P24, DOI 10.1038/sj.ejhg.5200409; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Gabriel HD, 1998, J CELL BIOL, V140, P1453, DOI 10.1083/jcb.140.6.1453; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Munroe RJ, 2000, NAT GENET, V24, P318, DOI 10.1038/73563; Nadeau JH, 2001, SCIENCE, V291, P1251, DOI 10.1126/science.1058244; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Scott DA, 1998, HUM MUTAT, V11, P387, DOI 10.1002/(SICI)1098-1004(1998)11:5<387::AID-HUMU6>3.3.CO;2-#; STEEL KP, 1996, WHATS WRONG MY MOUSE, P26; Thornton CE, 1999, MAMM GENOME, V10, P987, DOI 10.1007/s003359901145	15	141	145	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					255	256		10.1038/ng847	http://dx.doi.org/10.1038/ng847			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11850622				2022-12-27	WOS:000174157600007
J	Morgante, M; Hanafey, M; Powell, W				Morgante, M; Hanafey, M; Powell, W			Microsatellites are preferentially associated with nonrepetitive DNA in plant genomes	NATURE GENETICS			English	Article							SIMPLE SEQUENCE REPEATS; REPETITIVE ELEMENTS; RETROTRANSPOSONS; ORGANIZATION; ABUNDANCE; METHYLATION; EVOLUTION	Microsatellites are a ubiquitous class of simple repetitive DNA sequence. An excess of such repetitive tracts has been described in all eukaryotes analyzed and is thought to result from the mutational effects of replication slippage(1). Large-scale genomic and EST sequencing provides the opportunity to evaluate the abundance and relative distribution of microsatellites(2) between transcribed and nontranscribed regions and the relationship of these features to haploid genome size. Although this has been studied in microbial and animal genomes(3-6), information in plants is limited. We assessed microsatellite frequency in plant species with a 50-fold range in genome size that is mostly attributable to the recent amplification of repetitive DNA(7). Among species, the overall frequency of microsatellites was inversely related to genome size and to the proportion of repetitive DNA but remained constant in the transcribed portion of the genome. This indicates that most microsatellites reside in regions pre-dating the recent genome expansion in many plants. The microsatellite frequency was higher in transcribed regions, especially in the untranslated portions, than in genomic DNA. Contrary to previous reports suggesting a preferential mechanism for the origin of microsatellites from repetitive DNA in both animals(8,9) and plants(10), our findings show a significant association with the low-copy fraction of plant genomes.	Dupont Co Inc, DuPont Agr & Nutr Mol Genet, Newark, DE USA	DuPont	Morgante, M (corresponding author), Dupont Co Inc, DuPont Agr & Nutr Mol Genet, Newark, DE USA.	michele.morgante@usa.dupont.com		Powell, Wayne/0000-0002-5612-3398; MORGANTE, Michele/0000-0003-2591-2156				Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; Bennetzen JL, 2000, PLANT CELL, V12, P1021, DOI 10.1105/tpc.12.7.1021; Cardle L, 2000, GENETICS, V156, P847; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; DHAR MS, 1988, PLANT SCI, V55, P43, DOI 10.1016/0168-9452(88)90040-4; Elgar G, 1999, GENOME RES, V9, P960, DOI 10.1101/gr.9.10.960; GOLDBERG RB, 1978, BIOCHEM GENET, V16, P45, DOI 10.1007/BF00484384; Gur-Arie R, 2000, GENOME RES, V10, P62; HAKE S, 1980, CHROMOSOMA, V79, P251, DOI 10.1007/BF00327318; Hancock JM, 1996, BIOESSAYS, V18, P421, DOI 10.1002/bies.950180512; Hartl DL, 2000, NAT REV GENET, V1, P145, DOI 10.1038/35038580; Keller B, 2000, TRENDS PLANT SCI, V5, P246, DOI 10.1016/S1360-1385(00)01629-0; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; LAGERCRANTZ U, 1993, NUCLEIC ACIDS RES, V21, P1111, DOI 10.1093/nar/21.5.1111; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Metzgar D, 2000, GENOME RES, V10, P72; Meyerowitz E. M., 1992, Methods in Arabidopsis research., P100; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; MORGANTE M, 1993, PLANT J, V3, P175, DOI 10.1111/j.1365-313X.1993.tb00020.x; Nadir E, 1996, P NATL ACAD SCI USA, V93, P6470, DOI 10.1073/pnas.93.13.6470; Pfeiffer A, 1997, GENOME, V40, P411, DOI 10.1139/g97-055; Pupko T, 1999, J MOL EVOL, V48, P313, DOI 10.1007/PL00006474; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Ramsay L, 1999, PLANT J, V17, P415, DOI 10.1046/j.1365-313X.1999.00392.x; Roest Crollius H, 2000, GENOME RES, V10, P939, DOI 10.1101/gr.10.7.939; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Schlotterer C, 2000, MOL BIOL EVOL, V17, P1641, DOI 10.1093/oxfordjournals.molbev.a026263; Shama S, 1996, EUR J BIOCHEM, V236, P383, DOI 10.1111/j.1432-1033.1996.00383.x; SMITH DB, 1976, NUCLEIC ACIDS RES, V3, P2811, DOI 10.1093/nar/3.10.2811; Stuart-Rogers C, 2001, MOL BIOL EVOL, V18, P155, DOI 10.1093/oxfordjournals.molbev.a003789; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967	36	813	973	1	95	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					194	200		10.1038/ng822	http://dx.doi.org/10.1038/ng822			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11799393				2022-12-27	WOS:000173708700021
J	Baxter, RV; Ben Othmane, K; Rochelle, JM; Stajich, JE; Hulette, C; Dew-Knight, S; Hentati, F; Ben Hamida, M; Bel, S; Stenger, JE; Gilbert, JR; Pericak-Vance, MA; Vance, JM				Baxter, RV; Ben Othmane, K; Rochelle, JM; Stajich, JE; Hulette, C; Dew-Knight, S; Hentati, F; Ben Hamida, M; Bel, S; Stenger, JE; Gilbert, JR; Pericak-Vance, MA; Vance, JM			Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21	NATURE GENETICS			English	Article								We previously localized and fine-mapped Charcot Marie Tooth 4A (CMT4A), the autosoma[ recessive, demyelinating peripheral neuropathy, to chromosome 8. Through additional positional cloning, we have identified a good candidate gene, encoding ganglioside-induced differentiation-associated protein-1 (GDAP1). We found three different mutations in four different Tunisian families-two nonsense and one missense mutation. How mutations in GDAP1 lead to CMT4A remains to be understood.	Duke Univ, Med Ctr, Inst Genom Sci & Policy, Ctr Human Genet, Durham, NC 27710 USA; Inst Natl Neurol, Tunis 1007, Tunisia	Duke University; Universite de Tunis-El-Manar; Institut National de Neurologie	Vance, JM (corresponding author), Duke Univ, Med Ctr, Inst Genom Sci & Policy, Ctr Human Genet, Res Pk Bldg 11 Room 105,Box 2903, Durham, NC 27710 USA.	jeff@chg.mc.duke.edu	Stajich, Jason Eric/C-7297-2008	Stajich, Jason Eric/0000-0002-7591-0020; Vance, Jeffery/0000-0003-3815-8199				Barhoumi C, 2001, NEUROMUSCULAR DISORD, V11, P27, DOI 10.1016/S0960-8966(00)00162-0; Ben Othmane K, 1998, NEUROGENETICS, V2, P18, DOI 10.1007/s100480050047; Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798; De Jonghe P, 1997, J Peripher Nerv Syst, V2, P370; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; Martinotti Alessia, 1992, Human Molecular Genetics, V1, P331, DOI 10.1093/hmg/1.5.331; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; Vance JM, 2000, ARCH NEUROL-CHICAGO, V57, P638, DOI 10.1001/archneur.57.5.638	9	276	285	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					21	22		10.1038/ng796	http://dx.doi.org/10.1038/ng796			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743579				2022-12-27	WOS:000173105600006
J	Dyer, RB; McMurray, CT				Dyer, RB; McMurray, CT			Mutant protein in Huntington disease is resistant to proteolysis in affected brain	NATURE GENETICS			English	Article							INTRANUCLEAR NEURONAL INCLUSIONS; N-TERMINAL HUNTINGTIN; POLYGLUTAMINE TRACT; NUCLEAR-LOCALIZATION; GLUTAMINE REPEATS; STRIATAL NEURONS; CASPASE CLEAVAGE; TRANSGENIC MICE; IN-VITRO; EXPRESSION	The cause of Huntington disease pathophysiology is unknown, but a major hypothesis suggests that toxicity arises from the cleavage and accumulation of amino-terminal fragments containing an expanded polyglutamine region. In evaluating huntingtin protein (HD) from human brain, transgenic animals and cells, we observed, unexpectedly, that mutant HD is more resistant to proteolysis than normal HD. The N-terminal cleavage fragments we observed arise from the processing of normal HD and are sequestered by full-length mutant HD. Our results support a model in which inhibition of proteolysis of mutant HD leads to aggregation and toxicity through the sequestering of important targets, including normal HD.	Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mol Neurosci Program, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	McMurray, CT (corresponding author), Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, 200 1st St SW, Rochester, MN 55905 USA.	mcmurray.cynthia@mayo.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH031862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040738] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 43694] Funding Source: Medline; NIMH NIH HHS [MH/NS 31862] Funding Source: Medline; NINDS NIH HHS [NS40738] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; de Cristofaro T, 2000, BIOCHEM BIOPH RES CO, V272, P816, DOI 10.1006/bbrc.2000.2843; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Goellner GM, 1997, AM J HUM GENET, V60, P879; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1999, HUM MOL GENET, V8, P25, DOI 10.1093/hmg/8.1.25; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Kim M, 1999, J NEUROSCI, V19, P964; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; MCMURRAY CT, 1989, ENDOCRINOLOGY, V124, P49, DOI 10.1210/endo-124-1-49; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 1999, HUM MOL GENET, V8, P943; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6	48	70	72	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					270	278		10.1038/ng745	http://dx.doi.org/10.1038/ng745			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11600884				2022-12-27	WOS:000171911000012
J	Douglas, JA; Boehnke, M; Gillanders, E; Trent, JA; Gruber, SB				Douglas, JA; Boehnke, M; Gillanders, E; Trent, JA; Gruber, SB			Experimentally-derived haplotypes substantially increase the efficiency of linkage disequilibrium studies	NATURE GENETICS			English	Article							FREQUENCIES; INDIVIDUALS; PHENOTYPES	The study of complex genetic traits in humans is limited by the expense and difficulty of ascertaining populations of sufficient sample size to detect subtle genetic contributions to disease. Here we introduce an application of a somatic cell hybrid construction strategy called conversion(1-4) that maximizes the genotypic information from each sampled individual. The approach permits direct observation of individual haplotypes, thereby eliminating the need for collecting and genotyping DNA from family members for haplotype-based analyses. We describe experimental data that validate the use of conversion as a whole-genome haplotyping too[ and evaluate the theoretical efficiency of using conversion-derived haplotypes instead of conventional genotypes in the context of haplotype-frequency estimation. We show that, particularly when phenotyping is expensive, conversion-based haplotyping can be more efficient and cost-effective than standard genotyping.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; NHGRI, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.	boehnke@umich.edu			NATIONAL CANCER INSTITUTE [R01CA081488] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000376] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA81488] Funding Source: Medline; NHGRI NIH HHS [R01-HG00376] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; GLASER T, 1986, NATURE, V321, P882, DOI 10.1038/321882a0; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; Hodge SE, 1999, NAT GENET, V21, P360, DOI 10.1038/7687; Laken SJ, 1999, P NATL ACAD SCI USA, V96, P2322, DOI 10.1073/pnas.96.5.2322; LONG JC, 1995, AM J HUM GENET, V56, P799; MACLEAN C J, 1985, Genetic Epidemiology, V2, P263, DOI 10.1002/gepi.1370020304; McKeigue PM, 2000, AM J HUM GENET, V67, P1626, DOI 10.1086/316912; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Veldman T, 1997, NAT GENET, V15, P406, DOI 10.1038/ng0497-406; WEISS MC, 1967, P NATL ACAD SCI USA, V58, P1104, DOI 10.1073/pnas.58.3.1104; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Yen H, 2000, SCIENCE, V289, P1890	17	126	143	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					361	364		10.1038/ng582	http://dx.doi.org/10.1038/ng582			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11443299				2022-12-27	WOS:000170174800017
J	Gehring, NH; Frede, U; Neu-Yilik, G; Hundsdoerfer, P; Vetter, B; Hentze, MW; Kulozik, AE				Gehring, NH; Frede, U; Neu-Yilik, G; Hundsdoerfer, P; Vetter, B; Hentze, MW; Kulozik, AE			Increased efficiency of mRNA 3 ' end formation: a new genetic mechanism contributing to hereditary thrombophilia	NATURE GENETICS			English	Article							PROTHROMBIN GENE; G20210A MUTATION; HUMAN-BETA; POLYADENYLATION; DEGRADATION; THROMBOSIS	The G-->A mutation at position 20210 of the prothrombin or coagulation factor II gene (F2) represents a common genetic risk factor for the occurrence of thromboembolic events(1-3). This mutation affects the T-terminal nucleotide of the 3' untranslated region (UTR) of the mRNA and causes elevated prothrombin plasma concentrations(1-4) by an unknown mechanism. Here, we show that the mutation does not affect the amount of pre-mRNA, the site of 3' end cleavage or the length of the poly(A) tail of the mature mRNA. Rather, we demonstrate that the physiological F2 3' end cleavage signal is inefficient and that F2 20210 G-->A represents a gain-of-function mutation, causing increased cleavage site recognition, increased Tend processing and increased mRNA accumulation and protein synthesis. Enhanced mRNA 3' end formation efficiency emerges as a novel principle causing a genetic disorder and explains the role of the F2 20210 G-->A mutation in the pathogenesis of thrombophilia. This work also illustrates the pathophysiologic importance of quantitatively minor aberrations of RNA metabolism.	EMBL, Gene Express Programme, Heidelberg, Germany; Humboldt Univ, Charite, Dept Pediat, Berlin, Germany	European Molecular Biology Laboratory (EMBL); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kulozik, AE (corresponding author), Humboldt Univ, Charite, Dept Pediat, Berlin, Germany.	andreas.kulozik@charite.de	Hentze, Matthias W/V-3980-2017; Kulozik, Andreas/AAO-2432-2020	Hentze, Matthias W/0000-0002-4023-7876; 				BATT DB, 1994, NUCLEIC ACIDS RES, V22, P2811, DOI 10.1093/nar/22.14.2811; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Cattaneo M, 1999, THROMB RES, V93, P1, DOI 10.1016/S0049-3848(98)00136-4; CHEN F, 1995, NUCLEIC ACIDS RES, V23, P2614, DOI 10.1093/nar/23.14.2614; CHOU ZF, 1994, NUCLEIC ACIDS RES, V22, P2525, DOI 10.1093/nar/22.13.2525; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; KUGLER W, 1995, NUCLEIC ACIDS RES, V23, P413, DOI 10.1093/nar/23.3.413; Lane DA, 2000, BLOOD, V95, P1517, DOI 10.1182/blood.V95.5.1517.005k48_1517_1532; Makris M, 1997, THROMB HAEMOSTASIS, V78, P1426; Muhlrad D, 1999, RNA, V5, P1299, DOI 10.1017/S1355838299990829; Neu-Yilik G, 2001, EMBO J, V20, P532, DOI 10.1093/emboj/20.3.532; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; ROSS J, 1983, J MOL BIOL, V167, P607, DOI 10.1016/S0022-2836(83)80101-6; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Tosetto A, 1999, THROMB HAEMOSTASIS, V82, P1395; van Hoof A, 1999, CELL, V99, P347, DOI 10.1016/S0092-8674(00)81520-2; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	19	197	204	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					389	392		10.1038/ng578	http://dx.doi.org/10.1038/ng578			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11443298				2022-12-27	WOS:000170174800023
J	Xu, XL; Qiao, WH; Linke, SP; Cao, L; Li, WM; Furth, PA; Harris, CC; Deng, CX				Xu, XL; Qiao, WH; Linke, SP; Cao, L; Li, WM; Furth, PA; Harris, CC; Deng, CX			Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis	NATURE GENETICS			English	Letter							DAMAGE-INDUCED PHOSPHORYLATION; ATM-DEPENDENT PHOSPHORYLATION; DOUBLE-STRAND BREAKS; DNA-DAMAGE; GAMMA-IRRADIATION; MOUSE; MICE; PROTEIN; MDM2; MORPHOGENESIS	Breast cancer is a chief cause of cancer-related mortality that affects women worldwide. About 8% of cases are hereditary. and approximately half of these are associated with germline mutations of the breast tumor suppressor gene BRCA1 (refs. 1,2). We have previously reported a mouse model in which Brca1 exon 11 is eliminated in mammary epithelial cells through Cre-mediated excision(3). This mutation is often accompanied by alterations in transformation-related protein 53 (Trp53, encoding p53), which substantially accelerates mammary tumor formation. Here. we sought to elucidate the underlying mechanism(s) using mice deficient in the Brca1 exon 11 isoform (Brca1(Delta 11/Delta 11)). Brca1(Delta 11/Delta 11) embryos died late in gestation because of widespread apoptosis. Unexpectedly. elimination of one Trp53 allele completely rescues this embryonic lethality and restores normal mammary gland development. However, most female Brca1(Delta 11/Delta 11)Trp53(+/-) mice develop mammary tumors with loss of the remaining Trp53 allele within 6-12 months. Lymphoma and ovarian tumors also occurr at lower frequencies. Heterozygous mutation of Trp53 decreases p53 and results in attenuated apoptosis and G(1)-S checkpoint control, allowing Brca1(Delta 11/Delta 11) cells to proliferate. The p53 protein regulates Brca1 transcription both in vitro and in vivo, and Brca1 participates in p53 accumulation after gamma -irradiation through regulation of its phosphorylation and Mdm2 expression. These findings provide a mechanism for BRCA1-associated breast carcinogenesis.	NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; Univ Maryland, Sch Med, Dept Med, Inst Human Virol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Deng, CX (corresponding author), NIDDKD, Genet Dev & Dis Branch, NIH, 10-9N105, Bethesda, MD 20892 USA.		deng, chuxia/N-6713-2016	Linke, Steven/0000-0001-8584-4947	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056001, Z01DK056001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andres JL, 1998, ONCOGENE, V16, P2229, DOI 10.1038/sj.onc.1201752; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Casey Graham, 1997, Current Opinion in Oncology, V9, P88; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Cressman VL, 1999, MOL CELL BIOL, V19, P7061; Deng CX, 2000, BIOESSAYS, V22, P728; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hill ADK, 1997, BRIT J SURG, V84, P1334; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Linke SP, 1997, CANCER RES, V57, P1171; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; MacLachlan TK, 2000, J BIOL CHEM, V275, P31869, DOI 10.1074/jbc.M003338200; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; Nakagawa K, 1999, MOL CELL BIOL, V19, P2828; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Schuyer M, 1999, MOL CELL ENDOCRINOL, V155, P143, DOI 10.1016/S0303-7207(99)00117-3; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; WANG Y, 1992, P NATL ACAD SCI USA, V89, P4231, DOI 10.1073/pnas.89.10.4231; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	30	289	297	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					266	271		10.1038/90108	http://dx.doi.org/10.1038/90108			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431698				2022-12-27	WOS:000169656400020
J	Yoshikawa, H; Matsubara, K; Qian, GS; Jackson, P; Groopman, JD; Manning, JE; Harris, CC; Herman, JG				Yoshikawa, H; Matsubara, K; Qian, GS; Jackson, P; Groopman, JD; Manning, JE; Harris, CC; Herman, JG			SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity	NATURE GENETICS			English	Article							CONSTITUTIVE ACTIVATION; PROMOTER HYPERMETHYLATION; SIGNAL-TRANSDUCTION; LIVER-REGENERATION; DNA METHYLATION; GENE; PROTEIN; CELLS; INACTIVATION; LEUKEMIA	Hepatocellular carcinoma (HCC) is a major cause of cancer death, but the molecular mechanism for its development beyond its initiation has not been well characterized. Suppressor of cytokine signaling (SOCS-1; also known as JAB and SSI-1) switches cytokine signaling 'off' by means of its direct interaction with Janus kinase (JAK). We identified aberrant methylation in the CpG island of SOCS-1 that correlated with its transcription silencing in HCC cell lines. The incidence of aberrant methylation was 65% in the 26 human primary HCC tumor samples analyzed. Moreover, the restoration of SOCS-1 suppressed both growth rate and anchorage-independent growth of cells in which SOCS-1 was methylation-silenced and JAK2 was constitutively activated. This growth suppression was caused by apoptosis and was reproduced by AG490. a specific, chemical JAK2 inhibitor that reversed constitutive phosphorylation of STAT3 in SOCS-1 inactivated cells. The high prevalence of the aberrant SOCS-1 methylation and its growth suppression activity demonstrated the importance of the constitutive activation of the JAK/STAT pathway in the development of HCC. Our results also indicate therapeutic strategies for the treatment of HCC including use of SOCS-1 in gene therapy and inhibition of JAK2 by small molecules, such as AG490.	Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA; Nara Inst Sci & Technol, Nara, Japan; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD 21205 USA; Shanghai Canc Inst, Shanghai, Peoples R China; NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Medicine; Nara Institute of Science & Technology; Johns Hopkins University; Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Herman, JG (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA.		/X-4205-2019	/0000-0003-4690-2133; Manning, Jr., Jasper E./0000-0002-2376-8288	NCI NIH HHS [P50 CA58184] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058184] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Esteller M, 1999, CANCER RES, V59, P793; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; GRAFF JR, 1995, CANCER RES, V55, P5195; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; HERMAN JG, 1995, CANCER RES, V55, P4525; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Katzenellenbogen RA, 1999, BLOOD, V93, P4347, DOI 10.1182/blood.V93.12.4347.412k31_4347_4353; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Kramer JA, 1997, BIOTECHNIQUES, V22, P826, DOI 10.2144/97225bm07; Kramer JA, 1998, J EXP ZOOL, V282, P245, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2<245::AID-JEZ26>3.0.CO;2-R; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Losman JA, 1999, J IMMUNOL, V162, P3770; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; NAGAI H, 1994, CANCER RES, V54, P1545; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; RAMPONI G, 1992, INT J CANCER, V51, P652, DOI 10.1002/ijc.2910510424; Rashid A, 1999, BRIT J CANCER, V80, P59, DOI 10.1038/sj.bjc.6690321; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Trautwein C, 1996, GASTROENTEROLOGY, V110, P1854, DOI 10.1053/gast.1996.v110.pm8964411; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; WeberNordt RM, 1996, BLOOD, V88, P809; Yoshikawa H, 1997, GENE, V197, P129, DOI 10.1016/S0378-1119(97)00251-5; Yoshikawa H, 1998, GENOMICS, V49, P237, DOI 10.1006/geno.1998.5246; ZLATANOVA J S, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P211	44	625	666	0	35	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					29	35		10.1038/88225	http://dx.doi.org/10.1038/88225			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326271				2022-12-27	WOS:000168413300011
J	Costa, RM; Yang, T; Huynh, DP; Pulst, SM; Viskochil, DH; Silva, AJ; Brannan, CI				Costa, RM; Yang, T; Huynh, DP; Pulst, SM; Viskochil, DH; Silva, AJ; Brannan, CI			Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1	NATURE GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-1 NF1; LONG-TERM-MEMORY; RAS SIGNALING PATHWAY; MORRIS WATER MAZE; TARGETED MUTATION; MUTANT MICE; MOUSE MODEL; GENE; EXPRESSION; GAP	Neurofibromatosis type 1 (NF1) is a commonly inherited autosomal dominant disorder. Previous studies indicated that mice homozygous for a null mutation in Nf1 exhibit mid-gestation lethality, whereas heterozygous mice have an increased predisposition to tumors and learning impairments. Here we show that mice lacking the alternatively spliced exon 23a, which modifies the GTPase-activating protein (CAP) domain of Nf1, are viable and physically normal, and do not have an increased tumor predisposition, but show specific learning impairments. Our findings have implications for the development of a treatment for the learning disabilities associated with NF1 and indicate that the CAP domain of NF1 modulates learning and memory.	Univ Calif Los Angeles, Dept Neurobiol, BRI, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Psychiat, BRI, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Psychol, BRI, Los Angeles, CA USA; Univ Florida, Coll Med, Inst Brain, Gainesville, FL USA; Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Los Angeles, CA USA; Univ Utah, Div Med Genet, Salt Lake City, UT USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University System of Florida; University of Florida; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah	Brannan, CI (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, BRI, Los Angeles, CA 90024 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Costa, Rui M./0000-0003-0495-8374; Silva, Alcino/0000-0001-5525-0494	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038480] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS38480] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson J.C., 1992, J BUS-BUS MARK, V1, P3, DOI [10.1300/J033v01n01_02, DOI 10.1300/J033V01N01_02]; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Bunsey M, 1995, HIPPOCAMPUS, V5, P546, DOI 10.1002/hipo.450050606; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Cho YH, 1999, BEHAV BRAIN RES, V98, P77; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gutmann DH, 1995, PROG BRAIN RES, V105, P327; Gutmann DH, 1999, ANN NEUROL, V46, P777, DOI 10.1002/1531-8249(199911)46:5<777::AID-ANA15>3.0.CO;2-H; GUTMANN DH, 1994, METABOLIC MOL BASIS, P1; Hogan B, 1994, MANIPULATING MOUSE E; Huson SHR, 1994, NEUROFIBROMATOSES PA; HUYNH DP, 1994, DEV BIOL, V161, P538, DOI 10.1006/dbio.1994.1052; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Klose A, 1998, HUM MOL GENET, V7, P1261, DOI 10.1093/hmg/7.8.1261; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Metheny LJ, 1996, EXP CELL RES, V228, P44, DOI 10.1006/excr.1996.0297; NORDLUND ML, 1995, J NEUROPATH EXP NEUR, V54, P588, DOI 10.1097/00005072-199507000-00013; Ozonoff S, 1999, AM J MED GENET, V89, P45, DOI 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J; Rizvi TA, 1999, BRAIN RES, V816, P111, DOI 10.1016/S0006-8993(98)01133-0; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; UPADHYAYA M, 1998, NEUROFIBROMATOSIS TY, V1; Upadhyaya M., 1998, NEUROFIBROMATOSIS TY, P39; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253	38	136	144	1	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					399	405		10.1038/86898	http://dx.doi.org/10.1038/86898			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279521				2022-12-27	WOS:000167811200014
J	Shih, DQ; Bussen, M; Sehayek, E; Ananthanarayanan, M; Shneider, BL; Suchy, FJ; Shefer, S; Bollileni, JS; Gonzalez, FJ; Breslow, JL; Stoffel, M				Shih, DQ; Bussen, M; Sehayek, E; Ananthanarayanan, M; Shneider, BL; Suchy, FJ; Shefer, S; Bollileni, JS; Gonzalez, FJ; Breslow, JL; Stoffel, M			Hepatocyte nuclear factor-1 alpha is an essential regulator of bile acid and plasma cholesterol metabolism	NATURE GENETICS			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR LXR-ALPHA; TRANSCRIPTION FACTOR; TRANSGENIC MICE; GENE; EXPRESSION; ATHEROSCLEROSIS; LIVER; PROTEIN; PATHWAY	Maturity-onset diabetes of the young type 3 (MODY3) is caused by haploinsufficiency of hepatocyte nuclear factor-let (encoded by TCF1). Tcf1(-/-) mice have type 2 diabetes, dwarfism, renal Fanconi syndrome, hepatic dysfunction and hypercholestrolemia. Here we explore the molecular basis for the hypercholesterolemia using oligonucleotide microchip expression analysis. We demonstrate that Tcf1(-/-) mice have a defect in bile acid transport, increased bile acid and liver cholesterol synthesis, and impaired HDL metabolism. Tcf1(-/-) liver has decreased expression of the basolateral membrane bile acid transporters Slc10a1, Slc21a3 and Slc21a5, leading to impaired portal bile acid uptake and elevated plasma bile acid concentrations. In intestine and kidneys, Tcf1(-/-) mice lack expression of the ileal bile acid transporter (Slc10a2), resulting in increased fecal and urinary bile acid excretion. The Tcf1 protein (also known as HNF-1 alpha) also regulates transcription of the gene ((Nr1h4) encoding the farnesoid X receptor-1 (Fxr-1), thereby leading to reduced expression of small heterodimer partner-1 (Shp-1) and repression of Cyp7a1, the rate-limiting enzyme in the classic bile acid biosynthesis pathway. In addition, hepatocyte bile acid storage protein is absent from Tcf1(-/-) mice. Increased plasma cholesterol of Tcf1(-/-) mice resides predominantly in large, buoyant, high-density lipoprotein (HDL) particles. This is most likely due to reduced activity of the HDL-catabolic enzyme hepatic lipase (Lipc) and increased expression of HDL-cholesterol esterifying enzyme lecithin:cholesterol acyl transferase (Lcat). Our studies demonstrate that Tcf1, in addition to being an important regulator of insulin secretion, is an essential transcriptional regulator of bile acid and HDL-cholesterol metabolism.	Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; Rockefeller Univ, Biochem Genet & Metab Lab, New York, NY 10021 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY USA; Univ Med & Dent New Jersey, Dept Med, Piscataway, NJ 08854 USA; NCI, Bethesda, MD 20892 USA	Rockefeller University; Rockefeller University; Icahn School of Medicine at Mount Sinai; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stoffel, M (corresponding author), Rockefeller Univ, Lab Metab Dis, 1230 York Ave, New York, NY 10021 USA.		Breslow, Jan L/B-7544-2008	Stoffel, Markus/0000-0003-1304-5817	NICHD NIH HHS [HD20632] Funding Source: Medline; NIDDK NIH HHS [R01DK55033-01, DK02076, DK26756] Funding Source: Medline; NIGMS NIH HHS [GM07739] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020632, R37HD020632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K11DK002076, R01DK055033, R37DK026756, R01DK026756] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AALTOSETALA K, 1994, J CLIN INVEST, V93, P1776, DOI 10.1172/JCI117163; ANANTHANARAYANAN M, 1991, AM J PHYSIOL, V261, pG810, DOI 10.1152/ajpgi.1991.261.5.G810; Austin MA, 1996, CURR OPIN LIPIDOL, V7, P167, DOI 10.1097/00041433-199606000-00010; Bergwerk AJ, 1996, AM J PHYSIOL-GASTR L, V271, pG231, DOI 10.1152/ajpgi.1996.271.2.G231; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Christie DM, 1996, AM J PHYSIOL-GASTR L, V271, pG377, DOI 10.1152/ajpgi.1996.271.2.G377; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; FELKER TE, 1978, P NATL ACAD SCI USA, V75, P3459, DOI 10.1073/pnas.75.7.3459; Foger B, 1999, J BIOL CHEM, V274, P36912, DOI 10.1074/jbc.274.52.36912; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; HOMANICS GE, 1995, J BIOL CHEM, V270, P2974, DOI 10.1074/jbc.270.7.2974; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; LAGGNER P, 1977, EUR J BIOCHEM, V77, P165, DOI 10.1111/j.1432-1033.1977.tb11654.x; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Levine DM, 1997, CLIN CHEM, V43, P669; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; MAHLEY RW, 1975, BIOCHEMISTRY-US, V14, P2817, DOI 10.1021/bi00684a005; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MANZATO E, 1976, J CLIN INVEST, V57, P1248, DOI 10.1172/JCI108393; Meier PJ, 1997, HEPATOLOGY, V26, P1667, DOI 10.1002/hep.510260641; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285, DOI 10.1152/ajpgi.1997.272.6.G1285; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; NORUM KR, 1971, J CLIN INVEST, V50, P1131, DOI 10.1172/JCI106585; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; POWELL DR, 1993, DNA CELL BIOL, V12, P283, DOI 10.1089/dna.1993.12.283; Sehayek E, 1998, P NATL ACAD SCI USA, V95, P10194, DOI 10.1073/pnas.95.17.10194; SETCHELL KDR, 1983, J LIPID RES, V24, P1085; SETCHELL KDR, 1995, BIOCHEMISTRY-US, V34, P4169, DOI 10.1021/bi00013a004; Shneider BL, 1997, J BIOL CHEM, V272, P31006, DOI 10.1074/jbc.272.49.31006; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stieger B, 1998, CURR OPIN CELL BIOL, V10, P462, DOI 10.1016/S0955-0674(98)80059-8; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; STOLZ A, 1993, J BIOL CHEM, V268, P10448; TRANCHE T, 1994, LIVER GENE EXPRESSIO, P155; vanAntwerpen R, 1997, J LIPID RES, V38, P659; WONG MH, 1994, J BIOL CHEM, V269, P1340; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	43	339	353	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					375	382		10.1038/86871	http://dx.doi.org/10.1038/86871			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279518				2022-12-27	WOS:000167811200011
J	El-Maarri, O; Buiting, K; Peery, EG; Kroisel, PM; Balaban, B; Wagner, K; Urman, B; Heyd, J; Lich, C; Brannan, CI; Walter, J; Horsthemke, B				El-Maarri, O; Buiting, K; Peery, EG; Kroisel, PM; Balaban, B; Wagner, K; Urman, B; Heyd, J; Lich, C; Brannan, CI; Walter, J; Horsthemke, B			Maternal methylation imprints on human chromosome 15 are established during or after fertilization	NATURE GENETICS			English	Letter							PRADER-WILLI; SNRPN GENE; ANGELMAN; DEMETHYLATION; DELETIONS; DEFINE; GENOME	Prader-Willi syndrome (PWS) is a neurogenetic disorder that results from the lack of transcripts expressed from the paternal copy of the imprinted chromosomal region 15q11-q13 (refs, 1,2). In some patients, this is associated with a deletion of the SNURF-SNRPN exon 1 region inherited from the paternal grandmother and the presence of a maternal imprint on the paternal chromosome. Assuming that imprints are reset in the germ line, we and others have suggested that this region constitutes part of the 15q imprinting center (IC) and is important for the maternal to paternal imprint switch in the male germ line(3,4). Here we report that sperm DNA from two males with an IC deletion had a normal paternal methylation pattern along 15q11-q13, Similar findings were made in a mouse model. Our results indicate that the incorrect maternal methylation imprint in IC deletion patients is established de novo after fertilization, Moreover, we found that CpG-rich regions in SNURF-SNRPN and NDN, which in somatic tissues are methylated on the maternal allele, are hypomethylated in unfertilized human oocytes, Our results indicate that the normal maternal methylation imprints in 15q11-q13 also are established during or after fertilization.	Max Planck Inst Mol Genet, Berlin, Germany; Univ Essen Gesamthsch Klinikum, Inst Human Genet, D-4300 Essen, Germany; Univ Florida, Coll Med, Ctr Mammalian Genet, Dept Mol Genet & Microbiol, Gainesville, FL USA; Univ Florida, Coll Med, Inst Brain, Gainesville, FL USA; Graz Univ, Inst Med Biol & Human Genet, Graz, Austria; Amer Hastanasi, Assisted Reprod Technol Unit, TR-80200 Istanbul, Turkey	Max Planck Society; University of Duisburg Essen; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Graz; Amerikan Hospital	Walter, J (corresponding author), Univ Saarland, Postfach 151150, Saarbrucken, Germany.	j.walter@mx.uni-saarland.de		El-Maarri, Osman/0000-0002-6859-5819				BLELINSKA B, 2000, NAT GENET, V25, P74; Buiting K, 2000, CLIN GENET, V58, P284, DOI 10.1034/j.1399-0004.2000.580406.x; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; Lyko F, 1998, P NATL ACAD SCI USA, V95, P1698, DOI 10.1073/pnas.95.4.1698; Mann MRW, 2000, NAT GENET, V25, P4, DOI 10.1038/75575; Mann MRW, 1999, HUM MOL GENET, V8, P1867, DOI 10.1093/hmg/8.10.1867; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Prissette M, 2001, HUM MOL GENET, V10, P31, DOI 10.1093/hmg/10.1.31; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tilghman SM, 1998, NAT GENET, V18, P206, DOI 10.1038/ng0398-206; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Zeschnigk M, 1997, HUM MOL GENET, V6, P387, DOI 10.1093/hmg/6.3.387	20	164	166	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					341	344		10.1038/85927	http://dx.doi.org/10.1038/85927			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242121				2022-12-27	WOS:000167304200031
J	Crisponi, L; Deiana, M; Loi, A; Chiappe, F; Uda, M; Amati, P; Bisceglia, L; Zelante, L; Nagaraja, R; Porcu, S; Ristaldi, MS; Marzella, R; Rocchi, M; Nicolino, M; Lienhardt-Roussie, A; Nivelon, A; Verloes, A; Schlessinger, D; Gasparini, P; Bonneau, D; Cao, A; Pilia, G				Crisponi, L; Deiana, M; Loi, A; Chiappe, F; Uda, M; Amati, P; Bisceglia, L; Zelante, L; Nagaraja, R; Porcu, S; Ristaldi, MS; Marzella, R; Rocchi, M; Nicolino, M; Lienhardt-Roussie, A; Nivelon, A; Verloes, A; Schlessinger, D; Gasparini, P; Bonneau, D; Cao, A; Pilia, G			The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome	NATURE GENETICS			English	Article							PREMATURE OVARIAN FAILURE; IN-SITU HYBRIDIZATION; EYELID DEVELOPMENT; HELIX GENE; HUMAN HOMOLOG; BLEPHAROPHIMOSIS; PTOSIS; MOUSE; POSITION; MAP	In type I blepharophimosis/ptosis/epicanthus inversus syndrome (BPES), eyelid abnormalities are associated with ovarian failure. Type II BPES shows only the eyelid defects, but both types map to chromosome 3q23. We have positionally cloned a novel. putative winged helix/forkhead transcription factor gene, FOXL2, that is mutated to produce truncated proteins in type I families and larger proteins in type II. Consistent with an involvement in those tissues, FOXL2 is selectively expressed in the mesenchyme of developing mouse eyelids and in adult ovarian follicles; in adult humans, it appears predominantly in the ovary. FOXL2 represents a candidate gene for the polled/intersex syndrome XX sex-reversal goat.	Univ Cagliari, CNR, Ist Ric Talassemie & Anemie Mediterranee, Cagliari, Italy; Univ Cagliari, Osped Reg Microcitemie, Dipartimento Sci Biomed & Biotecnol, Cagliari, Italy; Ctr Hosp Univ Poitiers, Serv Genet Med, Poitiers, France; Osped CSS, IRCCS, Serv Genet Med, I-71013 San Giovanni Rotondo, Italy; NIA, Genet Lab, Baltimore, MD 21224 USA; Univ Bari, DAPEG, Sezione Genet, Bari, Italy; Hop Debrousse, Serv Endocrinol Pediat, Lyon, France; Ctr Hosp Univ Limoges, Serv Pediat, Limoges, France; Ctr Hosp Univ Dijion, Serv Genet, Dijon, France; Univ Liege, Wallonia Ctr Human Genet, Liege, Belgium	Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; University of Cagliari; CHU Poitiers; Universite de Poitiers; IRCCS Casa Sollievo Della Sofferenza; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universita degli Studi di Bari Aldo Moro; CHU Lyon; CHU Limoges; University of Liege	Pilia, G (corresponding author), Univ Cagliari, CNR, Ist Ric Talassemie & Anemie Mediterranee, Cagliari, Italy.	pilia@unica.it	Rocchi, Mariano/B-8451-2011; Ristaldi, Maria S/N-8549-2013; Porcu, Susanna/AAC-3031-2019; Uda, Manuela/AAC-2645-2019; Bonneau, Dominique/K-6110-2015; PORCU, SUSANNA/AAY-3325-2020; Bisceglia, Luigi/B-8720-2017; Crisponi, Laura/AAC-2642-2019; Gasparini, Paolo/B-6173-2014; Ristaldi, Maria Serafina/AAW-6270-2020; VERLOES, Alain/E-7287-2014	Uda, Manuela/0000-0002-4890-6456; PORCU, SUSANNA/0000-0001-8053-7075; Bisceglia, Luigi/0000-0001-5367-8518; Crisponi, Laura/0000-0001-9128-8537; Ristaldi, Maria Serafina/0000-0003-4122-9293; Gasparini, Paolo/0000-0002-0859-0856; VERLOES, Alain/0000-0003-4819-0264	NATIONAL INSTITUTE ON AGING [Z01AG000647, ZIAAG000647] Funding Source: NIH RePORTER; Telethon [E.0357] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Telethon(Fondazione Telethon)		AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Amati P, 1996, AM J HUM GENET, V58, P1089; AMATI P, 1995, HUM GENET, V96, P213, DOI 10.1007/BF00207381; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Bisceglia L, 1998, MOL CELL PROBE, V12, P255, DOI 10.1006/mcpr.1998.0171; BOCCIA M, 1994, S DAK REV, V32, P51; Brown CW, 2000, NAT GENET, V25, P453, DOI 10.1038/78140; Chan JKC., 1996, ADV ANAT PATHOL, V3, P156; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; De Baere E, 1999, GENOMICS, V57, P70, DOI 10.1006/geno.1999.5747; De Felice M, 1998, NAT GENET, V19, P395, DOI 10.1038/1289; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; FINDLATER GS, 1993, J ANAT, V183, P121; FRASER IS, 1988, FERTIL STERIL, V50, P747; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; Juriloff DM, 2000, MAMM GENOME, V11, P440, DOI 10.1007/s003350010084; Kaestner KH, 1997, GENE DEV, V11, P1583, DOI 10.1101/gad.11.12.1583; Kaestner KH, 2000, GENE DEV, V14, P142; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Labosky PA, 1997, DEVELOPMENT, V124, P1263; LAWSON CT, 1995, HUM MOL GENET, V4, P963, DOI 10.1093/hmg/4.5.963; Layman LC, 1998, FERTIL STERIL, V69, P300, DOI 10.1016/S0015-0282(97)00480-9; LICHTER P, 1990, P NATL ACAD SCI USA, V87, P6634, DOI 10.1073/pnas.87.17.6634; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; NICOLINO M, 1995, J PEDIATR ENDOCR MET, V8, P127; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Pilia G, 1999, HUM MUTAT, V14, P394, DOI 10.1002/(SICI)1098-1004(199911)14:5<394::AID-HUMU5>3.0.CO;2-1; Praphanphoj V, 2000, GENOMICS, V65, P67, DOI 10.1006/geno.2000.6157; Prueitt RL, 2000, CYTOGENET CELL GENET, V89, P44, DOI 10.1159/000015560; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAMBROOK J, 1989, MOL CLONING MOL LAB; Simpson JL, 1999, AM J MED GENET, V89, P186, DOI 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5; SMALL KW, 1995, HUM MOL GENET, V4, P443, DOI 10.1093/hmg/4.3.443; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Vaiman D, 1999, GENOMICS, V56, P31, DOI 10.1006/geno.1998.5691; VASSALLI A, 1994, GENE DEV, V8, P414, DOI 10.1101/gad.8.4.414; Vegetti W, 2000, MOL CELL ENDOCRINOL, V161, P53, DOI 10.1016/S0303-7207(99)00224-5; WALL DA, 1994, WEED TECHNOL, V8, P785, DOI 10.1017/S0890037X00028694; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; ZLOTOGORA J, 1983, AM J HUM GENET, V35, P1020	51	729	776	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2001	27	2					159	166		10.1038/84781	http://dx.doi.org/10.1038/84781			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175783				2022-12-27	WOS:000166839200016
J	Stiewe, T; Putzer, BM				Stiewe, T; Putzer, BM			Role of the p53-homologue p73 in EZF1-induced apoptosis	NATURE GENETICS			English	Article							P53; BINDING; PROTEIN; NEUROBLASTOMA; ACTIVATION; EXPRESSION; TARGET; GROWTH; E2F; RB	Most human cancers harbour aberrations of cell-cycle control(1), which result in deregulated activity of the E2F transcription factors with concomitant enhanced cell-cycle progression(2). Oncogenic signalling by E2F1 has recently been linked to stabilization and activation of the tumour suppressor p53 (refs 1,3,4). The p73 protein shares substantial sequence homology and functional similarity with p53 (refs 5-7). Hence, several previously considered p53-independent cellular activities may be attributable to p73. Here we provide evidence that E2F1 directly activates transcription of TP73, leading to activation of p53-responsive target genes and apoptosis. Disruption of p73 function by a tumour-derived p53 mutant reduced E2F1-mediated apoptosis. Thus, p73 activation by deregulated E2F1 activity might constitute a p53-independent, anti-tumorigenic safeguard mechanism.	Univ Essen Gesamthsch, Sch Med, Inst Mol Biol Canc Res, Essen, Germany	University of Duisburg Essen	Putzer, BM (corresponding author), Univ Essen Gesamthsch, Sch Med, Inst Mol Biol Canc Res, Essen, Germany.	brigitte.puetzer@uni-essen.de		Stiewe, Thorsten/0000-0003-0134-7826				BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Chiang SY, 1998, BIOCHEMISTRY-US, V37, P3109, DOI 10.1021/bi9721142; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Lee TA, 2000, ONCOGENE, V19, P2257, DOI 10.1038/sj.onc.1203556; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Ng SW, 2000, ONCOGENE, V19, P1885, DOI 10.1038/sj.onc.1203512; ORMEROD MG, 1993, ACTA ONCOL, V32, P417, DOI 10.3109/02841869309093620; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; Putzer BM, 2000, GENE THER, V7, P1317, DOI 10.1038/sj.gt.3301235; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yokomizo A, 1999, ONCOGENE, V18, P1629, DOI 10.1038/sj.onc.1202474; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000; Zhu JH, 1998, CANCER RES, V58, P5061; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	28	302	306	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2000	26	4					464	469		10.1038/82617	http://dx.doi.org/10.1038/82617			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101847				2022-12-27	WOS:000165671700022
J	Marini, AM; Matassi, G; Raynal, V; Andre, B; Cartron, JP; Cherif-Zahar, B				Marini, AM; Matassi, G; Raynal, V; Andre, B; Cartron, JP; Cherif-Zahar, B			The human Rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENE FAMILY; PERMEASE; EXPRESSION; EVOLUTION; CLONING; RH50	The Rhesus blood-group antigens are defined by a complex association of membrane polypeptides that includes the nonglycosylated Rh proteins (RhD and RhCE) and the RHag glycoprotein, which is strictly required for cell surface expression of these antigens', RhAG and the Rh polypeptides are erythroid-specific transmembrane proteins belonging to the same family (36% identity)(2,3). Despite their importance in transfusion medicine, the function of RhAG and Rh proteins remains unknown, except that their absence in Rh-null individuals leads to morphological and functional abnormalities of erythrocytes, known as the Rh-deficiency syndrome. We recently found significant sequence similarity between the Rh family proteins, especially RhAG, and Mep/Amt ammonium transporters(4,5). We show here that RhAG and also RhGK, a new human homologue expressed in kidney cells only, function as ammonium transport proteins when expressed in yeast. Both specifically complement the growth defect of a yeast mutant deficient in ammonium uptake. Moreover, ammonium efflux assays and growth tests in the presence of toxic concentrations of the analogue methylammonium indicate that RhAG and RhGK also promote ammonium export. Our results provide the first experimental evidence for a direct role of RhAG and RhGK in ammonium transport. These findings are of high interest, because no specific ammonium transport system has been characterized so far in human.	Free Univ Brussels, Lab Physiol Cellularie, Inst Biol & Med Mol, Gosselies, Belgium; Inst Natl Transfus Sanguine, Unite INSERM U76, F-75015 Paris, France; Stn Zool Anton Dohrn, Lab Evoluz Mol, Naples, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Stazione Zoologica Anton Dohrn di Napoli	Andre, B (corresponding author), Free Univ Brussels, Lab Physiol Cellularie, Inst Biol & Med Mol, Gosselies, Belgium.		André, Bruno/D-1725-2010; Matassi, Giorgio/G-6301-2014	Matassi, Giorgio/0000-0003-4923-226X; Cherif-Zahar, Baya/0000-0002-4965-7252				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avent ND, 2000, BLOOD, V95, P375, DOI 10.1182/blood.V95.2.375; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; CherifZahar B, 1996, NAT GENET, V12, P168, DOI 10.1038/ng0296-168; DEJONG CH, 1996, J GASTROENTEROL S, V218, P61; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GOOD DW, 1985, AM J PHYSIOL, V248, pF459, DOI 10.1152/ajprenal.1985.248.4.F459; HUIZENGA JR, 1994, ANN CLIN BIOCHEM, V31, P529, DOI 10.1177/000456329403100602; Iraqui I, 1999, MOL CELL BIOL, V19, P989; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Kitano T, 1998, BIOCHEM BIOPH RES CO, V249, P78, DOI 10.1006/bbrc.1998.9074; KNEPPER MA, 1989, PHYSIOL REV, V69, P179, DOI 10.1152/physrev.1989.69.1.179; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Matassi G, 1999, J MOL EVOL, V48, P151, DOI 10.1007/PL00006453; Matassi G, 1998, GENOMICS, V47, P286, DOI 10.1006/geno.1997.5112; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nakamura RL, 1997, J BIOL CHEM, V272, P1011, DOI 10.1074/jbc.272.2.1011; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Seack J, 1997, IMMUNOGENETICS, V46, P493, DOI 10.1007/s002510050310	26	267	272	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					341	344		10.1038/81656	http://dx.doi.org/10.1038/81656			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062476				2022-12-27	WOS:000165176500025
J	Lai, EC				Lai, EC			Micro RNAs are complementary to 3 ' UTR sequence motifs that mediate negative post-transcriptional regulation	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; ENHANCER; PROTEIN; LIN-14; ENCODES; BOX	Micro RNAs are a large family of noncoding RNAs of 21-22 nucleotides whose functions are generally unknown. Here a large subset of Drosophila micro RNAs is shown to be perfectly complementary to several classes of sequence motif previously demonstrated to mediate negative post-transcriptional regulation. These findings suggest a more general role for micro RNAs in gene regulation through the formation of RNA duplexes.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lai, EC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 545 Life Sci Addit 3200, Berkeley, CA 94720 USA.	lai@fruitfly.bdgp.berkeley.edu	Lai, Eric C/A-3412-2008; Lai, Eric/AAO-1143-2021	Lai, Eric/0000-0002-8432-5851				Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 1998, CELL, V93, P1103, DOI 10.1016/S0092-8674(00)81454-3; Lai EC, 1997, DEVELOPMENT, V124, P4847; Lai EC, 2000, DEVELOPMENT, V127, P291; Lai EC, 1998, DEVELOPMENT, V125, P4077; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leviten MW, 1997, DEVELOPMENT, V124, P4039; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	15	1143	1249	2	69	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2002	30	4					363	364		10.1038/ng865	http://dx.doi.org/10.1038/ng865			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11896390				2022-12-27	WOS:000174682000011
J	Tomlinson, IPM; Alam, NA; Rowan, AJ; Barclay, E; Jaeger, EEM; Kelsell, D; Leigh, I; Gorman, P; Lamlum, H; Rahman, S; Roylance, RR; Olpin, S; Bevan, S; Barker, K; Hearle, N; Houlston, RS; Kiuru, M; Lehtonen, R; Karhu, A; Vilkki, S; Laiho, P; Eklund, C; Vierimaa, O; Aittomaki, K; Hietala, M; Sistonen, P; Paetau, A; Salovaara, R; Herva, R; Launonen, V; Aaltonen, LA				Tomlinson, IPM; Alam, NA; Rowan, AJ; Barclay, E; Jaeger, EEM; Kelsell, D; Leigh, I; Gorman, P; Lamlum, H; Rahman, S; Roylance, RR; Olpin, S; Bevan, S; Barker, K; Hearle, N; Houlston, RS; Kiuru, M; Lehtonen, R; Karhu, A; Vilkki, S; Laiho, P; Eklund, C; Vierimaa, O; Aittomaki, K; Hietala, M; Sistonen, P; Paetau, A; Salovaara, R; Herva, R; Launonen, V; Aaltonen, LA		Multiple Leiomyoma Consortium	Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer	NATURE GENETICS			English	Article							FUMARASE DEFICIENCY; MITOCHONDRIAL; GENE; ENCEPHALOPATHY; PARAGANGLIOMA; RISK	Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesis(1-3). We previously mapped a gene that predisposes to multiple fibroids, cutaneous leiomyomata and renal cell carcinoma to chromosome 1q42.3-q43 (refs 4-6). Here we show, through a combination of mapping critical recombinants, identifying individuals with germline mutations and screening known and predicted transcripts, that this gene encodes fumarate hydratase, an enzyme of the tricarboxylic acid cycle. Leiomyomatosis-associated mutations are predicted to result in absent or truncated protein, or substitutions or deletions of highly conserved amino acids. Activity of fumarate hydratase is reduced in lymphoblastoid cells from individuals with leiomyomatosis. This enzyme acts as a tumor suppressor in familial leiomyomata, and its measured activity is very low or absent in tumors from individuals with leiomyomatosis. Mutations in FH also occur in the recessive condition fumarate hydratase deficiency(7-11), and some parents of people with this condition are susceptible to leiomyomata. Thus, heterozygous and homozygous or compound heterozygous mutants have very different clinical phenotypes. Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumor(12-14).	Imperial Canc Res Fund, Mol & Populat Genet Lab, London WC2A 3PX, England; Univ London Queen Mary Coll, St Bartholomews & London Sch Med & Dent, Ctr Cutaneous Res, London E1 4NS, England; Inst Child Hlth, Biochem Endocrinol & Metab Unit, London, England; Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England; Inst Canc Res, Haddow Labs, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Helsinki, Biomedicum Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Oulu Univ Hosp, Dept Clin Genet, FIN-90220 Oulu, Finland; Turku Univ Hosp, Dept Clin Genet, FIN-20520 Turku, Finland; Turku Univ Hosp, Dept Med Genet, FIN-20520 Turku, Finland; Finnish Red Cross Blood Transfus Serv, FIN-00310 Helsinki, Finland; Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland; Oulu Univ Hosp, Dept Pathol, FIN-90220 Oulu, Finland	Cancer Research UK; University of London; Queen Mary University London; University of London; University College London; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of London; Institute of Cancer Research - UK; University of Helsinki; University of Oulu; University of Turku; University of Turku; University of Helsinki; University of Oulu	Tomlinson, IPM (corresponding author), Imperial Canc Res Fund, Mol & Populat Genet Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.		Rahman, Shamima/M-7904-2019; Kelsell, David P/F-8767-2011; Toon, Christopher W/G-3610-2012; Aaltonen, Lauri/A-5375-2010; Rahman, Shamima/C-5232-2008	Aaltonen, Lauri/0000-0001-6839-4286; Rahman, Shamima/0000-0003-2088-730X; Kiuru, Maija/0000-0002-7010-5516; Lehtonen, Rainer Juhani/0000-0002-8343-0318; Karhu, Auli/0000-0002-7927-0796; Houlston, Richard/0000-0002-5268-0242; Bevan, Steve/0000-0003-0490-6830; Kelsell, David/0000-0002-9910-7144; olpin, simon/0000-0001-9018-5173; Kuismin, Outi/0000-0002-0157-8985	PHS HHS [U59309] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alam NA, 2001, AM J HUM GENET, V68, P1264, DOI 10.1086/320124; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BOURGERON T, 1994, J CLIN INVEST, V93, P2514, DOI 10.1172/JCI117261; Coughlin EM, 1998, MOL GENET METAB, V63, P254, DOI 10.1006/mgme.1998.2684; GELLERA C, 1990, NEUROLOGY, V40, P495, DOI 10.1212/WNL.40.3_Part_1.495; HATCH MD, 1978, ANAL BIOCHEM, V85, P271, DOI 10.1016/0003-2697(78)90299-3; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; Kiuru M, 2001, AM J PATHOL, V159, P825, DOI 10.1016/S0002-9440(10)61757-9; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; Luoto R, 2000, MATURITAS, V37, P15, DOI 10.1016/S0378-5122(00)00160-2; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Takamizawa S, 1999, GYNECOL OBSTET INVES, V48, P193, DOI 10.1159/000010172; VIKHLYAEVA EM, 1995, INT J GYNECOL OBSTET, V51, P127, DOI 10.1016/0020-7292(95)02533-I; Weaver T, 1997, PROTEIN SCI, V6, P834	17	1070	1099	0	46	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					406	410		10.1038/ng849	http://dx.doi.org/10.1038/ng849			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11865300				2022-12-27	WOS:000174682000018
J	Boerkoel, CF; Takashima, H; John, J; Yan, J; Stankiewicz, P; Rosenbarker, L; Andre, JL; Bogdanovic, R; Burguet, A; Cockfield, S; Cordeiro, I; Frund, S; Illies, F; Joseph, M; Kaitila, I; Lama, G; Loirat, C; McLeod, DR; Milford, DV; Petty, EM; Rodrigo, F; Saraiva, JM; Schmidt, B; Smith, GC; Spranger, J; Stein, A; Thiele, H; Tizard, J; Weksberg, R; Lupski, JR; Stockton, DW				Boerkoel, CF; Takashima, H; John, J; Yan, J; Stankiewicz, P; Rosenbarker, L; Andre, JL; Bogdanovic, R; Burguet, A; Cockfield, S; Cordeiro, I; Frund, S; Illies, F; Joseph, M; Kaitila, I; Lama, G; Loirat, C; McLeod, DR; Milford, DV; Petty, EM; Rodrigo, F; Saraiva, JM; Schmidt, B; Smith, GC; Spranger, J; Stein, A; Thiele, H; Tizard, J; Weksberg, R; Lupski, JR; Stockton, DW			Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia	NATURE GENETICS			English	Article							CRYSTAL-STRUCTURE; DNA; MUTATIONS; COMPLEX; MOTIFS; DOMAIN	Schimke immuno-osseous dysplasia (SIOD, MIM 242900) is an autosomal-recessive pleiotropic disorder with the diagnostic features of spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency(1-3). using genome-wide linkage mapping and a positional candidate approach, we determined that mutations in SMARCAL1 (SWI/SNF2-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1), are responsible for SIOD. Through analysis of data from persons with SIOD in 26 unrelated families, we observed that affected individuals from 13 of 23 families with severe disease had two alleles with nonsense, frameshift or splicing mutations, whereas affected individuals from 3 of 3 families with milder disease had a missense mutation on each allele. These observations indicate that some missense mutations allow retention of partial SMARCAL1 function and thus cause milder disease.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Kleberg Genotyping Ctr, Houston, TX 77030 USA; CHU Nancy, Hop Enfants, Vandoeuvre Les Nancy, France; Inst Mother & Child Hlth Care Serbia, Belgrade, Yugoslavia; CHU Besancon, Unite Nephrol Pediat, F-25030 Besancon, France; Univ Alberta, Edmonton, AB, Canada; Hosp Santa Maria, Unidade Genet, Serv Pediat, Lisbon, Portugal; KfH Kinderdialyse, Munster, Germany; Univ Essen Gesamthsch Klinikum, Kinderklin, D-4300 Essen, Germany; Phoenix Childrens Hosp, Sect Pediat Nephrol, Phoenix, AZ USA; Univ Helsinki, Cent Hosp, Clin Genet Unit, Helsinki, Finland; Univ Naples Federico II, Dept Pediat, Naples, Italy; Hop Robert Debre, Serv Nephrol, F-75019 Paris, France; Alberta Childrens Prov Gen Hosp, Calgary, AB T2T 5C7, Canada; Birmingham Childrens Hosp, Dept Nephrol, Birmingham, W Midlands, England; Univ Michigan, Sch Med, Div Med Genet, Ann Arbor, MI USA; Univ Madrid, Hosp Virgen Arrixaca, Madrid, Spain; Hosp Pediat Coimbra, Consulta Genet, Coimbra, Portugal; Univ Cologne, Kinderklin, Cologne, Germany; Univ Wales Hosp, KRUF Childrens Kidney Ctr, Cardiff CF4 4XW, S Glam, Wales; Johannes Gutenberg Univ Mainz, Kinderklin, D-6500 Mainz, Germany; Univ Halle Wittenberg, Inst Humangenet & Med Biol, Halle An Der Saale, Germany; Bristol Royal Hosp Children, Renal Unit, Bristol, Avon, England; Univ Toronto, Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Med Genet & Microbiol, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; CHU de Nancy; Universite de Franche-Comte; CHU Besancon; University of Alberta; Universidade de Lisboa; Hospital Santa Maria; University of Duisburg Essen; Phoenix Children's Hospital; University of Helsinki; Helsinki University Central Hospital; University of Naples Federico II; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Alberta Childrens Hospital; University of Calgary; University of Birmingham; University of Michigan System; University of Michigan; Hospital Clinico Universitario Virgen de la Arrixaca; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Cologne; Cardiff University; Johannes Gutenberg University of Mainz; Martin Luther University Halle Wittenberg; Bristol Royal Hospital For Children; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Boerkoel, CF (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	boerkoel@bcm.tmc.edu	Bogdanovic, Radovan/R-8847-2019; Thiele, Holger/ABE-6792-2020; Stankiewicz, Paweł/AAP-7906-2021; Boerkoel, Cornelius Franciscus/AFW-4948-2022	Thiele, Holger/0000-0002-0169-998X; Stankiewicz, Paweł/0000-0002-6456-7490; Boerkoel, Cornelius Franciscus/0000-0003-3097-241X; Yan, Jiong/0000-0003-0536-8130; Saraiva, Jorge Manuel/0000-0002-7232-3509; Stein, Anja/0000-0002-0497-4609				Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Boerkoel CF, 2000, EUR J PEDIATR, V159, P1, DOI 10.1007/s004310050001; Coleman MA, 2000, GENOMICS, V65, P274, DOI 10.1006/geno.2000.6174; den Dunnen JT, 2000, HUM MUTAT, V15, P7; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hall MC, 1997, J BIOL CHEM, V272, P18614, DOI 10.1074/jbc.272.30.18614; Hall MC, 1998, J MOL BIOL, V277, P257, DOI 10.1006/jmbi.1997.1614; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Havas K, 2001, CELL MOL LIFE SCI, V58, P673, DOI 10.1007/PL00000891; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Saraiva JM, 1999, J MED GENET, V36, P786, DOI 10.1136/jmg.36.10.786; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHIMKE RN, 1971, LANCET, V2, P1088; Sevenet N, 1999, HUM MOL GENET, V8, P2359, DOI 10.1093/hmg/8.13.2359; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; SPRANGER J, 1991, J PEDIATR-US, V119, P64, DOI 10.1016/S0022-3476(05)81040-6; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463	25	229	245	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					215	220		10.1038/ng821	http://dx.doi.org/10.1038/ng821			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11799392				2022-12-27	WOS:000173708700025
J	Enattah, NS; Sahi, T; Savilahti, E; Terwilliger, JD; Peltonen, L; Jarvela, I				Enattah, NS; Sahi, T; Savilahti, E; Terwilliger, JD; Peltonen, L; Jarvela, I			Identification of a variant associated with adult-type hypolactasia	NATURE GENETICS			English	Article							PERSISTENCE/NON-PERSISTENCE POLYMORPHISM; LACTASE-PHLORIZIN HYDROLASE; LINKAGE ANALYSIS; POINT MUTATIONS; GENE; DISEQUILIBRIUM; DEFICIENCY; EVOLUTION; CHILDREN; HUMANS	Adult-type hypolactasia, also known as lactase non-persistence (lactose intolerance), is a common autosomal recessive condition resulting from the physiological decline in activity of the lactase-phlorizin hydrolase (LPH) in intestinal cells after weaning. LPH hydrolyzes lactose into glucose and galactose. Sequence analyses of the coding and promoter regions of LCT, the gene encoding LPH, has revealed no DNA variations correlating with lactase nonpersistence(1,2). An associated haplotype spanning LCT, as well as a distinct difference in the transcript levels of 'non-persistence' and 'persistence' alleles in heterozygotes, suggest that a cis-acting element contributes to the lactase non-persistence phenotype(3,4). Using linkage disequilibrium (LD) and haplotype analysis of nine extended Finnish families, we restricted the locus to a 47-kb interval on 2q21. Sequence analysis of the complete region and subsequent association analyses revealed that a DNA variant, C/T-13910, roughly 14 kb upstream from the LCT locus, completely associates with biochemically verified lactase non-persistence in Finnish families and a sample set of 236 individuals from four different populations. A second variant, G/A(-22018), 8 kb telomeric to C/T-13910, is also associated with the trait in 229 of 236 cases. Prevalence of the C/T-13910 variant in 1,047 DNA samples is consistent with the reported prevalence of adult-type hypolactasla in four different populations. That the variant (C/T-13910) occurs in distantly related populations indicates that it is very old.	Natl Publ Hlth Inst, Dept Mol Med, FIN-00251 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, FIN-00014 Helsinki, Finland; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA; New York State Psychiat Inst & Hosp, Div Med Genet, New York, NY 10032 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA USA; HUCH, Diagnost Lab, Mol Genet Lab, FIN-00290 Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; Columbia University; Columbia University; New York State Psychiatry Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Haartmaninkatu 8,POB 104, FIN-00251 Helsinki, Finland.	lpeltonen@mednet.ucla.edu	Jarvela, Irma E/L-5836-2013	Jarvela, Irma E/0000-0002-1770-6187				AROLA H, 1994, SCAND J GASTROENTERO, V29, P26, DOI 10.3109/00365529409091742; BOLL W, 1991, AM J HUM GENET, V48, P889; CLARE H, 1997, HUM BIOL, V69, P605; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CUDDENEC Y, 1982, GASTROEN CLIN BIOL, V6, P776; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Harvey CB, 1996, FEBS LETT, V398, P135, DOI 10.1016/S0014-5793(96)01189-1; Harvey CB, 1998, ANN HUM GENET, V62, P215, DOI 10.1046/j.1469-1809.1998.6230215.x; HARVEY CB, 1995, EUR J HUM GENET, V3, P27; IHALAINEN J, 1994, BIOTECHNIQUES, V16, P938; Jarvela I, 1998, AM J HUM GENET, V63, P1078, DOI 10.1086/302064; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; MCCRACKEN RD, 1971, CURR ANTHROPOL, V12, P479, DOI 10.1086/201234; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; MESSER M, 1966, ANAL BIOCHEM, V14, P376, DOI 10.1016/0003-2697(66)90280-6; SAHI T, 1994, SCAND J GASTROENTERO, V29, P7, DOI 10.3109/00365529409091740; SAHI T, 1974, SCAND J GASTROENTERO, V9, P7; SAHI T, 1972, ACTA PAEDIATR SCAND, V61, P11, DOI 10.1111/j.1651-2227.1972.tb15897.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; SYVANEN AC, 1994, HUM MUTAT, V3, P172, DOI 10.1002/humu.1380030303; Wang YX, 1998, GASTROENTEROLOGY, V114, P1230, DOI 10.1016/S0016-5085(98)70429-9; WANG YX, 1995, HUM MOL GENET, V4, P657, DOI 10.1093/hmg/4.4.657	26	717	749	1	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					233	237		10.1038/ng826	http://dx.doi.org/10.1038/ng826			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11788828				2022-12-27	WOS:000173708700028
J	McFarland, R; Clark, KM; Morris, AAM; Taylor, RW; Macphail, S; Lightowlers, RN; Turnbull, DM				McFarland, R; Clark, KM; Morris, AAM; Taylor, RW; Macphail, S; Lightowlers, RN; Turnbull, DM			Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation	NATURE GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; ABNORMALITIES; DEAFNESS; MUSCLE	Mutations of mitochondrial DNA (mtDNA) are an important cause of genetic disease(1). We describe a family with an unusual homoplasmic mutation that resulted in six neonatal deaths and one surviving child with Leigh syndrome. The mother is clinically normal, but a severe biochemical and molecular genetic defect was present in both a fatally affected child and the mother. This family highlights the role of homoplasmic mt-tRNA mutations in genetic disease.	Univ Newcastle Upon Tyne, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Child Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Obstet & Gynaecol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Turnbull, DM (corresponding author), Univ Newcastle Upon Tyne, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.			McFarland, Robert/0000-0002-8833-2688				Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Borner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P; Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222; Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347; HAYASHI JI, 1994, J BIOL CHEM, V269, P19060; HOWELL N, 1991, AM J HUM GENET, V49, P939; JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Reid FM, 1997, HUM MOL GENET, V6, P443, DOI 10.1093/hmg/6.3.443; Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	14	132	134	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					145	146		10.1038/ng819	http://dx.doi.org/10.1038/ng819			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11799391				2022-12-27	WOS:000173708700011
J	Miller, DG; Rutledge, EA; Russell, DW				Miller, DG; Rutledge, EA; Russell, DW			Chromosomal effects of adeno-associated virus vector integration	NATURE GENETICS			English	Article							SITE-SPECIFIC INTEGRATION; ADENOASSOCIATED VIRUS; DNA; RECOMBINATION; JUNCTIONS; TRANSDUCTION; INCREASE	Adeno-associated virus (AAV) vectors are currently being used in several clinical gene-therapy trials (see the NIH OBA Human Gene Transfer Clinical Trials Database); however, little is known about the chromosomal effects of vector integration. Here we report that integrated vector proviruses are associated with chromosomal deletions and other rearrangements and are frequently located on chromosome 19 (although not at the wildtype AAV integration site).	Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Russell, DW (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.			Miller, Daniel/0000-0002-5700-3048	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK062100] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK062100] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEXANDER IE, 1994, J VIROL, V68, P8282, DOI 10.1128/JVI.68.12.8282-8287.1994; GIRAUD C, 1995, J VIROL, V69, P6917, DOI 10.1128/JVI.69.11.6917-6924.1995; Hirata RK, 2000, J VIROL, V74, P4612, DOI 10.1128/JVI.74.10.4612-4620.2000; KOTIN RM, 1992, EMBO J, V11, P5071, DOI 10.1002/j.1460-2075.1992.tb05614.x; Linden RM, 1996, P NATL ACAD SCI USA, V93, P11288, DOI 10.1073/pnas.93.21.11288; Nakai H, 1999, J VIROL, V73, P5438, DOI 10.1128/JVI.73.7.5438-5447.1999; RUSSELL DW, 1995, P NATL ACAD SCI USA, V92, P5719, DOI 10.1073/pnas.92.12.5719; Rutledge EA, 1997, J VIROL, V71, P8429, DOI 10.1128/JVI.71.11.8429-8436.1997; Yang CC, 1997, J VIROL, V71, P9231, DOI 10.1128/JVI.71.12.9231-9247.1997; Young SM, 2000, J VIROL, V74, P3953, DOI 10.1128/JVI.74.9.3953-3966.2000	10	123	127	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					147	148		10.1038/ng824	http://dx.doi.org/10.1038/ng824			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11799395				2022-12-27	WOS:000173708700012
J	Liu, PT; Jenkins, NA; Copeland, NG				Liu, PT; Jenkins, NA; Copeland, NG			Efficient Cre-IoxP-induced mitotic recombination in mouse embryonic stem cells	NATURE GENETICS			English	Article							GENETIC MOSAICS; PRADER-WILLI; DROSOPHILA; MICE; SEGREGATION; CHROMOSOMES; REGION; MODEL	FLP/FRT-induced mitotic recombination provides a powerful method for creating genetic mosaics in Drosophila and for discerning the function of recessive genes in a heterozygous individual. Here we show that mitotic recombination can be reproducibly induced in mouse embryonic stem (ES) cells, by Cre/loxP technology, at frequencies ranging from 4.2 x 10(-5) (Snrpn) to 7.0 x 10(-3) (D7Mit178) for single allelic loxP sites, and to 5.0 x 10(-2) (D7Mit178) for multiple allelic lox sites, after transient Cre expression. Notably, much of the recombination occurs in G2 and is followed by X segregation, where the recombinant chromatids segregate away from each other during mitosis. It is X segregation that is useful for genetic mosaic analysis because it produces clones of homozygous mutant daughter cells from heterozygous mothers. Our studies confirm the predictions made from studies in Drosophila(1) that suggest that X segregation will not be limited to organisms with strong mitotic pairing, because the forces (sister-chromatid cohesion) responsible for X segregation are an elemental feature of mitosis in all eukaryotes. Our studies also show that genetic mosaic analysis in mice is feasible, at least for certain chromosomal regions.	NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Copeland, NG (corresponding author), NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA.							Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; BATEMAN AJ, 1967, GENET RES, V9, P375, DOI 10.1017/S001667230001065X; BAUBONIS W, 1993, NUCLEIC ACIDS RES, V21, P2025, DOI 10.1093/nar/21.9.2025; Beumer KJ, 1998, GENETICS, V150, P173; CATTANACH BM, 1994, J INHERIT METAB DIS, V17, P403, DOI 10.1007/BF00711356; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FAVOR J, 1994, ANNU REV GENET, V28, P27, DOI 10.1146/annurev.ge.28.120194.000331; FISHER G, 1986, MUTAT RES, V164, P381, DOI 10.1016/0165-1161(86)90031-2; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; GERMAN J, 1964, SCIENCE, V144, P298, DOI 10.1126/science.144.3616.298; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Metz CW, 1916, J EXP ZOOL, V21, P213, DOI 10.1002/jez.1400210204; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; PANTHIER JJ, 1990, GENETICS, V125, P175; PIMPINELLI S, 1986, P NATL ACAD SCI USA, V83, P3900, DOI 10.1073/pnas.83.11.3900; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Riesselmann L, 1999, CYTOGENET CELL GENET, V86, P39, DOI 10.1159/000015426; Rossant J, 1998, TRENDS GENET, V14, P358, DOI 10.1016/S0168-9525(98)01552-2; Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230; Stevens N. M., 1908, Journal of Experimental Zoology Philadelphia, V5, DOI 10.1002/jez.1400050304; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000	31	71	76	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					66	72		10.1038/ng788	http://dx.doi.org/10.1038/ng788			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11740496				2022-12-27	WOS:000173105600015
J	Bennett, CB; Lewis, LK; Karthikeyan, G; Lobachev, KS; Jin, YH; Sterling, JF; Snipe, JR; Resnick, MA				Bennett, CB; Lewis, LK; Karthikeyan, G; Lobachev, KS; Jin, YH; Sterling, JF; Snipe, JR; Resnick, MA			Genes required for ionizing radiation resistance in yeast	NATURE GENETICS			English	Article							PUTATIVE RNA HELICASE; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; CELL-CYCLE; REPAIR; EXPRESSION; PROTEIN; CHECKPOINT; END; RECOMBINATION	The ability of Saccharomyces cerevisiae to tolerate ionizing radiation damage requires many DNA-repair and checkpoint genes, most having human orthologs. A genome-wide screen of diploid mutants homozygous with respect to deletions of 3,670 nonessential genes revealed 107 new loci that influence gamma -ray sensitivity. Many affect replication, recombination and checkpoint functions. Nearly 90% were sensitive to other agents, and most new genes could be assigned to the following functional groups: chromatin remodeling, chromosome segregation, nuclear pore formation, transcription, Golgi/vacuolar activities, ubiquitin-mediated protein degradation, cytokinesis, mitochondrial activity and cell wall maintenance. Over 50% share homology with human genes, including 17 implicated in cancer, indicating that a large set of newly identified human genes may have related roles in the toleration of radiation damage.	NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnick, MA (corresponding author), NIEHS, Mol Genet Lab, POB 12233, Res Triangle Pk, NC 27709 USA.		resnick, Michael/F-1668-2019	resnick, Michael/0000-0002-8473-7506	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES021091] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AGUILERA A, 1988, GENETICS, V119, P779; Alper T, 1977, Adv Exp Med Biol, V84, P139; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Bartsch S, 2000, MOL CELL BIOL, V20, P1194, DOI 10.1128/MCB.20.4.1194-1205.2000; BENNETT CB, 1989, RADIAT RES, V120, P102, DOI 10.2307/3577637; Bennett CB, 2001, MOL CELL BIOL, V21, P5359, DOI 10.1128/MCB.21.16.5359-5373.2001; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; COSS RA, 1981, RADIAT RES, V85, P99, DOI 10.2307/3575441; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Fasullo M, 1998, MOL CELL BIOL, V18, P1190, DOI 10.1128/MCB.18.3.1190; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Game JC, 2000, MUTAT RES-FUND MOL M, V451, P277, DOI 10.1016/S0027-5107(00)00055-5; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Hata H, 1998, GENETICS, V148, P571; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; HEUDE M, 1993, GENETICS, V133, P489; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Kerscher O, 2001, GENETICS, V157, P1543; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; LOVETT ST, 1987, GENETICS, V116, P547; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; MOORE CW, 1982, CANCER RES, V42, P929; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nakao K, 2000, INTERNAL MED, V39, P412, DOI 10.2169/internalmedicine.39.412; Negritto MC, 2001, MOL CELL BIOL, V21, P2349, DOI 10.1128/MCB.21.7.2349-2358.2001; Paglin S, 2001, CANCER RES, V61, P439; Perkins EL, 1999, P NATL ACAD SCI USA, V96, P2204, DOI 10.1073/pnas.96.5.2204; RAMOTAR D, 1991, MOL CELL BIOL, V11, P4537, DOI 10.1128/MCB.11.9.4537; Resnick MA, 2000, MUTAT RES-FUND MOL M, V451, P1, DOI 10.1016/S0027-5107(00)00036-1; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; THOMAS JH, 1985, GENETICS, V111, P715; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang XQ, 1996, NUCLEIC ACIDS RES, V24, P4791, DOI 10.1093/nar/24.23.4791; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WELCH MD, 1994, MOL BIOL CELL, V5, P617, DOI 10.1091/mbc.5.6.617; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu Z, 1999, ENVIRON MOL MUTAGEN, V33, P3, DOI 10.1002/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L	50	257	264	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					426	434		10.1038/ng778	http://dx.doi.org/10.1038/ng778			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726929				2022-12-27	WOS:000172507500018
J	Davuluri, RV; Grosse, I; Zhang, MQ				Davuluri, RV; Grosse, I; Zhang, MQ			Computational identification of promoters and first exons in the human genome	NATURE GENETICS			English	Article							CPG ISLANDS; DISCRIMINANT-ANALYSIS; DNA-SEQUENCE; BIOLOGY; REGIONS; GENES	The identification of promoters and first exons has been one of the most difficult problems in gene-finding. We present a set of discriminant functions that can recognize structural and compositional features such as CpG islands, promoter regions and first splice-donor sites. We explain the implementation of the discriminant functions into a decision tree that constitutes a new program called FirstEF. By using different models to predict CpG-related and non-CpG-related first exons, we showed by cross-validation that the program could predict 86% of the first exons with 17% false positives. We also demonstrated the prediction accuracy of FirstEF at the genome level by applying it to the finished sequences of human chromosomes 21 and 22 as well as by comparing the predictions with the locations of the experimentally verified first exons. Finally, we present the analysis of the predicted first exons for all of the 24 chromosomes of the human genome.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Zhang, MQ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mzhang@cshl.org	Davuluri, Ramana/D-7348-2011					Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Claverie JM, 2000, GENOME RES, V10, P1277, DOI 10.1101/gr.155500; CLEVERIE JM, 1997, HUM MOL GENET, V6, P1735; CROSS S, 1991, NUCLEIC ACIDS RES, V19, P1469, DOI 10.1093/nar/19.7.1469; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Galas DJ, 2001, SCIENCE, V291, P1257, DOI 10.1126/science.291.5507.1257; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hong SJ, 2001, PATTERN RECOGN LETT, V22, P55, DOI 10.1016/S0167-8655(00)00099-4; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Maroni G, 1996, EVOL BIOL, V29, P1; Perier RC, 2000, NUCLEIC ACIDS RES, V28, P302, DOI 10.1093/nar/28.1.302; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; Stormo GD, 2000, GENOME RES, V10, P394, DOI 10.1101/gr.10.4.394; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zhang MQ, 1998, GENOME RES, V8, P319, DOI 10.1101/gr.8.3.319; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565; [No title captured]	24	301	327	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					412	417		10.1038/ng780	http://dx.doi.org/10.1038/ng780			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726928				2022-12-27	WOS:000172507500016
J	Avner, P; Bruls, T; Poras, I; Eley, L; Gas, S; Ruiz, P; Wiles, MV; Sousa-Nunes, R; Kettleborough, R; Rana, A; Morissette, J; Bentley, L; Goldsworthy, M; Haynes, A; Herbert, E; Southam, L; Lehrach, H; Weissenbach, J; Manenti, G; Rodriguez-Tome, P; Beddington, R; Dunwoodie, S; Cox, RD				Avner, P; Bruls, T; Poras, I; Eley, L; Gas, S; Ruiz, P; Wiles, MV; Sousa-Nunes, R; Kettleborough, R; Rana, A; Morissette, J; Bentley, L; Goldsworthy, M; Haynes, A; Herbert, E; Southam, L; Lehrach, H; Weissenbach, J; Manenti, G; Rodriguez-Tome, P; Beddington, R; Dunwoodie, S; Cox, RD			A radiation hybrid transcript map of the mouse genome	NATURE GENETICS			English	Article							DELTA-HOMOLOG; PHYSICAL MAP; DLL3; WIDE; GENE	Expressed-sequence tag (EST) maps are an adjunct to sequence-based analytical methods of gene detection and localization for those species for which such data are available, and provide anchors for high-density homology and orthology mapping in species for which large-scale sequencing has yet to be done(1). Species for which radiation hybrid-based transcript maps have been established include human(2), rat(3-5), mouse(6), dog(7), cat(8) and zebrafish(9,10). We have established a comprehensive first-generation-placement radiation hybrid map of the mouse consisting of 5,904 mapped markers (3,993 ESTs and 1,911 sequence-tagged sites (STSs)). The mapped ESTs, which often originate from small-EST clusters, are enriched for genes expressed during early mouse embryogenesis and are probably different from those localized in humans. We have confirmed by in situ hybridization that even singleton ESTs, which are usually not retained for mapping studies, may represent bona fide transcribed sequences. Our studies on mouse chromosomes 12 and 14 orthologous to human chromosome 14 show the power of our radiation hybrid map as a predictive tool for orthology mapping in humans.	Ctr Natl Sequencage, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; Inst Pasteur, Unite Genet Mol Murine, Paris, France; MRC, Mammalian Genet Unit, Harwell, Berks, England; Max Planck Inst Mol Genet, Berlin, Germany; CHUL, Ctr Rech, Laval, PQ, Canada; Natl Inst Med Res, Lab Mammalian Dev, London NW7 1AA, England; Inst Nazl Tumori, Div Oncol, Milan, Italy; European Bioinformat Inst, European Mol Biol Lab Outstn, Cambridge, England; Victor Chang Cardiac Res Inst, Sydney, NSW, Australia	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Max Planck Society; Laval University; MRC National Institute for Medical Research; Fondazione IRCCS Istituto Nazionale Tumori Milan; European Molecular Biology Laboratory (EMBL); Victor Chang Cardiac Research Institute	Avner, P (corresponding author), Ctr Natl Sequencage, CP 5706, F-91057 Evry, France.	pavner@pasteur.fr	Sousa-Nunes, Rita/AAE-4628-2020; Ruiz Noppinger, Patricia/D-6418-2014; Dunwoodie, Sally L/M-4019-2018; Noppinger, Patricia Ruiz/AAH-1753-2019; Manenti, Giacomo/J-3339-2017	Ruiz Noppinger, Patricia/0000-0001-5617-8965; Dunwoodie, Sally L/0000-0002-2069-7349; Noppinger, Patricia Ruiz/0000-0001-5617-8965; Manenti, Giacomo/0000-0002-4887-4482; Goldsworthy, Michelle/0000-0003-1354-7737; Sousa-Nunes, Rita/0000-0002-7401-8081; Cox, Roger/0000-0001-7170-5014; wiles, michael/0000-0002-3620-8386				Agarwala R, 2000, GENOME RES, V10, P350, DOI 10.1101/gr.10.3.350; Applegate D. L., 1998, DOCUMENTA MATH, P645; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; BREEN M, 1994, HUM MOL GENET, V3, P621, DOI 10.1093/hmg/3.4.621; Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Elliott RW, 1999, GENOMICS, V57, P365, DOI 10.1006/geno.1998.5205; Geisler R, 1999, NAT GENET, V23, P86, DOI 10.1038/12692; Gusfield D., 1997, ALGORITHMS STRINGS T; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; HARRISON SM, 1995, DEVELOPMENT, V121, P2479; HUDSON TJ, NATURE GENET, V27, P201; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; Mellersh CS, 2000, MAMM GENOME, V11, P120, DOI 10.1007/s003350010024; Murphy WJ, 2000, GENOME RES, V10, P691, DOI 10.1101/gr.10.5.691; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Parsons JD, 2000, BIOINFORMATICS, V16, P313, DOI 10.1093/bioinformatics/16.4.313; Rodriguez-Tome P, 2000, NUCLEIC ACIDS RES, V28, P146, DOI 10.1093/nar/28.1.146; Sabile A, 1997, MAMM GENOME, V8, P81, DOI 10.1007/s003359900362; Scheetz TE, 2001, GENOME RES, V11, P497, DOI 10.1101/gr.GR-1516R; Steen RG, 1999, GENOME RES, V9, pAP1; Van Etten WJ, 1999, NAT GENET, V22, P384, DOI 10.1038/11962; Watanabe TK, 1999, NAT GENET, V22, P27, DOI 10.1038/8737; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Yang YP, 1998, GENOME RES, V8, P731, DOI 10.1101/gr.8.7.731	31	21	21	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2001	29	2					194	200		10.1038/ng1001-194	http://dx.doi.org/10.1038/ng1001-194			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586301				2022-12-27	WOS:000171374100027
J	Hadano, S; Hand, CK; Osuga, H; Yanagisawa, Y; Otomo, A; Devon, RS; Miyamoto, N; Showguchi-Miyata, J; Okada, Y; Singaraja, R; Figlewicz, DA; Kwiatkowski, T; Hosler, BA; Sagie, T; Skaug, J; Nasir, J; Brown, RH; Scherer, SW; Rouleau, GA; Hayden, MR; Ikeda, JE				Hadano, S; Hand, CK; Osuga, H; Yanagisawa, Y; Otomo, A; Devon, RS; Miyamoto, N; Showguchi-Miyata, J; Okada, Y; Singaraja, R; Figlewicz, DA; Kwiatkowski, T; Hosler, BA; Sagie, T; Skaug, J; Nasir, J; Brown, RH; Scherer, SW; Rouleau, GA; Hayden, MR; Ikeda, JE			A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2	NATURE GENETICS			English	Article							NUCLEOTIDE EXCHANGE FACTOR; CHROMOSOME CONDENSATION; CRYSTAL-STRUCTURE; AXONAL-TRANSPORT; RHO GTPASES; PROTEIN; LINKAGE; RCC1; GENERATION; INTERACTS	Amyotrophic lateral sclerosis 2 (ALS2) is an autosomal recessive form of juvenile ALS and has been mapped to human chromosome 2q33. Here we report the identification of two independent deletion mutations linked to ALS2 in the coding exons of the new gene ALS2. These deletion mutations result in frameshifts that generate premature stop codons. ALS2 is expressed in various tissues and cells, including neurons throughout the brain and spinal cord, and encodes a protein containing multiple domains that have homology to RanGEF as well as RhoGEF. Deletion mutations are predicted to cause a loss of protein function, providing strong evidence that ALS2 is the causative gene underlying this form of ALS.	Tokai Univ, Sch Med, Japan Sci & Technol Corp, Int Cooperat Res Project, Kanagawa 2591193, Japan; Tokai Univ, Inst Med Sci, Dept Mol Neurosci, Kanagawa 2591193, Japan; McGill Univ, Ctr Res Neurosci, Montreal, PQ H3A 2T5, Canada; Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC, Canada; Womens & Childrens Hosp, Vancouver, BC, Canada; Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA; Day Neuromuscular Res Lab, Charlestown, MA USA; E Wolfson Med Ctr, Pediat Neurol & Metab Neurogenet Clin, Holon, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Univ Sheffield, Royal Hallamshire Hosp, Div Genom Med, Sheffield S10 2JF, S Yorkshire, England; Univ Ottawa, Fac Med, Dept Paediat, Ottawa, ON, Canada	Japan Science & Technology Agency (JST); Tokai University; Tokai University; McGill University; McGill University; University of British Columbia; University of British Columbia; University of Rochester; University of Rochester; Tel Aviv University; Sackler Faculty of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Sheffield; University of Ottawa	Hayden, MR (corresponding author), Tokai Univ, Sch Med, Japan Sci & Technol Corp, Int Cooperat Res Project, Kanagawa 2591193, Japan.		Hand, Collette/GRY-7269-2022; Hadano, Shinji/ABA-5052-2021; Otomo, Asako/AAA-6374-2019; Scherer, Stephen W./B-3785-2013; Hayden, Michael R/D-8581-2011; Lerman-Sagie, Tally/AAY-7598-2021	Hadano, Shinji/0000-0002-4997-3968; Otomo, Asako/0000-0002-7849-4309; Scherer, Stephen W./0000-0002-8326-1999; Hayden, Michael R/0000-0001-5159-1419; Lerman-Sagie, Tally/0000-0001-6641-6875; Nasir, Jamal/0000-0001-6378-5616; Hand, Collette/0000-0003-2348-5058; Singaraja, Roshni/0000-0002-3418-3867				Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; BENHAMIDA M, 1990, BRAIN, V113, P347; Blair IP, 2000, NEUROGENETICS, V3, P1; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Hadano S, 1999, GENOMICS, V55, P106, DOI 10.1006/geno.1998.5637; Hadano S, 2001, GENOMICS, V71, P200, DOI 10.1006/geno.2000.6392; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hosler BA, 1998, NEUROGENETICS, V2, P34, DOI 10.1007/s100480050049; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; LermanSagie T, 1996, J CHILD NEUROL, V11, P54, DOI 10.1177/088307389601100114; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MARTIJN FBG, 1997, J CELL BIOL, V137, P1603; Matsumoto K, 1999, MOL REPROD DEV, V54, P103, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;103::AID-MRD1&gt;3.0.CO;2-V; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Nagase T, 2000, DNA RES, V7, P273; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; SIDDIQUE T, 1996, NEUROLOGY S2, V47, P27; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553	34	507	542	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					166	173		10.1038/ng1001-166	http://dx.doi.org/10.1038/ng1001-166			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586298				2022-12-27	WOS:000171374100022
J	Hudson, TJ; Church, DM; Greenaway, S; Nguyen, H; Cook, A; Steen, RG; Van Etten, WJ; Castle, AB; Strivens, MA; Trickett, P; Heuston, C; Davison, C; Southwell, A; Hardisty, R; Varela-Carver, A; Haynes, AR; Rodriguez-Tome, P; Doi, H; Ko, MSH; Pontius, J; Schriml, L; Wagner, L; Maglott, D; Brown, SDM; Lander, ES; Schuler, G; Denny, P				Hudson, TJ; Church, DM; Greenaway, S; Nguyen, H; Cook, A; Steen, RG; Van Etten, WJ; Castle, AB; Strivens, MA; Trickett, P; Heuston, C; Davison, C; Southwell, A; Hardisty, R; Varela-Carver, A; Haynes, AR; Rodriguez-Tome, P; Doi, H; Ko, MSH; Pontius, J; Schriml, L; Wagner, L; Maglott, D; Brown, SDM; Lander, ES; Schuler, G; Denny, P			A radiation hybrid map of mouse genes	NATURE GENETICS			English	Article							HUMAN GENOME	A comprehensive gene-based map of a genome is a powerful tool for genetic studies and is especially useful for the positional cloning and positional candidate approaches. The availability of gene maps for multiple organisms provides the foundation for detailed conserved-orthology maps showing the correspondence between conserved genomic segments, These maps make it possible to use cross-species information in gene hunts and shed light on the evolutionary forces that shape the genome. Here we report a radiation hybrid map of mouse genes, a combined project of the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research, the Medical Research Council UK Mouse Genome Centre, and the National Center for Biotechnology Information. The map contains 11,109 genes, screened against the T31 RH panel(1) and positioned relative to a reference map containing 2,280 mouse genetic markers(2). It includes 3,658 genes homologous to the human genome sequence(3) and provides a framework for overlaying the human genome sequence to the mouse and for sequencing the mouse genome.	MIT, Whitehead Inst, Ctr Genome Res, Cambridge, England; McGill Univ, Ctr Hlth, Montreal Genome Ctr, Montreal, PQ, Canada; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD USA; MRC, UK Mouse Genome Ctr, Oxford, England; Mammalian Genet Unit, Oxford, England; European Mol Biol Lab, European Bioinformat INst, Cambridge, England; Japan Sci & Technol Corp, ERATO, Doi Bioasymmetry Project, Chiba 2617112, Japan; NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; MIT, Dept Biol, Cambridge, MA USA	McGill University; National Institutes of Health (NIH) - USA; European Molecular Biology Laboratory (EMBL); Japan Science & Technology Agency (JST); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Massachusetts Institute of Technology (MIT)	Hudson, TJ (corresponding author), MIT, Whitehead Inst, Ctr Genome Res, Cambridge, England.	tjhudson@med.mcgill.ca	Ko, Minoru S. H./B-7969-2009; Schriml, Lynn/AFO-9472-2022	Ko, Minoru S. H./0000-0002-3530-3015; Hudson, Thomas/0000-0002-1376-4849; Denny, Paul/0000-0003-4659-6893; Schriml, Lynn/0000-0001-8910-9851	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001806] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG01806] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Arkel RM, 2001, MAMM GENOME, V12, P687, DOI 10.1007/s00335-001-2066-2; Chen XN, 1999, GENOME RES, V9, P492; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; EVANS EP, 1989, GENETIC VARIANTS STR, P576; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; FLURY B, 1997, 1 COURSE MULTIVARIAT, P656; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Ko MSH, 2000, DEVELOPMENT, V127, P1737; Ko MSH, 1998, HUM MOL GENET, V7, P1967, DOI 10.1093/hmg/7.12.1967; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Marra M, 1999, NAT GENET, V21, P191, DOI 10.1038/5976; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; Rhodes M, 1998, GENOME RES, V8, P531, DOI 10.1101/gr.8.5.531; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Slonim D, 1997, J COMPUT BIOL, V4, P487, DOI 10.1089/cmb.1997.4.487; Van Etten WJ, 1999, NAT GENET, V22, P384, DOI 10.1038/11962	18	48	50	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					201	205		10.1038/ng1001-201	http://dx.doi.org/10.1038/ng1001-201			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586302				2022-12-27	WOS:000171374100028
J	Esterbauer, H; Schneitler, C; Oberkofler, H; Ebenbichler, C; Paulweber, B; Sandhofer, F; Ladurner, G; Hell, E; Strosberg, AD; Patsch, JR; Krempler, F; Patsch, W				Esterbauer, H; Schneitler, C; Oberkofler, H; Ebenbichler, C; Paulweber, B; Sandhofer, F; Ladurner, G; Hell, E; Strosberg, AD; Patsch, JR; Krempler, F; Patsch, W			A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans	NATURE GENETICS			English	Letter							UNCOUPLING PROTEIN-3 GENE; MESSENGER-RNA EXPRESSION; BODY-MASS INDEX; ENERGY-METABOLISM; PIMA-INDIANS; WEIGHT; REGION; TISSUE; DIET	Obesity is the most common nutritional disorder in Western society. Uncoupling protein-2 (UCP2) is a recently identified member of the mitochondrial transporter superfamily that is expressed in many tissues, including adipose tissue(1,2). Like its close relatives UCP1 and UCP3. UCP2 uncouples proton entry in the mitochondrial matrix from ATP synthesis(1,3) and is therefore a candidate gene for obesity(4-6). We show here that a common G/A polymorphism in the UCP2 promoter region is associated with enhanced adipose tissue mRNA expression in vivo and results in increased transcription of a reporter gene in the human adipocyte cell line PAZ-6. In analyzing 340 obese and 256 never-obese middle-aged subjects, we found a modest but significant reduction in obesity prevalence associated with the less-common allele. We confirmed this association in a population-based sample of 791 middle-aged subjects from the same geographic area. Despite its modest effect, but because of its high frequency (similar to 63%). the more-common risk allele conferred a relatively large population-attributable risk accounting for 15% of the obesity in the population studied.	Landskliniken Salzburg, Dept Lab Med, Salzburg, Austria; Univ Innsbruck, Dept Internal Med, A-6020 Innsbruck, Austria; Landskliniken Salzburg, Dept Internal Med, Salzburg, Austria; Landskliniken Salzburg, Dept Neurol, Salzburg, Austria; Inst Cochin Genet Mol, F-75014 Paris, France	University of Innsbruck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Patsch, W (corresponding author), Landskliniken Salzburg, Dept Lab Med, Salzburg, Austria.	w.patsch@lks.at		Ebenbichler, Christoph/0000-0001-5025-7929; Esterbauer, Harald/0000-0001-7343-7455				Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Bouchard C, 1997, HUM MOL GENET, V6, P1887, DOI 10.1093/hmg/6.11.1887; BRADBURN MJ, 1998, STATA TECHNICAL B, V44, P4; Cassell PG, 2000, DIABETOLOGIA, V43, P1558, DOI 10.1007/s001250051569; Chiano MN, 1998, ANN HUM GENET, V62, P55, DOI 10.1046/j.1469-1809.1998.6210055.x; Dalgaard LT, 1999, DIABETOLOGIA, V42, P1413, DOI 10.1007/s001250051312; Esterbauer H, 2000, J BIOL CHEM, V275, P36394, DOI 10.1074/jbc.M005713200; Esterbauer H, 1999, DIABETOLOGIA, V42, P302, DOI 10.1007/s001250051155; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Kiefer I, 1998, ACTA MED AUST, V25, P126; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kozak LP, 2000, NAT MED, V6, P1092, DOI 10.1038/80412; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; MANDER AP, 2000, STAT TECH B, V55, P10; Oberkofler H, 1998, DIABETOLOGIA, V41, P940, DOI 10.1007/s001250051011; Otabe S, 2000, DIABETOLOGIA, V43, P245, DOI 10.1007/s001250050037; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; ROBINS J, 1986, AM J EPIDEMIOL, V124, P719, DOI 10.1093/oxfordjournals.aje.a114447; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Schrauwen P, 1999, INT J OBESITY, V23, P1242, DOI 10.1038/sj.ijo.0801057; Terwilliger J., 1994, HDB HUMAN GENETIC LI; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431; Zilberfarb V, 1997, J CELL SCI, V110, P801	30	307	321	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					178	183		10.1038/88911	http://dx.doi.org/10.1038/88911			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381268				2022-12-27	WOS:000169011800023
J	Rudolph, KL; Millard, M; Bosenberg, MW; DePinho, RA				Rudolph, KL; Millard, M; Bosenberg, MW; DePinho, RA			Telomere dysfunction and evolution of intestinal carcinoma in mice and humans	NATURE GENETICS			English	Letter							COMPARATIVE GENOMIC HYBRIDIZATION; COLORECTAL-CANCER; CHROMOSOMAL GAINS; DEFICIENT MICE; MOUSE; NEOPLASIA; TUMORIGENESIS; PROGRESSION; MUTATION; CELLS	Telomerase activation is a common feature of advanced human cancers' and facilitates the malignant transformation of cultured human cells(2) and in mice(3,4). These experimental observations are in accord with the presence of robust telomerase activity in more advanced stages of human colorectal carcinogenesis(5-7). However, the occurrence of colon carcinomas in telomerase RNA (Terc)-null, p53-mutant mice(8) has revealed complex interactions between telomere dynamics, checkpoint responses and carcinogenesis9. We therefore sought to determine whether telomere dysfunction exerts differential effects on cancer initiation versus progression of mouse and human intestinal neoplasia. In successive generations of Apc(Min) Terc(-/-) mice(10,11). progressive telomere dysfunction led to an increase in initiated lesions (microscopic adenomas), yet a significant decline in the multiplicity and size of macroscopic adenomas. That telomere dysfunction also contributes to human colorectal carcinogenesis is supported by the appearance of anaphase bridges (a correlate of telomere dysfunction) at the adenomaearly carcinoma transition, a transition recognized for marked chromosomal instability(12-15). Together. these data are consistent with a model in which telomere dysfunction promotes the chromosomal instability that drives early carcinogenesis, while telomerase activation restores genomic stability to a level permissive for tumor progression. We propose that early and transient telomere dysfunction is a major mechanism underlying chromosomal instability of human cancer.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30623 Hannover, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Hannover Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA.			Rudolph, Karl Lenhard/0000-0002-4839-2862; DePinho, Ronald/0000-0002-5625-577X				Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; CHADENEAU C, 1995, CANCER RES, V55, P2533; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; Hanahan D, 2000, NATURE, V406, P573, DOI 10.1038/35020662; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Luongo C, 1996, GENE CHROMOSOME CANC, V17, P194, DOI 10.1002/1098-2264(199611)17:3<194::AID-GCC2870170302>3.0.CO;2-E; McClintock B, 1941, GENETICS, V26, P234; Meijer GA, 1998, J CLIN PATHOL, V51, P901, DOI 10.1136/jcp.51.12.901; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; OKAMOTO M, 1988, NATURE, V331, P273, DOI 10.1038/331273a0; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tang RP, 1998, CANCER RES, V58, P4052; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; YOUNG J, 1993, HUM MUTAT, V2, P351, DOI 10.1002/humu.1380020505	31	421	441	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					155	159		10.1038/88871	http://dx.doi.org/10.1038/88871			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381263				2022-12-27	WOS:000169011800018
J	Fares, H; Greenwald, I				Fares, H; Greenwald, I			Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog	NATURE GENETICS			English	Article							ABNORMAL TRANSPORT; MEMBRANE-PROTEIN; GENE; IV; MUTATIONS; IDENTIFICATION; ALIGNMENT; TOOL	Loss of the human 1mucolipin-l gene underlies mucolipidosis type IV (MLIV), a lysosomal storage disease that results in severe developmental neuropathology(1-3). Unlike other lysosomal storage diseases, MLIV is not associated with a lack of lysosomal hydrolases(4); instead, MLIV cells display abnormal endocytosis of lipids and accumulate large vesicles, indicating that a defect in endocytosis may underlie the disease(4-6). Here we report the identification of a loss-of-function mutation in the Caenorhabditis elegans mucolipin-1 homolog, cup-5, and show that this mutation results in an enhanced rate of uptake of fluid-phase markers, decreased degradation of endocytosed protein and accumulation of large vacuoles. Overexpression of cup-5(+) causes the opposite phenotype, indicating that cup-5 activity controls aspects of endocytosis. Studies in model organisms such as C. elegans have helped illuminate fundamental mechanisms involved in normal cellular function and human disease; thus the C. elegans cup-5 mutant may be a useful model for studying conserved aspects of mucolipin-1 structure and function and for assessing the effects of potential therapeutic compounds.	Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY USA	Columbia University; Howard Hughes Medical Institute	Fares, H (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Life Sci S Room 531, Tucson, AZ 85721 USA.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bargal R, 1997, J INHERIT METAB DIS, V20, P625, DOI 10.1023/A:1005362123443; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Eeckman FH, 1995, METHOD CELL BIOL, V48, P583; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; HAN M, 1991, GENE DEV, V5, P2188, DOI 10.1101/gad.5.12a.2188; HOSONO R, 1982, J EXP ZOOL, V235, P409; Jakubowski J, 1999, GENETICS, V153, P743; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MERIN S, 1975, INVEST OPHTH VISUAL, V14, P437; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; ZEIGLER M, 1992, PRENATAL DIAG, V12, P1037, DOI 10.1002/pd.1970121209; ZHANG Y, IN PRESS MOL BIOL CE	22	179	183	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					64	68		10.1038/ng0501-64	http://dx.doi.org/10.1038/ng0501-64			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326278				2022-12-27	WOS:000168413300018
J	[Anonymous]				[Anonymous]			Harvesting the fruits of the human genome	NATURE GENETICS			English	Editorial Material							ANNOTATION; CHROMATIN; GENES											Antonarakis SE, 2001, NAT GENET, V27, P230, DOI 10.1038/85769; Burge CB, 2001, NAT GENET, V27, P232, DOI 10.1038/85772; Craig Venter J., 2001, SCIENCE; Gopal S, 2001, NAT GENET, V27, P337, DOI 10.1038/85922; Jasny BR, 2001, SCIENCE, V291, P1153, DOI 10.1126/science.291.5506.1153; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Little P, 2001, NAT GENET, V27, P229, DOI 10.1038/85766; Martienssen R, 2001, NAT GENET, V27, P240, DOI 10.1038/85787; Penn SG, 2000, NAT GENET, V26, P315, DOI 10.1038/81613; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; 2001, NATURE, V409, P745; 2001, BAC RESOURCE CONSORT, V409, P953	17	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					227	228						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242092				2022-12-27	WOS:000167304200001
J	Joosten, PHLJ; Toepoel, M; Mariman, ECM; Van Zoelen, EJJ				Joosten, PHLJ; Toepoel, M; Mariman, ECM; Van Zoelen, EJJ			Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects	NATURE GENETICS			English	Article							SPINA-BIFIDA OCCULTA; BINDING PROTEIN; TRANSCRIPTION; PREVALENCE; EXPRESSION; PAX1	Neural tube defects (NTDs), including anencephaly and spina bifida, are multifactorial diseases that occur with an incidence of 1 in 300 births in the United Kingdom(1). Mouse models have indicated that deregulated expression of the gene encoding the platelet-derived growth factor alpha -receptor (Pdgfra) causes congenital NTDs (refs. 2-4), whereas mutant forms of Pax-1 that have been associated with NTDs cause deregulated activation of the human PDGFRA promoter(2,5). There is an increasing awareness that genetic polymorphisms may have an important role in the susceptibility for NTDs (ref. 6). Here we identify five different haplotypes in the human PDGFRA promoter, of which the two most abundant ones, designated H1 and H2 alpha, differ in at least six polymorphic sites. In a transient transfection assay in human bone cells, the five haplotypes differ strongly in their ability to enhance reporter gene activity. In a group of patients with sporadic spina bifida, haplotypes with low transcriptional activity, including H1, were under-represented, whereas those with high transcriptional activity, including H2 alpha, were over-represented. When testing for haplotype combinations, HI homozygotes were fully absent from the group of sporadic patients, whereas H1/H2 alpha heterozygotes were over-represented in the groups of both sporadic and familial spina bifida patients, but strongly underrepresented in unrelated controls. Our data indicate that specific combinations of naturally occurring PDGFRA promoter haplotypes strongly affect NTD genesis.	Univ Nijmegen, Dept Cell Biol, Nijmegen, Netherlands; Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Joosten, PHLJ (corresponding author), Univ Nijmegen, Dept Cell Biol, Nijmegen, Netherlands.		van Zoelen, Everardus J./D-9192-2012					AFINK GB, 1995, ONCOGENE, V10, P1667; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Barber RC, 1998, AM J MED GENET, V76, P310, DOI 10.1002/(SICI)1096-8628(19980401)76:4<310::AID-AJMG6>3.0.CO;2-T; Barber RC, 1999, MOL GENET METAB, V66, P1, DOI 10.1006/mgme.1998.2787; BOONE D, 1985, CLIN RADIOL, V36, P159, DOI 10.1016/S0009-9260(85)80100-8; CAMPBELL LR, 1986, TERATOLOGY, V34, P171, DOI 10.1002/tera.1420340206; Copp Andrew J., 1994, Current Opinion in Pediatrics, V6, P624, DOI 10.1097/00008480-199412000-00002; DOLK H, 1991, TERATOLOGY, V44, P547, DOI 10.1002/tera.1420440508; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Epstein JA, 1998, MOL CELL BIOL, V18, P4118, DOI 10.1128/MCB.18.7.4118; FIDAS A, 1987, CLIN RADIOL, V38, P537, DOI 10.1016/S0009-9260(87)80150-2; Fleming A, 2000, HUM MOL GENET, V9, P575, DOI 10.1093/hmg/9.4.575; Fukuoka T, 1999, J BIOL CHEM, V274, P25576, DOI 10.1074/jbc.274.36.25576; HELWIG U, 1995, NAT GENET, V11, P60, DOI 10.1038/ng0995-60; Herrmann SM, 2000, J MOL MED-JMM, V78, P287, DOI 10.1007/s001090000111; Hol FA, 1996, J MED GENET, V33, P655, DOI 10.1136/jmg.33.8.655; Joosten PHLJ, 1998, P NATL ACAD SCI USA, V95, P14459, DOI 10.1073/pnas.95.24.14459; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Payne J, 1997, DEV DYNAM, V209, P105; Peters H, 1999, DEVELOPMENT, V126, P5399; Pirrotta V, 1999, BBA-REV CANCER, V1424, pM1; ROUSSET F, 1995, GENETICS, V140, P1413; Sambrook J., 2002, MOL CLONING LAB MANU; Shimizu-Nishikawa K, 1999, DEV GROWTH DIFFER, V41, P731; Soriano P, 1997, DEVELOPMENT, V124, P2691; WALLIN J, 1994, DEVELOPMENT, V120, P1109; Wang CY, 1996, MOL CELL BIOL, V16, P712; Zhang XQ, 1998, MECH DEVELOP, V70, P167, DOI 10.1016/S0925-4773(97)00190-1	28	77	79	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					215	217		10.1038/84867	http://dx.doi.org/10.1038/84867			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175793				2022-12-27	WOS:000166839200026
J	Brunkow, ME; Jeffery, EW; Hjerrild, KA; Paeper, B; Clark, LB; Yasayko, SA; Wilkinson, JE; Galas, D; Ziegler, SF; Ramsdell, F				Brunkow, ME; Jeffery, EW; Hjerrild, KA; Paeper, B; Clark, LB; Yasayko, SA; Wilkinson, JE; Galas, D; Ziegler, SF; Ramsdell, F			Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse	NATURE GENETICS			English	Article							STATIONARY NIGHT BLINDNESS; SF MOUSE; X-CHROMOSOME; DNA-BINDING; T-CELLS; GENE; MUTATION; DISEASE; EXPRESSION; MUTANT	Scurfy (sf) is an X-linked recessive mouse mutant resulting in lethality in hemizygous males 16-25 days after birth, and is characterized by overproliferation of CD4+CD8- T lymphocytes, extensive multiorgan infiltration and elevation of numerous cytokines(1-4). Similar to animals that lack expression of either Ctla-4 (refs, 5,6) or Tgf-beta (refs, 7,8), the pathology observed in sf mice seems to result from an inability to properly regulate CD4+CD8- T-cell activity(3,9). Here we identify the gene defective in sf mice by combining high-resolution genetic and physical mapping with large-scale sequence analysis. The protein encoded by this gene (designated Foxp3) is a new member of the forkhead/winged-helix family of transcriptional regulators and is highly conserved in humans. In sf mice, a frameshift mutation results in a product lacking the forkhead domain. Genetic complementation demonstrates that the protein product of Foxp3, scurfin, is essential for normal immune homeostasis.	Celltech Chirosci Inc, Bothell, WA USA; Oak Ridge Natl Lab, Oak Ridge, TN USA; Keck Grad Inst Appl Life Sci, Claremont, CA USA; Virginia Mason Res Ctr, Seattle, WA 98101 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of Applied Life Sciences; Virginia Mason Medical Center	Brunkow, ME (corresponding author), Celltech Chirosci Inc, Bothell, WA USA.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BLAIR PJ, 1994, J IMMUNOL, V153, P3764; BLAIR PJ, 1994, MAMM GENOME, V5, P652, DOI 10.1007/BF00411464; Boyd Y, 1997, MAMM GENOME, V7, pS313, DOI 10.1007/s003359900332; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Clark LB, 1999, J IMMUNOL, V162, P2546; COSTANZO F, 1984, EMBO J, V3, P23, DOI 10.1002/j.1460-2075.1984.tb01756.x; GODFREY VL, 1994, AM J PATHOL, V145, P281; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hong NA, 1997, MOL CELL BIOL, V17, P2151, DOI 10.1128/MCB.17.4.2151; Kaestner KH, 2000, GENE DEV, V14, P142; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; LI C, 1993, P NATL ACAD SCI USA, V90, P11583, DOI 10.1073/pnas.90.24.11583; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Means GD, 2000, GENOMICS, V65, P213, DOI 10.1006/geno.2000.6173; Schindelhauer D, 1996, GENOME RES, V6, P1056, DOI 10.1101/gr.6.11.1056; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; VERES G, 1987, SCIENCE, V237, P415, DOI 10.1126/science.3603027; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	31	1853	1993	0	71	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					68	73		10.1038/83784	http://dx.doi.org/10.1038/83784			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138001				2022-12-27	WOS:000166187900018
J	Lee, MH; Lu, K; Hazard, S; Yu, HW; Shulenin, S; Hidaka, H; Kojima, H; Allikmets, R; Sakuma, N; Pegoraro, R; Srivastava, AK; Salen, G; Dean, M; Patel, SB				Lee, MH; Lu, K; Hazard, S; Yu, HW; Shulenin, S; Hidaka, H; Kojima, H; Allikmets, R; Sakuma, N; Pegoraro, R; Srivastava, AK; Salen, G; Dean, M; Patel, SB			Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption	NATURE GENETICS			English	Article							BINDING CASSETTE TRANSPORTER-1; TANGIER-DISEASE; SITOSTEROLEMIA; XANTHOMATOSIS; MUTATIONS	The molecular mechanisms regulating the amount of dietary cholesterol retained in the body, as well as the body's ability to exclude selectively other dietary sterols, are poorly understood. An average western diet will contain about 250-500 mg of dietary cholesterol and about 200-400 mg of non-cholesterol sterols. About 50-60% of the dietary cholesterol is absorbed and retained by the normal human body, but less than 1% of the non-cholesterol sterols are retained. Thus, there exists a subtle mechanism that allows the body to distinguish between cholesterol and non-cholesterol sterols. In sitosterolemia, a rare autosomal recessive disorder, affected individuals hyperabsorb not only cholesterol but also all other sterols, including plant and shellfish sterols from the intestine(1,2). The major plant sterol species is sitosterol; hence the name of the disorder. Consequently, patients with this disease have very high levels of plant sterols in the plasma and develop tendon and tuberous xanthomas, accelerated atherosclerosis, and premature coronary artery disease(3). We previously mapped the STSL locus to human chromosome 2p21 (ref. 4) and further localized it to a region of less than 2 cM bounded by markers D2S2294 and D2S2291 (M.-H.L. et al., manuscript submitted). We now report that a new member of the ABC transporter family, ABCG5, is mutant in nine unrelated sitosterolemia patients.	Med Univ S Carolina, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA; NCI, Frederick Canc Res & Dev Ctr, Lab Genom Divers, Frederick, MD USA; Sanyo Elect Grp Hlth Insurance Assoc, Osaka, Japan; Shiga Univ Med Sci, Dept Med 3, Shiga 52021, Japan; Columbia Univ, Coll Phys & Surg, Dept Ophthalmol, New York, NY USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA; Nagoya City Univ, Dept Med 3, Nagoya, Aichi 467861, Japan; Univ Natal, Nelson R Mandela Sch Med, Dept Chem Pathol, ZA-4013 Durban, South Africa; JC Self Res Inst Human Genet, Greenwood Genet Ctr, Greenwood, SC USA; Univ Med & Dent New Jersey, Div Gastroenterol, Newark, NJ 07103 USA	Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Panasonic; Shiga University of Medical Science; Columbia University; Columbia University; Nagoya City University; University of Kwazulu Natal; Greenwood Genetic Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SB (corresponding author), Med Univ S Carolina, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA.		Allikmets, Rando/ABD-4533-2021; Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019; Eckhardt, Erik/G-1567-2010	Dean, Michael C/0000-0003-2234-0631; Patel, Shailendra/0000-0003-0046-5513	NCRR NIH HHS [M01 RR000633] Funding Source: Medline; NHLBI NIH HHS [R01 HL060613] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060613] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BHATTACHARYYA AK, 1974, J CLIN INVEST, V53, P1033, DOI 10.1172/JCI107640; Bjorkhem I., 1995, METABOLIC MOL BASES, P2073; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Erlinger S, 1996, J GASTROEN HEPATOL, V11, P575, DOI 10.1111/j.1440-1746.1996.tb01705.x; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; GREGG RE, 1986, J CLIN INVEST, V77, P1864, DOI 10.1172/JCI112513; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patel SB, 1998, J LIPID RES, V39, P1055; Patel SB, 1998, J CLIN INVEST, V102, P1041, DOI 10.1172/JCI3963; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SHULENIN S, IN PRESS CYTO CELL G; Sossey-Alaoui K, 1999, GENOMICS, V60, P330, DOI 10.1006/geno.1999.5924; Swofford David L., 1990, P411; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Witsch-Baumgartner M, 2000, AM J HUM GENET, V66, P402, DOI 10.1086/302760; Wu JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE1087, DOI 10.1152/ajpendo.1999.277.6.E1087; Yu HW, 2000, AM J MED GENET, V90, P347, DOI 10.1002/(SICI)1096-8628(20000214)90:4<347::AID-AJMG16>3.0.CO;2-7	22	518	547	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					79	83		10.1038/83799	http://dx.doi.org/10.1038/83799			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138003	Green Accepted			2022-12-27	WOS:000166187900020
J	Arsenijevic, D; Onuma, H; Pecqueur, C; Raimbault, S; Manning, BS; Miroux, B; Couplan, E; Alves-Guerra, MC; Goubern, M; Surwit, R; Bouillaud, F; Richard, D; Collins, S; Ricquier, D				Arsenijevic, D; Onuma, H; Pecqueur, C; Raimbault, S; Manning, BS; Miroux, B; Couplan, E; Alves-Guerra, MC; Goubern, M; Surwit, R; Bouillaud, F; Richard, D; Collins, S; Ricquier, D			Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production	NATURE GENETICS			English	Article							OBESITY; MOUSE	The gene Ucp2 is a member of a family of genes found in animals and plants, encoding a protein homologous to the brown fat uncoupling protein Ucp1 (refs 1-3). As Ucp2 is widely expressed in mammalian tissues(4,5), uncouples respiration(6) and resides within a region of genetic linkage to obesity(4), a role in energy dissipation has been proposed. We demonstrate here, however, that mice lacking Ucp2 following targeted gene disruption are not obese and have a normal response to cold exposure or high-fat diet. Expression of Ucp2 is robust in spleen, lung and isolated macrophages(4,5,7), suggesting a role for Ucp2 In immunity or inflammatory responsiveness(4). We investigated the response to infection with Toxoplasma gondii in Ucp2(-/-) mice, and found that they are completely resistant to infection, in contrast with the lethality observed in wild-type littermates. Parasitic cysts and inflammation sites in brain were significantly reduced in Ucp2(-/-) mice (63% decrease, P<0.04). Macrophages from Ucp2(-/-) mice generated more reactive oxygen species than wild-type mice (80% increase, P<0.001) in response to T. gondii, and had a fivefold greater toxoplasmacidal activity in vitro compared with wild-type mice (P<0.001), which was absent in the presence of a quencher of reactive oxygen species (ROS). Our results indicate a role for Ucp2 in the limitation of ROS and macrophage-mediated immunity.	Ctr Rech Endocrinol Mol & Dev, CNRS, UPR 9078, Meudon, France; INRA, Ecole Prat Hautes Etud, Jouy En Josas, France; Duke Univ, Med Ctr, Durham, NC USA; Univ Laval, Ctr Rech Metab Energet, Quebec City, PQ, Canada; Hop Laval, Ctr Rech, Quebec City, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Duke University; Laval University; Laval University	Ricquier, D (corresponding author), Ctr Rech Endocrinol Mol & Dev, CNRS, UPR 9078, Meudon, France.		Alves-Guerra, Marie-Clotilde/P-4356-2017; Bouillaud, Frédéric R/L-3238-2017; Miroux, Bruno/E-9267-2017; Arsenijevic, Denis/O-8315-2016; Pecqueur, Claire/L-3073-2015	Alves-Guerra, Marie-Clotilde/0000-0002-7918-1216; Bouillaud, Frédéric R/0000-0002-7518-9237; Arsenijevic, Denis/0000-0001-5741-9652; Pecqueur, Claire/0000-0002-7612-1672; Miroux, Bruno/0000-0002-3066-4700	NIDDK NIH HHS [R01 DK54024] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054024] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKINSHINA G T, 1975, Byulleten' Eksperimental'noi Biologii i Meditsiny, V80, P60; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Cohen RD, 1999, INFLAMM BOWEL DIS, V5, P1; Diehl AM, 1999, J BIOENERG BIOMEMBR, V31, P493, DOI 10.1023/A:1005452624640; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Laloi M, 1997, NATURE, V389, P135, DOI 10.1038/38156; Larrouy D, 1997, BIOCHEM BIOPH RES CO, V235, P760, DOI 10.1006/bbrc.1997.6852; Lee FYJ, 1999, AM J PHYSIOL-CELL PH, V276, pC386, DOI 10.1152/ajpcell.1999.276.2.C386; Makioka A, 1995, J PARASITOL, V81, P1021, DOI 10.2307/3284064; MARINI M, 1993, MUTAT RES, V301, P243, DOI 10.1016/0165-7992(93)90064-3; MURRAY HW, 1979, J EXP MED, V150, P950, DOI 10.1084/jem.150.4.950; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Pecqueur C, 1999, BIOCHEM BIOPH RES CO, V255, P40, DOI 10.1006/bbrc.1998.0146; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Richard D, 1998, J COMP NEUROL, V397, P549; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; ROOK GAW, 1985, J IMMUNOL METHODS, V82, P161, DOI 10.1016/0022-1759(85)90235-2; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Zamora R, 1997, BIOCHEMISTRY-US, V36, P15765, DOI 10.1021/bi971641i	28	891	923	2	68	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					435	439		10.1038/82565	http://dx.doi.org/10.1038/82565			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101840				2022-12-27	WOS:000165671700015
J	Horikawa, Y; Oda, N; Cox, NJ; Li, XQ; Orho-Melander, M; Hara, M; Hinokio, Y; Lindner, TH; Mashima, H; Schwarz, PEH; del Bosque-Plata, L; Horikawa, Y; Oda, Y; Yoshiuchi, I; Colilla, S; Polonsky, KS; Wei, S; Concannon, P; Iwasaki, N; Schulze, T; Baier, LJ; Bogardus, C; Groop, L; Boerwinkle, E; Hanis, CL; Bell, GI				Horikawa, Y; Oda, N; Cox, NJ; Li, XQ; Orho-Melander, M; Hara, M; Hinokio, Y; Lindner, TH; Mashima, H; Schwarz, PEH; del Bosque-Plata, L; Horikawa, Y; Oda, Y; Yoshiuchi, I; Colilla, S; Polonsky, KS; Wei, S; Concannon, P; Iwasaki, N; Schulze, T; Baier, LJ; Bogardus, C; Groop, L; Boerwinkle, E; Hanis, CL; Bell, GI			Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus	NATURE GENETICS			English	Article							MAJOR SUSCEPTIBILITY LOCUS; GENOME-WIDE SEARCH; DROSOPHILA-MELANOGASTER; MEXICAN-AMERICANS; LINKAGE; MUTATIONS; ONSET; CHROMOSOME-2; PROTEASE; NIDDM1	Type 2 or non-insulin-dependent diabetes mellitus (NIDDM) is the most common form of diabetes worldwide, affecting approximately 4% of the world's adult population. It is multifactorial in origin with both genetic and environmental factors contributing to its development. A genome-wide screen for type 2 diabetes genes carried out in Mexican Americans localized a susceptibility gene, designated NIDDM1, to chromosome 2. Here we describe the positional cloning of a gene located in the NIDDM1 region that shows association with type 2 diabetes in Mexican Americans and a Northern European population from the Botnia region of Finland. This putative diabetes-susceptibility gene encodes a ubiquitously expressed member of the calpain-like cysteine protease family, calpain-10 (CAPN10). This finding suggests a novel pathway that may contribute to the development of type 2 diabetes.	Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Lund, Malmo Univ Hosp, Dept Endocrinol, Malmo, Sweden; Univ Washington, Mol Genet Program, Virginia Mason Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Tokyo Womens Med Univ, Ctr Diabet, Tokyo, Japan; Tech Univ Dresden, Univ Clin Carl Gustav Carus, Dept Internal Med 3, D-8027 Dresden, Germany; NIDDKD, Phoenix Epidemiol & Clin Res Branch, NIH, Phoenix, AZ USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University of Chicago; Lund University; Skane University Hospital; University of Washington; University of Washington Seattle; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; Tokyo Women's Medical University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Health Science Center Houston	Bell, GI (corresponding author), Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA.		Mashima, Hirosato/ABE-6412-2020	del Bosque-Plata, Laura/0000-0003-3224-378X; YOSHIUCHI, ISSEI/0000-0002-6025-7962; Concannon, Patrick/0000-0002-5801-1859	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, Z01DK069071, P60DK020595, R01DK047486, P30DK042086] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-42086, DK-20595, DK-47486] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Barner H B, 1996, Semin Thorac Cardiovasc Surg, V8, P3; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Braun C, 1999, BIOCHEM BIOPH RES CO, V260, P671, DOI 10.1006/bbrc.1999.0948; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cadel S, 1997, P NATL ACAD SCI USA, V94, P2963, DOI 10.1073/pnas.94.7.2963; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; Ciccarese M, 1997, DIABETOLOGIA, V40, P1366, DOI 10.1007/s001250050835; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Dear N, 1997, GENOMICS, V45, P175, DOI 10.1006/geno.1997.4870; DELANEY SJ, 1991, P NATL ACAD SCI USA, V88, P7214, DOI 10.1073/pnas.88.16.7214; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Gavin JR, 1997, DIABETES CARE, V20, P1183; Ghosh S, 1998, J CLIN INVEST, V102, P704, DOI 10.1172/JCI2512; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Hani EH, 1997, DIABETES, V46, P1225, DOI 10.2337/diab.46.7.1225; HANIS CL, 1991, DIABETES CARE, V14, P618, DOI 10.2337/diacare.14.7.618; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Khoury M, 1993, FUNDAMENTALS GENETIC; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LEWONTIN RC, 1964, GENETICS, V49, P49; Maassen JA, 1996, DIABETOLOGIA, V39, P375; MACLEAN C J, 1985, Genetic Epidemiology, V2, P263, DOI 10.1002/gepi.1370020304; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; O'Dowd BF, 1998, GENOMICS, V47, P310, DOI 10.1006/geno.1998.5095; Patel YM, 1999, P NATL ACAD SCI USA, V96, P1279, DOI 10.1073/pnas.96.4.1279; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Smith LK, 1996, MOL CELL ENDOCRINOL, V122, P81, DOI 10.1016/0303-7207(96)03875-0; Stam LF, 1996, GENETICS, V144, P1559; Steiner D. F., 1995, METABOLIC MOL BASES, P897; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Taylor S. I., 1995, METABOLIC MOL BASES, P843; Thomas AW, 1997, HUM GENET, V101, P212, DOI 10.1007/s004390050617; Uitterlinden AG, 1998, NEW ENGL J MED, V338, P1016, DOI 10.1056/NEJM199804093381502; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; YAMASAKI H, 1984, MECHANISMS TUMOR PRO, V4, P1	50	1120	1205	0	73	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					163	175		10.1038/79876	http://dx.doi.org/10.1038/79876			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017071				2022-12-27	WOS:000089638800012
J	Kutsche, K; Yntema, H; Brandt, A; Jantke, I; Nothwang, HG; Orth, U; Boavida, MG; David, D; Chelly, J; Fryns, JP; Moraine, C; Ropers, HH; Hamel, BCJ; van Bokhoven, H; Gal, A				Kutsche, K; Yntema, H; Brandt, A; Jantke, I; Nothwang, HG; Orth, U; Boavida, MG; David, D; Chelly, J; Fryns, JP; Moraine, C; Ropers, HH; Hamel, BCJ; van Bokhoven, H; Gal, A			Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation	NATURE GENETICS			English	Letter							GENE; FAMILY; IDENTIFICATION; CHROMOSOME; REPEAT; DOMAIN; ACTIN; FMR2	X-linked forms of mental retardation (XLMR) include a variety of different disorders and may account for up to 25% of all inherited cases of mental retardation(1). So far, seven X-chromosomal genes mutated in nonspecific mental retardation (MRX) have been identified: FMR2, GDI1, RPS6KA3, IL1RAPL, TM4SF2, OPHN1 and PAK3 (refs 2-9). The products of the latter two have been implicated in regulation of neural plasticity by controlling the activity of small GTPases of the Rho family. Here we report the identification of a new MRX gene. ARHGEF6 (also known as alpha PIX or Cool-2). encoding a protein with homology to guanine nucleotide exchange factors for Rho GTPases (Rho GEF). Molecular analysis of a reciprocal X/21 translocation in a male with mental retardation showed that this gene in Xq26 was disrupted by the rearrangement. Mutation screening of 119 patients with nonspecific mental retardation revealed a mutation in the first intron of ARHGEF6 (IVS1-11T-->C) in all affected males in a large Dutch family(10). The mutation resulted in preferential skipping of exon 2. predicting a protein lacking 28 amino acids;. ARHGEF6 is the eighth MRX gene identified so far and the third such gene to encode a protein that interacts with Rho GTPases.	Univ Hamburg, Klinikum Eppendorf, Inst Human Genet, Hamburg, Germany; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Max Planck Inst Mol Genet, Berlin, Germany; INSA, Dept Human Genet, Lisbon, Portugal; CHU Cochin, INSERM, ICGM, U129, Paris, France; Univ Hosp Leuven, Ctr Human Genet, Louvain, Belgium; CHU Tours, Hop Bretonneau, Serv Genet, Tours, France	University of Hamburg; Radboud University Nijmegen; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; KU Leuven; University Hospital Leuven; CHU Tours	Gal, A (corresponding author), Univ Hamburg, Klinikum Eppendorf, Inst Human Genet, Hamburg, Germany.		van Bokhoven, Hans/D-8764-2012; Yntema, H.G./L-4771-2015; Nothwang, Hans G/C-5847-2011; Bokhoven, J.H.L.M. van van/H-8015-2014; Chelly, Jamel/J-7528-2015	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Chelly, Jamel/0000-0002-0939-8719; David, Dezso/0000-0003-2293-590X; Nothwang, Hans Gerd/0000-0001-7695-6437				Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bala S, 1997, HUM MUTAT, V10, P201; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BUNGE S, 1996, METH MOL G, V8, P26; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; CASTRESANA J, 1995, FEBS LETT, V374, P149, DOI 10.1016/0014-5793(95)01098-Y; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HART MJ, 1994, J BIOL CHEM, V269, P62; Katan M, 1999, FEBS LETT, V452, P36, DOI 10.1016/S0014-5793(99)00531-1; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lubs H, 1999, AM J MED GENET, V83, P237, DOI 10.1002/(SICI)1096-8628(19990402)83:4<237::AID-AJMG2>3.3.CO;2-#; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; VAN AL, 1997, GENE DEV, V11, P2295; vonBallestrem CL, 1996, CLIN GENET, V49, P156; WEEKS DE, 1995, GENOMICS, V26, P39, DOI 10.1016/0888-7543(95)80080-6; Yntema HG, 1998, J MED GENET, V35, P801, DOI 10.1136/jmg.35.10.801; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829	29	256	261	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					247	250		10.1038/80002	http://dx.doi.org/10.1038/80002			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017088				2022-12-27	WOS:000089638800029
J	Liu, WG; Dong, XY; Mai, M; Seelan, RS; Taniguchi, K; Krishnadath, KK; Halling, KC; Cunningham, JM; Qian, CP; Christensen, E; Roche, PC; Smith, DI; Thibodeau, SN				Liu, WG; Dong, XY; Mai, M; Seelan, RS; Taniguchi, K; Krishnadath, KK; Halling, KC; Cunningham, JM; Qian, CP; Christensen, E; Roche, PC; Smith, DI; Thibodeau, SN			Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling	NATURE GENETICS			English	Article							BAX GENE; CONDUCTIN; HOMOLOG; TUMOR		Mayo Clin & Mayo Med Sch, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN 55905 USA	Mayo Clinic	Liu, WG (corresponding author), Mayo Clin & Mayo Med Sch, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN 55905 USA.			Seelan, Ratnam/0000-0002-8925-1070	NATIONAL CANCER INSTITUTE [U01CA060117, R01CA048031, R01CA060117] Funding Source: NIH RePORTER; NCI NIH HHS [CA 48031, CA 60117] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Boland CR, 1998, CANCER RES, V58, P5248; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Liu WG, 1998, NUCLEIC ACIDS RES, V26, P1396, DOI 10.1093/nar/26.6.1396; Mai M, 1999, GENOMICS, V55, P341, DOI 10.1006/geno.1998.5650; MARRA G, 1995, J NATL CANCER I, V87, P1114, DOI 10.1093/jnci/87.15.1114; MIYASHITA T, 1995, CELL, V80, P293; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448	14	414	434	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					146	147		10.1038/79859	http://dx.doi.org/10.1038/79859			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017067				2022-12-27	WOS:000089638800009
J	Nikaido, M; Kawakami, A; Sawada, A; Furutani-Seiki, M; Takeda, H; Araki, K				Nikaido, M; Kawakami, A; Sawada, A; Furutani-Seiki, M; Takeda, H; Araki, K			Tbx24, encoding a T-box protein, is mutated in the zebrafish somite-segmentation mutant fused somites	NATURE GENETICS			English	Article							GENE; EXPRESSION; MUTATIONS; EMBRYOS; SOMITOGENESIS; SPADETAIL; MESODERM; FAMILY; GENOME; MOTIF	Somites are fundamental structures within the paraxial mesoderm of the vertebrate embryo that give rise to the vertebrae and muscle of the trunk and tail. Studies of knockout mice and gene expression analyses have shown that the Notch pathway is crucial in establishing the reiterative pattern of somites(1). A large-scale screen in zebrafish previously identified five mutants that show abnormalities in somite boundary formation(2). Four have essentially the same phenotype, with posterior somite defects(2-4) and neuronal hyperplasia(5,6); recent work has suggested that genes affected in these mutants encode components of the Notch signaling cascade(5). The fifth mutant, fused somites (fss), shows a different phenotype characterized by complete lack of somite formation along the entire antero-posterior axis(2,3). Gene expression and phenotypic analyses in mutant embryos have implicated Fss in somite formation independent of Notch signaling(4,5), suggesting the presence of a new pathway regulating somite boundary formation. We show here that the fss gene encodes a T-box transcription factor that is expressed in intermediate to anterior presomitic mesoderm (PSM) and is involved in PSM maturation.	Natl Inst Genet, Div Early Embryogenesis, Mishima, Shizuoka, Japan; Natl Res Inst Aquaculture, Div Genet, Cell Engn Sect, Mie, Wataria 5190423, Japan; Japan Sci & Technol Corp, ERATO Kondoh Differentiat Signaling Project, Sakyo Ku, Kyoto 6068305, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Fisheries Research & Education Agency (FRA); Japan Science & Technology Agency (JST)	Takeda, H (corresponding author), Natl Inst Genet, Div Early Embryogenesis, Mishima, Shizuoka, Japan.		Kawakami, Atsushi/D-3785-2019; TAKEDA, HIROYUKI/G-4950-2014	Kawakami, Atsushi/0000-0001-9461-6372; 				Alexandre D, 1996, DEVELOPMENT, V122, P735; Amemiya CT, 1999, METHOD CELL BIOL, V60, P235; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Durbin L, 2000, DEVELOPMENT, V127, P1703; Furthauer M, 1997, DEVELOPMENT, V124, P4253; Gray M, 2001, DEV BIOL, V237, P306, DOI 10.1006/dbio.2001.0381; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Holley SA, 2000, GENE DEV, V14, P1678; Hug B, 1997, DEV BIOL, V183, P61, DOI 10.1006/dbio.1996.8490; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; Kwok C, 1998, NUCLEIC ACIDS RES, V26, P3562, DOI 10.1093/nar/26.15.3562; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Reifers F, 1998, DEVELOPMENT, V125, P2381; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawada A, 2000, DEVELOPMENT, V127, P1691; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Van Eeden FJM, 1998, DEV GENET, V23, P65; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5	30	131	135	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					195	199		10.1038/ng899	http://dx.doi.org/10.1038/ng899			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12021786				2022-12-27	WOS:000175903500018
J	Agarwal, AK; Arioglu, E; de Almeida, S; Akkoc, N; Taylor, SI; Bowcock, AM; Barnes, RI; Garg, A				Agarwal, AK; Arioglu, E; de Almeida, S; Akkoc, N; Taylor, SI; Bowcock, AM; Barnes, RI; Garg, A			AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34	NATURE GENETICS			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASES; CDNA CLONING; EXPRESSION; LOCALIZATION; GENE	Congenital generalized lipodystrophy is an autosomal recessive disorder characterized by marked paucity of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. We report several different mutations of the gene (AGPAT2) encoding 1-acylglycerol-3-phosphate O-acyltransferase 2 in 20 affected individuals from 11 pedigrees of diverse ethnicities showing linkage to chromosome 9q34. The AGPAT2 enzyme catalyzes the acylation of lysophosphatidic acid to form phosphatidic acid, a key intermediate in the biosynthesis of triacylglycerol and glycerophospholipids. AGPAT2 mRNA is highly expressed in adipose tissue. We conclude that mutations in AGPAT2 may cause congenital generalized lipodystrophy by inhibiting triacylglycerol synthesis and storage in adipocytes.	Univ Texas, SW Med Ctr, Dept Internal Med, Div Nutr & Metab Dis, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Ctr Human Nutr, Dallas, TX 75390 USA; NIDDKD, Diabet Branch, Bethesda, MD 20892 USA; Hosp Dona Estefania, Serv Genet Med, Lisbon, Portugal; Dokuz Eylul Univ, Sch Med, Dept Internal Med, Izmir, Turkey; Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Dokuz Eylul University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garg, A (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Nutr & Metab Dis, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	abhimanyu.garg@utsouthwestern.edu	Akkoc, Nurullah/D-9870-2011	Akkoc, Nurullah/0000-0002-3718-171X; Bowcock, Anne/0000-0001-8691-9090; Oral, Elif/0000-0002-9171-1144				Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Eberhardt C, 1999, ADV EXP MED BIOL, V469, P351; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; GARG A, 1992, J CLIN ENDOCR METAB, V75, P358, DOI 10.1210/jc.75.2.358; Garg A, 1999, J CLIN ENDOCR METAB, V84, P3390, DOI 10.1210/jc.84.9.3390; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; HUSEMAN C, 1978, J PEDIATR-US, V93, P221, DOI 10.1016/S0022-3476(78)80500-9; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Pages C, 2001, PROSTAG OTH LIPID M, V64, P1, DOI 10.1016/S0090-6980(01)00110-1; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; Vigouroux C, 1997, J CLIN ENDOCR METAB, V82, P3438, DOI 10.1210/jc.82.10.3438; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691	15	363	377	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					21	23		10.1038/ng880	http://dx.doi.org/10.1038/ng880			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967537	Bronze			2022-12-27	WOS:000175362500009
J	Zhang, JZ; Zhang, YP; Rosenberg, HF				Zhang, JZ; Zhang, YP; Rosenberg, HF			Adaptive evolution of a duplicated pancreatic ribonuclease gene in a leaf-eating monkey	NATURE GENETICS			English	Article							POSITIVE DARWINIAN SELECTION; RAPID EVOLUTION; SUBSTITUTIONS; FEATURES; PROTEIN; RATES	Although the complete genome sequences of over 50 representative species have revealed the many duplicated genes in all three domains of life(1-4), the roles of gene duplication in organismal adaptation and biodiversity are poorly understood. In addition, the evolutionary forces behind the functional divergence of duplicated genes are often unknown, leading to disagreement on the relative importance of positive Darwinian selection versus relaxation of functional constraints in this process(5-10). The methodology of earlier studies relied largely on DNA sequence analysis but lacked functional assays of duplicated genes, frequently generating contentious results(11,12). Here we use both computational and experimental approaches to address these questions in a study of the pancreatic ribonuclease gene (RNASE1) and its duplicate gene (RNASE1B) in a leaf-eating colobine monkey, douc langur. We show that RNASE1B has evolved rapidly under positive selection for enhanced ribonucleolytic activity in an altered microenvironment, a response to increased demands for the enzyme for digesting bacterial RNA. At the same time, the ability to degrade double-stranded RNA, a non-digestive activity characteristic of primate RNASE1, has been lost in RNASE1B, indicating functional specialization and relaxation of purifying selection. Our findings demonstrate the contribution of gene duplication to organismal adaptation and show the power of combining sequence analysis and functional assays in delineating the molecular basis of adaptive evolution.	NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, JZ (corresponding author), NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.							BARNARD EA, 1969, NATURE, V221, P340, DOI 10.1038/221340a0; BEINTEMA JJ, 1990, MOL BIOL EVOL, V7, P470; BROOKFIELD JFY, 1994, TRENDS GENET, V10, P109, DOI 10.1016/0168-9525(94)90201-1; Charlesworth B, 1999, NATURE, V400, P519, DOI 10.1038/22922; CODE CF, 1968, HDB PHYSL, V3; Delson Eric, 1994, P11; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Gaudieri S, 1999, GENOME RES, V9, P541; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; GOODMAN M, 1975, NATURE, V253, P603, DOI 10.1038/253603a0; Guyton A.C., 2011, HALL TXB MED PHYSL; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Kay Robin N. B., 1994, P229; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kimura M., 1983, NEUTRAL THEORY MOL; LI WH, 1983, MOL BIOL EVOL, V1, P94; LI WH, 1997, MOL EVOLUTION, P221; LIBONATI M, 1969, EUR J BIOCHEM, V8, P81, DOI 10.1111/j.1432-1033.1969.tb00498.x; Lynch M, 2000, GENETICS, V154, P459; Makarova KS, 1999, GENOME RES, V9, P608; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; ROSENBERG HF, 1995, J BIOL CHEM, V270, P21539, DOI 10.1074/jbc.270.37.21539; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sorrentino S, 1997, FEBS LETT, V404, P1, DOI 10.1016/S0014-5793(97)00086-0; TAJIMA F, 1993, GENETICS, V135, P599; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	33	257	289	1	60	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					411	415		10.1038/ng852	http://dx.doi.org/10.1038/ng852			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11925567				2022-12-27	WOS:000174682000019
J	Jin, W; Riley, RM; Wolfinger, RD; White, KP; Passador-Gurgel, G; Gibson, G				Jin, W; Riley, RM; Wolfinger, RD; White, KP; Passador-Gurgel, G; Gibson, G			The contributions of sex, genotype and age to transcriptional variance in Drosophila melanogaster	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; GENE-EXPRESSION; MICROARRAY ANALYSIS; GENOME-WIDE; DISCOVERY; PATTERNS	Here we present a statistically rigorous approach to quantifying microarray expression data that allows the relative effects of multiple classes of treatment to be compared and incorporates analytical methods that are common to quantitative genetics. From the magnitude of gene effects and contributions of variance components, we find that gene expression in adult flies is affected most strongly by sex, less so by genotype and only weakly by age (for 1- and 6-wk flies); in addition, sex x genotype interactions may be present for as much as 10% of the Drosophila transcriptome. This interpretation is compromised to some extent by statistical issues relating to power and experimental design. Nevertheless, we show that changes in expression as small as 1.2-fold can be highly significant. Genotypic contributions to transcriptional variance may be of a similar magnitude to those relating to some quantitative phenotypes and should be considered when assessing the significance of experimental treatments.	N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; SAS Inst, Cary, NC 27513 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA	University of North Carolina; North Carolina State University; SAS Institute Inc; Yale University	Gibson, G (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.							Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Cochran WG, 1957, EXPT DESIGNS; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kerr MK, 2001, GENET RES, V77, P123; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Leips J, 2000, GENETICS, V155, P1773; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Long AD, 2000, GENETICS, V154, P1255; Lynch M., 1998, GENETICS ANAL QUANTI; Mace ML, 2000, MICROARRAY BIOCHIP TECHNOLOGY, P39; Nuzhdin SV, 1997, P NATL ACAD SCI USA, V94, P9734, DOI 10.1073/pnas.94.18.9734; Perrimon N, 1996, GENETICS, V144, P1681; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; SAS Institute Inc, 1999, SAS STAT SOFTW VERS; SPICER GS, 1991, BIOCHEM GENET, V29, P389, DOI 10.1007/BF00554145; WEBSTER GC, 1984, MECH AGEING DEV, V24, P335, DOI 10.1016/0047-6374(84)90118-0; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; WOLFINGER RD, IN PRESS J COMPUT BI; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	25	494	506	0	35	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					389	395		10.1038/ng766	http://dx.doi.org/10.1038/ng766			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726925				2022-12-27	WOS:000172507500013
J	Thomas, NA; Choong, DYH; Jokubaitis, VJ; Neville, PJ; Campbell, IG				Thomas, NA; Choong, DYH; Jokubaitis, VJ; Neville, PJ; Campbell, IG			Mutation of the ST7 tumor suppressor gene on 7q31.1 is rare in breast, ovarian and colorectal cancers	NATURE GENETICS			English	Article							SQUAMOUS-CELL; FREQUENT LOSS; CARCINOMAS; IDENTIFICATION; HETEROZYGOSITY; REGION	The gene ST7 has recently been implicated as the broad-range tumor suppressor on human chromosome 7q31.1. We did not detect somatic mutations in ST7 in any of 149 primary ovarian, breast or colon carcinomas. These data suggest that epigenetic downregulation or haploinsufficiency, rather than somatic genetic alterations, may be the primary mechanism of abrogation of ST7 function in these tumor types.	Peter MacCallum Canc Inst, Victorian Breast Canc Res Consortium, Canc Genet Lab, Melbourne, Vic 3002, Australia; Princess Anne Hosp, Dept Obstet & Gynecol, Southampton S016 5YA, Hants, England	Peter Maccallum Cancer Center	Campbell, IG (corresponding author), Peter MacCallum Canc Inst, Victorian Breast Canc Res Consortium, Canc Genet Lab, St Andrews Pl, Melbourne, Vic 3002, Australia.		campbell, Ian G/F-6006-2011	Campbell, Ian/0000-0002-7773-4155				Edelson MI, 1997, ONCOGENE, V14, P2979, DOI 10.1038/sj.onc.1201271; Koike M, 1997, GENE CHROMOSOME CANC, V19, P1, DOI 10.1002/(SICI)1098-2264(199705)19:1<1::AID-GCC1>3.0.CO;2-3; Miyamoto S, 1991, Hum Cell, V4, P38; OGATA T, 1993, MOL CELL BIOL, V13, P6036, DOI 10.1128/MCB.13.10.6036; Vincent JB, 2000, AM J HUM GENET, V67, P510, DOI 10.1086/303005; ZENKLUSEN JC, 1994, ONCOGENE, V9, P2817; ZENKLUSEN JC, 1995, ONCOGENE, V11, P359; ZENKLUSEN JC, 1994, P NATL ACAD SCI USA, V91, P12155, DOI 10.1073/pnas.91.25.12155; Zenklusen JC, 2001, NAT GENET, V27, P392, DOI 10.1038/86891; ZENKLUSEN JC, 1995, CANCER RES, V55, P1347; Zenklusen JC, 2000, ONCOGENE, V19, P1729, DOI 10.1038/sj.onc.1203488	11	16	17	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					379	380		10.1038/ng784	http://dx.doi.org/10.1038/ng784			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726923				2022-12-27	WOS:000172507500010
J	Zhao, XP; Alvarado, D; Rainier, S; Lemons, R; Hedera, P; Weber, CH; Tukel, T; Apak, M; Heiman-Patterson, T; Ming, L; Bui, M; Fink, JK				Zhao, XP; Alvarado, D; Rainier, S; Lemons, R; Hedera, P; Weber, CH; Tukel, T; Apak, M; Heiman-Patterson, T; Ming, L; Bui, M; Fink, JK			Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia	NATURE GENETICS			English	Article							GUANYLATE-BINDING PROTEIN-1; DYNAMIN; RECEPTOR; ENDOCYTOSIS; IMPAIRMENT; DATABASE; PROGRAMS; FAMILY	The hereditary spastic paraplegias (HSPs; Strumpell-Lorrain syndrome, MIM number 18260) are a diverse class of disorders characterized by insidiously progressive lower-extremity spastic weakness (reviewed in refs. 1-3). Eight autosomal dominant HSP (ADHSP) loci have been identified, the most frequent of which is that linked to the SPG4 locus on chromosome 2p22 (found in -42%)(1), followed by that linked to the SPG3A locus on chromosome 14q11-q21 (in similar to9%)(1). Only SPG4 has been identified(4) as a causative gene in ADHSP. Its protein (spastin) is predicted to participate in the assembly or function of nuclear protein complexes(4). Here we report the identification of mutations in a newly identified GTPase gene, SPG3A, in ADHSP affected individuals.	Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Univ Istanbul, Inst Child Hlth, Div Med Genet, Istanbul, Turkey; Med Coll Penn & Hahnemann Univ, Sch Med, Dept Neurol, Philadelphia, PA USA; Ann Arbor Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Istanbul University; Drexel University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Fink, JK (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.			Hedera, Peter/0000-0003-2699-4085	NINDS NIH HHS [R01NS33645, R01NS36177, R01NS38713] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036177, R01NS033645, R01NS038713] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Della Rocca GJ, 1999, J BIOL CHEM, V274, P4749, DOI 10.1074/jbc.274.8.4749; Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507; Fink JK, 1999, SEMIN NEUROL, V19, P301, DOI 10.1055/s-2008-1040846; FINK JK, 2001, IN PRESS EMERY RIMOI, V4; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hedera P, 2000, NEUROLOGY, V55, P1591, DOI 10.1212/WNL.55.10.1591; Hedera P, 2001, PRENATAL DIAG, V21, P202, DOI 10.1002/1097-0223(200103)21:3<202::AID-PD4>3.0.CO;2-U; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Nicoziani P, 2000, MOL BIOL CELL, V11, P481, DOI 10.1091/mbc.11.2.481; NODA Y, 1993, NEUROSCIENCE, V55, P113, DOI 10.1016/0306-4522(93)90459-S; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; RAINER S, 2001, IN PRESS J MED GENET; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Vogler O, 1998, J BIOL CHEM, V273, P12155, DOI 10.1074/jbc.273.20.12155; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	30	259	280	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					326	331		10.1038/ng758	http://dx.doi.org/10.1038/ng758			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11685207				2022-12-27	WOS:000171911000021
J	Spelbrink, JN; Li, FY; Tiranti, V; Nikali, K; Yuan, QP; Tariq, M; Wanrooij, S; Garrido, N; Comi, G; Morandi, L; Santoro, L; Toscano, A; Fabrizi, GM; Somer, H; Croxen, R; Beeson, D; Poulton, L; Suomalainen, A; Jacobs, HT; Zeviani, M; Larsson, C				Spelbrink, JN; Li, FY; Tiranti, V; Nikali, K; Yuan, QP; Tariq, M; Wanrooij, S; Garrido, N; Comi, G; Morandi, L; Santoro, L; Toscano, A; Fabrizi, GM; Somer, H; Croxen, R; Beeson, D; Poulton, L; Suomalainen, A; Jacobs, HT; Zeviani, M; Larsson, C			Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene LF-like protein localized in mitochondria	NATURE GENETICS			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MULTIPLE DELETIONS; CRYSTAL-STRUCTURE; CATALYTIC SUBUNIT; HELICASE DOMAIN; BACTERIOPHAGE-T7; MTDNA; POLYMERASE; PRIMASE; YEAST	The gene products involved in mammalian mitochondrial DNA (mtDNA) maintenance and organization remain largely unknown. We report here a novel mitochondrial protein. Twinkle, with structural similarity to phage T7 gene 4 primase/helicase and other hexameric ring helicases. Twinkle colocalizes with mtDNA in mitochondrial nucleoids. Screening of the gene encoding Twinkle in individuals with autosomal dominant progressive external ophthalmoplegia (adPEO). associated with multiple mtDNA deletions, identified 11 different coding-region mutations co-segregating with the disorder in 12 adPEO pedigrees of various ethnic origins. The mutations duster in a region of the protein proposed to be involved in subunit interactions. The function of Twinkle is inferred to be critical for lifetime maintenance of human mtDNA integrity.	Karolinska Hosp, Dept Mol Med, S-17176 Stockholm, Sweden; Tampere Univ Hosp, Tampere, Finland; Inst Med Technol, Tampere, Finland; Natl Neurol Inst C Besta, Div Biochem & Genet, Milan, Italy; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Pakistan Inst Med Sci, Dept Neurol, Islamabad, Pakistan; Univ Milan, Sch Med, Inst Clin Neurol, Dino Ferrari Ctr, Milan, Italy; Natl Neurol Inst C Besta, Dept Neuromuscular Disorders, Milan, Italy; Univ Naples Federico II, Dept Neurol Sci, Naples, Italy; Univ Messina, Inst Clin Neurol, Messina, Italy; Univ Verona, Inst Clin Neurol, I-37100 Verona, Italy; Univ Helsinki, Dept Neurol, Helsinki, Finland; John Radcliffe Hosp, Neurosci Grp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DS, England; McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland	Karolinska Institutet; Karolinska University Hospital; Tampere University; Tampere University Hospital; IRCCS Istituto Neurologico Besta; Finland National Institute for Health & Welfare; Pakistan Institute of Medical Sciences; University of Milan; IRCCS Istituto Neurologico Besta; University of Naples Federico II; University of Messina; University of Verona; University of Helsinki; University of Oxford; University of Oxford; McGill University; University of Glasgow	Spelbrink, JN (corresponding author), Inst Med Technol, Tampere, Finland.		Comi, Giacomo P/K-5702-2016; Zeviani, Massimo/K-2891-2014; Zeviani, Massimo/AAU-2632-2021; Spelbrink, Johannes N/L-4661-2015; Wanrooij, Sjoerd/J-1367-2019; Tiranti, Valeria/J-8233-2016; Jacobs, Howard T/G-2434-2011; Tiranti, Valeria/AFN-5783-2022	Comi, Giacomo P/0000-0002-1383-5248; Zeviani, Massimo/0000-0002-9067-5508; Spelbrink, Johannes N/0000-0002-9756-2602; Tiranti, Valeria/0000-0002-3584-7338; Tiranti, Valeria/0000-0002-3584-7338; Jacobs, Howard/0000-0003-1895-6003; Santoro, Lucio/0000-0001-9507-2303; Wanrooij, Sjoerd/0000-0001-6126-4382; Poulton, Joanna/0000-0002-2460-5587; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195	Telethon [1180] Funding Source: Medline	Telethon(Fondazione Telethon)		Battey, 1986, BASIC METHODS MOL BI; Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; FOURY F, 1989, J BIOL CHEM, V264, P20552; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43; HEHMAN GL, 1992, P NATL ACAD SCI USA, V89, P8562, DOI 10.1073/pnas.89.18.8562; Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; Iyengar B, 1999, GENETICS, V153, P1809; Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445; Kornberg A., 1992, DNA REPLICATION; Kuroiwa T, 1998, INT REV CYTOL, V181, P1, DOI 10.1016/S0074-7696(08)60415-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4; Leipe DD, 2000, GENOME RES, V10, P5; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Li FY, 2001, FEBS LETT, V494, P79, DOI 10.1016/S0014-5793(01)02319-5; Li FY, 1999, NEUROLOGY, V53, P1265, DOI 10.1212/WNL.53.6.1265; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Melberg A, 1996, MUSCLE NERVE, V19, P751; MIYAKAWA I, 1987, J CELL SCI, V88, P431; Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; PATEL SS, 1993, J BIOL CHEM, V268, P10668; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Santorelli FM, 2000, J INHERIT METAB DIS, V23, P155, DOI 10.1023/A:1005617916260; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; ZEVIANI M, 1990, AM J HUM GENET, V47, P904; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; ZHANG PL, 1994, MOL CARCINOGEN, V9, P46, DOI 10.1002/mc.2940090109	49	628	643	1	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					223	231		10.1038/90058	http://dx.doi.org/10.1038/90058			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431692				2022-12-27	WOS:000169656400014
J	Baulac, S; Huberfeld, G; Gourfinkel-An, I; Mitropoulou, G; Beranger, A; Prud'homme, JF; Baulac, M; Brice, A; Bruzzone, R; LeGuern, E				Baulac, S; Huberfeld, G; Gourfinkel-An, I; Mitropoulou, G; Beranger, A; Prud'homme, JF; Baulac, M; Brice, A; Bruzzone, R; LeGuern, E			First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma 2-subunit gene	NATURE GENETICS			English	Article							FEBRILE SEIZURES PLUS; POTASSIUM CHANNEL GENE; GENERALIZED EPILEPSY; SUBUNIT; FAMILY; LOCUS; IDENTIFICATION; DISEASE; MAPS	Major advances in the identification of genes implicated in idiopathic epilepsy have been made. Generalized epilepsy with febrile seizures plus (GEFS+), benign familiar neonatal convulsions and nocturnal frontal lobe epilepsy, three autosomal dominant idiopathic epilepsies, result from mutations affecting voltage-gated sodium and potassium channels, and nicotinic acetylcholine receptors, respectively(1-6), Disruption of GABAergic neurotransmission mediated by gamma -aminobutyric acid (GABA) has been implicated in epilepsy for many decades(7). We now report a K289M mutation in the GABA(A) receptor gamma2-subunit gene (GABRG2) that segregates in a family with a phenotype closely related to GEFS+ (ref. 8), an autosomal dominant disorder associating febrile seizures and generalized epilepsy previously linked to mutations in sodium channel genes(1,2). The K289M mutation affects a highly conserved residue located in the extracellular loop between transmembrane segments M2 and M3. Analysis of the mutated and wild-type alleles in Xenopus laevis oocytes confirmed the predicted effect of the mutation, a decrease in the amplitude of GABA-activated currents. We thus provide the first genetic evidence that a GABA(A) receptor is directly involved in human idiopathic epilepsy.	Hop La Pitie Salpetriere, INSERM, U289, Paris, France; Hop La Pitie Salpetriere, Ctr Epileptol, Paris, France; Hop La Pitie Salpetriere, Dept Genet Cytogenet & Embryol, Paris, France; Genethon, Evry, France; Inst Pasteur, NRSN, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	LeGuern, E (corresponding author), Hop La Pitie Salpetriere, INSERM, U289, Paris, France.		brice, alexis/AAE-8275-2019; Baulac, Stéphanie/O-2099-2016; Bruzzone, Roberto/G-9355-2017; Bruzzone, Roberto/C-4719-2009; Brice, Alexis/A-2170-2009	brice, alexis/0000-0002-0941-3990; Baulac, Stéphanie/0000-0001-6430-4693; Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; 				Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Boileau AJ, 1999, J NEUROSCI, V19, P10213; CASTRO RAMIREZ L.C., 2010, NAT GENET, VXXXI, P33; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Elmslie FV, 1996, J MED GENET, V33, P435, DOI 10.1136/jmg.33.5.435; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Kostrzewa M, 1996, EUR J HUM GENET, V4, P199; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Lopes-Cendes I, 2000, AM J HUM GENET, V66, P698, DOI 10.1086/302768; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; Moulard B, 1999, AM J HUM GENET, V65, P1396, DOI 10.1086/302621; Olsen R W, 1999, Adv Neurol, V79, P499; Ressot C, 1998, J NEUROSCI, V18, P4063; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; Sigel E, 1999, J NEUROCHEM, V73, P1758, DOI 10.1046/j.1471-4159.1999.731758.x; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; WILCOX AS, 1992, P NATL ACAD SCI USA, V89, P5857, DOI 10.1073/pnas.89.13.5857	21	612	649	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					46	48		10.1038/88254	http://dx.doi.org/10.1038/88254			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326274				2022-12-27	WOS:000168413300014
J	Kalantry, S; Manning, S; Haub, O; Tomihara-Newberger, C; Lee, HG; Fangman, J; Disteche, CM; Manova, K; Lacy, E				Kalantry, S; Manning, S; Haub, O; Tomihara-Newberger, C; Lee, HG; Fangman, J; Disteche, CM; Manova, K; Lacy, E			The amnionless gene, essential for mouse gastrulation, encodes a visceral-endoderm-specific protein with an extracellular cysteine-rich domain	NATURE GENETICS			English	Article							SNARE COMPLEX; EMBRYO; EMBRYOGENESIS; DROSOPHILA; DISRUPTION; LETHALITY; RECEPTOR; CHORDIN; MICE	Fate-mapping experiments in the mouse have revealed that the primitive streak can be divided into three functional regions': the proximal region gives rise to germ cells and the extra-embryonic mesoderm of the yolk sac; the distal region generates cardiac mesoderm and node-derived axial mesendoderm; and the middle streak region produces the paraxial, intermediate and lateral plate mesoderm of the trunk. To gain insight into the mechanisms that mediate the assembly of the primitive streak into these functional regions, we have cloned and functionally identified the gene disrupted in the amnionless (amn) mouse, which has a recessive, embryonic lethal mutation that interferes specifically with the formation and/or specification of the middle primitive streak region during gastrulation(2). Here we report that the gene Amn encodes a novel type I transmembrane protein that is expressed exclusively in the extra-embryonic visceral endoderm layer during gastrulation. The extracellular region of the Amn protein contains a cysteine-rich domain with similarity to bone morphogenetic protein (BMP)-binding cysteine-rich domains in chordin, its Drosophila melanogaster homolog (Short: gastrulation) and procollagen IIA (ref. 3). Our findings indicate that Amn may direct the production of trunk mesoderm derived from the middle streak by acting in the underlying visceral endoderm to modulate a BMP signaling pathway.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Mol Biol Grad Program, New York, NY USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Memorial Sloan Kettering Cancer Center; Cornell University; University of Washington; University of Washington Seattle	Lacy, E (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.			Lacy, Elizabeth/0000-0001-5457-0728	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058726] Funding Source: NIH RePORTER; NCI NIH HHS [CA-08748] Funding Source: Medline; NIGMS NIH HHS [GM58726] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Conley CA, 2000, DEVELOPMENT, V127, P3947; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; EDELHOFF S, 1994, ONCOGENE, V9, P665; Godwin AR, 1998, P NATL ACAD SCI USA, V95, P13042, DOI 10.1073/pnas.95.22.13042; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Katz L, 1998, EMBO J, V17, P6200, DOI 10.1093/emboj/17.21.6200; Kolle G, 2000, MECH DEVELOP, V90, P181, DOI 10.1016/S0925-4773(99)00248-8; Kopczynski CC, 1998, P NATL ACAD SCI USA, V95, P9973, DOI 10.1073/pnas.95.17.9973; Larrain J, 2000, DEVELOPMENT, V127, P821; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; MANOVA K, 1992, J NEUROSCI, V12, P4663; Matsui M, 2000, P NATL ACAD SCI USA, V97, P5291, DOI 10.1073/pnas.090020497; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Rossi G, 1997, J BIOL CHEM, V272, P16610, DOI 10.1074/jbc.272.26.16610; Tomihara-Newberger C, 1998, DEV BIOL, V204, P34, DOI 10.1006/dbio.1998.9034; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wang X, 1996, DEV BIOL, V177, P274, DOI 10.1006/dbio.1996.0162; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yu K, 2000, DEVELOPMENT, V127, P2143; Zhang HB, 1996, DEVELOPMENT, V122, P2977	23	106	109	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					412	416		10.1038/86912	http://dx.doi.org/10.1038/86912			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279523				2022-12-27	WOS:000167811200016
J	Guy, J; Hendrich, B; Holmes, M; Martin, JE; Bird, A				Guy, J; Hendrich, B; Holmes, M; Martin, JE; Bird, A			A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome	NATURE GENETICS			English	Letter							HISTONE DEACETYLASE COMPLEX; BINDING-PROTEIN MECP2; TRANSCRIPTIONAL REPRESSOR; CHROMOSOMAL PROTEIN; METHYLATED DNA; GENE; IDENTIFICATION; LOCALIZATION; SEQUENCE; GIRLS	Rett syndrome (RTT) is an inherited neurodevelopmental disorder of females that occurs once in 10,000-15,000 births(1,2) Affected females develop normally for 6-18 months, but then lose voluntary movements, including speech and hand skills. Most RTT patients are heterozygous for mutations in the X-linked gene MECP2 (refs, 3-12), encoding a protein that binds to methylated sites in genomic DNA and facilitates gene silencing(13-17). Previous work with Mecp2-null embryonic stem cells indicated that MeCP2 is essential for mouse embryogenesis(18) Here we generate mice lacking Mecp2 using Cre-loxP technology. Both Mecp2-null mice and mice in which Mecp2 was deleted in brain showed severe neurological symptoms at approximately six weeks of age. Compensation for absence of MeCP2 in other tissues by MeCP1 (refs, 19,20) was not apparent in genetic or biochemical tests. After several months, heterozygous female mice also showed behavioral symptoms. The overlapping delay before symptom onset in humans and mice, despite their profoundly different rates of development, raises the possibility that stability of brain function, not brain development per se, is compromised by the absence of MeCP2.	Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Ctr Cell Biol, Edinburgh, Midlothian, Scotland; Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; Queen Mary Univ London, Royal London Hosp, St Bartholomews & Royal London Sch Med & Dent, Inst Pathol, London E1 4NS, England	University of Edinburgh; University of Edinburgh; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London	Bird, A (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Ctr Cell Biol, Kings Bldg, Edinburgh, Midlothian, Scotland.	a.bird@ed.ac.uk	Hendrich, Brian/AAG-5898-2020	Hendrich, Brian/0000-0002-0231-3073; Bird, Adrian/0000-0002-8600-0372; Guy, Jacky/0000-0002-8440-5667				Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Buyse IM, 2000, AM J HUM GENET, V67, P1428, DOI 10.1086/316913; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; FREE A, IN PRESS J BIOL CHEM; Fujita N, 1999, MOL CELL BIOL, V19, P6415; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hampson K, 2000, J MED GENET, V37, P610, DOI 10.1136/jmg.37.8.610; HENDRICH B, IN PRESS GENES DEV; Huppke P, 2000, HUM MOL GENET, V9, P1369, DOI 10.1093/hmg/9.9.1369; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Obata K, 2000, J MED GENET, V37, P608, DOI 10.1136/jmg.37.8.608; Rett A, 1966, Wien Med Wochenschr, V116, P723; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tate P, 1996, NAT GENET, V12, P205, DOI 10.1038/ng0296-205; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172	31	1134	1173	4	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					322	326		10.1038/85899	http://dx.doi.org/10.1038/85899			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242117	Green Published			2022-12-27	WOS:000167304200027
J	Nicole, S; Davoine, CS; Topaloglu, H; Cattolico, L; Barral, D; Beighton, P; Ben Hamida, C; Hammouda, H; Cruaud, C; White, PS; Samson, D; Urtizberea, JA; Lehmann-Horn, F; Weissenbach, J; Hentati, F; Fontaine, B				Nicole, S; Davoine, CS; Topaloglu, H; Cattolico, L; Barral, D; Beighton, P; Ben Hamida, C; Hammouda, H; Cruaud, C; White, PS; Samson, D; Urtizberea, JA; Lehmann-Horn, F; Weissenbach, J; Hentati, F; Fontaine, B			Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)	NATURE GENETICS			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; EPIDERMAL-GROWTH-FACTOR; DENSITY-LIPOPROTEIN RECEPTOR; CELL-ADHESION MOLECULES; SYNDROME SJS; TENASCIN-R; GENE; CARTILAGE; LAMININ; MATRIX	Schwartz-Jampel syndrome (SJS1) is a rare autosomal recessive disorder characterized by permanent myotonia (prolonged failure of muscle relaxation) and skeletal dysplasia, resulting in reduced stature, kyphoscoliosis, bowing of the diaphyses and irregular epiphyses(1). Electromyographic investigations reveal repetitive muscle discharges, which may originate from both neurogenic and myogenic alterations(2,3). We previously localized the SJS1 locus to chromosome 1p34-p36.1 and found no evidence of genetic heterogeneity(4,5). Here we describe mutations, including missense and splicing mutations, of the gene encoding perlecan (HSPG2) in three SJS1 families. In so doing, we have identified the first human mutations in HSPG2, which underscore the importance of perlecan not only in maintaining cartilage integrity but also in regulating muscle excitability.	Fac Med Pitie Salpetriere, INSERM CJF9711, Paris, France; Hacettepe Univ, Fac Med, Dept Paediat Neurol, TR-06100 Ankara, Turkey; Genoscope, Evry, France; Univ Cape Town, Dept Human Genet, ZA-7700 Rondebosch, South Africa; Inst Natl Neurol, Tunis, Tunisia; Genethon, Evry, France; Childrens Hosp, Div Oncol, Philadelphia, PA 19104 USA; Grp Hosp Pitie Salpetriere, Inst Myol, F-75634 Paris, France; Univ Ulm, Dept Physiol, Ulm, Germany; Grp Hosp Pitie Salpetriere, Federat Neurol, F-75634 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Hacettepe University; University of Cape Town; Universite de Tunis-El-Manar; Institut National de Neurologie; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Ulm University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Fontaine, B (corresponding author), Fac Med Pitie Salpetriere, INSERM CJF9711, Paris, France.		Barral, Duarte/E-7548-2013; TOPALOGLU, HALUK AYDIN/I-9318-2013; NICOLE, Sophie/N-4348-2018	Barral, Duarte/0000-0001-8867-2407; NICOLE, Sophie/0000-0001-8793-7928; Cruaud, Corinne/0000-0002-4752-7278; Steinbach, Delphine/0000-0001-7144-7908				ABERFELD DC, 1965, BRAIN, V88, P313, DOI 10.1093/brain/88.2.313; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; BENHAMIDA M, 1991, REV NEUROL, V147, P279; CADILHAC J, 1975, Electromyography and Clinical Neurophysiology, V15, P5; Christova LG, 1999, J NEUROL NEUROSUR PS, V66, P252, DOI 10.1136/jnnp.66.2.252; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; COUCHMAN JR, 1989, MATRIX, V9, P311, DOI 10.1016/S0934-8832(89)80007-1; Fontaine B, 1996, HUM GENET, V98, P380, DOI 10.1007/s004390050225; Fontaine B, 1997, MOL ASPECTS MED, V18, P415, DOI 10.1016/S0098-2997(97)00050-2; Hansen PM, 1997, DIABETES, V46, P1658, DOI 10.2337/diacare.46.10.1658; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; KALLUNKI P, 1992, J CELL BIOL, V116, P559, DOI 10.1083/jcb.116.2.559; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; NICOLE S, 1995, HUM MOL GENET, V4, P1633, DOI 10.1093/hmg/4.9.1633; NOONAN DM, 1993, KIDNEY INT, V43, P53, DOI 10.1038/ki.1993.10; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; ROGALSKI TM, 1995, GENETICS, V139, P159; SCHULZE B, 1995, EUR J BIOCHEM, V231, P551, DOI 10.1111/j.1432-1033.1995.tb20731.x; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; SUNDARRAJ N, 1995, J CELL SCI, V108, P2663; VanDijk JG, 1996, MUSCLE NERVE, V19, P1127; VILJOEN D, 1992, J MED GENET, V29, P58, DOI 10.1136/jmg.29.1.58; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511	27	187	198	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					480	483		10.1038/82638	http://dx.doi.org/10.1038/82638			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101850				2022-12-27	WOS:000165671700025
J	Bamford, RN; Roessler, E; Burdine, RD; Saplakoglu, U; dela Cruz, J; Splitt, M; Towbin, J; Bowers, P; Marino, B; Schier, AF; Shen, MM; Muenke, M; Casey, B				Bamford, RN; Roessler, E; Burdine, RD; Saplakoglu, U; dela Cruz, J; Splitt, M; Towbin, J; Bowers, P; Marino, B; Schier, AF; Shen, MM; Muenke, M; Casey, B			Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects	NATURE GENETICS			English	Article							LEFT-RIGHT AXIS; ONE-EYED PINHEAD; GASTRULATION; ZEBRAFISH; MALFORMATIONS; MESODERM	Ail vertebrates display a characteristic asymmetry of internal organs with the cardiac apex, stomach and spleen towards the left, and the liver and gall bladder on the right(1-3). Left-right (L-R) axis abnormalities or laterality defects are common in humans (1 in 8,500 live births). Several genes (such as Nodal, Ebaf and Pitx2) have been implicated in L-R organ positioning in model organisms(2-4), In humans, relatively few genes have been associated with a small percentage of human situs defects. These include ZIC3 (ref. 5), LEFTB (formerly LEFTY2; ref. 6) and ACVR2B (encoding activin receptor IIB; ref, 7). The EGF-CFC genes(8), mouse Cfc1 (encoding the Cryptic protein; ref. 9) and zebrafish one-eyed pinhead (oep; refs 10,11) are essential for the establishment of the L-R axis(12,13). EGF-CFC proteins act as co-factors for Nodal-related signals(11), which have also been implicated in L-R axis development(4). Here we identify loss-of-function mutations in human CFC1 (encoding the CRYPTIC protein) in patients with heterotaxic phenotypes (randomized organ positioning). The mutant proteins have aberrant cellular localization in transfected cells and are functionally defective in a zebrafish oepmutant rescue assay. Our findings indicate that the essential role of EGF-CFC genes and Nodal signalling in left-right axis formation is conserved from fish to humans. Moreover, our results support a role for environmental and/or genetic modifiers in determining the ultimate phenotype in humans.	NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Dev Genet Program, New York, NY 10016 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08854 USA; Univ Newcastle Upon Tyne, Dept Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; Bambino Gesu Childrens Hosp, Dept Cardiol, Rome, Italy; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); New York University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Newcastle University - UK; Baylor College of Medicine; Yale University; IRCCS Bambino Gesu; Baylor College of Medicine	Muenke, M (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.		Shen, Michael M/C-7546-2009; Towbin, Jeffrey A./J-5595-2019	Shen, Michael M/0000-0002-4042-1657; Towbin, Jeffrey A./0000-0002-6585-714X; Burdine, Rebecca/0000-0001-6620-5015; Muenke, Maximilian/0000-0002-7719-6545; Schier, Alexander Franz/0000-0001-7645-5325				Burdine RD, 2000, GENE DEV, V14, P763; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; COLLIGNON DB, 1996, NATURE, V3881, P155; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Kane DA, 1996, DEVELOPMENT, V123, P47; Kosaki K, 1998, SEMIN CELL DEV BIOL, V9, P89, DOI 10.1006/scdb.1997.0187; Kosaki K, 1999, AM J HUM GENET, V64, P712, DOI 10.1086/302289; Kosaki R, 1999, AM J MED GENET, V82, P70, DOI 10.1002/(SICI)1096-8628(19990101)82:1<70::AID-AJMG14>3.0.CO;2-Y; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Minchiotti G, 2000, MECH DEVELOP, V90, P133, DOI 10.1016/S0925-4773(99)00235-X; NIIKAWA N, 1983, AM J MED GENET, V16, P43, DOI 10.1002/ajmg.1320160108; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Osada SI, 2000, DEVELOPMENT, V127, P2503; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shen MM, 1997, DEVELOPMENT, V124, P429; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	22	254	271	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					365	369		10.1038/81695	http://dx.doi.org/10.1038/81695			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062482				2022-12-27	WOS:000165176500031
J	Jacob, S; McClintock, MK; Zelano, B; Ober, C				Jacob, S; McClintock, MK; Zelano, B; Ober, C			Paternally inherited HLA alleles are associated with women's choice of male odor	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MATING PREFERENCES; MICE; RECOGNITION; HUMANS; MOUSE; GENES; INFORMATION; MOLECULES; PATTERNS	The major histocompatibility complex (MHC) is a source of unique individual odors that influence individual recognition, mating preferences, nesting behavior and selective block of pregnancy in animals(1-10). Such phenomena have been difficult to study in humans, because the human leukocyte antigen (HLA, human MHC loci are the most polymorphic loci in the human genome(11), with the potential to generate millions of unique combinations of genotypes. In addition, high variability in background odors, encoded by the rest of the genome and influenced by cultural practices, contribute to a low signal-to-noise ratio that could mask HLA-based olfactory cues. Here we show that women can detect differences of one HLA allele among male odor donors with different MHC genotypes. Notably, the mechanism for a woman's ability to discriminate and choose odors is based on HLA alleles inherited from her father but not her mother. The parents' HLA alleles that she does not inherit show no relationship with odor choice, despite exposure to these HLA-encoded odors throughout her life. Our data indicate that paternally inherited HLA-associated odors influence odor preference and may serve as social cues.	Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	McClintock, MK (corresponding author), Univ Chicago, Inst Mind & Biol, 5730 S Woodlawn Ave, Chicago, IL 60637 USA.	mkm1@midway.uchicago.edu	Jacob, Suma/J-7941-2013	Jacob, Suma/0000-0001-7434-7398	NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH082121] Funding Source: NIH RePORTER; NIMH NIH HHS [K23 MH082121] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amadou C, 1999, IMMUNOL REV, V167, P211, DOI 10.1111/j.1600-065X.1999.tb01394.x; Bateson P., 1983, P257; BEAUCHAMP GK, 1985, P NATL ACAD SCI USA, V82, P4186, DOI 10.1073/pnas.82.12.4186; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BROWN RE, 1987, PHYSIOL BEHAV, V40, P65, DOI 10.1016/0031-9384(87)90186-7; Devos M., 1990, STANDARDIZED HUMAN O; EGID K, 1989, ANIM BEHAV, V38, P548, DOI 10.1016/S0003-3472(89)80051-X; EKLUND A, 1991, ANIM BEHAV, V42, P693, DOI 10.1016/S0003-3472(05)80254-4; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; GILBERT AN, 1986, J COMP PSYCHOL, V100, P262, DOI 10.1037/0735-7036.100.3.262; GILDER PM, 1978, NATURE, V274, P364, DOI 10.1038/274364a0; HERRICK CJ, 1924, NEUROLOGICAL FDN BEH; Isles AR, 2001, NATURE, V409, P783, DOI 10.1038/35057323; MANNING CJ, 1992, NATURE, V360, P581, DOI 10.1038/360581a0; MCCARTY R, 1977, BEHAV BIOL, V19, P255, DOI 10.1016/S0091-6773(77)91542-5; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; OBER C, 1999, CHEM SIGNALS VERTEBR, V8, P189; Ochoa G, 1999, J THEOR BIOL, V199, P1, DOI 10.1006/jtbi.1999.0931; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Pause BM, 1996, BIOL PSYCHOL, V44, P31, DOI 10.1016/S0301-0511(96)05207-6; Pearse-Pratt R, 1998, GENETICA, V104, P223, DOI 10.1023/A:1026489524199; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; QUADAGNO DM, 1970, ANIM BEHAV, V18, P379, DOI 10.1016/S0003-3472(70)80051-3; SCHAAL B, 1991, ADV STUD BEHAV, V20, P135, DOI 10.1016/S0065-3454(08)60321-6; Schaefer ML, 2001, J NEUROSCI, V21, P2481, DOI 10.1523/JNEUROSCI.21-07-02481.2001; SMITH K, 2000, DEP PSYCHOL, P167; VINCENT C, 1979, TRANSPLANT P, V11, P1301; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; Weitkamp LR, 1999, IMMUNOGENETICS, V49, P491, DOI 10.1007/s002510050525; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1979, J EXP MED, V150, P755, DOI 10.1084/jem.150.4.755; YAMAZAKI K, 1988, SCIENCE, V240, P1331, DOI 10.1126/science.3375818; YAMAZAKI K, 1983, SCIENCE, V221, P186, DOI 10.1126/science.6857281; YAMAZAKI K, 1999, CHEM SIGNALS VERTEBR, V8, P173	38	293	306	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					175	179		10.1038/ng830	http://dx.doi.org/10.1038/ng830			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11799397				2022-12-27	WOS:000173708700017
J	Nordborg, M; Borevitz, JO; Bergelson, J; Berry, CC; Chory, J; Hagenblad, J; Kreitman, M; Maloof, JN; Noyes, T; Oefner, PJ; Stahl, EA; Weigel, D				Nordborg, M; Borevitz, JO; Bergelson, J; Berry, CC; Chory, J; Hagenblad, J; Kreitman, M; Maloof, JN; Noyes, T; Oefner, PJ; Stahl, EA; Weigel, D			The extent of linkage disequilibrium in Arabidopsis thaliana	NATURE GENETICS			English	Article							FLOWERING TIME; POPULATIONS; LOCUS; POLYMORPHISMS; ECOTYPES; RECOMBINATION; DIVERGENCE; DIVERSITY; GENES	Linkage disequilibrium (LD), the nonrandom occurrence of alleles in haplotypes, has long been of interest to population geneticists. Recently, the rapidly increasing availability of genomic polymorphism data has fueled interest in LD as a tool for fine-scale mapping, in particular for human disease loci(1). The chromosomal extent of LD is crucial in this context, because it determines how dense a map must be for associations to be detected and, conversely, limits how finely loci may be mapped(2). Arabidopsis thaliana is expected to harbor unusually extensive LD because of its high degree of selfing(3). Several polymorphism studies have found very strong LD within individual loci, but also evidence of some recombination(4-6). Here we investigate the pattern of LD on a genomic scale and show that in global samples, LD decays within approximately 1 cM, or 250 kb. We also show that LD in local populations may be much stronger than that of global populations, presumably as a result of founder events. The combination of a relatively high level of polymorphism and extensive haplotype structure bodes well for developing a genome-wide LD map in A. thaliana.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; Howard Hughes Med Inst, La Jolla, CA USA; Lund Univ, Dept Genet, S-22362 Lund, Sweden; Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany	University of Southern California; Salk Institute; University of Chicago; University of California System; University of California San Diego; Howard Hughes Medical Institute; Lund University; Stanford University; Max Planck Society	Nordborg, M (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.		Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022; Borevitz, Justin/B-5423-2012; Weigel, Detlef/AAR-3312-2021	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Borevitz, Justin/0000-0001-8408-3699; Maloof, Julin/0000-0002-9623-2599; Bergelson, Joy/0000-0001-7893-7387; Hagenblad, Jenny/0000-0002-9850-5546; Nordborg, Magnus/0000-0001-7178-9748				ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; Aguade M, 2001, MOL BIOL EVOL, V18, P1, DOI 10.1093/oxfordjournals.molbev.a003714; Altshuler D, 2000, NAT GENET, V26, P135, DOI 10.1038/79839; Bergelson J, 1998, GENETICS, V148, P1311; Breyne P, 1999, MOL GEN GENET, V261, P627, DOI 10.1007/s004380050005; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cho RJ, 1999, NAT GENET, V23, P203, DOI 10.1038/13833; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; HANFSTINGL U, 1994, GENETICS, V138, P811; Innan H, 1996, GENETICS, V143, P1761; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; KING G, 1993, THEOR APPL GENET, V86, P1028, DOI 10.1007/BF00211057; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Long AD, 1998, GENETICS, V149, P999; Miyashita NT, 1999, GENETICS, V152, P1723; Noel L, 1999, PLANT CELL, V11, P2099, DOI 10.1105/tpc.11.11.2099; Nordborg M, 1997, GENETICS, V146, P1501; Nordborg M, 1999, AM J BOT, V86, P470, DOI 10.2307/2656807; Nordborg M, 2000, GENETICS, V154, P923; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; TODOKORO S, 1995, JPN J GENET, V70, P543, DOI 10.1266/jjg.70.543; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	29	362	390	3	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					190	193		10.1038/ng813	http://dx.doi.org/10.1038/ng813			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11780140				2022-12-27	WOS:000173708700020
J	Gamse, JT; Shen, YC; Thisse, C; Thisse, B; Raymond, PA; Halpern, ME; Liang, JO				Gamse, JT; Shen, YC; Thisse, C; Thisse, B; Raymond, PA; Halpern, ME; Liang, JO			Otx5 regulates genes that show circadian expression in the zebrafish pineal complex	NATURE GENETICS			English	Article							HOMEODOMAIN PROTEIN; XENOPUS-LAEVIS; HOMEOBOX GENE; CLOCK; CRX; CLONING; FOREBRAIN; ANTERIOR; ELEMENT; RETINA	The photoneuroendocrine system translates environmental light conditions into the circadian production of endocrine and neuroendocrine signals. Central to this process is the pineal organ, which has a conserved role in the cyclical synthesis and release of melatonin to influence sleep patterns and seasonal reproduction(1). In lower vertebrates, the pineal organ contains photoreceptors; whose activity entrains an endogenous circadian clock and regulates transcription in pinealocytes(1). in mammals, pineal function is influenced by retinal photoreceptors that project to the suprachiasmatic nucleus-the site of the endogenous circadian clock. A multisynaptic pathway then relays information about circadian rhythmicity and photoperiod to the pineal organ(1). The gene cone rod homeobox (crx), a member of the orthodenticle homeobox (otx) family, is thought to regulate pineal circadian activity. In the mouse, targeted inactivation of Crx causes a reduction in pineal gene expression and attenuated entrainment to light/dark cycles(2). Here we show that crx and otx5 orthologs are expressed in both the pineal organ and the asymmetrically positioned parapineal of larval zebrafish. Circadian gene expression is unaffected by a reduction in Crx expression but is inhibited specifically by depletion of Otx5. Our results indicate that Otx5 rather than Crx regulates genes that show circadian expression in the zebrafish pineal complex.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; ULP CU, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Carnegie Institution for Science; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Halpern, ME (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.			Raymond, Pamela/0000-0003-1083-5530; THISSE, Christine/0000-0002-8684-1681				Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Bobola N, 1999, MECH DEVELOP, V82, P165, DOI 10.1016/S0925-4773(98)00162-2; BORG B, 1983, ACTA ZOOL-STOCKHOLM, V64, P211, DOI 10.1111/j.1463-6395.1983.tb00802.x; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Chuang JC, 1999, MECH DEVELOP, V84, P195, DOI 10.1016/S0925-4773(99)00077-5; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; Delaunay F, 2000, SCIENCE, V289, P297, DOI 10.1126/science.289.5477.297; Foulkes NS, 1996, P NATL ACAD SCI USA, V93, P14140, DOI 10.1073/pnas.93.24.14140; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; Guillaumond F, 2000, J NEUROCHEM, V75, P1398, DOI 10.1046/j.1471-4159.2000.0751398.x; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Korf H.-W., 1998, Advances in Anatomy Embryology and Cell Biology, V146, P1; Kuroda H, 2000, DEV GROWTH DIFFER, V42, P87; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; Liang JO, 2000, DEVELOPMENT, V127, P5101; Liu YH, 2001, INVEST OPHTH VIS SCI, V42, P481; Masai I, 1997, NEURON, V18, P43, DOI 10.1016/S0896-6273(01)80045-3; MORI H, 1994, MOL BRAIN RES, V27, P221, DOI 10.1016/0169-328X(94)90004-3; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Sakamoto K, 1999, NEUROSCI LETT, V261, P101, DOI 10.1016/S0304-3940(99)00008-7; Stenkamp D L, 1998, Mol Vis, V4, P26; Vignali R, 2000, MECH DEVELOP, V96, P3, DOI 10.1016/S0925-4773(00)00367-1; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	30	137	140	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					117	121		10.1038/ng793	http://dx.doi.org/10.1038/ng793			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11753388				2022-12-27	WOS:000173105600025
J	Ge, H; Liu, ZH; Church, GM; Vidal, M				Ge, H; Liu, ZH; Church, GM; Vidal, M			Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae	NATURE GENETICS			English	Article							EXPRESSION; GENOMES; YEAST	Genomic and proteomic approaches can provide hypotheses concerning function for the large number of genes predicted from genome sequences(1-5). Because of the artificial nature of the assays, however, the information from these high-throughput approaches should be considered with caution. Although it is possible that more meaningful hypotheses could be formulated by integrating the data from various functional genomic and proteomic projects(6), it has yet to be seen to what extent the data can be correlated and how such integration can be achieved. We developed a 'transcriptome-interactome correlation mapping' strategy to compare the interactions between proteins encoded by genes that belong to common expression-profiling clusters with those between proteins encoded by genes that belong to different clusters. Using this strategy with currently available data sets for Saccharomyces cerevisiae, we provide the first global evidence that genes with similar expression profiles are more likely to encode interacting proteins. We show how this correlation between transcriptome and interactome data can be used to improve the quality of hypotheses based on the information from both approaches. The strategy described here may help to integrate other functional genomic and proteomic data, both in yeast and in higher organisms.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol, Boston, MA USA; Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA USA; Harvard Univ, Sch Med, Lipper Ctr Computat Genet, Boston, MA USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Vidal, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.			church, george/0000-0001-6232-9969	NHGRI NIH HHS [1 RO1 HG01715-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Hartigan J., 1975, CLUSTERING ALGORITHM; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Kumar A, 2001, NAT REV GENET, V2, P302, DOI 10.1038/35066084; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Padilla PA, 1998, J BACTERIOL, V180, P5718, DOI 10.1128/JB.180.21.5718-5726.1998; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Sternberg PW, 2001, CELL, V105, P173, DOI 10.1016/S0092-8674(01)00308-7; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107	18	445	468	2	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					482	486		10.1038/ng776	http://dx.doi.org/10.1038/ng776			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11694880				2022-12-27	WOS:000172507500027
J	Pilpel, Y; Sudarsanam, P; Church, GM				Pilpel, Y; Sudarsanam, P; Church, GM			Identifying regulatory networks by combinatorial analysis of promoter elements	NATURE GENETICS			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CELL-CYCLE; COMPUTATIONAL ANALYSIS; EXCISION-REPAIR; GENOMIC SCALE; IDENTIFICATION; SEQUENCES; DATABASE	Several computational methods based on microarray data are currently used to study genome-wide transcriptional regulation. Few studies, however, address the combinatorial nature of transcription, a well-established phenomenon in eukaryotes. Here we describe a new approach using microarray data to uncover novel functional motif combinations in the promoters of Saccharomyces cerevisiae. In addition to identifying novel motif combinations that affect expression patterns during the cell cycle, sporulation and various stress responses, we observed regulatory cross-talk among several of these processes. We have also generated motif-association maps that provide a global view of transcription networks. The maps are highly connected, suggesting that a small number of transcription factors are responsible for a complex set of expression patterns in diverse conditions. This approach may be useful for modeling transcriptional regulatory networks in more complex eukaryotes.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Lipper Ctr Computat Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.			church, george/0000-0001-6232-9969				Aach J, 2000, GENOME RES, V10, P431, DOI 10.1101/gr.10.4.431; ARNDT KT, 1987, SCIENCE, V237, P874, DOI 10.1126/science.3303332; Brazma A, 1998, GENOME RES, V8, P1202, DOI 10.1101/gr.8.11.1202; BULYK ML, 2001, P NATL ACAD SCI US, V12; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DEQUARDCHABLAT M, 1991, J BIOL CHEM, V266, P15300; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fickett JW, 2000, CURR OPIN BIOTECH, V11, P19, DOI 10.1016/S0958-1669(99)00049-X; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; KEI OV, 1995, NUCLEIC ACIDS RES, V23, P4097; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Leem SH, 1998, NUCLEIC ACIDS RES, V26, P3154, DOI 10.1093/nar/26.13.3154; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Oehlen LJWM, 1996, MOL CELL BIOL, V16, P2830; Quandt K, 1996, GENOMICS, V33, P301, DOI 10.1006/geno.1996.0197; Reed SH, 1999, GENE DEV, V13, P3052, DOI 10.1101/gad.13.23.3052; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Umemura K, 1997, EUR J BIOCHEM, V243, P748, DOI 10.1111/j.1432-1033.1997.00748.x; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Wagner A, 1999, BIOINFORMATICS, V15, P776, DOI 10.1093/bioinformatics/15.10.776; Wang J, 1999, J MOL BIOL, V286, P315, DOI 10.1006/jmbi.1998.2489; Werner T, 1999, MAMM GENOME, V10, P168, DOI 10.1007/s003359900963; Wolfsberg TG, 1999, GENOME RES, V9, P775; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	39	472	497	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					153	159		10.1038/ng724	http://dx.doi.org/10.1038/ng724			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11547334				2022-12-27	WOS:000171374100020
J	Pasqualetti, M; Neun, R; Davenne, M; Rijli, FM				Pasqualetti, M; Neun, R; Davenne, M; Rijli, FM			Retinoic acid rescues inner ear defects in Hoxa1 deficient mice	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; SEGMENTATION MUTANT; MOUSE HINDBRAIN; 2 RHOMBOMERES; EXPRESSION; PROTEIN; GENES; TRANSFORMATION; BOUNDARIES; INDUCTION	Little is known about the genetic pathways involved in the early steps of inner ear morphogenesis. Hoxa1 is transiently expressed in the developing hindbrain; its targeted inactivation in mice results in severe abnormalities of the otic capsule and membranous labyrinth(1). Here we show that a single maternal administration of a low dose of the vitamin A metabolite retinoic acid is sufficient to compensate the requirement for Hoxa1 function. It rescues cochlear and vestibular defects in mutant fetuses without affecting the development of the wildtype fetuses. These results identify a temporal window of susceptibility to retinoids that is critical for mammalian inner ear specification, and provide the first evidence that a subteratogenic dose of vitamin A derivative can be effective in rescuing a congenital defect in the mammalian embryo.	Coll France, ULP, INSERM, CNRS,Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rijli, FM (corresponding author), Coll France, ULP, INSERM, CNRS,Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	rijli@igbmc.u-strasbg.fr	Pasqualetti, Massimo/F-8682-2012; RIJLI, Filippo/AAP-2516-2020	RIJLI, Filippo/0000-0003-0515-0182; Pasqualetti, Massimo/0000-0002-0844-8139				Brigande JV, 2000, DEV BIOL, V227, P256, DOI 10.1006/dbio.2000.9914; Brigande JV, 2000, P NATL ACAD SCI USA, V97, P11700, DOI 10.1073/pnas.97.22.11700; Cantos R, 2000, P NATL ACAD SCI USA, V97, P11707, DOI 10.1073/pnas.97.22.11707; CARPENTER EM, 1993, DEVELOPMENT, V118, P1063; Choo D, 1998, DEV BIOL, V204, P136, DOI 10.1006/dbio.1998.9095; Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399; CONLON RA, 1992, DEVELOPMENT, V116, P357; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Dupe V, 1999, DEVELOPMENT, V126, P5051; Dupe V, 1997, DEVELOPMENT, V124, P399; Fekete DM, 1999, TRENDS NEUROSCI, V22, P263, DOI 10.1016/S0166-2236(98)01366-6; Frenz DA, 1996, TERATOLOGY, V53, P292; FROHMAN MA, 1993, DEVELOPMENT, V117, P925; Gale E, 1999, MECH DEVELOP, V89, P43, DOI 10.1016/S0925-4773(99)00202-6; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Groves AK, 2000, DEVELOPMENT, V127, P3489; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; LEVY E, 1987, EUR J BIOCHEM, V166, P71, DOI 10.1111/j.1432-1033.1987.tb13485.x; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; MARK M, 1993, DEVELOPMENT, V119, P319; Marshall H, 1996, FASEB J, V10, P969, DOI 10.1096/fasebj.10.9.8801179; MCKAY IJ, 1994, DEVELOPMENT, V120, P2199; McKay IJ, 1996, DEV BIOL, V174, P370, DOI 10.1006/dbio.1996.0081; Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0; MORRISSKAY GM, 1991, EMBO J, V10, P2985, DOI 10.1002/j.1460-2075.1991.tb07849.x; Morsli H, 1998, J NEUROSCI, V18, P3327; Murakami A, 1999, J BIOL CHEM, V274, P17242, DOI 10.1074/jbc.274.24.17242; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Pasqualetti M, 2000, DEVELOPMENT, V127, P5367; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Rossel M, 1999, DEVELOPMENT, V126, P5027; SIMEONE A, 1995, MECH DEVELOP, V51, P83, DOI 10.1016/0925-4773(95)96241-M; SOPRANO DR, 1994, MECH DEVELOP, V45, P243, DOI 10.1016/0925-4773(94)90011-6; Studer M, 1998, DEVELOPMENT, V125, P1025; SULIK KK, 1988, DEVELOPMENT, V103, P213; SULIK KK, 1995, TERATOLOGY, V51, P398, DOI 10.1002/tera.1420510605; Torres M, 1998, MECH DEVELOP, V71, P5, DOI 10.1016/S0925-4773(97)00155-X; Torres MA, 1996, DEVELOPMENT, V122, P3381; Trainor P, 2000, NAT CELL BIOL, V2, P96, DOI 10.1038/35000051; VANDEWATER TR, 1982, ANAT REC, pA195; Vendrell V, 2000, DEVELOPMENT, V127, P2011; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; YNTEMA CL, 1950, J EXP ZOOL, V113, P211, DOI 10.1002/jez.1401130110; ZHANG MB, 1994, DEVELOPMENT, V120, P2431	49	55	60	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2001	29	1					34	39		10.1038/ng702	http://dx.doi.org/10.1038/ng702			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528388				2022-12-27	WOS:000170781300013
J	Matikainen, T; Perez, GI; Jurisicova, A; Pru, JK; Schlezinger, JJ; Ryu, HY; Laine, J; Sakai, T; Korsmeyer, SJ; Casper, RF; Sherr, DH; Tilly, JL				Matikainen, T; Perez, GI; Jurisicova, A; Pru, JK; Schlezinger, JJ; Ryu, HY; Laine, J; Sakai, T; Korsmeyer, SJ; Casper, RF; Sherr, DH; Tilly, JL			Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals	NATURE GENETICS			English	Article							DIOXIN-RESPONSIVE ENHANCER; PROTEIN-DNA INTERACTIONS; LIGANDED AH RECEPTOR; OOCYTE APOPTOSIS; CELL-DEATH; MOUSE OOCYTES; IN-VITRO; BCL-2; DESTRUCTION; FOLLICLES	Polycyclic aromatic hydrocarbons (PAHs) are toxic chemicals released into the environment by fossil fuel combustion. Moreover, a primary route of human exposure to PAHs is tobacco smoke(1,2). Oocyte destruction and ovarian failure occur in PAH-treated mice(1,2), and cigarette smoking causes early menopause in women(1,3). In many cells, PAHs activate the aromatic hydrocarbon receptor (Ahr), a member of the Per-Arnt-Sim family of transcription factors(4,5). The Ahr is also activated by dioxin, one of the most intensively studied environmental contaminants. Here we show that an exposure of mice to PAHs induces the expression of Bax in oocytes(6), followed by apoptosis. Ovarian damage caused by PAHs is prevented by Ahr or Bax inactivation. Oocytes microinjected with a Bax promoter-reporter construct show Ahr-dependent transcriptional activation after PAH, but not dioxin, treatment, consistent with findings that dioxin is not cytotoxic to oocytes. This difference in the action of PAHs versus dioxin is conveyed by a single base pair flanking each Ahr response element in the Bax promoter. Oocytes in human ovarian biopsies grafted into immunodeficient mice also accumulate Bax and undergo apoptosis after PAH exposure in vivo. Thus, Ahr-driven Bax transcription is a novel and evolutionarily conserved cell-death signaling pathway responsible for environmental toxicant-induced ovarian failure.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol,Vincent Ctr Reprod Biol, Boston, MA 02114 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Boston Univ, Sch Med, Dept Environm Hlth, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Publ Hlth, Boston, MA 02118 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA; Kyoto Prefectural Univ, Sch Med, Dept Prevent Med, Kyoto 6028566, Japan; Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst,Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyoto Prefectural University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Tilly, JL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol,Vincent Ctr Reprod Biol, Boston, MA 02114 USA.	jtilly@partners.org	Casper, Robert F./E-3775-2013; Jurisicova, Andrea/E-4580-2013; Perez, Gloria I/GMX-1286-2022	Casper, Robert F./0000-0002-6249-462X; Sherr, David/0000-0003-3353-0553; Schlezinger, Jennifer/0000-0001-6834-4369	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008430] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01-ES08430] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BLANK JA, 1987, MOL PHARMACOL, V32, P168; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Heidel SM, 1998, MOL PHARMACOL, V54, P1000, DOI 10.1124/mol.54.6.1000; Igata E, 1999, GENE, V238, P407, DOI 10.1016/S0378-1119(99)00348-0; JICK H, 1977, LANCET, V1, P1354; Jurisicova A, 1998, MOL REPROD DEV, V51, P243, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;243::AID-MRD3&gt;3.0.CO;2-P; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; LUSSKA A, 1993, J BIOL CHEM, V268, P6575; Mann KK, 1999, TOXICOL APPL PHARM, V161, P10, DOI 10.1006/taap.1999.8778; MATTISON DR, 1980, TOXICOL APPL PHARM, V56, P399, DOI 10.1016/0041-008X(80)90074-5; MATTISON DR, 1989, SEMIN REPROD ENDOCR, V7, P291, DOI 10.1055/s-2007-1021411; MATTISON DR, 1979, CANCER RES, V39, P3471; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Morita Y, 1999, MOL ENDOCRINOL, V13, P841, DOI 10.1210/me.13.6.841; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Pru JK, 2001, BIOL REPROD, V64, P965, DOI 10.1095/biolreprod64.3.965; Pru JK, 2001, MOL ENDOCRINOL, V15, P845, DOI 10.1210/me.15.6.845; QVIST R, 1990, J REPROD FERTIL, V89, P169, DOI 10.1530/jrf.0.0890169; Robles R, 2000, ENDOCRINOLOGY, V141, P450, DOI 10.1210/en.141.1.450; SHEN ES, 1992, J BIOL CHEM, V267, P6815; Shi SR, 1997, J HISTOCHEM CYTOCHEM, V45, P327, DOI 10.1177/002215549704500301; SILBERGELD EK, 1987, AM J IND MED, V11, P131, DOI 10.1002/ajim.4700110203; Sussman NB, 1999, J WOMENS HEALTH, V8, P217, DOI 10.1089/jwh.1999.8.217; TILLY JL, 1995, ENDOCRINOLOGY, V136, P232, DOI 10.1210/en.136.1.232; Weissman A, 1999, BIOL REPROD, V60, P1462, DOI 10.1095/biolreprod60.6.1462; Wilson CL, 1998, TOXICOL PATHOL, V26, P657, DOI 10.1177/019262339802600510	30	352	368	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					355	360		10.1038/ng575	http://dx.doi.org/10.1038/ng575			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11455387				2022-12-27	WOS:000170174800016
J	Maser, RS; Zinkel, R; Petrini, JHJ				Maser, RS; Zinkel, R; Petrini, JHJ			An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele	NATURE GENETICS			English	Article							RIBOSOME-ENTRY-SITE; ATAXIA-TELANGIECTASIA; MAMMALIAN-CELLS; DNA; GENE; REPAIR	Nijmegen breakage syndrome (NBS) is a rare chromosomal-instability syndrome associated with cancer predisposition, radiosensitivity and radioresistant DNA synthesis-S phase checkpoint deficiency, which results in the failure to suppress DNA replication origins following DNA damage. Approximately 90% of NBS patients are homozygous for the 657del5 allele(1,2), a truncating mutation of NBS1 that causes premature termination at codon 219. Because null mutations in MRE11 and RAD50, which encode binding partners of NBS1, are lethal in vertebrates(3-5), and mouse Nbs1-null mutants are inviable(6), we tested the hypothesis that the NBS1 657del5 mutation was a hypomorphic defect. We showed that NBS cells contain the predicted 26-kD amino-terminal protein fragment, NBS1(p26) and a 70-kD NBS1 protein (NBS1(p70)) lacking the native N terminus. The NBSp26 protein is not physically associated with the MRE11 complex, whereas the p70 species is physically associated with it. NBS1(p70) is produced by internal translation initiation within the NBS1 mRNA using an open reading frame generated by the 657del5 frameshift. We propose that the common NBS1 allele encodes a partially functional protein that diminishes the severity of the NBS phenotype.	Univ Wisconsin, Sch Med, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Petrini, JHJ (corresponding author), Univ Wisconsin, Sch Med, Genet Lab, Madison, WI 53706 USA.		Maser, Richard/B-2970-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059413] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59413] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; GEBALLE AP, 1996, TRANSLATIONAL CONTRO, P173; Hiel JA, 2000, ARCH DIS CHILD, V82, P400; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; THOMAS KR, 1986, NATURE, V324, P34, DOI 10.1038/324034a0; Tupler R, 1997, J MED GENET, V34, P196, DOI 10.1136/jmg.34.3.196; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	16	179	182	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					417	421		10.1038/86920	http://dx.doi.org/10.1038/86920			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279524				2022-12-27	WOS:000167811200017
J	Batourina, E; Gim, S; Bello, N; Shy, M; Clagett-Dame, M; Srinivas, S; Costantini, F; Mendelsohn, C				Batourina, E; Gim, S; Bello, N; Shy, M; Clagett-Dame, M; Srinivas, S; Costantini, F; Mendelsohn, C			Vitamin A controls epithelial/mesenchymal interactions through Ret expression	NATURE GENETICS			English	Article							RETINOIC ACID; URETERAL BUD; KIDNEY; RAT; DEFECTS; MICE; RESPONSIVENESS; ORGANOGENESIS; METANEPHROS; DEFICIENCY	Mutations or rearrangements in the gene encoding the receptor tyrosine kinase RET result in Hirschsprung disease, cancer and renal malformations, The standard model of renal development involves reciprocal signaling between the ureteric bud epithelium, inducing metanephric mesenchyme to differentiate into nephrons, and metanephric mesenchyme, inducing the ureteric bud to grow and branch(1,2). RET and GDNF (a RET ligand) are essential mediators of these epithelial-mesenchymal interactions'. Vitamin A deficiency has been associated with widespread embryonic abnormalities, including renal malformations(4), The vitamin A signal is transduced by nuclear retinoic acid receptors (RARs), We previously showed that two RAR genes, Rara and Rarb2, were colocalized in stromal mesenchyme, a third renal cell type, where their deletion led to altered stromal cell patterning, impaired ureteric bud growth and downregulation of Ret in the ureteric bud(5,6). Here we demonstrate that forced expression of Ret in mice deficient for both Rara and Rarb2 (Rara(-/-)Rarb2(-/-)) genetically rescues renal development, restoring ureteric bud growth and stromal cell patterning. Our studies indicate the presence of a new reciprocal signaling loop between the ureteric bud epithelium and the stromal mesenchyme, dependent on Ret and vitamin A, In the first part of the loop, vitamin-A-dependent signals secreted by stromal cells control Ret expression in the ureteric bud. In the second part of the loop, ureteric bud signals dependent on Rot control stromal cell patterning.	Columbia Univ, Dept Urol, New York, NY 10027 USA; Columbia Univ, Dept Genet & Dev, New York, NY USA; Univ Wisconsin, Dpet Biochem & Pharmaceut Sci, Madison, WI USA	Columbia University; Columbia University; University of Wisconsin System; University of Wisconsin Madison	Mendelsohn, C (corresponding author), Columbia Univ, Dept Urol, New York, NY 10027 USA.	clm20@columbia.edu	Bello, Natalie/J-1001-2019; Mendelsohn, Cathy/H-4280-2016	Bello, Natalie/0000-0003-3257-3623; Mendelsohn, Cathy/0000-0002-4026-4073; Srinivas, Shankar/0000-0001-5726-7791; Shy, Michael/0000-0001-8460-6971	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061459, R56DK082963] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK061459-07, R56 DK082963, R01 DK061459-06, R56 DK082963-01, R01 DK061459, R01 DK061459-09, R01 DK061459-07S1, R01 DK061459-08, R01 DK061459-05] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brenner BM, 1997, KIDNEY INT, pS124; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; GROBSTEIN C, 1953, SCIENCE, V118, P52, DOI 10.1126/science.118.3054.52; GROBSTEIN C, 1955, J EXP ZOOL, V130, P319, DOI 10.1002/jez.1401300207; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Moreau E, 1998, AM J PHYSIOL-RENAL, V275, pF938, DOI 10.1152/ajprenal.1998.275.6.F938; Napoli JL, 2000, PROG NUCLEIC ACID RE, V63, P139, DOI 10.1016/S0079-6603(08)60722-9; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Patrone G, 1997, FEBS LETT, V419, P76, DOI 10.1016/S0014-5793(97)01435-X; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; ROBERTSON K, 1995, MECH DEVELOP, V53, P329, DOI 10.1016/0925-4773(95)00449-1; Sariola H, 1999, INT J DEV BIOL, V43, P413; SARIOLA H, 1988, CELL, V54, P235, DOI 10.1016/0092-8674(88)90556-9; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Srinivas S, 1999, DEV GENET, V24, P241; Srinivas S, 1999, DEVELOPMENT, V126, P1375; Thang SH, 2000, J NEUROSCI, V20, P2917; Vilar J, 1996, KIDNEY INT, V49, P1478, DOI 10.1038/ki.1996.208; WELLER A, 1991, DEV BIOL, V144, P248, DOI 10.1016/0012-1606(91)90419-4; White JC, 1998, P NATL ACAD SCI USA, V95, P13459, DOI 10.1073/pnas.95.23.13459; White JC, 2000, DEV BIOL, V220, P263, DOI 10.1006/dbio.2000.9635; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303	26	186	191	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					74	78		10.1038/83792	http://dx.doi.org/10.1038/83792			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138002				2022-12-27	WOS:000166187900019
J	Wildin, RS; Ramsdell, F; Peake, J; Faravelli, F; Casanova, JL; Buist, N; Levy-Lahad, E; Mazzella, M; Goulet, O; Perroni, L; Bricarelli, FD; Byrne, G; McEuen, M; Proll, S; Appleby, M; Brunkow, ME				Wildin, RS; Ramsdell, F; Peake, J; Faravelli, F; Casanova, JL; Buist, N; Levy-Lahad, E; Mazzella, M; Goulet, O; Perroni, L; Bricarelli, FD; Byrne, G; McEuen, M; Proll, S; Appleby, M; Brunkow, ME			X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy	NATURE GENETICS			English	Article							MUTANT; DIARRHEA; HEAD	To determine whether human X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome (IPEX; MIM 304930) is the genetic equivalent of the scurfy (sf) mouse, we sequenced the human ortholog (FOXP3) of the gene mutated in scurfy mice (Foxp3), in IPEX patients. We found four non-polymorphic mutations. Each mutation affects the forkhead/winged-helix domain of the scurfin protein, indicating that the mutations may disrupt critical DNA interactions.	Oregon Hlth Sci Univ, Dept Mol & Med Genet L103A, Portland, OR 97201 USA; Celltech Chirosci Inc, Bothell, WA USA; Royal Childrens Hosp, Dept Paediat, Brisbane, Qld, Australia; Royal Childrens Hosp, Dept Child Hlth, Brisbane, Qld 4029, Australia; Galliera Hosp, Lab Human Genet, Genoa, Italy; Univ Paris, Hosp Necker Enfants Malad, Serv Immunol & Hematol Pediat, Lab Human Genet Infect Dis, F-75252 Paris, France; Oregon Hlth Sci Univ, Dept Pediat, Portland, OR 97201 USA; Shaare Zedek Med Ctr, Med Genet Unit, Jerusalem, Israel; G Gaslini Inst, Dept Neonatol, Neonatol Intens Care Unit, Genoa, Italy; Princess Margaret Hosp, Dept Endocrinol, Perth, WA, Australia	Oregon Health & Science University; Royal Children's Hospital Brisbane; Royal Children's Hospital Brisbane; Ente Ospedaliero Ospedali Galliera; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Oregon Health & Science University; Hebrew University of Jerusalem; Shaare Zedek Medical Center; University of Genoa; IRCCS Istituto Giannina Gaslini	Wildin, RS (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet L103A, Portland, OR 97201 USA.		Casanova, Jean-Laurent/I-3418-2017; Peake, Jane/B-4488-2011; Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921; Casanova, Jean-Laurent/0000-0002-7782-4169; Peake, Jane/0000-0001-9003-5861	Telethon [C.42] Funding Source: Medline	Telethon(Fondazione Telethon)		Bennett CL, 2000, AM J HUM GENET, V66, P461, DOI 10.1086/302761; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Clark LB, 1999, J IMMUNOL, V162, P2546; Ferguson PJ, 2000, AM J MED GENET, V90, P390, DOI 10.1002/(SICI)1096-8628(20000228)90:5<390::AID-AJMG9>3.0.CO;2-M; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Jin CW, 1999, J MOL BIOL, V289, P683, DOI 10.1006/jmbi.1999.2819; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; LEVYLAHAD E, IN PRESS J PEDIAT; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Means GD, 2000, GENOMICS, V65, P213, DOI 10.1006/geno.2000.6173; Peake JE, 1996, ARCH DIS CHILD-FETAL, V74, pF195, DOI 10.1136/fn.74.3.F195; POWELL BR, 1982, J PEDIATR-US, V100, P731, DOI 10.1016/S0022-3476(82)80573-8	13	1340	1385	0	35	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					18	20		10.1038/83707	http://dx.doi.org/10.1038/83707			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137992				2022-12-27	WOS:000166187900009
J	Peto, J; Mack, TM				Peto, J; Mack, TM			High constant incidence in twins and other relatives of women with breast cancer	NATURE GENETICS			English	Article							RISK-FACTORS; FAMILIAL RISK; ONSET; GENES; BRCA1	The incidence of breast cancer rises steeply between ages 25 and 50, and more slowly thereafter. In contrast, the incidence in the unaffected (contralateral) breast of women who have had breast cancer remains constant at about 0.7% per year for at least the next 20 years after diagnosis, irrespective of age at first diagnosis. The incidence in relatives of the patients seems to show a similar pattern. The incidence in a prospective study of monozygotic twins of patients was approximately constant at 1.3% per year (77 cases), again about 0.7% per breast. At ages older than a patient's age at diagnosis, her mother and sisters have an incidence of 0.3-0.4% per year. Above the index patient's age at diagnosis, the rate in relatives shows no temporal trend and is independent of the patient's age at diagnosis. A statistically simple explanation is that incidence in susceptible women increases to a high constant level by a predetermined age that varies between families, but this seems inconsistent with conventional models of carcinogenesis and susceptibility. The very high incidence in monozygotic twins of patients indicates that a high proportion, and perhaps the majority, of breast cancers arise in a susceptible minority of women.	Inst Canc Res, Epidemiol Sect, Surrey, England; London Sch Hyg & Trop Med, London WC1, England; USC Norris comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA USA	University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of Southern California	Peto, J (corresponding author), Inst Canc Res, Epidemiol Sect, Surrey, England.				NATIONAL CANCER INSTITUTE [R01CA032262, R35CA042581] Funding Source: NIH RePORTER; NCI NIH HHS [R35CA42581, R01CA32262] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahlbom A, 1997, J NATL CANCER I, V89, P287, DOI 10.1093/jnci/89.4.287; BERNSTEIN JL, 1992, AM J EPIDEMIOL, V136, P937, DOI 10.1093/oxfordjournals.aje.a116566; BERNSTEIN JL, 1992, AM J EPIDEMIOL, V136, P925, DOI 10.1093/oxfordjournals.aje.a116565; BOICE JD, 1992, NEW ENGL J MED, V326, P781, DOI 10.1056/NEJM199203193261201; BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P519, DOI 10.1007/BF00054160; Cerhan JR, 2000, J NATL CANCER I, V92, P261, DOI 10.1093/jnci/92.3.261; CHILVERS C, 1989, LANCET, V1, P973; Clarke M, 1998, LANCET, V351, P1451; CLAUS EB, 1991, AM J HUM GENET, V48, P232; CLAUS EB, 1990, AM J EPIDEMIOL, V131, P961, DOI 10.1093/oxfordjournals.aje.a115616; CLAUS EB, 1988, THESIS YALE U; Ekbom A, 1997, JNCI-J NATL CANCER I, V89, P71, DOI 10.1093/jnci/89.1.71; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Harvey E B, 1985, Natl Cancer Inst Monogr, V68, P99; HISLOP TG, 1984, BRIT J CANCER, V49, P79, DOI 10.1038/bjc.1984.12; Houlston Richard S., 1996, P208; Olsen JH, 1999, BRIT J CANCER, V79, P673, DOI 10.1038/sj.bjc.6690106; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Peto J, 1996, INT J CANCER, V65, P275, DOI 10.1002/(SICI)1097-0215(19960126)65:3&lt;275::AID-IJC1&gt;3.0.CO;2-X; ROBBINS GF, 1964, CANCER, V12, P1502; Roberts SA, 1999, AM J HUM GENET, V65, P784, DOI 10.1086/302544; Slack F, 1997, ANNU REV GENET, V31, P611, DOI 10.1146/annurev.genet.31.1.611; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; Waterhouse J., 1976, IARC SCI PUBLICATION, V15	25	222	231	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					411	414		10.1038/82533	http://dx.doi.org/10.1038/82533			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101836				2022-12-27	WOS:000165671700011
J	Xu, WT; Edmondson, DG; Evrard, YA; Wakamiya, M; Behringer, RR; Roth, SY				Xu, WT; Edmondson, DG; Evrard, YA; Wakamiya, M; Behringer, RR; Roth, SY			Loss of Gcn5/2 leads to increased apoptosis and mesodermal defects during mouse development	NATURE GENETICS			English	Letter							ADENOVIRAL ONCOPROTEIN E1A; DNA-DAMAGE; PCAF; P300; GENE; ACETYLTRANSFERASES; EXPRESSION; FAMILY; EMBRYO; TWIST	Histone acetyltransferases regulate transcription, but little is known about the role of these enzymes in developmental processes. Gcn5 (encoded by Gcn5/2) and Pcaf. mouse histone acetyltransferases. share similar sequences and enzymatic activities(1). Both interact with p300 and CBP (encoded by Ep300 and Crebbp, respectively), two other histone acetyltransferases that integrate multiple signalling pathways(1). Pcaf is thought to participate in many of the cellular processes regulated by p300/CBP (refs 2-8). but the functions of Gcn5 are unknown in mammalian cells. Here we show that the gene Pcaf is dispensable in mice. In contrast. Gcn5/2-null embryos die during embryogenesis. These embryos develop normally to 7.5 days post coitum (d.p.c.). but their growth is severely retarded by 8.5 d.p.c. and they fail to form dorsal mesoderm lineages, including chordamesoderm and paraxial mesoderm. Differentiation of extra-embryonic and cardiac mesoderm seems to be unaffected. Loss of the dorsal mesoderm lineages is due to a high incidence of apoptosis in the Gcn5/2 mutants that begins before the onset of morphological abnormality. Embryos null for both Gcn5/2 and Pcaf show even more severe defects, indicating that these histone acetyltransferases have overlapping functions during embryogenesis. Our studies are the first to demonstrate that specific acetyltransferases are required for cell survival and mesoderm formation during mammalian development.	Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Roth, SY (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.		Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269; Edmondson, Diane/0000-0003-3702-9715				ANG SL, 1993, DEVELOPMENT, V118, P139; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; BURGESS R, 1995, DEV BIOL, V168, P296, DOI 10.1006/dbio.1995.1081; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; Hogan B, 1994, MANIPULATING MOUSE E; Liu L, 1999, MOL CELL BIOL, V19, P1202; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; SASAKI H, 1993, DEVELOPMENT, V118, P47; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; Xu WT, 1998, MOL CELL BIOL, V18, P5659, DOI 10.1128/MCB.18.10.5659; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	20	194	204	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					229	232		10.1038/79973	http://dx.doi.org/10.1038/79973			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017084				2022-12-27	WOS:000089638800025
J	Kury, S; Dreno, B; Bezieau, S; Giraudet, S; Kharfi, M; Kamoun, R; Moisan, JP				Kury, S; Dreno, B; Bezieau, S; Giraudet, S; Kharfi, M; Kamoun, R; Moisan, JP			Identification of SLC39A4, a gene involved in acrodermatitis enteropathica	NATURE GENETICS			English	Article							ZINC TRANSPORTER; METAL TRANSPORTER; ARABIDOPSIS; PROTEIN; FAMILY; YEAST		Fac Med, Lab Etud Polymorphisme ADN, F-44035 Nantes, France; Hop Hotel Dieu, Ctr Hosp Univ, Serv Dermatol, F-44093 Nantes, France; Hop Charles Nicolle, Serv Dermatol, Tunis, Tunisia	Nantes Universite; CHU de Nantes; Universite de Tunis-El-Manar; Hopital Charles Nicolle	Kury, S (corresponding author), Fac Med, Lab Etud Polymorphisme ADN, 1 Rue Gaston Veil, F-44035 Nantes, France.		KÜRY, Sébastien/G-5971-2015; Bézieau, stéphane/G-5621-2015	KÜRY, Sébastien/0000-0001-5497-0465; Bézieau, stéphane/0000-0003-0095-1319				ATHERTON DJ, 1979, CLIN SCI, V56, P505, DOI 10.1042/cs0560505; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Guerinot ML, 1999, CURR OPIN PLANT BIOL, V2, P244, DOI 10.1016/S1369-5266(99)80042-9; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; LOMBECK I, 1975, LANCET, V1, P855; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; Wang K, 2001, AM J HUM GENET, V68, P1055, DOI 10.1086/319514; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	11	369	390	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					239	240		10.1038/ng913	http://dx.doi.org/10.1038/ng913			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12068297				2022-12-27	WOS:000176494100009
J	Philipp, M; Brede, ME; Hadamek, K; Gessler, M; Lohse, MJ; Hein, L				Philipp, M; Brede, ME; Hadamek, K; Gessler, M; Lohse, MJ; Hein, L			Placental alpha(2)-adrenoceptors control vascular development at the interface between mother and embryo	NATURE GENETICS			English	Article							RECEPTOR SUBTYPES; PROTEIN-KINASE; MICE LACKING; GENE; EXPRESSION; BRAIN; STIMULATION; MODULATION; APOPTOSIS; MUTATION	A substantial percentage of human pregnancies are lost as spontaneous abortions after implantation. This is often caused by an inadequately developed placenta. Proper development of the placental vascular system is essential to nutrient and gas exchange between mother and developing embryo. Here we show that alpha(2)-adrenoceptors, which are activated by adrenaline and noradrenaline, are important regulators of placental structure and function. Mice with deletions in the genes encoding alpha(2A)-, alpha(2B)- and alpha(2C)-adrenoceptors died between embryonic days 9.5 and 11.5 from a severe defect in yolk-sac and placenta development. In wildtype placentae, alpha(2)-adrenoceptors are abundantly expressed in giant cells, which secrete angiogenic factors to initiate development of the placental vascular labyrinth. In placentae deficient in alpha(2A)-, alpha(2B)- and alpha(2C)-adrenoceptors, the density of fetal blood vessels in the labyrinth was markedly lower than normal, leading to death of the embryos as a result of reduced oxygen and nutrient supply. Basal phosphorylation of the extracellular signal-regulated kinases ERK1 and ERK2 was also lower than normal, suggesting that activation of the mitogen-activated protein kinase (MAP kinase) pathway by alpha(2)-adrenoceptors is required for placenta and yolk-sac vascular development. Thus, alpha(2)-adrenoceptors are essential at the placental interface between mother and embryo to establish the circulatory system of the placenta and thus maintain pregnancy.	Univ Wurzburg, Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany; Univ Wurzburg, Theodor Boveri Inst Biowissensch, D-97074 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Hein, L (corresponding author), Univ Wurzburg, Inst Pharmakol & Toxikol, Versbacher Str 9, D-97078 Wurzburg, Germany.	hein@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012; Philipp, Melanie/B-5198-2016	Lohse, Martin J/0000-0002-0599-3510; Philipp, Melanie/0000-0003-2714-965X; Gessler, Manfred/0000-0002-7915-6045				Altman JD, 1999, MOL PHARMACOL, V56, P154, DOI 10.1124/mol.56.1.154; Bucheler MM, 2002, NEUROSCIENCE, V109, P819, DOI 10.1016/S0306-4522(01)00531-0; BYLUND DB, 1994, PHARMACOL REV, V46, P121; CERESA BP, 1994, J BIOL CHEM, V269, P29557; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; DIAMANT S, 1992, BRIT J PHARMACOL, V106, P101, DOI 10.1111/j.1476-5381.1992.tb14300.x; DieckmannSchuppert A, 1997, CELL TISSUE RES, V288, P119, DOI 10.1007/s004410050799; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Hein L, 2001, REV PHYSIOL BIOCH P, V142, P161, DOI 10.1007/BFb0117493; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Li YW, 1998, J NEUROPHYSIOL, V79, P583, DOI 10.1152/jn.1998.79.2.583; LINK RE, 1995, MOL PHARMACOL, V48, P48; Link RE, 1996, SCIENCE, V273, P803, DOI 10.1126/science.273.5276.803; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Pohjanoksa K, 1997, EUR J PHARMACOL, V335, P53, DOI 10.1016/S0014-2999(97)01154-0; Qian XL, 2000, EMBO J, V19, P642, DOI 10.1093/emboj/19.4.642; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sawamura S, 2000, J NEUROSCI, V20, P9242; Saxton TM, 2001, CURR BIOL, V11, P662, DOI 10.1016/S0960-9822(01)00198-1; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Simm A, 1997, FEBS LETT, V410, P481, DOI 10.1016/S0014-5793(97)00644-3; SURPRENANT A, 1992, SCIENCE, V257, P977, DOI 10.1126/science.1354394; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Wang R, 1996, NEUROSCIENCE, V74, P199, DOI 10.1016/0306-4522(96)00116-9; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 1998, MECH DEVELOP, V76, P141, DOI 10.1016/S0925-4773(98)00111-7; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zou AP, 2000, AM J PHYSIOL-REG I, V279, pR769, DOI 10.1152/ajpregu.2000.279.3.R769	30	55	57	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2002	31	3					311	315		10.1038/ng919	http://dx.doi.org/10.1038/ng919			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12068299				2022-12-27	WOS:000176494100022
J	Gerull, B; Gramlich, M; Atherton, J; McNabb, M; Trombitas, K; Sasse-Klaassen, S; Seidman, JG; Seidman, C; Granzier, H; Labeit, S; Frenneaux, M; Thierfelder, L				Gerull, B; Gramlich, M; Atherton, J; McNabb, M; Trombitas, K; Sasse-Klaassen, S; Seidman, JG; Seidman, C; Granzier, H; Labeit, S; Frenneaux, M; Thierfelder, L			Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy	NATURE GENETICS			English	Article							IDENTIFICATION; PROTEINS; ELASTICITY; EXPRESSION; CONNECTIN; SEQUENCE; DISEASE; GENE; EXON	Congestive heart failure (CHF) can result from various disease states with inadequate cardiac output. CHF due to dilated cardiomyopathy (DCM) is a familial disease in 20-30% of cases and is associated with mutations in genes encoding cytoskeletal, contractile or inner-nuclear membrane proteins(1). We show that mutations in the gene encoding giant-muscle filament titin (TTN) cause autosomal dominant DCM linked to chromosome 2q31 (CMD1G; MIM 604145). Titin molecules extend from sarcomeric Z-discs to M-lines, provide an extensible scaffold for the contractile machinery and are crucial for myofibrillar elasticity and integrity(2). in a large DCM kindred, a segregating 2-bp insertion mutation in TTN exon 326 causes a frameshift, truncating A-band titin. The truncated protein of approximately 2 mD is expressed in skeletal muscle, but western blot studies with epitope-specific anti-titin antibodies suggest that the mutant protein is truncated to a 1.14-mD subfragment by site-specific cleavage. In another large family with DCM linked to CMD1G, a TTN missense mutation (Trp930Arg) is predicted to disrupt a highly conserved hydrophobic core sequence of an immunoglobulin fold located in the Z-disc-1-band transition zone. The identification of TTN mutations in individuals with CMD1G should provide further insights into the pathogenesis of familial forms of CHF and myofibrillar titin turnover.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Humboldt Univ, HELIOS Kliniken GmbH, Franz Volhard Klin, Charite, Berlin, Germany; Royal Brisbane Hosp, Dept Cardiol, Brisbane, Qld 4029, Australia; Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Hosp Mannheim, D-68135 Mannheim, Germany; Cardiff Univ, Dept Cardiol, Cardiff CF4 4XN, S Glam, Wales	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken; Royal Brisbane & Women's Hospital; Washington State University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Ruprecht Karls University Heidelberg; Cardiff University	Thierfelder, L (corresponding author), Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.	lthier@mdc-berlin.de	Atherton, John J/B-9994-2011	Atherton, John J/0000-0003-2271-578X				Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Freiburg A, 2000, CIRC RES, V86, P1114; Granzier H, 1996, BIOPHYS J, V70, P430, DOI 10.1016/S0006-3495(96)79586-3; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hutchison CJ, 2001, J CELL SCI, V114, P9; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Macrae CA, 2000, EUR HEART J, V21, P1817, DOI 10.1053/euhj.2000.2374; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; TAKAHASHI K, 1992, J BIOCHEM-TOKYO, V111, P778, DOI 10.1093/oxfordjournals.jbchem.a123835; Trinick J, 1999, TRENDS CELL BIOL, V9, P377, DOI 10.1016/S0962-8924(99)01641-4; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816	19	394	414	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					201	204		10.1038/ng815	http://dx.doi.org/10.1038/ng815			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11788824				2022-12-27	WOS:000173708700022
J	Oota, H; Settheetham-Ishida, W; Tiwawech, D; Ishida, T; Stoneking, M				Oota, H; Settheetham-Ishida, W; Tiwawech, D; Ishida, T; Stoneking, M			Human mtDNA and Y-chromosome variation is correlated with matrilocal versus patrilocal residence	NATURE GENETICS			English	Article							MITOCHONDRIAL	Genetic differences among human populations are usually larger for the Y chromosome than for mtDNA(1-3). one possible explanation is the higher rate of female versus male migration due to the widespread phenomenon of patrilocality, in which the woman moves to her mate's residence after marriage. To test this hypothesis, we compare mtDNA and Y-chromosome variation in three matrilocal (in which the man moves to his mate's residence after marriage) and three patrilocal groups among the hill tribes of northern Thailand. Genetic diversity in these groups shows a striking correlation with residence pattern, supporting the role of sex-specific migration in influencing human genetic variation.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Khon Kaen Univ, Khon Kaen, Thailand; Natl Canc Inst, Bangkok, Thailand; Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo, Japan	Max Planck Society; Khon Kaen University; National Cancer Institute - Thailand; University of Tokyo	Stoneking, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Inselstr 22, D-04103 Leipzig, Germany.			Tiwawech, Danai/0000-0002-5023-7888				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; Burckhardt F, 1999, NUCLEIC ACIDS RES, V27, P138, DOI 10.1093/nar/27.1.138; Burton ML, 1996, CURR ANTHROPOL, V37, P87, DOI 10.1086/204474; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Kimura M, 1998, HUM BIOL, V70, P993; Nei M., 1987, MOL EVOLUTIONARY GEN; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Salem AH, 1996, AM J HUM GENET, V59, P741; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; SLATKIN M, 1995, GENETICS, V139, P457	12	223	229	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					20	21		10.1038/ng711	http://dx.doi.org/10.1038/ng711			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528385				2022-12-27	WOS:000170781300009
J	Ono, T; Isobe, K; Nakada, K; Hayashi, JI				Ono, T; Isobe, K; Nakada, K; Hayashi, JI			Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria	NATURE GENETICS			English	Letter							DEGENERATIVE DISEASES; MOUSE MTDNA; HUMAN BRAIN; MUTATIONS; RECOMBINATION; EMBRYOGENESIS; ELIMINATION; ORGANELLES; DELETIONS; GENETICS	Extensive complementation between fused mitochondria is indicated by recombination of 'parental' mitochondrial (mt) DNA (refs, 1,2) of yeast and plant cells. It has been difficult, however, to demonstrate the occurrence of complementation between fused mitochondria in mammalian species through the presence of recombinant mtDNA molecules(3), because sequence of mtDNA throughout an individual tends to be uniform(4) owing to its strictly maternal inheritance(5-7). We isolated two types of respiration-deficient cell lines, with pathogenic mutations in mitochondrial tRNA(lle) or tRNA(Leu(UUR)) genes from patients with mitochondrial diseases. The coexistence of their mitochondria within hybrids restored their normal morphology and respiratory enzyme activity by 10-14 days after fusion, indicating the presence of an extensive and continuous exchange of genetic contents between the mitochondria. This complementation between fused mitochondria may represent a defence of highly oxidative organelles against mitochondrial dysfunction caused by the accumulation of mtDNA lesions with age.	Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba; University of Tsukuba	Hayashi, JI (corresponding author), Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan.							BELLIARD G, 1979, NATURE, V281, P401, DOI 10.1038/281401a0; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; DUJON B, 1974, GENETICS, V78, P415; Enriquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HAYASHI JI, 1994, J BIOL CHEM, V269, P19060; HAYASHI JI, 1985, EXP CELL RES, V160, P387, DOI 10.1016/0014-4827(85)90185-5; HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446; Isobe K, 1998, J BIOL CHEM, V273, P4601, DOI 10.1074/jbc.273.8.4601; Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Lightowlers RH, 1999, TRENDS GENET, V15, P91, DOI 10.1016/S0168-9525(98)01684-9; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8; Nagley P, 1998, TRENDS GENET, V14, P513, DOI 10.1016/S0168-9525(98)01580-7; NAKADA K, IN PRESS NATURE MED; NONAKA I, 1989, J NEUROL SCI, V92, P193, DOI 10.1016/0022-510X(89)90136-6; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; SHAY JW, 1987, MUTAT RES, V186, P149, DOI 10.1016/0165-1110(87)90028-5; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Shitara H, 2000, GENETICS, V156, P1277; Shitara H, 1998, GENETICS, V148, P851; SOONG NW, 1992, NAT GENET, V2, P318; Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699	29	316	322	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					272	275		10.1038/90116	http://dx.doi.org/10.1038/90116			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431699				2022-12-27	WOS:000169656400021
J	Ferrigno, O; Virolle, T; Djabari, Z; Ortonne, JP; White, RJ; Aberdam, D				Ferrigno, O; Virolle, T; Djabari, Z; Ortonne, JP; White, RJ; Aberdam, D			Transposable B2SINE elements can provide mobile RNA polymerase II promoters	NATURE GENETICS			English	Article							HUMAN GENOME; TRANSCRIPTION; GENE; INITIATOR; SEQUENCE; DNA; ALU; USF; FAMILIES; REPEAT	Short interspersed elements (SINEs) are highly abundant components of mammalian genomes that are propagated by retrotransposition. SINEs are recognized as a causal agent of human disease and must also have had a profound influence in shaping eukaryotic genomes(1). The B2 SINE family constitutes approximately 0.7% of total mouse genomic DNA(ref, 2) and is also found at low abundance in humans(3) It resembles the Alufamily in several respects, such as its mechanism of propagation. BZ SINEs are derived from tRNA and are transcribed by RNA polymerase (pol) III to generate short transcripts that are not translated(4,5). We find here, however, that one B2 SINE also carries an active pol II promoter located outside the tRNA region. Indeed, a B2 element is responsible for the production of a mouse Lama3 transcript. The B2 pol Il promoters can be bound and stimulated by the transcription factor USF (for upstream stimulatory factor), as shown by transient transfection experiments. Moreover, this pol II activity does not preclude the pol III transcription necessary for retrotransposition(6). Dispersal of BZ SINEs by retrotransposition may therefore have provided numerous opportunities for creating regulated pol II transcription at novel genomic sites. This mechanism may have allowed the evolution of new transcription units and new genes.	Fac Med, INSERM, U385, Nice, France; Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Glasgow	Aberdam, D (corresponding author), Fac Med, INSERM, U385, Nice, France.		Virolle, Thierry/E-5838-2016; ferrigno, olivier/GSN-8581-2022; Aberdam, Daniel/G-3299-2013	ferrigno, olivier/0000-0001-7544-4384; Aberdam, Daniel/0000-0002-4019-5418				ABERDAM D, 2000, LAMININS, P228; BENNETT KL, 1984, MOL CELL BIOL, V4, P1561, DOI 10.1128/MCB.4.8.1561; BRINI AT, 1993, J BIOL CHEM, V268, P1355; Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; CHANDRASEKARAN B, 1992, IEEE EXPERT, V7, P2; Chen YL, 1998, T NONFERR METAL SOC, V8, P5; DANIELS GR, 1985, NATURE, V317, P819, DOI 10.1038/317819a0; DU H, 1993, EMBO J, V12, P501, DOI 10.1002/j.1460-2075.1993.tb05682.x; FEHLING HJ, 1995, IMMUNOGENETICS, V42, P275, DOI 10.1007/BF00176445; Ferrigno O, 1997, J BIOL CHEM, V272, P20502, DOI 10.1074/jbc.272.33.20502; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Makalowski W., 1995, IMPACT SHORT INTERSP, P81; Marinoni JC, 1997, METHODS, V12, P235, DOI 10.1006/meth.1997.0476; Mayorov VI, 2000, MAMM GENOME, V11, P177, DOI 10.1007/s003350010033; Novina CD, 1996, TRENDS GENET, V12, P351, DOI 10.1016/0168-9525(96)10034-2; POGNONEC P, 1991, MOL CELL BIOL, V11, P5125, DOI 10.1128/MCB.11.10.5125; REHN M, 1994, J BIOL CHEM, V269, P13929; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SAKAMOTO K, 1985, J MOL EVOL, V22, P134, DOI 10.1007/BF02101691; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; STEINBERG TH, 1990, J BIOL CHEM, V265, P499; Vailly J, 1998, GENE THER, V5, P1322, DOI 10.1038/sj.gt.3300730; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215	24	91	94	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					77	81		10.1038/ng0501-77	http://dx.doi.org/10.1038/ng0501-77			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326281				2022-12-27	WOS:000168413300021
J	Bennett, CL; Christie, J; Ramsdell, F; Brunkow, ME; Ferguson, PJ; Whitesell, L; Kelly, TE; Saulsbury, FT; Chance, PF; Ochs, HD				Bennett, CL; Christie, J; Ramsdell, F; Brunkow, ME; Ferguson, PJ; Whitesell, L; Kelly, TE; Saulsbury, FT; Chance, PF; Ochs, HD			The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3	NATURE GENETICS			English	Article							GENE; FKHL7	IPEX is a fatal disorder characterized by immune dysregulation, polyendocrinopathy, enteropathy and X-linked inheritance (MIM 304930). We present genetic evidence that different mutations of the human gene FOXP3, the ortholog of the gene mutated in scurfy mice (Foxp3), causes IPEX syndrome. Recent linkage analysis studies mapped the gene mutated in IPEX to an interval of 17-20-cM at Xp11.23-Xq13.3 (refs. 1,2).	Univ Washington, Dept Pediat, Div Immunol Infect Dis & Rheumatol, Seattle, WA 98195 USA; Celltech Chirosci Inc, Bothell, WA USA; Univ Washington, Div Genet & Dev, Seattle, WA 98195 USA; Univ Alabama, Dept Pediat, Birmingham, AL USA; Univ Arizona, Steele Mem Childrens Res Ctr, Dept Pediat, Tucson, AZ USA; Univ Virginia, Dept Pediat, Charlottesville, VA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; University of Arizona; University of Virginia	Ochs, HD (corresponding author), Univ Washington, Dept Pediat, Div Immunol Infect Dis & Rheumatol, Seattle, WA 98195 USA.		Chance, Phillip/AAX-5826-2020	Bennett, CRAIG/0000-0002-5847-1687	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017427, R01HD017427] Funding Source: NIH RePORTER; NICHD NIH HHS [HD17427] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bennett CL, 2000, AM J HUM GENET, V66, P461, DOI 10.1086/302761; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Ferguson PJ, 2000, AM J MED GENET, V90, P390, DOI 10.1002/(SICI)1096-8628(20000228)90:5<390::AID-AJMG9>3.0.CO;2-M; Kaestner KH, 2000, GENE DEV, V14, P142; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Mirzayans F, 2000, EUR J HUM GENET, V8, P71, DOI 10.1038/sj.ejhg.5200354; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; POWELL BR, 1982, J PEDIATR-US, V100, P731, DOI 10.1016/S0022-3476(82)80573-8	10	2390	2501	4	85	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					20	21		10.1038/83713	http://dx.doi.org/10.1038/83713			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137993				2022-12-27	WOS:000166187900010
J	Brenner, M; Johnson, AB; Boespflug-Tanguy, O; Rodriguez, D; Goldman, JE; Messing, A				Brenner, M; Johnson, AB; Boespflug-Tanguy, O; Rodriguez, D; Goldman, JE; Messing, A			Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease	NATURE GENETICS			English	Article							ALPHA-B-CRYSTALLIN; INTERMEDIATE FILAMENTS; PALATAL MYOCLONUS; TRANSGENIC MICE; WHITE-MATTER; GENE; MYOPATHY; DEVELOP; ATAXIA; BRAIN	Alexander disease is a rare disorder of the central nervous system of unknown etiology(1,2). Infants with Alexander disease develop a leukoencephalopathy with macrocephaly, seizures and psychomotor retardation, leading to death usually within the first decade; patients with juvenile or adult forms typically experience ataxia, bulbar signs and spasticity, and a more slowly progressive course. The pathological hallmark of all forms of Alexander disease is the presence of Rosenthal fibers, cytoplasmic inclusions in astrocytes that contain the intermediate filament protein GFAP in association with small heat-shock proteins(3,4). We previously found that overexpression of human GFAP in astrocytes of transgenic mice is fatal and accompanied by the presence of inclusion bodies indistinguishable from human Rosenthal fibers(5). These results suggested that a primary alteration in GFAP may be responsible for Alexander disease. Sequence analysis of DNA samples from patients representing different Alexander disease phenotypes revealed that most cases are associated with non-conservative mutations in the coding region of GFAP. Alexander disease therefore represents the first example of a primary genetic disorder of astrocytes, one of the major cell types in the vertebrate CNS.	Univ Wisconsin, Dept Pathobiol Sci, Waisman Ctr, Madison, WI USA; Univ Wisconsin, Sch Vet Med, Waisman Ctr, Madison, WI USA; Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; Fac Med, INSERM U384, Clermont Ferrand, France; Hop St Vincent de Paul, Serv neuropediat, AP HP, F-75674 Paris, France; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Columbia University; Columbia University	Messing, A (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Waisman Ctr, Madison, WI USA.	messing@waisman.wisc.edu	Rodriguez, Diana/GVR-7668-2022		NATIONAL EYE INSTITUTE [R01EY009331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022475] Funding Source: NIH RePORTER; Telethon [C.20] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		BESNARD F, 1991, J BIOL CHEM, V266, P18877; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; BRENNER M, 1990, MOL BRAIN RES, V7, P277, DOI 10.1016/0169-328X(90)90078-R; Coffeen CM, 2000, HUM MOL GENET, V9, P787, DOI 10.1093/hmg/9.5.787; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; DUCKETT S, 1995, PEDIAT NEUROPATHOLOG, P620; Fuchs E, 1996, ANNU REV GENET, V30, P197, DOI 10.1146/annurev.genet.30.1.197; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; HERNDON RM, 1970, J NEUROPATH EXP NEUR, V29, P524, DOI 10.1097/00005072-197010000-00002; HOWARD RS, 1993, J NEUROL NEUROSUR PS, V56, P977, DOI 10.1136/jnnp.56.9.977; Irvine AD, 1999, BRIT J DERMATOL, V140, P815, DOI 10.1046/j.1365-2133.1999.02810.x; Isaacs A, 1998, GENOMICS, V51, P152, DOI 10.1006/geno.1998.5360; IWAKI A, 1992, NEUROSCI LETT, V140, P89, DOI 10.1016/0304-3940(92)90689-5; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; JOHNSON AB, 1989, AM J ANAT, V185, P335, DOI 10.1002/aja.1001850228; JOHNSON AB, 1996, HDB CLIN NEUROLOGY, V22, P701; KLEIN EA, 1994, CLIN NEUROPATHOL, V13, P31; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; Liedtke W, 1998, AM J PATHOL, V152, P251; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Messing A, 1998, AM J PATHOL, V152, P391; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Reichard EAP, 1996, PEDIATR PATHOL LAB M, V16, P327, DOI 10.1080/107710496175804; Rosenthal W., 1898, BEITR PATHOL ANAT AL, V23, P111; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Schwankhaus JD, 1995, NEUROLOGY, V45, P2266, DOI 10.1212/WNL.45.12.2266; Sjoberg G, 1999, HUM MOL GENET, V8, P2191, DOI 10.1093/hmg/8.12.2191	30	496	509	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					117	120		10.1038/83679	http://dx.doi.org/10.1038/83679			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138011				2022-12-27	WOS:000166187900028
J	Ng, L; Hurley, LB; Dierks, B; Srinivas, M; Salto, C; Vennstrom, B; Reh, TA; Forrest, D				Ng, L; Hurley, LB; Dierks, B; Srinivas, M; Salto, C; Vennstrom, B; Reh, TA; Forrest, D			A thyroid hormone receptor that is required for the development of green cone photoreceptors	NATURE GENETICS			English	Article							MICE LACKING; BETA; EXPRESSION; ALPHA; RESISTANCE; MOUSE; ISOFORM; GENE; PIGMENTS; CELLS	Color vision is facilitated by distinct populations of cone photoreceptors in the retina. In rodents, cones expressing different opsin photopigments are sensitive to middle (M, 'green') and short (S, 'blue') wavelengths, and are differentially distributed across the retina(1,2). The mechanisms that control which opsin is expressed in a particular cone are poorly understood(2,3), but previous in vitro studies implicated thyroid hormone in cone differentiation(4,5). Thyroid hormone receptor beta2 (TR beta2) is a ligand-activated transcription factor that is expressed in the outer nuclear layer of the embryonic retina(6,7). Here we delete Thrb (encoding Tr beta2) in mice, causing the selective loss of M-cones and a concomitant increase in S-opsin immunoreactive cones. Moreover, the gradient of cone distribution is disturbed, with S-cones becoming widespread across the retina. The results indicate that cone photoreceptors throughout the retina have the potential to follow a default S-cone pathway and reveal an essential role for Tr beta2 in the commitment to an M-cone identity. Our findings raise the possibility that Thrb mutations may be associated with human cone disorders(8).	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Univ Washington, Hlth Sci Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Hlth Sci Ctr, Dept Biol Struct, Seattle, WA 98195 USA; Karolinska Inst, Dev Biol Lab, CMB, Stockholm, Sweden	Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Karolinska Institutet	Forrest, D (corresponding author), Mt Sinai Sch Med, Dept Human Genet, Box 1498, New York, NY 10029 USA.	tomreh@u.washington.edu; douglas.forrest@mssm.edu		Forrest, Douglas/0000-0002-3463-4162				Abel ED, 1999, J CLIN INVEST, V104, P291, DOI 10.1172/JCI6397; Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Bayer AU, 1999, DOC OPHTHALMOL, V98, P233, DOI 10.1023/A:1002416918247; BRADLEY DJ, 1994, P NATL ACAD SCI USA, V91, P439, DOI 10.1073/pnas.91.2.439; BROWMAN HI, 1994, VISION RES, V34, P1397, DOI 10.1016/0042-6989(94)90139-2; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; CHIU MI, 1994, VISUAL NEUROSCI, V11, P773, DOI 10.1017/S0952523800003072; Chomez P, 2000, DEVELOPMENT, V127, P1489; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; KELLEY MW, 1995, INVEST OPHTH VIS SCI, V36, P1280; KELLEY MW, 1995, DEVELOPMENT, V121, P3777; Langlois MF, 1997, J BIOL CHEM, V272, P24927, DOI 10.1074/jbc.272.40.24927; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; NEWELL FW, 1977, KLIN MONATSBL AUGENH, V171, P731; NG L, 1995, MOL ENDOCRINOL, V9, P1202, DOI 10.1210/me.9.9.1202; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Rusch A, 1998, P NATL ACAD SCI USA, V95, P15758, DOI 10.1073/pnas.95.26.15758; SJOBERG M, 1995, MOL CELL BIOL, V15, P4718; SJOBERG M, 1992, DEVELOPMENT, V114, P39; SJOBERG M, 1994, EXPRESSION FUNCTION; SZEL A, 1993, J COMP NEUROL, V331, P564, DOI 10.1002/cne.903310411; Szel A, 2000, J OPT SOC AM A, V17, P568, DOI 10.1364/JOSAA.17.000568; SZEL A, 1994, NATURE, V370, P336, DOI 10.1038/370336a0; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WOOD WM, 1991, MOL ENDOCRINOL, V5, P1049, DOI 10.1210/mend-5-8-1049	31	400	404	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					94	98		10.1038/83829	http://dx.doi.org/10.1038/83829			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138006				2022-12-27	WOS:000166187900023
J	Busjahn, A; Knoblauch, H; Faulhaber, HD; Aydin, A; Uhlmann, R; Tuomilehto, J; Kaprio, J; Jedrusik, P; Januszewicz, A; Strelau, J; Schuster, H; Luft, FC; Muller-Myhsok, B				Busjahn, A; Knoblauch, H; Faulhaber, HD; Aydin, A; Uhlmann, R; Tuomilehto, J; Kaprio, J; Jedrusik, P; Januszewicz, A; Strelau, J; Schuster, H; Luft, FC; Muller-Myhsok, B			A region on chromosome 3 is linked to dizygotic twinning	NATURE GENETICS			English	Article							VANISHING TWIN; GAMMA GENE; LOCUS		Humboldt Univ, Charite, Fac Med, Franz Volhard Clin, Berlin, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany; Natl Publ Hlth Inst, Helsinki, Finland; Infogen, Helsinki, Finland; Univ Helsinki, Finnish Twin Cohort Study, Helsinki, Finland; Warsaw Med Univ, Warsaw, Poland; Warsaw Univ, Warsaw, Poland; Natl Inst Cardiol, Warsaw, Poland; Bernhard Nocht Inst Trop Med, Hamburg, Germany	Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Finland National Institute for Health & Welfare; University of Helsinki; Medical University of Warsaw; University of Warsaw; Institute of Cardiology - Poland; Bernhard Nocht Institut fur Tropenmedizin	Luft, FC (corresponding author), Humboldt Univ, Charite, Fac Med, Franz Volhard Clin, Berlin, Germany.		Kaprio, Jaakko/A-1820-2008; Busjahn, Andreas/P-5023-2019; Müller-Myhsok, Bertram/A-3289-2013; Busjahn, Andreas/F-9936-2011	Kaprio, Jaakko/0000-0002-3716-2455; Busjahn, Andreas/0000-0001-9650-6919; Luft, Friedrich/0000-0002-8635-1199; Jedrusik, Piotr/0000-0003-0037-6035				CLARK P, 1982, HUM GENET, V61, P171, DOI 10.1007/BF00274213; ERIKSSON AW, 1973, HUM HERED, V23, P511, DOI 10.1159/000152619; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; KELLY MP, 1991, FERTIL STERIL, V56, P221; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Knoblauch H, 1999, ARTERIOSCL THROM VAS, V19, P2940, DOI 10.1161/01.ATV.19.12.2940; Landy HJ, 1998, HUM REPROD UPDATE, V4, P177, DOI 10.1093/humupd/4.2.177; Lewis CM, 1996, AM J MED GENET, V61, P237, DOI 10.1002/(SICI)1096-8628(19960122)61:3<237::AID-AJMG7>3.0.CO;2-R; Lummaa V, 1998, NATURE, V394, P533, DOI 10.1038/28977; Matte U., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P431; Milad MP, 1998, HUM REPROD, V13, P2296, DOI 10.1093/humrep/13.8.2296; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Weinberg W., 1909, ARCH RASSEN GES BIOL, V6,, P28; WYSHAK G, 1965, AM J PUBLIC HEALTH N, V55, P1586, DOI 10.2105/AJPH.55.10.1586	14	21	21	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					398	399		10.1038/82515	http://dx.doi.org/10.1038/82515			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101833				2022-12-27	WOS:000165671700009
J	Tong, ZB; Gold, L; Pfeifer, KE; Dorward, H; Lee, E; Bondy, CA; Dean, J; Nelson, LM				Tong, ZB; Gold, L; Pfeifer, KE; Dorward, H; Lee, E; Bondy, CA; Dean, J; Nelson, LM			Mater, a maternal effect gene required for early embryonic development in mice	NATURE GENETICS			English	Article							MOUSE EMBRYO; TRANSCRIPTION; ACTIVATION; PROTEINS; EXPRESSION; TRANSITION; DIVERSITY; FAMILY; STAGE		NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD USA; NICHD, Dev Endocrinol Branch, NIH, Bethesda, MD USA; NICHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD USA; Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Georgetown University	Dean, J (corresponding author), NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD USA.	jurrien@helix.nih.gov; nelsonl@cc1.nichd.nih.gov		Pfeifer, Karl/0000-0002-0254-682X				Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; BOLTON VN, 1984, J EMBRYOL EXP MORPH, V79, P139; BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; CONOVER JC, 1991, DEV BIOL, V144, P392, DOI 10.1016/0012-1606(91)90431-2; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Gardner RL, 1996, HUM REPROD UPDATE, V2, P3, DOI 10.1093/humupd/2.1.3; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; LATHAM KE, 1993, MOL REPROD DEV, V35, P140, DOI 10.1002/mrd.1080350207; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nothias JY, 1996, EMBO J, V15, P5715, DOI 10.1002/j.1460-2075.1996.tb00955.x; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Tong ZB, 2000, MAMM GENOME, V11, P281, DOI 10.1007/s003350010053	15	408	443	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					267	268		10.1038/81547	http://dx.doi.org/10.1038/81547			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062459				2022-12-27	WOS:000165176500008
J	McLysaght, A; Hokamp, K; Wolfe, KH				McLysaght, A; Hokamp, K; Wolfe, KH			Extensive genomic duplication during early chordate evolution	NATURE GENETICS			English	Article							VERTEBRATE EVOLUTION; LARGE-SCALE; GENE FAMILIES; ANCIENT; HYPOTHESIS; SEQUENCE; CHROMOSOMES; POLYPLOIDS; RECEPTOR; HISTORY	Opinions on the hypothesis(1) that ancient genome duplications contributed to the vertebrate genome range from strong skepticism(2-4) to strong credence(5-7). Previous studies concentrated on small numbers of gene families or chromosomal regions that might not have been representative of the whole genome(4,5), or used subjective methods to identify paralogous genes and regions(5,8). Here we report a systematic and objective analysis of the draft human genome sequence to identify paralogous chromosomal regions (paralogons) formed during chordate evolution and to estimate the ages of duplicate genes. We found that the human genome contains many more paralogons than would be expected by chance. Molecular clock analysis of all protein families in humans that have orthologs in the fly and nematode indicated that a burst of gene duplication activity took place in the period 350-650 Myr ago and that many of the duplicate genes formed at this time are located within paralogons. Our results support the contention that many of the gene families in vertebrates were formed or expanded by large- scale DNA duplications in an early chordate. Considering the incompleteness of the sequence data and the antiquity of the event, the results are compatible with at least one round of polyploidy.	Univ Dublin, Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland	Trinity College Dublin	Wolfe, KH (corresponding author), Univ Dublin, Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland.	khwolfe@tcd.ie	Wolfe, Kenneth H/B-4653-2009; Hokamp, Karsten/C-5534-2009	McLysaght, Aoife/0000-0003-2552-6220; Hokamp, Karsten/0000-0001-7464-2370; Wolfe, Kenneth/0000-0003-4992-4979				Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; Friedman R, 2001, GENOME RES, V11, P1842, DOI 10.1101/gr.200601; Gu X, 2002, GENOME RES, V12, P1, DOI 10.1101/gr.214402; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; Gu X, 1997, MOL BIOL EVOL, V14, P1106, DOI 10.1093/oxfordjournals.molbev.a025720; HOLLAND PWH, 1994, DEVELOPMENT, P125; Hughes AL, 1998, MOL BIOL EVOL, V15, P854, DOI 10.1093/oxfordjournals.molbev.a025990; Hughes AL, 2001, GENOME RES, V11, P771, DOI 10.1101/gr.GR-1600R; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Koh YS, 1999, GENOMICS, V57, P289, DOI 10.1006/geno.1998.5683; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Makalowski W, 2001, GENOME RES, V11, P667, DOI 10.1101/gr.188801; Martin A, 2001, MOL BIOL EVOL, V18, P89, DOI 10.1093/oxfordjournals.molbev.a003723; Miyata T, 2001, BIOESSAYS, V23, P1018, DOI 10.1002/bies.1147; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohno S., 1970, EVOLUTION GENE DUPLI; Pebusque MJ, 1998, MOL BIOL EVOL, V15, P1145, DOI 10.1093/oxfordjournals.molbev.a026022; Popovici C, 2001, BIOCHEM BIOPH RES CO, V288, P362, DOI 10.1006/bbrc.2001.5794; RUDDLE FH, 1994, DEVELOPMENT, P155; Smith NGC, 1999, BIOESSAYS, V21, P697, DOI 10.1002/(SICI)1521-1878(199908)21:8<697::AID-BIES9>3.0.CO;2-X; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Tomsig JL, 2000, BIOCHEMISTRY-US, V39, P16163, DOI 10.1021/bi0019949; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009	31	409	420	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					200	204		10.1038/ng884	http://dx.doi.org/10.1038/ng884			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12032567				2022-12-27	WOS:000175903500019
J	Pendas, AM; Zhou, ZJ; Cadinanos, J; Freije, JMP; Wang, JM; Hultenby, K; Astudillo, A; Wernerson, A; Rodriguez, F; Tryggvason, K; Lopez-Otin, C				Pendas, AM; Zhou, ZJ; Cadinanos, J; Freije, JMP; Wang, JM; Hultenby, K; Astudillo, A; Wernerson, A; Rodriguez, F; Tryggvason, K; Lopez-Otin, C			Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice	NATURE GENETICS			English	Article							ENCODING LAMIN A/C; NUCLEAR LAMINA; DYSTROPHY; MATURATION; PROTEINS; DISEASE; PROTEOLYSIS; MUTATIONS; HEART; GENE	The mouse ortholog of human FACE-1, Zmpste24, is a multi-spanning membrane protein widely distributed in mammalian tissues(1,2) and structurally related to Afc1p/ste24p, a yeast metalloproteinase involved in the maturation of fungal pheromones(3). Disruption of the gene Zmpste24 caused severe growth retardation and premature death in homozygous-null mice. Histopathological analysis of the mutant mice revealed several abnormalities, including dilated cardiomyopathy, muscular dystrophy and lipodystrophy. These alterations are similar to those developed by mice deficient in A-type lamin(4), a major component of the nuclear lamina(5), and phenocopy most defects observed in humans with diverse congenital laminopathies(6-8). In agreement with this finding, Zmpste24-null mice are defective in the proteolytic processing of prelamin A. This deficiency in prelamin A maturation leads to the generation of abnormalities in nuclear architecture that probably underlie the many phenotypes observed in both mice and humans with mutations in the lamin A gene. These results indicate that prelamin A is a specific substrate for Zmpste24 and demonstrate the usefulness of genetic approaches for identifying the in vivo substrates of proteolytic enzymes.	Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Pathol, S-14186 Huddinge, Sweden; Univ Oviedo, Hosp Cent Asturias, Serv Anat Patol, E-33080 Oviedo, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Karolinska Institutet; Karolinska Institutet; Central University Hospital Asturias; University of Oviedo	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.		Freije, José M.P./A-6535-2008; López-Otín, Carlos/AAB-2106-2020; Pendas, Alberto M/L-1017-2014; zhou, zhongjun/D-4818-2012; Zhou, Zhongjun/C-4476-2009	Freije, José M.P./0000-0002-4688-8266; López-Otín, Carlos/0000-0001-6964-1904; Zhou, Zhongjun/0000-0001-7092-8128; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809; Wernerson, Annika/0000-0003-2792-0010; Cadinanos, Juan/0000-0001-7561-7759; Pendas, Alberto M/0000-0001-9264-3721				Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Cohen M, 2001, TRENDS BIOCHEM SCI, V26, P41, DOI 10.1016/S0968-0004(00)01727-8; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Freije JMP, 1999, GENOMICS, V58, P270, DOI 10.1006/geno.1999.5834; Hogan B, 1994, MANIPULATING MOUSE E; Leung GK, 2001, J BIOL CHEM, V276, P29051, DOI 10.1074/jbc.M102908200; Manilal S, 1999, HUM MOL GENET, V8, P353, DOI 10.1093/hmg/8.2.353; Morris GE, 1999, HUM MOL GENET, V8, P1847, DOI 10.1093/hmg/8.10.1847; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; SINENSKY M, 1994, J CELL SCI, V107, P61; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	18	411	435	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2002	31	1					94	99		10.1038/ng871	http://dx.doi.org/10.1038/ng871			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11923874	Bronze			2022-12-27	WOS:000175362500022
J	Stromme, P; Mangelsdorf, ME; Shaw, MA; Lower, KM; Lewis, SME; Bruyere, H; Lutcherath, V; Gedeon, AK; Wallace, RH; Scheffer, IE; Turner, G; Partington, M; Frints, SGM; Fryns, JP; Sutherland, GR; Mulley, JC; Gecz, J				Stromme, P; Mangelsdorf, ME; Shaw, MA; Lower, KM; Lewis, SME; Bruyere, H; Lutcherath, V; Gedeon, AK; Wallace, RH; Scheffer, IE; Turner, G; Partington, M; Frints, SGM; Fryns, JP; Sutherland, GR; Mulley, JC; Gecz, J			Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy	NATURE GENETICS			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; INFANTILE SPASMS; WEST-SYNDROME; SPECTRUM; LINKAGE; DISEASE	Mental retardation and epilepsy often occur together. They are both heterogeneous conditions with acquired and genetic causes. Where causes are primarily genetic, major advances have been made in unraveling their molecular basis. The human X chromosome alone is estimated to harbor more than 100 genes that, when mutated, cause mental retardation(1). At least eight autosomal genes involved in idiopathic epilepsy have been identified(2), and many more have been implicated in conditions where epilepsy is a feature. We have identified mutations in an X chromosome-linked, Aristaless-related, homeobox gene (ARX), in nine families with mental retardation (syndromic and nonspecific), various forms of epilepsy, including infantile spasms and myoclonic seizures, and dystonia. Two recurrent mutations, present in seven families, result in expansion of polyalanine tracts of the ARX protein. These probably cause protein aggregation, similar to other polyalanine(3) and polyglutamine(4) disorders. In addition, we have identified a missense mutation within the ARX homeodomain and a truncation mutation. Thus, it would seem that mutation of ARX is a major contributor to X-linked mental retardation and epilepsy.	Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA 5006, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Childrens & Womens Hlth Ctr British Columbia, Dept Med Genet, Vancouver, BC, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Cent Hosp Rogaland, Dept Paediat, Stavanger, Norway; Univ Melbourne, Austin & Repatriat Med Ctr, Monash Med Ctr, Dept Med Neurol, Melbourne, Vic, Australia; Royal Childrens Hosp, Melbourne, Vic, Australia; Hunter Genet, Waratah, NSW, Australia; Univ Newcastle, Waratah, NSW, Australia; Univ Louvain Hosp VIB, Human Genome Lab, Louvain, Belgium; Univ Hosp, Dept Human Genet, B-3000 Louvain, Belgium; Univ Hosp, Dept Clin Genet, B-3000 Louvain, Belgium; Univ Adelaide, Dept Mol Biosci, Adelaide, SA, Australia	Womens & Childrens Hospital Australia; University of Adelaide; BC Women's Hospital & Health Centre; University of British Columbia; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; Royal Children's Hospital Melbourne; University of Newcastle; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; Universite Catholique Louvain Hospital; University of Adelaide	Gecz, J (corresponding author), Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA 5006, Australia.	jozef.gecz@adelaide.edu.au	Scheffer, Ingrid E/G-1668-2013; Gedeon, Agi/G-7890-2011; Mangelsdorf, Marie E/A-2318-2013; Gecz, Jozef/X-3469-2019; Sutherland, Grant Robert/D-2606-2012	Scheffer, Ingrid E/0000-0002-2311-2174; Mangelsdorf, Marie E/0000-0002-7855-7701; Gecz, Jozef/0000-0002-7884-6861; Wallace, Robyn/0000-0001-6141-3317; Lower, Karen/0000-0003-2196-5234; Lewis, Suzanne/0000-0002-6300-5381; Frints, Suzanna G.M./0000-0002-5027-8364				Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Berkovic SF, 2001, EPILEPSIA, V42, P16, DOI 10.1046/j.1528-1157.2001.0420s5016.x; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brown LY, 2001, HUM MOL GENET, V10, P791, DOI 10.1093/hmg/10.8.791; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Bruyere H, 1999, CLIN GENET, V55, P173, DOI 10.1034/j.1399-0004.1999.550305.x; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Claes S, 1997, ANN NEUROL, V42, P360, DOI 10.1002/ana.410420313; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; FEINBERG AP, 1977, DEV MED CHILD NEUROL, V19, P524; FRINTS SGM, IN PRESS AM J MED GE; Gall H, 1999, HAUTARZT, V50, P186, DOI 10.1007/s001050050887; Galliot B, 2000, TRENDS GENET, V16, P1, DOI 10.1016/S0168-9525(99)01888-0; Goodman FR, 2000, AM J HUM GENET, V67, P197, DOI 10.1086/302961; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Hill ME, 2001, BRAIN, V124, P522, DOI 10.1093/brain/124.3.522; Meijlink F, 1999, INT J DEV BIOL, V43, P651; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Ohira R, 2000, AM J HUM GENET, V67, P169; PARTINGTON MW, 1988, AM J MED GENET, V30, P251, DOI 10.1002/ajmg.1320300127; SCHEFFER IE, IN PRESS NEUROLOGY; Stromme P, 1999, J MED GENET, V36, P374; VIGEVANO F, 1993, EPILEPSIA, V34, P743, DOI 10.1111/j.1528-1157.1993.tb00456.x; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; Wong M, 2001, PEDIATR NEUROL, V24, P89, DOI 10.1016/S0887-8994(00)00238-1	29	352	361	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					441	445		10.1038/ng862	http://dx.doi.org/10.1038/ng862			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11889467				2022-12-27	WOS:000174682000025
J	Falck, J; Petrini, JHJ; Williams, BR; Lukas, J; Bartek, J				Falck, J; Petrini, JHJ; Williams, BR; Lukas, J; Bartek, J			The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways	NATURE GENETICS			English	Article							ATAXIA-TELANGIECTASIA; CHROMATIN ASSOCIATION; POLYMERASE-ALPHA; CELL-CYCLE; ATM; REPLICATION; COMPLEX; PHOSPHORYLATION; INITIATION; PROTEIN	To preserve genetic integrity, mammalian cells exposed to ionizing radiation activate the ATM kinase, which initiates a complex response including the S-phase checkpoint pathways to delay DNA replication(1,2). Defects in ATM or its substrates Nbs1 or Chk2 (ref. 3), the Nbs1-interacting Mre11 protein(4), or the Chk2-regulated Cdc25A-Cdk2 cascade all cause radio-resistant DNA synthesis (RDS)(5,6). It is unknown, however, whether these proteins operate in a common signaling cascade. Here we show that experimental blockade of either the Nbs1-Mre11 function or the Chk2-triggered events leads to a partial RDS phenotype in human cells. In contrast, concomitant interference with Nbs1-Mre11 and the Chk2-Cdc25A-Cdk2 pathways entirely abolishes inhibition of DNA synthesis induced by ionizing radiation, resulting in complete RDS analogous to that caused by defective ATM. In addition, Cdk2-dependent loading of Cdc45 onto replication origins, a prerequisite for recruitment of DNA polymerase(7,8), was prevented upon irradiation of normal or Nbs1/Mre11-defective cells but not cells with defective ATM. We conclude that in response to ionizing radiation, phosphorylations of Nbs1 and Chk2 by ATM trigger two parallel branches of the DNA damage-dependent S-phase checkpoint that cooperate by inhibiting distinct steps of DNA replication.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Univ Wisconsin, Sch Med, Madison, WI 53706 USA	Danish Cancer Society; University of Wisconsin System; University of Wisconsin Madison	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandblvd 49, DK-2100 Copenhagen, Denmark.		Bartek, Jiri/G-5870-2014	Lukas, Jiri/0000-0001-9087-506X				Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Carr AM, 2000, SCIENCE, V287, P1765, DOI 10.1126/science.287.5459.1765; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kukimoto I, 1999, EUR J BIOCHEM, V265, P936, DOI 10.1046/j.1432-1327.1999.00791.x; Larner JM, 1999, NUCLEIC ACIDS RES, V27, P803, DOI 10.1093/nar/27.3.803; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Takisawa H, 2000, CURR OPIN CELL BIOL, V12, P690, DOI 10.1016/S0955-0674(00)00153-8; Tao L, 2000, J CELL BIOCHEM, V78, P442, DOI 10.1002/1097-4644(20000901)78:3<442::AID-JCB9>3.0.CO;2-1; Trivedi A, 1998, DNA CELL BIOL, V17, P885, DOI 10.1089/dna.1998.17.885; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	30	301	308	1	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					290	294		10.1038/ng845	http://dx.doi.org/10.1038/ng845			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11850621				2022-12-27	WOS:000174157600013
J	Maison, C; Bailly, D; Peters, AHFM; Quivy, JP; Roche, D; Taddei, A; Lachner, M; Jenuwein, T; Almouzni, G				Maison, C; Bailly, D; Peters, AHFM; Quivy, JP; Roche, D; Taddei, A; Lachner, M; Jenuwein, T; Almouzni, G			Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component	NATURE GENETICS			English	Article							CHROMATIN; PROTEINS	Post-translational modification of histone tails is thought to modulate higher-order chromatin structure(1-3). Combinations of modifications including acetylation, phosphorylation and methylation have been proposed to provide marks recognized by specific proteins(4). This is exemplified, in both mammalian cells and fission yeast, by transcriptionally silent constitutive pericentric heterochromatin. Such heterochromatin contains histones that are generally hypoacetylated(5) and methylated by Suv39h methyltransferases at lysine 9 of histone H3 (H3- K9)(6,7). Each of these modification states has been implicated in the maintenance of HP1 protein-binding at pericentric heterochromatin, in transcriptional silencing and in centromere function(7-12). In particular, H3-K9 methylation is thought to provide a marking system for the establishment and maintenance of stably repressed regions and heterochromatin subdomains(3,13). To address the question of how these two types of modifications, as well as other unidentified parameters, function to maintain pericentric heterochromatin, we used a combination of histone deacetylase inhibitors, RNAse treatments and an antibody raised against methylated branched H3- K9 peptides. Our results show that both H3- K9 acetylation and methylation can occur on independent sets of H3 molecules in pericentric heterochromatin. In addition, we identify an RNA-and histone modification-dependent structure that brings methylated H3- K9 tails together in a specific configuration required for the accumulation of HP1 proteins in these domains.	Inst Curie, Res Sect, CNRS, UMR 218, F-75248 Paris 05, France; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Almouzni, G (corresponding author), Inst Curie, Res Sect, CNRS, UMR 218, 26 Rue Ulm, F-75248 Paris 05, France.		taddei, angela/AAL-2413-2021; Almouzni, Genevieve/ABG-1029-2021	taddei, angela/0000-0002-3217-0739; Almouzni, Genevieve/0000-0001-5570-0723; quivy, jean-pierre/0000-0001-6557-7204; Peters, Antoine/0000-0002-0311-1887				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jaeger L, 1997, CURR OPIN STRUC BIOL, V7, P324, DOI 10.1016/S0959-440X(97)80047-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; KIPLING D, 1994, CHROMOSOMA, V103, P46, DOI 10.1007/BF00364725; KORNBERG RD, 1989, METHOD ENZYMOL, V170, P3; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lyon MF, 1999, CURR BIOL, V9, pR235, DOI 10.1016/S0960-9822(99)80151-1; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; ONeill LP, 1996, METHOD ENZYMOL, V274, P189; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	30	542	555	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					329	334		10.1038/ng843	http://dx.doi.org/10.1038/ng843			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11850619				2022-12-27	WOS:000174157600021
J	Koishi, R; Ando, Y; Ono, M; Shimamura, M; Yasumo, H; Fujiwara, T; Horikoshi, H; Furukawa, H				Koishi, R; Ando, Y; Ono, M; Shimamura, M; Yasumo, H; Fujiwara, T; Horikoshi, H; Furukawa, H			Angptl3 regulates lipid metabolism in mice	NATURE GENETICS			English	Article							TRIGLYCERIDE-TRANSFER-PROTEIN; DEPENDENT DIABETES-MELLITUS; LIPOPROTEIN METABOLISM; APOLIPOPROTEIN-B; TANGIER-DISEASE; IN-VIVO; GENE; MUTATIONS; IDENTIFICATION; ABETALIPOPROTEINEMIA	The KK obese mouse is moderately obese and has abnormally high levels of plasma insulin (hyperinsulinemia), glucose (hyperglycemia) and lipids (hyperlipidemia). In one strain (KK/San), we observed abnormally low plasma lipid levels (hypolipidemia). This mutant phenotype is inherited recessively as a mendelian trait. Here we report the mapping of the hypolipidemia (hypo locus to the middle of chromosome 4 and positional cloning of the autosomal recessive mutation responsible for the hypolipidemia. The hypl locus encodes a unique angiopoietin-like lipoprotein modulator, which we named Allm1. it is identical to angiopoietin-like protein 3, encoded by Angptl3, and has a highly conserved counterpart in humans. Overexpression of Angpl3 or intravenous injection of the purified protein in KK/San mice elicited an increase in circulating plasma lipid levels. This increase was also observed in C57BL/6J normal mice. Taken together, these data suggest that Angptl3 regulates lipid metabolism in animals.	Sankyo Co Ltd, Biomed Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; Sankyo Co Ltd, Med Safety Res Labs, Shizuoka 4370065, Japan; Sankyo Co Ltd, Pharmacol & Mol Biol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; Sankyo Pharma Res Inst, La Jolla, CA 92037 USA	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Koishi, R (corresponding author), Sankyo Co Ltd, Biomed Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	koishi@shina.sankyo.co.jp		Ando, Yukio/0000-0001-7115-9105				Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BRUNZELL JD, 1976, METABOLISM, V25, P313, DOI 10.1016/0026-0495(76)90089-5; Conklin D, 1999, GENOMICS, V62, P477, DOI 10.1006/geno.1999.6041; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; FARESE RV, 1992, J INTERN MED, V231, P643, DOI 10.1111/j.1365-2796.1992.tb01253.x; Fujiwara T, 1998, GENOMICS, V54, P155, DOI 10.1006/geno.1998.5554; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GREENFIELD M, 1980, DIABETOLOGIA, V18, P441; GREENFIELD MS, 1982, ARCH INTERN MED, V142, P1498, DOI 10.1001/archinte.142.8.1498; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Kondo K., 1957, B EXP ANIM, V6, P107; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; NAKAMURA M, 1962, P JPN ACAD, V38, P348, DOI 10.2183/pjab1945.38.348; Nakamura M, 1967, Diabetologia, V3, P212, DOI 10.1007/BF01222198; NARCISI TME, 1995, AM J HUM GENET, V57, P1298; Parhofer KG, 1996, J LIPID RES, V37, P844; Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196; PURCELLHUYNH DA, 1995, J CLIN INVEST, V96, P1845, DOI 10.1172/JCI118230; REAVEN GM, 1987, METABOLISM, V36, P1, DOI 10.1016/0026-0495(87)90193-4; Rehberg EF, 1996, J BIOL CHEM, V271, P29945, DOI 10.1074/jbc.271.47.29945; Reue K, 1996, J LIPID RES, V37, P1387; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SCHAEFER EJ, 1994, ATHEROSCLEROSIS, V108, pS41, DOI 10.1016/0021-9150(94)90152-X; SCHONFELD G, 1995, ANNU REV NUTR, V15, P23, DOI 10.1146/annurev.nu.15.070195.000323; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SHIRAKI T, 1993, DIABETES FRONTIER, V4, P641; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; STANBURY JB, 1983, METABOLIC BASIS INHE, P589; TALMUD PJ, 1994, J LIPID RES, V35, P468; Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904; Welch CL, 1996, J LIPID RES, V37, P1406; WELTY FK, 1995, CIRCULATION, V92, P2036, DOI 10.1161/01.CIR.92.8.2036; WETTERAU JR, 1992, SCIENCE, V258, P999	38	306	351	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					151	157		10.1038/ng814	http://dx.doi.org/10.1038/ng814			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11788823				2022-12-27	WOS:000173708700014
J	Holmes, SE; O'Hearn, E; Rosenblatt, A; Callahan, C; Hwang, HS; Ingersoll-Ashworth, RG; Fleisher, A; Stevanin, G; Brice, A; Potter, NT; Ross, CA; Margolis, RL				Holmes, SE; O'Hearn, E; Rosenblatt, A; Callahan, C; Hwang, HS; Ingersoll-Ashworth, RG; Fleisher, A; Stevanin, G; Brice, A; Potter, NT; Ross, CA; Margolis, RL			A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2	NATURE GENETICS			English	Article							TRINUCLEOTIDE REPEAT; GENOMIC DNA	We recently described a disorder termed Huntington disease-like 2 (HDL2) that completely segregates with an unidentified CAG/CTG expansion in a large pedigree (W)(1). We now report the cloning of this expansion and its localization to a variably spliced exon of JPH3 (encoding junctophilin-3), a gene involved in the formation of junctional membrane structures.	Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Hop La Pitie Salpetriere, INSERM U289, Paris, France; Univ Tennessee, Med Ctr, Dept Med Genet, Knoxville, TN USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Tennessee System; University of Tennessee Health Science Center; Johns Hopkins University	Margolis, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA.	rmargoli@jhmi.edu	brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Ross, Christopher A/H-8395-2013; Stevanin, Giovanni/E-5038-2016	brice, alexis/0000-0002-0941-3990; Stevanin, Giovanni/0000-0001-9368-8657; , Roxann/0000-0002-4266-613X; Hwang, Hyon Sung/0000-0001-8117-0199	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038054, P50NS016375, P01NS016375] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16375, NS38054] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Margolis RL, 2001, ANN NEUROL, V50, P373, DOI 10.1002/ana.1124; Margolis RL, 1997, HUM GENET, V100, P114, DOI 10.1007/s004390050476; Nishi M, 2000, BIOCHEM BIOPH RES CO, V273, P920, DOI 10.1006/bbrc.2000.3011; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	10	193	203	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2001	29	4					377	378		10.1038/ng760	http://dx.doi.org/10.1038/ng760			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11694876				2022-12-27	WOS:000172507500009
J	Chapman, KL; Mortier, GR; Chapman, K; Loughlin, J; Grant, ME; Briggs, MD				Chapman, KL; Mortier, GR; Chapman, K; Loughlin, J; Grant, ME; Briggs, MD			Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia	NATURE GENETICS			English	Article							OLIGOMERIC MATRIX PROTEIN; IX COLLAGEN; PSEUDOACHONDROPLASIA; GENE; IDENTIFICATION; CHAIN; COMP; STATURE; COL9A2; FAMILY	Multiple epiphyseal dysplasia (MED) is a relatively mild and clinically variable osteochondrodysplasia, primarily characterized by delayed and irregular ossification of the epiphyses and early-onset osteoarthritis(1-3). Mutations in the genes encoding cartilage oligomeric matrix protein (COMP) and type IX collagen (COL9A2 and COL9A3) have previously been shown to cause different forms of MED (refs. 4-13). These dominant forms of MED (EDM1-3) are caused by mutations in the genes encoding structural proteins of the cartilage extracellular matrix (ECM); these proteins interact with high affinity in vitro(14,15). A recessive form of MED (EDM4) has also been reported; it is caused by a mutation in the diastrophic dysplasia sulfate transporter gene(16) (SLC26A). A genomewide screen of family with autosomal-dominant MED not linked to the EDM1-3 genes(17) provides significant genetic evidence for a MED locus on the short arm of chromosome 2 (2p24-p23), and a search for candidate genes identified MATN3 (ref. 18), encoding matrilin-3, within the critical region. Matrilin-3 is an oligomeric protein that is present in the cartilage ECM. We have identified two different missense mutations in the exon encoding the von Willebrand factor A (vWFA) domain of matrilin-3 in two unrelated families with MED (EDM5). These are the first mutations to be identified in any of the genes encoding the matrilin family of proteins and confirm a role for matrilin-3 in the development and homeostasis of cartilage and bone.	Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; Ghent Univ Hosp, Dept Med Genet, B-9000 Ghent, Belgium; Univ Oxford, Inst Mol Med, Oxford, England	University of Manchester; Ghent University; Ghent University Hospital; University of Oxford	Briggs, MD (corresponding author), Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	mike.briggs@man.ac.uk	Mortier, Geert/D-2542-2012	Mortier, Geert/0000-0001-9871-4578; Loughlin, John/0000-0003-2018-3361				Aszodi A, 1999, MOL CELL BIOL, V19, P7841; Belluoccio D, 1998, GENOMICS, V53, P391, DOI 10.1006/geno.1998.5519; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; Briggs MD, 2000, METH MOL B, V139, P133; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Deere M, 1999, AM J MED GENET, V85, P486, DOI 10.1002/(SICI)1096-8628(19990827)85:5<486::AID-AJMG10>3.0.CO;2-O; Delot E, 1998, J BIOL CHEM, V273, P26692, DOI 10.1074/jbc.273.41.26692; Haga N, 1998, J PEDIATR ORTHOPED, V18, P394, DOI 10.1097/00004694-199805000-00023; Hecht JT, 1998, MATRIX BIOL, V17, P269, DOI 10.1016/S0945-053X(98)90080-4; Hecht JT, 1998, MATRIX BIOL, V17, P625, DOI 10.1016/S0945-053X(98)90113-5; Holden P, 1999, AM J HUM GENET, V65, P31, DOI 10.1086/302440; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Ikegawa S, 1998, HUM GENET, V103, P633, DOI 10.1007/s004390050883; Lohiniva J, 2000, AM J MED GENET, V90, P216, DOI 10.1002/(SICI)1096-8628(20000131)90:3<216::AID-AJMG6>3.0.CO;2-1; Loughlin J, 1998, HUM MUTAT, pS10; Maddox BK, 1997, J BIOL CHEM, V272, P30993, DOI 10.1074/jbc.272.49.30993; MORTIER GR, IN PRESS EUR J HUM G; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; Rimoin DL, 1998, AM J MED GENET, V79, P376; Sasaki T, 2000, FASEB J, V14, P761, DOI 10.1096/fasebj.14.5.761; Spayde EC, 2000, MATRIX BIOL, V19, P121, DOI 10.1016/S0945-053X(00)00055-X; Superti-Furga A, 1999, J MED GENET, V36, P621; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; TREBLE NJ, 1990, J BONE JOINT SURG BR, V72, P1061, DOI 10.1302/0301-620X.72B6.2246289; Unger SL, 2001, PEDIATR RADIOL, V31, P10, DOI 10.1007/s002470000362; Wagener R, 2000, MAMM GENOME, V11, P85, DOI 10.1007/s003350010018	28	147	150	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					393	396		10.1038/ng573	http://dx.doi.org/10.1038/ng573			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479597				2022-12-27	WOS:000170174800024
J	Lieb, JD; Liu, XL; Botstein, D; Brown, PO				Lieb, JD; Liu, XL; Botstein, D; Brown, PO			Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; TELOMERIC HETEROCHROMATIN; YEAST TELOMERES; SIR4 PROTEINS; COMPLEX; SEQUENCES; TRANSCRIPTION; INTERACTS; DATABASE; TERMINI	We determined the distribution of repressor-activator protein 1 (Rap1) and the accessory silencing proteins Sir2, Sir3 and Sir4 in vivo on the entire yeast genome, at a resolution of 2 kb. Rap1 is central to the cellular economy during rapid growth, targeting 294 loci, about 5% of yeast genes, and participating in the activation of 37% of all RNA polymerase II initiation events in exponentially growing cells. Although the DNA sequence recognized by Rap1 is found in both coding and intergenic sequences, the binding of Rap1 to the genome was highly specific to intergenic regions with the potential to act as promoters. This global phenomenon, which may be a general characteristic of sequence-specific transcriptional factors, indicates the existence of a genome-wide molecular mechanism for marking promoter regions.	Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Stanford Med Informat, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Brown, PO (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	pbrown@cmgm.stanford.edu		Lieb, Jason/0000-0001-7601-8061				APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; CHERRY JM, 2000, SACCHAROMYCES GENOME; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; FREEMAN K, 1995, GENETICS, V141, P1253; Goncalves PM, 1996, MOL MICROBIOL, V19, P535, DOI 10.1046/j.1365-2958.1996.404939.x; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; GRAHAM IR, 1994, NUCLEIC ACIDS RES, V22, P124, DOI 10.1093/nar/22.2.124; Graham IR, 1999, MOL CELL BIOL, V19, P7481; Guarente L, 2000, GENE DEV, V14, P1021; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Idrissi FZ, 1999, BIOCHEM J, V341, P477, DOI 10.1042/0264-6021:3410477; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; Leblanc BP, 2000, P NATL ACAD SCI USA, V97, P10745, DOI 10.1073/pnas.200365097; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Liu X, 2001, Pac Symp Biocomput, P127; Lopez N, 1999, J BACTERIOL, V181, P3136, DOI 10.1128/JB.181.10.3136-3143.1999; Mewes HW, 1999, NUCLEIC ACIDS RES, V27, P44, DOI 10.1093/nar/27.1.44; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; REMACLE JE, 1992, MOL CELL BIOL, V12, P5516, DOI 10.1128/MCB.12.12.5516; Shore D, 1997, TRENDS BIOCHEM SCI, V22, P233, DOI 10.1016/S0968-0004(97)01082-7; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	36	535	546	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					327	334		10.1038/ng569	http://dx.doi.org/10.1038/ng569			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11455386				2022-12-27	WOS:000170174800012
J	Lin, K; Hsin, H; Libina, N; Kenyon, C				Lin, K; Hsin, H; Libina, N; Kenyon, C			Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR FKHR; AGE-1 PI3 KINASE; LIFE-SPAN; GENETIC-ANALYSIS; DAUER FORMATION; FACTOR AFX; DIAPAUSE; HOMOLOG; PHOSPHORYLATION; PATHWAY	The lifespan of Caenorhabditis elegans is regulated by the insulin/insulin-like growth factor (IGF)-1 receptor homolog DAF-2, which signals through a conserved phosphatidylinositol 3-kinase (PI 3-kinase)/Akt pathway(1-7) Mutants in this pathway remain youthful and active much longer than normal animals and can live more than twice as long, This lifespan extension requires DAF-16, a forkhead/winged-helix transcription factor(8,9). DAF-16 is thought to be the main target of the DAF-2 pathway. Insulin/IGF-1 signaling is thought to lead to phosphorylation of DAF-16 by AKT activity, which in turn shortens lifespan. Here, we show that the DAF-2 pathway prevents DAF-16 accumulation in nuclei. Disrupting Akt-consensus phosphorylation sites in DAF-16 causes nuclear accumulation in wild-type animals, but, surprisingly, has little effect on lifespan. Thus the DAF-2 pathway must have additional outputs. Lifespan in C. elegans can be extended by perturbing sensory neurons or germ cells(10,11). In both cases, lifespan extension requires DAF-16. We find that both sensory neurons and germline activity regulate DAF-16 accumulation in nuclei, but the nuclear localization patterns are different. Together these findings reveal unexpected complexity in the DAF-16-dependent pathways that regulate aging.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Genentech Inc, Dept Cell Biol & Technol, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; Roche Holding; Genentech	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu		Hsin, Honor/0000-0002-0510-7494				Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; DORMAN JB, 1995, GENETICS, V141, P1399; Gems D, 2000, J GERONTOL A-BIOL, V55, pB215, DOI 10.1093/gerona/55.5.B215; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; GOTTLIEB S, 1994, GENETICS, V137, P107; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lin SY, 1997, QUAL RELIAB ENG INT, V13, P9, DOI 10.1002/(SICI)1099-1638(199701)13:1<9::AID-QRE58>3.0.CO;2-W; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Malone EA, 1996, GENETICS, V143, P1193; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Riddle DL, 1997, C ELEGANS, P739; Rouault JP, 1999, CURR BIOL, V9, P329, DOI 10.1016/S0960-9822(99)80143-2; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; VALLEJO AN, 1994, PCR METH APPL, V4, pS123; VOWELS JJ, 1992, GENETICS, V130, P105; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	31	716	751	6	116	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2001	28	2					139	145		10.1038/88850	http://dx.doi.org/10.1038/88850			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381260				2022-12-27	WOS:000169011800015
J	Morahan, G; Huang, DX; Ymer, SI; Cancilla, MR; Stephen, K; Dabadghao, P; Werther, G; Tait, BD; Harrison, LC; Colman, PG				Morahan, G; Huang, DX; Ymer, SI; Cancilla, MR; Stephen, K; Dabadghao, P; Werther, G; Tait, BD; Harrison, LC; Colman, PG			Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele	NATURE GENETICS			English	Article							DISTAL CHROMOSOME 2Q; GENETIC SUSCEPTIBILITY; INSULIN; CELLS; CYTOKINE; MELLITUS; IDDM; TH2	Type 1 diabetes (T1D; or insulin-dependent diabetes mellitus, IDDM) is an autoimmune disease with both genetic and environmental components. In addition to the human leukocyte antigen (HLA) complex, the single major genetic contributor of susceptibility(1), an unknown number of other unidentified genes are required to mediate disease. Although many loci conferring susceptibility to T1D have been mapped(2), their identification has proven problematic(3) due to the complex nature of this disease. Our strategy for finding T1D susceptibility genes has been to test for human homologues of loci implicated in diabetes-prone NOD (non-obese diabetic) mice, together with application of biologically relevant stratification methods(4). We report here a new susceptibility locus, IDDM18 located near the interleukin-12 (IL-12)p40 gene, IL12B. Significant bias in transmission of IL12B alleles was observed in affected sibpairs and was confirmed in an independent cohort of simplex families. A single base change in the 3' UTR showed strong linkage disequilibrium with the T1D susceptibility locus. The IL12B 3' UTR alleles showed different levers of expression in cell lines. Variation in IL-12p40 production may influence T-cell responses crucial for either mediating or protecting against this and other autoimmune diseases.	Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; Royal Childrens Hosp, Dept Endocrinol, Melbourne, Vic, Australia; Royal Melbourne Hosp, Australian Red Cross Blood Serv, Victorian Transplantat & Immunogenet Serv, Rotary Bone Marrow Res Ctr, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; Royal Children's Hospital Melbourne; Australian Red Cross Blood Service; Royal Melbourne Hospital	Morahan, G (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Parkville, Vic, Australia.	morahan@wehi.edu.au	Werther, George/B-3784-2012; Morahan, Grant/T-7501-2019	Colman, Peter/0000-0001-8718-6175				Adorini L, 1996, ANN NY ACAD SCI, V795, P208, DOI 10.1111/j.1749-6632.1996.tb52670.x; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; DEGLIESPOSTI MA, 1993, HUM IMMUNOL, V38, P3, DOI 10.1016/0198-8859(93)90514-2; Fu J, 1998, DIABETOLOGIA, V41, P228, DOI 10.1007/s001250050894; GERMANN T, 1993, EUR J IMMUNOL, V23, P1762, DOI 10.1002/eji.1830230805; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HUANG D, IN PRESS GENES IMMUN; JOHNSON KJ, 1992, GENOMICS, V14, P745, DOI 10.1016/S0888-7543(05)80178-8; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Larsen ZM, 1999, AUTOIMMUNITY, V31, P35, DOI 10.3109/08916939908993857; LECAM A, 1995, EUR J BIOCHEM, V231, P620; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; ROBINSON WP, 1993, GENET EPIDEMIOL, V10, P273, DOI 10.1002/gepi.1370100502; Sambrook J, 1989, MOL CLONING; She JX, 1998, CURR OPIN IMMUNOL, V10, P682, DOI 10.1016/S0952-7915(98)80089-7; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Szelachowska M, 1997, HORM METAB RES, V29, P168, DOI 10.1055/s-2007-979014; Trembleau S, 1997, EUR J IMMUNOL, V27, P2330, DOI 10.1002/eji.1830270930; TREMBLEAU S, 1995, J EXP MED, V181, P817, DOI 10.1084/jem.181.2.817; WARRINGTON JA, 1994, GENOMICS, V24, P395, DOI 10.1006/geno.1994.1636; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOLF SF, 1991, J IMMUNOL, V146, P3074; YOUNES RN, 1994, SHOCK S, V1, P2; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	29	261	271	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2001	27	2					218	221		10.1038/84872	http://dx.doi.org/10.1038/84872			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175794				2022-12-27	WOS:000166839200027
J	Peterson, SE; Stellwagen, AE; Diede, SJ; Singer, MS; Haimberger, ZW; Johnson, CO; Tzoneva, M; Gottschling, DE				Peterson, SE; Stellwagen, AE; Diede, SJ; Singer, MS; Haimberger, ZW; Johnson, CO; Tzoneva, M; Gottschling, DE			The function of a stem-loop in telomerase RNA is linked to the DNA repair protein Ku	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; YEAST KU; MAINTENANCE; GENE; EST1; DISRUPTION; STRAINS; VECTORS	The telomerase enzyme lengthens telomeres, an activity essential for chromosome stability in most eukaryotes. The enzyme is composed of a specialized reverse transcriptase and a template RNA (ref. 1). In Saccharomyces cerevisiae, overexpression of TLC1, the telomerase RNA gene, disrupts telomeric structure(2). The result is both shortened telomere length and loss of a special chromatin structure that normally silences telomere-proximal genes. Because telomerase function is not required for telomeric silencing, we postulated that the dominant-negative effect caused by overexpression of TLC1 RNA originates in a normal interaction between the RNA and an unknown telomeric factor important for silencing; the overexpressed RNA presumably continues to bind the factor and compromises its function(3). Here we show that a 48-nt stem-loop structure within the 1.3-kb TLC1 RNA is necessary and sufficient for disrupting telomeric silencing and shortening telomeres. Moreover, this short RNA sequence appears to function through an interaction with the conserved DNA end-binding protein Ku (ref. 4). We propose that, in addition to its roles in telomeric silencing, homologous recombination and non-homologous end-joining (NHEJ), S. cerevisiae Ku also helps to recruit or activate telomerase at the telomere through an interaction with this stem-loop of TLC1 RNA.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; Univ Chicago, Chicago, IL 60637 USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Chicago; University of Washington; University of Washington Seattle	Gottschling, DE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	dgottsch@fhcrc.org	Diede, Scott/G-2288-2012	Diede, Scott/0000-0001-5422-549X				Brachmann CB, 1998, YEAST, V14, P115; Bryan TM, 1999, CURR OPIN CELL BIOL, V11, P318, DOI 10.1016/S0955-0674(99)80043-X; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Feldmann H, 1996, J BIOL CHEM, V271, P27765, DOI 10.1074/jbc.271.44.27765; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; HABER JE, 1984, GENETICS, V106, P207; LIN JJ, 1995, CELL, V81, P1127, DOI 10.1016/S0092-8674(05)80017-0; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Muniyappa K, 1998, CRIT REV BIOCHEM MOL, V33, P297, DOI 10.1080/10409239891204242; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Potter PM, 1996, BIOTECHNIQUES, V21, P198; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Runge KW, 1996, MOL CELL BIOL, V16, P3094; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Singer MS, 1998, GENETICS, V150, P613; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; SINGER MS, 1997, THESIS U CHICAGO; Steiner BR, 1996, P NATL ACAD SCI USA, V93, P2817, DOI 10.1073/pnas.93.7.2817; Tuteja R, 2000, CRIT REV BIOCHEM MOL, V35, P1, DOI 10.1080/10409230091169177	30	181	184	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					64	67		10.1038/83778	http://dx.doi.org/10.1038/83778			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138000				2022-12-27	WOS:000166187900017
J	Urness, LD; Sorensen, LK; Li, DY				Urness, LD; Sorensen, LK; Li, DY			Arteriovenous malformations in mice lacking activin receptor-like kinase-1	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; CARDIOVASCULAR DEVELOPMENT; HEMATOPOIETIC-CELLS; ENDOTHELIAL-CELLS; VASCULOGENESIS; MORPHOGENESIS; ANGIOGENESIS; EPHRIN-B2; EMBRYO	The mature circulatory system is comprised of two parallel, yet distinct, vascular networks that carry blood to and from the heart. Studies have suggested that endothelial tubes are specified as arteries and veins at the earliest stages of angiogenesis, before the onset of circulation(1-4). To understand the molecular basis for arterial-venous identity, we have focused our studies on a human vascular dysplasia, hereditary haemorrhagic telangiectasia (HHT), wherein arterial and venous beds fail to remain distinct. Genetic studies have demonstrated that HHT can be caused by loss-of-function mutations in the gene encoding activin receptor-like kinase-1 (ACVRL1; ref. 5). ACVRL1 encodes a type I receptor for the TGF-P superfamily of growth factors(6-8). At the earliest stage of vascular development, mice lacking Acvrl1 develop large shunts between arteries and veins, downregulate arterial Efnb2 and fail to confine intravascular haematopoiesis to arteries. These mice die by mid-gestation with severe arteriovenous malformations resulting from fusion of major arteries and veins. The early loss of anatomical, molecular and functional distinctions between arteries and Veins indicates that Acvrl1 is required for developing distinct arterial and venous vascular beds.	Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Li, DY (corresponding author), Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA.	dean.li@hci.utah.edu						Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Attisano Liliana, 1996, Cytokine and Growth Factor Reviews, V7, P327, DOI 10.1016/S1359-6101(96)00042-1; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; FLAMME I, 1992, DEVELOPMENT, V116, P435; GADSON PF, 1993, IN VITRO CELL DEV-AN, V29A, P773; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; HOGAN B, 1986, MANIPULATING MOUSE E; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; JOHNSON I, 1989, J SOCIAL WORK PRACTI, V1, P13; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Manaia A, 2000, DEVELOPMENT, V127, P643; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pepper MS, 1996, CURR TOP MICROBIOL, V213, P31; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; STJACQUES S, 1994, ENDOCRINOLOGY, V134, P2645, DOI 10.1210/en.134.6.2645; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1993, ONCOGENE, V8, P2879; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 1992, SITU HYBRIDIZATION P	26	327	341	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					328	331		10.1038/81634	http://dx.doi.org/10.1038/81634			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062473				2022-12-27	WOS:000165176500022
J	Nasevicius, A; Ekker, SC				Nasevicius, A; Ekker, SC			Effective targeted gene 'knockdown' in zebrafish	NATURE GENETICS			English	Letter							ONE-EYED PINHEAD; SONIC-HEDGEHOG; NO TAIL; PROTEIN; ORGANIZER; IDENTIFICATION; INDUCTION; HOMOLOG; ENCODES; EMBRYO	The sequencing of the zebrafish genome should be completed by the end of 2002. Direct assignment of function on the basis of this information would be facilitated by the development of a rapid, targeted 'knockdown' technology in this model vertebrate. We show here that antisense, morpholino-modified oligonucleotides(1) (morpholinos) are effective and specific translational inhibitors in zebrafish. We generated phenocopies of mutations of the genes no tail (ref. 2), chordin (ref. 3), one-eyed-pinhead (ref. 4), nacre (ref. 5) and sparse (ref. 6), removing gene function from maternal through post-segmentation and organogenesis developmental stages. We blocked expression from a ubiquitous green fluorescent protein (GFP) transgene, showing that, unlike tissue-restricted limitations found with RNA-based interference in the nematode(7), all zebrafish cells readily respond to this technique. We also developed also morpholino-based zebrafish models of human disease. Morpholinos targeted to the uroporphyrinogen decarboxylase gene(8) result in embryos with hepatoerythropoietic porphyria. We also used morpholinos for the determination of new gene functions. We showed that embryos with reduced sonic hedgehog (ref. 9) signalling and reduced tiggy-winkle hedgehog(ref. 10) function exhibit partial cyclopia and other specific midline abnormalities, providing a zebrafish genetic model for the common human disorder holoprosencephaly. Conserved vertebrate processes and diseases are now amenable to a systematic, in vivo, reverse-genetic paradigm using zebrafish embryos.	Univ Minnesota, Arnold & Mabel Beckman Ctr Transposon Ress, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Ekker, SC (corresponding author), Univ Minnesota, Arnold & Mabel Beckman Ctr Transposon Ress, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.			Ekker, Stephen/0000-0003-0726-4212				Arora V, 2000, J PHARMACOL EXP THER, V292, P921; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Concordet JP, 1996, DEVELOPMENT, V122, P2835; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Fekany K, 1999, DEVELOPMENT, V126, P1427; Fisher S, 1997, DEVELOPMENT, V124, P1301; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Haffter P, 1996, DEVELOPMENT, V123, P1; Halpern ME, 1997, DEV BIOL, V187, P154, DOI 10.1006/dbio.1997.8605; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Kappas A, 1995, METABOLIC MOL BASES, P2103; Koos DS, 1999, DEV BIOL, V215, P190, DOI 10.1006/dbio.1999.9479; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lister JA, 1999, DEVELOPMENT, V126, P3757; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Qin GZ, 2000, ANTISENSE NUCLEIC A, V10, P11, DOI 10.1089/oli.1.2000.10.11; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schier AF, 1997, DEVELOPMENT, V124, P327; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Wallis DE, 1999, MOL GENET METAB, V68, P126, DOI 10.1006/mgme.1999.2895; Wang H, 1998, NAT GENET, V20, P239, DOI 10.1038/3041; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	30	2014	2159	3	241	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					216	220		10.1038/79951	http://dx.doi.org/10.1038/79951			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017081				2022-12-27	WOS:000089638800022
J	Toma, DP; White, KP; Hirsch, J; Greenspan, RJ				Toma, DP; White, KP; Hirsch, J; Greenspan, RJ			Identification of genes involved in Drosophila melanogaster geotaxis, a complex behavioral trait	NATURE GENETICS			English	Article							MICROARRAY ANALYSIS; PROTEIN; EVOLUTION; PHOTORECEPTOR; CRYPTOCHROME; POPULATIONS; SELECTION; MUTATION; SYSTEMS; MUTANTS	Identifying the genes involved in polygenic traits has been difficult. In the 1950s and 1960s, laboratory selection experiments for extreme geotaxic behavior in fruit flies established for the first time that a complex behavioral trait has a genetic basis. But the specific genes responsible for the behavior have never been identified using this classical model. To identify the individual genes involved in geotaxic response, we used cDNA microarrays to identify candidate genes and assessed fly lines mutant in these genes for behavioral confirmation. We have thus determined the identities of several genes that contribute to the complex, polygenic behavior of geotaxis.	Inst Neurosci, San Diego, CA 92121 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Univ Illinois, Dept Psychol, Urbana, IL 61801 USA; Univ Illinois, Dept Biol Anim, Urbana, IL 61801 USA	Yale University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	White, KP (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.							CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; DOBZHANSKY T, 1972, PROC R SOC SER B-BIO, V180, P21, DOI 10.1098/rspb.1972.0003; DOBZHANSKY T, 1968, P ROY SOC LOND B BIO, V173, P191; DOBZHANSKY T, 1966, GENETICS, V55, P723; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; ERLENMEYER L, 1961, SCIENCE, V134, P1068, DOI 10.1126/science.134.3485.1068; ERLENMEYERKIMLI.L, 1962, J COMP PHYSIOL PSYCH, V55, P722, DOI 10.1037/h0042089; Greenspan RJ, 1997, CURR OPIN NEUROBIOL, V7, P805, DOI 10.1016/S0959-4388(97)80139-0; HIRSCH J, 1962, J COMP PHYSIOL PSYCH, V55, P732, DOI 10.1037/h0039714; HIRSCH J, 1961, SCIENCE, V134, P835, DOI 10.1126/science.134.3482.835; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KUSSEL P, 1995, J CELL BIOL, V129, P1491, DOI 10.1083/jcb.129.6.1491; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; MCMILLAN PA, 1992, BEHAV GENET, V22, P557, DOI 10.1007/BF01074308; Melzig J, 1998, J NEUROSCI, V18, P7160; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; RICKER JP, 1988, J COMP PSYCHOL, V102, P203, DOI 10.1037/0735-7036.102.3.203; RICKER JP, 1985, J COMP PSYCHOL, V99, P380, DOI 10.1037/0735-7036.99.4.380; Roch F, 1998, MOL GEN GENET, V257, P103, DOI 10.1007/PL00008620; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SONG W, 2001, DROS RES C, V42, P51; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stoltenberg SF, 1996, J COMP PSYCHOL, V110, P252, DOI 10.1037/0735-7036.110.3.252; TOROK I, 1995, J CELL BIOL, V129, P1473, DOI 10.1083/jcb.129.6.1473; Tully T, 1996, P NATL ACAD SCI USA, V93, P13460, DOI 10.1073/pnas.93.24.13460; White KP, 2001, NAT REV GENET, V2, P528, DOI 10.1038/35080565; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	32	154	159	0	33	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					349	353		10.1038/ng893	http://dx.doi.org/10.1038/ng893			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12042820				2022-12-27	WOS:000177147100008
J	Zhang, JH; Zhang, DS; McQuade, JS; Behbehani, M; Tsien, JZ; Xu, M				Zhang, JH; Zhang, DS; McQuade, JS; Behbehani, M; Tsien, JZ; Xu, M			c-fos regulates neuronal excitability and survival	NATURE GENETICS			English	Article							KAINIC ACID; INDUCED SEIZURES; NERVOUS-SYSTEM; BRAIN; EXPRESSION; MICE; GLUTAMATE; EPILEPSY; RECEPTOR; GENE	Excitotoxicity is a process in which glutamate or other excitatory amino acids induce neuronal cell death. Accumulating evidence suggests that excitotoxicity may contribute to human neuronal cell loss caused by acute insults and chronic degeneration in the central nervous system(1-4). The immediate early gene (IEG) c-fos encodes a transcription factor(5-6). The c-Fos proteins form heterodimers with Jun family proteins, and the resulting AP-1 complexes regulate transcription by binding to the AP-1 sequence found in many cellular genes(7-9). Emerging evidence suggests that c-fos is essential in regulating neuronal cell survival versus death(10). Although c-fos is induced by neuronal activity, including kainic acid induced seizures(11-14), whether and how c-fos is involved in excitotoxicity is still unknown. To address this issue, we generated a mouse in which c-fos expression is largely eliminated in the hippocampus. We found that these mutant mice have more severe kainic acid-induced seizures, increased neuronal excitability and neuronal cell death, compared with control mice. Moreover, c-Fos regulates the expression of the kainic acid receptor GluR6 and brain-derived neurotrophic factor (BDNF), both in vivo and in vitro. Our results suggest that c-fos is a genetic regulator for cellular mechanisms mediating neuronal excitability and survival.	Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Cellular & Mol Physiol, Cincinnati, OH 45267 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Princeton University	Xu, M (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA.		zhang, jianhua/D-3404-2009	Zhang, Jianhua/0000-0002-2128-9574				BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; FERKANY JW, 1984, NATURE, V308, P561, DOI 10.1038/308561a0; GALL CM, 1993, EXP NEUROL, V124, P150, DOI 10.1006/exnr.1993.1186; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Mandelzys A, 1997, J NEUROSCI, V17, P5407; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Medvedev A, 2000, BRAIN RES BULL, V52, P89, DOI 10.1016/S0361-9230(00)00239-2; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; MULLER R, 1983, NATURE, V304, P454, DOI 10.1038/304454a0; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; POPOVICI T, 1990, BRAIN RES, V536, P183, DOI 10.1016/0006-8993(90)90024-6; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; Tandon P, 1999, NEUROSCIENCE, V91, P293, DOI 10.1016/S0306-4522(98)00609-5; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	27	226	230	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					416	420		10.1038/ng859	http://dx.doi.org/10.1038/ng859			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11925568				2022-12-27	WOS:000174682000020
J	Lucht, JM; Mauch-Mani, B; Steiner, HY; Metraux, JP; Ryals, J; Hohn, B				Lucht, JM; Mauch-Mani, B; Steiner, HY; Metraux, JP; Ryals, J; Hohn, B			Pathogen stress increases somatic recombination frequency in Arabidopsis	NATURE GENETICS			English	Article							INTRACHROMOSOMAL HOMOLOGOUS RECOMBINATION; SYSTEMIC ACQUIRED-RESISTANCE; DISEASE RESISTANCE; SIGNAL-TRANSDUCTION; WHOLE PLANTS; EVOLUTION; GENES; RESPONSES; GENOME; EVENTS	Evolution is based on genetic variability and subsequent phenotypic selection. Mechanisms that modulate the rate of mutation according to environmental cues, and thus control the balance between genetic stability and flexibility, might provide a distinct evolutionary advantage(1-4). Stress-induced mutations stimulated by unfavorable environments, and possible mechanisms for their induction, have been described for several organisms(2-4), but research in this area has mainly focused on microorganisms. We have analyzed the influence of adverse environmental conditions on the genetic stability of the higher plant Arabidopsis thaliana. Here we show that a biotic stress factor-attack by the oomycete pathogen Peronospora parasitica can stimulate somatic recombination in Arabidopsis. The same effect was observed when plant pathogen-defense mechanisms were activated by the chemicals 2,6-dichloroisonicotinic acid (INA) or benzothiadiazole (BTH), or by a mutation (cim3). Together with previous studies of recombination induced by abiotic factors, these findings suggest that increased somatic recombination is a general stress response in plants. The increased genetic flexibility might facilitate evolutionary adaptation of plant populations to stressful environments.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland; Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; Syngenta, Res Triangle Pk, NC 27709 USA; Paradigm Genet, Res Triangle Pk, NC 27709 USA	Friedrich Miescher Institute for Biomedical Research; University of Fribourg; Syngenta	Lucht, JM (corresponding author), Univ Freiburg, Sonnenstr 5, D-79104 Freiburg, Germany.		Mauch-Mani, Brigitte/O-2387-2014; Metraux, Jean-Pierre JP/C-1111-2012	Lucht, Jan/0000-0002-4722-1244; Mauch-Mani, Brigitte/0000-0002-6743-8520				Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Caporale LH, 2000, BIOESSAYS, V22, P388, DOI 10.1002/(SICI)1521-1878(200004)22:4<388::AID-BIES9>3.0.CO;2-4; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; Gallego ME, 2001, PLANT J, V25, P31, DOI 10.1046/j.1365-313x.2001.00928.x; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Kovalchuk I, 1998, NAT BIOTECHNOL, V16, P1054, DOI 10.1038/3505; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; LEBEL EG, 1993, P NATL ACAD SCI USA, V90, P422, DOI 10.1073/pnas.90.2.422; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; Mittler R, 1997, PLANT MOL BIOL, V34, P209, DOI 10.1023/A:1005868402827; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; PUCHTA H, 1995, PLANT J, V7, P203, DOI 10.1046/j.1365-313X.1995.7020203.x; Puchta H, 1996, TRENDS PLANT SCI, V1, P340; PUCHTA H, 1995, PLANT MOL BIOL, V28, P281, DOI 10.1007/BF00020247; Radman M, 1999, ANN NY ACAD SCI, V870, P146, DOI 10.1111/j.1749-6632.1999.tb08874.x; Richter TE, 2000, PLANT MOL BIOL, V42, P195, DOI 10.1023/A:1006388223475; Ries G, 2000, NATURE, V406, P98, DOI 10.1038/35017595; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Saxe D, 2000, MOL CELL BIOL, V20, P5404, DOI 10.1128/MCB.20.15.5404-5414.2000; SWOBODA P, 1994, EMBO J, V13, P484, DOI 10.1002/j.1460-2075.1994.tb06283.x; TINLAND B, 1994, P NATL ACAD SCI USA, V91, P8000, DOI 10.1073/pnas.91.17.8000; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Walbot V, 1996, TRENDS PLANT SCI, V1, P27, DOI 10.1016/S1360-1385(96)80020-3; Weymann K, 1995, PLANT CELL, V7, P2013, DOI 10.1105/tpc.7.12.2013; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Young ND, 2000, CURR OPIN PLANT BIOL, V3, P285, DOI 10.1016/S1369-5266(00)00081-9	30	166	173	0	39	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					311	314		10.1038/ng846	http://dx.doi.org/10.1038/ng846			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11836502	Green Submitted			2022-12-27	WOS:000174157600017
J	Brett, D; Pospisil, H; Valcarcel, J; Reich, J; Bork, P				Brett, D; Pospisil, H; Valcarcel, J; Reich, J; Bork, P			Alternative splicing and genome complexity	NATURE GENETICS			English	Article							GENES	Alternative splicing of mRNA allows many gene products with different functions to be produced from a single coding sequence. It has recently been proposed as a mechanism by which higher-order diversity is generated. Here we show, using large-scale expressed sequence tag (EST) analysis, that among seven different eukaryotes the amount of alternative splicing is comparable, with no large differences between humans and other animals.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; European Mol Biol Lab, D-69012 Heidelberg, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; European Molecular Biology Laboratory (EMBL)	Brett, D (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.		Pospisil, Heike/G-7377-2016; Valcarcel, Juan/O-9814-2014; Bork, Peer/F-1813-2013	Valcarcel, Juan/0000-0001-5398-3571; Bork, Peer/0000-0002-2627-833X				Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1; Brett D, 2001, ONCOGENE, V20, P4581, DOI 10.1038/sj.onc.1204610; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	12	365	385	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					29	30		10.1038/ng803	http://dx.doi.org/10.1038/ng803			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743582				2022-12-27	WOS:000173105600010
J	Berger, J; Suzuki, T; Senti, KA; Stubbs, J; Schaffner, G; Dickson, BJ				Berger, J; Suzuki, T; Senti, KA; Stubbs, J; Schaffner, G; Dickson, BJ			Genetic mapping with SNP markers in Drosophila	NATURE GENETICS			English	Article							GENOME; MELANOGASTER; MOSAICS; DISCOVERY; SEQUENCE; KINASE	Map-based positional cloning of Drosophila melanogaster genes is hampered by both the time-consuming, error-prone nature of traditional methods for genetic mapping and the difficulties in aligning the genetic and cytological maps with the genome sequence. The identification of sequence polymorphisms in the Drosophila genome will make it possible to map mutations directly to the genome sequence with high accuracy and resolution. Here we report the identification of 7,223 single-nucleotide polymorphisms (SNPs) and 1,392 insertions/deletions (InDels) in common laboratory strains of Drosophila. These sequence polymorphisms define a map of 787 autosomal marker loci with a resolution of 114 kb. We have established PCR product-length polymorphism (PLP) or restriction fragment-length polymorphism (RFLP) assays for 215 of these markers. We demonstrate the use of this map by delimiting two mutations to intervals of 169 kb and 307 kb, respectively. Using a local high-density SNP map, we also mapped a third mutation to a resolution of approximately 2 kb, sufficient to localize the mutation within a single gene. These methods should accelerate the rate of positional cloning in Drosophila.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Suzuki, Takashi/D-3651-2019; Dickson, Barry/AAE-7632-2019; Senti, Kirsten-Andre/AAB-3036-2020	Suzuki, Takashi/0000-0001-9093-2562; Dickson, Barry/0000-0003-0715-892X; Senti, Kirsten-Andre/0000-0002-7208-7593				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Cho RJ, 1999, NAT GENET, V23, P203, DOI 10.1038/13833; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Hoskins RA, 2001, GENOME RES, V11, P1100, DOI 10.1101/gr.GR-1780R; Kimmerly W, 1996, GENOME RES, V6, P414, DOI 10.1101/gr.6.5.414; Kwok PY, 2001, ANNU REV GENOM HUM G, V2, P235, DOI 10.1146/annurev.genom.2.1.235; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Liu YR, 1999, DEVELOPMENT, V126, P1869; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Newsome TP, 2000, DEVELOPMENT, V127, P851; Petrov DA, 1999, P NATL ACAD SCI USA, V96, P1475, DOI 10.1073/pnas.96.4.1475; Pichaud F, 2001, DEVELOPMENT, V128, P815; Rorth P, 1998, DEVELOPMENT, V125, P1049; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Teeter K, 2000, J EXP ZOOL, V288, P63, DOI 10.1002/(SICI)1097-010X(20000415)288:1&lt;63::AID-JEZ7&gt;3.0.CO;2-1; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053	23	126	132	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					475	481		10.1038/ng773	http://dx.doi.org/10.1038/ng773			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726933				2022-12-27	WOS:000172507500026
J	Birkenhager, R; Otto, E; Schurmann, MJ; Vollmer, M; Ruf, EM; Maier-Lutz, I; Beekmann, F; Fekete, A; Omran, H; Feldmann, D; Milford, DV; Jeck, N; Konrad, M; Landau, D; Knoers, NVAM; Antignac, C; Sudbrak, R; Kispert, A; Hildebrandt, F				Birkenhager, R; Otto, E; Schurmann, MJ; Vollmer, M; Ruf, EM; Maier-Lutz, I; Beekmann, F; Fekete, A; Omran, H; Feldmann, D; Milford, DV; Jeck, N; Konrad, M; Landau, D; Knoers, NVAM; Antignac, C; Sudbrak, R; Kispert, A; Hildebrandt, F			Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure	NATURE GENETICS			English	Article							LANGE-NIELSEN-SYNDROME; CHLORIDE CHANNEL GENE; POTASSIUM CHANNEL; CAUSE JERVELL; HUMAN GENOME; COTRANSPORTER; LOCALIZATION; MAP; HETEROGENEITY; PROTEIN	Antenatal Bartter syndrome (aBS) comprises a heterogeneous group of autosomal recessive salt-losing nephropathies'. identification of three genes that code for renal transporters and channels as responsible for aBS(2-7) has resulted in new insights into renal salt handling, diuretic action and blood-pressure regulations. A gene locus of a fourth variant of aBS called BSND, which in contrast to the other forms is associated with sensorineural deafness (SND) and renal failure, has been mapped to chromosome 1p(9). We report here the identification by positional cloning, in a region not covered by the human genome sequencing projects, of a new gene, BSND, as the cause of BSND. We examined ten families with BSND and detected seven different mutations in BSND that probably result in loss of function. In accordance with the phenotype, BSND is expressed in the thin limb and the thick ascending limb of the loop of Henle in the kidney and in the dark cells of the inner ear. The gene encodes a hitherto unknown protein with two putative transmembrane a-helices and thus might function as a regulator for ion-transport proteins involved in aBS, or else as a new transporter or channel itself.	Univ Freiburg, Childrens Hosp, D-79106 Freiburg, Germany; Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary; Armand Trousseau Hosp, Dept Biochem, Paris, France; Birmingham Childrens Hosp, Birmingham, W Midlands, England; Univ Marburg, Childrens Hosp, Marburg, Germany; Soroka Med Ctr, Dept Pediat, IL-84101 Beer Sheva, Israel; Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Hop Necker Enfants Malad, INSERM U423, Paris, France; Max Planck Inst Mol Genet, Berlin, Germany; Hannover Med Sch, Inst Mol Biol, Hannover, Germany	University of Freiburg; Semmelweis University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Birmingham; Philipps University Marburg; Ben Gurion University; Soroka Medical Center; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society; Hannover Medical School	Hildebrandt, F (corresponding author), Univ Freiburg, Childrens Hosp, Hugstetter Str 55, D-79106 Freiburg, Germany.	hildebra@kikli.ukl.uni-freiburg.de	ANTIGNAC, Corinne/H-8945-2017; Sudbrak, Ralf/HHZ-8821-2022	ANTIGNAC, Corinne/0000-0002-9934-4940; Otto, Edgar/0000-0002-2387-9973	NIDDK NIH HHS [R01 DK088767] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088767] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brennan TMH, 1998, AM J HUM GENET, V62, P355, DOI 10.1086/301708; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; IGARASHI P, 1995, AM J PHYSIOL-RENAL, V269, pF405, DOI 10.1152/ajprenal.1995.269.3.F405; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Jeck N, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e5; Kaplan MR, 1996, KIDNEY INT, V49, P40, DOI 10.1038/ki.1996.6; Karolyi L, 1997, HUM MOL GENET, V6, P17; Kobayashi K, 2001, J AM SOC NEPHROL, V12, P1327, DOI 10.1681/ASN.V1271327; Kockerling A, 1996, J PEDIATR-US, V129, P519, DOI 10.1016/S0022-3476(96)70116-6; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lescher B, 1998, DEV DYNAM, V213, P440, DOI 10.1002/(SICI)1097-0177(199812)213:4<440::AID-AJA9>3.0.CO;2-6; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Nicolas MT, 2001, HEARING RES, V153, P132, DOI 10.1016/S0378-5955(00)00268-9; Nothwang HG, 1998, GENOMICS, V47, P276, DOI 10.1006/geno.1997.5102; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Rodriguez-Soriano J, 1998, PEDIATR NEPHROL, V12, P315, DOI 10.1007/s004670050461; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; TYSON KP, 1997, HUM MOL GENET, V6, P2179; Vargas-Poussou R, 1998, AM J HUM GENET, V62, P1332, DOI 10.1086/301872; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vollmer M, 2000, NEPHROL DIAL TRANSPL, V15, P970, DOI 10.1093/ndt/15.7.970; Yoshikawa M, 1999, AM J PHYSIOL-RENAL, V276, pF552, DOI 10.1152/ajprenal.1999.276.4.F552	31	369	382	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					310	314		10.1038/ng752	http://dx.doi.org/10.1038/ng752			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687798				2022-12-27	WOS:000171911000018
J	Rampoldi, L; Dobson-Stone, C; Rubio, JP; Danek, A; Chalmers, RM; Wood, NW; Verellen, C; Ferrer, X; Malandrini, A; Fabrizi, GM; Brown, R; Vance, J; Pericak-Vance, M; Rudolf, G; Carre, S; Alonso, E; Manfredi, M; Nemeth, AH; Monaco, AP				Rampoldi, L; Dobson-Stone, C; Rubio, JP; Danek, A; Chalmers, RM; Wood, NW; Verellen, C; Ferrer, X; Malandrini, A; Fabrizi, GM; Brown, R; Vance, J; Pericak-Vance, M; Rudolf, G; Carre, S; Alonso, E; Manfredi, M; Nemeth, AH; Monaco, AP			A conserved sorting-associated protein is mutant in chorea-acanthocytosis	NATURE GENETICS			English	Article							NEUROACANTHOCYTOSIS; LOCALIZATION; KEX2P; GENES	Chorea-acanthocytosis (CHAC. MIM 200150) is an autosomal recessive neurodegenerative disorder characterized by the gradual onset of hyperkinetic movements and abnormal erythrocyte morphology(1,2) (acanthocytosis). Neurological findings closely resemble those observed in Huntington disease(3-8). We identified a gene in the CHAC critical region(9) and found 16 different mutations in individuals with chorea-acanthocytosis. CHAC encodes an evolutionarily conserved protein that is probably involved in protein sorting.	Wellcome Trust Ctr Human Genet, Oxford, England; Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Munich, Neurol Klin, Munich, Germany; Neurol Inst, Dept Clin Neurol, London, England; Unite Genet Med, Brussels, Belgium; Ctr Hosp Univ Bordeaux, Hop Haut Leveque, Bordeaux, France; Ist Sci Neurol, Siena, Italy; Univ Verona, Dept Neurol & Visual Sci, Sect Clin Neurol, I-37100 Verona, Italy; Cecil B Day Lab Muscle Res, Charlestown, MA USA; Duke Univ, Med Ctr, Durham, NC USA; Hop Univ Strasbourg, Strasbourg, France; Natl Inst Neurol & Neurosurg Manuel Velasco Suarez, Dept Genet, Mexico City, DF, Mexico; Casa Cura Poliambulanza Neurol, Brescia, Italy; Churchill Hosp, Dept Clin Genet, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Munich; University of London; University College London; CHU Bordeaux; University of Verona; Duke University; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oxford	Monaco, AP (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford, England.		Rampoldi, Luca/L-3639-2018; Wood, Nicholas W/C-2505-2009; Danek, Adrian/G-7339-2011; Monaco, Anthony P/A-4495-2010; Rampoldi, Luca/AAN-6228-2020	Rampoldi, Luca/0000-0002-0544-7042; Wood, Nicholas W/0000-0002-9500-3348; Danek, Adrian/0000-0001-8857-5383; Monaco, Anthony P/0000-0001-7480-3197; Rampoldi, Luca/0000-0002-0544-7042; Nemeth, Andrea/0000-0002-2941-7657; RUBIO, JUSTIN/0000-0003-3750-917X; Vance, Jeffery/0000-0003-3815-8199; Rudolf, Gabrielle/0000-0002-2050-3911; Dobson-Stone, Carol/0000-0002-2211-0257	NINDS NIH HHS [2P01 NS26630] Funding Source: Medline; Telethon [359/B] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALONSO ME, 1989, CAN J NEUROL SCI, V16, P426, DOI 10.1017/S0317167100029516; Bostantjopoulou S, 2000, MOVEMENT DISORD, V15, P1271, DOI 10.1002/1531-8257(200011)15:6<1271::AID-MDS1037>3.0.CO;2-T; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; CRITCHLEY EM, 1968, ARCH NEUROL-CHICAGO, V18, P134, DOI 10.1001/archneur.1968.00470320036004; HARDIE RJ, 1991, BRAIN, V114, P13; Kutcher JS, 1999, J NEUROIMAGING, V9, P187, DOI 10.1111/jon199993187; LEVINE IM, 1968, ARCH NEUROL-CHICAGO, V19, P403, DOI 10.1001/archneur.1968.00480040069007; Redding K, 1996, MOL CELL BIOL, V16, P6208; RINNE JO, 1994, MOVEMENT DISORD, V9, P297, DOI 10.1002/mds.870090303; Rubio JP, 1997, AM J HUM GENET, V61, P899, DOI 10.1086/514876; Rubio JP, 1999, GENOMICS, V57, P84, DOI 10.1006/geno.1999.5758; SHIBASAKI H, 1982, ANN NEUROL, V12, P311, DOI 10.1002/ana.410120319	12	218	223	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					119	120		10.1038/88821	http://dx.doi.org/10.1038/88821			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381253				2022-12-27	WOS:000169011800008
J	Kuehl, P; Zhang, J; Lin, Y; Lamba, J; Assem, M; Schuetz, J; Watkins, PB; Daly, A; Wrighton, SA; Hall, SD; Maurel, P; Relling, M; Brimer, C; Yasuda, K; Venkataramanan, R; Strom, S; Thummel, K; Boguski, MS; Schuetz, E				Kuehl, P; Zhang, J; Lin, Y; Lamba, J; Assem, M; Schuetz, J; Watkins, PB; Daly, A; Wrighton, SA; Hall, SD; Maurel, P; Relling, M; Brimer, C; Yasuda, K; Venkataramanan, R; Strom, S; Thummel, K; Boguski, MS; Schuetz, E			Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN CYTOCHROME-P450 ENZYMES; HUMAN-LIVER; CLINICAL PRESENTATION; DRUG-METABOLISM; ALLELIC VARIANT; 3A; SUBSTITUTIONS; ASSOCIATION; CANDIDATE	Variation in the CYP3A enzymes, which act in drug metabolism, influences circulating steroid levels and responses to half of all oxidatively metabolized drugs. CYP3A activity is the sum activity of the family of CYP3A genes, including CYP3A5, which is polymorphically expressed at high levels in a minority of Americans of European descent and Europeans thereafter collectively referred to as 'Caucasians'). Only people with at least one CYP3A5*1 allele express large amounts of CYP3A5. Our findings show that single-nucleotide polymorphisms (SNPs) in CYP3A5*3 and CYP3A5*6 that cause alternative splicing and protein truncation result in the absence of CYP3A5 from tissues of some people. CYP3A5 was more frequently expressed in livers of African Americans (60%) than in those of Caucasians (33%). Because CYP3A5 represents at least 50% of the total hepatic CYP3A content in people polymorphically expressing CYP3A5, CYP3A5 may be the most important genetic contributor to interindividual and interracial differences in CYP3A-dependent drug clearance and in responses to many medicines.	St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; Univ Maryland, Dept Mol & Cell Biol, Baltimore, MD 21201 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; Johns Hopkins Univ, KcKusick Nathans Inst Geriatr Med, Baltimore, MD USA; Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; Univ N Carolina, Chapel Hill, NC USA; Newcastle Univ, Dept Pharmacol Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Eli Lilly & Co, Dept Drug Metab, Indianapolis, IN 46285 USA; Indiana Univ, Dept Clin Pharmacol, Indianapolis, IN 46204 USA; INSERM, Montpellier, France; Univ Pittsburgh, Dept Pharm, Pittsburgh, PA USA; Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Johns Hopkins University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; Newcastle University - UK; Eli Lilly; Indiana University System; Indiana University-Purdue University Indianapolis; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schuetz, E (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	erin.schuetz@stjude.org	Schuetz, John D/N-2692-2018; Daly, Ann/H-3144-2011; Relling, Mary/N-5032-2018; Schuetz, Erin/N-8087-2018; Strom, Stephen C/A-6501-2008; Cline, Cynthia D/F-7065-2012	Daly, Ann/0000-0002-7321-0629; 	NATIONAL CANCER INSTITUTE [R29CA051001, P30CA021765, R01CA051001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060346, U01GM061393, U01GM061374, P01GM032165] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765, CA51001] Funding Source: Medline; NIEHS NIH HHS [ES08658] Funding Source: Medline; NIGMS NIH HHS [GM60346, U01GM61374, GM32165, U01GM61393] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AOYAMA T, 1989, J BIOL CHEM, V264, P10388; Ball SE, 1999, CLIN PHARMACOL THER, V66, P288, DOI 10.1016/S0009-9236(99)70037-8; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CHOLERTON S, 1992, TRENDS PHARMACOL SCI, V13, P434, DOI 10.1016/0165-6147(92)90140-2; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Felix CA, 1998, P NATL ACAD SCI USA, V95, P13176, DOI 10.1073/pnas.95.22.13176; Finta C, 2000, GENE, V260, P13, DOI 10.1016/S0378-1119(00)00470-4; GILLAM EMJ, 1995, ARCH BIOCHEM BIOPHYS, V317, P374, DOI 10.1006/abbi.1995.1177; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; GORSKI JC, 1994, BIOCHEM PHARMACOL, V47, P1643; GROGAN WM, 1990, AM J PHYSIOL, V258, pC480, DOI 10.1152/ajpcell.1990.258.3.C480; Haehner BD, 1996, MOL PHARMACOL, V50, P52; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HASHIMOTO H, 1993, EUR J BIOCHEM, V218, P585, DOI 10.1111/j.1432-1033.1993.tb18412.x; Huang ZQ, 1998, CARCINOGENESIS, V19, P867, DOI 10.1093/carcin/19.5.867; Jounaidi Y, 1996, BIOCHEM BIOPH RES CO, V221, P466, DOI 10.1006/bbrc.1996.0618; Kivisto KT, 1995, BRIT J CLIN PHARMACO, V40, P523, DOI 10.1111/j.1365-2125.1995.tb05796.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Maquat LE, 2001, NAT GENET, V27, P5, DOI 10.1038/83759; MAQUAT LE, 1995, RNA, V1, P453; Nebert DW, 2000, PHARMACOGENETICS, V10, P279, DOI 10.1097/00008571-200006000-00001; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552; Paris PL, 1999, CANCER EPIDEM BIOMAR, V8, P901; Paulussen A, 2000, PHARMACOGENETICS, V10, P415, DOI 10.1097/00008571-200007000-00005; Rebbeck TR, 1998, J NATL CANCER I, V90, P1225, DOI 10.1093/jnci/90.16.1225; Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591; Sata F, 2000, CLIN PHARMACOL THER, V67, P48, DOI 10.1067/mcp.2000.104391; SCHUETZ EG, 1992, ARCH BIOCHEM BIOPHYS, V294, P206, DOI 10.1016/0003-9861(92)90159-T; Schuetz EG, 1996, MOL PHARMACOL, V49, P311; SCHUETZ JD, 1994, PHARMACOGENETICS, V4, P11, DOI 10.1097/00008571-199402000-00002; SCHUETZ JD, 1989, ARCH BIOCHEM BIOPHYS, V274, P355, DOI 10.1016/0003-9861(89)90449-9; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WATKINS PB, 1995, HEPATOLOGY, V22, P994, DOI 10.1002/hep.1840220342; Westlind A, 1999, BIOCHEM BIOPH RES CO, V259, P201, DOI 10.1006/bbrc.1999.0752; WRIGHTON SA, 1989, MOL PHARMACOL, V36, P97; WRIGHTON SA, 1990, MOL PHARMACOL, V38, P207	44	1688	1835	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2001	27	4					383	391		10.1038/86882	http://dx.doi.org/10.1038/86882			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279519	Green Submitted			2022-12-27	WOS:000167811200012
J	Mahadevaiah, SK; Turner, JMA; Baudat, F; Rogakou, EP; de Boer, P; Blanco-Rodriguez, J; Jasin, M; Keeney, S; Bonner, WM; Burgoyne, PS				Mahadevaiah, SK; Turner, JMA; Baudat, F; Rogakou, EP; de Boer, P; Blanco-Rodriguez, J; Jasin, M; Keeney, S; Bonner, WM; Burgoyne, PS			Recombinational DNA double-strand breaks in mice precede synapsis	NATURE GENETICS			English	Letter							CHROMOSOME SYNAPSIS; SEX-CHROMOSOMES; MEIOTIC RECOMBINATION; MOUSE; PROTEIN; GENE; RAD51; MEIOSIS; DMC1; SPERMATOCYTES	In Saccharomyces cerevisiae, meiotic recombination is initiated by Spo11-dependent double-strand breaks (DSBs), a process that precedes homologous synapsis. Here we use an antibody specific for a phosphorylated histone (gamma -H2AX, which marks the sites of DSBs) to investigate the timing, distribution and Spo11-dependence of meiotic DSBs in the mouse. We show that, as in yeast, recombination in the mouse is initiated by Spo11-dependent DSBs that form during leptotene. Loss of gamma -H2AX staining (which in irradiated somatic cells is temporally linked with DSB repair) is temporally and spatially correlated with synapsis, even when this synapsis is 'non-homologous'.	Natl Inst Med Res, Div Dev Genet, London NW7 1AA, England; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; Wageningen Inst Anim Sci, Genet Lab, Wageningen, Netherlands; Univ Valladolid, Sch Med, Dept Cell Biol, Valladolid, Spain	MRC National Institute for Medical Research; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Wageningen University & Research; Universidad de Valladolid	Burgoyne, PS (corresponding author), Natl Inst Med Res, Div Dev Genet, Mill Hill, London NW7 1AA, England.	pburgoy@nimr.mrc.ac.uk	Keeney, Scott/GVR-8515-2022	Baudat, Frederic/0000-0003-2415-8366; Keeney, Scott/0000-0002-1283-6417				Alsheimer M, 1996, EXP CELL RES, V228, P181, DOI 10.1006/excr.1996.0315; ASHLEY T, 2000, RESULTS PROBLEMS CEL, P131; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Barlow AL, 1997, EMBO J, V16, P5207, DOI 10.1093/emboj/16.17.5207; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; CALENDA A, 1994, EMBO J, V13, P100, DOI 10.1002/j.1460-2075.1994.tb06239.x; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; DOBSON MJ, 1994, J CELL SCI, V107, P2749; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Eijpe M, 2000, CHROMOSOMA, V109, P123, DOI 10.1007/s004120050420; Escalier D, 2000, CHROMOSOMA, V109, P259, DOI 10.1007/s004120000075; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kneitz B, 2000, GENE DEV, V14, P1085; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; MAHADEVAIAH S, 1988, CHROMOSOMA, V97, P145, DOI 10.1007/BF00327371; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; McKim KS, 1998, SCIENCE, V279, P876, DOI 10.1126/science.279.5352.876; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; MOSES MJ, 1981, CHROMOSOMA, V81, P519, DOI 10.1007/BF00285847; Page J, 1998, CHROMOSOME RES, V6, P639, DOI 10.1023/A:1009209628300; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Peters AHFM, 1997, CHROMOSOME RES, V5, P313, DOI 10.1023/B:CHRO.0000038762.60086.ef; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Plug AW, 1996, P NATL ACAD SCI USA, V93, P5920, DOI 10.1073/pnas.93.12.5920; Plug AW, 1998, J CELL SCI, V111, P413; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2	36	679	699	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					271	276		10.1038/85830	http://dx.doi.org/10.1038/85830			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242108				2022-12-27	WOS:000167304200018
J	Liu, HX; Cartegni, L; Zhang, MQ; Krainer, AR				Liu, HX; Cartegni, L; Zhang, MQ; Krainer, AR			A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes	NATURE GENETICS			English	Article							PRE-MESSENGER-RNA; SPLICE-SITE SELECTION; SINGLE-NUCLEOTIDE POLYMORPHISMS; SR PROTEINS; ENHANCER; SEQUENCES; IDENTIFICATION; ELEMENTS; SURVEILLANCE; CONSEQUENCES	Point mutations can generate defective and sometimes harmful proteins. The nonsense-mediated mRNA decay (NMD) pathway minimizes the potential damage caused by nonsense mutations(1-4). In-frame nonsense codons located at a minimum distance upstream of the last exon-exon junction are recognized as premature termination codons (PTCs), targeting the mRNA for degradation. Some nonsense mutations cause skipping of one or more exons, presumably during pre-mRNA splicing in the nucleus; this phenomenon is termed nonsense-mediated altered splicing (NAS), and its underlying mechanism is unclear(1,2,5,6). By analyzing NAS in BRCA1, we show here that inappropriate exon skipping can be reproduced in vitro, and results from disruption of a splicing enhancer in the coding sequence. Enhancers can be disrupted by single nonsense, missense and translationally silent point mutations, without recognition of an open reading frame as such. These results argue against a nuclear reading-frame scanning mechanism for NAS. Coding-region single-nucleotide polymorphisms(7) (cSNPs) within exonic splicing enhancers or silencers may affect the patterns or efficiency of mRNA splicing, which may in turn cause phenotypic variability and variable penetrance of mutations elsewhere in a gene.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Krainer, Adrian/0000-0001-9024-9501	NCI NIH HHS [CA13106] Funding Source: Medline; NHGRI NIH HHS [HG01696] Funding Source: Medline; NIGMS NIH HHS [GM42699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042699] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; CACERES JF, 1997, EUKARYOTIC MRNA PROC, P174; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Dietz HC, 1997, AM J HUM GENET, V60, P729; Gersappe A, 1999, MOL CELL BIOL, V19, P1640; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; KRAWCZAK M, 1992, HUM GENET, V90, P41; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Maquat LE, 1996, AM J HUM GENET, V59, P279; Mayeda A, 1999, MOL CELL BIOL, V19, P1853; Mayeda A, 1999, METH MOL B, V118, P315; Mayeda A, 1999, METH MOL B, V118, P309; Mazoyer S, 1998, AM J HUM GENET, V62, P713, DOI 10.1086/301768; Muro AF, 1999, MOL CELL BIOL, V19, P2657; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; Schaal TD, 1999, MOL CELL BIOL, V19, P261; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Shiga N, 1997, J CLIN INVEST, V100, P2204, DOI 10.1172/JCI119757; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; TIAN HC, 1995, MOL CELL BIOL, V15, P6291; Valcarcel J, 1996, TRENDS BIOCHEM SCI, V21, P296, DOI 10.1016/0968-0004(96)10039-6; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Vuillaumier-Barrot S, 1999, Hum Mutat, V14, P543, DOI 10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU17>3.0.CO;2-S; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407	30	367	394	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					55	58		10.1038/83762	http://dx.doi.org/10.1038/83762			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137998				2022-12-27	WOS:000166187900015
J	Dunham, MA; Neumann, AA; Fasching, CL; Reddel, RR				Dunham, MA; Neumann, AA; Fasching, CL; Reddel, RR			Telomere maintenance by recombination in human cells	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; ALTERNATIVE MECHANISM; HUMAN CANCER; ELONGATION; SENESCENCE; YEAST; CHROMOSOMES; SEQUENCES; PATHWAY; DEFECT	Telomeres of eukaryotic chromosomes contain many tandem repeats of a G-rich sequence (for example, TTAGGC in vertebrates(1)). In most normal human cells, telomeres shorten with each cell division, and it is proposed that this limits the number of times these cells can replicate(2). Telomeres may be maintained in germline cells, and in many immortalized cells and cancers, by the telomerase holoenzyme(3) (first discovered in the ciliate Tetrahymena(4)), which uses an RNA subunit as template for synthesis of telomeric DNA by the reverse transcriptase catalytic subunit(5). Some immortalized human cell lines and some tumours maintain their telomeres in the absence of any detectable telomerase activity by a mechanism referred to as alternative lengthening of telomeres(6,7) (ALT). Here we show that DNA sequences are copied from telomere to telomere in an immortalized human ALT cell line, indicating that ALT occurs by means of homologous recombination and copy switching.	Childrens Med Res Inst, Canc Res Unit, Sydney, NSW, Australia	Children's Medical Research Institute - Australia; University of Sydney	Reddel, RR (corresponding author), Childrens Med Res Inst, Canc Res Unit, Sydney, NSW, Australia.		Neumann, Axel/D-3319-2012; Reddel, Roger R/A-6635-2014	Reddel, Roger R/0000-0002-6302-6107				BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Colgin LM, 1999, CURR OPIN GENET DEV, V9, P97, DOI 10.1016/S0959-437X(99)80014-8; COLGIN LM, IN PRESS NEOPLASIA; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; Kass-Eisler A, 2000, TRENDS BIOCHEM SCI, V25, P200, DOI 10.1016/S0968-0004(00)01557-7; Lendvay TS, 1996, GENETICS, V144, P1399; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; MASON JM, 1995, TRENDS GENET, V11, P58, DOI 10.1016/S0168-9525(00)88998-2; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; MURNANE JP, 1993, MOL CELL BIOL, V13, P977, DOI 10.1128/MCB.13.2.977; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Perrem K, 1999, ONCOGENE, V18, P3383, DOI 10.1038/sj.onc.1202752; Reddel RR, 2000, CARCINOGENESIS, V21, P477, DOI 10.1093/carcin/21.3.477; Reddel RR, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1254; Roth CW, 1997, MOL CELL BIOL, V17, P5176, DOI 10.1128/MCB.17.9.5176; SAXON PJ, 1985, MOL CELL BIOL, V5, P140, DOI 10.1128/MCB.5.1.140; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Sprung CN, 1999, EXP CELL RES, V247, P29, DOI 10.1006/excr.1998.4293; Stout K, 1999, CHROMOSOME RES, V7, P323, DOI 10.1023/A:1009287111661; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; Teng SC, 1999, MOL CELL BIOL, V19, P8083; WALMSLEY RM, 1984, NATURE, V310, P157, DOI 10.1038/310157a0; Yeager TR, 1999, CANCER RES, V59, P4175	29	682	718	0	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					447	450		10.1038/82586	http://dx.doi.org/10.1038/82586			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101843				2022-12-27	WOS:000165671700018
J	Nestler, EJ				Nestler, EJ			Genes and addiction	NATURE GENETICS			English	Article							RECEPTOR KNOCKOUT MICE; INBRED MOUSE STRAINS; DOPAMINE-TRANSPORTER; ALCOHOL DEPENDENCE; RECENT PROGRESS; COCAINE; REWARD; LACKING; SENSITIZATION; CREB	Drug addiction, like all psychiatric disorders, is defined solely in behavioural terms. For example, addiction can be considered a loss of control over drug-taking, or compulsive drug-seeking and -taking despite horrendous consequences. Abnormal behaviours are a consequence of aberrant brain function, which means that it is a tangible goal to identify the biological underpinnings of addiction. The genetic basis of addiction encompasses two broad areas of enquiry. One of these is the identification of genetic variation in humans that partly determines susceptibility to addiction. The other is the use of animal models to investigate the role of specific genes in mediating the development of addiction. Whereas recent advances in this latter effort are heartening, a major challenge remains: to understand how the many genes implicated in rodent models interact to yield as complex a phenotype as addiction.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Ctr Neurosci, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75235 USA.							Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; BERRETTINI WH, 1994, NAT GENET, V7, P54, DOI 10.1038/ng0594-54; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Brodkin ES, 1998, BRAIN RES, V805, P55, DOI 10.1016/S0006-8993(98)00663-5; Burmeister M, 1999, BIOL PSYCHIAT, V45, P522, DOI 10.1016/S0006-3223(98)00316-3; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CHEN JS, IN PRESS J NEUROSCI; Chen YC, 1999, ALCOHOL CLIN EXP RES, V23, P1853, DOI 10.1097/00000374-199912000-00001; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; Crabbe JC, 1999, TRENDS NEUROSCI, V22, P173, DOI 10.1016/S0166-2236(99)01393-4; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Gerlai R, 1996, SEMIN NEUROSCI, V8, P153, DOI 10.1006/smns.1996.0020; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Horger BA, 1999, J NEUROSCI, V19, P4110; Kalivas PW, 1999, CURR OPIN NEUROBIOL, V9, P223, DOI 10.1016/S0959-4388(99)80031-2; Kalivas PW, 1999, SYNAPSE, V33, P153, DOI 10.1002/(SICI)1098-2396(199908)33:2<153::AID-SYN5>3.0.CO;2-N; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; KELZ MB, IN PRESS CURR OPIN N; KENDLER KS, 1994, AM J PSYCHIAT, V151, P707; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P261, DOI 10.1001/archpsyc.57.3.261; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Kuhar MJ, 1999, TRENDS NEUROSCI, V22, P316, DOI 10.1016/S0166-2236(98)01377-0; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Maldonado R, 1996, SCIENCE, V273, P657, DOI 10.1126/science.273.5275.657; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; McClung C, 1999, CURR BIOL, V9, P853, DOI 10.1016/S0960-9822(99)80389-3; Messer CJ, 2000, NEURON, V26, P247, DOI 10.1016/S0896-6273(00)81154-X; Mogil JS, 1996, P NATL ACAD SCI USA, V93, P3048, DOI 10.1073/pnas.93.7.3048; Murtra P, 2000, NATURE, V405, P180, DOI 10.1038/35012069; Nestler EJ, 1996, MOL PSYCHIATR, V1, P190; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Rocha BA, 1998, NATURE, V393, P175, DOI 10.1038/30259; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Whisler K., 1999, Society for Neuroscience Abstracts, V25, P811; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; ZACHARIOU V, IN PRESS NEUROPSYCHO; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3	53	159	166	2	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					277	281		10.1038/81570	http://dx.doi.org/10.1038/81570			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062465				2022-12-27	WOS:000165176500014
J	Delettre, C; Lenaers, G; Griffoin, JM; Gigarel, N; Lorenzo, C; Belenguer, P; Pelloquin, L; Grosgeorge, J; Turc-Carel, C; Perret, E; Astarie-Dequeker, C; Lasquellec, L; Arnaud, B; Ducommun, B; Kaplan, J; Hamel, CP				Delettre, C; Lenaers, G; Griffoin, JM; Gigarel, N; Lorenzo, C; Belenguer, P; Pelloquin, L; Grosgeorge, J; Turc-Carel, C; Perret, E; Astarie-Dequeker, C; Lasquellec, L; Arnaud, B; Ducommun, B; Kaplan, J; Hamel, CP			Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy	NATURE GENETICS			English	Letter							CHROMOSOME 3Q REGION; KJER TYPE; LINKAGE ANALYSIS; CLINICAL-FEATURES; DNA MAINTENANCE; LOCUS; HETEROGENEITY; IDENTIFICATION; NEUROPATHY; REFINEMENT	Optic: atrophy type 1 (OPA1. MIM 165500) is a dominantly inherited optic neuropathy occurring in 1 in 50.000 individuals(1-3) that features progressive loss in visual acuity leading, in many cases, to legal blindness(4-8). Phenotypic variations(5) and loss of retinal ganglion cells(9,10), as found in Leber hereditary optic neuropathy (LHON), have suggested possible mitochondrial impairment(11,12). The OPA1 gene has been localized to 3q28-q29 (refs 13-19). We describe here a nuclear gene, OPA1, that maps within the candidate region and encodes a dynamin-related protein localized to mitochondria. We found four different OPA1 mutations, including frameshift and missense mutations, to segregate with the disease, demonstrating a role for mitochondria in retinal ganglion cell pathophysiology.	INSERM, U254, Lab Neurobiol Audit, Montpellier, France; Univ Toulouse 3, Lab Biol Cellulaire & Mol Controle Proliferat, CNRS, UMR 5088, F-31062 Toulouse, France; Hop Necker Enfants Malad, INSERM, U393, Paris, France; Fac Med, CNRS, UNSA, UMR 6549, Nice, France; Sanofi Synthelabo, Labege, France; Inst Pharmacol & Biol Struct, CNRS, UPR 9062, Toulouse, France; Hop Gui Chauliac, Serv Ophthalmol, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Sanofi-Aventis; Sanofi France; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; CHU de Montpellier	Hamel, CP (corresponding author), INSERM, U254, Lab Neurobiol Audit, Montpellier, France.		Delettre, Cécile/AAC-3096-2020; Lenaers, guy/X-4727-2019; DUCOMMUN, Bernard/B-3208-2008; LENAERS, Guy/K-2421-2015	Delettre, Cécile/0000-0003-3269-2155; LENAERS, Guy/0000-0003-2736-3349; Astarie-Dequeker, Catherine/0000-0003-1801-8105; DUCOMMUN, Bernard/0000-0002-7126-8368; Belenguer, Pascale/0000-0003-0229-5554; Arnaune-Pelloquin, Laetitia/0000-0001-5284-4916				BONNEAU D, 1995, J MED GENET, V32, P951, DOI 10.1136/jmg.32.12.951; Brown J, 1997, ARCH OPHTHALMOL-CHIC, V115, P95, DOI 10.1001/archopht.1997.01100150097016; EIBERG H, 1994, HUM MOL GENET, V3, P977, DOI 10.1093/hmg/3.6.977; ELIOTT D, 1993, AM J OPHTHALMOL, V115, P360, DOI 10.1016/S0002-9394(14)73589-5; Howell N, 1997, J BIOENERG BIOMEMBR, V29, P165, DOI 10.1023/A:1022690030664; HOYT CS, 1980, OPHTHALMOLOGY, V87, P245; JAEGER W, 1988, PAEDIAT GENET, V9, P7; JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P668; Johnston RL, 1999, OPHTHALMOLOGY, V106, P123, DOI 10.1016/S0161-6420(99)90013-1; Johnston RL, 1997, ARCH OPHTHALMOL-CHIC, V115, P100, DOI 10.1001/archopht.1997.01100150102017; JONES BA, 1992, GENE DEV, V6, P380, DOI 10.1101/gad.6.3.380; Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805; KERRISON JB, 1995, OPHTHALMOLOGY, V102, P1509; KIVLIN JD, 1983, AM J HUM GENET, V35, P1190; Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3; KJER P, 1983, ACTA OPHTHALMOL, V61, P300; KJER P, 1959, ACTA OPHTHALMOL S54, V37, P1; LECABEC V, 1994, BIOCHEM J, V303, P481, DOI 10.1042/bj3030481; LUNKES A, 1995, AM J HUM GENET, V57, P968; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Pelloquin L, 1999, J CELL SCI, V112, P4151; Pelloquin L, 1998, BIOCHEM BIOPH RES CO, V251, P720, DOI 10.1006/bbrc.1998.9539; Seller MJ, 1997, J MED GENET, V34, P967, DOI 10.1136/jmg.34.12.967; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; SMITH DP, 1972, AMER J OPT ARCH AM A, V49, P183; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; Votruba M, 1998, HUM GENET, V102, P79, DOI 10.1007/s004390050657; Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793; Votruba M, 1997, J MED GENET, V34, P117, DOI 10.1136/jmg.34.2.117	30	1062	1099	2	62	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					207	210		10.1038/79936	http://dx.doi.org/10.1038/79936			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017079				2022-12-27	WOS:000089638800020
J	Arya, R; Duggirala, R; Almasy, L; Rainwater, DL; Mahaney, MC; Cole, S; Dyer, TD; Williams, K; Leach, RJ; Hixson, JE; MacCluer, JW; O'Connell, P; Stern, MP; Blangero, J				Arya, R; Duggirala, R; Almasy, L; Rainwater, DL; Mahaney, MC; Cole, S; Dyer, TD; Williams, K; Leach, RJ; Hixson, JE; MacCluer, JW; O'Connell, P; Stern, MP; Blangero, J			Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans	NATURE GENETICS			English	Article							COMPLEX TRAITS; SUSCEPTIBILITY LOCUS; RISK-FACTORS; GENE; ATHEROSCLEROSIS; DISEASE; LOCALIZATION; REPLICATION; MUTATIONS; LOCATION	High-density lipoproteins (HDLs) are anti-atherogenic lipoproteins that have a major role in transporting cholesterol from peripheral tissues to the liver, where it is removed(1,2). Epidemiologic studies have shown that low levels of high-density lipoprotein-cholesterol (HDL-C) are associated with an increased incidence of coronary heart disease and an increased mortality rate(3,4), indicating a protective role of high concentrations of HDL-C against atherogenesis and the development of coronary heart disease. HDL-C level is influenced by several genetic and nongenetic factors(3,5). Nongenetic factors include smoking, which has been shown to decrease the HDL-C level. Exercise and alcohol have been shown to increase HDL-C levels(6,7). Decreased HDL-C is often associated with other coronary heart disease risk factors such as obesity, hyperinsulinemia and insulin resistance, hyper-triglyceridemia and hypertension(3). Although several genes have been identified for rare forms of dyslipidemia, the genes accounting for major variation in HDL-C levels have yet to be identified(8). Using a multipoint variance components linkage approach, we found strong evidence of linkage (lod score=3.4; P=0.00004) of a quantitative trait locus (QTL) for HDL-C level to a genetic location between markers D9S925 and D9S741 on chromosome 9p in Mexican Americans. A replication study in an independent set of Mexican American families confirmed the existence of a QTL on chromosome 9p.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Cell & Struct Biol, San Antonio, TX 78284 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; Baylor Coll Med, Baylor Breast Ctr, Houston, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Arya, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78284 USA.		Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021	Leach, Robin/0000-0002-3201-5579; Hixson, James/0000-0002-0849-9315				Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Calabresi L, 1997, CURR OPIN LIPIDOL, V8, P219, DOI 10.1097/00041433-199708000-00005; Duggirala R, 2000, AM J HUM GENET, V66, P1237, DOI 10.1086/302849; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Dupuis J, 1999, GENETICS, V151, P373; FERNANDEZRUIZ E, 1993, GENOMICS, V17, P759, DOI 10.1006/geno.1993.1401; Fong IW, 2000, CAN MED ASSOC J, V163, P49; Gordon DJ, 1998, ENDOCRIN METAB CLIN, V27, P699, DOI 10.1016/S0889-8529(05)70034-7; Hauser ER, 1997, AM J HUM GENET, V61, pA278; Hegele RA, 2001, AM J HUM GENET, V69, P1161, DOI 10.1086/324647; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Imperatore G, 2000, ARTERIOSCL THROM VAS, V20, P2651, DOI 10.1161/01.ATV.20.12.2651; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; KLINGER KW, 1987, P NATL ACAD SCI USA, V84, P8548, DOI 10.1073/pnas.84.23.8548; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Luoma PV, 1997, PHARMACOL TOXICOL, V81, P57, DOI 10.1111/j.1600-0773.1997.tb00032.x; MacCluer JW, 1999, NUTR REV, V57, pS59, DOI 10.1111/j.1753-4887.1999.tb01790.x; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; OKA K, 1994, GENOMICS, V20, P298, DOI 10.1006/geno.1994.1171; OWERBACH D, 1981, P NATL ACAD SCI-BIOL, V78, P3123, DOI 10.1073/pnas.78.5.3123; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Rosenson RS, 1996, ARCH INTERN MED, V156, P1278, DOI 10.1001/archinte.156.12.1278; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; THOMPSON PD, 1991, CIRCULATION, V84, P140, DOI 10.1161/01.CIR.84.1.140; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; WEIDNER G, 1991, CIRCULATION, V83, P176, DOI 10.1161/01.CIR.83.1.176; WHITMORE TE, 1995, GENOMICS, V28, P599, DOI 10.1006/geno.1995.1198; WILT VM, 1996, ANN PHARMACOTHER, V31, P89	31	75	76	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					102	105		10.1038/ng810	http://dx.doi.org/10.1038/ng810			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743583				2022-12-27	WOS:000173105600022
J	Bodnar, JS; Chatterjee, A; Castellani, LW; Ross, DA; Ohmen, J; Cavalcoli, J; Wu, CY; Dains, KM; Catanese, J; Chu, M; Sheth, SS; Charugundla, K; Demant, P; West, DB; de Jong, P; Lusis, AJ				Bodnar, JS; Chatterjee, A; Castellani, LW; Ross, DA; Ohmen, J; Cavalcoli, J; Wu, CY; Dains, KM; Catanese, J; Chu, M; Sheth, SS; Charugundla, K; Demant, P; West, DB; de Jong, P; Lusis, AJ			Positional cloning of the combined hyperlipidemia gene Hyplip1	NATURE GENETICS			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; RECOMBINANT CONGENIC STRAINS; CORONARY HEART-DISEASE; UP-REGULATED PROTEIN-1; REDOX REGULATION; THIOREDOXIN FUNCTION; CHROMOSOME 1Q21-Q23; ACID; LINKAGE; EXPRESSION	Familial combined hyperlipidemia (FCHL, MIM-144250) is a common, multifactorial and heterogeneous dyslipidemia predisposing to premature coronary artery disease(1-2) and characterized by elevated plasma triglycerides, cholesterol, or both(3-4). We identified a mutant mouse strain, HcB-19/Dem (HcB-19), that shares features with FCHL, including hyper-triglyceridemia hypercholesterolemia, elevated plasma apolipoprotein B and increased secretion of triglyceride-rich lipoproteins(5). The hyperlipidemia results from spontaneous mutation at a locus, Hyplip1, on distal mouse chromosome 3 in a region syntenic with a 1q21-q23 FCHL locus identified in Finnish, German, Chinese and US families(6-8). We fine-mapped Hyplip1 to roughly 160 kb, constructed a BAC contig and sequenced overlapping BACs to identify 13 candidate genes. We found substantially decreased mRNA expression for thioredoxin interacting protein (Txnip). Sequencing of the critical region revealed a Txnip nonsense mutation in HcB-19 that is absent in its normolipidemic parental strains. Txnip encodes a cytoplasmic protein that binds and inhibits thioredoxin, a major regulator of cellular redox state, The mutant mice have decreased CO2 production but increased ketone body synthesis, suggesting that altered redox status down-regulates the citric-acid cycle, sparing fatty acids for triglyceride and ketone body production. These results reveal a new pathway of potential clinical significance that contributes to plasma lipid metabolism.	Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Pfizer Inc, Ann Arbor Labs, Dept Mol Sci, Pfizer Global Res & Dev, Ann Arbor, MI 48105 USA; Netherlands Canc Inst, Div Mol Genet, Amsterdam, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pfizer; Netherlands Cancer Institute	Lusis, AJ (corresponding author), Univ Calif Los Angeles, Sch Med, Inst Mol Biol, 47-123 CHS, Los Angeles, CA 90095 USA.				NHLBI NIH HHS [P01 HL030568-190011, P01 HL028481, P01 HL030568-190009, P01 HL028481-170010, P01 HL030568, P01 HL028481-17] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, P01HL028481] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Castellani LW, 1998, NAT GENET, V18, P374, DOI 10.1038/ng0498-374; CASTELLANI LW, 1991, BIOCHIM BIOPHYS ACTA, V1086, P197, DOI 10.1016/0005-2760(91)90008-6; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Coon H, 2000, ARTERIOSCL THROM VAS, V20, P2275, DOI 10.1161/01.ATV.20.10.2275; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; DOOLITTLE MH, 1987, J LIPID RES, V28, P1326; GASDASKA JR, 1995, CELL GROWTH DIFFER, V6, P1643; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GROOT PC, 1992, FASEB J, V6, P2826, DOI 10.1096/fasebj.6.10.1634045; GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; KIMURA RE, 1988, PEDIATR RES, V23, P262, DOI 10.1203/00006450-198803000-00006; Lanford Robert E., 1998, V19, P501; LANOUE KF, 1972, J BIOL CHEM, V247, P667; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; NIKKILA EA, 1973, LANCET, V1, P954; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; OLUBADEWO JO, 1993, BIOCHEM PHARMACOL, V45, P2441, DOI 10.1016/0006-2952(93)90225-L; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Pajukanta P, 2001, MAMM GENOME, V12, P238, DOI 10.1007/s003350010265; Pei WD, 2000, CLIN GENET, V57, P29, DOI 10.1034/j.1399-0004.2000.570105.x; Sambrook J., 2002, MOL CLONING LAB MANU; Ueda S, 1998, J IMMUNOL, V161, P6689; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; YODOI J, 1992, IMMUNOL TODAY, V13, P405, DOI 10.1016/0167-5699(92)90091-K	30	174	183	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					110	116		10.1038/ng811	http://dx.doi.org/10.1038/ng811			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11753387	Green Accepted			2022-12-27	WOS:000173105600024
J	Backman, SA; Stambolic, V; Suzuki, A; Haight, J; Elia, A; Pretorius, J; Tsao, MS; Shannon, P; Bolon, B; Ivy, GO; Mak, TW				Backman, SA; Stambolic, V; Suzuki, A; Haight, J; Elia, A; Pretorius, J; Tsao, MS; Shannon, P; Bolon, B; Ivy, GO; Mak, TW			Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR PTEN; SIGNALING PATHWAY; COWDEN-SYNDROME; CELL-SURVIVAL; GERMLINE MUTATIONS; PROTEUS SYNDROME; CANCER; GENE; CEREBELLUM; MICE	Initially identified in high-grade gliomas, mutations in the PTEN tumor-suppressor are also found in many sporadic cancers and a few related autosomal dominant hamartoma syndromes. PTEN is a 3'-specific phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P-3) phosphatase and functions as a negative regulator of PI3K signaling. We generated a tissue-specific deletion of the mouse homolog Pten to address its role in brain function. Mice homozygous for this deletion (Pten(loxP/loxP);Gfap-cre), developed seizures and ataxia by 9 wk and died by 29 wk. Histological analysis showed brain enlargement in Pten(loxP/loxP);Gfap-cre mice as a consequence of primary granule-cell dysplasia in the cerebellum and dentate gyrus. Pten mutant cells showed a cell-autonomous increase in soma size and elevated phosphorylation of Akt. These data represent the first evidence for the role of Pten and Akt in cell size regulation in mammals and provide an animal model for a human phakomatosis condition, Lhermitte-Duclos disease (LDD).	Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Amgen Res Inst, Toronto, ON M5G 2C1, Canada; Osaka Univ, Dept Mol Cell Biol, Microbial Dis Res Inst, Suita, Osaka 5650874, Japan; Amgen Inc, Dept Pathol, Thousand Oaks, CA 91320 USA; Univ Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; Toronto Western Hosp, Div Neuropathol, Toronto, ON M5T 2S8, Canada; Univ Hlth Care Network, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Psychol, Scarborough, ON M1C 1A4, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Osaka University; Amgen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Scarborough	Mak, TW (corresponding author), Univ Toronto, Dept Med Biophys, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	tmak@oci.utoronto.ca	Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017; Suzuki, Akira/GYD-6697-2022	Tsao, Ming Sound/0000-0002-9160-5405; Suzuki, Akira/0000-0002-5950-8808; Stambolic, Vuk/0000-0001-8853-3239				Biesecker LG, 1999, AM J MED GENET, V84, P389, DOI 10.1002/(SICI)1096-8628(19990611)84:5<389::AID-AJMG1>3.0.CO;2-O; Brown W., 1987, SURGICAL TREATMENT E, P511; Bruni P, 2000, ONCOGENE, V19, P3146, DOI 10.1038/sj.onc.1203633; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Ding H, 2001, CANCER RES, V61, P3826; Dorland W. A. N., 2000, DORLANDS ILLUSTRATED; Eng C, 1998, NAT GENET, V19, P223, DOI 10.1038/897; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; GRIFFITHS PD, 1994, NEUROPEDIATRICS, V25, P140, DOI 10.1055/s-2008-1073012; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hampe CS, 2001, J NEUROIMMUNOL, V113, P63, DOI 10.1016/S0165-5728(00)00423-9; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Huang H, 1999, DEVELOPMENT, V126, P5365; Iida S, 1998, INT J MOL MED, V1, P925; Karle J, 2001, NEUROL RES, V23, P39, DOI 10.1179/016164101101198262; KHURGEL M, 1995, NEUROBIOL DIS, V2, P23, DOI 10.1006/nbdi.1995.0003; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1998, J MED GENET, V35, P881, DOI 10.1136/jmg.35.11.881; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Morrison ME, 1998, J NEUROSCI, V18, P3563; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nishio S, 2000, NEUROSURG REV, V23, P84; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; PRIVAT A, 1976, J COMP NEUROL, V166, P201, DOI 10.1002/cne.901660207; RAKIC P, 1975, ADV NEUROL, V12, P117; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; ROESSMANN U, 1984, J NEUROSURG, V60, P845, DOI 10.3171/jns.1984.60.4.0845; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; SOTELO C, 1976, BRAIN RES, V111, P389, DOI 10.1016/0006-8993(76)90782-4; Stambolic V, 1999, ONCOGENE, V18, P6094, DOI 10.1038/sj.onc.1203126; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; STEWARD O, 1992, EPILEPSY RES, P197; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; VINCHON M, 1994, J NEUROL NEUROSUR PS, V57, P699, DOI 10.1136/jnnp.57.6.699; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; WIESTLER OD, 2000, PATHOLOGY GENETICS T, P235; WUENSCHELL CW, 1986, P NATL ACAD SCI USA, V83, P6193, DOI 10.1073/pnas.83.16.6193; Zhou XP, 2000, HUM MOL GENET, V9, P765, DOI 10.1093/hmg/9.5.765; Zhou XP, 2001, LANCET, V358, P210, DOI 10.1016/S0140-6736(01)05412-5	53	373	392	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2001	29	4					396	403		10.1038/ng782	http://dx.doi.org/10.1038/ng782			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726926				2022-12-27	WOS:000172507500014
J	Hughes, KA; Hurlstone, AFL; Tobias, ES; McFarlane, R; Black, DM				Hughes, KA; Hurlstone, AFL; Tobias, ES; McFarlane, R; Black, DM			Absence of ST7 mutations in tumor-derived cell lines and tumors	NATURE GENETICS			English	Article							GENE; IDENTIFICATION; SUPPRESSOR	The gene ST7 has been proposed as the multi-tissue tumor-suppressor gene (TSG) at chromosome 7q31.1. However, we have sought and failed to detect the truncating mutations reported to exist in this gene.	Beatson Inst Canc Res, Canc Res Campaign Labs, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Black, DM (corresponding author), Beatson Inst Canc Res, Canc Res Campaign Labs, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.		Tobias, Edward/D-4246-2009	Tobias, Edward/0000-0003-2649-7695; Hurlstone, Adam/0000-0001-5260-9457				Black DM, 1999, BRIT J CANCER, V80, P42; Hurlstone AFL, 1999, ONCOGENE, V18, P1881, DOI 10.1038/sj.onc.1202491; HURLSTONE AFL, 1998, THESIS U GLASGOW; OGATA T, 1993, MOL CELL BIOL, V13, P6036, DOI 10.1128/MCB.13.10.6036; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Tobias ES, 2001, ONCOGENE, V20, P2844, DOI 10.1038/sj.onc.1204433; Vincent JB, 2000, AM J HUM GENET, V67, P510, DOI 10.1086/303005; Zenklusen JC, 1996, MOL CARCINOGEN, V15, P167; Zenklusen JC, 2001, NAT GENET, V27, P392, DOI 10.1038/86891	9	15	15	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					380	381		10.1038/ng783	http://dx.doi.org/10.1038/ng783			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726924				2022-12-27	WOS:000172507500011
J	Hoffman, HM; Mueller, JL; Broide, DH; Wanderer, AA; Kolodner, RD				Hoffman, HM; Mueller, JL; Broide, DH; Wanderer, AA; Kolodner, RD			Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome	NATURE GENETICS			English	Article							PERIODIC FEVER SYNDROME; MEDITERRANEAN FEVER; MEVALONATE KINASE; CHROMOSOME 1Q44; URTICARIA; MEFV	Familial cold autoinflammatory syndrome (FCAS, MIM 120100), commonly known as familial cold urticaria (FCU), is an autosomal-dominant systemic inflammatory disease characterized by intermittent episodes of rash, arthralgia, fever and conjunctivitis after generalized exposure to cold(1-4). FCAS was previously mapped to a 10-cM region on chromosome 1q44 (refs. 5,6). Muckle-Wells syndrome (MWS; MIM 191900), which also maps to chromosome 1q44, is an autosomal-dominant periodic fever syndrome with a similar phenotype except that symptoms are not precipitated by cold exposure and that sensorineural hearing loss is frequently also present(6-8). To identify the genes for FCAS and MWS, we screened exons in the 1q44 region for mutations by direct sequencing of genomic DNA from affected individuals and controls. This resulted in the identification of four distinct mutations in a gene that segregated with the disorder in three families with FCAS and one family with MWS. This gene, called CIAS1, is expressed in peripheral blood leukocytes and encodes a protein with a pyrin domain(9-11), a nucleotide-binding site (NBS, NACHT subfamily(12)) domain and a leucine-rich repeat (LRR) motif region(13), suggesting a role in the regulation of inflammation and apoptosis.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, San Diego, CA 92103 USA; Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, San Diego, CA 92103 USA; Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; Univ Calif San Diego, Sch Med, Ctr Canc, San Diego, CA 92103 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat & Allergy, Denver, CO USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Hoffman, HM (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, San Diego, CA 92103 USA.	hahoffman@ucsd.edu		Broide, David/0000-0001-8405-9090	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001508] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI001508, 5-K08-AI01508] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aksentijevich I, 1997, CELL, V90, P797; Bernot A, 1997, NAT GENET, V17, P25; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Cuisset L, 1999, AM J HUM GENET, V65, P1054, DOI 10.1086/302589; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Hoffman HM, 2000, AM J HUM GENET, V66, P1693, DOI 10.1086/302874; HOFFMAN HM, IN PRESS J ALLERGY C; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jung M., 1996, American Journal of Human Genetics, V59, pA223; Kile RL., 1940, J AM MED ASS, V114, P1067, DOI [10.1001/jama.1940.62810120003010b, DOI 10.1001/JAMA.1940.62810120003010B]; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kolodner RD, 1999, CANCER RES, V59, P5068; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Mansfield E, 2001, BLOOD, V98, P851, DOI 10.1182/blood.V98.3.851; Martin Seamus J., 2001, Trends in Cell Biology, V11, P188, DOI 10.1016/S0962-8924(01)01971-7; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; McDermott MF, 2000, ARTHRITIS RHEUM-US, V43, P2034, DOI 10.1002/1529-0131(200009)43:9<2034::AID-ANR14>3.0.CO;2-J; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; MUCKLE TJ, 1979, BRIT J DERMATOL, V100, P87, DOI 10.1111/j.1365-2133.1979.tb03572.x; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; ORMEROD AD, 1993, ARCH DERMATOL, V129, P343, DOI 10.1001/archderm.129.3.343; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Tidow N, 2000, BLOOD, V95, P1451, DOI 10.1182/blood.V95.4.1451.004k52_1451_1455; TINDALL JP, 1969, ARCH INTERN MED, V124, P129, DOI 10.1001/archinte.124.2.129; ZIP CM, 1993, CLIN EXP DERMATOL, V18, P338, DOI 10.1111/j.1365-2230.1993.tb02212.x	29	1164	1227	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					301	305		10.1038/ng756	http://dx.doi.org/10.1038/ng756			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687797	Green Accepted			2022-12-27	WOS:000171911000016
J	de Lonlay, P; Valnot, I; Barrientos, A; Gorbatyuk, M; Tzagoloff, A; Taanman, JW; Benayoun, E; Chretien, D; Kadhom, N; Lombes, A; de Baulny, HO; Niaudet, P; Munnich, M; Rustin, P; Rotig, A				de Lonlay, P; Valnot, I; Barrientos, A; Gorbatyuk, M; Tzagoloff, A; Taanman, JW; Benayoun, E; Chretien, D; Kadhom, N; Lombes, A; de Baulny, HO; Niaudet, P; Munnich, M; Rustin, P; Rotig, A			A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure	NATURE GENETICS			English	Article							CYTOCHROME-C-OXIDASE; B GENE; SACCHAROMYCES-CEREVISIAE; EXERCISE INTOLERANCE; LEIGH-SYNDROME; BC(1) COMPLEX; MUTATIONS; EXPRESSION; REDUCTASE; SURF1	Complex III (CIII; ubiquinol cytochrome c reductase of the mitochondrial respiratory chain) catalyzes electron transfer from succinate and nicotinamide adenine dinucleotide-linked dehydrogenases to cytochrome c. CIII is made up of 11 subunits, of which all but one (cytochrome b) are encoded by nuclear DNA. CIII deficiencies are rare and manifest heterogeneous clinical presentations(1,2). Although pathogenic mutations in the gene encoding mitochondrial cytochrome b have been described(3-7), mutations in the nuclear-DNA-encoded subunits have not been reported. Involvement of various genes has been indicated in assembly of yeast CIII (refs. 8-11). So far only one such gene, BCS1L, has been identified in human(12). BCS1L represents, therefore, an obvious candidate gene in CIII deficiency. Here,we report BCS1L mutations in six patients, from four unrelated families and presenting neonatal proximal tubulopathy, hepatic involvement and encephalopathy. Complementation study in yeast confirmed the deleterious effect of these mutations. Mutation of BCS1L would seem to be a frequent cause of CIII deficiency, as one-third of our patients have BCS1L mutations.	Hop Necker Enfants Malad, INSERM, U393, F-75015 Paris, France; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; UCL Royal Free & Univ Coll Med Sch, Dept Clin Neurosci, London NW3 2PF, England; Inst Myol, INSERM, U523, F-75013 Paris, France; Hop Robert Debre, Serv Neuropediat, F-75019 Paris, France; Hop Necker Enfants Malad, Dept Pediat, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Columbia University; University of London; University College London; UCL Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Rotig, A (corresponding author), Hop Necker Enfants Malad, INSERM, U393, 149 Rue Sevres, F-75015 Paris, France.	roetig@necker.fr	Taanman, Jan W/A-5379-2011; Rötig, Agnès/G-9592-2017; Lombes, Anne/G-4684-2014	Taanman, Jan W/0000-0002-5476-9785; Rötig, Agnès/0000-0003-0589-0703; Lombes, Anne/0000-0002-9064-0399; Gorbatyuk, Marina/0000-0001-9060-856X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL022174, R56HL022174, R01HL022174] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL022174, HL22174] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Brasseur G, 1997, EUR J BIOCHEM, V246, P103, DOI 10.1111/j.1432-1033.1997.t01-1-00103.x; CRIVELLONE MD, 1994, J BIOL CHEM, V269, P21284; Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226; De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.3.CO;2-Q; Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900; Kuklin A, 1997, GENET TEST, V1, P201, DOI 10.1089/gte.1997.1.201; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; Mourmans J, 1997, J NEUROL SCI, V149, P111, DOI 10.1016/S0022-510X(97)05379-3; NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x; Papadopoulou LC, 1999, NAT GENET, V23, P333; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Rahman S, 2001, ANN NEUROL, V49, P797, DOI 10.1002/ana.1060; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988; von Kleist-Retzow JC, 1999, BBA-MOL BASIS DIS, V1455, P35, DOI 10.1016/S0925-4439(99)00050-2; von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957; Von Kleist-Retzow JC, 2001, J MED GENET, V38, P109, DOI 10.1136/jmg.38.2.109; WU M, 1989, J BIOL CHEM, V264, P11122; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	25	226	227	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2001	29	1					57	60		10.1038/ng706	http://dx.doi.org/10.1038/ng706			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528392				2022-12-27	WOS:000170781300017
J	Katsanis, N; Worley, KC; Lupski, JR				Katsanis, N; Worley, KC; Lupski, JR			An evaluation of the draft human genome sequence	NATURE GENETICS			English	Article							RADIATION HYBRID MAP; PROTEIN	The completed draft version of the human genome, comprised of multiple short contigs encompassing 85% or more of euchromatin, was announced in June of 2000 (ref. 1). The detailed findings of the sequencing consortium were reported several months later(2). The draft sequence has provided insight into global characteristics, such as the total number of genes and a more accurate definition of gene families. Also of importance are genome positional details such as local genome architecture, regional gene density and the location of transcribed units that are critical for disease gene identification. We carried out a series of mapping and computational experiments using a nonredundant collection of 925 expressed sequence tags (ESTs) and sections of the public draft genome sequence that were available at different timepoints between April 2000 and April 2001. We found discrepancies in both the reported coverage of the human genome and the accuracy of mapping of genomic clones, suggesting some limitations of the draft genome sequence in providing accurate positional information and detailed characterization of chromosomal subregions.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Katsanis, Nicholas/E-1837-2012	Worley, Kim/0000-0002-0282-1000; Katsanis, Nicholas/0000-0002-2480-0171	NATIONAL EYE INSTITUTE [R01EY011780, R01EY012666] Funding Source: NIH RePORTER; NEI NIH HHS [EY12666, EY11780] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; Katsanis N, 1998, GENOMICS, V51, P128, DOI 10.1006/geno.1998.5263; Katsanis N, 1998, GENOMICS, V47, P294, DOI 10.1006/geno.1997.5115; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; Pennisi E, 2000, SCIENCE, V288, P2304, DOI 10.1126/science.288.5475.2304; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P9794	11	25	25	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					88	91		10.1038/ng0901-88	http://dx.doi.org/10.1038/ng0901-88			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528399				2022-12-27	WOS:000170781300024
J	Vidal, VPI; Chaboissier, MC; de Rooij, DG; Schedl, A				Vidal, VPI; Chaboissier, MC; de Rooij, DG; Schedl, A			Sox9 induces testis development in XX transgenic mice	NATURE GENETICS			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; MOUSE; EXPRESSION; MUTATIONS; UPSTREAM	Mutations in SOX9 are associated with male-to-female sex reversal in humans(1,2). To analyze Sox9 function during sex determination, we ectopically expressed this gene in XX gonads. Here, we show that Sox9 is sufficient to induce testis formation in mice, indicating that it can substitute for the sex-determining gene Sry.	MDC Mol Med, D-13092 Berlin, Germany; Univ Utrecht, Med Ctr, Dept Cell Biol, Utrecht, Netherlands	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Utrecht University	Schedl, A (corresponding author), MDC Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	andreas.schedl@ncl.ac.uk	de Rooij, D.G./AAW-1195-2021; vidal, valerie/S-2597-2019; CHABOISSIER, Marie-Christine/AAZ-5905-2021; Schedl, Andreas/F-8823-2015; Schedl, Andreas/GOP-3427-2022; Vidal, Valerie/M-1477-2018; CHABOISSIER, Marie-Christine/F-6166-2019	CHABOISSIER, Marie-Christine/0000-0003-0934-8217; Schedl, Andreas/0000-0001-9380-7396; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; de Rooij, Dirk/0000-0003-3932-4419				Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Bergstrom DE, 2000, GENESIS, V28, P111, DOI 10.1002/1526-968X(200011/12)28:3/4<111::AID-GENE40>3.0.CO;2-5; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Hunt PA, 1998, MOL REPROD DEV, V49, P101, DOI 10.1002/(SICI)1098-2795(199802)49:2&lt;101::AID-MRD1&gt;3.0.CO;2-T; Kent J, 1996, DEVELOPMENT, V122, P2813; Moore AW, 1998, MECH DEVELOP, V79, P169, DOI 10.1016/S0925-4773(98)00188-9; Pask A, 1999, CELL MOL LIFE SCI, V55, P864, DOI 10.1007/s000180050340; SCHEDL A, 1993, NATURE, V362, P258, DOI 10.1038/362258a0; Scholz H, 1997, J BIOL CHEM, V272, P32836, DOI 10.1074/jbc.272.52.32836; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8	15	510	531	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					216	217		10.1038/90046	http://dx.doi.org/10.1038/90046			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431689				2022-12-27	WOS:000169656400011
J	Sklar, P; Schwab, SG; Williams, NM; Daly, M; Schaffner, S; Maier, W; Albus, M; Trixler, M; Eichhammer, P; Lerer, B; Hallmayer, J; Norton, N; Williams, H; Zammit, S; Cardno, AG; Jones, S; McCarthy, G; Milanova, V; Kirov, G; O'Donovan, MC; Lander, ES; Owen, MJ; Wildenauer, DB				Sklar, P; Schwab, SG; Williams, NM; Daly, M; Schaffner, S; Maier, W; Albus, M; Trixler, M; Eichhammer, P; Lerer, B; Hallmayer, J; Norton, N; Williams, H; Zammit, S; Cardno, AG; Jones, S; McCarthy, G; Milanova, V; Kirov, G; O'Donovan, MC; Lander, ES; Owen, MJ; Wildenauer, DB			Association analysis of NOTCH4 loci in schizophrenia using family and population-based controls	NATURE GENETICS			English	Article							SUSCEPTIBILITY	A genetic association between NOTCH4 and schizophrenia has previously been proposed(1). Unsing all markers previously shown to be associated, we found no evidence for such in three independent family-based samples (n=519 parent-offspring trios), and a case-control sample derived from the same ethnic background as the original observaton, These data strongly suggest that NOTCH4 is not a significant susceptibility allele for schizophrenia.	Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Univ Bonn, Dept Psychiat, Genet Mol Lab, D-53111 Bonn, Germany; Cardiff Univ, Dept Psychol Med, Cardiff CF4 4XN, S Glam, Wales; Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany; Mental State Hosp, D-85529 Haar, Germany; Univ Pecs, Sch Med, Dept Psychiat, H-7623 Pecs, Hungary; Univ Regensburg, Dept Psychiat, D-93042 Regensburg, Germany; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Psychiat, IL-91120 Jerusalem, Israel; Univ Western Australia, Graylands Hosp, Ctr Clin Res Neuropscyhiat, Mtr Claremont, WA 6010, Australia; Med Univ Sofia, Dept Psychiat, Sofia 1431, Bulgaria	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Bonn; Cardiff University; University of Bonn; University of Pecs; University of Regensburg; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Western Australia; Medical University Sofia	Sklar, P (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	sklar@genome.wi.mit.edu	Williams, Hywel/AAL-2440-2021; Daly, Mark J/B-2453-2017; O'Donovan, Michael C/P-7005-2018; McCarthy, Geraldine/AAU-9549-2021; Schaffner, Stephen F/D-1189-2011	Williams, Hywel/0000-0001-7758-0312; Daly, Mark J/0000-0002-0949-8752; O'Donovan, Michael C/0000-0001-7073-2379; Kirov, George/0000-0002-3427-3950; Zammit, Stanley/0000-0002-2647-9211; Schaffner, Stephen/0000-0001-6699-3568; McCarthy, Geraldine/0000-0002-1312-0998				Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Wei J, 2000, NAT GENET, V25, P376, DOI 10.1038/78044; 1999, NATURE GENET, V22, P1	5	57	59	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2001	28	2					126	128		10.1038/88836	http://dx.doi.org/10.1038/88836			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381257				2022-12-27	WOS:000169011800012
J	Lubke, T; Marquardt, T; Etzioni, A; Hartmann, E; von Figura, K; Korner, C				Lubke, T; Marquardt, T; Etzioni, A; Hartmann, E; von Figura, K; Korner, C			Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency	NATURE GENETICS			English	Article								Congenital disorders of glycosylation (CDG) comprise a rapidly growing group of inherited disorders in which glycosylation of glycoproteins is defective due to mutations in genes required for the assembly of lipid-linked oligosaccharides, their transfer to nascent glycoproteins (CDG-I) or the processing of protein-bound glycansl(1,2) (CDG-II). Previously' a defect in the GDP-fucose import into the lumen of the Golgi was identified in a person with CDG (A.C.) with a general deficiency of fucosyl residues in glycoproteins(3). This patient presents the clinical features of leukocyte adhesion deficiency type II (LAD II) including mental retardation, short stature, facial stigmata, and recurrent bacterial peripheral infections with persistently elevated peripheral leukocytes(4-7). Using a fucose-specific. lectin-staining procedure for detection of fucosylated glycoproteins and a retroviral cDNA library, we isolated a cDNA complementing the fucosylation defect in the patient's fibroblasts. The cDNA encodes a highly hydrophobic protein of 364 amino acids with multiple putative transmembrane domains. Restoration of CDP-fucose import activity in Golgi-enriched vesicles from the patient's fibroblasts verified the GDP-fucose transporter activity of this protein. We identified two missense mutations in the GDP-fucose transporter cDNA of patient A.C. and of two other people with LAD II. Thus complementation cloning allowed us to identify the human GDP-fucose transporter cDNA and GDP-fucose transporter deficiency as a cause for a new type of CDG. Following the recent recommendations(2,8) for the nomenclature for CDG, this new type is classified as CDG-IIc (formerly LAD II).	Univ Gottingen, Biochem Abt 2, Gottingen, Germany; Klin & Poliklin Kinderheilkunde, Munster, Germany; Rambam Med Ctr, B Rappaport Sch Med, Dept Pediat & Immunol, Haifa, Israel	University of Gottingen; University of Munster; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Korner, C (corresponding author), Univ Gottingen, Biochem Abt 2, Heinrich Duker Weg 12, Gottingen, Germany.	ckoerne@gwdg.de	Lübke, Torben/B-6019-2012; Hartmann, Enno/C-5687-2013	Lubke, Torben/0000-0002-3342-0090				Aebi M, 2000, GLYCOBIOLOGY, V10, pIII; Etzioni A, 1998, J ALLERGY CLIN IMMUN, V102, P323, DOI 10.1016/S0091-6749(98)70104-6; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; FRYDMAN M, 1992, AM J MED GENET, V44, P297, DOI 10.1002/ajmg.1320440307; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Krasnewich D, 1997, Adv Pediatr, V44, P109; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; MANIATIS NT, 1989, MOL CLONING LAB MANU; Marquardt T, 1999, J PEDIATR-US, V134, P681, DOI 10.1016/S0022-3476(99)70281-7; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Miera N, 1996, J BIOCHEM-TOKYO, V120, P236; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; 1999, GLYCOCONJ J, V16, P669	14	239	254	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					73	76		10.1038/88299	http://dx.doi.org/10.1038/88299			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326280	Green Published			2022-12-27	WOS:000168413300020
J	Boyartchuk, VL; Broman, KW; Mosher, RE; D'Orazio, SEF; Starnbach, MN; Dietrich, W				Boyartchuk, VL; Broman, KW; Mosher, RE; D'Orazio, SEF; Starnbach, MN; Dietrich, W			Multigenic control of Listeria monocytogenes susceptibility in mice	NATURE GENETICS			English	Letter							INFECTIOUS-DISEASES; BACTERIAL-INFECTION; RESISTANCE	We have used a novel quantitative trait locus model to study the genetics of survival of F2 progeny of susceptible BALB/cByJ and resistant C57BL/6ByJ mice that have been infected with Listeria monocytogenes. This allowed us to map modifiers of L. monocytogenes susceptibility to chromosomes 5 and 13.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; Faulkner Hosp, Dept Pathol, Jamaica Plain, MA USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Johns Hopkins University	Dietrich, W (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.		D'Orazio, Sarah E.F./AAI-3916-2020; D'Orazio, Sarah E.F./AAI-4968-2020	D'Orazio, Sarah E.F./0000-0003-0716-3518; Broman, Karl/0000-0002-4914-6671				Abel L, 1998, EMERG INFECT DIS, V4, P593, DOI 10.3201/eid0404.980409; CHEERS C, 1978, INFECT IMMUN, V19, P755, DOI 10.1128/IAI.19.3.755-762.1978; Dietrich WF, 2001, GENOME RES, V11, P325, DOI 10.1101/gr.173101; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; GERVAIS F, 1984, J IMMUNOL, V132, P2078; KRUGLYAK L, 1995, GENETICS, V139, P1421; LANDER ES, 1989, GENETICS, V121, P185; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; Lynch M., 1998, GENETICS ANAL QUANTI; MANDEL TE, 1980, INFECT IMMUN, V30, P851; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Qureshi ST, 1999, EMERG INFECT DIS, V5, P36, DOI 10.3201/eid0501.990105; SKAMENE E, 1985, CURR TOP MICROBIOL, V122, P128	13	64	65	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					259	260		10.1038/85812	http://dx.doi.org/10.1038/85812			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242105				2022-12-27	WOS:000167304200015
J	Peters, MA; Ostrander, EA				Peters, MA; Ostrander, EA			Prostate cancer: simplicity to complexity	NATURE GENETICS			English	Editorial Material							TUMOR SUPPRESSION; MICE LACKING; P27(KIP1); HYPERPLASIA; GENE	Prostate cancer is a complex disease to which a multitude of genetic and environmental factors contribute. Two new studies offer insights as to how the disease may arise and progress. The first describes mapping and cloning of a new candidate gene, ELAC2, whereas the second demonstrates how cooperation between Cdkn1b and Pten contribute to suppression of prostate tumors.	Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Peters, MA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98109 USA.			Ostrander, Elaine/0000-0001-6075-9738				Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Gibbs M, 2000, AM J HUM GENET, V67, P100, DOI 10.1086/302969; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P8272; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Makridakis NM, 1999, LANCET, V354, P975, DOI 10.1016/S0140-6736(98)11282-5; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; Philipp J, 1999, ONCOGENE, V18, P4689, DOI 10.1038/sj.onc.1202840; PROBER DA, IN PRESS CURR OPIN G; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Suarez BK, 2000, AM J HUM GENET, V66, P933, DOI 10.1086/302818; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Yang RM, 1998, J UROLOGY, V159, P941, DOI 10.1016/S0022-5347(01)63776-5	18	11	12	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					134	135		10.1038/84739	http://dx.doi.org/10.1038/84739			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175773				2022-12-27	WOS:000166839200005
J	Di Palma, F; Holme, RH; Bryda, EC; Belyantseva, IA; Pellegrino, R; Kachar, B; Steel, KP; Noben-Trauth, K				Di Palma, F; Holme, RH; Bryda, EC; Belyantseva, IA; Pellegrino, R; Kachar, B; Steel, KP; Noben-Trauth, K			Mutations in Cdh23, encoding a new type of cadherin, cause stereocilia disorganization in waltzer, the mouse model for Usher syndrome type 1D	NATURE GENETICS			English	Article							MYOSIN VIIA; GENE; MICE; IDENTIFICATION; DEAFNESS; CHROMOSOME-10; LOCALIZATION; ALLELE; ROLES; CA2+	Mouse chromosome 10 harbors several loci associated with hearing loss, including waltzer (v), modifier-of deaf waddler (mdfw) and Age-related hearing loss(1) (Ahl). The human region that is orthologous to the mouse 'waltzer' region is located at 10q21-q22 and contains the human deafness loci DFNB12 and USH1D (refs. 2,3). Numerous mutations at the waltzer locus have been documented causing erratic circling and hearing loss(4-7). Here we report the identification of a new gene mutated in v. The 10.5-kb Cdh23 cDNA encodes a very large, single-pass transmembrane protein, that we have called otocadherin. It has an extracellular domain that contains 27 repeats; these show significant homology to the cadherin ectodomain. In v(6J), a GT transversion creates a premature stop codon. In v(Alb), a Cr exchange generates an ectopic donor splice site, effecting deletion of 119 nucleotides of exonic sequence. In v(2J), a GA transition abolishes the donor splice site, leading to aberrant splice forms. All three alleles are predicted to cause loss of function. We demonstrate Cdh23 expression in the neurosensory epithelium and show that during early hair-cell differentiation, stereocilia organization is disrupted in v(2J) homozygotes. Our data indicate that otocadherin is a critical component of hair bundle formation. Mutations in human CDH23 cause Usher syndrome type 1D and thus, establish waltzer as the mouse model for USH1D.	Natl Inst Deafness & Other Commun Disorders, Sect Murine Genet, Genet Mol Lab, NIH, Rockville, MD USA; Natl Inst Deafness & Other Commun Disorders, Lab Cellular Biol, NIH, Rockville, MD USA; MRC, Inst Hearing Res, Nottingham, England; Marshall Univ, Sch Med, Dept Immunol & Mol Genet, Huntington, WV USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Marshall University	Noben-Trauth, K (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Murine Genet, Genet Mol Lab, NIH, Rockville, MD USA.	nobentk@nidcd.nih.gov		Di-Palma, Federica/0000-0002-4394-0102	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC003771, Z01DC000002, Z01DC000036, ZIADC000002] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC03771] Funding Source: Medline; PHS HHS [DZ 00036-04] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; BOLZ H, 2000, NAT GENET, V27, P105; Bryda EC, 1997, MAMM GENOME, V8, P1, DOI 10.1007/s003359900336; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; DEOL MS, 1956, J EMBRYOL EXP MORPH, V4, P190; DEOL MS, 1956, PROC R SOC SER B-BIO, V145, P206, DOI 10.1098/rspb.1956.0028; FLAHERTY L, 1992, P NATL ACAD SCI USA, V89, P2859, DOI 10.1073/pnas.89.7.2859; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HUNTERDUVAR IM, 1978, ACTA OTO-LARYNGOL, P3; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Liu XR, 1999, J NEUROSCI, V19, P6267; *MGD, 2000, MOUS GEN INF PROJ; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; Rost B, 1996, METHOD ENZYMOL, V266, P525; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Self T, 1998, DEVELOPMENT, V125, P557; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Suzuki ST, 1996, J CELL SCI, V109, P2609; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; Yagi T, 2000, GENE DEV, V14, P1169; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yonezawa S, 1999, HEARING RES, V134, P116, DOI 10.1016/S0378-5955(99)00080-5	29	331	339	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					103	107		10.1038/83660	http://dx.doi.org/10.1038/83660			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138008				2022-12-27	WOS:000166187900025
J	Le Stunff, C; Fallin, D; Schork, NJ; Bougneres, P				Le Stunff, C; Fallin, D; Schork, NJ; Bougneres, P			The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity	NATURE GENETICS			English	Article							DIABETES SUSCEPTIBILITY; LOCUS; MINISATELLITE; SECRETION; MELLITUS; WEIGHT; REGION; IDDM2	In millions of people, obesity leads to type 2 diabetes (T2D; also known as non-insulin-dependent diabetes mellitus(1)). During the early stages of juvenile obesity, the increase of insulin secretion in proportion to accumulated fat balances insulin resistance and protects patients from hyperglycaemia(2). After several decades, however, beta -cell function deteriorates and T2D develops in approximately 20% of obese patients(3,4). In modern societies, obesity has thus become the leading risk factor for T2D (ref. 5). The factors that predispose obese patients to alteration of insulin secretion upon gaining weight remain unknown. To determine which genetic factors predispose obese patients to beta -cell dysfunction, and possibly T2D, we studied single-nucleotide polymorphisms (SNPs) in the region of the insulin gene (INS) among 615 obese children. We found that, in the early phase of obesity, alleles of the INS variable number of tandem repeat (VNTR) locus are associated with different effects of body fatness on insulin secretion. Young obese patients homozygous for class I VNTR alleles secrete more insulin than those with other genotypes.	Hop St Vincent de Paul, Dept Pediat Endocrinol, F-75674 Paris, France; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Genset Corp, La Jolla, CA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Case Western Reserve University; Harvard University; Harvard T.H. Chan School of Public Health	Bougneres, P (corresponding author), Hop St Vincent de Paul, Dept Pediat Endocrinol, F-75674 Paris, France.		LE STUNFF, CATHERINE/Y-3270-2018	LE STUNFF, CATHERINE/0000-0001-8419-0451; Schork, Nicholas/0000-0003-0920-5013				Ahmed S, 1999, DIABETIC MED, V16, P910, DOI 10.1046/j.1464-5491.1999.00169.x; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Brancati FL, 1999, ARCH INTERN MED, V159, P957, DOI 10.1001/archinte.159.9.957; CARMELLI D, 1994, AM J HUM GENET, V55, P566; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Eaves IA, 1999, NAT GENET, V22, P324, DOI 10.1038/11890; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KARAM JH, 1963, DIABETES, V12, P197, DOI 10.2337/diab.12.3.197; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; LESTUNFF C, 1994, DIABETES, V43, P696, DOI 10.2337/diabetes.43.5.696; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; Ong KKL, 1999, NAT GENET, V21, P262, DOI 10.1038/6775; OWERBACH D, 1982, LANCET, V1, P880; PEDERSEN P, 1989, DIABETES METAB REV, V5, P505; PERMUTT MA, 1985, DIABETES, V34, P311, DOI 10.2337/diabetes.34.4.311; Snieder H, 1999, GENET EPIDEMIOL, V16, P426, DOI 10.1002/(SICI)1098-2272(1999)16:4<426::AID-GEPI8>3.3.CO;2-2; WEAVER H, 1992, PHYS WORLD, V5, P22, DOI 10.1088/2058-7058/5/11/23	23	128	133	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					444	446		10.1038/82579	http://dx.doi.org/10.1038/82579			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101842				2022-12-27	WOS:000165671700017
J	Matsuura, T; Yamagata, T; Burgess', DL; Rasmussen, A; Grewal, RP; Watase, K; Khajavi, M; McCall, AE; Davis, CF; Zu, L; Achari, M; Pulst, SM; Alonso, E; Noebels, JL; Nelson, DL; Zoghbi, HY; Ashizawa, T				Matsuura, T; Yamagata, T; Burgess', DL; Rasmussen, A; Grewal, RP; Watase, K; Khajavi, M; McCall, AE; Davis, CF; Zu, L; Achari, M; Pulst, SM; Alonso, E; Noebels, JL; Nelson, DL; Zoghbi, HY; Ashizawa, T			Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10	NATURE GENETICS			English	Article							TRINUCLEOTIDE REPEAT; POLYGLUTAMINE EXPANSION; CAG REPEAT; GENE; CLONING; DNA; REVEALS; DISEASE	Spinocerebellar ataxia type 10 (SCA10; MIM 603516; refs 1.2) is an autosomal dominant disorder characterized by cerebellar ataxia and seizures. The gene SCA10 maps to a 3.8-cM interval on human chromosome 22q13-qter (refs 1.2). Because several other SCA subtypes show trinucleotide repeat expansions, we examined microsatellites in this region. We found an expansion of a pentanucleotide (ATTCT) repeat in intron 9 of SCA10 in all patients in five Mexican SCA10 families. There was an inverse correlation between the expansion size, up to 22.5 kb larger than the normal allele, and the age of onset (r(2)=0.34, P=0.018). Analysis of 562 chromosomes from unaffected individuals of various ethnic origins (including 242 chromosomes from Mexican persons) showed a range of 10 to 22 ATTCT repeats with no evidence of expansions. Our data indicate that the new SCA10 intronic ATTCT pentanucleotide repeat in SCA10 patients is unstable and represents the largest microsatellite expansion found so far in the human genome.	Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Vet Affairs Med Ctr, Neurol Serv, Houston, TX 77030 USA; Inst Nacl Neurol & Neurocirugia, Mexico City, DF, Mexico; New Jersey Neurosci Inst, JKF Med Ctr, Edison, NJ USA; Univ Calif Los Angeles, Cedars Sinai Med Ctr, Rose Moss Lab Parkinson & Neurodgenerat Dis, Burns & Allen Res Inst,Div Neurol,Sch Med, Los Angeles, CA 90048 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ashizawa, T (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.		Rasmussen, Astrid/A-4878-2013	Rasmussen, Astrid/0000-0001-7744-2948; Davis, Caleb/0000-0002-5125-0494; Noebels, Jeffrey/0000-0002-2887-0839; Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699] Funding Source: NIH RePORTER; NICHD NIH HHS [HD29256, HD24064] Funding Source: Medline; NINDS NIH HHS [NS27699] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Breschel TS, 1997, HUM MOL GENET, V6, P1855, DOI 10.1093/hmg/6.11.1855; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Ikeuchi T, 1998, GENOMICS, V49, P321, DOI 10.1006/geno.1998.5266; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; Matsuura T, 1999, ANN NEUROL, V46, P480; Matsuura T, 1999, ANN NEUROL, V45, P407, DOI 10.1002/1531-8249(199903)45:3<407::AID-ANA21>3.0.CO;2-D; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; WELLS RD, 1998, GENETIC INSTABILITY; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zu L, 1999, AM J HUM GENET, V64, P594, DOI 10.1086/302247	20	352	374	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					191	194		10.1038/79911	http://dx.doi.org/10.1038/79911			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017075	Bronze			2022-12-27	WOS:000089638800016
J	Lin, YP; Ma, WL; Benchimol, S				Lin, YP; Ma, WL; Benchimol, S			Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis	NATURE GENETICS			English	Article							TRANSCRIPTIONAL ACTIVATION; GROWTH SUPPRESSION; ADAPTER MOLECULE; CELL-DEATH; INTERACTS; TRANSFORMATION; IDENTIFICATION; INHIBITION; MOTIF; RIP	The p53 tumour suppressor promotes cell-cycle arrest or apoptosis in response to cellular stress, such as DNA damage and oncogenesis. This role of p53 is important for its tumour-suppression function(1) and depends, at least in part, on its ability to bind to specific DNA sequences and activate the transcription of target genes(2-4). The pathway through which p53 promotes apoptosis is not fully understood. Here we describe a new gene regulated by p53 that encodes a predicted protein of 915 amino acids in mice (910 amino acids in humans), which we have named Pidd. The mouse Pidd cDNA contains a p53 consensus DNA binding sequence upstream of the Pidd-coding region. This sequence element bound to p53 and conferred p53-dependent inducibility on a heterologous reporter gene. Moreover, Pidd RNA was induced by ionizing radiation in a p53-dependent manner and the basal level of Pidd RNA was dependent on Trp53 status. Overexpression of Pidd inhibited cell growth in a p53-like manner by inducing apoptosis. Antisense inhibition of Pidd expression attenuated p53-mediated apoptosis. Our data suggest that Pidd is an effector of p53-dependent apoptosis.	Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Benchimol, S (corresponding author), Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, 500 Sherbourne St, Toronto, ON, Canada.			Benchimol, Samuel/0000-0003-3433-890X				Ahmad M, 1997, CANCER RES, V57, P615; BARRY ELR, 1993, BIOTECHNIQUES, V15, P1018; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FU L, 1966, EMBO J, V15, P4392; JOHNSON P, 1993, MOL CELL BIOL, V13, P1456, DOI 10.1128/MCB.13.3.1456; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LIN YP, 1995, MOL CELL BIOL, V15, P6045; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; SLINGERLAND JM, 1993, EMBO J, V12, P1029, DOI 10.1002/j.1460-2075.1993.tb05744.x; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1	26	264	275	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					122	125		10.1038/79102	http://dx.doi.org/10.1038/79102			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973264				2022-12-27	WOS:000089078000033
J	Futscher, BW; Oshiro, MM; Wozniak, RJ; Holtan, N; Hanigan, CL; Duan, H; Domann, FE				Futscher, BW; Oshiro, MM; Wozniak, RJ; Holtan, N; Hanigan, CL; Duan, H; Domann, FE			Role for DNA methylation in the control of cell type-specific maspin expression	NATURE GENETICS			English	Article							SUPPRESSOR GENE MASPIN; CPG ISLANDS; CYTOSINE METHYLATION; PROMOTER; DIFFERENTIATION; INACTIVATION; SITE; ETS	The nucleotide 5-methylcytosine is involved in processes crucial in mammalian development, such as X-chromosome inactivation and gene imprinting(1-5). In addition, cytosine methylation has long been speculated to be involved in the establishment and maintenance of cell type specific expression of developmentally regulated genes 6,7; however, it has been difficult to identify clear examples of such genes, particularly in humans(8). Here we provide evidence that cytosine methylation of the maspin gene (SERPINB5) promoter controls, in part, normal cell type specific SERPINB5 expression. In normal cells expressing SERPINB5, the SERPINB5 promoter is unmethylated and the promoter region has acetylated histones and an accessible chromatin structure. By contrast, normal cells that do not express SERPINB5 have a completely methylated SERPINB5 promoter with hypoacetylated histones, an inaccessible chromatin structure and a transcriptional repression that is relieved by inhibition of DNA methylation. These findings indicate that cytosine methylation is important in the establishment and maintenance of cell type restricted gene expression.	Univ Arizona, Arizona Canc Ctr, Bone Marrow Transplant Program, Dept Pharmacol & Toxicol, Tucson, AZ 85724 USA; Univ Iowa, Holden Comprehens Canc Ctr, Free Rad & Radiat Biol, Dept Radiat Oncol, Iowa City, IA 52242 USA	Arizona Center Cancer Care; University of Arizona; University of Iowa	Futscher, BW (corresponding author), Univ Arizona, Arizona Canc Ctr, Bone Marrow Transplant Program, Dept Pharmacol & Toxicol, Tucson, AZ 85724 USA.			Domann, Frederick/0000-0002-0489-2179				ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Baylin SB, 1998, ADV CANCER RES, V72, P141; BEARD C, 1995, GENE DEV, V9, P2325, DOI 10.1101/gad.9.19.2325; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cody DT, 1999, ORAL ONCOL, V35, P516, DOI 10.1016/S1368-8375(99)00026-3; Czerwenka KF, 2001, CANCER DETECT PREV, V25, P268; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Huang YH, 1999, ARCH BIOCHEM BIOPHYS, V364, P241, DOI 10.1006/abbi.1999.1142; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Johnson GK, 1997, J PERIODONTAL RES, V32, P447, DOI 10.1111/j.1600-0765.1997.tb00557.x; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; KONDO M, 1991, AM J PHYSIOL, V261, pL106, DOI 10.1152/ajplung.1991.261.2.L106; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Maass N, 2001, CLIN BIOCHEM, V34, P303, DOI 10.1016/S0009-9120(01)00220-X; Rice JC, 2000, NUCLEIC ACIDS RES, V28, P3233, DOI 10.1093/nar/28.17.3233; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; VENOLIA L, 1982, P NATL ACAD SCI-BIOL, V79, P2352, DOI 10.1073/pnas.79.7.2352; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Watts GS, 1997, MOL CELL BIOL, V17, P5612, DOI 10.1128/MCB.17.9.5612; Zabner J, 1996, J VIROL, V70, P6994, DOI 10.1128/JVI.70.10.6994-7003.1996; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhang M, 1997, CELL GROWTH DIFFER, V8, P179; Zou ZQ, 2000, J BIOL CHEM, V275, P6051, DOI 10.1074/jbc.275.9.6051; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	31	348	372	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					175	179		10.1038/ng886	http://dx.doi.org/10.1038/ng886			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12021783				2022-12-27	WOS:000175903500014
J	Suzuki, H; Gabrielson, E; Chen, W; Anbazhagan, R; van Engeland, M; Weijenberg, MP; Herman, JG; Baylin, SB				Suzuki, H; Gabrielson, E; Chen, W; Anbazhagan, R; van Engeland, M; Weijenberg, MP; Herman, JG; Baylin, SB			A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer	NATURE GENETICS			English	Article							METHYLATED CPG ISLAND; DIFFERENTIAL EXPRESSION; BETA-CATENIN; ANNEXIN-II; DNA; HYPERMETHYLATION; IDENTIFICATION; FAMILY; ASSAY; APC	Aberrant hypermethylation of gene promoters is a major mechanism associated with inactivation of tumor-suppressor genes in cancer. We previously showed this transcriptional silencing to be mediated by both methylation and histone deacetylase activity, with methylation being dominant. Here, we have used cDNA microarray analysis to screen for genes that are epigenetically silenced in human colorectal cancer. By screening over 10,000 genes, we show that our approach can identify a substantial number of genes with promoter hypermethylation in a given cancer; these are distinct from genes with unmethylated promoters, for which increased expression is produced by histone deacetylase inhibition alone. Many of the hypermethylated genes we identified have high potential for roles in tumorigenesis by virtue of their predicted function and chromosome position. We also identified a group of genes that are preferentially hypermethylated in colorectal cancer and gastric cancer. One of these genes, SFRP1, belongs to a gene family; we show that hypermethylation of four genes in this family occurs very frequently in colorectal cancer, providing for (i) a unique potential mechanism for loss of tumor-suppressor gene function and (ii) construction of a molecular marker panel that could detect virtually all colorectal cancer.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD USA; Univ Maastricht, Dept Pathol, Maastricht, Netherlands; Univ Maastricht, Dept Epidemiol, Maastricht, Netherlands; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Maastricht University; Maastricht University; Johns Hopkins University	Baylin, SB (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, 1650 Orleans St, Baltimore, MD 21231 USA.		van Engeland, Manon/A-7479-2009	van Engeland, Manon/0000-0002-7952-6843				Abu-Jawdeh G, 1999, LAB INVEST, V79, P439; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bachman KE, 1999, CANCER RES, V59, P798; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chang JHT, 1999, HUM MOL GENET, V8, P575, DOI 10.1093/hmg/8.4.575; Chetcuti A, 2001, CANCER RES, V61, P6331; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Esteller M, 2001, CANCER RES, V61, P3225; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Frattini A, 1997, GENOMICS, V46, P167, DOI 10.1006/geno.1997.5006; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gonzalgo ML, 1997, CANCER RES, V57, P594; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Heston WDW, 1997, UROLOGY, V49, P104, DOI 10.1016/S0090-4295(97)00177-5; KUBE E, 1991, GENE, V102, P255, DOI 10.1016/0378-1119(91)90086-Q; MAKOSWALES M, 1995, NAT MED, V1, P570; Matsuo K, 2001, BLOOD, V97, P3205, DOI 10.1182/blood.V97.10.3205; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Mimori-Kiyosue Y, 2001, J CELL BIOL, V154, P1105, DOI 10.1083/jcb.200106113; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Nishioka M, 2000, ONCOGENE, V19, P6251, DOI 10.1038/sj.onc.1204031; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Song CY, 2001, CANCER RES, V61, P3272; Strehl S, 1998, GENOMICS, V53, P81, DOI 10.1006/geno.1998.5467; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 2000, CANCER RES, V60, P4044; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Ugolini F, 1999, ONCOGENE, V18, P1903, DOI 10.1038/sj.onc.1202739; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; White GRM, 1998, ONCOGENE, V17, P3513, DOI 10.1038/sj.onc.1202487; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532	41	721	788	1	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					141	149		10.1038/ng892	http://dx.doi.org/10.1038/ng892			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	11992124	Green Published			2022-12-27	WOS:000175903500009
J	Gabriel, SB; Salomon, R; Pelet, A; Angrist, M; Amiel, J; Fornage, M; Attie-Bitach, T; Olson, JM; Hofstra, R; Buys, C; Steffann, J; Munnich, A; Lyonnet, S; Chakravarti, A				Gabriel, SB; Salomon, R; Pelet, A; Angrist, M; Amiel, J; Fornage, M; Attie-Bitach, T; Olson, JM; Hofstra, R; Buys, C; Steffann, J; Munnich, A; Lyonnet, S; Chakravarti, A			Segregation at three loci explains familial and population risk in Hirschsprung disease	NATURE GENETICS			English	Article							GERM-LINE MUTATIONS; LINKAGE ANALYSIS; MULTIGENIC INHERITANCE; GENETIC DISSECTION; GENOMIC STRUCTURE; COMPLEX TRAITS; RET; EXPRESSION; DEFECTS; MODELS	Hirschsprung disease (HSCR), the most common hereditary cause of intestinal obstruction, shows considerable variation and complex inheritance. Coding sequence mutations in RET, GDNF, EDNRB, EDN3 and SOX10 lead to long-segment (L-HSCR) and syndromic HSCR but fail to explain the transmission of the much more common short-segment form (S-HSCR). We conducted a genome scan in families with S-HSCR and identified susceptibility loci at 3p21, 10q11 and 19q12 that seem to be necessary and sufficient to explain recurrence risk and population incidence. The gene at 10q11 is probably RET, supporting its crucial role in all forms of HSCR; however, coding sequence mutations are present in only 40% of linked families, suggesting the importance of noncoding variation. Here we show oligogenic inheritance of S-HSCR, the 3p21 and 19q12 loci as RET-dependent modifiers, and a parent-of-origin effect at RET. This study demonstrates by a complete genetic dissection why the inheritance pattern of S-HSCR is nonmendelian.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Hosp Necker Enfants Malad, Dept Genet, Paris, France; Hosp Necker Enfants Malad, INSERM, U393, Paris, France; Univ Groningen, Dept Med Genet, Groningen, Netherlands	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Groningen	Chakravarti, A (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Metro Hlth Campus, Cleveland, OH 44106 USA.		amiel, jeanne/H-3501-2017; Steffann, Julie/I-2820-2017; Lyonnet, Stanislas/H-5483-2017; amiel, jeanne/AGX-1124-2022; ATTIE-BITACH, Tania/K-1453-2017	amiel, jeanne/0000-0001-5973-4728; Steffann, Julie/0000-0001-9493-3239; Lyonnet, Stanislas/0000-0001-5426-9417; ATTIE-BITACH, Tania/0000-0002-1155-3626; Hofstra, Robert/0000-0001-7498-3829; PELET, Anastella/0000-0002-8353-1725				Angrist M, 1998, ONCOGENE, V17, P3065, DOI 10.1038/sj.onc.1202226; Angrist M, 1998, GENOMICS, V48, P354, DOI 10.1006/geno.1997.5191; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; BADNER JA, 1990, AM J HUM GENET, V46, P568; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Borrego S, 2000, J MED GENET, V37, P572, DOI 10.1136/jmg.37.8.572; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; Doray B, 1998, HUM MOL GENET, V7, P1449, DOI 10.1093/hmg/7.9.1449; Fitze G, 1999, AM J HUM GENET, V65, P1469, DOI 10.1086/302618; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hofstra RMW, 1999, AM J HUM GENET, V64, P304, DOI 10.1086/302184; HOLSCHNEIDER AM, 1982, HIRSCHSPRUNGS DIS; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Myers SM, 1999, J MED GENET, V36, P217; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olson JM, 1997, HUM HERED, V47, P110, DOI 10.1159/000154398; Otterson GA, 1997, P NATL ACAD SCI USA, V94, P12036, DOI 10.1073/pnas.94.22.12036; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; RARVEHAREL N, 1997, AM J HUM GENET, V60, P87; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; SCHUCHARDT V, 1994, NATURE, V367, P380; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810	30	189	193	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2002	31	1					89	93		10.1038/ng868	http://dx.doi.org/10.1038/ng868			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11953745				2022-12-27	WOS:000175362500021
J	Pagani, F; Buratti, E; Stuani, C; Bendix, R; Dork, T; Baralle, FE				Pagani, F; Buratti, E; Stuani, C; Bendix, R; Dork, T; Baralle, FE			A new type of mutation causes a splicing defect in ATM	NATURE GENETICS			English	Article							SMALL NUCLEAR-RNA; MESSENGER-RNA; U1 SNRNP; ATAXIA-TELANGIECTASIA; SITE; GENE; EXON; ELEMENT; POLYADENYLATION; ASSOCIATION	Disease-causing splicing mutations described in the literature primarily produce changes in splice sites and, to a lesser extent, variations in exon-regulatory sequences such as the enhancer elements(1-6). The gene ATM is mutated in individuals with ataxia-telangiectasia; we have indentified the aberrant inclusion of a cryptic exon of 65 by in one affected individual with a deletion of four nucleotides (GTAA) in intron 20. The deletion is located 12 by downstream and 53 by upstream from the 5' and 3' ends of the cryptic exon, respectively. Through analysis of the splicing defect using a hybrid minigene system, we identified a new intron-splicing processing element (ISPE) complementary to U1 snRNA, the RNA component of the U1 small nuclear ribonucleoprotein (snRNP). This element mediates accurate intron processing and interacts specifically with U1 snRNP particles. The 4-nt deletion completely abolished this interaction, causing activation of the cryptic exon. On the basis of this analysis, we describe a new type of U1 snRNP binding site in an intron that is essential for accurate intron removal. Deletion of this sequence is directly involved in the splicing processing defect.	Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; Hannover Med Sch, Clin Obstet & Gynecol, Dept Radiat Oncol, D-3000 Hannover, Germany; Hannover Med Sch, Clin Obstet & Gynecol, Dept Biochem & Tumour Biol, D-3000 Hannover, Germany	International Center for Genetic Engineering & Biotechnology (ICGEB); Hannover Medical School; Hannover Medical School	Baralle, FE (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.		Buratti, Emanuele/K-4691-2016; Dörk, Thilo/J-8620-2012	Buratti, Emanuele/0000-0002-1356-9074; Dörk, Thilo/0000-0002-9458-0282	Telethon [GGP02453] Funding Source: Medline	Telethon(Fondazione Telethon)		Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; Ashe MP, 1997, EMBO J, V16, P5752, DOI 10.1093/emboj/16.18.5752; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; CHILLON M, 1995, AM J HUM GENET, V56, P623; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Hatton AR, 1998, MOL CELL, V2, P787, DOI 10.1016/S1097-2765(00)80293-2; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; Hwang DY, 1997, MOL CELL BIOL, V17, P7099, DOI 10.1128/MCB.17.12.7099; Karpova AY, 2000, GENE DEV, V14, P2813, DOI 10.1101/gad.813800; Labourier E, 2001, MOL CELL, V8, P363, DOI 10.1016/S1097-2765(01)00311-2; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lou H, 1998, MOL CELL BIOL, V18, P4977, DOI 10.1128/MCB.18.9.4977; LUND E, 1984, J BIOL CHEM, V259, P2013; McCullough AJ, 2000, MOL CELL BIOL, V20, P9225, DOI 10.1128/MCB.20.24.9225-9235.2000; McNally LM, 1999, J VIROL, V73, P2385, DOI 10.1128/JVI.73.3.2385-2393.1999; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Sandoval N, 1999, HUM MOL GENET, V8, P69, DOI 10.1093/hmg/8.1.69; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Vervoort R, 1998, HUM GENET, V103, P686, DOI 10.1007/PL00008709; Wang M, 1997, BREAST CANCER RES TR, V44, P145, DOI 10.1023/A:1005753117205; WASSARMAN KM, 1993, GENE DEV, V7, P647, DOI 10.1101/gad.7.4.647; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	27	163	177	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					426	429		10.1038/ng858	http://dx.doi.org/10.1038/ng858			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11889466				2022-12-27	WOS:000174682000022
J	Contente, A; Dittmer, A; Koch, MC; Roth, J; Dobbelstein, M				Contente, A; Dittmer, A; Koch, MC; Roth, J; Dobbelstein, M			A polymorphic microsatellite that mediates induction of PIG3 by p53	NATURE GENETICS			English	Article							DNA-BINDING; TRANSCRIPTIONAL REPRESSION; ADENOVIRUS TYPE-5; APOPTOSIS; PROTEIN; DOMAIN; ONCOPROTEINS; MUTATIONS; COMPLEXES; GROWTH	The gene PIG3 is induced by the tumor suppressor p53 but not by p53 mutants unable to induce apoptosis, suggesting its involvement in p53-mediated cell death(1-3). Here we show that p53 directly binds and activates the PIG3 promoter, but not through the previously described DNA element(1). Instead, p53 interacts with a pentanucleotide microsatellite sequence within the PIG3 promoter (TGYCC)(n) where Y= C or T. Despite its limited similarity to the p53-binding consensus(4,5), this sequence is necessary and sufficient for transcriptional activation of the PIG3 promoter by p53 and binds specifically to p53 in vitro and in vivo. In a population of 117 healthy donors from Germany, the microsatellite was found to be polymorphic, the number of pentanucleotide repeats being 10, 15, 16 or 17, and the frequency of alleles 5.1%, 62.0%, 21.4% and 11.5%, respectively. The number of repeats directly correlated with the extent of transcriptional activation by p53. This is the first time that a microsatellite has been shown to mediate the induction of a promoter through direct interaction with a transcription factor. Moreover, this sequence of PIG3 is the first p53-responsive element found to be polymorphic. Inheritance of this microsatellite may affect an individual's susceptibility to cancer.	Univ Marburg Klinikum, Inst Virol, Marburg, Germany; Univ Marburg Klinikum, Inst Humangenet, Marburg, Germany; Univ Marburg Klinikum, Abt Gastroenterol & Stoffwechsel, Marburg, Germany		Dobbelstein, M (corresponding author), Univ Marburg Klinikum, Inst Virol, Marburg, Germany.			Dobbelstein, Matthias/0000-0001-5052-3967				Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Djian P, 1998, CELL, V94, P155, DOI 10.1016/S0092-8674(00)81415-4; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Koch P, 2001, CANCER RES, V61, P5941; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Roth J, 2000, ONCOGENE, V19, P1834, DOI 10.1038/sj.onc.1203500; Roth J, 1998, J VIROL, V72, P8510, DOI 10.1128/JVI.72.11.8510-8516.1998; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Wienzek S, 2000, J VIROL, V74, P193, DOI 10.1128/JVI.74.1.193-202.2000; ZAUBERMAN A, 1993, EMBO J, V12, P2799, DOI 10.1002/j.1460-2075.1993.tb05941.x; Zhu JH, 1999, ONCOGENE, V18, P2149, DOI 10.1038/sj.onc.1202533; Zhu KC, 1999, ONCOGENE, V18, P7740, DOI 10.1038/sj.onc.1203235	22	193	204	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					315	320		10.1038/ng836	http://dx.doi.org/10.1038/ng836			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11919562				2022-12-27	WOS:000174157600018
J	Vreugde, S; Ereven, A; Kros, CJ; Marcotti, W; Fuchs, H; Kurima, K; Wilcox, ER; Friedman, TB; Griffith, AJ; Balling, R; de Angelis, MH; Avraham, KB; Steel, KP				Vreugde, S; Ereven, A; Kros, CJ; Marcotti, W; Fuchs, H; Kurima, K; Wilcox, ER; Friedman, TB; Griffith, AJ; Balling, R; de Angelis, MH; Avraham, KB; Steel, KP			Beethoven, a mouse model for dominant, progressive hearing loss DFNA36	NATURE GENETICS			English	Article							OUTER HAIR-CELLS; POTASSIUM CURRENT; EXPRESSION; DEAFNESS; INNER; MICE; COCHLEA; MAPS	Despite recent progress in identifying genes underlying deafness, there are still relatively few mouse models of specific forms of human deafness. Here we describe the phenotype of the Beethoven (Bth) mouse mutant and a missense mutation in Tmc1 (transmembrane cochlear-expressed gene 1). Progressive hearing loss (DFNA36) and profound congenital deafness (DFNB7/B11) are caused by dominant and recessive mutations of the human ortholog, TMC1 (ref. 1), for which Bth and deafness (dn)(1) are mouse models, respectively.	Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel; MRC, Inst Hearing Res, Nottingham NG7 2RD, England; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; GSF, Res Ctr Environm & Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany; Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD 20850 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Sussex; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Avraham, KB (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel.		de Angelis, Martin Hrabe/F-5531-2012; Fuchs, Helmut/M-7347-2014; Balling, Rudi/E-9680-2010	de Angelis, Martin Hrabe/0000-0002-7898-2353; Fuchs, Helmut/0000-0002-5143-2677; Balling, Rudi/0000-0003-2902-5650; Avraham, Karen B/0000-0002-4913-251X; Vreugde, Sarah/0000-0003-4719-9785	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000035, ZIADC000048, ZIADC000060, Z01DC000060, Z01DC000048, Z01DC000039, ZIADC000039] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BOCK GR, 1983, ACTA OTO-LARYNGOL, V96, P39, DOI 10.3109/00016488309132873; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; EHRET G, 1975, J COMP PHYSIOL, V103, P329, DOI 10.1007/BF00612025; KEATS BJB, 1995, MAMM GENOME, V6, P8, DOI 10.1007/BF00350886; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Marcotti W, 1999, PFLUG ARCH EUR J PHY, V439, P113, DOI 10.1007/s004240051134; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; STEEL KP, 1980, NATURE, V288, P159, DOI 10.1038/288159a0; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848	13	192	197	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					257	258		10.1038/ng848	http://dx.doi.org/10.1038/ng848			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	526YP	11850623				2022-12-27	WOS:000174157600008
J	Rioux, JD; Daly, MJ; Silverberg, MS; Lindblad, K; Steinhart, H; Cohen, Z; Delmonte, T; Kocher, K; Miller, K; Guschwan, S; Kulbokas, EJ; O'Leary, S; Winchester, E; Dewar, K; Green, T; Stone, V; Chow, C; Cohen, A; Langelier, D; Lapointe, G; Gaudet, D; Faith, J; Branco, N; Bull, SB; McLeod, RS; Griffiths, AM; Bitton, A; Greenberg, GR; Lander, ES; Siminovitch, KA; Hudson, TJ				Rioux, JD; Daly, MJ; Silverberg, MS; Lindblad, K; Steinhart, H; Cohen, Z; Delmonte, T; Kocher, K; Miller, K; Guschwan, S; Kulbokas, EJ; O'Leary, S; Winchester, E; Dewar, K; Green, T; Stone, V; Chow, C; Cohen, A; Langelier, D; Lapointe, G; Gaudet, D; Faith, J; Branco, N; Bull, SB; McLeod, RS; Griffiths, AM; Bitton, A; Greenberg, GR; Lander, ES; Siminovitch, KA; Hudson, TJ			Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; ASSOCIATION; REGION	Linkage disequilibrium (LD) mapping provides a powerful method for fine-structure localization of rare disease genes, but has not yet been widely applied to common disease(1). We sought to design a systematic approach for LD mapping and apply it to the localization of a gene (IBD5) conferring susceptibility to Crohn disease. The key issues are: (i) to detect a significant LD signal (ii) to rigorously bound the critical region and (iii) to identify the causal genetic variant within this region. We previously mapped the IBD5 locus to a large region spanning 18 cM of chromosome 5q31 (P<10(-4)). Using dense genetic maps of microsatellite markers and single-nucleotide polymorphisms (SNPs) across the entire region, we found strong evidence of LD. We bound the region to a common haplotype spanning 250 kb that shows strong association with the disease (P<2x10(-7)) and contains the cytokine gene cluster, This finding provides overwhelming evidence that a specific common haplotype of the cytokine region in 5q31 confers susceptibility to Crohn disease. However, genetic evidence alone is not sufficient to identify the causal mutation within this region, as strong LD across the region results in multiple SNPs having equivalent genetic evidence-each consistent with the expected properties of the 1BD5 locus. These results have important implications for Crohn disease in particular and LID mapping in general.	MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Immunol & Med Genet, Toronto, ON, Canada; Univ Toronto, Dept Surg, Toronto, ON, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; McGill Univ, Ctr Hlth, Dept Gastroenterol, Montreal, PQ, Canada; McGill Univ, Montreal Genome Ctr, Montreal, PQ, Canada; Ctr Hosp Sherbrooke, Sherbrooke, PQ, Canada; Ctr Hosp Sagamie, Chicoutimi, PQ, Canada; MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; Massachusetts Institute of Technology (MIT)	Rioux, JD (corresponding author), MIT, Whitehead Inst, Ctr Genome Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rioux@genome.wi.mit.edu; lander@wi.mit.edu; ksiminovitch@mtsinai.on.ca; tjhudson@med.mcgill.ca	Greenberg, Gordon/C-4620-2015; McLeod, Robin/K-1476-2013; Bull, Shelley B/A-1920-2013; Silverberg, Mark/B-4183-2008; Rioux, John D/A-9599-2015; Siminovitch, Katherine/K-1475-2013; Daly, Mark J/B-2453-2017	Rioux, John D/0000-0001-7560-8326; Daly, Mark J/0000-0002-0949-8752				Burckhardt G, 2000, AM J PHYSIOL-RENAL, V278, pF853, DOI 10.1152/ajprenal.2000.278.6.F853; Clavell M, 2000, J PEDIATR GASTR NUTR, V30, P43, DOI 10.1097/00005176-200001000-00016; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; FARTHING MJG, 1978, GUT, V19, P743, DOI 10.1136/gut.19.8.743; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; Spielman RS, 1996, AM J HUM GENET, V59, P983; Zhu YW, 2000, P NATL ACAD SCI USA, V97, P1137, DOI 10.1073/pnas.97.3.1137	15	632	655	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					223	228		10.1038/ng1001-223	http://dx.doi.org/10.1038/ng1001-223			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586304				2022-12-27	WOS:000171374100032
J	Eisenberg, I; Avidan, N; Potikha, T; Hochner, H; Chen, M; Olender, T; Barash, M; Shemesh, M; Sadeh, M; Grabov-Nardini, G; Shmilevich, I; Friedmann, A; Karpati, G; Bradley, WG; Baumbach, L; Lancet, D; Ben Asher, E; Beckmann, JS; Argov, Z; Mitrani-Rosenbaum, S				Eisenberg, I; Avidan, N; Potikha, T; Hochner, H; Chen, M; Olender, T; Barash, M; Shemesh, M; Sadeh, M; Grabov-Nardini, G; Shmilevich, I; Friedmann, A; Karpati, G; Bradley, WG; Baumbach, L; Lancet, D; Ben Asher, E; Beckmann, JS; Argov, Z; Mitrani-Rosenbaum, S			The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy	NATURE GENETICS			English	Article							ACETYLNEURAMINIC ACID BIOSYNTHESIS; BIFUNCTIONAL ENZYME CATALYZES; 1ST 2 STEPS; SEQUENCE ALIGNMENTS; DISTAL MYOPATHY; RIMMED VACUOLE; RAT-LIVER; LOCUS; 2-EPIMERASE; MAPS	Hereditary inclusion body myopathy (HIBM; OMIM 600737) is a unique group of neuromuscular disorders characterized by adult onset, slowly progressive distal and proximal weakness and a typical muscle pathology including rimmed vacuoles and filamentous inclusions'. The autosomal recessive form described in Jews of Persian descent(2) is the HIBM prototype. This myopathy affects mainly leg muscles, but with an unusual distribution that spares the quadriceps(3). This particular pattern of weakness distribution, termed quadriceps-sparing myopathy (QSM), was later found in Jews originating from other Middle Eastern countries as well as in non-Jews(4). We previously localized the gene causing HIBM in Middle Eastern Jews on chromosome 9p12-13 (ref. 5) within a genomic interval of about 700 kb (ref. 6). Haplotype analysis around the HIBM gene region of 104 affected people from 47 Middle Eastern families indicates one unique ancestral founder chromosome in this community. By contrast, single non-Jewish families from India, Georgia (USA) and the Bahamas, with QSM and linkage to the same 9p12-13 region, show three distinct haplotypes. After excluding other potential candidate genes, we eventually identified mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (GIVE) gene in the HIBM families: all patients from Middle Eastern descent shared a single homozygous missense mutation, whereas distinct compound heterozygotes were identified in affected individuals of families of other ethnic origins. our findings indicate that GIVE is the gene responsible for recessive HIBM.	Hebrew Univ Jerusalem, Hadassah Med Sch, Mol Biol Unit, IL-91010 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Neurol, IL-91010 Jerusalem, Israel; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Crown Genome Ctr, IL-76100 Rehovot, Israel; Wolfson Govt Hosp, Dept Neurol, Holon, Israel; McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; Univ Miami, Sch Med, Dept Neurol, Miami, FL USA; Univ Miami, Sch Med, Dept Pediat, Miami, FL USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science; Weizmann Institute of Science; McGill University; University of Miami; University of Miami	Mitrani-Rosenbaum, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Mol Biol Unit, IL-91010 Jerusalem, Israel.	stella@yam-suff.huji.ac.il	Barash, Mark/M-8757-2016; Beckmann, Jacques S/A-9772-2008; Shemesh, Moshe/AAR-7506-2020	Barash, Mark/0000-0002-5445-6316; Beckmann, Jacques S/0000-0002-9741-1900; Shemesh, Moshe/0000-0002-3854-6151; Mitrani-Rosenbaum, Stella/0000-0001-5335-8709				AGROV Z, 1998, CURR OPIN RHEUMATOL, V10, P543; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; ARGOV Z, 1997, INCLUSION BODY MYOSI, P200; Askanas Valerie, 1998, Current Opinion in Rheumatology, V10, P530, DOI 10.1097/00002281-199811000-00005; Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969; Effertz K, 1999, J BIOL CHEM, V274, P28771, DOI 10.1074/jbc.274.40.28771; Eisenberg I, 2001, EUR J HUM GENET, V9, P501, DOI 10.1038/sj.ejhg.5200665; Eisenberg I, 1999, GENOMICS, V55, P43, DOI 10.1006/geno.1998.5630; GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; HUMBEL R, 1975, CLIN CHIM ACTA, V60, P143, DOI 10.1016/0009-8981(75)90119-9; Ikeuchi T, 1997, ANN NEUROL, V41, P432, DOI 10.1002/ana.410410405; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Little S, 1995, CURRENT PROTOCOLS HU; MitraniRosenbaum S, 1996, HUM MOL GENET, V5, P159, DOI 10.1093/hmg/5.1.159; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; PONNAMBALAM S, 1994, GENOMICS, V24, P440, DOI 10.1006/geno.1994.1650; SADEH M, 1997, INCLUSION BODY MYOSI, P191; Salzberg SL, 2001, SCIENCE, V292, P1903, DOI 10.1126/science.1061036; Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411; Stasche R, 1997, J BIOL CHEM, V272, P24319, DOI 10.1074/jbc.272.39.24319; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221	25	364	387	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2001	29	1					83	87		10.1038/ng718	http://dx.doi.org/10.1038/ng718			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528398				2022-12-27	WOS:000170781300023
J	Wang, JB; Mager, J; Chen, YJ; Schneider, E; Cross, JC; Nagy, A; Magnuson, T				Wang, JB; Mager, J; Chen, YJ; Schneider, E; Cross, JC; Nagy, A; Magnuson, T			Imprinted X inactivation maintained by a mouse Polycomb group gene	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSION; DROSOPHILA; EMBRYOS; COMPLEX; EED; DIFFERENTIATION; MAINTENANCE; ACETYLATION	In mammals, dosage compensation of X-linked genes is achieved by the transcriptional silencing of one X chromosome in the female (reviewed in ref. 1). This process, called X inactivation, is usually random in the embryo proper. In marsupials and the extra-embryonic region of the mouse, however, X inactivation is imprinted: the paternal X chromosome is preferentially inactivated whereas the maternal X is always active. Having more than one active X chromosome is deleterious to extra-embryonic development in the mouse(2). Here we show that the gene eed (embryonic ectoderm development)(3,4), a member of the mouse Polycomb group (Pc-G) of genes, is required for primary and secondary trophoblast giant cell development in female embryos. Results from mice carrying a paternally inherited X-linked green fluorescent protein (GFP) transgene implicate eed in the stable maintenance of imprinted X inactivation in extra-embryonic tissues. Based on the recent finding that the Eed protein interacts with histone deacetylases, we suggest that this maintenance activity involves hypoacetylation of the inactivated paternal X chromosome in the extra-embryonic tissues.	Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ Calgary, Dept Biochem & Mol Biol, Genes & Dev Res Grp, Calgary, AB, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of Calgary; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Magnuson, T (corresponding author), Univ N Carolina, Dept Genet, CB 7264,102 Mason Farm Rd, Chapel Hill, NC 27599 USA.		Nagy, Andras/G-6465-2013; Cross, James/AAU-2973-2020; Cross, James/F-4814-2011	Nagy, Andras/0000-0003-4311-0413; Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378				BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Faust C, 1998, DEVELOPMENT, V125, P4495; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gilbert SL, 1999, P NATL ACAD SCI USA, V96, P13825, DOI 10.1073/pnas.96.24.13825; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Hansen RS, 1996, HUM MOL GENET, V5, P1345, DOI 10.1093/hmg/5.9.1345; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Keohane AM, 1998, DEV GENET, V22, P65, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;65::AID-DVG7&gt;3.0.CO;2-5; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MIGEON BR, 1988, NATURE, V335, P93, DOI 10.1038/335093a0; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; O'Neill LP, 1999, EMBO J, V18, P2897, DOI 10.1093/emboj/18.10.2897; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; RINCHIK EM, 1993, MAMM GENOME, V4, P349, DOI 10.1007/BF00360583; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; STRUHL G, 1985, EMBO J, V4, P3259, DOI 10.1002/j.1460-2075.1985.tb04075.x; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6; Tie F, 1998, DEVELOPMENT, V125, P3483; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	28	277	283	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					371	375		10.1038/ng574	http://dx.doi.org/10.1038/ng574			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479595				2022-12-27	WOS:000170174800019
J	Brown, JR; Douady, CJ; Italia, MJ; Marshall, WE; Stanhope, MJ				Brown, JR; Douady, CJ; Italia, MJ; Marshall, WE; Stanhope, MJ			Universal trees based on large combined protein sequence data sets	NATURE GENETICS			English	Letter							ORIGIN; GENE; LIFE; CLASSIFICATION; MITOCHONDRIAL; EUKARYOTES; EVOLUTION; BACTERIA; SUPPORT; ARCHAEA	Universal trees of life based on small-subunit (SSU) ribosomal RNA (rRNA) support the separate mono/holophyly of the domains Archaea (archaebacteria), Bacteria (eubacteria) and Eucarya (eukaryotes) and the placement of extreme thermophiles at the base of the Bacteria(1-4). The concept of universal tree reconstruction recently has been upset by protein trees that show intermixing of species from different domains(5,6). Such tree topologies have been attributed to either extensive horizontal gene transfer(7) or degradation of phylogenetic signals because of saturation for amino acid substitutions(8). Here we use large combined alignments of 23 orthologous proteins conserved across 45 species from all domains to construct highly robust universal trees. Although individual protein trees are variable in their support of domain integrity, trees based on combined protein data sets strongly support separate monophyletic domains. Within the Bacteria, we placed spirochaetes as the earliest derived bacterial group. However, elimination from the combined protein alignment of nine protein data sets, which were likely candidates for horizontal gene transfer, resulted in trees showing thermophiles as the earliest evolved bacterial lineage. Thus, combined protein universal trees are highly congruent with SSU rRNA trees in their strong support for the separate monophyly of domains as well as the early evolution of thermophilic Bacteria.	GlaxoSmithKline, Antimicrobial Bioinformat Grp, Collegeville, PA 19426 USA	GlaxoSmithKline	Brown, JR (corresponding author), GlaxoSmithKline, Antimicrobial Bioinformat Grp, 1250 S Collegeville Rd,UP1345 POB 5089, Collegeville, PA 19426 USA.	James_R_Brown@gsk.com	Puigbò, Pere/A-2214-2008; Douady, Christophe/N-3069-2019; Douady, Christophe J/N-1357-2014	Douady, Christophe/0000-0002-4503-8040; Douady, Christophe J/0000-0002-4503-8040; Italia, Michael/0000-0002-6941-6181				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Bond JP, 2000, J MOL EVOL, V50, P339, DOI 10.1007/s002399910037; Brown JR, 1998, CURR BIOL, V8, pR365, DOI 10.1016/S0960-9822(98)70238-6; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Chihade JW, 2000, P NATL ACAD SCI USA, V97, P12153, DOI 10.1073/pnas.220388797; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; FELSENSTEIN J, 2000, PHYLIP PHYLONGENY IN; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; FOX GE, 1977, P NATL ACAD SCI USA, V74, P4537, DOI 10.1073/pnas.74.10.4537; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; GOLDING GB, 1995, MOL BIOL EVOL, V12, P1; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; Hassanin A, 1998, CR ACAD SCI III-VIE, V321, P611, DOI 10.1016/S0764-4469(98)80464-2; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Logsdon JM, 1999, CURR BIOL, V9, pR747, DOI 10.1016/S0960-9822(99)80474-6; Miller SL, 1995, J MOL EVOL, V41, P689; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; PACE NR, 1991, CELL, V65, P531, DOI 10.1016/0092-8674(91)90082-A; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; Shah HN, 1997, REV MED MICROBIOL, V8, P103; Springer MS, 1999, SYST BIOL, V48, P65, DOI 10.1080/106351599260445; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Teichmann SA, 1999, J MOL EVOL, V49, P98, DOI 10.1007/PL00006538; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Xiong J, 1998, P NATL ACAD SCI USA, V95, P14851, DOI 10.1073/pnas.95.25.14851	30	298	313	0	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					281	285		10.1038/90129	http://dx.doi.org/10.1038/90129			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431701				2022-12-27	WOS:000169656400023
J	Murakami, H; Nurse, P				Murakami, H; Nurse, P			Regulation of premeiotic S phase and recombination-related double-strand DNA breaks during meiosis in fission yeast	NATURE GENETICS			English	Letter							CELL-CYCLE CONTROL; SCHIZOSACCHAROMYCES-POMBE; MEIOTIC RECOMBINATION; REPLICATION; INITIATION; GENES; P65(CDC18); MECHANISMS	The meiotic cell cycle is characterized by high levels of recombination induced by DNA double-strand breaks (DSBs). which appear after completion of premeiotic S phase(1-5), leading to the view that initiation of recombination depends on meiotic DNA replication(6,7). It has also been indicated that DNA replication initiation proteins may differ between the meiotic and mitotic cell cycles, giving rise to an altered S phase, which could contribute to the high level of recombination during meiosis(8). We have investigated these possibilities in the fission yeast Schizosaccharomyces pombe and found that core DNA replication initiation proteins used during the mitotic cell cycle(9,0), including Cdc18p (budding yeast Cdc6p), Cdc19p (Mcm2p), Cdc21p (Mcm4p) and Orp1p (Orc1p), are also required for premeiotic S phase. Reduced activity of these proteins prevents completion of DNA replication but not formation of DSBs. We conclude that recombination-related DSB formation does not depend on the completion of meiotic DNA replication and we propose two parallel developmental sequences during the meiotic cell cycle: one for premeiotic S phase and the other for initiating recombination.	Imperial Canc Res Fund, Cell Cycle Lab, London WC2A 3PX, England	Cancer Research UK	Murakami, H (corresponding author), Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	hmura@med.nagoya-cu.ac.jp						BAHLER J, 1993, J CELL BIOL, V121, P241, DOI 10.1083/jcb.121.2.241; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Ding R, 1998, MOL GEN GENET, V258, P663, DOI 10.1007/s004380050780; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Esposito R. E., 1981, MOL BIOL YEAST SACCH, V11, P211; Forsburg SL, 2000, NAT GENET, V25, P263, DOI 10.1038/77015; Fox ME, 1998, PROG NUCLEIC ACID RE, V61, P345, DOI 10.1016/S0079-6603(08)60831-4; IINO Y, 1995, GENETICS, V140, P1235; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Kupiec M., 1997, MOL CELLULAR BIOL YE, P889; Li YF, 1997, GENETICS, V146, P57; LIN YK, 1994, GENETICS, V136, P769; MACNEILL SA, 1997, MOL CELLULAR BIOL YE, P697; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Murakami H, 2000, BIOCHEM J, V349, P1, DOI 10.1042/0264-6021:3490001; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; Okayama H, 1996, ADV CANCER RES, V69, P17, DOI 10.1016/S0065-230X(08)60859-3; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; SUGIYAMA A, 1994, EMBO J, V13, P1881, DOI 10.1002/j.1460-2075.1994.tb06457.x; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Yamada T, 1997, TELECOMMUN SYST, V8, P1, DOI 10.1023/A:1019145000942; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x; Zenvirth D, 2000, CURR GENET, V38, P33, DOI 10.1007/s002940000126	29	49	51	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					290	293		10.1038/90142	http://dx.doi.org/10.1038/90142			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431703				2022-12-27	WOS:000169656400025
J	Ueki, Y; Tiziani, V; Santanna, C; Fukai, N; Maulik, C; Garfinkle, J; Ninomiya, C; doAmaral, C; Peters, H; Habal, M; Rhee-Morris, L; Doss, JB; Kreiberg, S; Olsen, BR; Reichenberger, E				Ueki, Y; Tiziani, V; Santanna, C; Fukai, N; Maulik, C; Garfinkle, J; Ninomiya, C; doAmaral, C; Peters, H; Habal, M; Rhee-Morris, L; Doss, JB; Kreiberg, S; Olsen, BR; Reichenberger, E			Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism	NATURE GENETICS			English	Article							IDENTIFICATION; 4P16.3; MAPS	Cherubism (MIM 118400) is an autosomal dominant inherited syndrome characterized by excessive bone degradation of the upper and lower jaws(1) followed by development of fibrous tissue masses, which causes a characteristic facial swelling. Here we describe seven mutations in the SH3-binding protein SH3BP2 (MIM 602104) on chromosome 4p16.3 that cause cherubism.	Harvard Univ, Sch Med, Harvard Forsyth Dept Oral Biol, Harvard Sch Dent Med, Boston, MA USA; Harvard Univ, Sch Med, Forsyth Inst, Boston, MA USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; Univ Fed Sao Paulo, EPM, Campinas, SP, Brazil; SOBRAPAR, Inst Cirug Plast Craniofacial, Campinas, SP, Brazil; Humboldt Univ, Inst Med Genet, Sch Med, Berlin, Germany; Tampa Craniofacial Ctr, Tampa, FL USA; Univ Calif Davis, Sacramento, CA 95817 USA; So Maine Oral & Maxillofacial Surg, S Portland, ME USA; Univ Copenhagen, Sch Dent, Dept Pediat Dent, Copenhagen, Denmark	Harvard University; Harvard Medical School; Harvard School of Dental Medicine; Harvard University; Forsyth Institute; Harvard Medical School; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Universidade Federal de Sao Paulo (UNIFESP); Humboldt University of Berlin; University of California System; University of California Davis; University of Copenhagen	Reichenberger, E (corresponding author), Harvard Univ, Sch Med, Harvard Forsyth Dept Oral Biol, Harvard Sch Dent Med, Boston, MA USA.		Tiziani, Valdenize/F-9848-2012	Tiziani, Valdenize/0000-0001-6783-9212	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036819, R37AR036820, R01AR036819, R01AR036820] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR36820, AR36819] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bell SM, 1997, GENOMICS, V44, P163, DOI 10.1006/geno.1997.4849; CHOMETTE G, 1988, INT J ORAL MAX SURG, V17, P219, DOI 10.1016/S0901-5027(88)80043-2; HIRSCHHORN K, 1965, HUMANGENETIK, V1, P479; Jones WA., 1933, AM J CANC, V17, P946, DOI [10.1158/ajc.1933.946, DOI 10.1158/AJC.1933.946]; Mangion J, 1999, AM J HUM GENET, V65, P151, DOI 10.1086/302454; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Tiziani V, 1999, AM J HUM GENET, V65, P158, DOI 10.1086/302456; Zollino M, 2000, AM J MED GENET, V94, P254, DOI 10.1002/1096-8628(20000918)94:3<254::AID-AJMG13>3.0.CO;2-7	8	245	259	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					125	126		10.1038/88832	http://dx.doi.org/10.1038/88832			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381256				2022-12-27	WOS:000169011800011
J	Luhn, K; Wild, MK; Eckhardt, M; Gerardy-Schahn, R; Vestweber, D				Luhn, K; Wild, MK; Eckhardt, M; Gerardy-Schahn, R; Vestweber, D			The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter	NATURE GENETICS			English	Article							GENERALIZED DEFECT; MOLECULAR-CLONING; DOMAINS; ACID	Leukocyte adhesion deficiency II(LAD II) is characterized by the lack of fucosylated glycoconjugates, including selectin ligands, causing immunodeficiency and severe mental and growth retardation(1-3) No deficiency in fucosyltransferase activities(2,4) or in the activities of enzymes involved in GDP-fucose biosynthesis(5) has been found. Instead, the transport of GDP-fucose into isolated Golgi vesicles of LAD II cells appeared to be reduced(6). To identify the gene mutated in LAD II, we cloned 12 cDNAs from Caenorhabditis elegans, encoding multi-spanning transmembrane proteins with homology to known nucleotide sugar transporters, and transfected them into fibroblasts from an LAD II patient. One of these clones re-established expression of fucosylated glycoconjugates with high efficiency and allowed us to identify a human homolog with 55% identity, which also directed re-expression of fucosylated glycoconjugates, Both proteins were localized to the Golgi, The corresponding endogenous protein in LAD II cells had an R147C amino acid change in the conserved fourth transmembrane region. Overexpression of this mutant protein in cells from a patient with LAD did not rescue fucosylation, demonstrating that the point mutation affected the activity of the protein. Thus, we have identified the first putative CDP fucose transporter, which has been highly conserved throughout evolution. A point mutation in its gene is responsible for the disease in this patient with LAD II.	Univ Munster, ZMBE, Inst Zellbiol, D-4400 Munster, Germany; Max Planck Inst Klin & Physiol Forsch, Bad Nauheim, Germany; Univ Bonn, Inst Physiol Chem, D-5300 Bonn, Germany; Hannover Med Sch, Inst Med Mikrobiol, Hannover, Germany	University of Munster; Max Planck Society; University of Bonn; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf	Vestweber, D (corresponding author), Univ Munster, ZMBE, Inst Zellbiol, D-4400 Munster, Germany.	vestweb@uni-muenster.de		Vestweber, Dietmar/0000-0002-3517-732X				Abeijon C, 1996, P NATL ACAD SCI USA, V93, P5963, DOI 10.1073/pnas.93.12.5963; Becker DJ, 1999, BBA-MOL BASIS DIS, V1455, P193, DOI 10.1016/S0925-4439(99)00071-X; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; DeBose-Boyd RA, 1998, GLYCOBIOLOGY, V8, P905, DOI 10.1093/glycob/8.9.905; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Gao XD, 2000, J BIOL CHEM, V275, P17718, DOI 10.1074/jbc.M909946199; GERARDYSCHAHN R, 2000, OLIGOSACCHARIDES CHE, V2, P19; Ishida N, 1999, J BIOCHEM, V126, P1107, DOI 10.1093/oxfordjournals.jbchem.a022556; Karsan A, 1998, J CLIN INVEST, V101, P2438, DOI 10.1172/JCI905; Korner C, 1999, J LEUKOCYTE BIOL, V66, P95; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2001, BLOOD, V97, P330, DOI 10.1182/blood.V97.1.330; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Marquardt T, 1999, J PEDIATR-US, V134, P681, DOI 10.1016/S0022-3476(99)70281-7; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Rost B, 1996, METHOD ENZYMOL, V266, P525; van Die I, 1999, FEBS LETT, V463, P189, DOI 10.1016/S0014-5793(99)01508-2; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181	23	238	252	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					69	72		10.1038/ng0501-69	http://dx.doi.org/10.1038/ng0501-69			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326279				2022-12-27	WOS:000168413300019
J	Jerome, LA; Papaioannou, VE				Jerome, LA; Papaioannou, VE			DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1	NATURE GENETICS			English	Letter							SYNDROME CANDIDATE GENE; CARDIO-FACIAL SYNDROME; MOUSE DEVELOPMENT; SYNDROME REGION; 22Q11 DELETION; NEURAL CREST; DEFICIENT; DEFECTS; HIRA; EXPRESSION	The DiGeorge/velocardiofacial syndrome (DGS/VCFS) is a relatively common human disorder, usually associated with deletions of chromosome 22q11. The genetic basis for the wide range of developmental anomalies in the heart. glands and facial structures has been elusive. We have investigated the potential role of one candidate gene, Tbx1, which encodes a transcription factor of the T-box family, by producing a null mutation in mice. We found that mice heterozygous for the mutation had a high incidence of cardiac outflow tract anomalies, thus modeling one of the major abnormalities of the human syndrome. Moreover, Tbx1(-/-) mice displayed a wide range of developmental anomalies encompassing almost all of the common DGS/VCFS features, including hypoplasia of the thymus and parathyroid glands, cardiac outflow tract abnormalities, abnormal facial structures, abnormal vertebrae and cleft palate. On the basis of this phenotype in mice, we propose that TBX1 in humans is a key gene in the etiology of DGS/VCFS.	Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Papaioannou, VE (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.			Papaioannou, Virginia/0000-0001-7558-8601	NICHD NIH HHS [HD33082] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD033082] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033082] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chieffo C, 1997, GENOMICS, V43, P267, DOI 10.1006/geno.1997.4829; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; Epstein JA, 2000, DEVELOPMENT, V127, P1869; Farrell MJ, 1999, CIRC RES, V84, P127, DOI 10.1161/01.RES.84.2.127; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; GOODSHIP J, 1995, J MED GENET, V32, P746, DOI 10.1136/jmg.32.9.746; Hogan B, 1994, MANIPULATING MOUSE E; Kimber WL, 1999, HUM MOL GENET, V8, P2229, DOI 10.1093/hmg/8.12.2229; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Mallo M, 1997, DEV DYNAM, V210, P146, DOI 10.1002/(SICI)1097-0177(199710)210:2<146::AID-AJA7>3.0.CO;2-G; McDonald-McGinn DM, 1997, GENET TEST, V1, P99, DOI 10.1089/gte.1997.1.99; MCLEAN SD, 1993, AM J DIS CHILD, V147, P1212; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Puech A, 2000, P NATL ACAD SCI USA, V97, P10090, DOI 10.1073/pnas.97.18.10090; Roberts C, 1997, HUM MOL GENET, V6, P237, DOI 10.1093/hmg/6.2.237; Saint-Jore B, 1998, HUM MOL GENET, V7, P1841, DOI 10.1093/hmg/7.12.1841; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Wakamiya M, 1997, COLD SPRING HARB SYM, V62, P145, DOI 10.1101/SQB.1997.062.01.019; Wakamiya M, 1998, HUM MOL GENET, V7, P1835, DOI 10.1093/hmg/7.12.1835; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; WILKINSON DG, 1992, WHOLE MOUNT IN SITU; Wilming LG, 1997, HUM MOL GENET, V6, P247, DOI 10.1093/hmg/6.2.247; Yamagishi H, 1999, SCIENCE, V283, P1158, DOI 10.1126/science.283.5405.1158	29	760	774	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					286	291		10.1038/85845	http://dx.doi.org/10.1038/85845			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242110				2022-12-27	WOS:000167304200020
J	Pabst, T; Mueller, BU; Zhang, P; Radomska, HS; Narravula, S; Schnittger, S; Behre, G; Hiddemann, W; Tenen, DG				Pabst, T; Mueller, BU; Zhang, P; Radomska, HS; Narravula, S; Schnittger, S; Behre, G; Hiddemann, W; Tenen, DG			Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBP alpha), in acute myeloid leukemia	NATURE GENETICS			English	Letter							CELL-PROLIFERATION; MESSENGER-RNA; TRANSCRIPTION; EXPRESSION; TRANSLATION; EPSILON; GENE; SUFFICIENT; ACTIVATION; PRODUCT	The transcription factor C/EBP alpha (for CCAAT/enhancer binding protein-alpha; encoded by the gene CEBPA) is crucial for the differentiation of granulocytes. Conditional expression of C/EBP alpha triggers neutrophilic differentiation, and no mature granulocytes are observed in Cebpa-mutant mice. Here we identify heterozygous mutations in CEBPA in ten patients with acute myeloid leukemia (AML). We found that five mutations in the amino terminus truncate the full-length protein, but did not affect a 30-kD protein initiated further downstream. The mutant proteins block wild-type C/EBP alpha DNA binding and transactivation of granulocyte target genes in a dominant-negative manner. and fails to induce granulocytic differentiation. Ours is the first report of CEBPA mutations in human neoplasia. and such mutations are likely to induce the differentiation block found in AML.	Harvard Univ, Sch Med, Inst Med, Div Hematol Oncol, Boston, MA 02115 USA; Univ Munich, Dept Med 3, Munich, Germany	Harvard University; Harvard Medical School; University of Munich	Tenen, DG (corresponding author), Harvard Univ, Sch Med, Inst Med, Div Hematol Oncol, Boston, MA 02115 USA.	dtenen@caregroup.harvard.edu		Tenen, Daniel/0000-0002-6423-3888	NATIONAL CANCER INSTITUTE [P01CA072009] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056745] Funding Source: NIH RePORTER; NCI NIH HHS [CA72009] Funding Source: Medline; NHLBI NIH HHS [HL56745] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		An MR, 1996, MOL CELL BIOL, V16, P2295; CALKHOVEN CF, 1994, NUCLEIC ACIDS RES, V22, P5540, DOI 10.1093/nar/22.25.5540; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; HENDRICKSTAYLOR LR, 1995, NUCLEIC ACIDS RES, V23, P4726, DOI 10.1093/nar/23.22.4726; HENDRICKSTAYLOR LR, 1992, GENOMICS, V14, P12, DOI 10.1016/S0888-7543(05)80276-9; Koike M, 1997, LEUKEMIA RES, V21, P833, DOI 10.1016/S0145-2126(97)00072-6; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Lekstrom-Himes J, 1999, BLOOD, V93, P3096; Lekstrom-Himes JA, 1999, J EXP MED, V189, P1847, DOI 10.1084/jem.189.11.1847; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; NERLOV C, 1994, GENE DEV, V8, P350, DOI 10.1101/gad.8.3.350; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; PAHL HL, 1991, EXP HEMATOL, V19, P1038; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; SCOTT LM, 1992, BLOOD, V80, P1725; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Swart GWM, 1997, BIOL CHEM, V378, P373, DOI 10.1515/bchm.1997.378.5.373; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Watkins PJ, 1996, CANCER RES, V56, P1063; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Wolff L, 1997, BBA-REV CANCER, V1332, pF67, DOI 10.1016/S0304-419X(97)00006-1; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	32	703	728	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					263	270		10.1038/85820	http://dx.doi.org/10.1038/85820			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242107				2022-12-27	WOS:000167304200017
J	Lee, YA; Wahn, U; Kehrt, R; Tarani, L; Businco, L; Gustafsson, D; Andersson, F; Oranje, AP; Wolkertstorfer, A; von Berg, A; Hoffmann, U; Kuster, W; Wienker, T; Ruschendorf, F; Reis, A				Lee, YA; Wahn, U; Kehrt, R; Tarani, L; Businco, L; Gustafsson, D; Andersson, F; Oranje, AP; Wolkertstorfer, A; von Berg, A; Hoffmann, U; Kuster, W; Wienker, T; Ruschendorf, F; Reis, A			A major susceptibility locus for atopic dermatitis maps to chromosome 3q21	NATURE GENETICS			English	Article							GENOME-WIDE SEARCH; LINKAGE ANALYSIS; LOD SCORES; ASTHMA; DISEASE; ASSOCIATION; POPULATION; ECZEMA; PREVALENCE; GUIDELINES	Atopic dermatitis (eczema) is a chronic inflammatory skin disease with onset mainly in early childhood(1). It is commonly the initial clinical manifestation of allergic disease, often preceding the onset of respiratory allergies(2,3). Along with asthma and allergic rhinitis, atopic dermatitis is an important manifestation of atopy that is characterized by the formation of allergy antibodies (IgE) to environmental allergens. In the developed countries, the prevalence of atopic dermatitis is approximately 15%, with a steady increase over the past decades(4,5). Genetic and environmental factors interact to determine disease susceptibility and expression(6), and twin studies indicate that the genetic contribution is substantial(7). To identify susceptibility loci for atopic dermatitis, we ascertained 199 families with at least two affected siblings based on established diagnostic criteria(8,9). A genome-wide linkage study revealed highly significant evidence for linkage on chromosome 3q21 (Z(all)=4.31, P= 8.42x10(-6)). Moreover, this locus provided significant evidence for linkage of allergic sensitization under the assumption of paternal imprinting (hlod=3.71, alpha =44%), further supporting the presence of an atopy gene in this region. Our findings indicate that distinct genetic factors contribute to susceptibility to atopic dermatitis and that the study of this disease opens new avenues to dissect the genetics of atopy.	Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Humboldt Univ, Dept Paediat Pneumol & Immunol, Berlin, Germany; Univ La Sapienza, Dept Paediat, Rome, Italy; Orebro Med Ctr Hosp, Dept Paediat, S-70185 Orebro, Sweden; Univ Rotterdam Hosp, Dept Dermatol & Venereol, Rotterdam, Netherlands; Marienhosp, Dept Paediat, Wesel, Germany; Tech Univ Munich, Kinderklin Schwabing, D-8000 Munich, Germany; TOMESA Fachklin, Bad Salzschlirf, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; Humboldt Univ, Dept Human Genet, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Sapienza University Rome; Erasmus University Rotterdam; Erasmus MC; St. Marien Hospital; Technical University of Munich; University of Bonn; Humboldt University of Berlin	Reis, A (corresponding author), Univ Erlangen Nurnberg, Dept Human Genet, Erlangen, Germany.		Reis, André/D-2309-2009; Wolkerstorfer, Albert/F-8866-2013	Reis, André/0000-0002-6301-6363; Wolkerstorfer, Albert/0000-0003-1421-1493				Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Bergmann RL, 1998, CLIN EXP ALLERGY, V28, P965; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Cox HE, 1998, BRIT J DERMATOL, V138, P182; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOLD S, 1992, ARCH DIS CHILD, V67, P1018, DOI 10.1136/adc.67.8.1018; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HANIFIN JM, 1998, ATOPIC DERMATITIS; HANIFIN JM, 1980, ACTA DERM-VENEREOL S, V92, P44, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; KAY J, 1994, J AM ACAD DERMATOL, V30, P35, DOI 10.1016/S0190-9622(94)70004-4; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANIER LL, 1995, J IMMUNOL, V154, P97; LARSEN FS, 1986, J AM ACAD DERMATOL, V15, P487; Leung DYM, 1997, ANN ALLERG ASTHMA IM, V79, P197, DOI 10.1016/S1081-1206(10)63003-7; Mao XQ, 1996, LANCET, V348, P581, DOI 10.1016/S0140-6736(95)10244-2; Marsh DG, 1997, NAT GENET, V15, P389; Moffatt MF, 1998, CLIN EXP ALLERGY, V28, P56; Nickel RG, 2000, J IMMUNOL, V164, P1612, DOI 10.4049/jimmunol.164.3.1612; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; TAYLOR B, 1984, LANCET, V2, P1255, DOI 10.1016/S0140-6736(84)92805-8; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806	30	201	213	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					470	473		10.1038/82625	http://dx.doi.org/10.1038/82625			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101848				2022-12-27	WOS:000165671700023
J	Meij, IC; Koenderink, JB; van Bokhoven, H; Assink, KFH; Groenestege, WT; de Pont, JJHHM; Bindels, RJM; Monnens, LAH; van den Heuvel, LPWJ; Knoers, NVAM				Meij, IC; Koenderink, JB; van Bokhoven, H; Assink, KFH; Groenestege, WT; de Pont, JJHHM; Bindels, RJM; Monnens, LAH; van den Heuvel, LPWJ; Knoers, NVAM			Dominant isolated renal magnesium loss is caused by misrouting of the Na+,K+-ATPase gamma-subunit	NATURE GENETICS			English	Article							NA,K-ATPASE; CELLS		Univ Nijmegen, Med Ctr, Inst Cellular Signaling, Dept Human Genet, Nijmegen, Netherlands; Univ Nijmegen, Med Ctr, Inst Cellular Signaling, Dept Pediat, Nijmegen, Netherlands; Univ Nijmegen, Med Ctr, Inst Cellular Signaling, Dept Biochem, Nijmegen, Netherlands; Univ Nijmegen, Med Ctr, Inst Cellular Signaling, Dept Cell Physiol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Knoers, NVAM (corresponding author), Univ Nijmegen, Med Ctr, Inst Cellular Signaling, Dept Human Genet, Nijmegen, Netherlands.		Koenderink, Jan/N-3578-2014; Monnens, L.A.H./L-4526-2015; van Bokhoven, Hans/D-8764-2012; van den Heuvel, Lambertus/AAM-1772-2021; van den Heuvel, L.P.W.J./H-8044-2014; Bindels, René JM/B-9824-2013; Bokhoven, J.H.L.M. van van/H-8015-2014	van den Heuvel, Lambertus/0000-0003-3917-6727; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Bindels, René JM/0000-0003-1167-1339; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254				Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; Dai LJ, 1997, KIDNEY INT, V51, P1008, DOI 10.1038/ki.1997.141; GEVEN WB, 1987, KIDNEY INT, V31, P1140, DOI 10.1038/ki.1987.120; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Kuster B, 2000, J BIOL CHEM, V275, P18441, DOI 10.1074/jbc.M001411200; Meij IC, 1999, AM J HUM GENET, V64, P180, DOI 10.1086/302199; MEIJ IC, IN PRESS ADV NEPHROL; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; NING G, 1993, FEBS LETT, V336, P521, DOI 10.1016/0014-5793(93)80868-U; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; Therien AG, 1999, J BIOL CHEM, V274, P12252, DOI 10.1074/jbc.274.18.12252	12	180	186	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					265	266		10.1038/81543	http://dx.doi.org/10.1038/81543			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062458				2022-12-27	WOS:000165176500007
J	Lercher, MJ; Urrutia, AO; Hurst, LD				Lercher, MJ; Urrutia, AO; Hurst, LD			Clustering of housekeeping genes provides a unified model of gene order in the human genome	NATURE GENETICS			English	Article							MAP; CHROMOSOME; EXPRESSION; COMPLEX	It is often supposed that, except for tandem duplicates, genes are randomly distributed throughout the human genome. However, recent analyses suggest that when all the genes expressed in a given tissue (notably placenta(1) and skeletal muscle(2)) are examined, these genes do not map to random locations but instead resolve to clusters. We have asked three questions: (i) is this clustering true for most tissues, or are these the exceptions; (ii) is any clustering simply the result of the expression of tandem duplicates and (iii) how, if at all, does this relate to the observed clustering of genes with high expression rates(3) ? We provide a unified model of gene clustering that explains the previous observations. We examined Serial Analysis of Gene Expression (SAGE)(4) data for 14 tissues and found significant clustering, in each tissue, that persists even after the removal of tandem duplicates. We confirmed clustering by analysis of independent expressed-sequence tag (EST) data. We then tested the possibility that the human genome is organized into subregions, each specializing in genes needed in a given tissue. By comparing genes expressed in different tissues, we show that this is not the case: those genes that seem to be tissue-specific in their expression do not, as a rule, cluster. We report that genes that are expressed in most tissues (housekeeping genes) show strong clustering. In addition, we show that the apparent clustering of genes with high expression rates(3) is a consequence of the clustering of housekeeping genes.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	Lercher, Martin/K-7939-2013; Martinez, Octavio/B-7375-2009; Hurst, Laurence/F-9215-2010	Lercher, Martin/0000-0003-3940-1621; Hurst, Laurence/0000-0002-1002-1054; Urrutia, Araxi/0000-0001-9011-8675				Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Blumenthal T, 1998, BIOESSAYS, V20, P480, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;480::AID-BIES6&gt;3.0.CO;2-Q; Bortoluzzi S, 1998, GENOME RES, V8, P817, DOI 10.1101/gr.8.8.817; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DURET L, 1994, NUCLEIC ACIDS RES, V22, P2360, DOI 10.1093/nar/22.12.2360; Fisher RA, 1930, GENETICAL THEORY NAT; Hurst LD, 1996, NAT GENET, V12, P234, DOI 10.1038/ng0396-234; Ko MSH, 1998, HUM MOL GENET, V7, P1967, DOI 10.1093/hmg/7.12.1967; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051; Paul AL, 1999, PLANT MOL BIOL, V41, P713, DOI 10.1023/A:1006323222693; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947	15	418	431	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					180	183		10.1038/ng887	http://dx.doi.org/10.1038/ng887			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	11992122				2022-12-27	WOS:000175903500015
J	Abi-Rached, L; Gilles, A; Shiina, T; Pontarotti, P; Inoko, H				Abi-Rached, L; Gilles, A; Shiina, T; Pontarotti, P; Inoko, H			Evidence of en bloc duplication in vertebrate genomes	NATURE GENETICS			English	Article							CLASS-I; EVOLUTION; LINKAGE; REGION; SYSTEM; GENES; BLAST	It has been 30 years since it was first proposed that the vertebrate genome evolved through several rounds of genome-wide duplications (polyploidizations)(1). Despite rapid advances in genetics, including sequencing of the complete genomes of several divergent species, this hypothesis has not been tested rigorously and is still a matter of debate(2). If polyploidizations occurred during chordate evolution, there should be a network of paralogous regions in the present-day jawed vertebrate (Gnathostomata) genomes(3). Here we present an investigation of the major histocompatibility complex (MHC) paralogous regions, which we accomplished by characterizing the corresponding region in amphioxus by identifying nine anchor genes and sequencing both the anchor genes and the regions that flank them (a total of 400 kb). Phylogenetic analysis of 31 genes (including the anchor genes) in these regions shows that duplications occurred after the divergence of cephalochordates and vertebrates but before the Gnathostomata radiation. The distribution of human and amphioxus orthologs in their respective genomes and the relationship between these distributions support the en bloc duplication events. Our analysis represents the first step towards demonstrating that the human ancestral genome has undergone polyploidization. Moreover, reconstruction of the pre-duplicated region indicates that one of the duplicated regions retains the ancestral organization.	INSERM, U119, F-13009 Marseille, France; Univ Aix Marseille 1, UPRES Biodivers 2202, F-13331 Marseille 3, France; Tokai Univ, Sch Med, Dept Mol Life Sci, Kanagawa 2591193, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Tokai University	Abi-Rached, L (corresponding author), INSERM, U119, 27 Bd Lei Roure, F-13009 Marseille, France.	abi-rached@marseille.inserm.fr; pontarot@marseille.inserm.fr	Abi-Rached, Laurent/H-7236-2012; , pontarotti/ABB-1753-2021	Pierre, Pontarotti/0000-0001-7202-3648; Shiina, Takashi/0000-0002-2067-6708				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Boone M, 2000, BIOINFORMATICS, V16, P1054, DOI 10.1093/bioinformatics/16.11.1054; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Clark MS, 2001, IMMUNOGENETICS, V52, P174, DOI 10.1007/s002510000285; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Gelfand MS, 1996, P NATL ACAD SCI USA, V93, P9061, DOI 10.1073/pnas.93.17.9061; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Guigo R, 2000, GENOME RES, V10, P1631, DOI 10.1101/gr.122800; Hansen JD, 1999, J IMMUNOL, V163, P774; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kasahara M, 1997, TRENDS GENET, V13, P90, DOI 10.1016/S0168-9525(97)01065-2; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Maresco DL, 1998, CYTOGENET CELL GENET, V82, P71, DOI 10.1159/000015067; Ohno S., 1970, EVOLUTION GENE DUPLI; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 1989, MOL CLONING; Shiina T, 2001, GENOME RES, V11, P789, DOI 10.1101/gr.175801; SOLOVYEV V, 1997, ISMB, V5, P294; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Takami K, 1997, J IMMUNOL, V159, P6052; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; ZEHETNER G, 1994, NATURE, V367, P489, DOI 10.1038/367489a0	30	198	207	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					100	105		10.1038/ng855	http://dx.doi.org/10.1038/ng855			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967531				2022-12-27	WOS:000175362500023
J	Shen-Orr, SS; Milo, R; Mangan, S; Alon, U				Shen-Orr, SS; Milo, R; Mangan, S; Alon, U			Network motifs in the transcriptional regulation network of Escherichia coli	NATURE GENETICS			English	Article							GENE-REGULATION; ORGANIZATION; SIMULATION; ELEMENTS; OPERON	Little is known about the design principles(1-10) of transcriptional regulation networks that control gene expression in cells. Recent advances in data collection and analysis(2,11,12), however, are generating unprecedented amounts of information about gene regulation networks. To understand these complex wiring diagrams(1-10,13), we sought to break down such networks into basic building blocks(2). We generalize the notion of motifs, widely used for sequence analysis, to the level of networks. We define 'network motifs' as patterns of interconnections that recur in many different parts of a network at frequencies much higher than those found in randomized networks. We applied new algorithms for systematically detecting network motifs to one of the best-characterized regulation networks, that of direct transcriptional interactions in Escherichia coli(3,6). We find that much of the network is composed of repeated appearances of three highly significant motifs. Each network motif has a specific function in determining gene expression, such as generating temporal expression programs and governing the responses to fluctuating external signals. The motif structure also allows an easily interpretable view of the entire known transcriptional network of the organism. This approach may help define the basic computational elements of other biological networks.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@wisemail.weizmann.ac.il	Yang, Chen/G-1379-2010; Milo, Hilla/C-8767-2016	Milo, Ron/0000-0003-1641-2299; Shen-Orr, Shai/0000-0002-6991-7736; Li, Jun/0000-0003-4440-5862				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Duda R. O., 1973, PATTERN CLASSIFICATI; Hartemink A J, 2001, Pac Symp Biocomput, P422; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HENGGEARONIS R, 1993, CELL, V72, P165, DOI 10.1016/0092-8674(93)90655-A; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Rao CV, 2001, ANNU REV BIOMED ENG, V3, P391, DOI 10.1146/annurev.bioeng.3.1.391; Salgado H, 2001, NUCLEIC ACIDS RES, V29, P72, DOI 10.1093/nar/29.1.72; SAVAGEAU M, 1996, ESCHERICHIA COLL SAL, P1310; Schleif R, 2000, TRENDS GENET, V16, P559, DOI 10.1016/S0168-9525(00)02153-3; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896	21	1945	2021	4	137	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					64	68		10.1038/ng881	http://dx.doi.org/10.1038/ng881			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967538	Bronze			2022-12-27	WOS:000175362500016
J	Carpten, J; Nupponen, N; Isaacs, S; Sood, R; Robbins, C; Xu, J; Faruque, M; Moses, T; Ewing, C; Gillanders, E; Hu, P; Buinovszky, P; Makalowska, I; Baffoe-Bonnie, A; Faith, D; Smith, J; Stephan, D; Wiley, K; Brownstein, M; Gildea, D; Kelly, B; Jenkins, R; Hostetter, G; Matikainen, M; Schleutker, J; Klinger, K; Connors, T; Xiang, Y; Wang, Z; De Marzo, A; Papadopoulos, N; Kallioniemi, OP; Burk, R; Meyers, D; Gronberg, H; Meltzer, P; Silverman, R; Bailey-Wilson, J; Walsh, P; Isaacs, W; Trent, J				Carpten, J; Nupponen, N; Isaacs, S; Sood, R; Robbins, C; Xu, J; Faruque, M; Moses, T; Ewing, C; Gillanders, E; Hu, P; Buinovszky, P; Makalowska, I; Baffoe-Bonnie, A; Faith, D; Smith, J; Stephan, D; Wiley, K; Brownstein, M; Gildea, D; Kelly, B; Jenkins, R; Hostetter, G; Matikainen, M; Schleutker, J; Klinger, K; Connors, T; Xiang, Y; Wang, Z; De Marzo, A; Papadopoulos, N; Kallioniemi, OP; Burk, R; Meyers, D; Gronberg, H; Meltzer, P; Silverman, R; Bailey-Wilson, J; Walsh, P; Isaacs, W; Trent, J			Germline mutations in the ribonuclease L gene in families showing linkage with HPC1	NATURE GENETICS			English	Article							PROSTATE-CANCER INCIDENCE; 2-5A-DEPENDENT RNASE; INTERFERON ACTION; PROTEIN-SYNTHESIS; EXPRESSION; MORTALITY; CLEAVAGE; TRENDS; CELLS	Although prostate cancer is the most common non-cutaneous malignancy diagnosed in men in the United States(1,2), little is known about inherited factors that influence its genetic predisposition(3-5). Here we report that germline mutations in the gene encoding 2'-5'-oligoadenylate(2-5A)-dependent RNase L (RNASEL)(6-8) segregate in prostate cancer families that show linkage to the HPC1 (hereditary prostate cancer 1) region at 1q24-25 (ref. 9). We identified RNASEL by a positional cloning/candidate gene method, and show that a nonsense mutation and a mutation in an initiation codon of RNASEL segregate independently in two HPC1-linked families. inactive RNASEL alleles are present at a low frequency in the general population. RNASEL regulates cell proliferation and apoptosis through the interferon-regulated 2-5A pathway and has been suggested to be a candidate tumor suppressor gene(10-12). We found that microdissected tumors with a germline mutation showed loss of heterozygosity and loss of RNase L protein, and that RNASEL activity was reduced in lymphoblasts from heterozyogous individuals compared with family members who were homozygous with respect to the wildtype allele. Thus, germline mutations in RNASEL may be of diagnostic value, and the 2-5A pathway might provide opportunities for developing therapies for those with prostate cancer.	NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA; Vanderbilt Univ, Div Med Genet, Nashville, TN USA; Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; NIMH, Genet Lab, NIH, Bethesda, MD 20892 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Univ Tampere, Canc Genet Lab, Inst Med Technol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Canc Genet Lab, Inst Med Technol, Tampere, Finland; Genzyme Mol Oncol, Framingham, MA USA; Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Columbia Univ, Dept Pathol, Inst Canc Genet, New York, NY USA; Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Albert Einstein Sch Med, Bronx, NY 10461 USA; Umea Univ, Dept Oncol, Umea, Sweden	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins Medicine; Wake Forest University; Wake Forest Baptist Medical Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Fox Chase Cancer Center; Vanderbilt University; Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Mayo Clinic; Tampere University; Tampere University; Tampere University Hospital; Sanofi-Aventis; Cleveland Clinic Foundation; Columbia University; Yeshiva University; Albert Einstein College of Medicine; Umea University	Trent, J (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.		Brownstein, Michael/B-8609-2009; Makalowska, Izabela/AAF-4967-2021; Makalowska, Izabela/AAU-2682-2021; Smith, Jeff/C-3484-2012; Kallioniemi, Olli P/H-5111-2011; Papadopoulos, Nickolas/K-7272-2012	Makalowska, Izabela/0000-0002-8144-5671; Kallioniemi, Olli P/0000-0002-3231-0332; Schleutker, Johanna/0000-0002-1863-0305; Smith, Jeffrey/0000-0001-8424-910X; Bailey-Wilson, Joan/0000-0002-9153-2920	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002771] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Carpten JD, 2000, GENOMICS, V64, P1, DOI 10.1006/geno.1999.6051; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; Dennis LK, 2000, PROSTATE, V42, P247; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; Hankey BF, 1999, JNCI-J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; Hartge P, 1999, AM J HUM GENET, V64, P963, DOI 10.1086/302320; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; ISAACS JT, 1994, SEMIN CANCER BIOL, V5, P391; KAIGHN ME, 1979, INVEST UROL, V17, P16; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; LENGYEL P, 1993, P NATL ACAD SCI USA, V90, P5893, DOI 10.1073/pnas.90.13.5893; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; SHERMAN F, 1980, BIOCHIM BIOPHYS ACTA, V609, P343, DOI 10.1016/0005-2787(80)90246-4; SILVERMAN RH, 1983, J VIROL, V46, P1051, DOI 10.1128/JVI.46.3.1051-1055.1983; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Sood R, 2001, GENOMICS, V73, P211, DOI 10.1006/geno.2001.6500; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Tnani M, 1998, BBA-MOL CELL RES, V1402, P139, DOI 10.1016/S0167-4889(97)00158-4; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	23	381	398	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					181	184		10.1038/ng823	http://dx.doi.org/10.1038/ng823			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11799394	Green Published			2022-12-27	WOS:000173708700018
J	Derynck, R; Akhurst, RJ; Balmain, A				Derynck, R; Akhurst, RJ; Balmain, A			TGF-beta signaling in tumor suppression and cancer progression	NATURE GENETICS			English	Review							GROWTH-FACTOR-BETA; RECEPTOR-TYPE-II; CELL-CYCLE ARREST; MAMMARY EPITHELIAL-CELLS; WD-DOMAIN PROTEIN; TRANSFORMING GROWTH-FACTOR-BETA-1; BREAST-CANCER; INDUCED APOPTOSIS; SMAD PROTEINS; TRANSCRIPTIONAL ACTIVATION	Epithelial and hematopoietic cells have a high turnover and their progenitor cells divide continuously, making them prime targets for genetic and epigenetic changes that lead to cell transformation and tumorigenesis. The consequent changes in cell behavior and responsiveness result not only from genetic alterations such as activation of oncogenes or inactivation of tumor suppressor genes, but also from altered production of, or responsiveness to, stimulatory or inhibitory growth and differentiation factors. Among these, transforming growth factor beta (TGF-beta) and its signaling effectors act as key determinants of carcinoma cell behavior. The autocrine and paracrine effects of TGF-beta on tumor cells and the tumor micro-environment exert both positive and negative influences on cancer development. Accordingly, the TGF-beta signaling pathway has been considered as both a tumor suppressor pathway and a promoter of tumor progression and invasion. Here we evaluate the role of TGF-beta in tumor development and attempt to reconcile the positive and negative effects of TGF-beta in carcinogenesis.	Univ Calif San Francisco, Dept Growth & Dev, Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Mt Zion Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of California System; University of California San Francisco	Derynck, R (corresponding author), Univ Calif San Francisco, Dept Growth & Dev, Cell Biol Program, San Francisco, CA 94143 USA.	derynck@itsa.ucsf.edu	yang, xiao-jun/B-1927-2009	AKHURST, ROSEMARY/0000-0002-4474-9668				Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Aghdasi B, 2001, P NATL ACAD SCI USA, V98, P2425, DOI 10.1073/pnas.041614198; Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Amoroso SR, 1998, P NATL ACAD SCI USA, V95, P189, DOI 10.1073/pnas.95.1.189; Ananth S, 1999, CANCER RES, V59, P2210; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Arteaga CL, 1999, JNCI-J NATL CANCER I, V91, P46, DOI 10.1093/jnci/91.1.46; ARTEAGA CL, 1993, CELL GROWTH DIFFER, V4, P193; ARTEAGA CL, 1993, J CLIN INVEST, V92, P2569, DOI 10.1172/JCI116871; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Ashcroft GS, 1999, MICROBES INFECT, V1, P1275, DOI 10.1016/S1286-4579(99)00257-9; Atfi A, 1997, J BIOL CHEM, V272, P24731, DOI 10.1074/jbc.272.40.24731; Bandyopadhyay A, 1999, CANCER RES, V59, P5041; BATTIFORA H, 1976, CANCER, V37, P2275, DOI 10.1002/1097-0142(197605)37:5<2275::AID-CNCR2820370518>3.0.CO;2-3; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bitzer M, 2000, GENE DEV, V14, P187; Botti C, 1998, INT J BIOL MARKER, V13, P51; Bottinger EP, 1997, CANCER RES, V57, P5564; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Bubb VJ, 1996, ONCOGENE, V12, P2641; BUCHMANN A, 1991, CANCER RES, V51, P4097; BUTTA A, 1992, CANCER RES, V52, P4261; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; CAULIN C, 1995, CELL GROWTH DIFFER, V6, P1027; CHANG E, 1995, J BIOL CHEM, V270, P4473, DOI 10.1074/jbc.270.9.4473; Chang H, 1999, DEVELOPMENT, V126, P1631; CHAOUCHI N, 1995, ONCOGENE, V11, P1615; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Chen JJ, 1998, SCIENCE, V282, P1714, DOI 10.1126/science.282.5394.1714; CHEN RH, 1995, NATURE, V377, P548, DOI 10.1038/377548a0; Chen RH, 1999, J BIOL CHEM, V274, P23013, DOI 10.1074/jbc.274.33.23013; Chen RH, 1997, CELL GROWTH DIFFER, V8, P821; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; CHEN RH, 1993, SCIENCE, V260, P1335, DOI 10.1126/science.8388126; Chen T, 2001, CANCER RES, V61, P4679; Chen TP, 1998, CANCER RES, V58, P4805; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Chipuk JE, 2001, J BIOL CHEM, V276, P26614, DOI 10.1074/jbc.M100913200; CHOI ME, 1995, J BIOL CHEM, V270, P21144, DOI 10.1074/jbc.270.36.21144; Choy L, 1998, J BIOL CHEM, V273, P31455, DOI 10.1074/jbc.273.47.31455; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; Chung YJ, 1996, CANCER RES, V56, P4662; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; COFFEY RJ, 1988, MOL CELL BIOL, V8, P3088, DOI 10.1128/MCB.8.8.3088; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; CZARNIECKI CW, 1988, J IMMUNOL, V140, P4217; Dai JL, 1999, MOL CARCINOGEN, V26, P37, DOI 10.1002/(SICI)1098-2744(199909)26:1<37::AID-MC5>3.0.CO;2-6; Dai JL, 1999, P NATL ACAD SCI USA, V96, P1427, DOI 10.1073/pnas.96.4.1427; Dai JL, 1998, CANCER RES, V58, P4592; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Datto MB, 1999, MOL CELL BIOL, V19, P2495; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; De Jong JS, 1998, J PATHOL, V184, P53, DOI 10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DERYNCK R, 1987, CANCER RES, V47, P707; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Derynck R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P105; DESOUZA AT, 1995, NAT GENET, V11, P447, DOI 10.1038/ng1295-447; DICKSON RB, 1987, P NATL ACAD SCI USA, V84, P837, DOI 10.1073/pnas.84.3.837; Duivenvoorden WCM, 1999, CLIN EXP METASTAS, V17, P27; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Engle SJ, 1999, CANCER RES, V59, P3379; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; EVANS HL, 1993, SEMIN DIAGN PATHOL, V10, P286; EWEN ME, 1995, GENE DEV, V9, P204, DOI 10.1101/gad.9.2.204; EWEN ME, 1993, CELL, V74, P1009, DOI 10.1016/0092-8674(93)90723-4; FAFEUR V, 1993, MOL BIOL CELL, V4, P135, DOI 10.1091/mbc.4.2.135; Fakhrai H, 1996, P NATL ACAD SCI USA, V93, P2909, DOI 10.1073/pnas.93.7.2909; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; Fink SP, 2001, CANCER RES, V61, P256; Fortunel NO, 2000, BLOOD, V96, P2022; FUMAGALLI S, 1993, MELANOMA RES, V3, P23, DOI 10.1097/00008390-199304000-00004; Furuta K, 1999, INT J CANCER, V81, P851, DOI 10.1002/(SICI)1097-0215(19990611)81:6<851::AID-IJC2>3.0.CO;2-D; GAJDUSEK CM, 1993, J CELL PHYSIOL, V157, P133, DOI 10.1002/jcp.1041570118; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GEISER AG, 1992, J BIOL CHEM, V267, P2588; GEISER AG, 1991, MOL CELL BIOL, V11, P84, DOI 10.1128/MCB.11.1.84; GEISER AG, 1993, P NATL ACAD SCI USA, V90, P9944, DOI 10.1073/pnas.90.21.9944; GLICK AB, 1991, MOL CARCINOGEN, V4, P210, DOI 10.1002/mc.2940040308; Go C, 1999, CANCER RES, V59, P2861; Goggins M, 1998, CANCER RES, V58, P5329; Goto D, 1998, FEBS LETT, V430, P201, DOI 10.1016/S0014-5793(98)00658-9; Grady WM, 1999, CANCER RES, V59, P320; Griswold-Prenner I, 1998, MOL CELL BIOL, V18, P6595, DOI 10.1128/MCB.18.11.6595; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Guo YP, 1997, INT J CANCER, V71, P573, DOI 10.1002/(SICI)1097-0215(19970516)71:4<573::AID-IJC11>3.3.CO;2-1; Hagedorn HG, 2001, INT J ONCOL, V18, P669; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Hata A, 1998, MOL MED TODAY, V4, P257, DOI 10.1016/S1357-4310(98)01247-7; Hayes SA, 2001, CANCER RES, V61, P2112; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Horwitz DA, 1997, IMMUNOL TODAY, V18, P538, DOI 10.1016/S0167-5699(97)01149-3; HOSOBUCHI M, 1989, IN VITRO CELL DEV B, V25, P705; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Hua XX, 1999, P NATL ACAD SCI USA, V96, P13130, DOI 10.1073/pnas.96.23.13130; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Iavarone A, 1997, NATURE, V387, P417; Iglesias M, 2000, ONCOGENE, V19, P4134, DOI 10.1038/sj.onc.1203764; INGE TH, 1992, CANCER RES, V52, P1386; Ishisaki A, 1998, J BIOL CHEM, V273, P24293, DOI 10.1074/jbc.273.38.24293; ITO N, 1995, CANCER LETT, V89, P45, DOI 10.1016/0304-3835(94)03651-X; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; IVANOVIC V, 1995, NAT MED, V1, P282, DOI 10.1038/nm0495-282; Izumoto S, 1997, CANCER LETT, V112, P251, DOI 10.1016/S0304-3835(96)04583-1; Janji B, 1999, INT J CANCER, V83, P255, DOI 10.1002/(SICI)1097-0215(19991008)83:2<255::AID-IJC18>3.3.CO;2-O; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Jeffers M, 1996, MOL CELL BIOL, V16, P1115; JIRTLE RL, 1994, CARCINOGENESIS, V15, P1473, DOI 10.1093/carcin/15.8.1473; Junker U, 1996, CYTOKINE, V8, P794, DOI 10.1006/cyto.1996.0105; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Kang HY, 2001, P NATL ACAD SCI USA, V98, P3018, DOI 10.1073/pnas.061305498; Kawate S, 1999, INT J ONCOL, V14, P127; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Kim RH, 2000, GENE DEV, V14, P1605; Kim SJ, 2000, CYTOKINE GROWTH F R, V11, P159, DOI 10.1016/S1359-6101(99)00039-8; Kim TK, 2001, LUNG CANCER-J IASLC, V31, P181, DOI 10.1016/S0169-5002(00)00169-0; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2; Kitagawa K, 1996, INT J CANCER, V66, P91, DOI 10.1002/(SICI)1097-0215(19960328)66:1<91::AID-IJC16>3.0.CO;2-E; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; KNABBE C, 1987, CELL, V48, P417, DOI 10.1016/0092-8674(87)90193-0; Knaus PI, 1996, MOL CELL BIOL, V16, P3480; Koli KM, 1997, J BIOL CHEM, V272, P8296, DOI 10.1074/jbc.272.13.8296; Kong FM, 2000, ONCOGENE, V19, P1572, DOI 10.1038/sj.onc.1203437; KORDULA T, 1992, FEBS LETT, V313, P143, DOI 10.1016/0014-5793(92)81431-K; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; Lakkis MM, 1998, DEVELOPMENT, V125, P4359; Lallemand F, 2001, ONCOGENE, V20, P879, DOI 10.1038/sj.onc.1204167; Landstrom M, 2000, CURR BIOL, V10, P535, DOI 10.1016/S0960-9822(00)00470-X; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lee BI, 2001, CANCER RES, V61, P931; Lee DK, 2001, GENE DEV, V15, P455, DOI 10.1101/gad.856201; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Lu SL, 1996, CANCER RES, V56, P4595; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Luttges J, 2001, AM J PATHOL, V158, P1677, DOI 10.1016/S0002-9440(10)64123-5; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; MA D, 1995, IMMUNOLOGY, V86, P263; MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Marzo AL, 1997, CANCER RES, V57, P3200; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MCADAM AJ, 1994, J IMMUNOTHER, V15, P155, DOI 10.1097/00002371-199404000-00001; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; MIYAZONO K, 1993, GROWTH FACTORS, V8, P11, DOI 10.3109/08977199309029130; Moren A, 2000, ONCOGENE, V19, P4396, DOI 10.1038/sj.onc.1203798; Mori N, 2001, BLOOD, V97, P2137, DOI 10.1182/blood.V97.7.2137; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; MYEROFF LL, 1995, CANCER RES, V55, P5545; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Ohtaki N, 2001, INT J ONCOL, V18, P265; Ohue M, 1996, INT J CANCER, V68, P203, DOI 10.1002/(SICI)1097-0215(19961009)68:2<203::AID-IJC11>3.0.CO;2-B; Oklu R, 2000, BIOCHEM J, V352, P601, DOI 10.1042/0264-6021:3520601; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; OWEN RD, 1990, P NATL ACAD SCI USA, V87, P3866, DOI 10.1073/pnas.87.10.3866; Pardali E, 2000, J BIOL CHEM, V275, P3552, DOI 10.1074/jbc.275.5.3552; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Park JA, 1997, CANCER GENE THER, V4, P42; PARK KC, 1994, P NATL ACAD SCI USA, V91, P8772, DOI 10.1073/pnas.91.19.8772; Patil S, 2000, J BIOL CHEM, V275, P38363, DOI 10.1074/jbc.M004861200; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Peron P, 2001, J BIOL CHEM, V276, P10524, DOI 10.1074/jbc.M005919200; PERTOVAARA L, 1994, J BIOL CHEM, V269, P6271; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Piek E, 1999, J CELL SCI, V112, P4557; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Portella G, 1998, CELL GROWTH DIFFER, V9, P393; POTTS JD, 1989, DEV BIOL, V134, P392, DOI 10.1016/0012-1606(89)90111-5; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Prunier C, 1999, J BIOL CHEM, V274, P22919, DOI 10.1074/jbc.274.33.22919; Prunier C, 2001, MOL CELL BIOL, V21, P3302, DOI 10.1128/MCB.21.10.3302-3313.2001; Qing J, 2000, J BIOL CHEM, V275, P38802, DOI 10.1074/jbc.M004731200; Reddy KB, 1999, INT J CANCER, V82, P268, DOI 10.1002/(SICI)1097-0215(19990719)82:2<268::AID-IJC18>3.3.CO;2-W; Reiss M, 1999, MICROBES INFECT, V1, P1327, DOI 10.1016/S1286-4579(99)00251-8; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; ROTELLO RJ, 1991, P NATL ACAD SCI USA, V88, P3412, DOI 10.1073/pnas.88.8.3412; Saito H, 1999, CANCER, V86, P1455, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1455::AID-CNCR11>3.0.CO;2-L; Saltzman A, 1998, EXP CELL RES, V242, P244, DOI 10.1006/excr.1998.4096; Sandhu C, 1997, MOL CELL BIOL, V17, P2458, DOI 10.1128/MCB.17.5.2458; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Santibanez JF, 1999, J CELL BIOCHEM, V74, P61, DOI 10.1002/(SICI)1097-4644(19990701)74:1<61::AID-JCB7>3.3.CO;2-2; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; Schiemann WP, 1999, BLOOD, V94, P2854, DOI 10.1182/blood.V94.8.2854.420k07_2854_2861; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Schwarte-Waldhoff I, 2000, P NATL ACAD SCI USA, V97, P9624, DOI 10.1073/pnas.97.17.9624; Sehgal I, 1999, MOL BIOL CELL, V10, P407, DOI 10.1091/mbc.10.2.407; SELVAKUMARAN M, 1994, MOL CELL BIOL, V14, P2352, DOI 10.1128/MCB.14.4.2352; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Seon BK, 1997, CLIN CANCER RES, V3, P1031; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Shih WL, 2000, J BIOL CHEM, V275, P25858, DOI 10.1074/jbc.M003578200; Shima Y, 1999, HEPATOLOGY, V30, P1215, DOI 10.1002/hep.510300503; Shimizu S, 1996, CANCER RES, V56, P3366; Shioda T, 1998, P NATL ACAD SCI USA, V95, P9785, DOI 10.1073/pnas.95.17.9785; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stander M, 1998, GENE THER, V5, P1187, DOI 10.1038/sj.gt.3300709; Stearns ME, 1999, CLIN CANCER RES, V5, P711; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; STOLER AB, 1993, J CELL BIOL, V122, P1103, DOI 10.1083/jcb.122.5.1103; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; SUN L, 1998, J BIOL CHEM, V269, P26449; SUNDERKOTTER C, 1991, PHARMACOL THERAPEUT, V51, P195, DOI 10.1016/0163-7258(91)90077-Y; Taipale J, 1998, ADV CANCER RES, V75, P87, DOI 10.1016/S0065-230X(08)60740-X; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takagi Y, 1998, BRIT J CANCER, V78, P1152, DOI 10.1038/bjc.1998.645; Takaku K, 1999, CANCER RES, V59, P6113; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Tanaka S, 1996, CANCER RES, V56, P3391; Tang BW, 1999, CANCER RES, V59, P4834; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; THOMPSON AM, 1991, BRIT J CANCER, V63, P609, DOI 10.1038/bjc.1991.140; Tomita S, 1999, BREAST CANCER RES TR, V53, P33, DOI 10.1023/A:1006167210269; TORREAMIONE G, 1990, P NATL ACAD SCI USA, V87, P1486, DOI 10.1073/pnas.87.4.1486; Turco A, 1999, INT J CANCER, V80, P85, DOI 10.1002/(SICI)1097-0215(19990105)80:1<85::AID-IJC17>3.0.CO;2-P; UEKI N, 1992, BIOCHIM BIOPHYS ACTA, V1137, P189; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; Venkatasubbarao K, 2000, ANTICANCER RES, V20, P43; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Vincent F, 1996, BIOCHEM BIOPH RES CO, V223, P561, DOI 10.1006/bbrc.1996.0934; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; WALLICK SC, 1990, J EXP MED, V172, P1777, DOI 10.1084/jem.172.6.1777; Wang D, 2000, CANCER RES, V60, P4507; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Wang XJ, 1999, P NATL ACAD SCI USA, V96, P8483, DOI 10.1073/pnas.96.15.8483; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; WEINBERG WC, 1990, DIFFERENTIATION, V45, P168, DOI 10.1111/j.1432-0436.1990.tb00470.x; WIESER R, 1993, MOL CELL BIOL, V13, P7239, DOI 10.1128/MCB.13.12.7239; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; WojtowiczPraga S, 1996, J IMMUNOTHER, V19, P169, DOI 10.1097/00002371-199605000-00001; Won JW, 1999, CANCER RES, V59, P1273; Wong C, 1999, MOL CELL BIOL, V19, P1821; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Xu J, 2000, P NATL ACAD SCI USA, V97, P4820, DOI 10.1073/pnas.97.9.4820; Xu XL, 2000, ONCOGENE, V19, P1868, DOI 10.1038/sj.onc.1203504; Yahata T, 2000, J BIOL CHEM, V275, P8825, DOI 10.1074/jbc.275.12.8825; Yakicier MC, 1999, ONCOGENE, V18, P4879, DOI 10.1038/sj.onc.1202866; YAMAGATA M, 1994, CANCER J - FRANCE, V7, P6; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yamanaka R, 1999, J NEURO-ONCOL, V43, P27, DOI 10.1023/A:1006289901702; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yanagisawa K, 1998, ONCOGENE, V17, P1743, DOI 10.1038/sj.onc.1202052; YANG EY, 1990, J CELL BIOL, V111, P731, DOI 10.1083/jcb.111.2.731; Yang X, 1999, DEVELOPMENT, V126, P1571; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yao DY, 2000, J BIOL CHEM, V275, P13149, DOI 10.1074/jbc.275.17.13149; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Yu Q, 2000, GENE DEV, V14, P163; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; ZHANG L, 1994, CHIN J PHARMACOEPIDE, V3, P4; Zhang Y, 2000, J BIOL CHEM, V275, P16979, DOI 10.1074/jbc.M001526200; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zhang Y, 1999, TRENDS CELL BIOL, V9, P274, DOI 10.1016/S0962-8924(99)01579-2; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	312	1867	1999	3	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2001	29	2					117	129		10.1038/ng1001-117	http://dx.doi.org/10.1038/ng1001-117			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586292				2022-12-27	WOS:000171374100012
J	Meguro, M; Kashiwagi, A; Mitsuya, K; Nakao, M; Kondo, I; Saitoh, S; Oshimura, M				Meguro, M; Kashiwagi, A; Mitsuya, K; Nakao, M; Kondo, I; Saitoh, S; Oshimura, M			A novel maternally expressed gene, ATP10C, encodes a putative aminophospholipid translocase associated with Angelman syndrome	NATURE GENETICS			English	Article							PRADER-WILLI; SNRPN GENE; MOUSE	Lack of a maternal contribution to the genome at the imprinted domain on proximal chromosome 15 causes Angelman syndrome (AS) associated with neurobehavioral anomalies that include severe mental retardation, ataxia and epilepsy(1,2). Although AS patients have infrequent mutations in the gene encoding an EG-AP ubiquitin ligase required for long-term synaptic potentiation (LTP), most cases are attributed to de novo maternal deletions of 15q11-q13 (ref. 3). We report here that a novel maternally expressed gene, ATP10C, maps within the most common interval of deletion and that ATP10C expression is virtually absent from AS patients with imprinting mutations, as well as from patients with maternal deletions of 15q11-q13.	Tottori Univ, Fac Med, Sch Life Sci, Dept Mol & Cell Genet,CREST Project, Tottori 680, Japan; Kumamoto Univ, Sch Med, Dept Tumor Genet & Biol, Kumamoto 860, Japan; Ehime Univ, Sch Med, Dept Hyg, Matsuyama, Ehime 790, Japan; Hokkaido Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido 060, Japan	Japan Science & Technology Agency (JST); Tottori University; Kumamoto University; Ehime University; Hokkaido University	Oshimura, M (corresponding author), Tottori Univ, Fac Med, Sch Life Sci, Dept Mol & Cell Genet,CREST Project, Tottori 680, Japan.		Mitsuya, Kohzoh/F-4437-2010; Kashiwagi, Atsunori/H-8712-2019	Saitoh, Shinji/0000-0001-6911-3351; Mitsuya, Kohzoh/0000-0002-0950-5406				Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Bielinska B, 2000, NAT GENET, V25, P74, DOI 10.1038/75629; Cattanach BM, 1997, MAMM GENOME, V8, P472, DOI 10.1007/s003359900479; Dhar M, 2000, PHYSIOL GENOMICS, V4, P93, DOI 10.1152/physiolgenomics.2000.4.1.93; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; Gillessen-Kaesbach G, 1999, EUR J HUM GENET, V7, P638, DOI 10.1038/sj.ejhg.5200362; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; Jiang YH, 1998, CURR OPIN GENET DEV, V8, P334, DOI 10.1016/S0959-437X(98)80091-9; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Mann MRW, 1999, HUM MOL GENET, V8, P1867, DOI 10.1093/hmg/8.10.1867; Moncla A, 1999, EUR J HUM GENET, V7, P131, DOI 10.1038/sj.ejhg.5200258; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Saitoh S, 1999, CLIN GENET, V55, P277, DOI 10.1034/j.1399-0004.1999.550411.x; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329	15	116	119	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					19	20		10.1038/ng0501-19	http://dx.doi.org/10.1038/ng0501-19			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326269				2022-12-27	WOS:000168413300009
J	Glatt, CE; DeYoung, JA; Delgado, S; Service, SK; Giacomini, KM; Edwards, RH; Risch, N; Freimer, NB				Glatt, CE; DeYoung, JA; Delgado, S; Service, SK; Giacomini, KM; Edwards, RH; Risch, N; Freimer, NB			Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DNA POLYMORPHISM; TRANSPORTER; SELECTION	Most human sequence variation is in the form of single-nucleotide polymorphisms(1-3) (SNPs). It has been proposed that coding-region SNPs (cSNPs) be used for direct association studies to determine the genetic basis of complex traits(4,5). The success of such studies depends on the frequency of disease-associated alleles, and their distribution in different ethnic populations(6,7). If disease-associated alleles are frequent in most populations, then direct genotyping of candidate variants could show robust associations in manageable study samples(6). This approach is less feasible if the genetic risk from a given candidate gene is due to many infrequent alleles. Previous studies of several genes demonstrated that most variants are relatively infrequent(2,3) (<0.05). These surveys genotyped small samples (n<75) and thus had limited ability to identify rare alleles. Here we evaluate the prevalence and distribution of such rare alleles by genotyping an ethnically diverse reference sample that is more than six times larger than those used in previous studies(8) (n=450). We screened for variants in the complete coding sequence and intron-exon junctions of two candidate genes for neuropsychiatric phenotypes: SLC6A4, encoding the serotonin transporter; and SLC18A2, encoding the vesicular monoamine transporter(9,10). Both genes have unique roles in neuronal transmission, and variants in either gene might be associated with neurobehavioral phenotypes(11-13).	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genome Core Facil, Program Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol & Physiol, San Francisco, CA 94143 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Calif San Francisco, Neurogenet Lab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco	Freimer, NB (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Gonda Ctr, Los Angeles, CA 90024 USA.		Giacomini, Kathleen/AEF-2452-2022		NIGMS NIH HHS [GM61390] Funding Source: Medline; NIMH NIH HHS [MH01375, MH49499] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061390, U01GM061390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001375, R01MH049499] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BLAKELY RD, 1994, J EXP BIOL, V196, P263; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hayward C, 1997, HUM MUTAT, V10, P415, DOI 10.1002/(SICI)1098-1004(1997)10:6<415::AID-HUMU1>3.3.CO;2-2; Jones AC, 1999, CLIN CHEM, V45, P1133; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lesch KP, 1998, BIOL PSYCHIAT, V44, P179, DOI 10.1016/S0006-3223(98)00121-8; Liu Y, 1996, COLD SPRING HARB SYM, V61, P747; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Peter D, 1996, NIDA Res Monogr, V161, P176; Rees JL, 1999, ANN NY ACAD SCI, V885, P134; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; TAJIMA F, 1989, GENETICS, V123, P585; Xu WM, 1997, MOL BRAIN RES, V45, P41, DOI 10.1016/S0169-328X(96)00218-5	19	120	120	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					435	438		10.1038/86948	http://dx.doi.org/10.1038/86948			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279528				2022-12-27	WOS:000167811200021
J	Lefebvre, L; Dionne, N; Karaskova, J; Squire, JA; Nagy, A				Lefebvre, L; Dionne, N; Karaskova, J; Squire, JA; Nagy, A			Selection for transgene homozygosity in embryonic stem cells results in extensive loss of heterozygosity	NATURE GENETICS			English	Letter							MICE; LACKING; ALLELE	Embryonic stem cells offer unprecedented opportunities for random or targeted genome alterations in the mouse. We present here an efficient strategy to create chromosome-specific loss of heterozygosity in embryonic stem cells. The combination of this method with genome-wide mutagenesis in ES cells (using chemical mutagens or gene-trap vectors) opens up the possibility for in vitro or in vivo functional screening of recessive mutations in the mouse.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Lefebvre, L (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.		Squire, Jeremy A/A-9352-2012; Nagy, Andras/G-6465-2013	Squire, Jeremy A/0000-0002-9863-468X; Nagy, Andras/0000-0003-4311-0413				ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen YJ, 2000, NAT GENET, V24, P314, DOI 10.1038/73557; Dufort D, 1998, DEVELOPMENT, V125, P3015; Festing MFW, 1999, MAMM GENOME, V10, P836, DOI 10.1007/s003359901099; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Munroe RJ, 2000, NAT GENET, V24, P318, DOI 10.1038/73563; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; PALUDAN K, 1989, GENE, V85, P421, DOI 10.1016/0378-1119(89)90435-6; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Robinson WP, 2000, BIOESSAYS, V22, P452; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Threadgill DW, 1997, MAMM GENOME, V8, P390, DOI 10.1007/s003359900453	15	36	39	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					257	258		10.1038/85808	http://dx.doi.org/10.1038/85808			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242104				2022-12-27	WOS:000167304200014
J	Bussemaker, HJ; Li, H; Siggia, ED				Bussemaker, HJ; Li, H; Siggia, ED			Regulatory element detection using correlation with expression	NATURE GENETICS			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATOR; CELL-CYCLE; GENOME; PATTERNS; SEQUENCE; PROTEIN; HYBRIDIZATION; MICROARRAY	We present here a new computational method for discovering cis-regulatory elements that circumvents the need to cluster genes based on their expression profiles. Based on a model in which upstream motifs contribute additively to the log-expression level of a gene, this method requires a single genome-wide set of expression ratios and the upstream sequence for each gene, and outputs statistically significant motifs. Analysis of publicly available expression data for Saccharomyces cerevisiae reveals several new putative regulatory elements, some of which plausibly control the early, transient induction of genes during sporulation. Known motifs generally have high statistical significance.	Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University	Bussemaker, HJ (corresponding author), Univ Amsterdam, Amsterdam Ctr Computat Sci, Swammerdam Inst Life Sci, Kruislaan 403, Amsterdam, Netherlands.							Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DELLASETA F, 1990, MOL CELL BIOL, V10, P2437, DOI 10.1128/MCB.10.5.2437; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; HALFTER H, 1989, EMBO J, V8, P4265, DOI 10.1002/j.1460-2075.1989.tb08612.x; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; MAGASANIK B, 1992, MOL CELLULAR BIOL YE, V2, P283; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Ptashne M, 1998, CURR BIOL, V8, pR897; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484	24	509	526	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					167	171		10.1038/84792	http://dx.doi.org/10.1038/84792			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175784				2022-12-27	WOS:000166839200017
J	Johnson, KR; Zheng, QY; Bykhovskaya, Y; Spirina, O; Fischel-Ghodsian, N				Johnson, KR; Zheng, QY; Bykhovskaya, Y; Spirina, O; Fischel-Ghodsian, N			A nuclear-mitochondrial DNA interaction affecting hearing impairment in mice	NATURE GENETICS			English	Article							RIBOSOMAL-RNA MUTATION; NON-SYNDROMIC DEAFNESS; MOUSE; GENE; STRAINS; PHENOTYPE	The pathophysiologic pathways and clinical expression of mitochondrial DNA (mtDNA) mutations are not well understood. This is mainly the result of the heteroplasmic nature of most pathogenic mtDNA mutations and of the absence of clinically relevant animal models with mtDNA mutations, mtDNA mutations predisposing to hearing impairment in humans are generally homoplasmic, yet some individuals with these mutations have severe hearing loss, whereas their maternal relatives with the identical mtDNA mutation have normal hearing(1,2). Epidemiologic, biochemical and genetic data indicate that nuclear genes are often the main determinants of these differences in phenotype(3-5). To identify a mouse model for maternally inherited hearing loss, we screened reciprocal backcrosses of three inbred mouse strains, A/J. NOD/LtJ and SKH2/J, with age-related hearing loss (AHL). In the (A/JxCAST/Ei)xA/J backcross. mtDNA derived from the A/J strain exerted a significant detrimental effect on hearing when compared with mtDNA from the CAST/Ei strain. This effect was not seen in the (NOD/LtJ xCAST/Ei)xNOD/LtJ and (SKH2/JxCAST/Ei)xSKH2/J backcrosses. Genotyping revealed that this effect was seen only in mice homozygous for the A/J allele at the Ahl locus on mouse chromosome 10. Sequencing of the mitochondrial genome in the three inbred strains revealed a single nucleotide insertion in the fRNA-Arg gene (mt-Tr) as the probable mediator of the mitochondrial effect. This is the first mouse model with a naturally occurring mtDNA mutation affecting a clinical phenotype, and it provides an experimental model to dissect the pathophysiologic processes connecting mtDNA mutations to hearing loss.	Jackson Lab, Bar Harbor, ME 04609 USA; Cedars Sinai Med Ctr, Ahmanson Dept Pediat,Burns & Allen Res Inst, Steven Spielberg Pediat Res Ctr, Ctr Med Genet Birth Defects, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Jackson Laboratory; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fischel-Ghodsian, N (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.		Zheng, Qing/C-1731-2012		NIDCD NIH HHS [R01 DC004301-01, R01 DC005827, R01 DC001402, R01 DC005827-01, R03 DC004376-01A1, R01 DC004092-01, R01 DC001402-07, R01 DC004301] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001402, R01DC004092, R03DC004376, R01DC005827, R01DC004301] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAL U, 1997, AM J OTOL, V18, P449; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Bryda EC, 1997, MAMM GENOME, V8, P1, DOI 10.1007/s003359900336; Bykhovskaya Y, 2000, AM J HUM GENET, V66, P1905, DOI 10.1086/302914; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; DEOL MS, 1956, PROC R SOC SER B-BIO, V145, P206, DOI 10.1098/rspb.1956.0028; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; Fischel-Ghodsian N, 1998, MOL GENET METAB, V65, P97, DOI 10.1006/mgme.1998.2751; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; FischelGhodsian N, 1997, HEARING RES, V110, P147, DOI 10.1016/S0378-5955(97)00077-4; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86; Johnson KR, 2000, GENOMICS, V70, P171, DOI 10.1006/geno.2000.6377; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955; LI HS, 1994, ORL J OTO-RHINO-LARY, V56, P61, DOI 10.1159/000276611; Liu W, 1999, BBA-GEN SUBJECTS, V1473, P356, DOI 10.1016/S0304-4165(99)00143-9; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; SLIGH JE, 2000, AM J HUM GENET S2, V67, pA53; Spongr VP, 1997, J ACOUST SOC AM, V101, P3546, DOI 10.1121/1.418315; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; WAYNE S, 1996, HUM MOL GENET, V10, P1689; Willott JF, 1998, HEARING RES, V119, P27, DOI 10.1016/S0378-5955(98)00029-X; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	30	127	135	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					191	194		10.1038/84831	http://dx.doi.org/10.1038/84831			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175788	Green Accepted			2022-12-27	WOS:000166839200021
J	Zhang, XH; Zhao, J; Li, CF; Gao, S; Qiu, CC; Liu, P; Wu, GY; Qiang, BQ; Lo, WHY; Shen, Y				Zhang, XH; Zhao, J; Li, CF; Gao, S; Qiu, CC; Liu, P; Wu, GY; Qiang, BQ; Lo, WHY; Shen, Y			DSPP mutation in dentinogenesis imperfecta Shields type II	NATURE GENETICS			English	Article							GENOMIC ORGANIZATION; DENTIN PHOSPHOPROTEIN; CAUSATIVE ROLE; LOCUS; GENE; SIALOPROTEIN; PATHOGENESIS; EXCLUSION; SEQUENCE	We identified a nonsense mutation (Gln45stop) in exon 3 of the dentin sialophospho-protein (DSPP) gene in a Chinese family with dentinogenesis imperfecta Shields type II(DGI-II), in which the affected members showed discoloration and severe attrition of their teeth, with obliterated pulp chambers.	Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing, Peoples R China; Tianjin Univ, Stomatol Hosp, Tianjin 300072, Peoples R China; Natl Ctr Human Genome Res, Beijing 100176, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tianjin University	Shen, Y (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing, Peoples R China.							Aplin HM, 1999, J DENT RES, V78, P1270, DOI 10.1177/00220345990780061201; Butler WT, 1998, EUR J ORAL SCI, V106, P204, DOI 10.1111/j.1600-0722.1998.tb02177.x; CROSBY AH, 1995, AM J HUM GENET, V57, P832; Crosby AH, 1996, MAMM GENOME, V7, P149, DOI 10.1007/s003359900037; CROSBY AH, 1995, GENOMICS, V27, P155, DOI 10.1006/geno.1995.1018; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Gu K, 2000, EUR J ORAL SCI, V108, P35, DOI 10.1034/j.1600-0722.2000.00765.x; Hirst KL, 1997, GENOMICS, V42, P38, DOI 10.1006/geno.1997.4700; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; TAKAGI Y, 1986, J ORAL PATHOL MED, V15, P463, DOI 10.1111/j.1600-0714.1986.tb00659.x; VELS A, 1998, EUR J ORAL SCI, V106, P234; WITKOP C J, 1957, Acta Genet Stat Med, V7, P236	12	211	243	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					151	152		10.1038/84765	http://dx.doi.org/10.1038/84765			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175779				2022-12-27	WOS:000166839200012
J	Luo, GB; Santoro, IM; McDaniel, LD; Nishijima, I; Mills, M; Youssoufian, H; Vogel, H; Schultz, RA; Bradley, A				Luo, GB; Santoro, IM; McDaniel, LD; Nishijima, I; Mills, M; Youssoufian, H; Vogel, H; Schultz, RA; Bradley, A			Cancer predisposition caused by elevated mitotic recombination in Bloom mice	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; WERNERS-SYNDROME GENES; INTESTINAL ADENOMAS; RECQ FAMILY; HELICASE; CLONING; MOUSE; HOMOLOG; LOCALIZATION; DISRUPTION	Bloom syndrome is a disorder associated with genomic instability that causes affected people to be prone to cancer. Bloom cell lines show increased sister chromatid exchange, yet are proficient in the repair of various DNA lesions. The underlying cause of this disease are mutations in a gene encoding a RECQ DNA helicase. Using embryonic stem cell technology, we have generated viable Bloom mice that are prone to a wide variety of cancers. Cell lines from these mice show elevations in the rates of mitotic recombination. We demonstrate that the increased rate of loss of heterozygosity (LOH) resulting from mitotic recombination in vivo constitutes the underlying mechanism causing tumour susceptibility in these mice.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bradley, A (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge, England.			Bradley, Allan/0000-0002-2349-8839; Vogel, Otto Hannes/0000-0002-0960-3508				Abuin A, 1996, MOL CELL BIOL, V16, P1851; Bilger A, 1996, SEMIN CANCER BIOL, V7, P249, DOI 10.1006/scbi.1996.0033; Chakraverty RK, 1999, BIOESSAYS, V21, P286; Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382; COLLET B, 1995, INTERNET WORLD, V6, P8; Davey S, 1998, MOL CELL BIOL, V18, P2721, DOI 10.1128/MCB.18.5.2721; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GERMAN J, 1994, CURRENT PROTOCOLS HU; Gharibyan V, 1999, MOL CARCINOGEN, V26, P261, DOI 10.1002/(SICI)1098-2744(199912)26:4<261::AID-MC5>3.0.CO;2-A; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; HASTY P, 1991, MOL CELL BIOL, V11, P4509, DOI 10.1128/MCB.11.9.4509; Jacoby RF, 1996, CANCER RES, V56, P710; Jones SN, 1996, P NATL ACAD SCI USA, V93, P14106, DOI 10.1073/pnas.93.24.14106; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; LUONGO C, 1994, CANCER RES, V54, P5947; Luria SE, 1943, GENETICS, V28, P491; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Watt PM, 1996, GENETICS, V144, P935; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	34	319	335	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					424	429		10.1038/82548	http://dx.doi.org/10.1038/82548			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101838				2022-12-27	WOS:000165671700013
J	Martinez-Botas, J; Anderson, JB; Tessier, D; Lapillonne, A; Chang, BHJ; Quast, MJ; Gorenstein, D; Chen, KH; Chan, L				Martinez-Botas, J; Anderson, JB; Tessier, D; Lapillonne, A; Chang, BHJ; Quast, MJ; Gorenstein, D; Chen, KH; Chan, L			Absence of perilipin results in leanness and reverses obesity in Lepr db db mice	NATURE GENETICS			English	Article							HORMONE-SENSITIVE LIPASE; NEUTRAL LIPID DROPLETS; ADIPOSE-TISSUE; ADIPOCYTES; RECEPTOR; PROTEINS; CELLS; GENE	Obesity is a disorder of energy balance(1). Hormone-sensitive lipase (HSL) mediates the hydrolysis of triacylglycerol(2). the major form of stored energy in the body. Perilipin (encoded by the gene Plin), an adipocyte protein, has been postulated to modulate HSL activity(3-5). We show here that targeted disruption of Plin results in healthy mice that have constitutively activated fat-cell HSL. Plin(-/-) mice consume more food than control mice, but have normal body weight. They are much leaner and more muscular than controls, have 62% smaller white adipocytes, show elevated basal lipolysis that is resistant to beta -adrenergic agonist stimulation, and are cold-sensitive except when fed. They are also resistant to diet-induced obesity. Breeding the Plin(-/-) alleles into Lepr(db/db) mice reverses the obesity by increasing the metabolic rate of the mice. Our results demonstrate a role for perilipin in mining in basal HSL activity and regulating lipolysis and energy balance; thus, agents that inactivate perilipin may prove useful as anti-obesity medications.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; ARS, USDA, Childrens Nutr Res Ctr, Houston, TX USA; Univ Texas, Med Branch, Inst Marine Biomed, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Radiol, Galveston, TX 77550 USA; Univ Texas, Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77550 USA	Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Chan, L (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.		Martinez-Botas, Javier/AAD-8733-2021	Martinez-Botas, Javier/0000-0002-5190-3619	NHLBI NIH HHS [HL-51586] Funding Source: Medline; NIEHS NIH HHS [ES-06676] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Anand A, 2000, NAT GENET, V24, P377, DOI 10.1038/74207; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Holm C, 1997, METHOD ENZYMOL, V286, P45; LONDOS C, 1995, BIOCHEM SOC T, V23, P611, DOI 10.1042/bst0230611; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; MUZZIN P, 1991, J BIOL CHEM, V266, P24053; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; YEAMAN SJ, 1990, BIOCHIM BIOPHYS ACTA, V1052, P128, DOI 10.1016/0167-4889(90)90067-N	15	465	485	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					474	479		10.1038/82630	http://dx.doi.org/10.1038/82630			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101849				2022-12-27	WOS:000165671700024
J	Tsoka, S; Ouzounis, CA				Tsoka, S; Ouzounis, CA			Prediction of protein interactions: metabolic enzymes are frequently involved in gene fusion	NATURE GENETICS			English	Article							GENOME		EMBL, European Bioinformat Inst, Res Programme, Computat Genom Grp,Cambridge Outstation, Cambridge, England	European Molecular Biology Laboratory (EMBL)	Ouzounis, CA (corresponding author), EMBL, European Bioinformat Inst, Res Programme, Computat Genom Grp,Cambridge Outstation, Cambridge, England.		Ouzounis, Christos A/G-2302-2010	Ouzounis, Christos A/0000-0002-0086-8657; Tsoka, Sophia/0000-0001-8403-1282				Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bulow L, 1990, Biochem Soc Symp, V57, P123; Doolittle RF, 1999, NAT GENET, V23, P6, DOI 10.1038/12597; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Karp PD, 1999, NUCLEIC ACIDS RES, V27, P55, DOI 10.1093/nar/27.1.55; Karp PP, 1999, TRENDS BIOTECHNOL, V17, P275, DOI 10.1016/S0167-7799(99)01316-5; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Sali A, 1999, NATURE, V402, P23, DOI 10.1038/46915	10	54	56	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					141	142		10.1038/79847	http://dx.doi.org/10.1038/79847			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017064				2022-12-27	WOS:000089638800006
J	Collin, GB; Marshall, JD; Ikeda, A; So, WV; Russell-Eggitt, I; Maffei, P; Beck, S; Boerkoel, CF; Sicolo, N; Martin, M; Nishina, PM; Naggert, JK				Collin, GB; Marshall, JD; Ikeda, A; So, WV; Russell-Eggitt, I; Maffei, P; Beck, S; Boerkoel, CF; Sicolo, N; Martin, M; Nishina, PM; Naggert, JK			Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; NATURAL-HISTORY; GENE; INHERITANCE; DYSFUNCTION; DISORDER; LINKAGE; FAMILY	Alstrom syndrome is a homogeneous autosomal recessive disorder that is characterized by childhood obesity associated with hyperinsulinemia, chronic hyperglycemia and neurosensory deficits(1,2). The gene involved in Alstrom syndrome probably interacts with genetic modifiers, as subsets of affected individuals present with additional features such as dilated cardiomyopathy(3), hepatic dysfunction(4), hypothyroidism(5), male hypogonadism, short stature and mild to moderate developmental delay, and with secondary complications normally associated with type 2 diabetes, such as hyperlipidemia and atherosclerosis. Our detection of an uncharacterized transcript, KIAA0328, led us to identify the gene ALMS1, which contains sequence variations, including four frameshift mutations and two nonsense mutations, that segregate with Alstrom syndrome in six unrelated families. ALMS1 is ubiquitously expressed at low levels and does not share significant sequence homology with other genes reported so far. The identification of ALMS1 provides an entry point into a new pathway leading toward the understanding of both Alstrom syndrome and the common diseases that characterize it.	Jackson Lab, Bar Harbor, ME 04609 USA; Hoffmann La Roche Inc, Computat Genom & Genet, Nutley, NJ 07110 USA; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Univ Padua, Ist Semeiot Med, I-35100 Padua, Italy; Inst Nacl Saude, Lisbon, Portugal; Baylor Coll Med, Houston, TX 77030 USA	Jackson Laboratory; Roche Holding; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Padua; Instituto Nacional de Saude Dr. Ricardo Jorge; Baylor College of Medicine	Naggert, JK (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	jkn@jax.org	Boerkoel, Cornelius Franciscus/AFW-4948-2022; Maffei, Pietro/O-1878-2013	Boerkoel, Cornelius Franciscus/0000-0003-3097-241X; Maffei, Pietro/0000-0002-1717-263X; Ikeda, Akihiro/0000-0001-8440-3891				Alstrom CH, 1959, ACTA PSYCHIAT S S129, V34, P1; CHARLES SJ, 1990, J MED GENET, V27, P590, DOI 10.1136/jmg.27.9.590; Collin GB, 1999, HUM GENET, V105, P474, DOI 10.1007/s004390051133; Collin GB, 1996, GENOMICS, V37, P125, DOI 10.1006/geno.1996.0529; Collin GB, 1997, HUM MOL GENET, V6, P213, DOI 10.1093/hmg/6.2.213; CONNOLLY MB, 1991, AM J MED GENET, V40, P421, DOI 10.1002/ajmg.1320400408; Froguel P, 2001, RECENT PROG HORM RES, V56, P91, DOI 10.1210/rp.56.1.91; GOLDSTEIN JL, 1973, MEDICINE, V52, P53, DOI 10.1097/00005792-197301000-00003; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Inui A, 1999, TRENDS NEUROSCI, V22, P62, DOI 10.1016/S0166-2236(98)01292-2; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; Macari F, 1998, HUM GENET, V103, P658, DOI 10.1007/s004390050887; Marshall JD, 1997, AM J MED GENET, V73, P150, DOI 10.1002/(SICI)1096-8628(19971212)73:2<150::AID-AJMG9>3.0.CO;2-Y; Michaud JL, 1996, J PEDIATR-US, V128, P225, DOI 10.1016/S0022-3476(96)70394-3; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Naggert J, 1997, CURR OPIN GENET DEV, V7, P398, DOI 10.1016/S0959-437X(97)80155-4; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Nishina PM, 1998, GENOMICS, V54, P215, DOI 10.1006/geno.1998.5567; Rastogi P A, 2000, Methods Mol Biol, V132, P47; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116	22	257	271	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					74	78		10.1038/ng867	http://dx.doi.org/10.1038/ng867			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11941369	Bronze			2022-12-27	WOS:000175362500018
J	Mears, AJ; Kondo, M; Swain, PK; Takada, Y; Bush, RA; Saunders, TL; Sieving, PA; Swaroop, A				Mears, AJ; Kondo, M; Swain, PK; Takada, Y; Bush, RA; Saunders, TL; Sieving, PA; Swaroop, A			Nrl is required for rod photoreceptor development	NATURE GENETICS			English	Article							CELL-FATE DETERMINATION; LEUCINE-ZIPPER; PROTEIN; DEGENERATION; RECEPTOR; RETINA; GENE; CRX; HOMEODOMAIN; DISRUPTION	The protein neural retina leucine zipper (Nrl) is a basic motif-leucine zipper transcription factor that is preferentially expressed in rod photoreceptors(1,2). it acts synergistically with Crx to regulate rhodopsin transcription(3-5). Missense mutations in human NRL have been associated with autosomal dominant retinitis pigmentosa(6,7). Here we report that deletion of Nrl in mice results in the complete loss of rod function and super-normal cone function, mediated by S cones. The photoreceptors in the Nrl(-/-) retina have cone-like nuclear morphology(8) and short, sparse outer segments with abnormal disks. Analysis of retinal gene expression confirms the apparent functional transformation of rods into S cones in the Nrl(-/-) retina. On the basis of these findings, we postulate that Nrl acts as a 'molecular switch' during rod-cell development by directly modulating rod-specific genes while simultaneously inhibiting the S-cone pathway through the activation of Nr2e3.	Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Nagoya Univ, Sch Med, Dept Ophthalmol, Nagoya, Aichi 4668550, Japan; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; NEI, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; Nagoya University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Swaroop, A (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, 1500 E Med Ctr Dr, Ann Arbor, MI 48105 USA.	swaroop@umich.edu		Swaroop, Anand/0000-0002-1975-1141; Saunders, Thom/0000-0003-2015-101X	NATIONAL EYE INSTITUTE [R01EY011115] Funding Source: NIH RePORTER; NEI NIH HHS [EY11115, EY07003] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Coligan JE, 1999, CURRENT PROTOCOLS PR; Fan W, 1996, EXP EYE RES, V63, P9, DOI 10.1006/exer.1996.0086; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HITCHCOCK PF, 1989, J COMP NEUROL, V283, P177, DOI 10.1002/cne.902830203; Trujillo MJ, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<80::AID-HUMU27>3.0.CO;2-G; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Kosaka J, 1998, J NEUROSCI RES, V54, P655, DOI 10.1002/(SICI)1097-4547(19981201)54:5<655::AID-JNR10>3.3.CO;2-Q; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Saari JC, 1997, GLIA, V21, P259; Sambrook J., 2001, MOL CLONING LAB MANU; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; Toda K, 1999, VISUAL NEUROSCI, V16, P391, DOI 10.1017/S0952523899162187; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VERDERBER L, 1995, INVEST OPHTH VIS SCI, V36, P1137; WILLIAMS DS, 1991, BIOESSAYS, V13, P171, DOI 10.1002/bies.950130405; Zhao XY, 1998, J BIOL CHEM, V273, P5124, DOI 10.1074/jbc.273.9.5124	31	701	713	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2001	29	4					447	452		10.1038/ng774	http://dx.doi.org/10.1038/ng774			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11694879				2022-12-27	WOS:000172507500021
J	Wu, Y; Berends, MJW; Sijmons, RH; Mensink, RGJ; Verlind, E; Kooi, KA; van der Sluis, T; Kempinga, C; van der Zee, AGJ; Hollema, H; Buys, CHCM; Kleibeuker, JH; Hofstra, RMW				Wu, Y; Berends, MJW; Sijmons, RH; Mensink, RGJ; Verlind, E; Kooi, KA; van der Sluis, T; Kempinga, C; van der Zee, AGJ; Hollema, H; Buys, CHCM; Kleibeuker, JH; Hofstra, RMW			A role for MLH3 in hereditary nonpolyposis colorectal cancer	NATURE GENETICS			English	Article							INTERNATIONAL-COLLABORATIVE-GROUP; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; ICG-HNPCC; MUTATIONS; MUTL	We investigated a possible role of the mismatch-repair gene MLH3 in hereditary nonpolyposis colorectal cancer by scanning for mutations in 39 HNPCC families and in 288 patients suspected of having HNPCC. We identified ten different germline MLH3 variants, one frameshift and nine missense mutations, in 12 patients suspected of HNPCC. Three of the 12 also carried a mutation in MSH6.	Univ Groningen, Dept Med Genet, Groningen, Netherlands; Univ Groningen, Dept Gastroenterol, Groningen, Netherlands; Univ Groningen, Dept Pathol, Groningen, Netherlands; Univ Groningen, Dept Gynecol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Hofstra, RMW (corresponding author), Univ Groningen, Dept Med Genet, Groningen, Netherlands.		Sijmons, Rolf/E-5829-2012	Sijmons, Rolf/0000-0001-8446-2779; Hofstra, Robert/0000-0001-7498-3829				Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Boland CR, 1998, CANCER RES, V58, P5248; Dietmaier W, 1997, CANCER RES, V57, P4749; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Jiricny J, 2000, NAT GENET, V24, P6, DOI 10.1038/71698; Kondo E, 2001, NUCLEIC ACIDS RES, V29, P1695, DOI 10.1093/nar/29.8.1695; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; Park JG, 1999, DIS COLON RECTUM, V42, P710, DOI 10.1007/BF02236922; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612	13	127	133	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					137	138		10.1038/ng1001-137	http://dx.doi.org/10.1038/ng1001-137			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586295				2022-12-27	WOS:000171374100016
J	Yang, Y; Hentati, A; Deng, HX; Dabbagh, O; Sasaki, T; Hirano, M; Hung, WY; Ouahchi, K; Yan, JH; Azim, AC; Cole, N; Gascon, G; Yagmour, A; Ben-Hamida, M; Pericak-Vance, M; Hentati, F; Siddique, T				Yang, Y; Hentati, A; Deng, HX; Dabbagh, O; Sasaki, T; Hirano, M; Hung, WY; Ouahchi, K; Yan, JH; Azim, AC; Cole, N; Gascon, G; Yagmour, A; Ben-Hamida, M; Pericak-Vance, M; Hentati, F; Siddique, T			The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							SUPEROXIDE-DISMUTASE; SPASTIC PARALYSIS; LINKAGE; REGULATOR; HOMOLOGY; FEATURES; COMPLEX; FAMILY; MUTANT; SOD1	Amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS) are neurodegenerative conditions that affect large motor neurons of the central nervous system. We have identified a familial juvenile PLS (JPLS) locus overlapping the previously identified ALS2 locus on chromosome 2q33. We report two deletion mutations in a new gene that are found both in individuals with ALS2 and those with JPLS, indicating that these conditions have a common genetic origin. The predicted sequence of the protein (alsin) may indicate a mechanism for motor-neuron degeneration, as it may include several cell-signaling motifs with known functions, including three associated with guanine-nucleotide exchange factors for GTPases (GEFs).	Northwestern Univ, Sch Med, Dept Neurol, Chicago, IL 60611 USA; King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; Brown Univ, Div Pediat Neurol, Providence, RI 02912 USA; King Fahad Mil Hosp, Jeddah, Saudi Arabia; Inst Neurol, Tunis, Tunisia; Duke Univ, Med Ctr, Durham, NC USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA	Northwestern University; King Faisal Specialist Hospital & Research Center; Brown University; Universite de Tunis-El-Manar; Institut National de Neurologie; Duke University; Northwestern University; Northwestern University	Siddique, T (corresponding author), Northwestern Univ, Sch Med, Dept Neurol, Chicago, IL 60611 USA.	t-siddique@northwestern.edu	AZIM, ANSER/U-3483-2019; Siddique, Teepu/AAT-8166-2021	Siddique, Teepu/0000-0001-7293-9146; Deng, Han-Xiang/0000-0002-0030-8465	NINDS NIH HHS [R01 NS40308, R01 NS37912, P01 NS21442] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037912, R01NS040308, P01NS021442] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATWATER JA, 1990, ANNU REV GENET, V24, P519; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BEAL MF, 1981, ARCH NEUROL-CHICAGO, V38, P630, DOI 10.1001/archneur.1981.00510100058008; BENHAMIDA M, 1990, BRAIN, V113, P347; Brown RH, 1998, NAT MED, V4, P1362, DOI 10.1038/3945; BROWN WF, 1992, MUSCLE NERVE, V15, P626, DOI 10.1002/mus.880150515; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Charcot J-M, 1865, B SOC MED HOP PAR S2, V10, P24; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; den Dunnen JT, 2000, HUM MUTAT, V15, P7; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DENG HX, 1992, HUM GENET, V89, P13, DOI 10.1007/BF00207034; Deng HX, 2000, ARCH NEUROL-CHICAGO, V57, P1695, DOI 10.1001/archneur.57.12.1695; *EL ESC WORLD FED, 1994, J NEUROL SCI S, V124, P96; Erb WH, 1875, BERLINER KLIN WOCHEN, V12, P357; FISHER CM, 1977, CAN J NEUROL SCI, V4, P251, DOI 10.1017/S0317167100025075; Gascon GG, 1995, NEUROPEDIATRICS, V26, P313, DOI 10.1055/s-2007-979781; GRUNNET ML, 1989, NEUROLOGY, V39, P1530, DOI 10.1212/WNL.39.11.1530; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Heene R, 1996, FORTSCHR NEUROL PSYC, V64, P192, DOI 10.1055/s-2007-996385; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; HUDSON AJ, 1993, BRAIN RES BULL, V30, P359, DOI 10.1016/0361-9230(93)90265-D; Kahana JA, 2001, SCIENCE, V291, P1718, DOI 10.1126/science.1059765; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; LermanSagie T, 1996, J CHILD NEUROL, V11, P54, DOI 10.1177/088307389601100114; Mourelatos Z, 1996, P NATL ACAD SCI USA, V93, P5472, DOI 10.1073/pnas.93.11.5472; OTT J, 1991, ANAL HUMAN GENETIC L, P194; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; PRINGLE CE, 1992, BRAIN, V115, P495, DOI 10.1093/brain/115.2.495; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Rosa JL, 1997, ONCOGENE, V15, P1, DOI 10.1038/sj.onc.1201170; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; RUSSO LS, 1982, ARCH NEUROL-CHICAGO, V39, P662, DOI 10.1001/archneur.1982.00510220060015; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHOSHANI T, 1994, J CLIN INVEST, V93, P1502, DOI 10.1172/JCI117128; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; SOTANIEMI KA, 1985, ACTA NEUROL SCAND, V71, P334; STARK FM, 1945, J NERV MENT DIS, V102, P332, DOI 10.1097/00005053-194510000-00002; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Yan D, 1998, J BIOL CHEM, V273, P19656, DOI 10.1074/jbc.273.31.19656; YOUNGER DS, 1988, ARCH NEUROL-CHICAGO, V45, P1304, DOI 10.1001/archneur.1988.00520360022005	50	562	584	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2001	29	2					160	165		10.1038/ng1001-160	http://dx.doi.org/10.1038/ng1001-160			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586297				2022-12-27	WOS:000171374100021
J	Cleary, MA; van Raamsdonk, CD; Levorse, J; Zheng, BH; Bradley, A; Tilghman, SM				Cleary, MA; van Raamsdonk, CD; Levorse, J; Zheng, BH; Bradley, A; Tilghman, SM			Disruption of an imprinted gene cluster by a targeted chromosomal translocation in mice	NATURE GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; EMBRYONIC STEM-CELLS; MOUSE; P57(KIP2); SEQUENCE; 11P15.5; DOMAIN; REGION; KVLQT1; DIFFERENTIATION	Genomic imprinting is an epigenetic process in which the activity of a gene is determined by its parent of origin. Mechanisms governing genomic imprinting are just beginning to be understood. However, the tendency of imprinted genes to exist in chromosomal clusters suggests a sharing of regulatory elements. To better understand imprinted gene clustering, we disrupted a cluster of imprinted genes on mouse distal chromosome 7 using the Cre/loxP recombination system. In mice carrying a site-specific translocation separating Cdkn1c and Kcnq1, imprinting of the genes retained on chromosome 7, including Kcnq1, Kcnq1ot1, Ascl2, H19 and lgf2, is unaffected, demonstrating that these genes are not regulated by elements near or telomeric to Cdkn1c. In contrast, expression and imprinting of the translocated Cdkn1c, Slc22a1l and Tssc3 on chromosome 11 are affected, consistent with the hypothesis that elements regulating both expression and imprinting of these genes lie within or proximal to Kcnq1. These data support the proposal that chromosomal abnormalities, including translocations, within KCNQ1 that are associated with the human disease Beckwith-Wiedemann syndrome (BWS) may disrupt CDKN1C expression. These results underscore the importance of gene clustering for the proper regulation of imprinted genes.	Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Sanger Ctr, Cambridge, England	Howard Hughes Medical Institute; Princeton University; Princeton University; Stanford University; University of California System; University of California San Francisco; Wellcome Trust Sanger Institute	Tilghman, SM (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.		Van Raamsdonk, Catherine D./B-6207-2017	Van Raamsdonk, Catherine D./0000-0002-4309-3513; Bradley, Allan/0000-0002-2349-8839				BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Brown LS, 1996, WOMEN THER, V19, P5, DOI 10.1300/J015v19n01_02; Casimiro MC, 2001, P NATL ACAD SCI USA, V98, P2526, DOI 10.1073/pnas.041398998; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; Cooper PR, 1998, GENOMICS, V49, P38, DOI 10.1006/geno.1998.5221; Dao D, 1998, HUM MOL GENET, V7, P597, DOI 10.1093/hmg/7.4.597; Hatada I, 1996, NAT GENET, V14, P171, DOI 10.1038/ng1096-171; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Lee MP, 1997, AM J HUM GENET, V61, P304, DOI 10.1086/514858; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Mitsuya K, 1999, HUM MOL GENET, V8, P1209, DOI 10.1093/hmg/8.7.1209; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; OKeefe D, 1997, AM J HUM GENET, V61, P295, DOI 10.1086/514854; Onyango P, 2000, GENOME RES, V10, P1697, DOI 10.1101/gr.161800; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Qian N, 1997, HUM MOL GENET, V6, P2021, DOI 10.1093/hmg/6.12.2021; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; ROBERTSON EJ, 1987, TERATOCARCINOMAS EMB, P108; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Thorvaldsen JL, 2000, SCIENCE, V288, P2145, DOI 10.1126/science.288.5474.2145; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; VAN DJ, 1995, P NATL ACAD SCI USA, V92, P7376; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yatsuki H, 2000, DNA RES, V7, P195, DOI 10.1093/dnares/7.3.195; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000	30	46	52	1	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					78	82		10.1038/ng715	http://dx.doi.org/10.1038/ng715			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528397				2022-12-27	WOS:000170781300022
J	Grohmann, K; Schuelke, M; Diers, A; Hoffmann, K; Lucke, B; Adams, C; Bertini, E; Leonhardt-Horti, H; Muntoni, F; Ouvrier, R; Pfeufer, A; Rossi, R; Van Maldergem, L; Wilmshurst, JM; Wienker, TR; Sendtner, M; Rudnik-Schoneborn, S; Zerres, K; Hubner, C				Grohmann, K; Schuelke, M; Diers, A; Hoffmann, K; Lucke, B; Adams, C; Bertini, E; Leonhardt-Horti, H; Muntoni, F; Ouvrier, R; Pfeufer, A; Rossi, R; Van Maldergem, L; Wilmshurst, JM; Wienker, TR; Sendtner, M; Rudnik-Schoneborn, S; Zerres, K; Hubner, C			Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1	NATURE GENETICS			English	Article							SURVIVAL MOTOR-NEURON; DEAD BOX PROTEIN; HUMAN S-MU-BP-2; SMN GENE; COMPLEX; IDENTIFICATION; TRANSCRIPTION; DEGENERATION; HELICASE; PROMOTER	Classic spinal muscular atrophy (SMA) is caused by mutations in the telomeric copy of SMN1. Its product is involved in various cellular processes, including cytoplasmic assembly of spliceosomal small nuclear ribonucleoproteins, pre-mRNA processing and activation of transcription(1-8). Spinal muscular atrophy with respiratory distress (SMARD) is clinically and genetically distinct from SMA(9-13). Here we demonstrate that SMARD type 1 (SMARD1) results from mutations in the gene encoding immunoglobulin mu -binding protein 2 (IGHMBP2; on chromosome 11q13.2-q13.4). In six SMARD1 families, we detected three recessive missense mutations (exons 5, 11 and 12), two nonsense mutations (exons 2 and 5), one frameshift deletion (exon 5) and one splice donor-site mutation (intron 13). Mutations in mouse Ighmbp2 (ref. 14) have been shown to be responsible for spinal muscular atrophy in the neuromuscular degeneration (nmd) mouse(15), whose phenotype resembles the SMARD1 phenotype. Like the SMN1 product, IGHMBP2 colocalizes with the RNA-processing machinery in both the cytoplasm and the nucleus(16-19). Our results show that IGHMBP2 is the second gene found to be defective in spinal muscular atrophy, and indicate that IGHMBP2 and SMN share common functions important for motor neuron maintenance and integrity in mammals.	Humboldt Univ, Charite, Dept Neuropediat, D-13353 Berlin, Germany; Max Delbrueck Ctr Mol Med, Gene Mapping Ctr, D-13092 Berlin, Germany; Univ Calgary, Alberta Childrens Hosp, Div Pediat Neurol, Calgary, AB T2T 5C7, Canada; Bambino Gesu Pediat Hosp, Dept Neurosci, I-00165 Rome, Italy; Bambino Gesu Pediat Hosp, Mol Med Unit, I-00165 Rome, Italy; Childrens Hosp, D-63069 Offenbach, Germany; Hammersmith Hosp, Dept Paediat, London W12 0HS, England; Childrens Hosp Westmead, Inst Neuromuscular Res, Parramatta, NSW 2124, Australia; GSF Res Inst, Inst Human Genet, D-85764 Neuherberg, Germany; Childrens Hosp Neukolln, D-12051 Berlin, Germany; Inst Pathol & Genet, Ctr Genet Humaine, B-6280 Loveral, Belgium; Univ Bonn, Inst Med Biometry, D-53105 Bonn, Germany; Univ Wurzburg, Inst Clin Neurobiol, D-97080 Wurzburg, Germany; Rhein Westfal TH Aachen, Dept Human Genet, D-52074 Aachen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Alberta Childrens Hospital; University of Calgary; IRCCS Bambino Gesu; IRCCS Bambino Gesu; Imperial College London; University of Sydney; University of Bonn; University of Wurzburg; RWTH Aachen University	Hubner, C (corresponding author), Humboldt Univ, Charite, Dept Neuropediat, Campus Virchow Klinikum, D-13353 Berlin, Germany.		Pfeufer, Arne/B-6634-2013; Bertini, Enrico/ABG-1278-2020; Bertini, Enrico/A-2284-2014; Van Maldergem, Lionel/O-3242-2019; Van Maldergem, Lionel/G-9849-2017; Sendtner, Michael/J-1542-2012; Rudnik-Schöneborn, Sabine/F-8473-2015; Sendtner, Michael/M-8137-2014	Bertini, Enrico/0000-0001-9276-4590; Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; Wilmshurst, Jo/0000-0001-7328-1796; Schuelke, Markus/0000-0003-2824-3891				BERTINI E, 1989, AM J MED GENET, V33, P328, DOI 10.1002/ajmg.1320330309; Campbell L, 2000, HUM MOL GENET, V9, P1093, DOI 10.1093/hmg/9.7.1093; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Chen NN, 1997, GENE, V185, P55, DOI 10.1016/S0378-1119(96)00630-0; COOK SA, 1995, MAMM GENOME, V6, P187, DOI 10.1007/BF00293010; Cox GA, 1998, NEURON, V21, P1327, DOI 10.1016/S0896-6273(00)80652-2; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; FUKITA Y, 1993, J BIOL CHEM, V268, P17463; Grishin NV, 1998, TRENDS BIOCHEM SCI, V23, P329, DOI 10.1016/S0968-0004(98)01258-4; Grohmann K, 1999, AM J HUM GENET, V65, P1459, DOI 10.1086/302636; Grundhoff AT, 1999, J BIOL CHEM, V274, P19136, DOI 10.1074/jbc.274.27.19136; Jablonka S, 2001, HUM MOL GENET, V10, P497, DOI 10.1093/hmg/10.5.497; Lefebvre S, 1998, HUM MOL GENET, V7, P1531, DOI 10.1093/hmg/7.10.1531; Lorson CL, 1998, HUM MOL GENET, V7, P1269, DOI 10.1093/hmg/7.8.1269; McEntagart M, 2001, AM J HUM GENET, V68, P1270, DOI 10.1086/320122; Meister G, 2000, HUM MOL GENET, V9, P1977, DOI 10.1093/hmg/9.13.1977; MELLINS RB, 1974, PEDIATRICS, V53, P33; Miao M, 2000, EUR J BIOCHEM, V267, P7237, DOI 10.1046/j.1432-1327.2000.01836.x; MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761; Mohan WS, 1998, J LIPID RES, V39, P255; Molnar GM, 1997, P NATL ACAD SCI USA, V94, P7831, DOI 10.1073/pnas.94.15.7831; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; RudnikSchoneborn S, 1996, NEUROPEDIATRICS, V27, P8, DOI 10.1055/s-2007-973741; Strasswimmer J, 1999, HUM MOL GENET, V8, P1219, DOI 10.1093/hmg/8.7.1219; Wilmshurst JM, 2001, MUSCLE NERVE, V24, P760, DOI 10.1002/mus.1067; Zerres K, 1999, Neuromuscul Disord, V9, P272, DOI 10.1016/S0960-8966(99)00016-4; Zhang Q, 1999, VIROLOGY, V255, P160, DOI 10.1006/viro.1998.9588	27	249	255	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					75	77		10.1038/ng703	http://dx.doi.org/10.1038/ng703			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528396				2022-12-27	WOS:000170781300021
J	Vorechovsky, I; Kralovicova, J; Tchilian, E; Masterman, T; Zhang, ZP; Ferry, B; Misbah, S; Chapel, H; Webster, D; Hellgren, D; Anvret, M; Hillert, J; Hammarstrom, L; Beverley, PC				Vorechovsky, I; Kralovicova, J; Tchilian, E; Masterman, T; Zhang, ZP; Ferry, B; Misbah, S; Chapel, H; Webster, D; Hellgren, D; Anvret, M; Hillert, J; Hammarstrom, L; Beverley, PC			Does 77C -> G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus?	NATURE GENETICS			English	Article							POINT MUTATION; MULTIPLE-SCLEROSIS; CELL MATURATION; EXON-A; CD45; ANTIGEN; IMMUNODEFICIENCY; ABNORMALITIES; EXPRESSION; SELECTION	A 77G allele of the gene encoding CD45, also known as the protein tyrosine phosphatase receptor-type C gene (PTPRC), has been associated with multiple sclerosis (MS). Here we determine allele frequencies in large numbers of MS patients, primary immunodeficiencies linked to the major histocompatability complex (MHC) locus and over 1,000 controls to assess whether aberrant splicing of PTPRC caused by the 77C-->G polymorphism results in increased susceptibility to these diseases. Our results show no difference in the frequency of the 77G allele in patients and controls and thus do not support a causative role for the polymorphism in the development of disorders with a strong autoimmune component in etiology.	UCL, London, England; NOVUM, Karolinska Inst, Dept Biosci, Stockholm, Sweden; Edward Jenner Inst Vaccine Res, Compton, Berks, England; Huddinge Univ Hosp, Karolinska Inst, Div Neurol, Stockholm, Sweden; Sodertalje, AstraZeneca, Dept Mol Sci, Stockholm, Sweden; John Radcliffe Hosp, Dept Immunol, Oxford OX3 9DU, England	University of London; University College London; Karolinska Institutet; Karolinska Institutet; AstraZeneca; University of Oxford	Vorechovsky, I (corresponding author), UCL, Royal Free Campus, London, England.	igvo@cbt.ki.se	Tchilian, Elma Z/Q-5976-2017; Kralovicova, Jana/AAA-1693-2022	Tchilian, Elma Z/0000-0002-4869-5118; Vorechovsky, Igor/0000-0002-6740-6502; Beverley, Peter/0000-0003-0481-2180				Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Cale CM, 1997, ARCH DIS CHILD, V76, P163, DOI 10.1136/adc.76.2.163; Czyzyk J, 2000, MOL CELL BIOL, V20, P8740, DOI 10.1128/MCB.20.23.8740-8747.2000; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; LEBRANCHU Y, 1991, CLIN IMMUNOL IMMUNOP, V61, P83, DOI 10.1016/S0090-1229(06)80009-7; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; Tchilian EZ, 2001, J IMMUNOL, V166, P6144, DOI 10.4049/jimmunol.166.10.6144; THUDE H, 1995, EUR J IMMUNOL, V25, P2101, DOI 10.1002/eji.1830250745; Trop S, 2000, J IMMUNOL, V165, P3073, DOI 10.4049/jimmunol.165.6.3073; Vorechovsky I, 1999, AM J HUM GENET, V64, P1096, DOI 10.1086/302326; Zilch CF, 1998, EUR J IMMUNOL, V28, P22, DOI 10.1002/(SICI)1521-4141(199801)28:01<22::AID-IMMU22>3.0.CO;2-7	15	50	50	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2001	29	1					22	23		10.1038/ng723	http://dx.doi.org/10.1038/ng723			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11548742				2022-12-27	WOS:000170781300010
J	Martignetti, JA; Al Aqeel, A; Al Sewairi, W; Boumah, CE; Kambouris, M; Al Mayouf, S; Sheth, KV; Al Eid, W; Dowling, O; Harris, J; Glucksman, MJ; Bahabri, S; Meyer, BF; Desnick, RJ				Martignetti, JA; Al Aqeel, A; Al Sewairi, W; Boumah, CE; Kambouris, M; Al Mayouf, S; Sheth, KV; Al Eid, W; Dowling, O; Harris, J; Glucksman, MJ; Bahabri, S; Meyer, BF; Desnick, RJ			Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome	NATURE GENETICS			English	Letter							GELATINASE-A; TISSUE INHIBITOR; IV COLLAGENASE; DOMAIN; ACTIVATION; BINDING; TIMP-2; METALLOPROTEINASE-2; DEGRADATION; MECHANISM	The inherited osteolyses or 'vanishing bone' syndromes are a group of rare disorders of unknown etiology characterized by destruction and resorption of affected bones. The multicentric osteolyses are notable for interphalangeal joint erosions that mimic severe juvenile rheumatoid arthritis (OMIMs 166300. 259600, 259610 and 277950). We recently described an autosomal recessive form of multicentric osteolysis with carpal and tarsal resorption. crippling arthritic changes, marked osteoporosis, palmar and plantar subcutaneous nodules and distinctive facies in a number of consanguineous Saudi Arabian families(1,2). We localized the disease gene to 16q12-21 by using members of these families for a genome-wide search for homozygous-by-descent microsatellite markers. Haplotype analysis narrowed the critical region to a 1.2-cM region that spans the gene encoding MMP-2 (gelatinase A, collagenase type IV; (ref. 3). We detected no MMP2 enzymatic activity in the serum or fibroblasts of affected family members. We identified two family-specific homoallelic MMP2 mutations: R101H and Y244X. The nonsense mutation effects a deletion of the substrate-binding and catalytic sites and the fibronectin type II-like and hemopexin/TIMP2 binding domains. Based on molecular modeling. the missense mutation disrupts hydrogen bond formation within the highly conserved prodomain adjacent to the catalytic zinc ion.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurobiol, Struct Neurobiol & Proteom Lab, New York, NY 10029 USA; Riyadh Armed Forces Hosp, Dept Pediat, Riyadh, Saudi Arabia; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; Yale Univ, Sch Med, New Haven, CT USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Prince Sultan Military Medical City; King Faisal Specialist Hospital & Research Center; Yale University	Martignetti, JA (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, Box 1498,5th Ave & 100th St, New York, NY 10029 USA.	john.martignetti@mssm.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026824, R37DK034045] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00071] Funding Source: Medline; NICHD NIH HHS [5 P30 HD 28822] Funding Source: Medline; NIDDK NIH HHS [5 R01 DK26824, 5 R37 DK34045] Funding Source: Medline; NINDS NIH HHS [R01 NS39893] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Al Aqeel A, 2000, AM J MED GENET, V93, P11, DOI 10.1002/1096-8628(20000703)93:1<11::AID-AJMG3>3.0.CO;2-3; Al-Mayouf SM, 2000, AM J MED GENET, V93, P5, DOI 10.1002/1096-8628(20000703)93:1<5::AID-AJMG2>3.0.CO;2-Y; Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Butler S, 1998, OBJECT ORIENTED SYST, V5, P1; Chen WT, 1996, ENZYME PROTEIN, V49, P59, DOI 10.1159/000468616; Creemers LB, 1998, MATRIX BIOL, V17, P35, DOI 10.1016/S0945-053X(98)90072-5; Everts V, 2000, J BONE MINER RES, V15, pS349; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; HARRIS ED, 1972, BIOCHIM BIOPHYS ACTA, V258, P566, DOI 10.1016/0005-2744(72)90249-5; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; HUHTALA P, 1990, GENOMICS, V6, P554, DOI 10.1016/0888-7543(90)90486-E; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Kanwar YS, 1999, AM J PHYSIOL-RENAL, V277, pF934, DOI 10.1152/ajprenal.1999.277.6.F934; Karelina TV, 2000, J INVEST DERMATOL, V114, P371, DOI 10.1046/j.1523-1747.2000.00886.x; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; MURPHY G, 1992, BIOCHEM J, V283, P637, DOI 10.1042/bj2830637; NGUYEN Q, 1994, BIOCHEMISTRY-US, V33, P2089, DOI 10.1021/bi00174a015; Rutter JL, 1998, CANCER RES, V58, P5321; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P17374; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; YE QZ, 1995, BIOCHEMISTRY-US, V34, P4702, DOI 10.1021/bi00014a026; Ye S, 2000, MATRIX BIOL, V19, P623, DOI 10.1016/S0945-053X(00)00102-5; Yu AE, 1998, BIOL EXTRAC, P85; Zhao WG, 2000, J CLIN INVEST, V106, P941, DOI 10.1172/JCI10158	30	213	223	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					261	265		10.1038/90100	http://dx.doi.org/10.1038/90100			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431697				2022-12-27	WOS:000169656400019
J	Laitinen, T; Daly, MJ; Rioux, JD; Kauppi, P; Laprise, C; Petays, T; Green, T; Cargill, M; Haahtela, T; Lander, ES; Laitinen, LA; Hudson, TJ; Kere, J				Laitinen, T; Daly, MJ; Rioux, JD; Kauppi, P; Laprise, C; Petays, T; Green, T; Cargill, M; Haahtela, T; Lander, ES; Laitinen, LA; Hudson, TJ; Kere, J			A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; DISEASE GENE; SERUM IGE; EXAMPLE; SEARCH	The genetics of asthma and atopy have been difficult to determine because these diseases are genetically heterogeneous and modified by environment. The pedigrees in our study (n=86) originate in eastern central Finland (Kainuu province). According to census records, this region had only 200 households (2,000 inhabitants) in the mid sixteenth to mid seventeenth centuries. The current population of 100.000 represents the expansion of these founders within the past 400 years. Because this population is relatively homogeneous(1,2), we hypothesized that the molecular genetic mechanisms underlying asthma might also have reduced heterogeneity and therefore be easier to dissect than in mixed populations. A recent twin family study supported a strong genetic component for asthma in Finland(3). We carried out a genome-wide scan for susceptibility loci in asthma in the Kainuu subpopulation. We identified two regions of suggestive linkage and studied them further with higher-density mapping. We obtained evidence for linkage in a 20-cM region of chromosome 7p14-p15 for three phenotypes: asthma, a high level of immunoglobulin E (IgE; atopy) and the combination of the phenotypes. The strongest linkage was seen for high serum IgE(non-parametric linkage (NPL) score 3.9, P=0.0001), exceeding the threshold for genome-wide significance based on simulations. We also observed linkage between this locus and asthma or atopy in two independent data sets.	Univ Helsinki, Haartman Inst, Dept Med Genet, FIN-00014 Helsinki, Finland; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Helsinki, Cent Hosp, Dept Pulm Med, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Allergol Dis, Helsinki, Finland; McGill Univ, Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; Chicoutimi Hosp, Chicoutimi, PQ, Canada; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland; MIT, Dept Biol, Cambridge, MA USA; Univ Helsinki, Finnish Genome Ctr, Helsinki, Finland	University of Helsinki; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; McGill University; Finland National Institute for Health & Welfare; Massachusetts Institute of Technology (MIT); University of Helsinki	Laitinen, T (corresponding author), Univ Helsinki, Haartman Inst, Dept Med Genet, FIN-00014 Helsinki, Finland.	tarja.laitinen@helsinki.fi; juha.kere@helsinki.fi	Daly, Mark J/B-2453-2017; Rioux, John D/A-9599-2015; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Hudson, Thomas/0000-0002-1376-4849; Laprise, Catherine/0000-0001-5526-9945				Austerlitz F, 1999, GENET EPIDEMIOL, V16, P2, DOI 10.1002/(SICI)1098-2272(1999)16:1<2::AID-GEPI2>3.0.CO;2-9; BARBEE RA, 1987, J ALLERGY CLIN IMMUN, V79, P919, DOI 10.1016/0091-6749(87)90241-7; CANONICA GW, 1989, ALLERGY, V44, P1, DOI 10.1111/j.1398-9995.1989.tb00438.x; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DANTZKER DR, 1987, AM REV RESPIR DIS, V136, P225; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; DEBRAEKELEER M, 1995, ANN HUM BIOL, V22, P111, DOI 10.1080/03014469500003772; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; GUGLIELMINO CR, 1990, AM J PHYS ANTHROPOL, V83, P57, DOI 10.1002/ajpa.1330830107; Juniper EF, 1991, HISTAMINE METHACHOLI; Kauppi P, 1998, RESP MED, V92, P1281, DOI 10.1016/S0954-6111(98)90229-3; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laitinen T, 1998, AM J RESP CRIT CARE, V157, P1073, DOI 10.1164/ajrccm.157.4.9704041; Laitinen T, 1997, HUM MOL GENET, V6, P2069, DOI 10.1093/hmg/6.12.2069; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Mak TW, 1998, NAT MED, V4, P764, DOI 10.1038/nm0798-764; Marsh DG, 1997, NAT GENET, V15, P389; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Vuorio AF, 1997, ARTERIOSCL THROM VAS, V17, P3127, DOI 10.1161/01.ATV.17.11.3127; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Zuany-Amorim C, 1998, SCIENCE, V280, P1265, DOI 10.1126/science.280.5367.1265	25	152	160	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					87	91		10.1038/ng0501-87	http://dx.doi.org/10.1038/ng0501-87			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326283				2022-12-27	WOS:000168413300023
J	Chen, RZ; Akbarian, S; Tudor, M; Jaenisch, R				Chen, RZ; Akbarian, S; Tudor, M; Jaenisch, R			Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice	NATURE GENETICS			English	Letter							LINKED MENTAL-RETARDATION; HISTONE DEACETYLASE; MECP2; MUTATION; EXPRESSION; BRAIN; GENE; COMPLEX; MALES; MOUSE	Mecp2 is an X-linked gene encoding a nuclear protein that binds specifically to methylated DNA (ref. 1) and functions as a general transcriptional repressor by associating with chromatin-remodeling complexes(2,3) Mecp2 is expressed at high levels in the postnatal brain(1,4), indicating that methylation-dependent regulation of gene expression may have a crucial role in the mammalian central nervous system. Consistent with this notion is the recent demonstration that MECP2 mutations cause Rett syndrome(5-8) (RTT, MIM 312750), a childhood neurological disorder that represents one of the most common causes of mental retardation in females(9-11) Here we show that Mecp2-deficient mice exhibit phenotypes that resemble some of the symptoms of RTT patients. Mecp2-null mice were normal until 5 weeks of age, when they began to develop disease, leading to death between 6 and 12 weeks. Mutant brains showed substantial reduction in both weight and neuronal cell size, but no obvious structural defects or signs of neurodegeneration. Brain-specific deletion of Mecp2 at embryonic day resulted in a phenotype identical to that of the null mutation, indicating that the phenotype is caused by Mecp2 deficiency in the CNS rather than in perpherial tissues. Deletion of Mecp2 in postnatal CNS neurons led to a similar neuronal phenotype, although at a later age. Our results indicate that role of Mecp2 is not restricted to the immature brain, but becomes critical in mature neurons. Mecp2 deficiency in these neurons is sufficient to cause neuronal dysfunction with symptomatic manifestation similar to Rett syndrome.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA.			Tudor, Matthew/0000-0001-8766-195X				Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Armstrong DD, 1997, J NEUROPATH EXP NEUR, V56, P843, DOI 10.1097/00005072-199708000-00001; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581; BAUMAN ML, 1995, NEUROPEDIATRICS, V26, P105, DOI 10.1055/s-2007-979737; Clayton-Smith J, 2000, LANCET, V356, P830, DOI 10.1016/S0140-6736(00)02661-1; Coy JF, 1999, HUM MOL GENET, V8, P1253, DOI 10.1093/hmg/8.7.1253; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Dragich J, 2000, HUM MOL GENET, V9, P2365, DOI 10.1093/hmg/9.16.2365; Ellaway C, 1999, J PAEDIATR CHILD H, V35, P419, DOI 10.1046/j.1440-1754.1999.355403.x; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hagberg G, 2000, ACTA PAEDIATR, V89, P198, DOI 10.1080/080352500750028834; JELLINGER K, 1988, ACTA NEUROPATHOL, V76, P142, DOI 10.1007/BF00688098; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Rett A, 1966, Wien Med Wochenschr, V116, P723; Schanen C, 1998, AM J HUM GENET, V63, P267, DOI 10.1086/301932; Schanen NC, 1998, J CHILD NEUROL, V13, P229, DOI 10.1177/088307389801300507; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tate P, 1996, NAT GENET, V12, P205, DOI 10.1038/ng0296-205; Trumpp A, 1999, GENE DEV, V13, P3136, DOI 10.1101/gad.13.23.3136; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690	29	953	986	1	46	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					327	331		10.1038/85906	http://dx.doi.org/10.1038/85906			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242118				2022-12-27	WOS:000167304200028
J	Jacobs, JJL; Keblusek, P; Robanus-Maandag, E; Kristel, P; Lingbeek, M; Nederlof, PM; van Welsem, T; van de Vijver, MJ; Koh, EY; Daley, GQ; van Lohuizen, M				Jacobs, JJL; Keblusek, P; Robanus-Maandag, E; Kristel, P; Lingbeek, M; Nederlof, PM; van Welsem, T; van de Vijver, MJ; Koh, EY; Daley, GQ; van Lohuizen, M			Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers	NATURE GENETICS			English	Article							ARF TUMOR-SUPPRESSOR; CELL-CYCLE ARREST; INK4A LOCUS; C-MYC; STABILIZES P53; GENE FAMILY; MDM2; APOPTOSIS; LYMPHOMAGENESIS; AMPLIFICATION	To identify new immortalizing genes with potential roles in tumorigenesis, we performed a genetic screen aimed to bypass the rapid and tight senescence arrest of primary fibroblasts deficient for the oncogene Bmi1. We identified the T-box member TBX2 as a potent immortalizing gene that acts by downregulating Cdkn2a (p19(ARF)). TBX2 represses the Cdkn2a (p19(ARF)) promoter and attenuates E2F1, Myc or HRAS-mediated induction of Cdkn2a (p19(ARF)). We found TBX2 to be amplified in a subset of primary human breast cancers, indicating that it might contribute to breast cancer development.	Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands; Whitehead Inst, Cambridge, MA 02142 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	van Lohuizen, M (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands.	lohuizen@nki.nl	Jacobs, Jacqueline/ABA-5652-2020	Jacobs, Jacqueline/0000-0002-7704-4795; van de Vijver, Marc/0000-0002-0385-4787	NATIONAL CANCER INSTITUTE [R29CA076418] Funding Source: NIH RePORTER; NCI NIH HHS [CA76418-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alkema MJ, 1997, ONCOGENE, V15, P899, DOI 10.1038/sj.onc.1201262; Barlund M, 1997, GENE CHROMOSOME CANC, V20, P372, DOI 10.1002/(SICI)1098-2264(199712)20:4<372::AID-GCC8>3.0.CO;2-Z; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Clahsen PC, 1998, J CLIN ONCOL, V16, P470, DOI 10.1200/JCO.1998.16.2.470; Couch FJ, 1999, CANCER RES, V59, P1408; Courjal F, 1997, CANCER RES, V57, P4368; Cuny M, 2000, CANCER RES, V60, P1077; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; HAUPT Y, 1993, ONCOGENE, V8, P3161; He ML, 1999, P NATL ACAD SCI USA, V96, P10212, DOI 10.1073/pnas.96.18.10212; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; LAW DJ, 1995, MAMM GENOME, V6, P793, DOI 10.1007/BF00539006; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; PEDEUTOUR F, 1995, CANCER RES, V55, P2400; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; QUELLE DE, 1995, CELL, V83, P993; QUELLE DE, 1995, ONCOGENE, V11, P635; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber RG, 1997, P NATL ACAD SCI USA, V94, P14719, DOI 10.1073/pnas.94.26.14719; Wicking C, 1999, ONCOGENE, V18, P7844, DOI 10.1038/sj.onc.1203282; Wynford-Thomas D, 1999, J PATHOL, V187, P100; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	50	306	320	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					291	299		10.1038/81583	http://dx.doi.org/10.1038/81583			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062467				2022-12-27	WOS:000165176500016
J	Ogonuki, N; Inoue, K; Yamamoto, Y; Noguchi, Y; Tanemura, K; Suzuki, O; Nakayama, H; Doi, K; Ohtomo, Y; Satoh, M; Nishida, A; Ogura, A				Ogonuki, N; Inoue, K; Yamamoto, Y; Noguchi, Y; Tanemura, K; Suzuki, O; Nakayama, H; Doi, K; Ohtomo, Y; Satoh, M; Nishida, A; Ogura, A			Early death of mice cloned from somatic cells	NATURE GENETICS			English	Article							CLONING	Here we report that the lifespan of mice cloned from somatic cells is significantly shorter than that of genotype- and sex-matched controls, most likely due to severe pneumonia and hepatic failure. This finding demonstrates the possibility of long-term deleterious effects of somatic-cell cloning, even after normal birth.	Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Tokyo, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Tokyo, Japan; Tohoku Univ, Fac Agr, Grad Sch Agr Sci, Sendai, Miyagi, Japan	National Institute of Infectious Diseases (NIID); University of Tokyo; Tohoku University	Ogura, A (corresponding author), Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Tokyo, Japan.		Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988				Antonini JM, 2001, CHEST, V120, P240, DOI 10.1378/chest.120.1.240; Fein AM, 1999, CLIN INFECT DIS, V28, P726, DOI 10.1086/515218; Keefer CL, 2001, BIOL REPROD, V64, P849, DOI 10.1095/biolreprod64.3.849; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; MILLER RA, 1991, INT REV CYTOL, V124, P187; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; Tamashiro KLK, 2000, BIOL REPROD, V63, P328, DOI 10.1095/biolreprod63.1.328; Tian XC, 2000, NAT GENET, V26, P272, DOI 10.1038/81559; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; WEIR DM, 1973, HDB EXPT IMMUNOLOGY	11	172	189	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					253	254		10.1038/ng841	http://dx.doi.org/10.1038/ng841			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11836501				2022-12-27	WOS:000174157600006
J	Herron, BJ; Lu, WN; Rao, C; Liu, SM; Peters, H; Bronson, RT; Justice, MJ; McDonald, JD; Beier, DR				Herron, BJ; Lu, WN; Rao, C; Liu, SM; Peters, H; Bronson, RT; Justice, MJ; McDonald, JD; Beier, DR			Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; MOUSE MUTANT; GENOME-WIDE; GENE; MICE; ETHYLNITROSOUREA; DEFECTS	Treatment with N-ethyl-N-nitrosourea (ENU) efficiently generates single-nucleotide mutations in mice(1-3). Along with the renewed interest in this approach, much attention has been given recently to large screens with broad aims(4,5); however, more finely focused studies have proven very productive as well(6-8). Here we show how mutagenesis together with genetic mapping can facilitate the rapid characterization of recessive loci required for normal embryonic development. We screened third-generation progeny of mutagenized mice at embryonic day (E) 18.5 for abnormalities of organogenesis. We ascertained 15 monogenic mutations in the 54 families that were comprehensively analyzed. We carried out the experiment as an outcross, which facilitated the genetic mapping of the mutations by haplotype analysis. We mapped seven of the mutations and identified the affected locus in two lines. Using a hierarchical approach, it is possible to maximize the effciency of this analysis so that it can be carried out easily with modest infrastructure and resources.	Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA; Baylor Coll Med, Houston, TX 77030 USA; Wichita State Univ, Wichita, KS USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tufts University; Baylor College of Medicine; Wichita State University	Beier, DR (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA.			Lu, Weining/0000-0002-6570-3044				Beckers J, 2000, MECH DEVELOP, V95, P35, DOI 10.1016/S0925-4773(00)00323-3; BODE VC, 1988, GENETICS, V118, P299; Daniells C, 1998, HUM GENET, V102, P216, DOI 10.1007/s004390050681; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Favor J, 2000, MAMM GENOME, V11, P520, DOI 10.1007/s003350010099; Hentges K, 1999, DEVELOPMENT, V126, P1601; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; LUNA IJ, 1960, MANUAL HISTOLOGIC ST; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Neuhaus IM, 1998, MAMM GENOME, V9, P150, DOI 10.1007/s003359900706; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; RUSSELL WL, 1982, P NATL ACAD SCI-BIOL, V79, P3592, DOI 10.1073/pnas.79.11.3592; RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818; Sporle R, 1996, DEVELOPMENT, V122, P79; Sporle R, 1998, DEV GENET, V22, P359, DOI 10.1002/(SICI)1520-6408(1998)22:4<359::AID-DVG6>3.0.CO;2-5; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Turco AE, 1997, HUM MUTAT, V10, P164, DOI 10.1002/(SICI)1098-1004(1997)10:2<164::AID-HUMU9>3.3.CO;2-8; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6	23	147	151	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					185	189		10.1038/ng812	http://dx.doi.org/10.1038/ng812			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11818962				2022-12-27	WOS:000173708700019
J	Zhang, PM; Li, MMZ; Elledge, SJ				Zhang, PM; Li, MMZ; Elledge, SJ			Towards genetic genome projects: genomic library screening and gene-targeting vector construction in a single step	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; RAPID CONSTRUCTION; DNA; MOUSE; COMPLEMENTATION; IDENTIFICATION; MORPHOGENESIS; DROSOPHILA; DISRUPTION	We have developed technologies that simplify genomic library construction and screening, substantially reducing both the time and the cost associated with traditional library screening methods and facilitating the generation of gene-targeting constructs. By taking advantage of homologous recombination in Escherichia coli, we were able to use as little as 80 bp of total sequence homology to screen for a specific gene from a genomic library in plasmid or phage form. This method, called recombination cloning (REC), takes only a few days instead of the several weeks required for traditional plaque-lift methods. In addition, because every clone in the mouse genomic library we have constructed has a negative selection marker adjacent to the genomic insert, REC screening can generate gene-targeting vectors in one step, from library screening to finished construct. Conditional targeting constructs can be generated easily with minimal additional manipulation.	Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA.							ANGRAND PO, 1999, NUCLEIC ACIDS RES, V27, pE15; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; CLARK AJ, 1973, ANNU REV GENET, V7, P67, DOI 10.1146/annurev.ge.07.120173.000435; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; ELLEDGE SJ, 1985, J BACTERIOL, V162, P777, DOI 10.1128/JB.162.2.777-783.1985; ELLEDGE SJ, 1989, GENE DEV, V3, P185, DOI 10.1101/gad.3.2.185; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Gumbiner-Russo LM, 2001, GENE, V273, P97, DOI 10.1016/S0378-1119(01)00565-0; Hasty P., 1993, Gene targeting: a practical approach., P1; KARN J, 1980, P NATL ACAD SCI-BIOL, V77, P5172, DOI 10.1073/pnas.77.9.5172; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KUSHNER SR, 1974, P NATL ACAD SCI USA, V71, P3593, DOI 10.1073/pnas.71.9.3593; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; LLOYD RG, 1974, MOL GEN GENET, V134, P249, DOI 10.1007/BF00267719; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Poteete AR, 1999, J BACTERIOL, V181, P5402, DOI 10.1128/JB.181.17.5402-5408.1999; SMITH GR, 1995, PHILOS T ROY SOC B, V347, P13, DOI 10.1098/rstb.1995.0003; Storck T, 1996, NUCLEIC ACIDS RES, V24, P4594, DOI 10.1093/nar/24.22.4594; TAYLOR DP, 1979, J BACTERIOL, V137, P92, DOI 10.1128/JB.137.1.92-104.1979; THOMAS R, 1976, EUR J BIOCHEM, V71, P211, DOI 10.1111/j.1432-1033.1976.tb11108.x; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; WINANS SC, 1985, J BACTERIOL, V161, P1219, DOI 10.1128/JB.161.3.1219-1221.1985; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	29	69	76	1	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					31	39		10.1038/ng797	http://dx.doi.org/10.1038/ng797			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11753384				2022-12-27	WOS:000173105600011
J	Pailhoux, E; Vigier, B; Chaffaux, S; Servel, N; Taourit, S; Furet, JP; Fellous, M; Grosclaude, F; Cribiu, EP; Cotinot, C; Vaiman, D				Pailhoux, E; Vigier, B; Chaffaux, S; Servel, N; Taourit, S; Furet, JP; Fellous, M; Grosclaude, F; Cribiu, EP; Cotinot, C; Vaiman, D			A 11.7-kb deletion triggers intersexuality and polledness in goats	NATURE GENETICS			English	Article							MAMMALIAN SEX DETERMINATION; SRY; BLEPHAROPHIMOSIS; PTOSIS; REGION; MAP; IDENTIFICATION; TRANSLOCATION; DEFINITION; REVERSAL	Mammalian sex determination is governed by the presence of the sex determining region Y gene (SRY) on the Y chromosome(1). Familial cases of SRY-negative XX sex reversal are rare in humans, often hampering the discovery of new sex-determining genes(2,3). The mouse model is also insufficient to correctly apprehend the sex-determination cascade, as the human pathway is much more sensitive to gene dosage(4-6). Other species might therefore be considered in this respect(7). In goats, the polled intersex syndrome (PIS) mutation associates polledness and intersexuality(8,9). The sex reversal affects exclusively the XX individuals in a recessive manner, whereas the absence of horns is dominant in both sexes. The syndrome is caused by an autosomal gene located at chromosome band 1q43 (ref. 9), shown to be homologous to human chromosome band 3q23 (ref. 10). Through a positional cloning approach, we demonstrate that the mutation underlying PIS is the deletion of a critical 11.7-kb DNA element containing mainly repetitive sequences. This deletion affects the transcription of at least two genes: PISRT1, encoding a 1.5-kb mRNA devoid of open reading frame (ORF), and FOXL2, recently shown to be responsible for blepharophimosis ptosis epicanthus inversus syndrome (BPES) in humans(11). These two genes are located 20 and 200 kb telomeric from the deletion, respectively.	INRA, Ctr Rech, Lab Genet Biochim & Cytogenet, Dept Genet Anim, F-78352 Jouy En Josas, France; INRA, Ctr Rech, Dept Anim Physiol, Lab Biol Dev & Biotechnol, F-78352 Jouy En Josas, France; Inst Pasteur, Human Immunogenet Lab, F-75015 Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Vaiman, D (corresponding author), INRA, Ctr Rech, Lab Genet Biochim & Cytogenet, Dept Genet Anim, F-78352 Jouy En Josas, France.		Vaiman, Daniel/O-6030-2015	Vaiman, Daniel/0000-0002-1915-0717; Servel, Nathalie/0000-0001-6925-6256				AASEN E, 1990, BIO-TECHNOL, V8, P1279, DOI 10.1038/nbt1290-1279; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Asdell S. A., 1944, SCIENCE, V99, P124, DOI 10.1126/science.99.2563.124; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; De Baere E, 2000, GENOMICS, V68, P296, DOI 10.1006/geno.2000.6304; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GIESE K, 1994, P NATL ACAD SCI USA, V91, P3368, DOI 10.1073/pnas.91.8.3368; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koopman P, 1999, CELL MOL LIFE SCI, V55, P839; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KROB G, 1994, EUR J PEDIATR, V153, P2, DOI 10.1007/s004310050077; LAWSON CT, 1995, HUM MOL GENET, V4, P963, DOI 10.1093/hmg/4.5.963; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; Praphanphoj V, 2000, GENOMICS, V65, P67, DOI 10.1006/geno.2000.6157; Schibler L, 2000, GENOME RES, V10, P311, DOI 10.1101/gr.10.3.311; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Vaiman D, 2000, TRENDS GENET, V16, P488, DOI 10.1016/S0168-9525(00)02126-0; Vaiman D, 1996, MAMM GENOME, V7, P133, DOI 10.1007/s003359900033; Vaiman D, 1996, GENETICS, V144, P279; Vaiman D, 1999, GENOMICS, V56, P31, DOI 10.1006/geno.1998.5691	22	260	270	1	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					453	458		10.1038/ng769	http://dx.doi.org/10.1038/ng769			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726932				2022-12-27	WOS:000172507500022
J	Cai, WW; Chow, CW; Damani, S; Gregory, SG; Marra, M; Bradley, A				Cai, WW; Chow, CW; Damani, S; Gregory, SG; Marra, M; Bradley, A			An SSLP marker-anchored BAC framework map of the mouse genome	NATURE GENETICS			English	Article							HYBRIDIZATION	We have constructed a BAC framework map of the mouse genome consisting of 2,808 PCR-confirmed BAC clusters, using a previously described method(1). Fingerprints of BACs from selected clusters confirm the accuracy of the map. Combined with BAC fingerprint data, the framework map covers 37% of the mouse genome.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Sanger Ctr, Cambridge, England; British Columbia Canc Agcy, Genome Sequence Ctr, Vancouver, BC V5Z 4E6, Canada	Baylor College of Medicine; Wellcome Trust Sanger Institute; British Columbia Cancer Agency	Bradley, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.		Marra, Marco A/B-5987-2008	Marra, Marco A/0000-0001-7146-7175; Bradley, Allan/0000-0002-2349-8839; Gregory, Simon/0000-0002-7805-1743				Cai WW, 1998, GENOMICS, V54, P387, DOI 10.1006/geno.1998.5620; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Nusbaum C, 1999, NAT GENET, V22, P388, DOI 10.1038/11967; Osoegawa K, 2000, GENOME RES, V10, P116; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Rhodes M, 1998, GENOME RES, V8, P531, DOI 10.1101/gr.8.5.531; STALLINGS RL, 1990, P NATL ACAD SCI USA, V87, P6218, DOI 10.1073/pnas.87.16.6218	7	9	9	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					133	134		10.1038/ng1001-133	http://dx.doi.org/10.1038/ng1001-133			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586294				2022-12-27	WOS:000171374100014
J	Yasutomo, K; Horiuchi, T; Kagami, S; Tsukamoto, H; Hashimura, C; Urushihara, M; Kuroda, Y				Yasutomo, K; Horiuchi, T; Kagami, S; Tsukamoto, H; Hashimura, C; Urushihara, M; Kuroda, Y			Mutation of DNASE1 in people with systemic lupus erythematosus	NATURE GENETICS			English	Article								Systemic lupus erythematosus (SLE) is a highly prevalent human autoimmune diseases that causes progressive glomerulonephritis, arthritis and an erythematoid rash(1,2). Mice deficient in deoxyribonuclease I (Dnase1) develop an SLE-like syndrome(3). Here we describe two patients with a heterozygous nonsense mutation in exon 2 of DNASE1, decreased DNASE1 activity and an extremely high immunoglobulin G titer against nucleosomal antigens. These data are consistent with the hypothesis that a direct connection exists between low activity of DNASE1 and progression of human SLE.	Univ Tokushima, Sch Med, Dept Pediat, Tokushima 7708503, Japan; Kyushu Univ, Fac Med, Dept Internal Med 1, Fukuoka 8128582, Japan	Tokushima University; Kyushu University	Kuroda, Y (corresponding author), Univ Tokushima, Sch Med, Dept Pediat, Tokushima 7708503, Japan.			Yasutomo, Koji/0000-0003-0411-2037				Amoura Z, 1997, ARTHRITIS RHEUM, V40, P2217, DOI 10.1002/art.1780401217; Arnett F C, 2000, Int Rev Immunol, V19, P297, DOI 10.3109/08830180009055501; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Eilat D, 1999, IMMUNOL TODAY, V20, P339, DOI 10.1016/S0167-5699(99)01457-7; Herrmann M, 2000, IMMUNOL TODAY, V21, P424, DOI 10.1016/S0167-5699(00)01675-3; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Tsao B P, 2000, Int Rev Immunol, V19, P319, DOI 10.3109/08830180009055502; Vyse TJ, 1998, ANNU REV IMMUNOL, V16, P261, DOI 10.1146/annurev.immunol.16.1.261; Wagrowska-Danilewicz M, 1998, J NEPHROL, V11, P44; Wu JM, 1999, ARTHRITIS RHEUM, V42, P2601, DOI 10.1002/1529-0131(199912)42:12<2601::AID-ANR13>3.0.CO;2-4	10	419	440	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					313	314		10.1038/91070	http://dx.doi.org/10.1038/91070			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479590				2022-12-27	WOS:000170174800009
J	Zhou, B; Westaway, SK; Levinson, B; Johnson, MA; Gitschier, J; Hayflick, SJ				Zhou, B; Westaway, SK; Levinson, B; Johnson, MA; Gitschier, J; Hayflick, SJ			A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome	NATURE GENETICS			English	Article							REGIONAL DISTRIBUTION; ALZHEIMERS-DISEASE; ESCHERICHIA-COLI; COENZYME-A; IRON; BRAIN; CYSTEINE; PATHOGENESIS; PEROXIDATION; PARKINSONS	Hallervorden-Spatz syndrome (HSS) is an autosomal recessive neurodegenerative disorder associated with iron accumulation in the brain. Clinical features include extrapyramidal dysfunction, onset in childhood, and a relentlessly progressive course(1). Histologic study reveals iron deposits in the basal ganglia(2). In this respect, HSS may serve as a model for complex neurodegenerative diseases, such as Parkinson disease(3), Alzheimer disease(4), Huntington diseases and human immunodeficiency virus (HIV) encephalopathy(6), in which pathologic accumulation of iron in the brain is also observed. Thus, understanding the biochemical defect in HSS may provide key insights into the regulation of iron metabolism and its perturbation in this and other neurodegenerative diseases. Here we show that HSS is caused by a defect in a novel pantothenate kinase gene and propose a mechanism for oxidative stress in the pathophysiology of the disease.	Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hayflick, SJ (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	hayflick@ohsu.edu						ABIKO Y, 1967, J BIOCHEM, V61, P290, DOI 10.1093/oxfordjournals.jbchem.a128547; Afshar K, 2001, GENETICS, V157, P1267; ANGELINI L, 1992, J NEUROL, V239, P417, DOI 10.1007/BF00856805; BLACKWOOD EM, 1994, MOL BIOL CELL, V5, P597, DOI 10.1091/mbc.5.5.597; Calder RB, 1999, J BIOL CHEM, V274, P2014, DOI 10.1074/jbc.274.4.2014; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; COPPETO JR, 1990, NEUROLOGY, V40, P1359, DOI 10.1212/WNL.40.9.1359; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; DOOLING EC, 1974, ARCH NEUROL-CHICAGO, V30, P70, DOI 10.1001/archneur.1974.00490310072012; GRAVEL RA, 1994, AM J HUM GENET, V55, P51; HEAFIELD MT, 1990, NEUROSCI LETT, V110, P216, DOI 10.1016/0304-3940(90)90814-P; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Karim MA, 2000, AM J HUM GENET, V67, P185; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Miszkziel KA, 1997, MAGN RESON IMAGING, V15, P1113, DOI 10.1016/S0730-725X(97)00089-1; PARK BE, 1975, NEUROLOGY, V25, P1172, DOI 10.1212/WNL.25.12.1172; PERRY TL, 1985, ANN NEUROL, V18, P482, DOI 10.1002/ana.410180411; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; SEARLE AJF, 1983, BIOCHEM J, V212, P549, DOI 10.1042/bj2120549; SHEVELL M, 1992, NEUROLOGY, V42, P2214, DOI 10.1212/WNL.42.11.2214; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; SWAIMAN KF, 1991, ARCH NEUROL-CHICAGO, V48, P1285, DOI 10.1001/archneur.1991.00530240091029; Taylor TD, 1996, NAT GENET, V14, P479, DOI 10.1038/ng1296-479; TRIPATHI RC, 1992, ACTA NEUROPATHOL, V83, P113, DOI 10.1007/BF00308470; VALLARI DS, 1987, J BACTERIOL, V169, P5795, DOI 10.1128/jb.169.12.5795-5800.1987; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang EY, 2000, REDOX REP, V5, P371, DOI 10.1179/135100000101535942; Yoon SJ, 2000, MUTAT RES-FUND MOL M, V448, P97, DOI 10.1016/S0027-5107(00)00005-1; Yun M, 2000, J BIOL CHEM, V275, P28093	30	526	562	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					345	349		10.1038/ng572	http://dx.doi.org/10.1038/ng572			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479594				2022-12-27	WOS:000170174800014
J	Bressler, J; Tsai, TF; Wu, MY; Tsai, SF; Ramirez, MA; Armstrong, D; Beaudet, AL				Bressler, J; Tsai, TF; Wu, MY; Tsai, SF; Ramirez, MA; Armstrong, D; Beaudet, AL			The SNRPN promoter is not required for genomic imprinting of the PraderWilli/Angelman domain in mice	NATURE GENETICS			English	Article							PRADER-WILLI-SYNDROME; EMBRYONIC STEM-CELLS; MOUSE NECDIN GENE; ANGELMAN-SYNDROME; DNA METHYLATION; REGION; EXPRESSION; LETHALITY; MUTATIONS; DELETION	In mice and humans, the locus encoding the gene for small nuclear ribonucleoprotein N (SNRPN/Snrpn), as well as other loci in the region are subject to genomic imprinting. The SNRPN promoter is embedded in a maternally methylated CpG island, is expressed only from the paternal chromosome and lies within an imprinting center that is required for switching to and/or maintenance of the paternal epigenotype. We show here that a 0.9-kb deletion of exon 1 of mouse Snrpn did not disrupt imprinting or elicit any obvious phenotype. although it did allow the detection of previously unknown upstream exons. In contrast, a larger, overlapping 4.8-kb deletion caused a partial or mosaic imprinting defect and perinatal lethality when paternally inherited.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Genet, Taipei 112, Taiwan	Baylor College of Medicine; Baylor College of Medicine; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.		Tsai, Shih-Feng/E-3997-2010		NICHD NIH HHS [HD-37283] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abuin A, 1996, MOL CELL BIOL, V16, P1851; Bielinska B, 2000, NAT GENET, V25, P74, DOI 10.1038/75629; Blaydes SM, 1999, MAMM GENOME, V10, P549, DOI 10.1007/s003359901042; Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; Buiting K, 1999, HUM GENET, V105, P665, DOI 10.1007/s004390051160; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Conroy JM, 1997, AM J HUM GENET, V61, P388, DOI 10.1086/514852; DELOS ST, 2000, AM J HUM GENET, V67, P1067; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Farber C, 1999, HUM MOL GENET, V8, P337, DOI 10.1093/hmg/8.2.337; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FergusonSmith AC, 1996, NAT GENET, V14, P119, DOI 10.1038/ng1096-119; Gabriel JM, 1998, MAMM GENOME, V9, P788, DOI 10.1007/s003359900868; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gillessen-Kaesbach G, 1999, EUR J HUM GENET, V7, P638, DOI 10.1038/sj.ejhg.5200362; Glenn CC, 1996, AM J HUM GENET, V58, P335; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Huq AHMM, 1997, GENOME RES, V7, P642, DOI 10.1101/gr.7.6.642; Jiang YH, 1998, CURR OPIN GENET DEV, V8, P334, DOI 10.1016/S0959-437X(98)80091-9; Kuslich CD, 1999, AM J HUM GENET, V64, P70, DOI 10.1086/302177; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Mann MRW, 1999, HUM MOL GENET, V8, P1867, DOI 10.1093/hmg/8.10.1867; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; REIS A, 1994, AM J HUM GENET, V54, P741; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Sambrook J., 2002, MOL CLONING LAB MANU; Schulze A, 1996, NAT GENET, V12, P452, DOI 10.1038/ng0496-452; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sun YM, 1996, HUM MOL GENET, V5, P517, DOI 10.1093/hmg/5.4.517; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tilghman SM, 1998, NAT GENET, V18, P206, DOI 10.1038/ng0398-206; Tsai TF, 1999, NAT GENET, V22, P15, DOI 10.1038/8722; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Watrin F, 1997, EUR J HUM GENET, V5, P324, DOI 10.1159/000484784; Wevrick R, 1997, HUM MOL GENET, V6, P325, DOI 10.1093/hmg/6.2.325; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25	49	85	87	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					232	240		10.1038/90067	http://dx.doi.org/10.1038/90067			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431693				2022-12-27	WOS:000169656400015
J	Max, M; Shanker, YG; Huang, LQ; Rong, M; Liu, Z; Campagne, F; Weinstein, H; Damak, S; Margolskee, RF				Max, M; Shanker, YG; Huang, LQ; Rong, M; Liu, Z; Campagne, F; Weinstein, H; Damak, S; Margolskee, RF			Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac	NATURE GENETICS			English	Article							SACCHARIN PREFERENCE; BITTER; MICE; SUBSTANCES; RESPONSES; GUSTDUCIN; GENETICS; SUCROSE; CELLS	The ability to taste the sweetness of carbohydrate-rich foodstuffs has a critical role in the nutritional status of humans. Although several components of bitter transduction pathways have been identified(1-6), the receptors and other sweet transduction elements remain unknown. The Sac locus in mouse, mapped to the distal end of chromosome 4 (refs. 7-9), is the major determinant of differences between sweet-sensitive and -insensitive strains of mice in their responsiveness to saccharin, sucrose and other sweeteners(10-13). To identify the human Sac locus, we searched for candidate genes within a region of approximately one million base pairs of the sequenced human genome syntenous to the region of Sac in mouse. From this search, we identified a likely candidate: T1R3, a previously unknown G protein-coupled receptor (GPCR) and the only GPCR in this region. Mouse Tas1r3 (encoding T1r3) maps to within 20,000 bp of the marker closest to Sac (ref. 9) and, like human TA5IR3, is expressed selectively in taste receptor cells. By comparing the sequence of Tas1r3 from several independently derived strains of mice, we identified a specific polymorphism that assorts between taster and non-taster strains. According to models of its structure. T1r3 from non-tasters is predicted to have an extra amino-terminal glycosylation site that, if used, would interfere with dimerization.	NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, New York, NY 10012 USA; NYU, Mt Sinai Sch Med, Dept Phys & Biophys, New York, NY USA; NYU, Mt Sinai Sch Med, Inst Computat Biomed, New York, NY USA	Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University	Margolskee, RF (corresponding author), NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, 550 1st Ave, New York, NY 10012 USA.	Bob@inka.mssm.edu	Campagne, Fabien/F-5158-2010; WEINSTEIN, HAREL/O-8245-2019	WEINSTEIN, HAREL/0000-0003-3473-9818; Margolskee, Robert/0000-0002-9572-2887; Campagne, Fabien/0000-0001-6237-3564; Huang, Liquan/0000-0003-3400-0685	NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH057241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003155] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC00310, DC03155] Funding Source: Medline; NIMH NIH HHS [MH57241] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; Blizard DA, 1999, CHEM SENSES, V24, P373, DOI 10.1093/chemse/24.4.373; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CAPELESS CG, 1995, CHEM SENSES, V20, P291, DOI 10.1093/chemse/20.3.291; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; HIJI Y, 1975, NATURE, V256, P427, DOI 10.1038/256427a0; Hogan B, 1994, MANIPULATING MOUSE E; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; LUSH IE, 1995, GENET RES, V66, P167, DOI 10.1017/S0016672300034510; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Nakashima K, 1998, CELL PHYSIOL BIOCHEM, V8, P224, DOI 10.1159/000016285; Rossler P, 2000, CHEM SENSES, V25, P413, DOI 10.1093/chemse/25.4.413; Rossler P, 1998, EUR J CELL BIOL, V77, P253; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	25	433	469	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					58	63		10.1038/88270	http://dx.doi.org/10.1038/88270			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326277				2022-12-27	WOS:000168413300017
J	Vermeulen, W; Rademakers, S; Jaspers, NGJ; Appeldoorn, E; Raams, A; Klein, B; Kleijer, WJ; Hansen, LK; Hoeijmakers, JHJ				Vermeulen, W; Rademakers, S; Jaspers, NGJ; Appeldoorn, E; Raams, A; Klein, B; Kleijer, WJ; Hansen, LK; Hoeijmakers, JHJ			A temperature-sensitive disorder in basal transcription and DNA repair in humans	NATURE GENETICS			English	Letter							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-D; XERODERMA-PIGMENTOSUM; COCKAYNE-SYNDROME; TRICHOTHIODYSTROPHY; TFIIH; GENE; MUTATIONS; MECHANISM	The xeroderma pigmentosum group D (XPD) helicase subunit of TFIIH functions in DNA repair and transcription initiation(1,2). Different mutations in XPD give rise to th ree ultraviolet-sensitive syndromes: the skin cancer-prone disorder xeroderma pigmentosum (XP). in which repair of ultraviolet damage is affected; and the severe neurodevelopmental conditions Cockayne syndrome (CS) and trichothiodystrophy (TTD). In the latter two, the basal transcription function of TFIIH is also presumed to be affected(3-5). Here we report four unusual TTD patients with fever-dependent reversible deterioration of TTD features such as brittle hair. Cells from these patients show an in vivo temperature-sensitive defect of transcription and DNA repair due to thermo-instability of TFIIH. Our findings reveal the clinical consequences of impaired basal transcription and mutations in very fundamental processes in humans, which previously were only known in lower organisms.	Erasmus Univ, Ctr Biomed Genet, Dept Cell Biol & Genet, MGC, Rotterdam, Netherlands; Leiden Univ, Sylvius Labs, Dept Radiat Genet & Chem Mutagenesis, MGC, Leiden, Netherlands; Odense Univ Hosp, Dept Pediat, DK-5000 Odense, Denmark	Erasmus University Rotterdam; Leiden University; Leiden University - Excl LUMC; University of Southern Denmark; Odense University Hospital	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Ctr Biomed Genet, Dept Cell Biol & Genet, MGC, POB 1738, Rotterdam, Netherlands.		Vermeulen, Wim/W-8708-2019; Hoeijmakers, Jan/AAX-6972-2021	Vermeulen, Wim/0000-0003-3616-734X; 				BOOTSMA D, 1998, NUCLEOTIDE EXCISION, P245; Broughton BC, 1996, MUTAT RES-DNA REPAIR, V362, P209, DOI 10.1016/0921-8777(95)00054-2; BRUCE D, 1994, J CLIN INVEST, V94, P2265, DOI 10.1172/JCI117589; Citterio E, 2000, CELL, V101, P447, DOI 10.1016/S0092-8674(00)80854-5; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Hanawalt PC, 2000, NATURE, V405, P415, DOI 10.1038/35013197; Hansen L K, 1993, Ugeskr Laeger, V155, P1949; JOHNSON RT, 1992, MUTAT RES, V273, P97, DOI 10.1016/0921-8777(92)90072-B; KLEIJER WJ, 1994, AM J MED GENET, V52, P227, DOI 10.1002/ajmg.1320520220; KLEIN B, 1990, EXP CELL RES, V191, P256, DOI 10.1016/0014-4827(90)90012-Y; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Lehmann AR, 1998, BIOESSAYS, V20, P146, DOI 10.1002/(SICI)1521-1878(199802)20:2<146::AID-BIES7>3.3.CO;2-5; Lind H, 1999, BLOOD PRESSURE, V8, P9, DOI 10.1080/080370599438338; Powell B., 1994, KERATINOCYTE HDB, P401; Satoh MS, 1997, BBA-GENE STRUCT EXPR, V1354, P241, DOI 10.1016/S0167-4781(97)00102-4; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Takayama K, 1996, AM J HUM GENET, V58, P263; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Vermeulen W, 2000, NAT GENET, V26, P307, DOI 10.1038/81603; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; ZINKHAM WH, 1979, JOHNS HOPKINS MED J, V144, P109	25	80	81	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					299	303		10.1038/85864	http://dx.doi.org/10.1038/85864			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242112				2022-12-27	WOS:000167304200022
J	Prueitt, RL; Zinn, AR				Prueitt, RL; Zinn, AR			A fork in the road to fertility	NATURE GENETICS			English	Editorial Material							TRANSCRIPTION FACTOR; GENE; BLEPHAROPHIMOSIS; TRANSLOCATION; MUTATIONS; T(3/4)(Q23,P15.2); PATIENT; PTOSIS; FKHL7	Haploinsufficiency of FOXL2, a new forkhead transcription factor, causes blepharophimosis/ptosis/epicanthus inversus syndrome (BPES), a rare developmental disorder affecting the eyelid and sometimes the ovary. A new study implicates FOXL2 as the first human gene required for the maintenance of ovarian follicles, The discovery of FOXL2 may provide insight into the causes of idiopathic premature ovarian failure, a disease that burdens many infertile couple.	Univ Texas, SW Med Sch, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Prueitt, RL (corresponding author), Univ Texas, SW Med Sch, McDermott Ctr Human Growth & Dev, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	andrew.zinn@utsouthwestern.edu		Zinn, Andrew/0000-0002-4935-3291				AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; De Baere E, 2000, GENOMICS, V68, P296, DOI 10.1006/geno.2000.6304; De Baere E, 1999, GENOMICS, V57, P70, DOI 10.1006/geno.1999.5747; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; FRASER IS, 1988, FERTIL STERIL, V50, P747; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Ogata T, 1998, HORM RES, V50, P190, DOI 10.1159/000023272; Praphanphoj V, 2000, GENOMICS, V65, P67, DOI 10.1006/geno.2000.6157; VASSALLI A, 1994, GENE DEV, V8, P414, DOI 10.1101/gad.8.4.414; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	16	41	43	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2001	27	2					132	134		10.1038/84735	http://dx.doi.org/10.1038/84735			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175772				2022-12-27	WOS:000166839200004
J	Xiao, SX; Yu, C; Chou, XM; Yuan, WJ; Wang, Y; Bu, L; Fu, G; Qian, MQ; Yang, J; Shi, YZ; Hu, LD; Han, B; Wang, ZM; Huang, W; Liu, J; Chen, Z; Zhao, GP; Kong, XY				Xiao, SX; Yu, C; Chou, XM; Yuan, WJ; Wang, Y; Bu, L; Fu, G; Qian, MQ; Yang, J; Shi, YZ; Hu, LD; Han, B; Wang, ZM; Huang, W; Liu, J; Chen, Z; Zhao, GP; Kong, XY			Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP	NATURE GENETICS			English	Article							OSTEOGENESIS IMPERFECTA; DENTIN SIALOPROTEIN; SEQUENCE DETERMINATION; GENOMIC ORGANIZATION; BONE SIALOPROTEIN; CAUSATIVE ROLE; I COLLAGEN; GENE; LOCUS; PATHOGENESIS	Dentinogenesis imperfecta 1 (DGI1, MIM 125490) is an autosomal dominant dental disease characterized by abnormal dentin production and mineralization. The DGI1 locus was recently refined to a 2-Mb interval on 4q21 (ref. 1). Here we study three Chinese families carrying DCI1. We find that the affected individuals of two families also presented with progressive sensorineural high-frequency hearing loss (gene DfNA39). We identified three disease-specific mutations within the dentin sialophosphoprotein gene (DSPP) in these three families. We detected a G-->A transition at the donor-splicing site of intron 3 in one family without DFNA39, a mutation predicted to result in the skipping of exon 3. In two other families affected with both DGI1 and DFNA39, however, we identified two independent nucleotide transversions in exons a and 3 of DSPP, respectively. that cause missense mutations of two adjacent amino-acid residues in the predicted transmembrane region of the protein. Moreover, transcripts of DSPP previously reported to be expressed specifically in teeth(2) are also detected in the inner ear of mice. We have thus demonstrated for the first time that distinct mutations in DSPP are responsible for the clinical manifestations of DGI1 with or without DFNA39.	Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Res Ctr Biotechnol, Shanghai 200233, Peoples R China; Univ Sci & Technol China, Hefei 230027, Anhui, Peoples R China; 82 Hosp Peoples Liberat Army China, Huaiyin 223001, Jiangsu, Peoples R China; Stomatol Hosp Yang Pu Community Shanghai, Shanghai 200090, Peoples R China; Fourth Mil Med Univ, Xian 710032, Peoples R China; Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Acad Sci, Natl Ctr Gene Res, Shanghai 200233, Peoples R China; Fudan Univ, Coll Med, EENT Hosp, Dept Otolaryngol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Air Force Military Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Kong, XY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Res Ctr Biotechnol, Shanghai 200233, Peoples R China.		Yang, Jun/B-6976-2008; Yang, Jun J./ABG-5646-2020	Yang, Jun/0000-0002-0770-9659; Yang, Jun J./0000-0002-0770-9659; Zhao, Guo-Ping/0000-0002-7621-6620				Aplin HM, 1999, J DENT RES, V78, P1270, DOI 10.1177/00220345990780061201; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; Butler W T, 1995, Connect Tissue Res, V33, P59, DOI 10.3109/03008209509016983; Butler WT, 1998, EUR J ORAL SCI, V106, P204, DOI 10.1111/j.1600-0722.1998.tb02177.x; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Crosby AH, 1996, MAMM GENOME, V7, P149, DOI 10.1007/s003359900037; CROSBY AH, 1995, GENOMICS, V27, P155, DOI 10.1006/geno.1995.1018; FUJISAWA R, 1992, CALCIFIED TISSUE INT, V51, P438; Hirst KL, 1997, GENOMICS, V42, P38, DOI 10.1006/geno.1997.4700; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; MacDougall M, 1998, EUR J ORAL SCI, V106, P227, DOI 10.1111/j.1600-0722.1998.tb02180.x; Nicholls AC, 1996, HUM MUTAT, V7, P219, DOI 10.1002/(SICI)1098-1004(1996)7:3<219::AID-HUMU6>3.0.CO;2-5; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; RITCHIE HH, 1994, J BIOL CHEM, V269, P3698; Ritchie HH, 1997, EUR J ORAL SCI, V105, P405, DOI 10.1111/j.1600-0722.1997.tb02137.x; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; Sobel E, 1996, AM J HUM GENET, V58, P1323; SUPERTIFURGA A, 1989, J MED GENET, V26, P358, DOI 10.1136/jmg.26.6.358; TAKAGI Y, 1988, J ORAL PATHOL MED, V17, P208, DOI 10.1111/j.1600-0714.1988.tb01526.x; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Xiao SX, 2000, GENOMICS, V68, P247, DOI 10.1006/geno.2000.6285	21	249	289	1	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					201	204		10.1038/84848	http://dx.doi.org/10.1038/84848			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175790				2022-12-27	WOS:000166839200023
J	Penn, SG; Rank, DR; Hanzel, DK; Barker, DL				Penn, SG; Rank, DR; Hanzel, DK; Barker, DL			Mining the human genome using microarrays of open reading frames	NATURE GENETICS			English	Article							SEQUENCE	To test the hypothesis that the human genome project will uncover many genes not previously discovered by sequencing of expressed sequence tags (ESTs), we designed and produced a set of microarrays using probes based on open reading frames (ORFs) in 350 Mb of finished and draft human sequence. Our approach aims to identify all genes directly from genomic sequence by querying gene expression. We analysed genomic sequence with a suite of ORF prediction programs, selected approximately one ORF per gene, amplified the ORFs from genomic DNA and arrayed the amplicons onto treated glass slides. Of the first 10,000 arrayed ORFs, 31% are completely novel and 29% are similar, but not identical, to sequences in public databases. Approximately one-half of these are expressed in the tissues we queried by microarray. Subsequent verification by other techniques confirmed expression of several of the novel genes. Expressed sequence tags (ESTs) have yielded vast amounts of data(1,2), but our results indicate that many genes in the human genome will only be found by genomic sequencing.	Mol Dynam Inc, Adv Res Team, Sunnyvale, CA USA; Illumina Inc, San Diego, CA USA	Illumina	Rank, DR (corresponding author), Mol Dynam Inc, Adv Res Team, Sunnyvale, CA USA.			Rank, David/0000-0001-9213-6965				ADAMS MD, 1995, NATURE, V377, P3; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansari-Lari MA, 1998, GENOME RES, V8, P29; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Heizmann CW, 1999, NEUROCHEM RES, V24, P1097, DOI 10.1023/A:1020700117665; Joshi JG, 1995, J NEUROL SCI, V134, P52, DOI 10.1016/0022-510X(95)00208-J; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; Strausberg RL, 1997, NAT GENET, V15, P415, DOI 10.1038/ng0497supp-415; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Worley J, 2000, MICROARRAY BIOCHIP TECHNOLOGY, P65	14	29	42	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					315	318		10.1038/81613	http://dx.doi.org/10.1038/81613			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062470				2022-12-27	WOS:000165176500019
J	Sun, H; Smallwood, PM; Nathans, J				Sun, H; Smallwood, PM; Nathans, J			Biochemical defects in ABCR protein variants associated with human retinopathies	NATURE GENETICS			English	Letter							DISEASE GENE ABCR; RECESSIVE RETINITIS-PIGMENTOSA; ROD OUTER SEGMENTS; STARGARDT-DISEASE; MACULAR DEGENERATION; TRANSPORTER GENE; RIM PROTEIN; MUTATIONS; DYSTROPHY; HETEROGENEITY	Mutations in the gene encoding ABCR (ABCA4), a photoreceptor-specific ATP-binding cassette (ABC) transporter(1-4), are responsible for autosomal recessive Stargardt disease (STGD), an early onset macular degeneration(1,5-11), and some forms of autosomal recessive cone-rod dystrophy(12) and autosomal recessive retinitis pigmentosa(12-14). Heterozygosity for ABCA4 mutations may also represent a risk factor for age-related macular degeneration(15) (AMD), although this idea is controversial(7,16,17). An ongoing challenge in the analysis of ABCA4-based retinopathies arises from the observation that most of the ABCA4 sequence variants identified so far are missense mutations that are rare in both patient and control populations. With the current sample size of most sequence variants, one cannot determine statistically whether a particular sequence variant is pathogenic or neutral. A related challenge is to determine the degree to which each pathogenic variant impairs ABCR function, as genotype-phenotype analyses indicate that age of onset and disease severity correlate with different ABCA4 alleles(6,8-10). To address these questions, we performed a functional analysis of human ABCR and its variants. These experiments reveal a wide spectrum of biochemical defects in these variants and provide insight into the transport mechanism of ABCR.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.			Nathans, Jeremy/0000-0001-8106-5460				Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Azarian SM, 1997, FEBS LETT, V409, P247, DOI 10.1016/S0014-5793(97)00517-6; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; De La Paz MA, 1999, OPHTHALMOLOGY, V106, P1531, DOI 10.1016/S0161-6420(99)90449-9; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fishman GA, 1999, ARCH OPHTHALMOL-CHIC, V117, P504, DOI 10.1001/archopht.117.4.504; GOLDBERG AFX, 1995, BIOCHEMISTRY-US, V34, P14213, DOI 10.1021/bi00043a028; HORIO T, 1971, METHOD ENZYMOL, V23, P650; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; MERBS SL, 1992, PHOTOCHEM PHOTOBIOL, V56, P869, DOI 10.1111/j.1751-1097.1992.tb09708.x; Nasonkin I, 1998, HUM GENET, V102, P21, DOI 10.1007/s004390050649; Papaioannou M, 2000, INVEST OPHTH VIS SCI, V41, P16; Rozet JM, 1999, J MED GENET, V36, P447; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; Souied EH, 2000, INVEST OPHTH VIS SCI, V41, P244; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9	28	154	161	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					242	246		10.1038/79994	http://dx.doi.org/10.1038/79994			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017087				2022-12-27	WOS:000089638800028
J	Chen, AS; Marsh, DJ; Trumbauer, ME; Frazier, EG; Guan, XM; Yu, H; Rosenblum, CI; Vongs, A; Feng, Y; Cao, LH; Metzger, JM; Strack, AM; Camacho, RE; Mellin, TN; Nunes, CN; Min, W; Fisher, J; Gopal-Truter, S; MacIntyre, DE; Chen, HY; Van der Ploeg, LHT				Chen, AS; Marsh, DJ; Trumbauer, ME; Frazier, EG; Guan, XM; Yu, H; Rosenblum, CI; Vongs, A; Feng, Y; Cao, LH; Metzger, JM; Strack, AM; Camacho, RE; Mellin, TN; Nunes, CN; Min, W; Fisher, J; Gopal-Truter, S; MacIntyre, DE; Chen, HY; Van der Ploeg, LHT			Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass	NATURE GENETICS			English	Article							FRAMESHIFT MUTATION; OBESITY; MICE; IDENTIFICATION; MELANOTROPIN; ANTAGONIST; PEPTIDES; LINKAGE; PROTEIN; MC4R	Genetic(1-8) and pharmacological(6,9-12) studies have defined a role for the melanocortin-4 receptor (Mc4r) in the regulation of energy homeostasis. The physiological function of Mc3r, a melanocortin receptor expressed at high levels in the hypothalamus(13), has remained unknown. We evaluated the potential role of Mc3r in energy homeostasis by studying Mc3r-deficient (Mc3r(-/-)) mice and compared the functions of Mc3r and Mc4r in mice deficient for both genes. The 4-6-month Mc3r(-/-) mice have increased fat mass, reduced lean mass and higher feed efficiency than wild-type littermates. despite being hypophagic and maintaining normal metabolic rates. (Feed efficiency is the ratio of weight gain to food intake.) Consistent with increased fat mass. Mc3r(-/-) mice are hyperleptinaemic and male Mc3r(-/-) mice develop mild hyperinsulinaemia. Mc3r(-/-) mice did not have significantly altered corticosterone or total thyroxine (T4) levels. Mice lacking both Mc3r and Mc4r become significantly heavier than Mc4r(-/-) mice. We conclude that Mc3r and Mc4r serve nonredundant roles in the regulation of energy homeostasis.	Merck Res Labs, Dept Obes Res, Rahway, NJ 07065 USA; Merck Res Labs, Dept Anim Pharmacol, Rahway, NJ USA; Merck Res Labs, Dept Comparat Med, Rahway, NJ USA	Merck & Company; Merck & Company; Merck & Company	Van der Ploeg, LHT (corresponding author), Merck Res Labs, Dept Obes Res, Rahway, NJ 07065 USA.		chen, airu/HHM-4281-2022					Bagnol D, 1999, J NEUROSCI, V19; Chagnon YC, 1997, MOL MED, V3, P663, DOI 10.1007/BF03401705; CHEN A, IN PRESS TRANSGENIC; Chhajlani V, 1996, BIOCHEM MOL BIOL INT, V38, P73; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fekete C, 2000, J NEUROSCI, V20, P1550; FRIGERI LG, 1988, INT J OBESITY, V12, P305; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; Guan XM, 1998, MOL BRAIN RES, V59, P273, DOI 10.1016/S0169-328X(98)00150-8; HRUBY VJ, 1995, J MED CHEM, V38, P3454, DOI 10.1021/jm00018a005; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JOHNSON PR, 1972, J LIPID RES, V13, P2; Jones BH, 1996, AM J PHYSIOL-ENDOC M, V270, pE192, DOI 10.1152/ajpendo.1996.270.1.E192; Kelly TL, 1998, APPL RADIAT ISOTOPES, V49, P511, DOI 10.1016/S0969-8043(97)00226-1; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; MICHAUD EJ, 1994, P NATL ACAD SCI USA, V91, P2562, DOI 10.1073/pnas.91.7.2562; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; SHIMIZU H, 1989, LIFE SCI, V45, P543, DOI 10.1016/0024-3205(89)90105-7; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Xue BZ, 1998, FASEB J, V12, P1391, DOI 10.1096/fasebj.12.13.1391; YEN T T T, 1970, Hormone and Metabolic Research, V2, P200; YEN TT, 1976, BIOCHIM BIOPHYS ACTA, V441, P213, DOI 10.1016/0005-2760(76)90164-8; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	30	721	749	0	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					97	102		10.1038/79254	http://dx.doi.org/10.1038/79254			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973258				2022-12-27	WOS:000089078000027
J	Gu, X; Wang, YF; Gu, JY				Gu, X; Wang, YF; Gu, JY			Age distribution of human gene families shows significant roles of both large- and small-scale duplications in vertebrate evolution	NATURE GENETICS			English	Article							GENOME DUPLICATIONS; DIVERGENCE; HYPOTHESIS; SEQUENCE; SUPPORT; REGIONS; TREES; RULE	The classical (two-round) hypothesis(1) of vertebrate genome duplication proposes two successive whole-genome duplication( s) (polyploidizations) predating the origin of fishes, a view now being seriously challenged(2-7). As the debate largely concerns the relative merits of the 'big-bang mode' theory(8-13) (large-scale duplication) and the 'continuous mode' theory (constant creation by small-scale duplications)(2-7,14), we tested whether a significant proportion of paralogous genes in the contemporary human genome was indeed generated in the early stage of vertebrate evolution. After an extensive search of major databases, we dated 1,739 gene duplication events from the phylogenetic analysis of 749 vertebrate gene families. We found a pattern characterized by two waves (I, II) and an ancient component. Wave I represents a recent gene family expansion by tandem or segmental duplications(15), whereas wave II, a rapid paralogous gene increase in the early stage of vertebrate evolution, supports the idea of genome duplication( s) (the big-bang mode). Further analysis indicated that large- and small-scale gene duplications both make a significant contribution during the early stage of vertebrate evolution to build the current hierarchy of the human proteome.	Iowa State Univ, Dept Zool & Genet, Ames, IA 50011 USA; Iowa State Univ, LHB Ctr Bioinformat & Biol Stat, Ames, IA 50011 USA; ATCC, Dept Bioinformat, Manassas, VA USA	Iowa State University; Iowa State University	Gu, X (corresponding author), Iowa State Univ, Dept Zool & Genet, Ames, IA 50011 USA.	xgu@iastate.edu		Wang, Yufeng/0000-0002-9959-4149				Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; Hughes AL, 1999, J MOL EVOL, V48, P565, DOI 10.1007/PL00006499; Hughes AL, 2001, GENOME RES, V11, P771, DOI 10.1101/gr.GR-1600R; Iwabe N, 1996, MOL BIOL EVOL, V13, P483, DOI 10.1093/oxfordjournals.molbev.a025609; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Long MY, 2001, SCIENCE, V293, P1551; Lopreato GF, 2001, P NATL ACAD SCI USA, V98, P7588, DOI 10.1073/pnas.131171798; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Martin A, 2001, MOL BIOL EVOL, V18, P89, DOI 10.1093/oxfordjournals.molbev.a003723; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nadeau JH, 1997, GENETICS, V147, P1259; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; Nikoh N, 1997, J MOL EVOL, V45, P97, DOI 10.1007/PL00006208; Ohno S., 1970, EVOLUTION GENE DUPLI; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHUGHART K, 1989, P NATL ACAD SCI USA, V86, P7067, DOI 10.1073/pnas.86.18.7067; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang YF, 2000, J MOL EVOL, V51, P88, DOI 10.1007/s002390010069; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Xun G, 1998, J MOL EVOL, V47, P369, DOI 10.1007/PL00013150	30	202	212	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2002	31	2					205	209		10.1038/ng902	http://dx.doi.org/10.1038/ng902			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12032571				2022-12-27	WOS:000175903500020
J	Gottlieb, PD; Pierce, SA; Sims, RJ; Yamagishi, H; Weihe, EK; Harriss, JV; Maika, SD; Kuziel, WA; King, HL; Olson, EN; Nakagawa, O; Srivastava, D				Gottlieb, PD; Pierce, SA; Sims, RJ; Yamagishi, H; Weihe, EK; Harriss, JV; Maika, SD; Kuziel, WA; King, HL; Olson, EN; Nakagawa, O; Srivastava, D			Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis	NATURE GENETICS			English	Article							LIGHT CHAIN-2 EXPRESSION; DEVELOPING HEART; CHROMATIN STRUCTURE; MOUSE CD8B; TRANSCRIPTION; DHAND; METHYLTRANSFERASES; SPECIFICATION; LEUKEMIA; SUBCLASS	Many transcription factors regulate specific temporal-spatial events during cardiac differentiation; however, the mechanisms that regulate such events are largely unknown. Using a modified subtractive hybridization method to identify specific genes that influence early cardiac development, we found that Bop is expressed specifically in cardiac and skeletal muscle precursors before differentiation of these lineages. Bop encodes a protein containing MYND and SET domains, which have been shown to regulate transcription by mediating distinct chromatin modifications. We show that m-Bop is a histone deacetylase-dependent transcriptional repressor. Targeted deletion of Bop in mice disrupted maturation of ventricular cardiomyocytes and interfered with formation of the right ventricle. Normal expression of Hand2, a transcription factor essential for right ventricular development, in cardiomyocyte precursors is dependent upon m-Bop. These results indicate that m-Bop is essential for cardiomyocyte differentiation and cardiac morphogenesis.	Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, SW Med Ctr, Dept Pediat Cardiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Gottlieb, PD (corresponding author), Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78712 USA.		Yamagishi, Hiroyuki/A-6345-2017					Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; BERNANKE DH, 1984, DEV BIOL, V106, P360, DOI 10.1016/0012-1606(84)90234-3; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Bruneau BG, 2000, DEV BIOL, V217, P266, DOI 10.1006/dbio.1999.9548; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Firulli AB, 1997, TRENDS GENET, V13, P364, DOI 10.1016/S0168-9525(97)01171-2; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; GREEN SJ, 1988, J CELL SCI, V90, P145; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; HURLE JM, 1980, J EMBRYOL EXP MORPH, V56, P211; Hwang I, 1997, J IMMUNOL, V158, P1165; HWANG I, 1995, IMMUNOGENETICS, V42, P353, DOI 10.1007/BF00179396; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; McFadden DG, 2000, DEVELOPMENT, V127, P5331; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; OBRIEN TX, 1993, P NATL ACAD SCI USA, V90, P5157, DOI 10.1073/pnas.90.11.5157; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Yamagishi H, 1999, SCIENCE, V283, P1158, DOI 10.1126/science.283.5405.1158; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510	38	235	247	2	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2002	31	1					25	32		10.1038/ng866	http://dx.doi.org/10.1038/ng866			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11923873	Bronze			2022-12-27	WOS:000175362500010
J	Ikeda, A; Zheng, QY; Zuberi, AR; Johnson, KR; Naggert, JK; Nishina, PM				Ikeda, A; Zheng, QY; Zuberi, AR; Johnson, KR; Naggert, JK; Nishina, PM			Microtubule-associated protein 1A is a modifier of tubby hearing (moth1)	NATURE GENETICS			English	Article							RETINAL DEGENERATION; GENE FAMILY; MOUSE; IDENTIFICATION; LOCALIZATION; ORGANIZATION; MUTATION; INSULIN; MICE	Once a mutation in the gene tub was identified as the cause of obesity, retinal degeneration and hearing loss in tubby mice(1-2), it became increasingly evident that the members of the tub gene family (tulps) influence maintenance and function of the neuronal cell lineage(3-6). Suggested molecular functions of tubby-like proteins include roles in vesicular trafficking(4,7), mediation of insulin signaling(8) and gene transcription(9,10). The mechanisms through which tub functions in neurons, however, have yet to be elucidated. Here we report the positional cloning of an auditory quantitative trait locus (QTL), the modifier of tubby hearing 1 gene (moth1)(11), whose wildtype alleles from strains AKR/J, CAST/Ei and 129P2/OlaHsd protect tubby mice from hearing loss. Through a transgenic rescue experiment, we verified that sequence polymorphisms in the neuron-specific microtubule-associated protein 1a gene (Mtap1a) observed in the susceptible strain C57BL/6J(B6) are crucial for the hearing-loss phenotype. We also show that these polymorphisms change the binding efficiency of MTAP1A to postsynaptic density molecule 95 (PSD95), a core component in the cytoarchitecture of synapses. This indicates that at least some of the observed polymorphisms are functionally important and that the hearing loss in C57BL/6J-tub/tub (B6-tub/tub) mice may be caused by impaired protein interactions involving MTAP1A. We therefore propose that tub may be associated with synaptic function in neuronal cells.	Jackson Lab, Bar Harbor, ME 04609 USA; Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Jackson Laboratory; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Nishina, PM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.		Zheng, Qing/C-1731-2012	Ikeda, Akihiro/0000-0001-8440-3891	NATIONAL EYE INSTITUTE [R01EY016501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004376, R01DC004301, R01DC005827] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016501-06, R01 EY016501] Funding Source: Medline; NIDCD NIH HHS [R01 DC005827-01, R01 DC004301, R03 DC004376-01A1, R01 DC004301-01, R01 DC005827] Funding Source: Medline; NIDDK NIH HHS [R01 DK046977-10, R01 DK046977, R01 DK046977-07] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; Brenman JE, 1998, J NEUROSCI, V18, P8805; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Hagstrom SA, 2001, INVEST OPHTH VIS SCI, V42, P1955; Hata Y, 1999, CELL MOL LIFE SCI, V56, P461, DOI 10.1007/s000180050445; HECKENLIVELY JR, 1995, P NATL ACAD SCI USA, V92, P11100, DOI 10.1073/pnas.92.24.11100; Ikeda A, 1999, HUM MOL GENET, V8, P1761, DOI 10.1093/hmg/8.9.1761; Ikeda A, 2001, HUM MOL GENET, V10, P1325, DOI 10.1093/hmg/10.12.1325; Ikeda S, 1999, INVEST OPHTH VIS SCI, V40, P2706; Ikeda S, 2000, HUM MOL GENET, V9, P155, DOI 10.1093/hmg/9.2.155; Kapeller R, 1999, J BIOL CHEM, V274, P24980, DOI 10.1074/jbc.274.35.24980; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Ohlemiller KK, 1997, AUDIOL NEURO-OTOL, V2, P175, DOI 10.1159/000259242; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Stubdal H, 2000, MOL CELL BIOL, V20, P878, DOI 10.1128/MCB.20.3.878-882.2000; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8	20	70	72	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					401	405		10.1038/ng838	http://dx.doi.org/10.1038/ng838			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11925566	Green Accepted			2022-12-27	WOS:000174682000017
J	Cuesta, A; Pedrola, L; Sevilla, T; Garcia-Planells, J; Chumillas, MJ; Mayordomo, F; LeGuern, E; Marin, I; Vilchez, JJ; Palau, F				Cuesta, A; Pedrola, L; Sevilla, T; Garcia-Planells, J; Chumillas, MJ; Mayordomo, F; LeGuern, E; Marin, I; Vilchez, JJ; Palau, F			The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease	NATURE GENETICS			English	Article							CMT4A LOCUS; TRANSFERASES	We identified three distinct mutations and six mutant alleles in GDAP1 in three families with axonal Charcot-Marie-Tooth (CMT) neuropathy and vocal cord paresis, which were previously linked to the CMT4A locus on chromosome 8q21.1. These results establish the molecular etiology of CMT4A (MIM 214400) and suggest that it may be associated with both axonal and demyelinating phenotypes.	CSIC, Inst Biomed, Lab Genet & Mol Med, E-46010 Valencia, Spain; Univ Valencia, Hosp La Fe, Dept Neurol, E-46100 Valencia, Spain; Univ Valencia, Hosp La Fe, Dept Clin Neurophysiol, E-46100 Valencia, Spain; Univ Valencia, Hosp La Fe, Dept Pathol, E-46100 Valencia, Spain; Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris, France; Hop La Pitie Salpetriere, Dept Genet Cytogenet & Foetopathol, F-75651 Paris, France; Univ Valencia, Dept Genet, E-46100 Valencia, Spain; Univ Valencia, Inst Cavanilles Biodivers & Biol Evolut, E-46100 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Hospital Universitari i Politecnic La Fe; University of Valencia; Hospital Universitari i Politecnic La Fe; University of Valencia; Hospital Universitari i Politecnic La Fe; University of Valencia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Valencia; University of Valencia	Palau, F (corresponding author), CSIC, Inst Biomed, Lab Genet & Mol Med, Jaime Roig 11, E-46010 Valencia, Spain.	fpalau@ibv.csic.es	Palau, Francesc/A-9391-2014; Sevilla, Teresa/L-3292-2017; Marin, Ignacio/A-9524-2009	Palau, Francesc/0000-0002-8635-5421; Marin, Ignacio/0000-0002-1315-8961; Garcia-Planells, Javier/0000-0002-3224-2966; Sevilla, Teresa/0000-0003-4716-2667; Pedrola, Laia/0000-0002-3031-6124; Vilchez, Juan J/0000-0002-0532-2872				Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796; Ben Othmane K, 1998, NEUROGENETICS, V2, P18, DOI 10.1007/s100480050047; BENOTHMANE K, 1995, GENOMICS, V28, P286, DOI 10.1006/geno.1995.1143; Dyck P.J, 1993, PNP, P1094; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HENTATI F, 2001, ACTA MYOL, V20, P25; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lewis RA, 2000, MUSCLE NERVE, V23, P1472, DOI 10.1002/1097-4598(200010)23:10<1472::AID-MUS3>3.0.CO;2-#; Liu H, 1999, J NEUROCHEM, V72, P1781, DOI 10.1046/j.1471-4159.1999.0721781.x; Lupski JR, 2001, METABOLIC MOL BASES, P5759; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; Salinas AE, 1999, CURR MED CHEM, V6, P279; SEVILLA T, 2001, ACTA MYOL, V20, P49	14	261	269	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					22	25		10.1038/ng798	http://dx.doi.org/10.1038/ng798			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743580				2022-12-27	WOS:000173105600007
J	Miceli-Richard, C; Lesage, S; Rybojad, M; Prieur, AM; Manouvrier-Hanu, S; Hafner, R; Chamaillard, M; Zouali, H; Thomas, G; Hugot, JP				Miceli-Richard, C; Lesage, S; Rybojad, M; Prieur, AM; Manouvrier-Hanu, S; Hafner, R; Chamaillard, M; Zouali, H; Thomas, G; Hugot, JP			CARD15 mutations in Blau syndrome	NATURE GENETICS			English	Article							FAMILIAL GRANULOMATOUS ARTHRITIS; EARLY-ONSET; SKIN RASH; SARCOIDOSIS; IRITIS	We have identified three missense mutations in the nucleotide-binding domain (NBD) of CARD15/NOD2 in four French and German families with Blau syndrome. Our findings indicate that, in addition to Crohn disease, CARD15 is involved in the susceptibility to a second granulomatous disorder.	CEPH, Fdn Jean Dausset, Paris, France; Hop Robert Debre, F-75019 Paris, France; Hop Necker Enfants Malad, Dept Pediat Immunol, Paris, France; Hop Jeanne de Flandre, Dept Genet, Lille, France; Childrens Hosp, Dept Pediat Rheumatol, Garmish Partenkirchen, Germany; INSERM, U434, Paris, France	Foundation Jean Dausset-CEPH; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hugot, JP (corresponding author), CEPH, Fdn Jean Dausset, Paris, France.		Chamaillard, Mathias/L-6542-2013; Hugot, Jean-Pierre/F-6594-2012	Chamaillard, Mathias/0000-0002-0243-9717; Hugot, Jean-Pierre/0000-0002-8446-6056				BLAU EB, 1985, J PEDIATR-US, V107, P689, DOI 10.1016/S0022-3476(85)80394-2; HAFNER R, 1993, CLIN EXP RHEUMATOL, V11, P685; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Manouvrier-Hanu S, 1998, AM J MED GENET, V76, P217, DOI 10.1002/(SICI)1096-8628(19980319)76:3<217::AID-AJMG4>3.0.CO;2-N; MILLER JJ, 1986, J PEDIATR-US, V109, P387, DOI 10.1016/S0022-3476(86)80411-5; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P21228, DOI 10.1074/jbc.M011381200; Tromp G, 1996, AM J HUM GENET, V59, P1097	9	701	737	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					19	20		10.1038/ng720	http://dx.doi.org/10.1038/ng720			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528384				2022-12-27	WOS:000170781300008
J	Parkinson, NJ; Olsson, CL; Hallows, JL; McKee-Johnson, J; Keogh, BP; Noben-Trauth, K; Kujawa, SG; Tempel, BL				Parkinson, NJ; Olsson, CL; Hallows, JL; McKee-Johnson, J; Keogh, BP; Noben-Trauth, K; Kujawa, SG; Tempel, BL			Mutant beta-spectrin 4 causes auditory and motor neuropathies in quivering mice	NATURE GENETICS			English	Article							CHANNEL; NEURONS; EXPRESSION	The autosomal recessive mouse mutation quivering (qv), which arose spontaneously in 1953, produces progressive ataxia with hind limb paralysis, deafness and tremor(1). Six additional spontaneous alleles, qv(J), qv(2J), qv(3J), qv(4J) qv(ind) and qv(Ind2J), have been identified(2,3). Ear twitch responses (Preyer's reflex) to sound are absent in homozygous qv/qv mice, although cochlear morphology seems normal and cochlear potentials recorded at the round window are no different from those of control mice(4). However, responses from brainstem auditory nuclei show abnormal transmission of auditory information, indicating that, in contrast to the many known mutations causing deafness originating in the cochlea, deafness in qv is central in origin(4-6). Here we report that quivering mice carry loss-of-function mutations in the mouse beta -spectrin 4 gene (Spnb4) that cause alterations in ion channel localization in myelinated nerves; this provides a rationale for the auditory and motor neuropathies of these mice.	Univ Washington, Sch Med, Virginia Merrill Bloedel Hearing Res Ctr, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Otolaryngol Head & Neck Surg, Seattle, WA USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Natl Inst Deafness & Other Commun Disorders, Neurogenet Sect, NIH, Rockville, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Tempel, BL (corresponding author), Univ Washington, Sch Med, Virginia Merrill Bloedel Hearing Res Ctr, Seattle, WA 98195 USA.				NIDCD NIH HHS [DC02739, DC04661, Z01DC00056-01, DC00018] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000056, R01DC002739, P30DC004661, Z01DC000036] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; BOCK GR, 1983, ACTA OTO-LARYNGOL, V96, P371, DOI 10.3109/00016488309132722; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; BRONSON RT, 1992, J NEUROGENET, V8, P71, DOI 10.3109/01677069209084153; DEOL MS, 1983, BRAIN RES, V258, P177, DOI 10.1016/0006-8993(83)91248-9; Grosson CLS, 1996, MOL BRAIN RES, V42, P222, DOI 10.1016/S0169-328X(96)00123-4; Hallows JL, 1998, J NEUROSCI, V18, P5682; HORNER KC, 1985, BRAIN RES, V331, P217, DOI 10.1016/0006-8993(85)91547-1; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Keogh B, 1998, J CELL PHYSIOL, V176, P624, DOI 10.1002/(SICI)1097-4652(199809)176:3<624::AID-JCP19>3.0.CO;2-Z; Kujawa SG, 1999, J NEUROPHYSIOL, V82, P863, DOI 10.1152/jn.1999.82.2.863; Leal A, 2001, AM J HUM GENET, V68, P269, DOI 10.1086/316934; RAUCH SD, 1987, MOUSE NEWS LETT, V78, P44; Sambrook J., 2002, MOL CLONING LAB MANU; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Tse WT, 2001, J BIOL CHEM, V276, P23974, DOI 10.1074/jbc.M009307200; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WILLIAMS GW, 1998, NIX NUCLEOTIDE IDENT; WILLIAMS GW, 1999, PIX PEPTIDE IDENTIFI; YOON C. H., 1957, JOUR HEREDITY, V48, P176; Zeng FG, 1999, NEUROREPORT, V10, P3429, DOI 10.1097/00001756-199911080-00031	24	98	100	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					61	65		10.1038/ng710	http://dx.doi.org/10.1038/ng710			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528393				2022-12-27	WOS:000170781300018
J	Cho, C; Willis, WD; Goulding, EH; Haesook, JH; Choi, YC; Hecht, NB; Eddy, EM				Cho, C; Willis, WD; Goulding, EH; Haesook, JH; Choi, YC; Hecht, NB; Eddy, EM			Haploinsufficiency of protamine-1 or-2 causes infertility in mice	NATURE GENETICS			English	Article							MAMMALIAN SPERM NUCLEI; MALE GERM-CELLS; MOUSE PROTAMINE-1; PROTEINS; SEQUENCE; FERTILITY; DEFICIENT; GENES; CDNA	Protamines are the major DNA-binding proteins in the nucleus of sperm in most vertebrates(1-5) and package the DNA in a volume less than 5% of a somatic cell nucleus(6). Many mammals have one protamine, but a few species, including humans and mice, have two(7-13). Here we use gene targeting to determine if the second protamine provides redundancy to an essential process, or if both protamines are necessary. We disrupted the coding sequence of one allele of either Prm1 or Prm2 in embryonic stem (ES) cells derived from 129-strain mice, and injected them into blastocysts from C57BL/6-strain mice. Male chimeras produced 129-genotype sperm with disrupted Prm1 or Prm2 alleles, but failed to sire offspring carrying the 129 genome. We also found that a decrease in the amount of either protamine disrupts nuclear formation, processing of protamine-2 and normal sperm function. Our studies show that both protamines are essential and that haploinsufficiency caused by a mutation in one allele of Prm1or Prm2 prevents genetic transmission of both mutant and wild-type alleles.	NIEHS, Gamet Biol Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; Univ Penn, Med Ctr, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Eddy, EM (corresponding author), NIEHS, Gamet Biol Sect, Reprod & Dev Toxicol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	eddy@niehs.nih.gov			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070076, ZIAES070076] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BALHORN R, 1977, BIOCHEMISTRY-US, V16, P4074, DOI 10.1021/bi00637a021; BALHORN R, 1984, EXP CELL RES, V150, P298, DOI 10.1016/0014-4827(84)90572-X; BALHORN R, 1988, EXPERIENTIA, V44, P52, DOI 10.1007/BF01960243; Balhorn R., 1989, P366; Balhorn R, 1999, MALE GAMETE: FROM BASIC SCIENCE TO CLINICAL APPLICATIONS, P55; BELLVE AR, 1975, DEV BIOL, V47, P349, DOI 10.1016/0012-1606(75)90289-4; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; CALDWELL KA, 1991, P NATL ACAD SCI USA, V88, P2407, DOI 10.1073/pnas.88.6.2407; CHO C, 1997, PCR METHOD DISTINGUI; DEBARLE M, 1995, MOL REPROD DEV, V40, P84, DOI 10.1002/mrd.1080400111; DEYEBRA L, 1993, J BIOL CHEM, V268, P10553; DOMENJOUD L, 1988, NUCLEIC ACIDS RES, V16, P7733, DOI 10.1093/nar/16.15.7733; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; HECHT NB, 1990, J REPROD FERTIL, V88, P679, DOI 10.1530/jrf.0.0880679; Hecht NB, 1989, HISTONES OTHER BASIC, P347; KLEENE KC, 1985, BIOCHEMISTRY-US, V24, P719, DOI 10.1021/bi00324a027; KOSOWER NS, 1992, J ANDROL, V13, P342; Kuratani S, 1997, DEV DYNAM, V209, P139, DOI 10.1002/(SICI)1097-0177(199706)209:2<139::AID-AJA1>3.0.CO;2-J; Lee K, 1995, P NATL ACAD SCI USA, V92, P12451, DOI 10.1073/pnas.92.26.12451; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; MCKAY DJ, 1985, BIOSCIENCE REP, V5, P383, DOI 10.1007/BF01116555; Meistrich M., 1989, HISTONES OTHER BASIC, P165; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; STANKER LH, 1993, MOL IMMUNOL, V30, P1633, DOI 10.1016/0161-5890(93)90436-F; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; WYROBEK AJ, 1976, BIOPHYS J, V16, P811, DOI 10.1016/S0006-3495(76)85730-X; YELICK PC, 1987, MOL CELL BIOL, V7, P2173, DOI 10.1128/MCB.7.6.2173; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683	28	388	405	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					82	86		10.1038/ng0501-82	http://dx.doi.org/10.1038/ng0501-82			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326282				2022-12-27	WOS:000168413300022
J	Gopal, S; Schroeder, M; Pieper, U; Sczyrba, A; Aytekin-Kurban, G; Bekiranov, S; Fajardo, JE; Eswar, N; Sanchez, R; Sali, A; Gaasterland, T				Gopal, S; Schroeder, M; Pieper, U; Sczyrba, A; Aytekin-Kurban, G; Bekiranov, S; Fajardo, JE; Eswar, N; Sanchez, R; Sali, A; Gaasterland, T			Homology-based annotation yields 1,042 new candidate genes in the Drosophila melanogaster genome	NATURE GENETICS			English	Letter							PSI-BLAST; DATABASE; DNA; DISCOVERY	The approach to annotating a genome critically affects the number acid accuracy of genes identified in the genome sequence. Genome annotation based on stringent gene identification is prone to underestimate the complement of genes encoded in a genome. In contrast, over-prediction of putative genes followed by exhaustive computational sequence, motif and structural homology search will find rarely expressed, possibly unique, new genes at the risk of including non-functional genes. We developed a two-stage approach that combines the merits of stringent genome annotation with the benefits of over-prediction. First we identify plausible genes regardless of matches with EST, cDNA or protein sequences from the organism (stage 1). In the second stage, proteins predicted from the plausible genes are compared at the protein level with EST. cDNA and protein sequences, and protein structures from other organisms (stage 2). Remote but biologically meaningful protein sequence or structure homologies provide supporting evidence for genuine genes. The method, applied to the Drosophila melanogaster genome, validated 1,042 novel candidate genes after filtering 19,410 plausible genes, of which 12,124 matched the original 13,601 annotated genes(1). This annotation strategy is applicable to genomes of all organisms, including human.	Rockefeller Univ, Lab Computat Genom, New York, NY 10021 USA; Rockefeller Univ, Dept Biophys, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Gaasterland, T (corresponding author), Rockefeller Univ, Lab Computat Genom, 1230 York Ave, New York, NY 10021 USA.	gaasterland@rockefeller.edu	Pieper, Ursula/E-4444-2010	Pieper, Ursula/0000-0002-3168-8122	NCI NIH HHS [R33CA84699] Funding Source: Medline; NIGMS NIH HHS [P50GM62529] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA084699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062529] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Bhat TN, 2001, NUCLEIC ACIDS RES, V29, P214, DOI 10.1093/nar/29.1.214; BOGUSKI MS, 1994, SCIENCE, V265, P1993, DOI 10.1126/science.8091218; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Burley SK, 1999, NAT GENET, V23, P151, DOI 10.1038/13783; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Gaasterland T, 2000, GENOME RES, V10, P502, DOI 10.1101/gr.10.4.502; Gaasterland T, 1998, Microb Comp Genomics, V3, P177, DOI 10.1089/omi.1.1998.3.177; Henikoff JG, 1999, NUCLEIC ACIDS RES, V27, P226, DOI 10.1093/nar/27.1.226; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Reese MG, 2000, GENOME RES, V10, P483, DOI 10.1101/gr.10.4.483; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez R, 1999, BIOINFORMATICS, V15, P1060, DOI 10.1093/bioinformatics/15.12.1060; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Sanchez R, 1997, PROTEINS, P50; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455	26	47	51	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					337	340		10.1038/85922	http://dx.doi.org/10.1038/85922			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242120				2022-12-27	WOS:000167304200030
J	Daluiski, A; Engstrand, T; Bahamonde, ME; Gamer, LW; Agius, E; Stevenson, SL; Cox, K; Rosen, V; Lyons, KM				Daluiski, A; Engstrand, T; Bahamonde, ME; Gamer, LW; Agius, E; Stevenson, SL; Cox, K; Rosen, V; Lyons, KM			Bone morphogenetic protein-3 is a negative regulator of bone density	NATURE GENETICS			English	Article							SIGNALING PATHWAYS; II RECEPTORS; ACTIVIN-A; DIFFERENTIATION; EXPRESSION; CELLS; IDENTIFICATION; CULTURES; OSTEOPOROSIS; DROSOPHILA	Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-beta (TGF-beta) superfamily. Many BMPs are produced in bone and show osteogenic activity, suggesting that they may be determinants of bone mass. BMP3 was originally purified from bone as osteogenin, which induces osteogenic differentiation(1). Recombinant BMP3 (rhBMP3) has no biological activity, however, leaving its role in skeletal growth unclear. Here we show that BMP3 is an antagonist of osteogenic BMPs: BMP3 dorsalizes Xenopus laevis embryos, inhibits BMP2-mediated induction of Msx2 and blocks BMP2-mediated differentiation of osteoprogenitor cells into osteoblasts. These effects appear to be mediated through activin receptors. Finally, Smp3(-/-) mice have twice as much trabecular bone as wild-type littermates, indicating that BMP3, the most abundant BMP in adult bone, is a negative determinant of bone density.	Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; Inst Genet, Cambridge, MA USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Case Western Reserve University	Lyons, KM (corresponding author), Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90024 USA.		agius, Eric/AHC-9705-2022	Agius, Eric/0000-0003-2123-9283	NIAMS NIH HHS [AR44528] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044528] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Candia AF, 1997, DEVELOPMENT, V124, P4467; CENTRELLA M, 1991, MOL CELL BIOL, V11, P250, DOI 10.1128/MCB.11.1.250; CENTRELLA M, 1995, MOL CELL BIOL, V15, P3273; Engstrand T, 2000, HUM GENE THER, V11, P205, DOI 10.1089/10430340050016274; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; HARLAND RM, 1994, P NATL ACAD SCI USA, V91, P10243, DOI 10.1073/pnas.91.22.10243; HAZAMA M, 1995, BIOCHEM BIOPH RES CO, V209, P859, DOI 10.1006/bbrc.1995.1578; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Ikenoue T, 1999, J CELL BIOCHEM, V75, P206, DOI 10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.3.CO;2-K; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; LIU YH, 1995, P NATL ACAD SCI USA, V92, P6137, DOI 10.1073/pnas.92.13.6137; LUYTEN FP, 1989, J BIOL CHEM, V264, P13377; LUYTEN FP, 1992, J BIOL CHEM, V267, P3691; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Piek E, 1999, J CELL PHYSIOL, V180, P141, DOI 10.1002/(SICI)1097-4652(199908)180:2<141::AID-JCP1>3.0.CO;2-I; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; Takao M, 1996, BIOCHEM BIOPH RES CO, V219, P656, DOI 10.1006/bbrc.1996.0289; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; Wozney J. M., 1993, PHYSL PHARM BONE, P725; Yi SE, 2000, DEVELOPMENT, V127, P621; Zhao RB, 1999, DEV BIOL, V212, P68, DOI 10.1006/dbio.1999.9326; Zmuda JM, 1999, GENET EPIDEMIOL, V16, P356, DOI 10.1002/(SICI)1098-2272(1999)16:4<356::AID-GEPI3>3.0.CO;2-I	30	313	358	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					84	88		10.1038/83810	http://dx.doi.org/10.1038/83810			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138004				2022-12-27	WOS:000166187900021
J	Lewandoski, M; Sun, X; Martin, GR				Lewandoski, M; Sun, X; Martin, GR			Fgf8 signalling from the AER is essential for normal limb development	NATURE GENETICS			English	Article							APICAL ECTODERMAL RIDGE; VERTEBRATE LIMB; MOUSE; OUTGROWTH; INITIATION; ROLES; GENE; MORPHOGENESIS; GASTRULATION; MAINTENANCE	Vertebrate limb development depends on signals from the apical ectodermal ridge (AER), which rims the distal tip of the limb bud(1). Removal of the AER in chick results in limbs lacking distal skeletal elements(2,3). Fibroblast growth factor (FGF) proteins can substitute for the AER (refs 4-7), suggesting that FGF signalling mediates AER activity. Of the four mouse Fgf genes (Fgf4, Fgf8, Fgf9, Fgf17) known to display AER-specific expression domains within the limb bud (AER-Fgfs), only Fgf8 is expressed throughout the AER. Moreover, Fgf8 expression precedes that of other AER-Fgfs (refs 8-13), suggesting that Fgf8 may perform unique functions early in limb development(6,7). In mice, loss of function of Fgf4 (refs 13,14), Fgf9 (D. Ornitz, pers. comm.) or Fgf17 (ref. 15) has no effect on limb formation. We report here that inactivating Fgf8 in early limb ectoderm causes a substantial reduction in limb-bud size, a delay in Shh expression, misregulation of Fgf4 expression, and hypoplasia or aplasia of specific skeletal elements. Our data identify Fgf8 as the only known AER-Fgf individually necessary for normal limb development, and provide insight into the function of Fgf signalling from the AER in the normal outgrowth and patterning of the limb.	Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Program Dev Biol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Martin, GR (corresponding author), Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA.			Lewandoski, Mark/0000-0002-1066-3735	NICHD NIH HHS [R01 HD34380] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034380] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; MAHMOOD R, 1995, CURR BIOL, V5, P797, DOI 10.1016/S0960-9822(95)00157-6; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Merino R, 1999, DEVELOPMENT, V126, P5515; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Moon AM, 2000, DEVELOPMENT, V127, P989; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1992, DEVELOPMENT, V114, P755; OHUCHI H, 1994, BIOCHEM BIOPH RES CO, V204, P882, DOI 10.1006/bbrc.1994.2542; Pizette S, 1999, DEVELOPMENT, V126, P883; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tabin CJ, 1998, NATURE, V396, P322, DOI 10.1038/24516; TICKLE C, 1994, ANNU REV CELL BIOL, V10, P121; Vogel A, 1996, DEVELOPMENT, V122, P1737; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu JS, 2000, DEVELOPMENT, V127, P1833; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	30	345	357	1	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					460	463		10.1038/82609	http://dx.doi.org/10.1038/82609			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101846				2022-12-27	WOS:000165671700021
J	Gharavi, AG; Yan, Y; Scolari, F; Schena, FP; Frasca, GM; Ghiggeri, GM; Cooper, K; Amoroso, A; Viola, BF; Battini, G; Caridi, G; Canova, C; Farhi, A; Subramanian, V; Nelson-Williams, C; Woodford, S; Julian, BA; Wyatt, RJ; Lifton, RP				Gharavi, AG; Yan, Y; Scolari, F; Schena, FP; Frasca, GM; Ghiggeri, GM; Cooper, K; Amoroso, A; Viola, BF; Battini, G; Caridi, G; Canova, C; Farhi, A; Subramanian, V; Nelson-Williams, C; Woodford, S; Julian, BA; Wyatt, RJ; Lifton, RP			IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; NATURAL-HISTORY; IMMUNOGLOBULIN; DISEASE; POLYMORPHISM; POPULATIONS; GUIDELINES; WORLDWIDE; LOCI	End-stage renal disease (ESRD) is a major public: health problem, affecting 1 in 1,000 individuals and with an annual death rate of 20% despite dialysis treatment(1,2). IgA nephropathy (IgAN) is the most common form of glomerulonephritis, a principal cause of ESRD worldwide(1,2); it affects up to 1.3% of the population(3-6) and its pathogenesis Is unknown. Kidneys of people with IgAN show deposits of IgA-containing immune complexes with proliferation of the glomerular mesangium (Fig. 1). Typical clinical features include onset before age 40 with haematuria and proteinuria (blood and protein in the urine), and episodes of gross haematuria following mucosal infections are common; 30% of patients develop progressive renal failure(6-9). Although not generally considered a hereditary disease, striking ethnic variation in prevalence(1-6,10) and familial clustering(11-16), along with subclinical renal abnormalities among relatives of IgAN cases(9,14-16), have suggested a heretofore undefined genetic component. By genome-wide analysis of linkage in 30 multiplex IgAN kindreds, we demonstrate linkage of IgAN to 6q22-23 under a dominant model of transmission with incomplete penetrance, with a lod score of 5.6 and 60% of kindreds linked. These findings for the first time indicate the existence of a locus with large effect on development of IgAN and identify the chromosomal location of this disease gene.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; Mt Sinai Sch Med, Dept Med, New York, NY USA; Univ Brescia, Spedali Civili, Div Nephrol, Brescia, Italy; Univ Brescia, Spedali Civili, Chair Nephrol, Brescia, Italy; Univ Bari, Inst Nephrol, Polyclin, Bari, Italy; Policlin S Orsola, Div Nephrol, Bologna, Italy; Giannina Gaslini Inst, Lab Nephrol, Genoa, Italy; Giannina Gaslini Inst, Dept Nephrol, Genoa, Italy; IRCCS Burlo Garofolo, Serv Genet, Trieste, Italy; IRCCS Burlo Garofolo, Cattedra Genet, Trieste, Italy; Denzenzano Hosp, Dialysis Serv, Desenzano, Italy; St Orsola Univ Hosp, Dept Nephrol, Bologna, Italy; Univ Tennessee, Ctr Hlth Sci, Crippled Childrens Res Fdn, Memphis, TN 38163 USA; Univ Alabama, Dept Med, Birmingham, AL 35294 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Icahn School of Medicine at Mount Sinai; Hospital Spedali Civili Brescia; University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; Universita degli Studi di Bari Aldo Moro; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.		amoroso, antonio/AAL-1475-2020; AMOROSO, ANTONIO/AAN-3884-2020; Ghiggeri, Gian Marco/N-4712-2015; Schena, Francesco P/K-6982-2016; Caridi, Gianluca/F-7052-2010; scolari, francesco/AAC-5957-2022	amoroso, antonio/0000-0002-9437-9407; Ghiggeri, Gian Marco/0000-0003-3659-9062; Schena, Francesco P/0000-0001-7927-5207; Caridi, Gianluca/0000-0001-6700-3001; Scolari, Francesco/0000-0003-0233-9705; Wyatt, Robert/0000-0001-6077-0259				Allen AC, 1997, NEPHROL DIAL TRANSPL, V12, P701, DOI 10.1093/ndt/12.4.701; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; DAMICO G, 1987, Q J MED, V64, P709; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; Fennessy M, 1996, KIDNEY INT, V49, P477, DOI 10.1038/ki.1996.67; HOY WE, 1993, AM J KIDNEY DIS, V21, P486, DOI 10.1016/S0272-6386(12)80394-5; IBELS LS, 1994, MEDICINE, V73, P79, DOI 10.1097/00005792-199403000-00002; JENNETTE JC, 1985, KIDNEY INT, V28, P944, DOI 10.1038/ki.1985.222; Julian B A, 1999, Adv Nephrol Necker Hosp, V29, P53; JULIAN BA, 1985, NEW ENGL J MED, V312, P202, DOI 10.1056/NEJM198501243120403; JULIAN BA, 1988, AM J MED, V84, P129, DOI 10.1016/0002-9343(88)90019-8; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Maisonneuve P, 2000, AM J KIDNEY DIS, V35, P157, DOI 10.1016/S0272-6386(00)70316-7; SCHENA FP, 1993, CONTRIB NEPHROL, V104, P36; SCHENA FP, 1990, AM J MED, V89, P209; SCHENA FP, 1995, KIDNEY INT, V48, P1998, DOI 10.1038/ki.1995.503; Scolari F, 1999, AM J KIDNEY DIS, V33, P857, DOI 10.1016/S0272-6386(99)70417-8; SCOLARI F, 1992, NEPHROL DIAL TRANSPL, V7, P587, DOI 10.1093/ndt/7.7.587; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; *US REN DAT SYST, USRDS 1999 ANN DAT R; van Zandbergen G, 1998, NEPHROL DIAL TRANSPL, V13, P3058, DOI 10.1093/ndt/13.12.3058; VARIS J, 1993, J CLIN PATHOL, V46, P607, DOI 10.1136/jcp.46.7.607; WYATT RJ, 1987, AM J HUM GENET, V41, P36; Yano N, 1998, J IMMUNOL, V160, P4936; Zhang ZJ, 1997, DNA CELL BIOL, V16, P73, DOI 10.1089/dna.1997.16.73; Zheng F, 1999, NAT MED, V5, P1018, DOI 10.1038/12458	30	225	253	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					354	357		10.1038/81677	http://dx.doi.org/10.1038/81677			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062479	Green Published			2022-12-27	WOS:000165176500028
J	Janssens, K; Gershoni-Baruch, R; Guanabens, N; Migone, N; Ralston, S; Bonduelle, M; Lissens, W; Van Maldergem, L; Vanhoenacker, F; Verbruggen, L; Van Hul, W				Janssens, K; Gershoni-Baruch, R; Guanabens, N; Migone, N; Ralston, S; Bonduelle, M; Lissens, W; Van Maldergem, L; Vanhoenacker, F; Verbruggen, L; Van Hul, W			Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; PRO REGION; TGF-BETA; BONE; FACTOR-BETA-1; CULTURES		Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Rambam Med Ctr, Inst Human Genet, Haifa, Israel; Hosp Clin Barcelona, Dept Rheumatol, Barcelona, Spain; Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland; Univ Hosp Brussels, Dept Med Genet, Brussels, Belgium; Univ Hosp Brussels, Dept Rheumatol, Brussels, Belgium; Inst Pathol & Genet, Ctr Human Genet, Loverval, Belgium; Univ Antwerp Hosp, Dept Radiol, Antwerp, Belgium	University of Antwerp; Rambam Health Care Campus; Technion Israel Institute of Technology; University of Barcelona; Hospital Clinic de Barcelona; University of Turin; University of Aberdeen; University Hospital Brussels; University Hospital Brussels; University of Antwerp	Van Hul, W (corresponding author), Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium.	vhuh@uia.ua.ac.be	Lissens, Willy/B-2892-2013; Van Maldergem, Lionel/G-9849-2017; Van Maldergem, Lionel/O-3242-2019	Lissens, Willy/0000-0003-3875-9955; Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Van Hul, Wim/0000-0002-5065-7858; Bonduelle, Mary-Louise/0000-0002-1805-9962				BECK LS, 1991, J BONE MINER RES, V6, P961; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Fuller K, 2000, J CELL SCI, V113, P2445; Galvin RJS, 1999, BIOCHEM BIOPH RES CO, V265, P233, DOI 10.1006/bbrc.1999.1632; Ghadami M, 2000, AM J HUM GENET, V66, P143, DOI 10.1086/302728; Janssens K, 2000, J MED GENET, V37, P245, DOI 10.1136/jmg.37.4.245; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; MUNDY GR, 1991, CIBA F SYMP, V157, P137; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991; PFEILSCHIFTER J, 1988, J CLIN INVEST, V82, P680, DOI 10.1172/JCI113647; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Roberts Anita B., 2000, P221; SHA X, 1991, J CELL BIOL, V114, P827, DOI 10.1083/jcb.114.4.827; Vaughn SP, 2000, GENOMICS, V66, P119, DOI 10.1006/geno.2000.6192; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569	16	163	178	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					273	275		10.1038/81563	http://dx.doi.org/10.1038/81563			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062463				2022-12-27	WOS:000165176500012
J	Meloni, I; Muscettola, M; Raynaud, M; Longo, I; Bruttini, M; Moizard, MP; Gomot, M; Chelly, J; des Portes, V; Fryns, JP; Ropers, HH; Magi, B; Bellan, C; Volpi, N; Yntema, HG; Lewis, SE; Schaffer, JE; Renieri, A				Meloni, I; Muscettola, M; Raynaud, M; Longo, I; Bruttini, M; Moizard, MP; Gomot, M; Chelly, J; des Portes, V; Fryns, JP; Ropers, HH; Magi, B; Bellan, C; Volpi, N; Yntema, HG; Lewis, SE; Schaffer, JE; Renieri, A			FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation	NATURE GENETICS			English	Article							ALPORT-SYNDROME; RETT-SYNDROME; MIDFACE HYPOPLASIA; GENE; SYNTHETASE; ELLIPTOCYTOSIS; IDENTIFICATION; MECP2; INACTIVATION; EXPRESSION	X-linked mental retardation (XLMR) is an inherited condition that causes failure to develop cognitive abilities, owing to mutations in a gene on the X chromosome. The latest XLMR update lists up to 136 conditions leading to 'syndromic', or 'specific', mental retardation (MRXS) and 66 entries leading to 'nonspecific' mental retardation (MRX)(1). For 9 of the 66 MRX entries, the causative gene has been identified 1. Our recent discovery of the contiguous gene deletion syndrome ATS-MR (previously known as Alport syndrome, mental retardation, midface hypoplasia, elliptocytosis, OMIM #300194), characterized by Alport syndrome (ATS) and mental retardation (MR), indicated Xq22.3 as a region containing one mental retardation gene(2,3). Comparing the extent of deletion between individuals with ATS-MR and individuals with ATS alone allowed us to define a critical region for mental retardation of approximately 380 kb, containing four genes(4-6). Here we report the identification of two point mutations, one missense and one splice-site change, in the gene FACL4 in two families with nonspecific mental retardation. Analysis of enzymatic activity in lymphoblastoid cell lines from affected individuals of both families revealed low levels compared with normal cells, indicating that both mutations are null mutations. All carrier females with either point mutations or genomic deletions in FACL4 showed a completely skewed X-inactivation, suggesting that the gene influences survival advantage. FACL4 is the first gene shown to be involved in nonspecific mental retardation and fatty-acid metabolism.	Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; INSERM, U316, Serv Genet, Tours, France; CHU Cochin, ICGM, INSERM, U129, Paris, France; Katholieke Univ Leuven, Dept Genet, Louvain, Belgium; Max Planck Inst Mol Genet, Berlin, Germany; Univ Siena, Dept Pathol, I-53100 Siena, Italy; Univ Siena, Dept Biomed Sci, I-53100 Siena, Italy; Dept Human Genet, Nijmegen, Netherlands; Washington Univ, Dept Internal Med, St Louis, MO USA; Washington Univ, Dept Mol Biol, St Louis, MO USA; Washington Univ, Dept Pharmacol, St Louis, MO USA	University of Siena; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; KU Leuven; Max Planck Society; University of Siena; University of Siena; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Renieri, A (corresponding author), Univ Siena, Dept Mol Biol, I-53100 Siena, Italy.	renieri@unisi.it	Raynaud, Martine/R-9811-2019; Yntema, H.G./L-4771-2015; Meloni, Ilaria/R-6627-2018; Lewis, Sheena E M/ABI-8338-2020; Renieri, Alessandra/K-5950-2016; BELLAN, CRISTIANA/L-3903-2013; Chelly, Jamel/J-7528-2015; BELLAN, CRISTIANA/ABG-4750-2021; Gomot, Marie/N-3135-2016	Raynaud, Martine/0000-0002-6888-6480; Meloni, Ilaria/0000-0002-6255-9761; Renieri, Alessandra/0000-0002-0846-9220; BELLAN, CRISTIANA/0000-0001-6119-9007; Chelly, Jamel/0000-0002-0939-8719; BELLAN, CRISTIANA/0000-0001-6119-9007; Gomot, Marie/0000-0003-1747-5806; Longo, Ilaria/0000-0003-2056-8763; VOLPI, NILA/0000-0002-0837-1864	Telethon [E.1145] Funding Source: Medline	Telethon(Fondazione Telethon)		American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Black PN, 1997, J BIOL CHEM, V272, P4896, DOI 10.1074/jbc.272.8.4896; BURGEMEISTER B, 1954, MANUAL USE COLUMBIA; Cao Y, 2000, FEBS LETT, V467, P263, DOI 10.1016/S0014-5793(00)01159-5; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cao Y, 1998, GENOMICS, V49, P327, DOI 10.1006/geno.1998.5268; Chiurazzi P, 2001, EUR J HUM GENET, V9, P71, DOI 10.1038/sj.ejhg.5200603; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; des Portes V, 1999, AM J MED GENET, V85, P263, DOI 10.1002/(SICI)1096-8628(19990730)85:3<263::AID-AJMG15>3.0.CO;2-0; Faergeman NJ, 1997, BIOCHEM J, V323, P1; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Goodglass H., 2001, BOSTON DIAGNOSTIC AP, VThird; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Jonsson JJ, 1998, J MED GENET, V35, P273, DOI 10.1136/jmg.35.4.273; Malhotra KT, 1999, BIOCHEM J, V344, P135, DOI 10.1042/0264-6021:3440135; McCarthy D., 1972, MANUAL MCCARTHY SCAL; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; MELONI I, IN PRESS J MED GENET, V39; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Nielsen JB, 2001, EUR J HUM GENET, V9, P178, DOI 10.1038/sj.ejhg.5200600; PEGORARO E, 1994, AM J HUM GENET, V54, P989; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Piccini M, 1998, GENOMICS, V47, P350, DOI 10.1006/geno.1997.5104; Raynaud M, 2000, EUR J HUM GENET, V8, P253, DOI 10.1038/sj.ejhg.5200437; Stuhlsatz-Krouper SM, 1998, J BIOL CHEM, V273, P28642, DOI 10.1074/jbc.273.44.28642; Tanaka T, 1981, Methods Enzymol, V71 Pt C, P334; Vitelli F, 1999, GENOMICS, V55, P335, DOI 10.1006/geno.1998.5666; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Wechsler D, 1987, WMS R WECHSLER MEMOR; Zappella M, 2001, AM J MED GENET, V104, P14, DOI 10.1002/ajmg.10005	30	120	126	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2002	30	4					436	440		10.1038/ng857	http://dx.doi.org/10.1038/ng857			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11889465				2022-12-27	WOS:000174682000024
J	Olbrich, H; Haffner, K; Kispert, A; Volkel, A; Volz, A; Sasmaz, G; Reinhardt, R; Hennig, S; Lehrach, H; Konietzko, N; Zariwala, M; Noone, PG; Knowles, M; Mitchison, HM; Meeks, M; Chung, EMK; Hildebrandt, F; Sudbrak, R; Omran, H				Olbrich, H; Haffner, K; Kispert, A; Volkel, A; Volz, A; Sasmaz, G; Reinhardt, R; Hennig, S; Lehrach, H; Konietzko, N; Zariwala, M; Noone, PG; Knowles, M; Mitchison, HM; Meeks, M; Chung, EMK; Hildebrandt, F; Sudbrak, R; Omran, H			Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right and asymmetry	NATURE GENETICS			English	Article							INTERMEDIATE-CHAIN; HEAVY-CHAIN; DYNEIN; GENE; INVERSUS	Primary ciliary dyskinesia (PCD, MIM 242650) is characterized by recurrent infections of the respiratory tract due to reduced mucociliary clearance and by sperm immobility. Half of the affected offspring have situs inversus (reversed organs), which results from randomization of left-right (LR) asymmetry(1). We previously localized to chromosome 5p a PCD locus containing DNAH5, which encodes a protein highly similar to the Chlamydomonas gamma-dynein heavy chain(2). Here we characterize the full-length 14-kb transcript of DNAH5. Sequence analysis in individuals with PCD with randomization of LR asymmetry identified mutations resulting in non-functional DNAH5 proteins.	Univ Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; Med Hochschule Hannover, Hannover, Germany; Max Planck Inst Mol Genet, Berlin, Germany; Ruhrland Klin, Essen, Germany; Univ N Carolina, Chapel Hill, NC USA; Royal Free & UCL, Dept Paediat & Child Hlth, London, England	University of Freiburg; Hannover Medical School; Max Planck Society; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London	Omran, H (corresponding author), Univ Freiburg, Dept Pediat & Adolescent Med, Hugstetter Str 55, D-79106 Freiburg, Germany.	omran@kikli.uk.uni-freiburg.de	Volz, Andreas/AAA-6290-2019; Sudbrak, Ralf/HHZ-8821-2022; Mitchison, Hannah M./C-1891-2008	Meeks, Maggie/0000-0003-2593-235X; Reinhardt, Richard/0000-0001-9376-2132; Omran, Heymut/0000-0003-0282-6765; Mitchison, Hannah/0000-0002-3163-6293				Afzelius BA, 1995, METABOLIC MOL BASES, P3943; ASDAI J, 2001, TRENDS CELL BIOL, V11, P196; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Guichard C, 2001, AM J HUM GENET, V68, P1030, DOI 10.1086/319511; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Omran H, 2000, AM J RESP CELL MOL, V23, P696, DOI 10.1165/ajrcmb.23.5.4257; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; WILKERSON CG, 1995, J CELL BIOL, V129, P169, DOI 10.1083/jcb.129.1.169; WILKERSON CG, 1994, J CELL SCI, V107, P497	15	375	397	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					143	144		10.1038/ng817	http://dx.doi.org/10.1038/ng817			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11788826				2022-12-27	WOS:000173708700010
J	Boggs, BA; Cheung, P; Heard, E; Spector, DL; Chinault, AC; Allis, CD				Boggs, BA; Cheung, P; Heard, E; Spector, DL; Chinault, AC; Allis, CD			Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes	NATURE GENETICS			English	Article							FEMALE MAMMALS; ACETYLATION; CELLS; GENES	Studies of histone methylation have shown that H3 can be methylated at lysine 4 (Lys4) or lysine 9 (Lys9)(1.2). Whereas H3-Lys4 methylation has been correlated with active gene expression(3), H3-Lys9 methylation has been linked to gene silencing and assembly of heterochromatin in mouse and Schizosaccharomyces pombe(4-7). The chromodomain of mouse HP1 (and Swi6 in S. pombe) binds H3 methylated at Lys9, and methylation at this site is thought to mark and promote heterochromatin assembly. We have used a well-studied model of mammalian epigenetic silencing, the human inactive X chromosome, to show that enrichment for H3 methylated at Lys9 is also a distinguishing mark of facultative heterochromatin. In contrast, H3 methylated at Lys4 is depleted in the inactive X chromosome, except in three 'hot spots' of enrichment along its length. Chromatin immunoprecipitation analyses further show that Lys9 methylation is associated with promoters of inactive genes, whereas Lys4 methylation is associated with active genes on the X chromosome. These data demonstrate that differential methylation at two distinct sites of the H3 amino terminus correlates with contrasting gene activities and may be part of a 'histone code' involved in establishing and maintaining facultative heterochromatin.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Baylor College of Medicine; University of Virginia; Cold Spring Harbor Laboratory	Allis, CD (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.		Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117				Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARR ML, 1962, ACTA CYTOL, V6, P34; Belyaev ND, 1996, HUM GENET, V97, P573; Boggs BA, 1996, CHROMOSOMA, V105, P303, DOI 10.1007/BF02524648; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; ELLIS N, 1987, SOMAT CELL MOLEC GEN, V13, P191, DOI 10.1007/BF01535202; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Gilbert SL, 1999, P NATL ACAD SCI USA, V96, P13825, DOI 10.1073/pnas.96.24.13825; HEARD E, IN PRESS CELL; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; MORISHIMA A, 1962, P NATL ACAD SCI USA, V48, P756, DOI 10.1073/pnas.48.5.756; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; NORRIS DP, 1991, MAMM GENOME, V1, P78, DOI 10.1007/BF02443782; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967	30	301	311	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					73	76		10.1038/ng787	http://dx.doi.org/10.1038/ng787			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11740495				2022-12-27	WOS:000173105600016
J	Hodgson, G; Hager, JH; Volik, S; Hariono, S; Wernick, M; Moore, D; Albertson, DG; Pinkel, D; Collins, C; Hanahan, D; Gray, JW				Hodgson, G; Hager, JH; Volik, S; Hariono, S; Wernick, M; Moore, D; Albertson, DG; Pinkel, D; Collins, C; Hanahan, D; Gray, JW			Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas	NATURE GENETICS			English	Article							PROTEIN PHOSPHATASE 2A; CDNA MICROARRAYS; TRANSGENIC MICE; CELL-LINES; HYBRIDIZATION; DNA; CHROMOSOME-16; AMPLIFICATION; ONCOGENE; AMPLICON	Carcinomas that develop in the pancreatic islets of transgenic mice expressing the SV40 T-antigens (Tag) under transcriptional control of the rat insulin II promoter (RIP) progress through well-characterized stages that are similar to aspects of human tumor progression, including hyperplastic growth, increased angiogenesis and reduced apoptosis'. The latter two stages have been associated with recurrent loss of heterozygosity (LOH)(2) and reduced genome copy number(3) on chromosomes 9 (LOH9) and 16 (LOH16), aberrations which we believe contribute to these phenotypes. Earlier analyses localized LOH9 to approximately 3 Mb and LOH16 to approximately 30 Mb (both syntenic with human 3q21-q25) but were limited by low throughput and a lack of informative polymorphic markers. Here we show that comparative genomic hybridization to DNA microarrays (array CGH)(4-7) overcomes these limitations by allowing efficient, genome-wide analyses of relative genome copy number. The CGH arrays used in these experiments carried BACs distributed at 2-20-MB intervals across the mouse genome and at higher density in regions of interest. Using array CGH, we further narrowed the loci for LOH9 and LOH16 and defined new or previously unappreciated recurrent regions of copy-number decrease on chromosomes 6, 8 and 14 (syntenic with human chromosomes 12p11-p13, 16q24.3 and 13q11-q32, respectively) and regions of copy-number increase on chromosomes 2 and 4 (syntenic to human chromosomes 20q13.2 and 1p32-p36, respectively). Our analyses of human genome sequences syntenic to these regions suggest that CYP24, PFDN4, STMN1, CDKN1B, PPP2R3 and FSTL1 are candidate oncogenes or tumor-suppressor genes. We also show that irradiation and genetic background influence the spectrum of aberrations present in these tumors.	Univ Calif San Francisco, Ctr Canc, Canc Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Canc, Breast Oncol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Diabet, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Gray, JW (corresponding author), Univ Calif San Francisco, Ctr Canc, Canc Genet Program, Box 0808, San Francisco, CA 94143 USA.	jgray@cc.ucsf.edu			NCI NIH HHS [R37-CA45234, CA82103, CA78601] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA082103, R37CA045234, R01CA078601] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Collins C, 2001, GENOME RES, V11, P1034, DOI 10.1101/gr.GR1743R; Curmi PA, 2000, BRIT J CANCER, V82, P142, DOI 10.1054/bjoc.1999.0891; Deng XM, 1998, J BIOL CHEM, V273, P34157, DOI 10.1074/jbc.273.51.34157; DIETRICH WF, 1994, P NATL ACAD SCI USA, V91, P9451, DOI 10.1073/pnas.91.20.9451; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Han CS, 2000, GENOME RES, V10, P714, DOI 10.1101/gr.10.5.714; Heiskanen MA, 2000, CANCER RES, V60, P799; Iijima M, 1996, ACTA MED OKAYAMA, V50, P73; Korenberg JR, 1999, GENOME RES, V9, P514; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; PARANGI S, 1995, CANCER RES, V55, P6071; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Shi YP, 1997, GENE CHROMOSOME CANC, V19, P104, DOI 10.1002/(SICI)1098-2264(199706)19:2<104::AID-GCC6>3.3.CO;2-S; Shi YP, 1997, GENOMICS, V45, P42, DOI 10.1006/geno.1997.4904; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; STAHELI IJP, 2001, EXP CELL RES, V264, P148; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	25	229	236	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					459	464		10.1038/ng771	http://dx.doi.org/10.1038/ng771			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11694878				2022-12-27	WOS:000172507500023
J	Ioannidis, JPA; Ntzani, EE; Trikalinos, TA; Contopoulos-Ioannidis, DG				Ioannidis, JPA; Ntzani, EE; Trikalinos, TA; Contopoulos-Ioannidis, DG			Replication validity of genetic association studies	NATURE GENETICS			English	Article							INDIVIDUAL PATIENT; METAANALYSIS; TRIALS; PUBLICATION; LINKAGE; REVIEWS	The rapid growth of human genetics creates countless opportunities for studies of disease association. Given the number of potentially identifiable genetic markers and the multitude of clinical outcomes to which these may be linked, the testing and validation of statistical hypotheses in genetic epidemiology is a task of unprecedented scale(1,2). Meta-analysis provides a quantitative approach for combining the results of various studies on the same topic, and for estimating and explaining their diversity(3,4). Here, we have evaluated by meta-analysis 370 studies addressing 36 genetic associations for various outcomes of disease. We show that significant between-study heterogeneity (diversity) is frequent, and that the results of the first study correlate only modestly with subsequent research on the same association. The first study often suggests a stronger genetic effect than is found by subsequent studies. Both bias and genuine population diversity might explain why early association studies tend to overestimate the disease protection or predisposition conferred by a genetic polymorphism. We conclude that a systematic meta-analytic approach may assist in estimating population-wide effects of genetic risk factors in human disease.	Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece; Ioannina Biomed Res Inst, GR-45110 Ioannina, Greece; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20010 USA	University of Ioannina; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts University; George Washington University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece.		Ntzani, Evangelina E./K-1565-2019; Califano, Andrea/F-7239-2012; Ioannidis, John P. A./G-9836-2011; Trikalinos, Thomas A/A-1217-2009	Ntzani, Evangelia/0000-0003-3712-4181				Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; GERSHON ES, 1994, GENETIC APPROACHES M; Greenberg DA, 1999, GENET EPIDEMIOL, V17, pS429; Gu C, 1999, GENET EPIDEMIOL, V17, pS599; HEDGES LV, 1985, STAT METHODS META AN; HOSMER DW, 1989, APPL LOGISTIC REGRES; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998; Ioannidis JPA, 1998, J CLIN EPIDEMIOL, V51, P709, DOI 10.1016/S0895-4356(98)00042-0; Ioannidis JPA, 1999, J CLIN EPIDEMIOL, V52, P281, DOI 10.1016/S0895-4356(98)00159-0; Khoury MJ, 2000, AM J EPIDEMIOL, V151, P2; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; MANTEL N, 1959, J NATL CANCER I, V22, P719; McCarthy JJ, 2000, NAT BIOTECHNOL, V18, P505, DOI 10.1038/75360; Mosteller F, 1996, ANNU REV PUBL HEALTH, V17, P1, DOI 10.1146/annurev.pu.17.050196.000245; Orwin R.G., 1994, HDB RES SYNTHESIS; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Vieland VJ, 2001, HUM HERED, V51, P199, DOI 10.1159/000053343; Wang K, 1999, GENET EPIDEMIOL, V17, pS749; Yudkin PL, 1996, LANCET, V347, P241, DOI 10.1016/S0140-6736(96)90410-9	23	1491	1661	2	62	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					306	309		10.1038/ng749	http://dx.doi.org/10.1038/ng749			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11600885				2022-12-27	WOS:000171911000017
J	Saada, A; Shaag, A; Mandel, H; Nevo, Y; Eriksson, S; Elpeleg, O				Saada, A; Shaag, A; Mandel, H; Nevo, Y; Eriksson, S; Elpeleg, O			Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy	NATURE GENETICS			English	Article							SKELETAL-MUSCLE; MTDNA DEPLETION; CLONING; EXPRESSION; CDNA; DISEASE; LIVER; GENE	The mitochondrial deoxyribonucleotide (dNTP) pool is separated from the cytosolic pool because the mitochondria inner membrane is impermeable to charged molecules. The mitochondrial pool is maintained by either import of cytosolic dNTPs through dedicated transporters(1,2) or by salvaging deoxynucleasides within the mitochondria; apparently, enzymes of the de novo dNTP synthesis pathway are not present in the mitochondria. In non-replicating cells, where cytosolic dNTP synthesis is downregulated, mtDNA synthesis depends solely on the mitochondrial salvage pathway enzymes, the deoxyribonucleosides kinases. Two of the four human deoxyribonucleoside kinases, deoxyguanosine kinase (dGK) and thymidine kinase-2 (TK2), are expressed in mitochondria(3-6). Human dGK efficiently phosphorylates deoxyguanosine and deoxyadenosine, whereas TK2 phosphorylates deoxythymidine, deoxycytidine and deoxyuridine. Here we identify two mutations in TK2, histidine 90 to asparagine and isoleucine 181 to asparagine, in four individuals who developed devastating myopathy and depletion of muscular mitochondrial DNA in infancy. In these individuals, the activity of TK2 in muscle mitochondria is reduced to 14-45% of the mean value in healthy control individuals. Mutations in TK2 represent a new etiology for mitochondrial DNA depletion, underscoring the importance of the mitochondrial dNTP pool in the pathogenesis of mitochondrial depletion.	Hebrew Univ Jerusalem, Fac Med, Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel; Rambam Med Ctr, Dept Pediat, IL-31096 Haifa, Israel; Tel Aviv Sourasky Med Ctr, Pediat Neurol Unit, IL-65211 Tel Aviv, Israel; Swedish Univ Agr Sci, Dept Vet Med Chem, SE-75123 Uppsala, Sweden	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Swedish University of Agricultural Sciences	Elpeleg, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel.		Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656				BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0; BODNAR AG, 1993, AM J HUM GENET, V53, P663; Bridges EG, 1999, J BIOL CHEM, V274, P4620, DOI 10.1074/jbc.274.8.4620; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998; DOOIJEWAARD G, 1976, BIOCHIM BIOPHYS ACTA, V440, P1, DOI 10.1016/0005-2728(76)90109-2; Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1; FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4; HOPPEL C, 1969, ARCH BIOCHEM BIOPHYS, V135, P173, DOI 10.1016/0003-9861(69)90528-1; Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454; Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; MARIOTTI C, 1995, J NEUROL, V242, P547, DOI 10.1007/BF00868806; MORAES CT, 1991, AM J HUM GENET, V48, P492; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Spelbrink JN, 1998, HUM GENET, V102, P327, DOI 10.1007/s004390050700; Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935; TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209; Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783; Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6; Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469; Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0	28	451	462	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					342	344		10.1038/ng751	http://dx.doi.org/10.1038/ng751			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687801				2022-12-27	WOS:000171911000024
J	Curtis, ARJ; Fey, C; Morris, CM; Bindoff, LA; Ince, PG; Chinnery, PF; Coulthard, A; Jackson, MJ; Jackson, AP; McHale, DP; Hay, D; Barker, WA; Markham, AF; Bates, D; Curtis, A; Burn, J				Curtis, ARJ; Fey, C; Morris, CM; Bindoff, LA; Ince, PG; Chinnery, PF; Coulthard, A; Jackson, MJ; Jackson, AP; McHale, DP; Hay, D; Barker, WA; Markham, AF; Bates, D; Curtis, A; Burn, J			Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease	NATURE GENETICS			English	Article							NEURODEGENERATIVE DISEASES; HUMAN-H; IRON; MAP; CERULOPLASMIN; METABOLISM; METALS; BRAIN	We describe here a previously unknown, dominantly inherited, late-onset basal ganglia disease, variably presenting with extrapyramidal features similar to those of Huntington's disease (HD) or parkinsonism. We mapped the disorder, by linkage analysis, to 19q13.3, which contains the gene for ferritin light polypeptide (FTL). We found an adenine insertion at position 460-461 that is predicted to alter carboxy-terminal residues of the gene product. Brain histochemistry disclosed abnormal aggregates of ferritin and iron. Low serum ferritin levels also characterized patients. Ferritin, the main iron storage protein, is composed of 24 subunits of two types (heavy, H and light, L) which form a soluble, hollow sphere(1). Brain iron deposition increases normally with age, especially in the basal ganglia, and is a suspected causative factor in several neurodegenerative diseases(2) in which it correlates with visible pathology(3), possibly by its involvement in toxic free-radical reactions(4). We found the same mutation in five apparently unrelated subjects with similar extrapyramidal symptoms. An abnormality in ferritin strongly indicates a primary function for iron in the pathogenesis of this new disease, for which we propose the name 'neuroferritinopathy'.	Inst Human Genet, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Ctr Dev Clin Brain Ageing, Joint MRC, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Newcastle Hosp NHS Trust, Dept Neurol, Newcastle Upon Tyne, Tyne & Wear, England; Newcastle Hosp NHS Trust, Dept Neuropathol, Newcastle Upon Tyne, Tyne & Wear, England; Newcastle Hosp NHS Trust, Dept Radiol, Newcastle Upon Tyne, Tyne & Wear, England; St Jamess Univ Hosp, Mol Med Unit, Leeds, W Yorkshire, England	Newcastle University - UK; Newcastle General Hospital; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Saint James's University Hospital; University of Leeds	Burn, J (corresponding author), Inst Human Genet, 19-20 Claremont Pl, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.		Jackson, Andrew P/D-3442-2009; Ince, Paul G/A-5064-2009; Coulthard, Alan/C-3649-2011	Jackson, Andrew P/0000-0002-8739-2646; Ince, Paul G/0000-0001-6677-8753; Coulthard, Alan/0000-0003-1110-9207; Bindoff, Laurence/0000-0003-0988-276X; Chinnery, Patrick/0000-0002-7065-6617; Burn, John/0000-0002-9823-2322; Morris, Christopher/0000-0002-3749-0993				ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; DEXTER DT, 1992, ANN NEUROL, V32, pS94, DOI 10.1002/ana.410320716; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GATTI RA, 1987, AM J HUM GENET, V41, P654; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Jappelli R, 1998, BIOCHEM BIOPH RES CO, V250, P342, DOI 10.1006/bbrc.1998.9317; Juan SH, 1999, ARCH BIOCHEM BIOPHYS, V361, P295, DOI 10.1006/abbi.1998.0998; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; MCGILL JR, 1987, HUM GENET, V76, P66; MORRIS CM, 1992, ACTA ANAT, V144, P235; Nappi AJ, 2000, CELL MOL BIOL, V46, P637; OLANOW CW, 1994, CURR OPIN NEUROL, V7, P548, DOI 10.1097/00019052-199412000-00013; REGUIGNEARNOULD I, 1995, CYTOGENET CELL GENET, V71, P158, DOI 10.1159/000134098; SANTORO C, 1986, NUCLEIC ACIDS RES, V14, P2863, DOI 10.1093/nar/14.7.2863; Sheth S, 2000, ANNU REV MED, V51, P443, DOI 10.1146/annurev.med.51.1.443; Takahashi Y, 1996, HUM MOL GENET, V5, P81, DOI 10.1093/hmg/5.1.81; Taylor TD, 1996, NAT GENET, V14, P479, DOI 10.1038/ng1296-479; WORWOOD M, 1987, HAEMATOLOGIA, V20, P229	23	394	401	1	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					350	354		10.1038/ng571	http://dx.doi.org/10.1038/ng571			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11438811				2022-12-27	WOS:000170174800015
J	Ueno, S; Maruki, Y; Nakamura, M; Tomemori, Y; Kamae, K; Tanabe, H; Yamashita, Y; Matsuda, S; Kaneko, S; Sano, A				Ueno, S; Maruki, Y; Nakamura, M; Tomemori, Y; Kamae, K; Tanabe, H; Yamashita, Y; Matsuda, S; Kaneko, S; Sano, A			The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis	NATURE GENETICS			English	Article							LINKAGE	Chorea-acanthocytosis is a neurodegenerative disorder with peripheral red cell acanthocytosis'. Linkage of chorea-acanthocytosis to chromosome 9q21 has been found(2). We refined the locus region and identified a previously unknown, full-length cDNA encoding a presumably structural protein, which we called chorein, We found a deletion in the coding region of the cDNA leading to a frame shift resulting in the production of a truncated protein in both alleles of patients and in single alleles of obligate carriers.	Ehime Univ, Sch Med, Dept Neuropsychiat, Shigenobu, Ehime 79102, Japan; Matsuyama Red Cross Hosp, Dept Neurol, Matsuyama, Ehime, Japan; Ehime Univ, Sch Med, Dept Anat, Shigenobu, Ehime, Japan; Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan	Ehime University; Matsuyama Red Cross Hospital; Ehime University; Hirosaki University	Sano, A (corresponding author), Ehime Univ, Sch Med, Dept Neuropsychiat, Shigenobu, Ehime 79102, Japan.	sano@m.ehime-u.ac.jp		Sano, Akira/0000-0001-5843-9786				BRIN MF, 1993, HDB CLIN NEUROLOGY, V19, P271; Cavalli G, 1995, Ann Ital Med Int, V10, P249; FAILLACE RT, 1982, ANN INTERN MED, V96, P616, DOI 10.7326/0003-4819-96-5-616; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Redding K, 1996, MOL CELL BIOL, V16, P6208; Rubio JP, 1997, AM J HUM GENET, V61, P899, DOI 10.1086/514876; Rubio JP, 1999, GENOMICS, V57, P84, DOI 10.1006/geno.1999.5758; Stege JT, 1999, DEV GENET, V25, P64, DOI 10.1002/(SICI)1520-6408(1999)25:1<64::AID-DVG7>3.0.CO;2-1; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777	10	191	197	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2001	28	2					121	122		10.1038/88825	http://dx.doi.org/10.1038/88825			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381254				2022-12-27	WOS:000169011800009
J	Doffinger, R; Smahi, A; Bessia, C; Geissmann, F; Feinberg, J; Durandy, A; Bodemer, C; Kenwrick, S; Dupuis-Girod, S; Blanche, S; Wood, P; Rabia, SH; Headon, DJ; Overbeek, PA; Le Deist, F; Holland, SM; Belani, K; Kumararatne, DS; Fischer, A; Shapiro, R; Conley, ME; Reimund, E; Kalhoff, H; Abinun, M; Munnich, A; Israel, A; Courtois, G; Casanova, JL				Doffinger, R; Smahi, A; Bessia, C; Geissmann, F; Feinberg, J; Durandy, A; Bodemer, C; Kenwrick, S; Dupuis-Girod, S; Blanche, S; Wood, P; Rabia, SH; Headon, DJ; Overbeek, PA; Le Deist, F; Holland, SM; Belani, K; Kumararatne, DS; Fischer, A; Shapiro, R; Conley, ME; Reimund, E; Kalhoff, H; Abinun, M; Munnich, A; Israel, A; Courtois, G; Casanova, JL			X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappa B signaling	NATURE GENETICS			English	Letter							GAMMA-DEFICIENT MICE; CELL WALL COMPONENTS; TOLL-LIKE RECEPTOR-2; HUMAN T-CELLS; INCONTINENTIA PIGMENTI; KINASE COMPLEX; CUTTING EDGE; HOST-DEFENSE; IFN-GAMMA; IKK-GAMMA	The molecular basis of X-linked recessive anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) has remained elusive. Here we report hypomorphic mutations in the gene IKBKG in 12 males with EDA-ID from 8 kindreds. and 2 patients with a related and hitherto unrecognized syndrome of EDA-ID with osteopetrosis and lymphoedema (OL-EDA-ID). Mutations in the coding region of IKBKG are associated with EDA-ID. and stop codon mutations, with OL-EDA-ID. IKBKG encodes NEMO, the regulatory subunit of the IKK (I kappaB kinase) complex, which is essential for NF-kappaB signaling. Germline loss-of-function mutations in IKBKG are lethal in male fetuses. We show that IKBKG mutations causing OL-EDA-ID and EDA-ID impair but do not abolish NF-kappaB signaling. We also show that the ectodysplasin receptor, DL, triggers NF-kappaB through the NEMO protein, indicating that EDA results from impaired NF-kappaB signaling. Finally. we show that abnormal immunity in OL-EDA-ID patients results from impaired cell responses to lipopolysaccharide, interleukin (IL)-1 beta, IL-18, TNF alpha and CD154. We thus report for the first time that impaired but not abolished NF-kappaB signaling in humans results in two related syndromes that associate specific developmental and immunological defects.	Fac Med Necker Enfants Malades, Lab Genet Humaine Malad Infect, Paris, France; Hop Necker Enfants Malad, INSERM U 393, Unite Rech Handicaps Genet Enfant, Paris, France; Inst Pasteur, URA CNRS 1773, Unite Biol Mol Express Gen, Paris, France; Hop Necker Enfants Malad, INSERM U 429, URA CNRS 1461, Paris, France; Hop Necker Enfants Malad, INSERM U 429, Dev Normal & Pathol Syst Immunitaire, Paris, France; Hop Necker Enfants Malad, Serv Dermatol, Paris, France; Univ Cambridge, Addenbrookes Hosp, Dept Med, Wellcome Trust Ctr Mol Mechanisms Dis, Cambridge CB2 2QQ, England; Hop Necker Enfants Malad, Unite Immunol Pediat, Paris, France; Heartlands Hosp, Dept Paediat, Birmingham, W Midlands, England; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; NIH, Host Def Lab, Bethesda, MD 20892 USA; Midwest Immunol Clin, Plymouth, MN USA; Addenbrookes Hosp, Dept Clin Immunol, Cambridge, England; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; Med S Pathol Associates, Greenville, MS USA; Childrens Hosp, Dept Paediat, Dortmund, Germany; Newcastle Gen Hosp, Childrens Dept, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Heart of England NHS Foundation Trust; Baylor College of Medicine; National Institutes of Health (NIH) - USA; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; St Jude Children's Research Hospital; Newcastle General Hospital	Casanova, JL (corresponding author), Fac Med Necker Enfants Malades, Lab Genet Humaine Malad Infect, Paris, France.		Casanova, Jean-Laurent/I-3418-2017; Smahi, Asma/J-4184-2017; Dupuis-Girod, Sophie/D-6268-2014; Kalhoff, Hermann/F-7110-2017; Durandy, Anne/H-7475-2017	Smahi, Asma/0000-0002-6002-0981; Kalhoff, Hermann/0000-0003-0911-2511; Casanova, Jean-Laurent/0000-0002-7782-4169; COURTOIS, Gilles/0000-0003-3117-9595; Durandy, Anne/0000-0001-7706-8466; Hadj-Rabia, Smail/0000-0001-6801-7106; Dupuis-Girod, Sophie/0000-0002-8834-5526; geissmann, frederic/0000-0001-5029-2468; Overbeek, Paul/0000-0001-9784-2084	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000647, ZIAAI000647] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abinun M, 1996, EUR J PEDIATR, V155, P146, DOI 10.1007/s004310050395; ABINUN M, 1995, ARCH DIS CHILD, V73, P185, DOI 10.1136/adc.73.2.185; BERBERICH I, 1994, J IMMUNOL, V153, P4357; BROOKS EG, 1994, CLIN IMMUNOL IMMUNOP, V71, P44, DOI 10.1006/clin.1994.1050; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ezer S, 1999, HUM MOL GENET, V8, P2079, DOI 10.1093/hmg/8.11.2079; Francis JS, 1997, SEMIN CUTAN MED SURG, V16, P54, DOI 10.1016/S1085-5629(97)80036-3; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Frix C D 3rd, 1986, Pediatr Dermatol, V3, P464, DOI 10.1111/j.1525-1470.1986.tb00652.x; GOLDFELD AE, 1990, P NATL ACAD SCI USA, V87, P9769, DOI 10.1073/pnas.87.24.9769; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; JHAVERI M, 1989, AM J DIS CHILD, V143, P12, DOI 10.1001/archpedi.1989.02150130022005; Jirapongsananuruk O, 1999, CLIN EXP IMMUNOL, V118, P1; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kuhns DB, 1997, J IMMUNOL, V158, P3959; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; LANE P, 1992, EUR J IMMUNOL, V22, P2573, DOI 10.1002/eji.1830221016; Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; MASSE JF, 1994, ARCH DIS CHILD, V71, P1, DOI 10.1136/adc.71.1.1; McKusick V.A., 1998, MENDELIAN INHERITANC; Means TK, 1999, J IMMUNOL, V163, P3920; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; PINHEIRO M, 1994, AM J MED GENET, V53, P153, DOI 10.1002/ajmg.1320530207; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schweizer P, 1999, KLIN PADIATR, V211, P459, DOI 10.1055/s-2008-1043834; SITTON JE, 1992, NEUROPEDIATRICS, V23, P108, DOI 10.1055/s-2008-1071322; Smahi A, 2000, NATURE, V405, P466; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tominaga K, 2000, INT IMMUNOL, V12, P151, DOI 10.1093/intimm/12.2.151; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914; ZONANA J, 1993, SEMIN DERMATOL, V12, P241	50	604	623	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					277	285		10.1038/85837	http://dx.doi.org/10.1038/85837			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242109				2022-12-27	WOS:000167304200019
J	He, L; Gunn, TM; Bouley, DM; Lu, XY; Watson, SJ; Schlossman, SF; Duke-Cohan, JS; Barsh, GS				He, L; Gunn, TM; Bouley, DM; Lu, XY; Watson, SJ; Schlossman, SF; Duke-Cohan, JS; Barsh, GS			A biochemical function for attractin in agouti-induced pigmentation and obesity	NATURE GENETICS			English	Article							STIMULATING-HORMONE-RECEPTOR; YELLOW A(Y) MUTATION; MELANOCORTIN RECEPTORS; TRANSGENIC MICE; COAT COLOR; NERVOUS-SYSTEM; IN-VITRO; PROTEIN; MOUSE; EXPRESSION	Agouti protein, a paracrine signaling molecule normally limited to skin, is ectopically expressed in lethal yellow (A(y)) mice, and causes obesity by mimicking agouti-related protein (Agrp), found primarily in the hypothalamus. Mouse attractin (Atrn) is a widely expressed transmembrane protein whose loss of function in mahogany (Atrn(mg-3J)/Atrn(mg-3J)) mutant mice blocks the pleiotropic effects of A(y). Here we demonstrate in transgenic, biochemical and genetic-interaction experiments that attractin is a low-affinity receptor for agouti protein, but not Agrp, in vitro and in vivo. Additional histopathologic abnormalities in Atrn(mg-3J)/Atrn(mg-3J) mice and cross-species genomic comparisons indicate that Atrn has multiple functions distinct from both a physiologic and an evolutionary perspective.	Stanford Univ, Sch Med, Dept Pediat & Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; Univ Michigan, Sch Med, Mental Hlth Res Inst, Ann Arbor, MI USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Barsh, GS (corresponding author), Stanford Univ, Sch Med, Dept Pediat & Genet, Stanford, CA 94305 USA.		Lu, Xin-Yun/M-8657-2016; Duke-Cohan, Jonathan/A-5812-2010	Duke-Cohan, Jonathan/0000-0002-9478-9609; Gunn, Teresa/0000-0003-2688-6420	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048506] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-48506] Funding Source: Medline; NIMH NIH HHS [MH42251] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cone RD, 1996, RECENT PROG HORM RES, V51, P287; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Dinulescu DM, 1998, P NATL ACAD SCI USA, V95, P12707, DOI 10.1073/pnas.95.21.12707; Dinulescu DM, 2000, J BIOL CHEM, V275, P6695, DOI 10.1074/jbc.275.10.6695; DUHL DMJ, 1994, DEVELOPMENT, V120, P1695; Duke-Cohan JS, 1998, P NATL ACAD SCI USA, V95, P11336, DOI 10.1073/pnas.95.19.11336; DUKECOHAN JS, 1995, J BIOL CHEM, V270, P14107, DOI 10.1074/jbc.270.23.14107; EBERLE AN, 1988, MELANOTROPINS CHEM P; Fuh G, 2000, J BIOL CHEM, V275, P26690; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; Gunn TM, 1999, NATURE, V398, P152, DOI 10.1038/18217; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; Jackson IJ, 1999, TRENDS GENET, V15, P429, DOI 10.1016/S0168-9525(99)01824-7; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kiefer LL, 1997, BIOCHEMISTRY-US, V36, P2084, DOI 10.1021/bi962647v; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Kucera GT, 1996, DEV BIOL, V173, P162, DOI 10.1006/dbio.1996.0014; KURAMOTO T, IN PRESS P NATL ACAD; LAMOREUX ML, 1986, GENET RES, V48, P35, DOI 10.1017/S0016672300024630; LANE PRISCILLA W., 1960, JOUR HEREDITY, V51, P228; Little CC, 1916, AM NAT, V50, P335, DOI 10.1086/279546; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lu XY, 1999, FEBS LETT, V462, P101, DOI 10.1016/S0014-5793(99)01494-5; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; MICHAUD EJ, 1994, P NATL ACAD SCI USA, V91, P2562, DOI 10.1073/pnas.91.7.2562; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Miller KA, 1997, GENETICS, V146, P1407; Nagle DL, 1999, NATURE, V398, P148, DOI 10.1038/18210; Ollmann MM, 1999, J BIOL CHEM, V274, P15837, DOI 10.1074/jbc.274.22.15837; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Perry WL, 1996, GENETICS, V144, P255; QUISTAD GB, 1994, J BIOL CHEM, V269, P11098; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rosenfeld RD, 1998, BIOCHEMISTRY-US, V37, P16041, DOI 10.1021/bi981027m; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shimizu M, 2000, J CELL BIOL, V148, P1283, DOI 10.1083/jcb.148.6.1283; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Suto J, 2000, MAMM GENOME, V11, P639, DOI 10.1007/s003350010136; Takeuchi S, 2000, BBA-MOL CELL RES, V1496, P261, DOI 10.1016/S0167-4889(00)00022-7; Tang W, 2000, P NATL ACAD SCI USA, V97, P6025, DOI 10.1073/pnas.110139897; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VANDOREN K, 1984, J VIROL, V50, P606, DOI 10.1128/JVI.50.2.606-614.1984; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; WILLARD DH, 1995, BIOCHEMISTRY-US, V34, P12341, DOI 10.1021/bi00038a030; Yang YK, 1997, MOL ENDOCRINOL, V11, P274, DOI 10.1210/me.11.3.274; Yang YK, 1999, MOL ENDOCRINOL, V13, P148, DOI 10.1210/me.13.1.148	50	115	122	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					40	47		10.1038/83741	http://dx.doi.org/10.1038/83741			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137996				2022-12-27	WOS:000166187900013
J	Primig, M; Williams, RM; Winzeler, EA; Tevzadze, GG; Conway, AR; Hwang, SY; Davis, RW; Esposito, RE				Primig, M; Williams, RM; Winzeler, EA; Tevzadze, GG; Conway, AR; Hwang, SY; Davis, RW; Esposito, RE			The core meiotic transcriptome in budding yeasts	NATURE GENETICS			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; MEIOSIS-SPECIFIC GENE; SACCHAROMYCES-CEREVISIAE; NEGATIVE REGULATOR; DNA-SEQUENCE; CELL-CYCLE; EXPRESSION; RECOMBINATION; SPORULATION; GENOME	We used high-density oligonucleotide microarrays to analyse the genomes and meiotic expression patterns of two yeast strains, SK1 and W303, that display distinct kinetics and efficiencies of sporulation. Hybridization of genomic DNA to arrays revealed numerous gene deletions and polymorphisms in both backgrounds. The expression analysis yielded approximately 1,600 meiotically regulated genes in each strain, with a core set of approximately 60% displaying similar patterns in both strains. Most of these (95%) are MATa/MAT alpha -dependent and are not similarly expressed in near-isogenic meiosis-deficient controls. The transcript profiles correlate with the distribution of defined meiotic promoter elements and with the time of known gene function.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Silicon Genet, San Carlos, CA USA	University of Chicago; Stanford University	Esposito, RE (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA.		Winzeler, Elizabeth/AAP-6752-2020; Primig, Michael/G-3175-2013	Winzeler, Elizabeth/0000-0002-4049-2113; Primig, Michael/0000-0002-2061-0119; Williams, Roy/0000-0002-5442-9166	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029182] Funding Source: NIH RePORTER; NHGRI NIH HHS [1RO1HG01633] Funding Source: Medline; NIGMS NIH HHS [1R01GM29182] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON SF, 1995, PROTEIN SCI, V4, P1832, DOI 10.1002/pro.5560040918; ATCHESON CL, 1987, P NATL ACAD SCI USA, V84, P8035, DOI 10.1073/pnas.84.22.8035; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; BOWDISH KS, 1995, MOL CELL BIOL, V15, P2955; BRIZA P, 1990, GENE DEV, V4, P1775, DOI 10.1101/gad.4.10.1775; BUCKINGHAM LE, 1990, P NATL ACAD SCI USA, V87, P9406, DOI 10.1073/pnas.87.23.9406; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; COVITZ PA, 1993, GENE DEV, V7, P1598, DOI 10.1101/gad.7.8.1598; DELLASETA F, 1990, J BIOL CHEM, V265, P15168; DORSMAN JC, 1989, NUCLEIC ACIDS RES, V17, P4917, DOI 10.1093/nar/17.13.4917; Dujon B, 1998, ELECTROPHORESIS, V19, P617, DOI 10.1002/elps.1150190427; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ESPOSITO MS, 1969, GENETICS, V61, P79; Esposito R. E., 1981, MOL BIOL YEAST SACCH, V11, P211; Freire R, 1998, GENE DEV, V12, P2560, DOI 10.1101/gad.12.16.2560; GailusDurner V, 1996, MOL CELL BIOL, V16, P2777; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; HEPWORTH SR, 1995, MOL CELL BIOL, V15, P3934; KABACK DB, 1985, MOL CELL BIOL, V5, P751, DOI 10.1128/MCB.5.4.751; KLAPHOLZ S, 1985, GENETICS, V110, P187; KUPIEC M, 1997, SACCHAROMYCES CEREVI, P889; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Ozsarac N, 1997, MOL CELL BIOL, V17, P1152, DOI 10.1128/MCB.17.3.1152; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pierce M, 1998, MOL CELL BIOL, V18, P5970, DOI 10.1128/MCB.18.10.5970; Planta RJ, 1995, BIOCHEM CELL BIOL, V73, P825, DOI 10.1139/o95-090; Rolfes RJ, 1997, J BIOL CHEM, V272, P13343, DOI 10.1074/jbc.272.20.13343; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Steber CM, 1995, P NATL ACAD SCI USA, V92, P12490, DOI 10.1073/pnas.92.26.12490; Striano S, 1986, Acta Neurol (Napoli), V8, P1; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; SUMRADA RA, 1987, P NATL ACAD SCI USA, V84, P3997, DOI 10.1073/pnas.84.12.3997; SUROSKY RT, 1992, MOL CELL BIOL, V12, P3948, DOI 10.1128/MCB.12.9.3948; Sweet DH, 1997, MOL CELL BIOL, V17, P6223, DOI 10.1128/MCB.17.11.6223; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Zalevsky J, 1999, GENETICS, V153, P1271	43	356	369	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					415	423		10.1038/82539	http://dx.doi.org/10.1038/82539			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101837				2022-12-27	WOS:000165671700012
J	Thompson, AA; Nguyen, LT				Thompson, AA; Nguyen, LT			Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation	NATURE GENETICS			English	Article							HOMEOBOX GENES; HEMATOPOIESIS; HOXD13; MOUSE		Univ Calif Los Angeles, Sch Med, Dept Pediat, Div Hematol Oncol,Gwynne Hazen Cherry Mem Labs, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Thompson, AA (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pediat, Div Hematol Oncol,Gwynne Hazen Cherry Mem Labs, Los Angeles, CA 90024 USA.		Nguyen, T.T. Loan/D-2495-2019	Nguyen, T.T. Loan/0000-0001-6440-6462				ALTER BP, 1992, J HAND SURG-AM, V17A, P566, DOI 10.1016/0363-5023(92)90372-V; Davis AP, 1996, DEVELOPMENT, V122, P1175; Evans T, 1997, HEMATOL ONCOL CLIN N, V11, P1115, DOI 10.1016/S0889-8588(05)70485-8; Favier B, 1996, DEVELOPMENT, V122, P449; HALL JG, 1987, J MED GENET, V24, P79, DOI 10.1136/jmg.24.2.79; Johnson KR, 1998, HUM MOL GENET, V7, P1033, DOI 10.1093/hmg/7.6.1033; Lawrence HJ, 1996, STEM CELLS, V14, P281, DOI 10.1002/stem.140281; Mark M, 1997, PEDIATR RES, V42, P421, DOI 10.1203/00006450-199710000-00001; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Rijli FM, 1997, CURR OPIN GENET DEV, V7, P481, DOI 10.1016/S0959-437X(97)80074-3; SCHROEDERKURTH TM, 1989, FANCONI ANEMIA CLIN, P264; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495	15	134	140	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					397	398		10.1038/82511	http://dx.doi.org/10.1038/82511			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101832				2022-12-27	WOS:000165671700008
J	Flores-Rozas, H; Clark, D; Kolodner, RD				Flores-Rozas, H; Clark, D; Kolodner, RD			Proliferating cell nuclear antigen and Msh2p-Msh6p interact to form an active mispair recognition complex	NATURE GENETICS			English	Article							DNA MISMATCH REPAIR; SACCHAROMYCES-CEREVISIAE; REPLICATION FIDELITY; HETERODUPLEX DNA; DISTINCT ROLES; HMUTS-ALPHA; YEAST; PCNA; BINDING; IDENTIFICATION	Proliferating cell nuclear antigen (PCNA) is required for mismatch repair (MMR) and has been shown to interact with complexes containing Msh2p or MLH1 (refs 1-4). PCNA has been implicated to act in MMR before and during the DNA synthesis step, although the biochemical basis for the role of PCNA early in MMR is unclear(1,3,5). Here we observe an interaction between PCNA and Msh2p-Msh6p mediated by a specific PCNA-binding site present in Msh6p. An msh6 mutation that eliminated the PCNA-binding site caused a mutator phenotype and a defect in the interaction with PCNA. The association of PCNA with Msh2p-Msh6p stimulated the preferential binding of Msh2p-Msh6p to DNA containing mispaired bases. Mutant PCNA proteins encoded by MMR-defective pol30 alleles were defective for interaction with Msh2p-Msh6p and for stimulation of mispair binding by Msh2p-Msh6p. Our results suggest that PCNA functions directly in mispair recognition and that mispair recognition requires a higher-order complex containing proteins in addition to Msh2p-Msh6p.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA.				NIGMS NIH HHS [GM50006] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Alani E, 1996, MOL CELL BIOL, V16, P5604; Amin NS, 1996, GENETICS, V144, P479; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Chen C, 1999, MOL CELL BIOL, V19, P7801; Drotschmann K, 1998, NUCLEIC ACIDS RES, V26, P948, DOI 10.1093/nar/26.4.948; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Hughes P, 1999, NUCLEIC ACIDS RES, V27, P2108, DOI 10.1093/nar/27.10.2108; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; Kokoska RJ, 1999, GENETICS, V151, P511; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Rose MD., 1990, METHODS YEAST GENETI; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; Umar A, 1996, EUR J BIOCHEM, V238, P297, DOI 10.1111/j.1432-1033.1996.0297z.x; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Vallejo Abbe N., 1995, P603; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R	28	188	192	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					375	378		10.1038/81708	http://dx.doi.org/10.1038/81708			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062484				2022-12-27	WOS:000165176500033
J	Silva, JP; Kohler, M; Graff, C; Oldfors, A; Magnuson, MA; Berggren, PO; Larsson, NG				Silva, JP; Kohler, M; Graff, C; Oldfors, A; Magnuson, MA; Berggren, PO; Larsson, NG			Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes	NATURE GENETICS			English	Article							GENE MUTATION; DNA; MEDICINE; MOUSE	Mitochondrial dysfunction is an important contributor to human pathology(1-4) and it is estimated that mutations of mitochondrial DNA (mtDNA) cause approximately 0.5-1% of all types of diabetes mellitus(5,6). We have generated a mouse model for mitochondrial diabetes by tissue-specific disruption of the nuclear gene encoding mitochondrial transcription factor A (Tfam, previously mtTFA; ref, 7) in pancreatic beta -cells. This transcriptional activator is imported to mitochondria, where it is essential for mtDNA expression and maintenance(8,9). The Tfam-mutant mice developed diabetes from the age of approximately 5 weeks and displayed severe mtDNA depletion, deficient oxidative phosphorylation and abnormal appearing mitochondria in islets at the ages of 7-9 weeks, We performed physiological studies of beta -cell stimulus-secretion coupling in islets isolated from 7-9-week-old mutant mice and found reduced hyperpolarization of the mitochondrial membrane potential, impaired Ca2+-signalling and lowered insulin release in response to glucose stimulation. We observed reduced beta -cell mass in older mutants. Our findings identity two phases in the pathogenesis of mitochondrial diabetes; mutant beta -cells initially display reduced stimulus-secretion coupling, later followed by beta -cell loss, This animal model reproduces the beta -cell pathology of human mitochondrial diabetes and provides genetic evidence for a critical role of the respiratory chain in insulin secretion.	Karolinska Inst, Karolinska Hosp, Dept Mol Med, Rolf Luft Ctr Diabet Res, S-10401 Stockholm, Sweden; Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Vanderbilt University	Larsson, NG (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Mol Med, Rolf Luft Ctr Diabet Res, S-10401 Stockholm, Sweden.			Graff, Caroline/0000-0002-9949-2951; Berggren, Per-Olof/0000-0001-8991-413X; Magnuson, Mark/0000-0002-8824-6499; Larsson, Nils-Goran/0000-0001-5100-996X; Oldfors, Anders/0000-0002-5758-7397; Kohler, Martin/0000-0001-6487-4303				BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Graff C, 1999, J INTERN MED, V246, P11, DOI 10.1046/j.1365-2796.1999.00514.x; GUENETTE DR, 1995, CD-ROM PROF, V8, P10; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; KANATSUNA T, 1981, DIABETES, V30, P231, DOI 10.2337/diabetes.30.3.231; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Kobayashi T, 1997, DIABETES, V46, P1567, DOI 10.2337/diabetes.46.10.1567; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Larsson NG, 1999, FEBS LETT, V455, P199, DOI 10.1016/S0014-5793(99)00854-6; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; Otabe S, 1999, BIOCHEM BIOPH RES CO, V259, P149, DOI 10.1006/bbrc.1999.0650; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089	21	340	345	1	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					336	340		10.1038/81649	http://dx.doi.org/10.1038/81649			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062475				2022-12-27	WOS:000165176500024
J	Krings, M; Capelli, C; Tschentscher, F; Geisert, H; Meyer, S; von Haeseler, A; Grossschmidt, K; Possnert, G; Paunovic, M; Paabo, S				Krings, M; Capelli, C; Tschentscher, F; Geisert, H; Meyer, S; von Haeseler, A; Grossschmidt, K; Possnert, G; Paunovic, M; Paabo, S			A view of Neandertal genetic diversity	NATURE GENETICS			English	Article							DNA; MITOCHONDRIAL; SEQUENCE		Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; Univ Cattolica Sacro Cuore, Inst Legal Med, Rome, Italy; Univ Munich, Inst Zool, D-8000 Munich, Germany; Univ Vienna, Inst Histol & Embryol, A-1090 Vienna, Austria; Angstrom Lab, Div Ion Phys, Uppsala, Sweden; Croatian Acad Sci & Arts, Inst Quaternay Paleontol & Geol, Zagreb, Croatia	Max Planck Society; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Munich; University of Vienna; Croatian Academy of Sciences & Arts	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.		von Haeseler, Arndt/HCI-9958-2022	von Haeseler, Arndt/0000-0002-3366-4458; Capelli, Cristian/0000-0001-9348-9084				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Burckhardt F, 1999, NUCLEIC ACIDS RES, V27, P138, DOI 10.1093/nar/27.1.138; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; KRINGS M, IN PRESS VINDIJA NEA; Malez M., 1982, PALAEONTOLOGIA JUGOS, V29, P1; Nordborg M, 1998, AM J HUM GENET, V63, P1237, DOI 10.1086/302052; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; SAUNDERS IW, 1984, ADV APPL PROBAB, V16, P471, DOI 10.2307/1427285; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; WOLPOFF MH, 1981, AM J PHYS ANTHROPOL, V54, P499, DOI 10.1002/ajpa.1330540407	14	224	236	2	47	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					144	146		10.1038/79855	http://dx.doi.org/10.1038/79855			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017066				2022-12-27	WOS:000089638800008
J	Korstanje, R; Paigen, B				Korstanje, R; Paigen, B			From QTL to gene: the harvest begins	NATURE GENETICS			English	Letter							SUBUNIT PROMOTER VARIANT; SUSCEPTIBILITY GENE; ALZHEIMERS-DISEASE; SODIUM-CHANNEL; FATTY-ACID; PROTEIN; IDENTIFICATION; ASSOCIATION; MUTATION; HYPERTENSION		Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Paigen, B (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	bjp@jax.org						Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; BAIER LJ, 1995, J CLIN INVEST, V95, P1281, DOI 10.1172/JCI117778; Belknap JK, 2001, BEHAV GENET, V31, P5, DOI 10.1023/A:1010249607128; BOUCHARD G, 2000, S HON G PAUMG, P97; Cicila GT, 2001, GENOMICS, V72, P51, DOI 10.1006/geno.2000.6442; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cormier RT, 1997, NAT GENET, V17, P88, DOI 10.1038/ng0997-88; Deschepper CF, 2001, CIRC RES, V88, P223; Forsell PKAL, 2000, GENE, V260, P145, DOI 10.1016/S0378-1119(00)00464-9; Glorioso N, 2001, HYPERTENSION, V38, P204, DOI 10.1161/01.HYP.38.2.204; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hamilton-Williams EE, 2001, P NATL ACAD SCI USA, V98, P11533, DOI 10.1073/pnas.191383798; Herrera VLM, 2001, MOL MED, V7, P125, DOI 10.1007/BF03401946; Hixson JE, 1999, J CLIN ENDOCR METAB, V84, P3187, DOI 10.1210/jc.84.9.3187; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ikeda A, 2002, NAT GENET, V30, P401, DOI 10.1038/ng838; Iwai N, 2002, J AM SOC NEPHROL, V13, P80, DOI 10.1681/ASN.V13180; Iwai N, 2001, HYPERTENSION, V38, P86, DOI 10.1161/01.HYP.38.1.86; Jansen H, 1999, ARTERIOSCL THROM VAS, V19, P303, DOI 10.1161/01.ATV.19.2.303; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Podolin PL, 2000, CYTOKINE, V12, P477, DOI 10.1006/cyto.1999.0609; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Sen S, 2001, GENETICS, V159, P371; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; Symula DJ, 1999, NAT GENET, V23, P241, DOI 10.1038/13880; Theuns J, 2000, HUM MOL GENET, V9, P325, DOI 10.1093/hmg/9.3.325; Uitterlinden AG, 2001, J BONE MINER RES, V16, P379, DOI 10.1359/jbmr.2001.16.2.379; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Zhang SL, 2001, MOL CELL BIOL, V21, P310, DOI 10.1128/MCB.21.1.310-318.2001	35	177	188	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2002	31	3					235	236		10.1038/ng0702-235	http://dx.doi.org/10.1038/ng0702-235			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12089518				2022-12-27	WOS:000176494100006
J	Lomazzi, M; Moroni, MC; Jensen, MR; Frittoli, E; Helin, K				Lomazzi, M; Moroni, MC; Jensen, MR; Frittoli, E; Helin, K			Suppression of the p53-or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry	NATURE GENETICS			English	Article							CELL-CYCLE ARREST; TRANSCRIPTION FACTORS E2F-1; RETINOBLASTOMA PROTEIN; DEREGULATED EXPRESSION; ADENOVIRUS E1A; INK4A LOCUS; PROLIFERATION; APOPTOSIS; BINDING; FAMILY	Deregulation of the retinoblastoma protein (pRB) pathway is a hallmark of cancer(1). In the absence of other genetic alterations, this deregulation results in lack of differentiation, hyperproliferation and apoptosis(2). The pRB protein acts as a transcriptional repressor by targeting the E2F transcription factors, whose functions are required for entry into S phase(3,4). Increased E2F activity can induce S phase in quiescent cells this is a central element of most models for the development of cancer 1,3,4. We show that although E2F1 alone is not sufficient to induce S phase in diploid mouse and human fibroblasts, increased E2F1 activity can result in S-phase entry in diploid fibroblasts in which the p53-mediated G1 checkpoint is suppressed. In addition, we show that E2F1 can induce S phase in primary mouse fibroblasts lacking pRB. These results indicate that, in addition to acting as an E2F-dependent transcriptional repressor, pRB is also required for the cells to retain the G1 checkpoint in response to unprogrammed proliferative signals.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; FIRC Inst Mol Oncol, Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology	Helin, K (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Ripamonti 435, I-20141 Milan, Italy.		Helin, Kristian/K-2526-2019; Jensen, Michael/E-9677-2011; Helin, Kristian/HDM-8306-2022; Moroni, Maria Cristina/H-7044-2018	Helin, Kristian/0000-0003-1975-6097; Moroni, Maria Cristina/0000-0003-2409-5764				BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FATTAEY AR, 1993, MOL CELL BIOL, V13, P7267, DOI 10.1128/MCB.13.12.7267; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HELIN K, 1994, J VIROL, V68, P5027, DOI 10.1128/JVI.68.8.5027-5035.1994; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; JOHNSON AF, 1993, ECOSYSTEMS WORLD, V2, P365; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; Mann DJ, 1996, CURR BIOL, V6, P474, DOI 10.1016/S0960-9822(02)00515-8; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; QUINLAN MP, 1987, P NATL ACAD SCI USA, V84, P3283, DOI 10.1073/pnas.84.10.3283; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; ZERLER B, 1987, MOL CELL BIOL, V7, P821, DOI 10.1128/MCB.7.2.821	30	70	72	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					190	194		10.1038/ng891	http://dx.doi.org/10.1038/ng891			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	11992123				2022-12-27	WOS:000175903500017
J	Kalachikov, S; Evgrafov, O; Ross, B; Winawer, M; Barker-Cummings, C; Boneschi, FM; Choi, C; Morozov, P; Das, K; Teplitskaya, E; Yu, A; Cayanis, E; Penchaszadeh, G; Kottmann, AH; Pedley, TA; Hauser, WA; Ottman, R; Gilliam, TC				Kalachikov, S; Evgrafov, O; Ross, B; Winawer, M; Barker-Cummings, C; Boneschi, FM; Choi, C; Morozov, P; Das, K; Teplitskaya, E; Yu, A; Cayanis, E; Penchaszadeh, G; Kottmann, AH; Pedley, TA; Hauser, WA; Ottman, R; Gilliam, TC			Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; MEMBRANE-PROTEINS; CHROMOSOME 10Q; GENE; MAP; IDENTIFICATION; DROSOPHILA; SEQUENCES; HELICES; SLIT	The epilepsies are a common, clinically heterogeneous group of disorders defined by recurrent unprovoked seizures(1). Here we describe identification of the causative gene in autosomal-dominant partial epilepsy with auditory features (ADPEAF, MIM 600512), a rare form of idiopathic lateral temporal lobe epilepsy characterized by partial seizures with auditory disturbances(2,3). We constructed a complete, 4.2-Mb physical map across the genetically implicated disease-gene region, identified 28 putative genes (Fig. 1) and resequenced all or part of 21 genes before identifying presumptive mutations in one copy of the leucine-rich, glioma-inactivated 1 gene (LGI1) in each of five families with ADPEAF. Previous studies have indicated that loss of both copies of LGI1 promotes glial tumor progression. We show that the expression pattern of mouse Lgi1 is predominantly neuronal and is consistent with the anatomic regions involved in temporal lobe epilepsy. Discovery of LGI1 as a cause of ADPEAF suggests new avenues for research on pathogenic mechanisms of idiopathic epilepsies.	Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ, Dept Epidemiol, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Epidemiol Brain Disorders, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Med Genet, New York, NY 10032 USA; PsychoGenics Inc, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; New York State Psychiatry Institute	Ottman, R (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, 630 W 168 St,P&S Box 16, New York, NY 10032 USA.		Ottman, Ruth/O-2371-2013; Hauser, W Allen/AAB-5277-2020; Kottmann, Andreas/Y-1180-2019; Boneschi, Filippo Martinelli/H-8592-2012	Ottman, Ruth/0000-0001-7074-242X; Kottmann, Andreas/0000-0002-5435-7502; martinelli boneschi, filippo/0000-0002-9955-1368	NINDS NIH HHS [R01 NS036319-08, R01 NS020656-13, R01 NS036319, R01 NS020656] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036319, R01NS020656] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aita VM, 1999, AM J HUM GENET, V64, P210, DOI 10.1086/302185; Battye R, 2001, J NEUROSCI, V21, P4290, DOI 10.1523/JNEUROSCI.21-12-04290.2001; CHANG Z, 1993, DEV BIOL, V160, P315, DOI 10.1006/dbio.1993.1310; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; Commission on Classification and Terminology of the International League Against Epilepsy, 1989, EPILEPSIA, V30, P389; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; GRAY IC, 1995, GENOMICS, V28, P328, DOI 10.1006/geno.1995.1149; Gray IC, 1997, GENOMICS, V43, P85, DOI 10.1006/geno.1997.4809; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Juretic D, 1998, COMPUT CHEM, V22, P279, DOI 10.1016/S0097-8485(97)00070-3; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Mautner VF, 2000, NEUROGENETICS, V3, P31, DOI 10.1007/s100480000091; Meisler MH, 2001, ANNU REV GENET, V35, P567, DOI 10.1146/annurev.genet.35.102401.091142; Michelucci R, 2000, EPILEPSIA, V41, P967, DOI 10.1111/j.1528-1157.2000.tb00280.x; MILPETZ F, 1995, TRENDS BIOCHEM SCI, V20, P204, DOI 10.1016/S0968-0004(00)89009-X; Nobile C, 1998, MAMM GENOME, V9, P835, DOI 10.1007/s003359900877; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Poza JJ, 1999, ANN NEUROL, V45, P182, DOI 10.1002/1531-8249(199902)45:2<182::AID-ANA8>3.0.CO;2-G; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shah AB, 1997, AM J HUM GENET, V61, P317, DOI 10.1086/514864; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Somerville RPT, 2000, MAMM GENOME, V11, P622, DOI 10.1007/s0033500101280; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Winawer MR, 2000, NEUROLOGY, V54, P2173, DOI 10.1212/WNL.54.11.2173; WINAWER MR, 2002, EPILEPSIA, V43, P55; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477	30	457	476	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					335	341		10.1038/ng832	http://dx.doi.org/10.1038/ng832			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11810107	Green Accepted			2022-12-27	WOS:000174157600022
J	Karsunky, H; Zeng, H; Schmidt, T; Zevnik, B; Kluge, R; Schmid, KW; Duhrsen, U; Moroy, T				Karsunky, H; Zeng, H; Schmidt, T; Zevnik, B; Kluge, R; Schmid, KW; Duhrsen, U; Moroy, T			Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1	NATURE GENETICS			English	Article							ZINC-FINGER PROTEIN; T-CELL LYMPHOMAGENESIS; PIM-1; MYC; NEUTROPHILS; STAT3	The transcriptional repressor Gfi1 is a nuclear zinc-finger protein expressed in T-cell precursors in the thymus and in activated mature T lymphocytes(1-4). Previous experiments have shown that Gfi1 is involved in T-cell lymphomagenesis and in the development of T-cell progenitors(5-7). Here we show that Gfi1 is also expressed outside the lymphoid system in granulocytes and activated macrophages, cells that mediate innate immunity (that is, non-specific immunity). We have generated Gfi1-deficient mice (Gfi1(-/-)) and show that these animals are severely neutropenic and accumulate immature monocytic cells in blood and bone marrow. Their myeloid precursor cells are unable to differentiate into granulocytes upon stimulation with granulocyte colony-stimulating factor (G-CSF) but can develop into mature macrophages. We found that Gfi1(-/-) macrophages produce enhanced levels of inflammatory cytokines, such as tumor necrosis factor (TNF), interleukin-10 (IL-10) and IL-1beta, when stimulated with bacterial lipopolysaccharide (LPS) and that Gfi1(-/-) mice succumb to low doses of this endotoxin that are tolerated by wildtype mice. We conclude that Gfi1 influences the differentiation of myeloid precursors into granulocytes or monocytes and acts in limiting the inflammatory immune response.	Univ Essen Gesamthsch Klinikum, IFZ, Inst Zellbiol Tumorforsch, D-45122 Essen, Germany; Rhein Westfal TH Aachen, Inst Versuchstierkunde, D-52074 Aachen, Germany; Univ Essen Gesamthsch Klinikum, Inst Pathol, D-45122 Essen, Germany; Univ Essen Gesamthsch Klinikum, Hamatol Abt, D-45122 Essen, Germany	University of Duisburg Essen; RWTH Aachen University; University of Duisburg Essen; University of Duisburg Essen	Moroy, T (corresponding author), Univ Essen Gesamthsch Klinikum, IFZ, Inst Zellbiol Tumorforsch, D-45122 Essen, Germany.		Moroy, Tarik/D-9923-2011; Zevnik, Branko/AAB-7853-2020	Zevnik, Branko/0000-0001-7845-9522				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; Schmidt T, 1998, EMBO J, V17, P5349, DOI 10.1093/emboj/17.18.5349; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Zornig M, 1996, ONCOGENE, V12, P1789; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	12	246	251	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					295	300		10.1038/ng831	http://dx.doi.org/10.1038/ng831			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11810106				2022-12-27	WOS:000174157600014
J	Nakano, M; Yamada, K; Fain, J; Sener, EC; Selleck, CJ; Awad, AH; Zwaan, J; Mullaney, PB; Bosley, TM; Engle, EC				Nakano, M; Yamada, K; Fain, J; Sener, EC; Selleck, CJ; Awad, AH; Zwaan, J; Mullaney, PB; Bosley, TM; Engle, EC			Homozygous mutations in ARIX (PHOX2A) result in congenital fibrosis of the extraocular muscles type 2	NATURE GENETICS			English	Article							DUANES RETRACTION SYNDROME; HOMEODOMAIN PROTEIN; GENE; TRANSCRIPTION; MAPS; EXPRESSION; PROMOTER; DEFECTS	Isolated strabismus affects 1-5% of the general population(1). Most forms of strabismus are multifactorial in origin; although there is probably an inherited component, the genetics of these disorders remain unclear. The congenital fibrosis syndromes (CFS) represent a subset of monogenic isolated strabismic disorders that are characterized by restrictive ophthalmoplegia, and include congenital fibrosis of the extraocular muscles (CFEOM) and Duane syndrome (DURS)(2). Neuropathologic studies indicate that these disorders may result from the maldevelopment of the oculomotor (nIII), trochlear (nIV) and abducens (nVI) cranial nerve nuclei(3-5). To date, five CFS loci have been mapped (FEOM1, FEOM2, FEOM3, DURS1 and DURS2)(6-10), but no genes have been identified. Here, we report three mutations in ARIX (also known as PHOX2A) in four CFEOM2 pedigrees. ARIX encodes a homeodomain transcription factor protein previously shown to be required for nIIInIV development in mouse and zebrafish(1,12). Two of the mutations are predicted to disrupt splicing, whereas the third alters an amino acid within the conserved brachyury-like domain(13,14). These findings confirm the hypothesis that CFEOM2 results from the abnormal development of nIII/nIV (ref. 7) and emphasize a critical role for ARIX in the development of these midbrain motor nuclei(13-19).	Hacettepe Univ, Ankara, Turkey; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA USA; King Khalid Eye Specialist Hosp, Riyadh 11462, Saudi Arabia; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Hacettepe University; Harvard University; Boston Children's Hospital; Harvard Medical School; King Khaled Eye Specialist Hospital; University of Texas System; University of Texas Health San Antonio	Engle, EC (corresponding author), Hacettepe Univ, Ankara, Turkey.	engle@enders.tch.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012498] Funding Source: NIH RePORTER; NEI NIH HHS [EY12498] Funding Source: Medline; NICHD NIH HHS [P30HD18655] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adachi M, 2000, DNA CELL BIOL, V19, P539, DOI 10.1089/104454900439773; Appukuttan B, 1999, AM J HUM GENET, V65, P1639, DOI 10.1086/302656; Brown HW., 1950, STRABISMUS OPHTHALMI, P205; Doherty EJ, 1999, INVEST OPHTH VIS SCI, V40, P1687; Engle EC, 1997, AM J HUM GENET, V60, P1150; ENGLE EC, 1995, AM J HUM GENET, V57, P1086; Engle EC, 1997, ANN NEUROL, V41, P314, DOI 10.1002/ana.410410306; Engle EC, 1998, OX MG MED G, P477; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; HOTCHKISS MG, 1980, ARCH OPHTHALMOL-CHIC, V98, P870, DOI 10.1001/archopht.1980.01020030864013; MILLER NR, 1982, ARCH OPHTHALMOL-CHIC, V100, P1468; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2000, MOL CELL NEUROSCI, V15, P235, DOI 10.1006/mcne.1999.0826; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; ROBERTSON D, 1991, HYPERTENSION, V18, P1, DOI 10.1161/01.HYP.18.1.1; Ross M.T., 1999, CURRENT PROTOCOLS HU; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Swanson DJ, 2000, J BIOL CHEM, V275, P2911, DOI 10.1074/jbc.275.4.2911; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; VALARCHE I, 1993, DEVELOPMENT, V119, P881; VINCENT C, 1994, HUM MOL GENET, V3, P1859, DOI 10.1093/hmg/3.10.1859; Wang SM, 1998, AM J HUM GENET, V63, P517, DOI 10.1086/301980; Yang CY, 1998, J NEUROCHEM, V71, P1813; Zellmer E, 1995, J NEUROSCI, V15, P8109; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	30	142	158	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					315	320		10.1038/ng744	http://dx.doi.org/10.1038/ng744			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11600883				2022-12-27	WOS:000171911000019
J	Wilson, JF; Weale, ME; Smith, AC; Gratrix, F; Fletcher, B; Thomas, MG; Bradman, N; Goldstein, DB				Wilson, JF; Weale, ME; Smith, AC; Gratrix, F; Fletcher, B; Thomas, MG; Bradman, N; Goldstein, DB			Population genetic structure of variable drug response	NATURE GENETICS			English	Article							FUNCTIONAL-SIGNIFICANCE; CYP1A2 GENE; METABOLISM; CYP2D6; POLYMORPHISMS; DEBRISOQUINE; MEPHENYTOIN; CYP2C19; HUMANS; DEFECT	Geographic patterns of genetic variation, including variation at drug metabolizing enzyme (DME) loci and drug targets, indicate that geographic structuring of inter-individual variation in drug response may occur frequently. This raises two questions: how to represent human population genetic structure in the evaluation of drug safety and efficacy, and how to relate this structure to drug response. We address these by (i) inferring the genetic structure present in a heterogeneous sample and (ii) comparing the distribution of DME variants across the inferred genetic clusters of individuals. We find that commonly used ethnic labels are both insufficient and inaccurate representations of the inferred genetic clusters, and that drug-metabolizing profiles, defined by the distribution of DME variants, differ significantly among the clusters. We note, however, that the complexity of human demographic history means that there is no obvious natural clustering scheme, nor an obvious appropriate degree of resolution. Our comparison of drug-metabolizing profiles across the inferred clusters establishes a framework for assessing the appropriate level of resolution in relating genetic structure to drug response.	UCL, Dept Biol, Galton Lab, London, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; UCL, Dept Biol, Ctr Genet Anthropol, London, England; Genost Ltd, London WC1A 2HN, England	University of London; University College London; University of Oxford; University of London; University College London	Wilson, JF (corresponding author), UCL, Dept Biol, Galton Lab, Mortimer St, London, England.	d.goldstein@ucl.ac.uk	Goldstein, David/AAY-8125-2020; Weale, Michael E/F-2587-2010; Wilson, James F/A-5704-2009; Thomas, Mark G/A-2219-2012	Weale, Michael E/0000-0003-4593-1186; Wilson, James F/0000-0001-5751-9178; Thomas, Mark G/0000-0002-2452-981X				Basile VS, 2000, MOL PSYCHIATR, V5, P410, DOI 10.1038/sj.mp.4000736; Bernal ML, 1999, PHARMACOGENETICS, V9, P657, DOI 10.1097/00008571-199910000-00013; BLUM M, 1991, P NATL ACAD SCI USA, V88, P5237, DOI 10.1073/pnas.88.12.5237; Daly D. A., 1993, AM J SPEECH-LANG PAT, V2, P6, DOI [10.1044/1058-0360.0202.06., DOI 10.1044/1058-0360.0202.06]; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Ferguson RJ, 1998, J PHARMACOL EXP THER, V284, P356; Gaedigk A, 1998, PHARMACOGENETICS, V8, P305, DOI 10.1097/00008571-199808000-00004; Gaedigk A, 1999, PHARMACOGENETICS, V9, P669, DOI 10.1097/01213011-199912000-00002; Goldstein JA, 1996, METHOD ENZYMOL, V272, P210, DOI 10.1016/S0076-6879(96)72025-6; GOUGH AC, 1990, NATURE, V347, P773, DOI 10.1038/347773a0; KAGIMOTO M, 1990, J BIOL CHEM, V265, P17209; KOHLMEIER L, 1997, DESIGN CONCEPTS NUTR, P312; Krajinovic M, 1999, BLOOD, V93, P1496, DOI 10.1182/blood.V93.5.1496.405a36_1496_1501; Meyer UA, 1997, ANNU REV PHARMACOL, V37, P269, DOI 10.1146/annurev.pharmtox.37.1.269; Pritchard JK, 2000, GENETICS, V155, P945; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; WEBER WW, 1997, PHARMACOGENETICS; Wilson JF, 2000, AM J HUM GENET, V67, P926, DOI 10.1086/303083; 1998, INT C HARM ETHN FACT	21	326	339	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					265	269		10.1038/ng761	http://dx.doi.org/10.1038/ng761			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11685208				2022-12-27	WOS:000171911000011
J	Seeliger, MW; Grimm, C; Stahlberg, F; Friedburg, C; Jaissle, G; Zrenner, E; Guo, H; Reme, CE; Humphries, P; Hofmann, F; Biel, M; Fariss, RN; Redmond, TM; Wenzel, A				Seeliger, MW; Grimm, C; Stahlberg, F; Friedburg, C; Jaissle, G; Zrenner, E; Guo, H; Reme, CE; Humphries, P; Hofmann, F; Biel, M; Fariss, RN; Redmond, TM; Wenzel, A			New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis	NATURE GENETICS			English	Article							RETINAL DYSTROPHY; CONE DYSTROPHY; ALPHA-SUBUNIT; MUTATIONS; PHOTORECEPTORS; CHANNEL; GENE; MICE	Leber congenital amaurosis (LCA) is the most serious form of the autosomal recessive childhood-onset retinal dystrophies. Mutations in the gene encoding RPE65, a protein vital for regeneration of the visual pigment rhodopsin in the retinal pigment epithelium(1), account for 10-15% of LCA cases(2,3). Whereas previous studies of RPE65 deficiency in both animal models(1,4) and patients(5,6) attributed remaining visual function to cones, we show here that light-evoked retinal responses in fact originate from rods. For this purpose, we selectively impaired either rod or cone function in Rpe65(-/-) mice by generating double-mutant mice with models of pure cone function(7) (rhodopsin-deficient mice; Rho(-/-)) and pure rod function, (cyclic nucleotide-gated channel alpha3-deficient mice; Cnga3(-/-)). The electroretinograms (ERGs) of Rpe65(-/-) and Rpe65(-/-)Cnga3(-/-) mice were almost identical, whereas there was no assessable response in Rpe65(-/-)Rho(-/-) mice. Thus, we conclude that the rod system is the source of vision in RPE65 deficiency. Furthermore, we found that lack of RPE65 enables rods to mimic cone function by responding under normally cone-isolating lighting conditions. We propose as a mechanism decreased rod sensitivity due to a reduction in rhodopsin content to less than 1%. In general, the dissection of pathophysiological processes in animal models through the introduction of additional, selective mutations is a promising concept in functional genetics.	Univ Tubingen, Dept Ophthalmol, Retinal Electrodiagnost Res Grp, D-72074 Tubingen, Germany; Univ Zurich Hosp, Lab Retinal Cell Biol, CH-8091 Zurich, Switzerland; Swedish Univ Agr Sci, Fac Vet Med, Dept Med & Surg, S-75007 Uppsala, Sweden; Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland; Tech Univ Munich, Inst Pharmakol & Toxikol, D-8000 Munich, Germany; Univ Munich, Zentrum Pharmaforsch, Dept Pharm, D-80539 Munich, Germany; NEI, Lab Mechanisms Ocular Dis, Bethesda, MD 20892 USA; NEI, Retinal Cell & Mol Biol Lab, Bethesda, MD 20892 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; University Zurich Hospital; Swedish University of Agricultural Sciences; Trinity College Dublin; Technical University of Munich; University of Munich; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Seeliger, MW (corresponding author), Univ Tubingen, Dept Ophthalmol, Retinal Electrodiagnost Res Grp, D-72074 Tubingen, Germany.		Biel, Martin/G-1175-2014; Fariss, Robert/ABI-1771-2020	Biel, Martin/0000-0002-9974-3052; Redmond, T. Michael/0000-0002-1813-5291; Grimm, Christian/0000-0001-9318-4352; Fariss, Robert/0000-0003-3227-7170	NATIONAL EYE INSTITUTE [Z01EY000260, ZIAEY000260] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Arden, 1991, PRINCIPLES PRACTICE; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Cideciyan AV, 2000, VISUAL NEUROSCI, V17, P667, DOI 10.1017/S0952523800175029; CONNER JD, 1977, SCIENCE, V195, P698, DOI 10.1126/science.841308; DOWLING JE, 1960, AM J OPHTHALMOL, V50, P875, DOI 10.1016/0002-9394(60)90340-8; FISHMAN GA, 1990, ELECTROPHYSIOLOGIC T; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hirano AA, 2000, J COMP NEUROL, V421, P80, DOI 10.1002/(SICI)1096-9861(20000522)421:1<80::AID-CNE5>3.0.CO;2-O; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; MARMOR M, 1995, DOC OPHTHALMOL, V89, P99; Nakamura M, 2000, INVEST OPHTH VIS SCI, V41, P3925; Paupoo AAV, 2000, J PHYSIOL-LONDON, V529, P469, DOI 10.1111/j.1469-7793.2000.00469.x; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2000, METHOD ENZYMOL, V316, P705; Sadowski Bettina, 1994, Ophthalmologe, V91, P719; Thomas MM, 1999, J PHYSIOL-LONDON, V518, P479, DOI 10.1111/j.1469-7793.1999.0479p.x; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Veske A, 1999, GENOMICS, V57, P57, DOI 10.1006/geno.1999.5754; Wenzel A, 2000, J NEUROSCI, V20, P81, DOI 10.1523/JNEUROSCI.20-01-00081.2000	26	203	206	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					70	74		10.1038/ng712	http://dx.doi.org/10.1038/ng712			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528395				2022-12-27	WOS:000170781300020
J	Van Goethem, G; Dermaut, B; Lofgren, A; Martin, JJ; Van Broeckhoven, C				Van Goethem, G; Dermaut, B; Lofgren, A; Martin, JJ; Van Broeckhoven, C			Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions	NATURE GENETICS			English	Article							MITOCHONDRIAL-DNA POLYMERASE; MULTIPLE DELETIONS; REPLICATION; DISORDER; GAMMA; GENE	Progressive external ophthalmoplegias (PEO) characterized by accumulation of large-scale mitochondrial DNA (mtDNA) deletions are rare human diseases. We mapped a new locus for dominant PEO at 15q22-q26 in a Belgian pedigree and identified a heterozygous mutation (Y955C) in the polymerase motif B of the mtDNA polymerase gamma (POLG). We identified three additional POLG missense mutations compatible with recessive PEO In two nuclear families. POLG is the only DNA polymerase responsible for mtDNA replication.	Univ Antwerp VIB, Born Bunge Fdn, Dept Mol Genet, B-2610 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Univ Antwerp, Born Bunge Fdn, Neuropathol Lab, Dept Med, B-2610 Antwerp, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Antwerp	Van Broeckhoven, C (corresponding author), Univ Antwerp VIB, Born Bunge Fdn, Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	cvbroeck@uia.ua.ac.be	Van Broeckhoven, Christine/G-8362-2017; Dermaut, Bart/AAM-2483-2020; Van Broeckhoven, Christine/M-7853-2019	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665				Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Heringa Jaap, 1994, P87; Iyengar B, 1999, GENETICS, V153, P1809; Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445; Liu HT, 2000, J VIROL, V74, P11681, DOI 10.1128/JVI.74.24.11681-11689.2000; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Pinz KG, 2000, J BIOL CHEM, V275, P12509, DOI 10.1074/jbc.275.17.12509; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; Van Goethem G, 2000, J MED GENET, V37, P547, DOI 10.1136/jmg.37.7.547; VanGoethem G, 1997, EUR J NEUROL, V4, P476; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	18	595	604	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					211	212		10.1038/90034	http://dx.doi.org/10.1038/90034			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431686				2022-12-27	WOS:000169656400008
J	Waikel, RL; Kawachi, Y; Waikel, PA; Wang, XJ; Roop, DR				Waikel, RL; Kawachi, Y; Waikel, PA; Wang, XJ; Roop, DR			Deregulated expression of c-Myc depletes epidermal stem cells	NATURE GENETICS			English	Letter							HUMAN KERATINOCYTE MIGRATION; DIFFERENTIATION; FIBRONECTIN; INTEGRIN; PROLIFERATION; MARKERS; DEATH; MICE	The beta -catenin/TCF signaling pathway is essential for the maintenance of epithelial stem cells in the small intestine(1). c-Myc a downstream target of beta -catenin/TCF (ref. 2), can induce differentiation of epidermal stem cells in vitro(3). To determine the role of c-Myc in epidermal stem cells in vivo, we have targeted expression of human MYC2 to the hair follicles and the basal layer of mouse epidermis using a keratin 14 vector (K14,MYC2), Adult K14,MYC2 mice gradually lose their hair and develop spontaneous ulcerated lesions due to a severe impairment in wound healing; their keratinocytes show impaired migration in response to wounding. The expression of beta1 integrin, which is preferentially expressed in epidermal stem cells(4) is unusually low in the epidermis of K14.MYC2 mice. Label-retaining analysis to identify epidermal stem cells reveals a 75% reduction in the number of stem cells in 3-month-old K14.MYC2 mice, compared with wildtype mice. We conclude that deregulated expression of c-Myc in stem cells reduces beta1 integrin expression, which is essential to both keratinocyte migration and stem cell maintenance.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Roop, DR (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025479] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA052607, R01CA079998] Funding Source: NIH RePORTER; NCI NIH HHS [CA52607, CA09197, CA79998] Funding Source: Medline; NIAMS NIH HHS [AR62228] Funding Source: Medline; NICHD NIH HHS [HD25479] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; Arin MJ, 2001, J CELL BIOL, V152, P645, DOI 10.1083/jcb.152.3.645; ARNOLD I, IN PRESS CURR BIOL; Barr LF, 1998, CANCER RES, V58, P5537; Berton TR, 2000, GENESIS, V26, P160, DOI 10.1002/(SICI)1526-968X(200002)26:2<160::AID-GENE20>3.0.CO;2-#; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; BIRO S, 1993, P NATL ACAD SCI USA, V90, P654, DOI 10.1073/pnas.90.2.654; CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; GUO M, 1990, J CELL SCI, V96, P197; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Judware R, 1997, ONCOGENE, V14, P1341, DOI 10.1038/sj.onc.1200955; KIM JP, 1992, J CELL PHYSIOL, V151, P443, DOI 10.1002/jcp.1041510303; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; MACKENZIE IC, 1985, CELL TISSUE RES, V242, P551; POTTEN CS, 1982, CELL TISSUE KINET, V15, P305, DOI 10.1111/j.1365-2184.1982.tb01050.x; STANLEY JR, 1983, J CELL BIOL, V96, P1809, DOI 10.1083/jcb.96.6.1809; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Waikel RL, 1999, ONCOGENE, V18, P4870, DOI 10.1038/sj.onc.1203040; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; WANG XT, 1995, J BEHAV DECIS MAKING, V8, P279, DOI 10.1002/bdm.3960080405; Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427	25	259	275	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					165	168		10.1038/88889	http://dx.doi.org/10.1038/88889			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381265				2022-12-27	WOS:000169011800020
J	Cookson, WOCM; Ubhi, B; Lawrence, R; Abecasis, GR; Walley, AJ; Cox, HE; Coleman, R; Leaves, NI; Trembath, RC; Moffatt, MF; Harper, JI				Cookson, WOCM; Ubhi, B; Lawrence, R; Abecasis, GR; Walley, AJ; Cox, HE; Coleman, R; Leaves, NI; Trembath, RC; Moffatt, MF; Harper, JI			Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci	NATURE GENETICS			English	Article							17Q; REGION; SCAN; 3Q21; MAPS; HLA; 4Q	We have carried out a genome screen for atopic dermatitis (AD) and have identified linkage to AD on chromosomes 1q21, 17q25 and 20p. These regions correspond closely with known psoriasis loci, as does a previously identified AD locus on chromosome 3q21. The results indicate that AD is influenced by genes with general effects on dermal inflammation and immunity.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Inst Child Hlth, London, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Leicester	Cookson, WOCM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	william.cookson@ndm.ox.ac.uk	Walley, Andrew J/D-2573-2009; Abecasis, Goncalo R/B-7840-2010; Cookson, William/HHC-1790-2022	Walley, Andrew J/0000-0001-7707-7549; Trembath, Richard/0000-0003-0550-3400; Abecasis, Goncalo/0000-0003-1509-1825				Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; BOS J, 2000, IMMUNOLOGY ATOPIC DE, P178; Capon F, 1999, J INVEST DERMATOL, V112, P32, DOI 10.1046/j.1523-1747.1999.00471.x; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Enlund F, 1999, EUR J HUM GENET, V7, P783, DOI 10.1038/sj.ejhg.5200365; Enlund F, 1999, HUM HERED, V49, P2, DOI 10.1159/000022832; Hardas BD, 1996, J INVEST DERMATOL, V106, P753, DOI 10.1111/1523-1747.ep12345807; JUHLIN L, 1969, ARCH DERMATOL, V100, P12, DOI 10.1001/archderm.100.1.12; LARSEN FS, 1993, J AM ACAD DERMATOL, V28, P719, DOI 10.1016/0190-9622(93)70099-F; LARSEN FS, 1986, J AM ACAD DERMATOL, V15, P487; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Matthews D, 1996, NAT GENET, V14, P231, DOI 10.1038/ng1096-231; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813	15	284	296	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2001	27	4					372	373		10.1038/86867	http://dx.doi.org/10.1038/86867			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279517				2022-12-27	WOS:000167811200010
J	Dawkins, JL; Hulme, DJ; Brahmbhatt, SB; Auer-Grumbach, M; Nicholson, GA				Dawkins, JL; Hulme, DJ; Brahmbhatt, SB; Auer-Grumbach, M; Nicholson, GA			Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I	NATURE GENETICS			English	Letter							SPHINGOLIPID SYNTHESIS; CHROMOSOME 9Q22.1-Q22.3; BIOSYNTHESIS; INHIBITION; APOPTOSIS; LINKAGE; ENZYME; CELLS; LOCI; GENE	Hereditary sensory neuropathy type I (HSN1) is the most common hereditary disorder of peripheral sensory neurons. HSN1 is an autosomal dominant progressive degeneration of dorsal root ganglia and motor neurons with onset in the second or third decades. Initial symptoms are sensory loss in the feet followed by distal muscle wasting and weakness. Loss of pain sensation leads to chronic: skin ulcers and distal amputations(1,2). The HSN1 locus has been mapped to chromosome 9q22.1-22.3 (refs. 3,4). Here we map the gene SPTLC1, encoding serine palmitoyltransferase. long chain base subunit-l. to this locus. Mutation screening revealed 3 different missense mutations resulting in changes to 2 amino acids in all affected members of 11 HSN1 families. We found two mutations to be located in exon 5 (C133Y and C133W) and one mutation to be located in exon 6 of SPTLC1 (V144D). All families showing definite or probable linkage to chromosome 9 had mutations in these two exons. These mutations are associated with increased de novo glucosyl ceramide synthesis in lymphoblast cell lines in affected individuals. Increased de novo ceramide synthesis triggers apoptosis(5,6) and is associated with massive cell death during neural tube closure(7), raising the possibility that neural degeneration in HSN1 is due to ceramide-induced apoptotic cell death.	Univ Sydney, Concord Hosp, Anzac Res Inst, Neurobiol Lab, Concord, NSW, Australia; Karl Franzens Univ Graz, Dept Neurol, Graz, Austria	Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Graz	Nicholson, GA (corresponding author), Univ Sydney, Concord Hosp, Anzac Res Inst, Neurobiol Lab, Concord, NSW, Australia.		Ekanayake, Kanchana/P-8817-2016; Research Institute, ANZAC/CAE-9030-2022	Nicholson, Garth/0000-0001-9694-066X				AndreuttiZaugg C, 1997, CANCER RES, V57, P3288; Auer-Grumbach M, 2000, NEUROLOGY, V54, P45, DOI 10.1212/WNL.54.1.45; Bejaoui K, 1999, NEUROLOGY, V52, P510, DOI 10.1212/WNL.52.3.510; Blair IP, 1998, GENOMICS, V51, P277, DOI 10.1006/geno.1998.5373; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Dyck P. J., 1993, PERIPHERAL NEUROPATH, V3rd, P1065; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Herget T, 2000, J BIOL CHEM, V275, P30344, DOI 10.1074/jbc.M000714200; MATHEWS CK, 1990, BIOCHEMISTRY, V617; MEDLOCK KA, 1988, BIOCHEMISTRY-US, V27, P7079, DOI 10.1021/bi00418a061; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Nagiec MM, 1996, GENE, V177, P237, DOI 10.1016/0378-1119(96)00309-5; Nicholson GA, 1996, NAT GENET, V13, P101, DOI 10.1038/ng0596-101; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; SARKAR G, 1992, GENOMICS, V13, P441, DOI 10.1016/0888-7543(92)90266-U; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; SNELL EE, 1970, CHEM PHYS LIPIDS, V5, P116, DOI 10.1016/0009-3084(70)90013-7; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; THOMAS PK, 1993, BRAIN PATHOL, V3, P157, DOI 10.1111/j.1750-3639.1993.tb00740.x; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x	20	299	312	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					309	312		10.1038/85879	http://dx.doi.org/10.1038/85879			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242114				2022-12-27	WOS:000167304200024
J	Puccio, H; Simon, D; Cossee, M; Criqui-Filipe, P; Tiziano, F; Melki, J; Hindelang, C; Matyas, R; Rustin, P; Koenig, M				Puccio, H; Simon, D; Cossee, M; Criqui-Filipe, P; Tiziano, F; Melki, J; Hindelang, C; Matyas, R; Rustin, P; Koenig, M			Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits	NATURE GENETICS			English	Article							RESPIRATORY-CHAIN; MITOCHONDRIAL; FRATAXIN; HOMOLOG; ACCUMULATION; ACONITASE	Friedreich ataxia (FRDA), the most common autosomal recessive ataxia, is characterized by degeneration of the large sensory neurons and spinocerebellar tracts, cardiomyopathy and increased incidence in diabetes(1,2). FRDA is caused by severely reduced levels of frataxin, a mitochondrial protein(3) of unknown function. Yeast knockout models as well as histological and biochemical data from heart biopsies or autopsies of FRDA patients have shown that frataxin defects cause a specific iron-sulfur protein deficiency and intramitochondrial iron accumulation(4-7). We have recently shown that complete absence of frataxin in the mouse leads to early embryonic lethality(8), demonstrating an important role for frataxin during mouse development. Through a conditional gene-targeting approach, we have generated in parallel a striated muscle frataxin-deficient line and a neuron/cardiac muscle frataxin-deficient line, which together reproduce important progressive pathophysiological and biochemical features of the human disease: cardiac hypertrophy without skeletal muscle involvement, large sensory neuron dysfunction without alteration of the small sensory and motor neurons, and deficient activities of complexes I-III of the respiratory chain and of the aconitases, Our models demonstrate time-dependent intramitochondrial iron accumulation in a frataxin-deficient mammal, which occurs after onset of the pathology and after inactivation of the Fe-S-dependent enzymes. These mutant mice represent the first mammalian models to evaluate treatment strategies for the human disease.	Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, Illkirch, CU Strasbourg, France; GENOPOLE, INSERM E9913, Mol Neurogenet Lab, Evry, France; Hop Necker Enfants Malad, INSERM U393, Unite Rech Handicaps Gent Enfant, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Genopole; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Koenig, M (corresponding author), Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, BP 163, Illkirch, CU Strasbourg, France.		Tiziano, Francesco Danilo/A-7260-2010; Puccio, Hélène/G-1717-2013	Tiziano, Francesco Danilo/0000-0002-5545-6158; Puccio, Hélène/0000-0003-4711-2248				Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; BURCK U, 1981, NEUROPEDIATRICS, V12, P267, DOI 10.1055/s-2008-1059657; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Dierich A, 1997, METHODS IN DEVELOPMENTAL TOXICOLOGY AND BIOLOGY, P111; Doevendans PA, 1998, CARDIOVASC RES, V39, P34, DOI 10.1016/S0008-6363(98)00073-X; Dupe V, 1997, DEVELOPMENT, V124, P399; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Jiralerspong S, 1997, NEUROBIOL DIS, V4, P103, DOI 10.1006/nbdi.1997.0139; KOENIG M, 2001, METABOLIC MOL BASIS; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Lamarche J., 1993, HDB CEREBELLAR DIS, P453; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sambrook J., 2002, MOL CLONING LAB MANU; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; WATMOUGH NJ, 1990, J CLIN INVEST, V85, P177, DOI 10.1172/JCI114409	26	544	560	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					181	186		10.1038/84818	http://dx.doi.org/10.1038/84818			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175786				2022-12-27	WOS:000166839200019
J	Bolz, H; von Brederlow, B; Ramirez, A; Bryda, EC; Kutsche, K; Nothwang, HG; Seeliger, M; Cabrera, MDS; Vila, MC; Molina, OP; Gal, A; Kubisch, C				Bolz, H; von Brederlow, B; Ramirez, A; Bryda, EC; Kutsche, K; Nothwang, HG; Seeliger, M; Cabrera, MDS; Vila, MC; Molina, OP; Gal, A; Kubisch, C			Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D	NATURE GENETICS			English	Article							MYOSIN VIIA GENE; CELL-ADHESION MOLECULES; EXTRACELLULAR-MATRIX; RECESSIVE DEAFNESS; MAP	Usher syndrome type I (USH1) is an autosomal recessive disorder characterized by congenital sensorineural hearing loss, vestibular dysfunction and visual impairment due to early onset retinitis pigmentosa(1) (RP). So far, six loci (USH1A-USH1F) have been mapped, but only two USH1 genes have been identified: MYO7A (ref. 2) for USH1B and the gene encoding harmonin(3,4) for USH1C. We identified a Cuban pedigree linked to the locus for Usher syndrome type 1D (MIM 601067) within the q2 region of chromosome 10 (ref. 5). Affected individuals present with congenital deafness and a highly variable degree of retinal degeneration. Using a positional candidate approach, we identified a new member of the cadherin gene superfamily, CDH23. It encodes a protein of 3,354 amino acids with a single transmembrane domain and 27 cadherin repeats. In the Cuban family, we detected two different mutations: a severe course of the retinal disease was observed in individuals homozygous for what is probably a truncating splice-site mutation (c.4488G-->C), whereas mild RP is present in individuals carrying the homozygous missense mutation R1746Q. A variable expression of the retinal phenotype was seen in patients with a combination of both mutations. In addition, we identified two mutations, Delta M1281 and IVS51+5G-->A, in a German USH1 patient. Our data show that different mutations in CDH23 result in USH1D with a variable retinal phenotype. In an accompanying paper(6), it is shown that mutations in the mouse ortholog cause disorganization of inner ear stereocilia and deafness in the waltzer mouse.	Univ Hamburg, Krankenhaus Eppendorf, Inst Human Genet, D-2000 Hamburg, Germany; Univ Bonn, Inst Humangenet, D-5300 Bonn, Germany; Marshall Univ, Dept Microbiol Immunol & Mol Genet, Huntington, WV USA; MPI Mol Genet, Berlin, Germany; Univ Tubingen, Abt 2, Augenklin, Tubingen, Germany; Ctr Int REtinosis Pigmentaria, Habana, Cuba	University of Hamburg; University of Bonn; Marshall University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Gal, A (corresponding author), Univ Hamburg, Krankenhaus Eppendorf, Inst Human Genet, D-2000 Hamburg, Germany.		Nothwang, Hans G/C-5847-2011; Ramirez, Alfredo/S-5126-2019; Kubisch, Christian/F-1893-2011	Ramirez, Alfredo/0000-0003-4991-763X; Kubisch, Christian/0000-0003-4220-0978; Nothwang, Hans Gerd/0000-0001-7695-6437				Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bryda EC, 1997, MAMM GENOME, V8, P1, DOI 10.1007/s003359900336; Carrasquillo MM, 1997, HUM MOL GENET, V6, P2163, DOI 10.1093/hmg/6.12.2163; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Jain PK, 1998, GENOMICS, V50, P290, DOI 10.1006/geno.1998.5320; JONES CT, 1992, HUM MOL GENET, V1, P11, DOI 10.1093/hmg/1.1.11; Keats BJB, 1999, AM J MED GENET, V89, P158, DOI 10.1002/(SICI)1096-8628(19990924)89:3<158::AID-AJMG6>3.3.CO;2-R; Legan PK, 1997, SEMIN CELL DEV BIOL, V8, P217, DOI 10.1006/scdb.1997.0145; Liu XZ, 1998, AM J HUM GENET, V63, P909, DOI 10.1086/302026; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Mount SM, 2000, AM J HUM GENET, V67, P788, DOI 10.1086/303098; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; WAYNE S, 1996, HUM MOL GENET, V10, P1689; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WELL D, 1997, NAT GENET, V16, P191; Yagi T, 2000, GENE DEV, V14, P1169; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	27	360	377	1	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					108	112		10.1038/83667	http://dx.doi.org/10.1038/83667			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138009				2022-12-27	WOS:000166187900026
J	Bishop, CE; Whitworth, DJ; Qin, YJ; Agoulnik, AI; Agoulnik, IU; Harrison, WR; Behringer, RR; Overbeek, PA				Bishop, CE; Whitworth, DJ; Qin, YJ; Agoulnik, AI; Agoulnik, IU; Harrison, WR; Behringer, RR; Overbeek, PA			A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse	NATURE GENETICS			English	Article							Y-CHROMOSOME; CAMPOMELIC DYSPLASIA; DETERMINING REGION; SRY; GENE; EXPRESSION; TYROSINASE; MUTATIONS; SEQUENCES; SUGGESTS	In most mammals, male development is triggered by the transient expression of the Y-chromosome gene, Sry, which initiates a cascade of gene interactions ultimately leading to the formation of a testis from the indifferent fetal gonad(1-4). Several genes(5-8), in particular Sox9, have a crucial role in this pathway(9-14). Despite this, the direct downstream targets of Sry and the nature of the pathway itself remain to he clearly established(15,16). We report here a new dominant insertional mutation, Odsex (Ods), in which XX mice carrying a 150-kb deletion (approximately 1 Mb upstream of Sox9) develop as sterile XX males lacking Sry, During embryogenesis, wild-type XX fetal gonads downregulate Sox9 expression, whereas XY and XX Ods/+ fetal gonads upregulate and maintain its expression(13,14). We propose that Ods has removed a long-range, gonad-specific regulatory element that mediates the repression of Sox9 expression in XX fetal gonads. This repression would normally be antagonized by Sry protein in XY embryos. Our data ate consistent with Sox9 being a direct downstream target of Sry and provide genetic evidence to support a general repressor model of sex determination in mammals(17,18).	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine	Bishop, CE (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	bishop@bcm.tmc.edu	Agoulnik, Irina/AAD-4687-2020; Agoulnik, Alexander/AAK-3213-2020; Whitworth, Deanne/AAE-1019-2020	Agoulnik, Irina/0000-0003-4889-0324; Agoulnik, Alexander/0000-0001-6587-6845; Whitworth, Deanne/0000-0002-9097-0240; Overbeek, Paul/0000-0001-9784-2084; Qin, Jane Yangjun/0000-0003-0116-6988				BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bishop CE, 1998, MAMM GENOME, V8, pS378, DOI 10.1007/s003359900666; Burgoyne PS, 1998, BIOESSAYS, V20, P363, DOI 10.1002/(SICI)1521-1878(199805)20:5&lt;363::AID-BIES2&gt;3.0.CO;2-P; CAPEL B, 1993, NAT GENET, V5, P301, DOI 10.1038/ng1193-301; Capel B, 1998, ANNU REV PHYSIOL, V60, P497, DOI 10.1146/annurev.physiol.60.1.497; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Grandi A, 2000, MECH DEVELOP, V90, P323, DOI 10.1016/S0925-4773(99)00282-8; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FOSTER JW, 1992, NATURE, V359, P531, DOI 10.1038/359531a0; Graves JAM, 1998, BIOESSAYS, V20, P264, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;264::AID-BIES10&gt;3.0.CO;2-1; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Hustert E, 1996, MAMM GENOME, V7, P881, DOI 10.1007/s003359900261; Kent J, 1996, DEVELOPMENT, V122, P2813; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; MANSOUR S, 1995, J MED GENET, V32, P415, DOI 10.1136/jmg.32.6.415; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; Moniot B, 2000, MECH DEVELOP, V91, P323, DOI 10.1016/S0925-4773(99)00267-1; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SUTCLIFFE MJ, 1989, DEVELOPMENT, V107, P373; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; YOKOYAMA T, 1990, NUCLEIC ACIDS RES, V18, P7293, DOI 10.1093/nar/18.24.7293; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zhao SL, 1999, DEV BIOL, V216, P154, DOI 10.1006/dbio.1999.9480	29	287	299	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2000	26	4					490	494		10.1038/82652	http://dx.doi.org/10.1038/82652			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101852				2022-12-27	WOS:000165671700027
J	Gal, A; Li, Y; Thompson, DA; Weir, J; Orth, U; Jacobson, SG; Apfelstedt-Sylla, E; Vollrath, D				Gal, A; Li, Y; Thompson, DA; Weir, J; Orth, U; Jacobson, SG; Apfelstedt-Sylla, E; Vollrath, D			Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa	NATURE GENETICS			English	Article							C-MER; EPITHELIUM; PROTOONCOGENE		Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Krankenhaus Eppendorf, Inst Human Genet, Hamburg, Germany; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA; Univ Eye Clin, Dept Pathophysiol Vis & Neuroophthalmol, Tubingen, Germany	Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Pennsylvania; Pennsylvania Medicine; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Vollrath, D (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.			Thompson, Debra/0000-0003-3485-0794; Jacobson, Samuel/0000-0003-2122-169X				BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Bourne M C, 1938, Br J Ophthalmol, V22, P613, DOI 10.1136/bjo.22.10.613; BOURNE MC, 1939, J HERED, V30, P130; BUNGE S, 1996, METH MOL G, V8, P26; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; EDWARDS RB, 1977, SCIENCE, V197, P1001, DOI 10.1126/science.560718; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; HERRON WL, 1969, INVEST OPHTH VISUAL, V8, P595; LI LX, 1988, EXP EYE RES, V47, P911, DOI 10.1016/0014-4835(88)90073-5; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Weier HUG, 1999, CYTOGENET CELL GENET, V84, P91, DOI 10.1159/000015223; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	15	529	552	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					270	271		10.1038/81555	http://dx.doi.org/10.1038/81555			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062461				2022-12-27	WOS:000165176500010
J	Healey, CS; Dunning, AM; Teare, MD; Chase, D; Parker, L; Burn, J; Chang-Claude, J; Mannermaa, A; Kataja, V; Huntsman, DG; Pharoah, PDP; Luben, RN; Easton, DF; Ponder, BAJ				Healey, CS; Dunning, AM; Teare, MD; Chase, D; Parker, L; Burn, J; Chang-Claude, J; Mannermaa, A; Kataja, V; Huntsman, DG; Pharoah, PDP; Luben, RN; Easton, DF; Ponder, BAJ			A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability	NATURE GENETICS			English	Article							KLOTHO GENE; DNA-REPAIR; MUTATION; MICE	Inherited mutations in the gene BRCA2 predispose carriers to early onset breast cancer, but such mutations account for fewer than 2% of all cases in East Anglia. It is likely that low penetrance alleles explain the greater part of inherited susceptibility to breast cancer; polymorphic variants in strongly predisposing genes, such as BRCA2, are candidates for this role. BRCA2 is thought to be involved in DNA double strand break-repair(1,2) Few mice in which Brca2 is truncated survive to birth; of those that do, most are male, smaller than their normal littermates and have high cancer incidence(3,4). Here we show that a common human polymorphism (N372H) in exon 10 of BRCA2 confers an increased risk of breast cancer: the HH homozygotes have a 1.31-fold (95% Cl, 1.07-1.61) greater risk than the NN group. Moreover, in normal female controls of all ages there is a significant deficiency of homozygotes compared with that expected from Hardy-Weinberg equilibrium, whereas in males there is an excess of homozygotes: the HH group has an estimated fitness of 0.82 in females and 1.38 in males. Therefore, this variant of BRCA2 appears also to affect fetal survival in a sex-dependent manner.	Univ Cambridge, CRC, Dept Oncol, Strangeways Res Lab, Cambridge, England; Univ Cambridge, CRC, Genet Epidemiol Grp, Strangeways Res Lab, Cambridge, England; Univ Cambridge, EPIC, Strangeways Res Lab, Cambridge, England; Univ Newcastle, Royal Victoria Infirm, Inst Child Hlth, Newcastle Upon Tyne, Tyne & Wear, England; Univ Newcastle, Sch Biochem & Genet, Human Genet Unit, Newcastle Upon Tyne, Tyne & Wear, England; Deutsch Krebsforschungszentrum, Abt Epidemiol, D-6900 Heidelberg, Germany; Kuopio Univ Hosp, Dept Clin Genet, SF-70210 Kuopio, Finland; Univ Kuopio, Dept Oncol & Radiotherapy, FIN-70211 Kuopio, Finland; Childrens & Womens Hlth Ctr British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada	University of Cambridge; University of Cambridge; University of Cambridge; Newcastle University - UK; Newcastle University - UK; Helmholtz Association; German Cancer Research Center (DKFZ); Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; BC Women's Hospital & Health Centre	Healey, CS (corresponding author), Univ Cambridge, CRC, Dept Oncol, Strangeways Res Lab, Cambridge, England.		Huntsman, David/ABE-6082-2020; Luben, Robert N/H-5519-2015; Pharoah, Paul/V-6658-2019	Luben, Robert N/0000-0002-5088-6343; Pharoah, Paul/0000-0001-8494-732X; Kataja, Vesa/0000-0003-4846-4843; Chase, Diana/0000-0002-3678-0032; Burn, John/0000-0002-9823-2322; Dunning, Alison Margaret/0000-0001-6651-7166				Calaf GM, 2000, CARCINOGENESIS, V21, P769, DOI 10.1093/carcin/21.4.769; CHANGCLAUDE J, IN PRESS CANC CAUSES; Chase DS, 1998, J MED GENET, V35, P413, DOI 10.1136/jmg.35.5.413; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Day N, 1999, BRIT J CANCER, V80, P95; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Friedman LS, 1998, CANCER RES, V58, P1338; Fuks F, 1998, ONCOGENE, V17, P2531, DOI 10.1038/sj.onc.1202475; Jernstrom H, 1998, EUR J CANCER, V34, P368, DOI 10.1016/S0959-8049(97)10088-0; KHOURY MJ, 1993, FUNDAMENTALS GENETIC, P78; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lomax B, 2000, AM J HUM GENET, V66, P1516, DOI 10.1086/302878; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Spillman MA, 1996, ONCOGENE, V13, P1639	16	138	147	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					362	364		10.1038/81691	http://dx.doi.org/10.1038/81691			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062481				2022-12-27	WOS:000165176500030
J	Pusch, CM; Zeitz, C; Brandau, O; Pesch, K; Achatz, H; Feil, S; Scharfe, C; Maurer, J; Jacobi, FK; Pinckers, A; Andreasson, S; Hardcastle, A; Wissinger, B; Berger, W; Meindl, A				Pusch, CM; Zeitz, C; Brandau, O; Pesch, K; Achatz, H; Feil, S; Scharfe, C; Maurer, J; Jacobi, FK; Pinckers, A; Andreasson, S; Hardcastle, A; Wissinger, B; Berger, W; Meindl, A			The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein	NATURE GENETICS			English	Article							SWISS-MODEL; FAMILY; GROWTH; LOCALIZATION; EXPRESSION; LOCUS; RP3	X-linked congenital stationary night blindness (XLCSNB) is characterized by impaired scotopic Vision with associated ocular symptoms such as myopia, hyperopia, nystagmus and reduced visual acuity(1). Genetic mapping in families with XLCSNB revealed two different loci on the proximal short arm of the X chromosome(2). These two genetic subtypes can be distinguished on the basis of electroretinogram (ERG) responses and psychophysical testing as a complete (CSNB1) and an incomplete (CSNB2) form(3,4). The CSNB1 locus has been mapped to a 5-cM linkage interval in Xp11.4 (refs 2,5-7). Here we construct and analyse a contig between the markers DXS993 and DXS228, leading to the identification of a new gene mutated in CSNB1 patients. It is partially deleted in 3 families and mutation analysis in a further 21 families detected another 13 different mutations. This gene, designated NYX, encodes a protein of 481 amino acids (nyctalopin) and is expressed at low levels in tissues including retina, brain, testis and muscle. The predicted polypeptide is a glycosylphosphatidylinositol (GPI)-anchored extracellular protein with 11 typical and 2 cysteine-rich, leucine-rich repeats (LRRs). This motif is important for protein-protein interactions and members of the LRR superfamily are involved in cell adhesion and axon guidance(8-10). Future functional analysis of nyctalopin might therefore give insight into the fine-regulation of cell-cell contacts in the retina.	LMU, Abt Padiatr Genet, Munich, Germany; Univ Tubingen, Augenklin, Mol Genet Lab, D-7400 Tubingen, Germany; Max Planck Inst Mol Genet, Berlin, Germany; Univ Tubingen, Augenklin Abt 2, D-7400 Tubingen, Germany; Univ Nijmegen Hosp, NL-6500 HB Nijmegen, Netherlands; Univ Lund Hosp, Dept Ophthalmol, S-22185 Lund, Sweden; UCL, Inst Ophthalmol, London, England; Lund Univ, Dept Expt Pathol, Lund, Sweden	University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; Eberhard Karls University of Tubingen; Radboud University Nijmegen; Lund University; Skane University Hospital; University of London; University College London; Lund University	Meindl, A (corresponding author), LMU, Abt Padiatr Genet, Munich, Germany.	alfons@pedgen.med.uni-muenchen.de	Zeitz, Christina/F-2757-2017	Zeitz, Christina/0000-0002-3510-1712; Hardcastle, Alison/0000-0002-0038-6770				Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; BERGEN AAB, 1995, HUM MOL GENET, V4, P931, DOI 10.1093/hmg/4.5.931; Bernstein SL, 1996, GENOMICS, V32, P301, DOI 10.1006/geno.1996.0123; Boycott KM, 1998, AM J HUM GENET, V62, P865, DOI 10.1086/301781; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hardcastle AJ, 1997, INVEST OPHTH VIS SCI, V38, P2750; Heon E, 1994, MOL GENETICS INHERIT, P277; HICKEY MJ, 1993, P NATL ACAD SCI USA, V90, P8237; Hobby P, 2000, MOL VIS, V6, P72; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Janosi JBM, 1999, J BIOL CHEM, V274, P23328, DOI 10.1074/jbc.274.33.23328; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KRANTZ DE, EMBO J, V6, P1969; LEONG SR, 1992, MOL ENDOCRINOL, V6, P860; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; OLLENDORFF V, 1994, CELL GROWTH DIFFER, V5, P213; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Phelan JK, 2000, EXP EYE RES, V71, P119, DOI 10.1006/exer.2000.0861; Roepman R, 1996, HUM MOL GENET, V5, P827, DOI 10.1093/hmg/5.6.827; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Rozzo C, 1999, EUR J HUM GENET, V7, P574, DOI 10.1038/sj.ejhg.5200332; Ruether K, 1993, Ger J Ophthalmol, V2, P429; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940	28	193	201	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					324	327		10.1038/81627	http://dx.doi.org/10.1038/81627			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062472				2022-12-27	WOS:000165176500021
J	Akama, TO; Nishida, K; Nakayama, J; Watanabe, H; Ozaki, K; Nakamura, T; Dota, A; Kawasaki, S; Inoue, Y; Maeda, N; Yamamoto, S; Fujiwara, T; Thonar, EJMA; Shimomura, Y; Kinoshita, S; Tanigami, A; Fukuda, MN				Akama, TO; Nishida, K; Nakayama, J; Watanabe, H; Ozaki, K; Nakamura, T; Dota, A; Kawasaki, S; Inoue, Y; Maeda, N; Yamamoto, S; Fujiwara, T; Thonar, EJMA; Shimomura, Y; Kinoshita, S; Tanigami, A; Fukuda, MN			Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene	NATURE GENETICS			English	Letter							KERATAN SULFATE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; SULFOTRANSFERASE; EXPRESSION; HETEROGENEITY; MARKER; BLOOD	Macular corneal dystrophy (MCD; MIM 217800) is an autosomal recessive hereditary disease in which progressive punctate opacities in the cornea result in bilateral loss of vision, eventually necessitating corneal transplantation. MCD is classified into two subtypes. type I and type II, defined by the respective absence and presence of sulphated keratan sulphate in the patient serum, although both types have clinically indistinguishable phenotypes(1,2). The gene responsible for MCD type I has been mapped to chromosome 16q22, and that responsible for MCD type II may involve the same locus(3-5). Here we identify a new carbohydrate sulphotransferase gene (CHST6). encoding an enzyme designated corneal N-acetylglucosamine-6-sulphotransferase (C-GlcNAc6ST), within the critical region of MCD type I. In MCD type I. we identified several mutations that may lead to inactivation of C-GlcNAc6ST within the coding region of CHST6. In MCD type II, we found large deletions and/or replacements caused by homologous recombination in the upstream region of CHST6. In situ hybridization analysis did not detect CHST6 transcripts in corneal epithelium in an MCD type II patient, suggesting that the mutations found in type II lead to loss of cornea-specific expression of CHST6.	Burnham Inst, Glycobiol Program, La Jolla, CA 92037 USA; Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; Shinshu Univ, Grad Sch Med, Inst Organ Transplants Reconstruct Med & Tissue E, Matsumoto, Nagano 390, Japan; Shinshu Univ Hosp, Cent Clin Labs, Matsumoto, Nagano, Japan; Osaka Univ, Sch Med, Dept Ophthalmol, Osaka, Japan; Otsuka Pharmaceut Co Ltd, Otsuka GEN Res Inst, Tokushima 77101, Japan; Rush Med Coll, Rush Presbyterian St Lukes Med Ctr, Dept Biochem & Internal Med, Chicago, IL 60612 USA	Sanford Burnham Prebys Medical Discovery Institute; Kyoto Prefectural University of Medicine; Shinshu University; Shinshu University; Osaka University; Otsuka Pharmaceutical; Rush University	Fukuda, MN (corresponding author), Burnham Inst, Glycobiol Program, La Jolla, CA 92037 USA.			Nishida, Kohji/0000-0001-9069-3610; Ozaki, Kouichi/0000-0003-0028-1570	NCI NIH HHS [CA71932] Funding Source: Medline; NIAMS NIH HHS [AR39239] Funding Source: Medline; NIA NIH HHS [AG04736] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR039239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG004736] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; EDWARD DP, 1990, OPHTHALMOLOGY, V97, P1194; EDWARD DP, 1988, ARCH OPHTHALMOL-CHIC, V106, P1579, DOI 10.1001/archopht.1988.01060140747049; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; HUDSON TJ, 1997, CURRENT PROTOCOLS HU; Jonasson F, 1996, OPHTHALMOLOGY, V103, P1111, DOI 10.1016/S0161-6420(96)30559-9; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Kawakami M, 1997, CANCER RES, V57, P2321; Klinkhammer GP, 1997, MAR CHEM, V56, P1, DOI 10.1016/S0304-4203(96)00079-5; KLINTWORTH GK, 1986, OPHTHALMIC PAED GEN, V7, P139, DOI 10.3109/13816818609004130; Lee JK, 1999, BIOCHEM BIOPH RES CO, V263, P543, DOI 10.1006/bbrc.1999.1324; Liu NP, 1998, AM J HUM GENET, V63, P912, DOI 10.1086/302001; Liu NP, 1998, BRIT J OPHTHALMOL, V82, P241, DOI 10.1136/bjo.82.3.241; NAKAZAWA K, 1984, J BIOL CHEM, V259, P3751; SHIOZAWA T, 1991, GYNECOL OBSTET INVES, V32, P239, DOI 10.1159/000293040; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THONAR EJM, 1986, AM J OPHTHALMOL, V102, P561, DOI 10.1016/0002-9394(86)90525-8; THONAR EJMA, 1985, ARTHRITIS RHEUM, V28, P1367, DOI 10.1002/art.1780281209; Uchimura K, 1998, J BIOCHEM-TOKYO, V124, P670, DOI 10.1093/oxfordjournals.jbchem.a022164; Vance JM, 1996, AM J HUM GENET, V58, P757; YANG CJ, 1988, AM J OPHTHALMOL, V106, P65, DOI 10.1016/S0002-9394(14)76390-1	25	197	211	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					237	241		10.1038/79987	http://dx.doi.org/10.1038/79987			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017086				2022-12-27	WOS:000089638800027
J	Capecchi, MR				Capecchi, MR			Choose your target	NATURE GENETICS			English	Article							STEM-CELLS; DISRUPTION; GENES; GENOME	The technology of modifying endogenous genes has recently been extended from mice to Drosophila and sheep. Concurrently, genomic sequencing is uncovering thousands of previously uncharacterized genes. Armed with today's technologies, what are our best options for delineating the functions of these new genes?	Univ Utah, Sch Med, Dept Human Genet, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Sch Med, Dept Human Genet, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA.	mario.capecchi@genetics.utah.edu						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; CAPECCHI M, 1990, NATURE, V344, P105, DOI 10.1038/344105a0; CAPECCHI MR, 1994, SCI AM, V270, P52, DOI 10.1038/scientificamerican0394-52; DENG CX, 1993, MOL CELL BIOL, V13, P2134, DOI 10.1128/MCB.13.4.2134; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; JASIN M, 1988, GENE DEV, V2, P1353, DOI 10.1101/gad.2.11.1353; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; RONG YS, 2000, IN PRESS SCIENCE; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Spradling AC, 1999, GENETICS, V153, P135; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	17	14	14	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2000	26	2					159	161		10.1038/82825	http://dx.doi.org/10.1038/82825			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017070				2022-12-27	WOS:000089638800011
J	Perez-Iratxeta, C; Bork, P; Andrade, MA				Perez-Iratxeta, C; Bork, P; Andrade, MA			Association of genes to genetically inherited diseases using data mining	NATURE GENETICS			English	Article								Although approximately one-quarter of the roughly 4,000 genetically inherited diseases currently recorded in respective databases (LocusLink(1), OMIM2) are already linked to a region of the human genome, about 450 have no known associated gene. Finding disease-related genes requires laborious examination of hundreds of possible candidate genes (sometimes, these are not even annotated; see, for example, refs 3,4). The public availability of the human genome(5) draft sequence has fostered new strategies to map molecular functional features of gene products to complex phenotypic descriptions, such as those of genetically inherited diseases. Owing to recent progress in the systematic annotation of genes using controlled vocabularies 6, we have developed a scoring system for the possible functional relationships of human genes to 455 genetically inherited diseases that have been mapped to chromosomal regions without assignment of a particular gene. In a benchmark of the system with 100 known disease-associated genes, the disease-associated gene was among the 8 best-scoring genes with a 25% chance, and among the best 30 genes with a 50% chance, showing that there is a relationship between the score of a gene and its likelihood of being associated with a particular disease. The scoring also indicates that for some diseases, the chance of identifying the underlying gene is higher.	European Mol Biol Lab, D-69012 Heidelberg, Germany; Max Delbruck Ctr Mol Med, Dept Bioinformat, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69012 Heidelberg, Germany.	bork@embl-heidelberg.de	Andrade, Miguel A/B-6565-2008; Bork, Peer/F-1813-2013	Andrade, Miguel A/0000-0001-6650-1711; Bork, Peer/0000-0002-2627-833X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; PLAITAKIS A, 1993, CAN J NEUROL SCI, V20, P5109; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572; Zimmermann HJ, 1996, FUZZY SET THEORY ITS	11	253	262	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2002	31	3					316	319		10.1038/ng895	http://dx.doi.org/10.1038/ng895			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12006977				2022-12-27	WOS:000176494100023
J	Xue, F; Tian, XC; Du, FL; Kubota, C; Taneja, M; Dinnyes, A; Dai, YP; Levine, H; Pereira, LV; Yang, XZ				Xue, F; Tian, XC; Du, FL; Kubota, C; Taneja, M; Dinnyes, A; Dai, YP; Levine, H; Pereira, LV; Yang, XZ			Aberrant patterns of X chromosome inactivation in bovine clones	NATURE GENETICS			English	Article							MAMMALIAN DEVELOPMENT; MOUSE EMBRYOS; GENE; METHYLATION; EXPRESSION; BEHAVIOR; GENOMES; MICE; MAOA	In mammals, epigenetic marks on the X chromosomes are involved in dosage compensation. Specifically, they are required for X chromosome inactivation (XCI), the random transcriptional silencing of one of the two X chromosomes in female cells during late blastocyst development(1-8). During natural reproduction, both X chromosomes are active in the female zygote(2). In somatic-cell cloning, however, the cloned embryos receive one active (Xa) and one inactive (Xi) X chromosome from the donor cells. Patterns of XCI have been reported normal in cloned mice(9), but have yet to be investigated in other species. We examined allele-specific expression of the X-linked monoamine oxidase type A (MAOA) gene and the expression of nine additional X-linked genes in nine cloned XX calves. We found aberrant expression patterns in nine of ten X-linked genes and hypomethylation of Xist in organs of deceased clones. Analysis of MAOA expression in bovine placentae from natural reproduction revealed imprinted XCI with preferential inactivation of the paternal X chromosome. In contrast, we found random XCI in placentae of the deceased clones but completely skewed XCI in that of live clones. Thus, incomplete nuclear reprogramming may generate abnormal epigenetic marks on the X chromosomes of cloned cattle, affecting both random and imprinted XCI.	Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; Kagoshima Prefectural Cattle Breeding & Dev Inst, Kagoshima, Japan; Tufts Univ, Sch Vet Med, Dept Environm & Populat Hlth, S Woodstock, CT USA; Univ Sao Paulo, Inst Biociencias, Dept Biol, Ctr Estudos Genoma Humano, Sao Paulo, Brazil	University of Connecticut; University of Connecticut; Tufts University; Universidade de Sao Paulo	Yang, XZ (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA.		Pillay, Nischalan/F-9536-2012; Pereira, Lygia V/C-1049-2012; Dinnyes, Andras/D-5131-2013	Pereira, Lygia V/0000-0002-0002-725X; Dinnyes, Andras/0000-0003-3791-2583				Band MR, 2000, GENOME RES, V10, P1359, DOI 10.1101/gr.145900; Bassi MT, 1999, AM J HUM GENET, V64, P1604, DOI 10.1086/302408; BEIDLER JL, 1982, ANAL BIOCHEM, V126, P374, DOI 10.1016/0003-2697(82)90530-9; Brockdorff N, 1998, CURR OPIN GENET DEV, V8, P328, DOI 10.1016/S0959-437X(98)80090-7; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; De La Fuente R, 1999, BIOL REPROD, V60, P769, DOI 10.1095/biolreprod60.3.769; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Goto T, 1998, MICROBIOL MOL BIOL R, V62, P362, DOI 10.1128/MMBR.62.2.362-378.1998; HARPER MI, 1982, J EMBRYOL EXP MORPH, V67, P127; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Park Y, 2001, SCIENCE, V293, P1083, DOI 10.1126/science.1063073; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tivol EA, 1996, AM J MED GENET, V67, P92, DOI 10.1002/(SICI)1096-8628(19960216)67:1<92::AID-AJMG16>3.0.CO;2-K; Wrenzycki C, 2002, BIOL REPROD, V66, P127, DOI 10.1095/biolreprod66.1.127; Yool DA, 2000, HUM MOL GENET, V9, P987, DOI 10.1093/hmg/9.6.987	28	233	255	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					216	220		10.1038/ng900	http://dx.doi.org/10.1038/ng900			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12032569				2022-12-27	WOS:000175903500022
J	Xu, XL; Meiler, SE; Zhong, TP; Mohideen, M; Crossley, DA; Burggren, WW; Fishman, MC				Xu, XL; Meiler, SE; Zhong, TP; Mohideen, M; Crossley, DA; Burggren, WW; Fishman, MC			Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin	NATURE GENETICS			English	Article							DILATED CARDIOMYOPATHY; CARDIAC-MUSCLE; DANIO-RERIO; GENE; DISRUPTION; EXPRESSION; EMBRYOS; SYSTEM	The zebrafish embryo is transparent and can tolerate absence of blood flow because its oxygen is delivered by diffusion rather than by the cardiovascular system(1). It is therefore possible to attribute cardiac failure directly to particular genes by ruling out the possibility that it is due to a secondary effect of hypoxia. We focus here on pickwick(m171) (pik(m171)), a recessive lethal mutation discovered in a large-scale genetic screen(2). There are three other alleles in the pik complementation group with this phenotype (pik(m242), pik(m740), pik(m186); ref. 3) and one allele (pik(mVO62H)) with additional skeletal paralysis(4). The pik heart develops normally but is poorly contractile from the first beat. Aside from the edema that inevitably accompanies cardiac dysfunction, development is normal during the first three days. We show by positional cloning that the 'causative' mutation is in an alternatively-spliced exon of the gene (ttn) encoding Titin. Titin is the biggest known protein and spans the half-sarcomere from Z-disc to M-line in heart and skeletal muscles. It has been proposed to provide a scaffold for the assembly of thick and thin filaments(6) and to provide elastic recoil engendered by stretch during diastole(7). We found that nascent myofibrils form in pik mutants, but normal sarcomeres are absent. Mutant cells transplanted to wildtype hearts remain thin and bulge outwards as individual cell aneurysms without affecting nearby wildtype cardiomyocytes, indicating that the contractile deficiency is cell-autonomous. Absence of Titin function thus results in blockage of sarcomere assembly and causes a functional disorder resembling human dilated cardiomyopathies, one form of which is described in another paper in this issue(8).	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Univ Calif Irvine, Dept Biol Sci, Irvine, CA 92697 USA; Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	Harvard University; Massachusetts General Hospital; University of California System; University of California Irvine; University of North Texas System; University of North Texas Denton	Fishman, MC (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 149 13th St, Charlestown, MA 02129 USA.		Burggren, Warren W/A-1561-2016	Burggren, Warren W/0000-0001-8023-420X				Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; BURGGREN WW, 1991, ANNU REV PHYSIOL, V53, P107, DOI 10.1146/annurev.physiol.53.1.107; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Driever W, 1996, DEVELOPMENT, V123, P37; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Freiburg A, 2000, CIRC RES, V86, P1114; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Helmes M, 1999, CIRC RES, V84, P1339, DOI 10.1161/01.RES.84.11.1339; Hertig CM, 1999, J BIOL CHEM, V274, P37362, DOI 10.1074/jbc.274.52.37362; HO RK, 1990, NATURE, V348, P720; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Linke WA, 1999, J CELL BIOL, V146, P631, DOI 10.1083/jcb.146.3.631; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Person V, 2000, J CELL SCI, V113, P3851; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Stainier DYR, 1996, DEVELOPMENT, V123, P285; THISSE C, 1993, DEVELOPMENT, V119, P1203; Trinick J, 1996, CURR BIOL, V6, P258, DOI 10.1016/S0960-9822(02)00472-4; van der Ven PFM, 2000, J CELL SCI, V113, P1405; Warren KS, 2000, PHILOS T R SOC B, V355, P939, DOI 10.1098/rstb.2000.0629; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Zhang Y, 2000, J CELL SCI, V113, P3103	29	206	213	1	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					205	209		10.1038/ng816	http://dx.doi.org/10.1038/ng816			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11788825				2022-12-27	WOS:000173708700023
J	Mandel, H; Szargel, R; Labay, V; Elpeleg, O; Saada, A; Shalata, A; Anbinder, Y; Berkowitz, D; Hartman, C; Barak, M; Eriksson, S; Cohen, N				Mandel, H; Szargel, R; Labay, V; Elpeleg, O; Saada, A; Shalata, A; Anbinder, Y; Berkowitz, D; Hartman, C; Barak, M; Eriksson, S; Cohen, N			The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA	NATURE GENETICS			English	Article							MTDNA DEPLETION; LIVER; EXPRESSION; CLONING; LOCALIZATION; DEFECTS; CDNA	Mitochondrial DNA (mtDNA)-depletion syndromes (MDS; OMIM 251880) are phenotypically heterogeneous, autosomal-recessive disorders characterized by tissue-specific reduction in mtDNA copy number(1-8). Affected individuals with the hepatocerebral form of MDS have early progressive liver failure and neurological abnormalities, hypoglycemia and increased lactate in body fluids. Affected tissues show both decreased activity of the mtDNA-encoded respiratory chain complexes (I, III, IV, V) and mtDNA depletion(1-4,8-13). We used homozygosity mapping in three kindreds of Druze origin to map the gene causing hepatocerebral MDS to a region of 6.1 cM on chromosome 2p13, between markers D2S291 and D2S2116. This interval encompasses the gene (DGUOK) encoding the mitochondrial deoxyguanosine kinase (dGK)(14-16). We identified a single-nucleotide deletion (204delA) within the coding region of DGUOK that segregates with the disease in the three kindreds studied. Western-blot analysis did not detect dGK protein in the liver of affected individuals. The main supply of deoxyribonucleotides (dNTPs) for mtDNA synthesis comes from the salvage pathway initiated by dGK and thymidine kinase-2 (TK2)(17-19). The association of mtDNA depletion with mutated DGUOK suggests that the salvage-pathway enzymes are involved in the maintenance of balanced mitochondrial dNTP pools.	Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Dept Pediat,Metab Dis Unit, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Tamkin Human Mol Genet Res Facil, Dept Genet, IL-31096 Haifa, Israel; Shaare Zedek Med Ctr, Metab Dis Unit, Jerusalem, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Pediat Gastroenterol & Nutr Unit, IL-31096 Haifa, Israel; Western Galilee Med Ctr, Neonatal Intens Care Unit, Nahariyya, Israel; Swedish Univ Agr Sci, Dept Vet Med Chem, Uppsala, Sweden	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Western Galilee Hospital; Swedish University of Agricultural Sciences	Cohen, N (corresponding author), RW Johnson Pharmaceut Res Inst, 1000 Rd 202, Raritan, NJ 08869 USA.		Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656				ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Bakker HD, 1996, J PEDIATR-US, V128, P683, DOI 10.1016/S0022-3476(96)80135-1; BODNAR AG, 1993, AM J HUM GENET, V53, P663; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1; GIBLETT ER, 1976, NEW ENGL J MED, V295, P1375, DOI 10.1056/NEJM197612092952409; Gyapay Gabor, 1996, Methods (Orlando), V9, P91, DOI 10.1006/meth.1996.0012; Hirano M, 2000, BRAIN PATHOL, V10, P451; Jenuth JP, 1996, BIOCHEM CELL BIOL, V74, P219, DOI 10.1139/o96-022; Johansson M, 1996, GENOMICS, V38, P450, DOI 10.1006/geno.1996.0654; Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258; Jullig M, 2000, EUR J BIOCHEM, V267, P5466, DOI 10.1046/j.1432-1327.2000.01607.x; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; MAASWINKELMOOIJ PD, 1996, J PEDIATR, V128, P979; Marin-Garcia J, 2000, PEDIATR NEUROL, V22, P122, DOI 10.1016/S0887-8994(99)00117-4; MARRIOTI C, 1995, J NEUROL, V242, P547; MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X; MORAES CT, 1991, AM J HUM GENET, V48, P492; Morris AAM, 1998, J HEPATOL, V28, P556, DOI 10.1016/S0168-8278(98)80278-X; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Shaag A, 1999, AM J MED GENET, V82, P177, DOI 10.1002/(SICI)1096-8628(19990115)82:2<177::AID-AJMG15>3.3.CO;2-0; Spelbrink JN, 1998, HUM GENET, V102, P327, DOI 10.1007/s004390050700; Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935; Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783; Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6; Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0	31	402	413	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					337	341		10.1038/ng746	http://dx.doi.org/10.1038/ng746			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687800				2022-12-27	WOS:000171911000023
J	van Steensel, B; Delrow, J; Henikoff, S				van Steensel, B; Delrow, J; Henikoff, S			Chromatin profiling using targeted DNA adenine methyltransferase	NATURE GENETICS			English	Letter							GAGA TRANSCRIPTION FACTOR; DROSOPHILA-MELANOGASTER; TRANSPOSABLE ELEMENTS; IN-VIVO; SACCHAROMYCES-CEREVISIAE; PROTEINS; HETEROCHROMATIN; PROMOTER; SIR2P	Chromatin is the highly complex structure consisting of DNA and hundreds of associated proteins. Most chromatin proteins exert their regulatory and structural functions by binding to specific chromosomal loci. Knowledge of the identity of these in vivo target loci is essential for the understanding of the functions and mechanisms of action of chromatin proteins. We report here large-scale mapping of in vivo binding sites of chromatin proteins, using a novel approach based on a combination of targeted DNA methylation and microarray technology. We show that three distinct chromatin proteins in Drosophila melanogaster cells each associate with specific sets of genes. HP1 binds predominantly to pericentric genes and transposable elements. GAGA factor associates with euchromatic genes that are enriched in (GA), motifs, A Drosophila homolog of Saccharomyces cerevisiae Sir2p is associated with several active genes and is excluded from heterochromatin. High-resolution, genome-wide maps of target loci of chromatin proteins ('chromatin profiles') provide new insights into chromatin structure and gene regulation.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, DNA Array Facil, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center	van Steensel, B (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Kruislaan 403, Amsterdam, Netherlands.			Henikoff, Steven/0000-0002-7621-8685				Benyajati C, 1997, NUCLEIC ACIDS RES, V25, P3345, DOI 10.1093/nar/25.16.3345; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; CARMENA M, 1995, CHROMOSOMA, V103, P676; CHARLESWORTH B, 1994, GENET RES, V64, P183, DOI 10.1017/S0016672300032845; Cockell MM, 2000, GENETICS, V154, P1069; Cuperus G, 2000, EMBO J, V19, P2641, DOI 10.1093/emboj/19.11.2641; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gartenberg MR, 2000, CURR OPIN MICROBIOL, V3, P132, DOI 10.1016/S1369-5274(00)00064-3; Gotta M, 1997, EMBO J, V16, P3243, DOI 10.1093/emboj/16.11.3243; Guarente L, 2000, GENE DEV, V14, P1021; Henikoff S, 2000, BBA-REV CANCER, V1470, pO1, DOI 10.1016/S0304-419X(99)00034-7; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Kopczynski CC, 1998, P NATL ACAD SCI USA, V95, P9973, DOI 10.1073/pnas.95.17.9973; OBRIEN T, 1995, GENE DEV, V9, P1098, DOI 10.1101/gad.9.9.1098; PIMPINELLI S, 1995, P NATL ACAD SCI USA, V92, P3804, DOI 10.1073/pnas.92.9.3804; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SOELLER WC, 1993, MOL CELL BIOL, V13, P7961, DOI 10.1128/MCB.13.12.7961; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; Wines DR, 1996, CHROMOSOMA, V104, P332, DOI 10.1007/s004120050123	26	241	254	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					304	308		10.1038/85871	http://dx.doi.org/10.1038/85871			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242113				2022-12-27	WOS:000167304200023
J	Avraham, KB				Avraham, KB			Modifying with mitochondria	NATURE GENETICS			English	Editorial Material							MUTATIONS; HEARING; MICE	An elegant set of mouse crosses has been used to identify a mitochondrial variant that interacts with a nuclear locus on chromosome 10, Ahl, to modify age-related hearing loss. This discovery sets the stage for the identification of factors that modify expression levels and variability of human hearing impairments.	Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Avraham, KB (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel.			Avraham, Karen B/0000-0002-4913-251X				Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Ikeda A, 1999, HUM MOL GENET, V8, P1761, DOI 10.1093/hmg/8.9.1761; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; Johnson KR, 2000, GENOMICS, V70, P171, DOI 10.1006/geno.2000.6377; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; NAGLEY P, 1993, MITOCHONDRIAL DNA HU; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Sobe T, 2000, HUM GENET, V106, P50, DOI 10.1007/s004390051009; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	14	1	1	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					136	137		10.1038/84743	http://dx.doi.org/10.1038/84743			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175774				2022-12-27	WOS:000166839200006
J	Young, LE; Fernandes, K; McEvoy, TG; Butterwith, SC; Gutierrez, CG; Carolan, C; Broadbent, PJ; Robinson, JJ; Wilmut, I; Sinclair, KD				Young, LE; Fernandes, K; McEvoy, TG; Butterwith, SC; Gutierrez, CG; Carolan, C; Broadbent, PJ; Robinson, JJ; Wilmut, I; Sinclair, KD			Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture	NATURE GENETICS			English	Article							BINDING-PROTEINS; PERINATAL LETHALITY; IN-VITRO; GROWTH; GENE; CATTLE; SERUM	Manipulation or non-physiological embryo culture environments can lead to defective fetal programming in livestock. Our demonstration of reduced fetal methylation and expression of ovine IGF2R suggests pre-implantation embryo procedures may be vulnerable to epigenetic alterations in imprinted genes. This highlights the potential benefits of epigenetic diagnostic screening in developing embryo procedures.	Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; Scottish Agr Coll, Aberdeen, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; Scottish Agricultural College	Young, LE (corresponding author), Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland.		Gutierrez, Carlos G/H-3192-2013	Gutierrez, Carlos G/0000-0002-6098-3913; Young, Lorraine/0000-0001-5450-5723; Sinclair, Kevin/0000-0002-6375-215X				ARMSTRONG DG, 1989, J ENDOCRINOL, V120, P373, DOI 10.1677/joe.0.1200373; BUTLER JH, 1986, J ENDOCRINOL, V109, P333, DOI 10.1677/joe.0.1090333; Dean W, 1998, DEVELOPMENT, V125, P2273; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Gutierrez CG, 1997, J ENDOCRINOL, V153, P231, DOI 10.1677/joe.0.1530231; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Sinclair KD, 1998, THERIOGENOLOGY, V49, P218, DOI 10.1016/S0093-691X(98)90571-4; Vogt T, 1998, CLIN CANCER RES, V4, P791; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Young LE, 2000, THERIOGENOLOGY, V53, P627, DOI 10.1016/S0093-691X(99)00263-0; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155	15	619	658	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					153	154		10.1038/84769	http://dx.doi.org/10.1038/84769			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175780				2022-12-27	WOS:000166839200013
J	Bech-Hansen, NT; Naylor, MJ; Maybaum, TA; Sparkes, RL; Koop, B; Birch, DG; Bergen, AAB; Prinsen, CFM; Polomeno, RC; Gal, A; Drack, AV; Musarella, MA; Jacobson, SG; Young, RSL; Weleber, RG				Bech-Hansen, NT; Naylor, MJ; Maybaum, TA; Sparkes, RL; Koop, B; Birch, DG; Bergen, AAB; Prinsen, CFM; Polomeno, RC; Gal, A; Drack, AV; Musarella, MA; Jacobson, SG; Young, RSL; Weleber, RG			Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness	NATURE GENETICS			English	Article							RETINITIS-PIGMENTOSA; GENE; LOCALIZATION; REPEAT; SITES; ELECTRORETINOGRAM; IDENTIFICATION; XP11.23; PROTEIN; REGION	During development, visual photoreceptors, bipolar cells and other neurons establish connections within the retina enabling the eye to process visual images over approximately 7 log units of illumination(1). Within the retina, cells that respond to light increment and light decrement are separated into ON- and OFF-pathways. Hereditary diseases are known to disturb these retinal pathways, causing either progressive degeneration or stationary deficits(2). Congenital stationary night blindness (CSNB) is a group of stable retinal disorders that are characterized by abnormal night vision. Genetic subtypes of CSNB have been defined and different disease actions have been postulated(3-5). The molecular bases have been elucidated in several subtypes, providing a better understanding of the disease mechanisms and developmental retinal neurobiology(2). Here we have studied 22 families with 'complete' X-linked CSNB (CSNB1; MIM 310500; ref. 4) in which affected males have night blindness, some photopic vision loss and a defect of the ON-pathway. We have found 14 different mutations, including 1 founder mutation in 7 families from the United States, in a novel candidate gene, NYX. NYX, which encodes a glycosylphosphatidyl (GPI)-anchored protein called nyctalopin, is a new and unique member of the small leucine-rich proteoglycan (SLRP) family(6). The role of other SLRP proteins suggests that mutant nyctalopin disrupts developing retinal interconnections involving the ON-bipolar cells, leading to the visual losses seen in patients with complete CSNB.	Univ Calgary, Fac Med, Dept Med Genet, Calgary, AB, Canada; Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; Univ Victoria, Environm Res Ctr, Victoria, BC, Canada; Retina Fdn SW, Dallas, TX USA; Netherlands Ophthalm Res Inst, NL-1100 AC Amsterdam, Netherlands; Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada; Childrens Hosp, Dept Ophthalmol, Montreal, PQ, Canada; McGill Univ, Montreal, PQ, Canada; Univ Hamburg, Klinikum Eppendorf, Inst Humangenet, Hamburg, Germany; Emory Eye Ctr, Dept Ophthalmol, Atlanta, GA USA; Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; Texas Tech Univ, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Lubbock, TX 79430 USA; Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA	University of Calgary; University of Victoria; University of Victoria; Retina Foundation of the Southwest; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Calgary; McGill University; McGill University; University of Hamburg; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Pennsylvania; Pennsylvania Medicine; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Oregon Health & Science University	Bech-Hansen, NT (corresponding author), Univ Calgary, Fac Med, Dept Med Genet, Calgary, AB, Canada.	ntbech@ucalgary.ca	Bergen, Arthur/J-3637-2013; Koop, Ben F./A-8151-2008	Koop, Ben F./0000-0003-0045-5200; Birch, David/0000-0002-6594-2897; Jacobson, Samuel/0000-0003-2122-169X; Bergen, Arthur/0000-0002-6333-9576; Drack, Arlene/0000-0002-8195-8426	NEI NIH HHS [EY-05627, EY05235] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Antonarakis SE, 1998, HUM MUTAT, V11, P1; Bech-Hansen NT, 1998, HUM GENET, V103, P124, DOI 10.1007/s004390050794; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; BERGEN AAB, 1995, HUM MOL GENET, V4, P931, DOI 10.1093/hmg/4.5.931; Bergen AAB, 1996, J MED GENET, V33, P869, DOI 10.1136/jmg.33.10.869; Boycott KM, 1998, AM J HUM GENET, V62, P865, DOI 10.1086/301781; Candille SI, 1999, INVEST OPHTH VIS SCI, V40, P2748; Carr R E, 1974, Trans Am Ophthalmol Soc, V72, P448; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; GAL A, 1989, HUM GENET, V81, P315, DOI 10.1007/BF00283682; Hocking AM, 1998, MATRIX BIOL, V17, P1; JACOBSON SG, 1986, OPHTHALMOLOGY, V93, P1604; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KRANTZ DE, 1990, EMBO J, V9, P1969, DOI 10.1002/j.1460-2075.1990.tb08325.x; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; MIYAKE Y, 1987, JPN J OPHTHALMOL, V31, P81; MUSARELLA MA, 1989, GENOMICS, V5, P727, DOI 10.1016/0888-7543(89)90114-6; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pellegata NS, 2000, NAT GENET, V25, P91, DOI 10.1038/75664; PLAAS AHK, 1990, J BIOL CHEM, V265, P20634; Prinsen CFM, 2000, J NEUROSCI, V20, P1424; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Rodieck R.W., 1998, 1 STEPS SEEING; ROWEN L, 1994, AUTOMATED DNA SEQUEN; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; SHARP DM, 1990, CLIN VISION SCI, V5, P217; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Sparkes RL, 2000, GENOMICS, V68, P97, DOI 10.1006/geno.2000.6270; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Vainio S, 1997, CELL, V90, P975, DOI 10.1016/S0092-8674(00)80363-3; YOUNG RSL, 1986, CLIN VISION SCI, V1, P137; YOUNG RSL, 1991, CLIN VISION SCI, V6, P309	33	255	265	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					319	323		10.1038/81619	http://dx.doi.org/10.1038/81619			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062471				2022-12-27	WOS:000165176500020
J	Cox, GA; Mahaffey, CL; Nystuen, A; Letts, VA; Frankel, WN				Cox, GA; Mahaffey, CL; Nystuen, A; Letts, VA; Frankel, WN			The mouse fidgetin gene defines a new role for AAA family proteins in mammalian development	NATURE GENETICS			English	Letter							ENCODES; SUBUNIT; ATPASE; DOMAIN	The mouse mutation fidget arose spontaneously in a heterogeneous albino stock(1). This mutant mouse is characterized by a side-to-side head-shaking and circling behaviour, due to reduced or absent semicircular canals(2). Fidget mice also have small eyes, associated with cell-cycle delay and insufficient growth of the retinal neural epithelium(3,4) and lower penetrance skeletal abnormalities, including pelvic girdle dysgenesis, skull bone fusions and polydactyly(2,5). By positional cloning, we found the gene mutated in fidget mice, fidgetin (Fign), which encodes a new member of the 'meiotic'(6) or subfamily-7 (SF7; ref. 7) group of ATPases associated with diverse cellular activities (AAA proteins). We also discovered two closely related mammalian genes. AAA proteins are molecular chaperones that facilitate a variety of functions, including membrane fusion, proteolysis, peroxisome biogenesis. endosome sorting and meiotic spindle formation(8), but functions for the SF7 AAA proteins are largely unknown. Fidgetin is the first mutant AAA protein found in a mammalian developmental mutant, thus defining a new role for these proteins in embryonic development.	Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Frankel, WN (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.				NIDCD NIH HHS [DC03611] Funding Source: Medline; NINDS NIH HHS [NS32801] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032801, R01NS032801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003611] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Beyer A, 1997, PROTEIN SCI, V6, P2043; Brown NL, 1998, DEVELOPMENT, V125, P4821; CARTER TC, 1950, HEREDITY, V4, P373, DOI 10.1038/hdy.1950.29; CLARKMAQUIRE S, 1994, GENETICS, V136, P53; Cox GA, 1998, NEURON, V21, P1327, DOI 10.1016/S0896-6273(00)80652-2; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gruneberg H, 1943, J GENET, V45, P22, DOI 10.1007/BF02982771; GRUNEBERG HANS, 1955, JOUR GENETICS, V53, P515, DOI 10.1007/BF02981671; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Kaufmann MH, 1992, ATLAS MOUSE DEV; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KONYUKHO.BV, 1972, GENETIKA+, V8, P79; KONYUKHOV BV, 1976, DEV BIOL, V54, P13, DOI 10.1016/0012-1606(76)90282-7; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Letts VA, 1997, GENOMICS, V43, P62, DOI 10.1006/geno.1997.4780; Muller JMM, 1999, J BIOL CHEM, V274, P10154, DOI 10.1074/jbc.274.15.10154; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Swaffield JC, 1997, J MOL EVOL, V45, P549, DOI 10.1007/PL00006259; Truslove G. M., 1956, Journal of Genetics, V54, P64, DOI 10.1007/BF02981704; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	21	86	89	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					198	202		10.1038/79923	http://dx.doi.org/10.1038/79923			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017077				2022-12-27	WOS:000089638800018
J	Kelley, MJ; Jawien, W; Ortel, TL; Korczak, JF				Kelley, MJ; Jawien, W; Ortel, TL; Korczak, JF			Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly	NATURE GENETICS			English	Article							DIFFERENTIAL LOCALIZATION; ISOFORMS; GENE; PLATELETS; SEQUENCE; BLOOD; CELLS	May-Hegglin anomaly(1,2) (MHA) is an autosomal dominant macrothrombocytopenia of unclear pathogenesis characterized by thrombocytopenia. giant platelets and leukocyte inclusions. Studies have indicated that platelet structure and function are normal(3-7). suggesting a defect in megakaryocyte fragmentations(5). The disorder has been linked to chromosome 22q12-13. Here we screen a candidate gene in this region, encoding nonmuscle myosin heavy chain A (MYH9). for mutations in ten families. In each family, we identified one of three sequence variants within either the alpha-helical coiled coil or the tailpiece domain that co-segregated with disease status. The E1841K mutation was found in 5 families and occurs at a conserved site in the rod domain. This mutation was not found in 40 normal individuals. Four families had a nonsense mutation that resulted in truncation of most of the tailpiece. One family had a T1155I mutation present in an affected mother and daughter, but not in the mother's parents, thus representing a new mutation. Among the 30 affected individuals. 21 unaffected individuals and 13 spouses in the 10 families, there was correlation of a variant of MYH9 with the presence of MHA. The identification of MYH9 as the disease gene for MHA establishes the pathogenesis of the disorder, should provide further insight into the processes of normal platelet formation and may facilitate identification of the genetic basis of related disorders.	Duke Univ, Dept Med, Durham, NC 27706 USA; Portsmouth Naval Hosp, Portsmouth, VA USA; Georgetown Univ, Med Ctr, Lombardi Canc Ctr, Dept Oncol, Washington, DC 20007 USA	Duke University; Georgetown University	Kelley, MJ (corresponding author), Duke Univ, Dept Med, Durham, NC 27706 USA.	kelleym@duke.edu	Kelley, Michael/AAC-8939-2019	Kelley, Michael/0000-0001-9523-6080	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066192] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CIULLA TA, 1988, ANAL BIOCHEM, V174, P485, DOI 10.1016/0003-2697(88)90047-4; COLLER BS, 1981, BLOOD, V58, P279; CONRAD AH, 1995, CELL MOTIL CYTOSKEL, V31, P93, DOI 10.1002/cm.970310203; Cripps RM, 1999, EMBO J, V18, P1793, DOI 10.1093/emboj/18.7.1793; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; GODWIN HA, 1974, BRIT J HAEMATOL, V26, P117, DOI 10.1111/j.1365-2141.1974.tb00455.x; HAMILTON RW, 1980, AM J CLIN PATHOL, V74, P663; HEGGLIN R, 1945, Helv Med Acta, V12, P439; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; Kelley MJ, 2000, HUM GENET, V106, P557, DOI 10.1007/s004390050025; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; Kolega J, 1998, J CELL SCI, V111, P2085; Kunishima S, 1999, HUM GENET, V105, P379, DOI 10.1007/s004390051119; LUSHER JM, 1968, BLOOD, V32, P950, DOI 10.1182/blood.V32.6.950.950; Martignetti JA, 2000, AM J HUM GENET, V66, P1449, DOI 10.1086/302873; MAUPIN P, 1994, J CELL SCI, V107, P3077; May R, 1909, DTSCH ARCH KLIN MED, V96, P1; MCLAUGHLIN ML, 1982, HUM COMMUN RES, V8, P299, DOI 10.1111/j.1468-2958.1982.tb00669.x; Moores SL, 1998, MOL CELL, V1, P1043, DOI 10.1016/S1097-2765(00)80104-5; Noris P, 1998, AM J MED, V104, P355, DOI 10.1016/S0002-9343(98)00062-X; Redowicz MJ, 1999, J MUSCLE RES CELL M, V20, P241, DOI 10.1023/A:1005403725521; RICCI G, 1985, THROMB HAEMOSTASIS, V54, P862; Weiss A, 1999, J MOL BIOL, V290, P61, DOI 10.1006/jmbi.1999.2865; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506; 2000, NATURE GENET, V26, P105	27	184	194	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2000	26	1					106	108		10.1038/79069	http://dx.doi.org/10.1038/79069			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973260				2022-12-27	WOS:000089078000029
J	Reilly, KM; Loisel, DA; Bronson, RT; McLaughlin, ME; Jacks, T				Reilly, KM; Loisel, DA; Bronson, RT; McLaughlin, ME; Jacks, T			Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects	NATURE GENETICS			English	Article							NF1 TUMOR-SUPPRESSOR; NEUROFIBROMATOSIS TYPE-1; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; MOLECULAR ANALYSIS; TRANSGENIC MICE; P53 MUTATIONS; BRAIN-TUMORS; PROGRESSION; PATHWAYS; CELLS	Astrocytomas are the leading cause of brain cancer in humans. Because these tumours are highly infiltrative, current treatments that rely on targeting the tumour mass are often ineffective. A mouse model for astrocytoma would be a powerful tool for dissecting tumour progression and testing therapeutics. Mouse models of astrocytoma have been designed to express oncogenic proteins in astrocytes, but have had limited success due to low tumour penetrance or limited tumour progression(1-3). We present here a mouse model of astrocytomas involving mutation of two tumour-suppressor genes, Nf1 and Trp53. Humans with mutations in NF1 develop neurofibromatosis type I (NF1) and have increased risk of optic gliomas, astrocytomas and glioblastomas(4,5). The TP53 tumour suppressor is often mutated in a subset of astrocytomas that develop at a young age and progress slowly to glioblastoma (termed secondary glioblastomas, in contrast to primary glioblastomas that develop rapidly de novo(6-10)). This mouse model shows a range of astrocytoma stages, from low-grade astrocytoma to glioblastoma multiforme, and may accurately model human secondary glioblastoma involving TP53 loss. This is the first reported mouse model of astrocytoma initiated by loss of tumour suppressors, rather than overexpression of transgenic oncogenes.	MIT, Dept Biol, Cambridge, England; MIT, Ctr Canc Res, Cambridge, England; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Vet Med, Dept Pathol, Boston, MA 02111 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; MIT, Howard Hughes Med Inst, Cambridge, MA USA	Tufts University; Tufts University; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, Dept Biol, Cambridge, England.		Reilly, Karlyne/V-4475-2019; Loisel, Dagan/A-6671-2010	Reilly, Karlyne/0000-0001-9109-4409; 				Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; DANKS RA, 1995, CANCER RES, V55, P4302; EASTGATE AR, 1993, J ANAL ATOM SPECTROM, V8, P305, DOI 10.1039/ja9930800305; GOULD VE, 1986, HUM PATHOL, V17, P979, DOI 10.1016/S0046-8177(86)80080-6; Gutmann DH, 1999, ONCOGENE, V18, P4450, DOI 10.1038/sj.onc.1202829; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Huson SHR, 1994, NEUROFIBROMATOSES PA; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Kleihues P., 1997, PATHOLOGY GENETICS T; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; MARSDEN HB, 1983, INT J CANCER, V31, P439, DOI 10.1002/ijc.2910310408; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; RASHEED BKA, 1994, CANCER RES, V54, P1324; Rizvi TA, 1999, BRAIN RES, V816, P111, DOI 10.1016/S0006-8993(98)01133-0; Scherer HJ, 1940, BRAIN, V63, P1, DOI 10.1093/brain/63.1.1; SORENSEN SA, 1986, NEW ENGL J MED, V314, P1010, DOI 10.1056/NEJM198604173141603; TISCHLER AS, 1995, ENDOCR PATHOL, V6, P323, DOI 10.1007/BF02738732; VANMEYEL DJ, 1994, JNCI-J NATL CANCER I, V86, P1011, DOI 10.1093/jnci/86.13.1011; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Watanabe K, 1997, CLIN CANCER RES, V3, P523; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Weissenberger J, 1997, ONCOGENE, V14, P2005, DOI 10.1038/sj.onc.1201168	27	267	278	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					109	113		10.1038/79075	http://dx.doi.org/10.1038/79075			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973261				2022-12-27	WOS:000089078000030
J	Li, J; Yang, Y; Peng, Y; Austin, RJ; van Eyndhoven, G; Nguyen, KCQ; Gabriele, T; McCurrach, ME; Marks, JR; Hoey, T; Lowe, SW; Powers, S				Li, J; Yang, Y; Peng, Y; Austin, RJ; van Eyndhoven, G; Nguyen, KCQ; Gabriele, T; McCurrach, ME; Marks, JR; Hoey, T; Lowe, SW; Powers, S			Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23	NATURE GENETICS			English	Article							COPY-NUMBER; AMPLICON; PROTEIN; KINASE; ZNF217; TUMORS; DNA	We found that PPM1D, encoding a serine/threonine protein phosphatase, lies within an epicenter of the region at 17q23 that is amplified in breast cancer. We show that overexpression of this gene confers two oncogenic phenotypes on cells in culture: attenuation of apoptosis induced by serum starvation and transformation of primary cells in cooperation with RAS.	Tularik Inc, Genom Div, Greenlawn, NY USA; Tularik Inc, San Francisco, CA USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Duke Univ, Ctr Med, Dept Surg, Durham, NC USA	Cold Spring Harbor Laboratory; Duke University	Powers, S (corresponding author), Tularik Inc, Genom Div, 266 Pulaski Rd, Greenlawn, NY USA.			Powers, Scott/0000-0003-2769-1932	NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA129243] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Lanni JS, 1997, P NATL ACAD SCI USA, V94, P9679, DOI 10.1073/pnas.94.18.9679; Latham C, 2001, CANCER GENET CYTOGEN, V127, P16, DOI 10.1016/S0165-4608(00)00427-1; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; Nonet GH, 2001, CANCER RES, V61, P1250; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Schwab M, 1999, SEMIN CANCER BIOL, V9, P319, DOI 10.1006/scbi.1999.0126; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Wu GJ, 2001, CANCER RES, V61, P4951; Zheng PZ, 1998, P NATL ACAD SCI USA, V95, P14745, DOI 10.1073/pnas.95.25.14745	15	208	222	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					133	134		10.1038/ng888	http://dx.doi.org/10.1038/ng888			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12021784				2022-12-27	WOS:000175903500007
J	Manfredi, G; Fu, J; Ojaimi, J; Sadlock, JE; Kwong, JQ; Guy, J; Schon, EA				Manfredi, G; Fu, J; Ojaimi, J; Sadlock, JE; Kwong, JQ; Guy, J; Schon, EA			Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus	NATURE GENETICS			English	Article							INTERMEDIATE PEPTIDASE; ESCHERICHIA-COLI; ATPASE-6 GENE; CELL-LINES; SUBUNIT-C; SYNTHASE; MUTATION; SEQUENCE; PROTEIN; IMPORT	AT-->G transversion at nt 8993 in mitochondrial DNA of MTATP6 (encoding ATPase 6 of complex V of the respiratory chain) causes impaired mitochondrial ATP synthesis in two related mitochondrial disorders: neuropathy, ataxia and retinitis pigmentosa(1) and maternally inherited Leigh syndrome(2). To overcome the biochemical defect, we expressed wildtype ATPase 6 protein allotopically(3) from nucleus-transfected constructs encoding an amino-terminal mitochondrial targeting signal appended to a recoded ATPase 6 gene (made compatible with the universal genetic code) that also contained a carboxy-terminal FLAG epitope tag. After transfection of human cells, the precursor polypeptide was expressed, imported into and processed within mitochondria, and incorporated into complex V. Allotopic expression of stably transfected constructs in cytoplasmic hybrids (cybrids) homoplasmic with respect to the 8993T-->G mutation showed a significantly improved recovery after growth in selective medium as well as a significant increase in ATP synthesis. This is the first successful demonstration of allotopic expression of an mtDNA-encoded polypeptide in mammalian cells and could form the basis of a genetic approach to treat a number of human mitochondrial disorders.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Cornell Univ, Dept Neurol & Neurosci, New York, NY USA; Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; Columbia Univ, Dept Genet & Dev, New York, NY USA	Columbia University; Cornell University; State University System of Florida; University of Florida; Columbia University	Schon, EA (corresponding author), Columbia Univ, Dept Neurol, Room 4-431,630 W 168th St, New York, NY 10032 USA.		Fu, Jin/A-3510-2012; Kwong, Jennifer/L-4348-2019					Altendorf K, 2000, J EXP BIOL, V203, P19; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BRANDA SS, 1995, J BIOL CHEM, V270, P27366, DOI 10.1074/jbc.270.45.27366; BREEN GAM, 1986, J BIOL CHEM, V261, P1680; Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061; DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319; DiMauro S, 2000, BRAIN PATHOL, V10, P431; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; GALANIS M, 1991, FEBS LETT, V282, P425, DOI 10.1016/0014-5793(91)80529-C; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Geromel V, 2001, ANTISENSE NUCLEIC A, V11, P175, DOI 10.1089/108729001300338708; Gray R E, 1996, Methods Enzymol, V264, P369, DOI 10.1016/S0076-6879(96)64035-X; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; HERLITZE S, 1990, GENE, V91, P143, DOI 10.1016/0378-1119(90)90177-S; HIGUTI T, 1993, BIOCHIM BIOPHYS ACTA, V1173, P87, DOI 10.1016/0167-4781(93)90249-D; HOLT IJ, 1990, AM J HUM GENET, V46, P428; Hutcheon ML, 2001, P NATL ACAD SCI USA, V98, P8519, DOI 10.1073/pnas.151236798; ISAYA G, 1992, P NATL ACAD SCI USA, V89, P8317, DOI 10.1073/pnas.89.17.8317; Jager H, 1998, EUR J BIOCHEM, V251, P122, DOI 10.1046/j.1432-1327.1998.2510122.x; JOHN UP, 1986, FEBS LETT, V207, P79, DOI 10.1016/0014-5793(86)80016-3; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; LAW RHP, 1988, FEBS LETT, V236, P501, DOI 10.1016/0014-5793(88)80086-3; Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386; Manfredi G, 2001, METHOD CELL BIOL, V65, P133, DOI 10.1016/S0091-679X(01)65008-8; MARIOTTINI P, 1986, P NATL ACAD SCI USA, V83, P1563, DOI 10.1073/pnas.83.6.1563; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Rees S, 1996, BIOTECHNIQUES, V20, P102; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; Seibel M, 1999, BIOL CHEM, V380, P961, DOI 10.1515/BC.1999.119; Strub A, 2000, BIOL CHEM, V381, P943, DOI 10.1515/BC.2000.115; SUTHERLAND L, 1995, BIOTECHNIQUES, V18, P458; TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390; TATUCH Y, 1992, AM J HUM GENET, V50, P852; VazquezMemije ME, 1996, J INHERIT METAB DIS, V19, P43, DOI 10.1007/BF01799347; White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	44	196	210	1	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					394	399		10.1038/ng851	http://dx.doi.org/10.1038/ng851			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11925565				2022-12-27	WOS:000174682000016
J	El-Assal, SED; Alonso-Blanco, C; Peeters, AJM; Raz, V; Koornneef, M				El-Assal, SED; Alonso-Blanco, C; Peeters, AJM; Raz, V; Koornneef, M			A QTL for flowering time in Arabidopsis reveals a novel allele of CRY2	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; THALIANA; TOMATO; PROTEINS; MUTANTS; GENE; PHOTORECEPTORS; AGROBACTERIUM; CRYPTOCHROMES; DEFICIENT	Variation of flowering time is found in the natural populations of many plant species. The underlying genetic variation, mostly of a quantitative nature, is presumed to reflect adaptations to different environments contributing to reproductive success. Analysis of natural variation for flowering time in Arabidopsis thaliana has identified several quantitative trait loci (QTL)(1), which have yet to be characterized at the molecular level. A major environmental factor that determines flowering time is photoperiod or day length, the length of the light period, which changes across the year differently with geographical latitude(2). We identified the EDI locus as a QTL partly accounting for the difference in flowering response to the photoperiod between two Arabidopsis accessions: the laboratory strain Landsberg erecta (Ler), originating in Northern Europe, and Cvi, collected in the tropical Cape Verde Islands(3). Positional cloning of the EDI QTL showed it to be a novel allele of CRY2, encoding the blue-light photoreceptor cryptochrome-2 that has previously been shown to promote flowering in long-day (LD) photoperiods(4). We show that the unique EDI flowering phenotype results from a single amino-acid substitution that reduces the light-induced downregulation of CRY2 in plants grown under Short photoperiods, leading to early flowering.	Univ Wageningen & Res Ctr, Genet Lab, NL-6703 HA Wageningen, Netherlands; Ctr Nacl Biotecnol, E-28049 Madrid, Spain; Univ Utrecht, Dept Plant Ecophysiol, NL-3584 CA Utrecht, Netherlands; Univ Wageningen & Res Ctr, Mol Biol Lab, NL-6703 HA Wageningen, Netherlands	Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Utrecht University; Wageningen University & Research	Koornneef, M (corresponding author), Univ Wageningen & Res Ctr, Genet Lab, Dreijenlaan 2, NL-6703 HA Wageningen, Netherlands.	maarten.koornneef@genetics.dpw.wau.nl	Alonso-Blanco, Carlos/F-8864-2016; Peeters, Anton J.M./B-9610-2011	Alonso-Blanco, Carlos/0000-0002-4738-5556; Koornneef, Maarten/0000-0002-7759-4869				Ahmad M, 1998, PLANT CELL, V10, P197, DOI 10.1105/tpc.10.2.197; Alonso-Blanco C, 1998, GENETICS, V149, P749; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chou IT, 1997, PLANT MOL BIOL, V35, P873, DOI 10.1023/A:1005930024796; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; JANSEN RC, 1995, THEOR APPL GENET, V91, P33, DOI 10.1007/BF00220855; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; KARLSSON BH, 1993, AM J BOT, V80, P646, DOI 10.2307/2445435; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; KOORNNEEF M, 1995, PHYSIOL PLANTARUM, V95, P260, DOI 10.1111/j.1399-3054.1995.tb00836.x; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mizoguchi T, 2000, TRENDS PLANT SCI, V5, P409, DOI 10.1016/S1360-1385(00)01747-7; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; PETERS JL, 1992, PHOTOCHEM PHOTOBIOL, V56, P75, DOI 10.1111/j.1751-1097.1992.tb09605.x; Raz V, 1999, DEVELOPMENT, V126, P3661; SESSA G, 1995, PLANT MOL BIOL, V28, P537, DOI 10.1007/BF00020400; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Swarup K, 1999, PLANT J, V20, P67, DOI 10.1046/j.1365-313X.1999.00577.x; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Thomas B., 1997, PHOTOPERIODISM PLANT; VANTUINEN A, 1995, MOL GEN GENET, V246, P133, DOI 10.1007/BF00294675; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473	36	299	314	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2001	29	4					435	440		10.1038/ng767	http://dx.doi.org/10.1038/ng767			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726930				2022-12-27	WOS:000172507500019
J	Kwon, CH; Zhu, XY; Zhang, JY; Knoop, LL; Tharp, R; Smeyne, RJ; Eberhart, CG; Burger, PC; Baker, SJ				Kwon, CH; Zhu, XY; Zhang, JY; Knoop, LL; Tharp, R; Smeyne, RJ; Eberhart, CG; Burger, PC; Baker, SJ			Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease	NATURE GENETICS			English	Article							CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; SIGNALING PATHWAY; PROSTATE-CANCER; COWDEN-SYNDROME; PTEN(+/-) MICE; GLIOMA-CELLS; GENE; EXPRESSION; PTEN/MMAC1	Somatic inactivation of PTEN occurs in different human tumors including glioblastoma, endometrial carcinoma and prostate carcinoma. Germline mutations in PTEN result in a range of phenotypic abnormalities that occur with variable penetrance, including neurological features such as macrocephaly, seizures, ataxia and Lhermitte-Duclos disease (also described as dysplastic gangliocytoma of the cerebellum). Homozygous deletion of Pten causes embryonic lethality in mice. To investigate function in the brain, we used Cre-loxP technology to selectively inactivate Pten in specific mouse neuronal populations. Loss of Pten resulted in progressive macrocephaly and seizures. Neurons lacking Pten expressed high levels of phosphorylated Akt and showed a progressive increase in soma size without evidence of abnormal proliferation. Cerebellar abnormalities closely resembled the histopathology of human Lhermitte-Duclos disease. These results indicate that Pten regulates neuronal size in vivo in a cell-autonomous manner and provide new insights into the etiology of Lhermitte-Duclos disease.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Tennessee, Dept Pathol, Memphis, TN 38163 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Johns Hopkins University	Baker, SJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale, Memphis, TN 38105 USA.	suzanne.baker@stjude.org	Baker, Suzanne J/N-8167-2018; Kwon, Chang-hyuk/E-3450-2011		NATIONAL CANCER INSTITUTE [P30CA021765, P01CA071907] Funding Source: NIH RePORTER; NCI NIH HHS [CA71907, CA21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Bruni P, 2000, ONCOGENE, V19, P3146, DOI 10.1038/sj.onc.1203633; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cheyney IW, 1999, CANCER RES, V59, P2318; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies MA, 1998, CANCER RES, V58, P5285; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Furnari FB, 1998, CANCER RES, V58, P5002; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goldowitz D, 2000, J NEUROSCI, V20, P4129; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Huang H, 1999, DEVELOPMENT, V126, P5365; Iida S, 1998, INT J MOL MED, V1, P925; KUHAR SG, 1993, DEVELOPMENT, V117, P97; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li J, 1998, CANCER RES, V58, P5667; Li Y, 2001, BMC Mol Biol, V2, P2, DOI 10.1186/1471-2199-2-2; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Marcus CD, 1996, NEURORADIOLOGY, V38, P529; Marino S, 2000, GENE DEV, V14, P994; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Miyazawa K, 2000, J NEUROSCI, V20, P5756, DOI 10.1523/JNEUROSCI.20-15-05756.2000; MUCKE L, 1991, NEW BIOL, V3, P465; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; RAINOV NG, 1995, CLIN NEUROL NEUROSUR, V97, P175, DOI 10.1016/0303-8467(95)00017-E; Robinson S, 2000, NEUROSURGERY, V46, P371, DOI 10.1097/00006123-200002000-00021; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Tuli S, 1997, CAN J NEUROL SCI, V24, P155, DOI 10.1017/S031716710002151X; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; VINCHON M, 1994, J NEUROL NEUROSUR PS, V57, P699, DOI 10.1136/jnnp.57.6.699; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Zhu XY, 2001, CANCER RES, V61, P4569; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	50	342	356	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2001	29	4					404	411		10.1038/ng781	http://dx.doi.org/10.1038/ng781			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726927				2022-12-27	WOS:000172507500015
J	Maloof, JN; Borevitz, JO; Dabi, T; Lutes, J; Nehring, RB; Redfern, JL; Trainer, GT; Wilson, JM; Asami, T; Berry, CC; Weigel, D; Chory, J				Maloof, JN; Borevitz, JO; Dabi, T; Lutes, J; Nehring, RB; Redfern, JL; Trainer, GT; Wilson, JM; Asami, T; Berry, CC; Weigel, D; Chory, J			Natural variation in light sensitivity of Arabidopsis	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; PHYTOCHROME; EVOLUTION; RESPONSES; THALIANA; SURFACE; PROTEIN; PLANTS; SHADE; SIZE	Because plants depend on light for growth, their development and physiology must suit the particular light environment. Plants native to different environments show heritable, apparently adaptive, changes in their response to light(1,2). As a first step in unraveling the genetic and molecular basis of these naturally occurring differences, we have characterized intraspecific variation in a light-dependent developmental process-seedling emergence. We examined 141 Arabidopsis thaliana accessions for their response to four light conditions, two hormone conditions and darkness. There was significant variation in all conditions, confirming that Arabidopsis is a rich source of natural genetic diversity. Hierarchical clustering revealed that some accessions had response patterns similar to known photoreceptor mutants, suggesting changes in specific signaling pathways. We found that the unusual far-red response of the Lm-2 accession is due to a single amino-acid change in the phytochrome A (PHYA) protein. This change stabilizes the light-labile PHYA protein in light and causes a 100-fold shift in the threshold for far-red light sensitivity. Purified recombinant Lm-2 PHYA also shows subtle photochemical differences and has a reduced capacity for autophosphorylation. These biochemical changes contrast with previously characterized natural alleles in loci controlling plant development, which result in altered gene expression or loss of gene function(3-9).	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; Univ Calif San Diego, Dept Family Prevent Med, La Jolla, CA 92093 USA; Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Salk Institute; Howard Hughes Medical Institute; Salk Institute; RIKEN; University of California System; University of California San Diego; Max Planck Society	Weigel, D (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022; Borevitz, Justin/B-5423-2012	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Borevitz, Justin/0000-0001-8408-3699; Maloof, Julin/0000-0002-9623-2599	NIGMS NIH HHS [GM52413, GM08666] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Asami T, 1999, TRENDS PLANT SCI, V4, P348, DOI 10.1016/S1360-1385(99)01456-9; Briggs WR, 2001, PLANT CELL, V13, P993, DOI 10.1105/tpc.13.5.993; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Clough RC, 1997, PLANT CELL ENVIRON, V20, P713, DOI 10.1046/j.1365-3040.1997.d01-107.x; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DUDLEY SA, 1995, FUNCT ECOL, V9, P655, DOI 10.2307/2390158; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELASSAL SE, 2001, NATURE GENET, V29; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; JOHNSON FS, 1976, PHOTOCHEM PHOTOBIOL, V23, P179, DOI 10.1111/j.1751-1097.1976.tb07239.x; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; LOPEZJUEZ E, 1992, PLANT CELL, V4, P241, DOI 10.1105/tpc.4.3.241; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Murphy JT, 1997, PHOTOCHEM PHOTOBIOL, V65, P750, DOI 10.1111/j.1751-1097.1997.tb01920.x; NAGATANI A, 1984, PLANT CELL PHYSIOL, V25, P1059; Neff MM, 2000, GENE DEV, V14, P257; Pinheiro J, 2001, MIXED EFFECTS MODELS; ROBERTSON A, 1959, BIOMETRICS, V15, P469, DOI 10.2307/2527750; Schmitt J, 1999, AM NAT, V154, pS43, DOI 10.1086/303282; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	30	217	226	0	34	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					441	446		10.1038/ng777	http://dx.doi.org/10.1038/ng777			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726931				2022-12-27	WOS:000172507500020
J	Daly, MJ; Rioux, JD; Schaffner, SE; Hudson, TJ; Lander, ES				Daly, MJ; Rioux, JD; Schaffner, SE; Hudson, TJ; Lander, ES			High-resolution haplotype structure in the human genome	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; MAXIMUM-LIKELIHOOD; SEQUENCE VARIATION; REGION; COMPLEX; GENE; IDENTIFICATION; RECOMBINATION; PROMOTER	Linkage disequilibrium (LD) analysis is traditionally based on individual genetic markers and often yields an erratic, nonmonotonic picture, because the power to detect allelic associations depends on specific properties of each marker, such as frequency and population history. Ideally, LD analysis should be based directly on the underlying haplotype structure of the human genome, but this structure has remained poorly understood. Here we report a high-resolution analysis of the haplotype structure across 500 kilobases. on chromosome 5q31 using 103 single-nucleotide polymorphisms (SNPs) in a European-derived population. The results show a picture of discrete haplotype blocks (of tens to hundreds of kilobases), each with limited diversity punctuated by apparent sites of recombination. In addition, we develop an analytical model for LID mapping based on such haplotype blocks. If our observed structure is general (and published data suggest that it may be), it offers a coherent framework for creating a haplotype map of the human genome.	MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; McGill Univ, Montreal Genome Ctr, Montreal, PQ, Canada; MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; McGill University; Massachusetts Institute of Technology (MIT)	Daly, MJ (corresponding author), MIT, Whitehead Inst, Ctr Genome Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mjdaly@genome.wi.mit.edu; lander@wi.mit.edu	Daly, Mark J/B-2453-2017; Rioux, John D/A-9599-2015	Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; Schaffner, Stephen/0000-0001-6699-3568				Bonnen PE, 2000, AM J HUM GENET, V67, P1437, DOI 10.1086/316908; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; D'Alfonso S, 2000, GENES IMMUN, V1, P231, DOI 10.1038/sj.gene.6363666; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; HEDRICK PW, 1987, GENETICS, V117, P331; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jordanides N, 2000, GENES IMMUN, V1, P451, DOI 10.1038/sj.gene.6363699; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEWONTIN RC, 1964, GENETICS, V49, P49; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; Nachman MW, 2000, GENETICS, V156, P297; Park HY, 2000, CLIN EXP PHARMACOL P, V27, P690, DOI 10.1046/j.1440-1681.2000.03321.x; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Smith A, 1998, PHARM SCI TECHNOL TO, V1, P92, DOI 10.1016/S1461-5347(98)00027-3; SVED J A, 1971, Theoretical Population Biology, V2, P125; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699	25	1257	1367	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2001	29	2					229	232		10.1038/ng1001-229	http://dx.doi.org/10.1038/ng1001-229			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586305				2022-12-27	WOS:000171374100033
J	Chen, P; Hao, WS; Rife, L; Wang, XP; Shen, DW; Chen, J; Ogden, T; Van Boemel, GB; Wu, LY; Yang, M; Fong, HKW				Chen, P; Hao, WS; Rife, L; Wang, XP; Shen, DW; Chen, J; Ogden, T; Van Boemel, GB; Wu, LY; Yang, M; Fong, HKW			A photic visual cycle of rhodopsin regeneration is dependent on Rgr	NATURE GENETICS			English	Letter							PIGMENT-EPITHELIUM; VITAMIN-A; OPSIN HOMOLOG; RETINOCHROME; CHROMOPHORE; ISOMERS; RETINA; EYE	During visual excitation, rhodopsin undergoes photoactivation and bleaches to opsin and all-trans-retinal(1,2). To regenerate rhodopsin and maintain normal visual sensitivity, the all-trans isomer must be metabolized and reisomerized to produce the chromophore 11-cis-retinal in biochemical steps that constitute the visual cycle and involve the retinal pigment epithelium (RPE; refs, 3-8). A key step in the visual cycle is isomerization of an all-trans retinoid to 11-cis-retinol in the RPE (refs, 9-11). It could be that the retinochrome-like opsins. peropsin, or the retinal G protein-coupled receptor (RGR) opsin12-16 are isomerases in the RPE. In contrast to visual pigments. RGR is bound predominantly to endogenous all-transretinal, and irradiation of RGR in vitro results in stereospecific conversion of the bound all-trans isomer to 11-cis-retinal(17). Here we show that RGR is involved in the formation of 11-cis-retinal in mice and functions in a light-dependent pathway of the rod visual cycle. Mutations in the human gene encoding RGR are associated with retinitis pigmentosa(18).	Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Microbiol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90033 USA; Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; Doheny Eye Inst, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Doheny Eye Institute	Fong, HKW (corresponding author), Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA.				NEI NIH HHS [EY08364, EY03040] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY003040, R01EY008364] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALPERN M, 1971, J PHYSIOL-LONDON, V217, P447, DOI 10.1113/jphysiol.1971.sp009580; BRIDGES CDB, 1976, EXP EYE RES, V22, P435, DOI 10.1016/0014-4835(76)90182-2; CHEN P, 2001, J BIOL CHEM     0327; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; DOWLING JE, 1960, NATURE, V188, P114, DOI 10.1038/188114a0; GROENENDIJK GWT, 1979, ANAL BIOCHEM, V99, P304, DOI 10.1016/S0003-2697(79)80011-1; GROENENDIJK GWT, 1980, BIOCHIM BIOPHYS ACTA, V617, P430, DOI 10.1016/0005-2760(80)90009-0; Hao WS, 1996, BIOCHEMISTRY-US, V35, P6251, DOI 10.1021/bi952420k; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; HUBBARD R, 1952, J GEN PHYSIOL, V36, P269, DOI 10.1085/jgp.36.2.269; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; LANDERS GM, 1990, METHOD ENZYMOL, V189, P70; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; OZAKI K, 1986, VISION RES, V26, P691, DOI 10.1016/0042-6989(86)90083-0; OZAKI K, 1983, BIOPHYS J, V44, P127, DOI 10.1016/S0006-3495(83)84285-4; PANDEY S, 1994, EXP EYE RES, V58, P605, DOI 10.1006/exer.1994.1055; RANDO RR, 1991, J BIOENERG BIOMEMBR, V23, P133; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; Stryer L, 1991, Harvey Lect, V87, P129; Tao L, 1998, Mol Vis, V4, P25; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; ZIMMERMAN WF, 1974, VISION RES, V14, P795, DOI 10.1016/0042-6989(74)90143-6; [No title captured]	25	143	145	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					256	260		10.1038/90089	http://dx.doi.org/10.1038/90089			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431696				2022-12-27	WOS:000169656400018
J	Kibar, Z; Vogan, KJ; Groulx, N; Justice, MJ; Underhill, DA; Gros, P				Kibar, Z; Vogan, KJ; Groulx, N; Justice, MJ; Underhill, DA; Gros, P			Ltap, a mammalian homolog of Drosophila Strabismus/Van Gogh, is altered in the mouse neural tube mutant Loop-tail	NATURE GENETICS			English	Letter							CONVERGENT EXTENSION MOVEMENTS; TISSUE POLARITY; MESSENGER-RNA; PDZ DOMAINS; DEFECTS; GASTRULATION; RECOGNITION; EXPRESSION; VICINITY; MUTATION	Neural tube defects (NTDs) such as spina bifida and anencephaly are common congenital malformations in humans (1/1,000 births) that result from failure of the neural tube to close during embryogenesis(1,2). The etiology of NTDs is complex, with both genetic and environmental contributions; the genetic component has been extensively studied with mouse models(3). Loop-tail (Lp) is a semidominant mutation on mouse chromosome 1 (ref. 4). In the two known Lp alleles (Lp. Lp(m1Jus)), heterozygous mice exhibit a characteristic looped tail, and homozygous embryos show a completely open neural tube in the hindbrain and spinal region, a condition similar to the severe craniorachischisis defect in humans(4-6). Morphological and neural patterning studies indicate a role for the Lp gene product in controlling early morphogenesis and patterning of both axial midline structures and the developing neural plate(7). The 0.6-cM/0.7-megabase (Mb) Lp interval is delineated proximally by D1Mit113/Apoa2/Fcer1g and distally by Fcer1a/D1Mit149/Spna1 and contains a minimum of 17 transcription units(8-11). One of these genes, Ltap, encodes a homolog of Drosophila Strabismus/Van Gogh (Stbm/Vang), a component of the frizzled/dishevelled tissue polarity pathway(12-14). Ltap is expressed broadly in the neuroectoderm throughout early neurogenesis and is altered in two independent Lp alleles, identifying this gene as a strong candidate for Lp.	McGill Univ, Dept Biochem, Montreal, PQ, Canada; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	McGill University; Harvard University; Harvard Medical School; Baylor College of Medicine; University of Alberta	Gros, P (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.			Vogan, Kyle/0000-0001-9565-9665; Underhill, Darrell/0000-0003-0957-7407	NCI NIH HHS [P01 CA75719] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA075719] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; CAMPBELL LR, 1986, TERATOLOGY, V34, P171, DOI 10.1002/tera.1420340206; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COPP AJ, 1990, PROG NEUROBIOL, V35, P363, DOI 10.1016/0301-0082(90)90037-H; Djiane A, 2000, DEVELOPMENT, V127, P3091; Doudney K, 2001, GENOMICS, V72, P180, DOI 10.1006/geno.2000.6463; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Gerrelli D, 1997, DEV BRAIN RES, V102, P217, DOI 10.1016/S0165-3806(97)00099-0; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Kibar Z, 2001, GENOMICS, V72, P331, DOI 10.1006/geno.2000.6493; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; MULLICK A, 1995, GENOMICS, V26, P479, DOI 10.1016/0888-7543(95)80166-J; SMITH LJ, 1962, J EMBRYOL EXP MORPH, V10, P73; Sokol S, 2000, NAT CELL BIOL, V2, pE124, DOI 10.1038/35017136; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STEIN KF, 1953, J HERED, V44, P59, DOI 10.1093/oxfordjournals.jhered.a106356; STRONG LC, 1949, J HERED, V40, P329, DOI 10.1093/oxfordjournals.jhered.a105976; Taylor MF, 1998, ANTISENSE NUCLEIC A, V8, P199, DOI 10.1089/oli.1.1998.8.199; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Underhill DA, 1999, GENOMICS, V55, P185, DOI 10.1006/geno.1998.5643; Underhill DA, 2000, MAMM GENOME, V11, P633, DOI 10.1007/s003350010118; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WILSON DB, 1992, ACTA ANAT, V143, P89; Wolff T, 1998, DEVELOPMENT, V125, P1149	30	388	395	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					251	255		10.1038/90081	http://dx.doi.org/10.1038/90081			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431695				2022-12-27	WOS:000169656400017
J	Oosthuyse, B; Moons, L; Storkebaum, E; Beck, H; Nuyens, D; Brusselmans, K; Van Dorpe, J; Hellings, P; Gorselink, M; Heymans, S; Theilmeier, G; Dewerchin, M; Laudenbach, V; Vermylen, P; Raat, H; Acker, T; Vleminckx, V; Van den Bosch, L; Cashman, N; Fujisawa, H; Drost, MR; Sciot, R; Bruyninckx, F; Hicklin, DJ; Ince, C; Gressens, P; Lupu, F; Plate, KH; Robberecht, W; Herbert, JM; Collen, D; Carmeliet, P				Oosthuyse, B; Moons, L; Storkebaum, E; Beck, H; Nuyens, D; Brusselmans, K; Van Dorpe, J; Hellings, P; Gorselink, M; Heymans, S; Theilmeier, G; Dewerchin, M; Laudenbach, V; Vermylen, P; Raat, H; Acker, T; Vleminckx, V; Van den Bosch, L; Cashman, N; Fujisawa, H; Drost, MR; Sciot, R; Bruyninckx, F; Hicklin, DJ; Ince, C; Gressens, P; Lupu, F; Plate, KH; Robberecht, W; Herbert, JM; Collen, D; Carmeliet, P			Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration	NATURE GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FACTOR MESSENGER-RNA; SPINAL-CORD; INDUCIBLE FACTOR-1; FACTOR EXPRESSION; MODEL; VEGF; MECHANISMS; BINDING; ANGIOGENESIS	Hypoxia stimulates angiogenesis through the binding of hypoxia-inducible factors to the hypoxia-response element in the vascular endothelial growth factor (Vegf) promotor. Here, we report that deletion of the hypoxia-response element in the Vegf promotor reduced hypoxic Vegf expression in the spinal cord and caused adult-onset progressive motor neuron degeneration, reminiscent of amyotrophic lateral sclerosis, The neurodegeneration seemed to be due to reduced neural vascular perfusion. In addition. Vegf(165) promoted survival of motor neurons during hypoxia through binding to Vegf receptor 2 and neuropilin 1. Acute ischemia is known to cause nonselective neuronal death. Our results indicate that chronic vascular insufficiency and, possibly, insufficient Vegf-dependent neuroprotection lead to the select degeneration of motor neurons.	Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; FAU Erlangen Nurnberg, Dept Neuropathol, D-91054 Erlangen, Germany; Katholieke Univ Leuven, Fac Med, B-3000 Louvain, Belgium; Univ Maastricht, CARIM, NL-6200 MD Maastricht, Netherlands; Hop Robert Debre, INSERM E9935, F-75019 Paris, France; Hop Robert Debre, Serv Neruol Pediat, F-75019 Paris, France; Univ Amsterdam, Dept Anesthesiol, Amsterdam, Netherlands; Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Nagoya Univ, Dept Biol Mol, Nagoya, Aichi 46401, Japan; ImClone Syst Inc, New York, NY 10014 USA; Thrombosis Res Inst, Vasc Biol Lab, London SW3 6LR, England	Flanders Institute for Biotechnology (VIB); KU Leuven; University of Erlangen Nuremberg; KU Leuven; Maastricht University; Maastricht University Medical Centre (MUMC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; University of Toronto; Nagoya University; Eli Lilly; Thrombosis Research Institute	Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.ac.be	Hellings, Peter W/I-4068-2018; Van Den Bosch, Ludo/B-7258-2012; Carmeliet, Peter/AAQ-5140-2020; Lupu, Florea/C-3162-2009; Lupu, Florea/AAV-3257-2021; Storkebaum, Erik/B-5389-2017; gressens, pierre/M-7557-2017	Hellings, Peter W/0000-0001-6898-688X; Carmeliet, Peter/0000-0001-7961-1821; Lupu, Florea/0000-0003-1249-9278; Lupu, Florea/0000-0003-1249-9278; Storkebaum, Erik/0000-0002-9519-5642; gressens, pierre/0000-0002-0909-4221; Nuyens, Dieter/0000-0001-9390-3273; sciot, raf/0000-0003-2244-5839; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Heymans, Stephane/0000-0001-9477-7803; Van Den Bosch, Ludo/0000-0003-0104-4067; Acker, Till/0000-0001-6357-7227				Al Theys P, 1999, J NEUROL, V246, P438, DOI 10.1007/s004150050379; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Bromberg MB, 1999, CURR OPIN NEUROL, V12, P581, DOI 10.1097/00019052-199910000-00012; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; Dor Y, 1997, TRENDS CARDIOVAS MED, V7, P289, DOI 10.1016/S1050-1738(97)00091-1; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Gorselink M, 2000, PFLUG ARCH EUR J PHY, V439, P665, DOI 10.1007/s004240050991; Green SL, 1999, LAB ANIM SCI, V49, P480; Gupta M, 2000, BLOOD, V96, P491; Hayashi T, 1999, NEUROPATH APPL NEURO, V25, P63; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; KAWAMURA Y, 1977, J NEUROPATH EXP NEUR, V36, P853, DOI 10.1097/00005072-197709000-00009; Knight JA, 1997, ANN CLIN LAB SCI, V27, P11; Kong JM, 1998, J NEUROSCI, V18, P3241; Kostic V, 1997, ANN NEUROL, V41, P497, DOI 10.1002/ana.410410413; Lang-Lazdunski L, 2000, STROKE, V31, P208, DOI 10.1161/01.STR.31.1.208; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Marti HH, 1998, P NATL ACAD SCI USA, V95, P15809, DOI 10.1073/pnas.95.26.15809; Martin LJ, 2000, INT J MOL MED, V5, P3; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Nohl H, 1997, EXP GERONTOL, V32, P485, DOI 10.1016/S0531-5565(96)00169-6; Ochiai-Kanai R, 1999, BRAIN RES, V847, P59, DOI 10.1016/S0006-8993(99)02020-X; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P654, DOI 10.1097/00005072-199906000-00010; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; ROBBERECHT WL, 2000, AMYOTROPHIC LATERAL, P211; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Schultz A, 1999, CIRCULATION, V100, P547, DOI 10.1161/01.CIR.100.5.547; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Vandenberghe W, 1998, BRAIN RES, V807, P1, DOI 10.1016/S0006-8993(98)00569-1; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Yu HH, 1999, NEURON, V22, P11, DOI 10.1016/S0896-6273(00)80672-8	46	796	833	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2001	28	2					131	138		10.1038/88842	http://dx.doi.org/10.1038/88842			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381259				2022-12-27	WOS:000169011800014
J	Ranger, AM; Malynn, BA; Korsmeyer, SJ				Ranger, AM; Malynn, BA; Korsmeyer, SJ			Mouse models of cell death	NATURE GENETICS			English	Article							BCL-2 PROTEIN EXPRESSION; FAS-MEDIATED APOPTOSIS; CYTOCHROME-C; DEFICIENT MICE; IN-VIVO; EMBRYONIC LETHALITY; CASPASE ACTIVATION; MURINE DEVELOPMENT; BAX; MITOCHONDRIA	Cell death is critical for the development and orderly maintenance of cellular homeostasis in metazoans. Developmental genetics in model systems, including Caenorhabditis elegans and Drosophila melanogaster, have helped to identify and order the components of cell-death pathways. An even more complex network of apoptotic pathways has evolved in higher organisms that possess homologs within each set of cell-death regulators. Whereas biochemical studies provide details of molecular mechanisms, genetic models reveal the essential physiologic roles. Transgenic and gene-ablated mice have helped to elucidate mammalian apoptotic pathways and identify the principal effect of each cell death regulator. Here, we review the details of the apoptotic machinery as revealed by mice deficient in critical components of cell-death pathways; we concentrate on cell-death regulators classified as members of the caspase and Bcl2 families or, broadly, as adaptors and mitochondrial released factors.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst,Dept Pathol & Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst,Dept Pathol & Med, Boston, MA USA.	stanley_korsmeyer@dfci.harvard.edu						Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; MERRY DE, 1994, DEVELOPMENT, V120, P301; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; NOVACK DV, 1994, AM J PATHOL, V145, P61; Pellegrini M, 1999, J CLIN IMMUNOL, V19, P365, DOI 10.1023/A:1020598632068; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Print CG, 1998, P NATL ACAD SCI USA, V95, P12424, DOI 10.1073/pnas.95.21.12424; Rinkenberger JL, 2000, GENE DEV, V14, P23; Ross AJ, 1998, NAT GENET, V18, P251, DOI 10.1038/ng0398-251; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; White R, 1998, ENDOCR-RELAT CANCER, V5, P1, DOI 10.1677/erc.0.0050001; Woo M, 1999, J IMMUNOL, V163, P4909; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zheng TS, 1998, P NATL ACAD SCI USA, V95, P13618, DOI 10.1073/pnas.95.23.13618; Zhou P, 1998, BLOOD, V92, P3226, DOI 10.1182/blood.V92.9.3226.421k49_3226_3239	65	209	216	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2001	28	2					113	118		10.1038/88815	http://dx.doi.org/10.1038/88815			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381252				2022-12-27	WOS:000169011800007
J	Lee, SH; Girard, S; Macina, D; Busa, M; Zafer, A; Belouchi, A; Gros, P; Vidal, SM				Lee, SH; Girard, S; Macina, D; Busa, M; Zafer, A; Belouchi, A; Gros, P; Vidal, SM			Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily	NATURE GENETICS			English	Article							RESISTANCE LOCUS CMV1; GENE-COMPLEX; LY49; MHC; FAMILY; MAP; CHROMOSOME-6; SPECIFICITY; RECOGNITION; EXPRESSION	Cytomegalovirus is the leading cause of congenital viral disease and the most important opportunistic infection in immunocompromised patients(1,2). We have used a mouse experimental infection model (MCMV) to study the genetic parameters of host/virus interaction. Susceptibility to infection with MCMV is controlled by Cmv1, a chromosome 6 locus that regulates natural killer (NK) cell activity against virally infected targets(3-5). Here, we use a positional cloning strategy to isolate the gene mutated at the Cmv1 locus. Cmv1 maps within a 0.35-cM interval defined by markers D6Ott8 and D6Ott115, which corresponds to a physical distance of 1.6 Mb (refs. 6-8). A transcript map of the region identified 19 genes(8), including members of the killer cell lectin-like receptor family a (Klra, formerly Ly49; refs. 9-12), which encode inhibitory or activating NK cell receptors that interact with MHC class I molecules(13-15). Klra genes have different copy numbers and genomic organization, and are highly polymorphic among inbred strains, making it difficult to distinguish between normal allelic variants and distinct Klra genes(15-17), or possible mutations associated with Cmv1. The recombinant inbred strain BXD-8/Ty (BXD-8; ref. 18), derived from Cmv1(r) C57BL/6 (B6, resistant) and Cmv1(s) DBA/2 (susceptible), is of particular interest because it is highly susceptible to MCMV infection despite having a B6 haplotype at Cmv1, We determined that MCMV susceptibility in BXD-8 is associated with the deletion of Klra8 (formerly Ly49h).	Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; Galileo Genom Inc, Montreal, PQ, Canada; McGill Univ, Dept Biochem, Montreal, PQ, Canada	University of Ottawa; McGill University	Vidal, SM (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.							BRENNAN J, 1994, J EXP MED, V180, P2287, DOI 10.1084/jem.180.6.2287; Brown MG, 1997, IMMUNOL REV, V155, P53, DOI 10.1111/j.1600-065X.1997.tb00939.x; Brown MG, 1997, GENOMICS, V42, P16, DOI 10.1006/geno.1997.4721; DELAINE M, 1995, PHYS WORLD, V8, P6; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Depatie C, 1997, GENOMICS, V39, P154, DOI 10.1006/geno.1996.4498; Depatie C, 1999, INT IMMUNOL, V11, P1541, DOI 10.1093/intimm/11.9.1541; Depatie C, 2000, GENOMICS, V66, P161, DOI 10.1006/geno.2000.6186; Farrell H, 2000, MICROBES INFECT, V2, P521, DOI 10.1016/S1286-4579(00)00315-4; Gosselin P, 1999, J LEUKOCYTE BIOL, V66, P165, DOI 10.1002/jlb.66.1.165; HO M, 1994, TRANSPLANT P, V5, P7; Hoglund P, 1997, IMMUNOL REV, V155, P11, DOI 10.1111/j.1600-065X.1997.tb00936.x; Hurme M, 1998, SCAND J INFECT DIS, V30, P447, DOI 10.1080/00365549850161403; Idris AH, 1998, J EXP MED, V188, P2243, DOI 10.1084/jem.188.12.2243; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kuboto A, 1999, J IMMUNOL, V163, P212; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Makrigiannis AP, 2000, J LEUKOCYTE BIOL, V68, P765; Makrigiannis AP, 2000, IMMUNOL RES, V21, P39, DOI 10.1385/IR:21:1:39; McQueen KL, 1998, IMMUNOGENETICS, V48, P174, DOI 10.1007/s002510050421; Nakamura MC, 1999, J EXP MED, V189, P493, DOI 10.1084/jem.189.3.493; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; SMITH HRC, 1994, J IMMUNOL, V153, P1068; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; Threlkeld MG, 1995, MANDELL DOUGLAS BENN, P1351	30	331	337	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					42	45		10.1038/ng0501-42	http://dx.doi.org/10.1038/ng0501-42			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326273				2022-12-27	WOS:000168413300013
J	Schaner, P; Richards, N; Wadhwa, A; Aksentijevich, I; Kastner, D; Tucker, P; Gumucio, D				Schaner, P; Richards, N; Wadhwa, A; Aksentijevich, I; Kastner, D; Tucker, P; Gumucio, D			Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states	NATURE GENETICS			English	Letter							FAMILIAL MEDITERRANEAN-FEVER; GENE; MEFV; SUBSTITUTION; INHERITANCE; FREQUENCY; SELECTION	Familiar Mediterranean fever (FMF; MIM 249100) is an autosomal recessive disease characterized by recurrent attacks of fever with synovial, pleural or peritoneal inflammation(1). The disease is caused by mutations in the gene encoding the pyrin protein(2-4), Human population studies have revealed extremely high allele frequencies for several different pyrin mutations, leading to the conclusion that the mutant alleles confer a selective advantage(5-7). Here we examine the ret finger protein (rfp) domain (which contains most of the disease-causing mutations) of pyrin during primate evolution. Amino acids that cause human disease are often present as wild type in other species. This is true at positions 653 (a novel mutation), 680, 681. 726. 744 and 761, For several of these human mutations, the mutant represents the reappearance of an ancestral amino acid state. Examination of lineage-specific d(N)/d(S) ratios revealed a pattern consistent with the signature of episodic positive selection, Our data, together with previous human population studies, indicate that selective pressures may have caused functional evolution of pyrin in humans and other primates.	Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol, Ann Arbor, MI 48109 USA; NIAMSD, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Gumucio, D (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	dgumucio@umich.edu	Aksentijevich, Ivona/AAF-1335-2019		NICHD NIH HHS [T32-HD07505] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041083] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akar E, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<71::AID-HUMU8>3.0.CO;2-3; Aksentijevich I, 1999, AM J HUM GENET, V64, P949, DOI 10.1086/302327; Aksentijevich I, 1997, CELL, V90, P797; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bernot A, 1997, NAT GENET, V17, P25; Booth DR, 2000, QJM-INT J MED, V93, P217, DOI 10.1093/qjmed/93.4.217; Booth DR, 1998, QJM-INT J MED, V91, P603, DOI 10.1093/qjmed/91.9.603; Cazeneuve C, 1999, AM J HUM GENET, V65, P88, DOI 10.1086/302459; Chae JJ, 2000, MAMM GENOME, V11, P428, DOI 10.1007/s003350010082; DANIELS M, 1995, AM J MED GENET, V55, P311, DOI 10.1002/ajmg.1320550313; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Kastner DL, 1998, HOSP PRACT, V33, P131, DOI 10.3810/hp.1998.04.90; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; ROGERS DB, 1989, AM J MED GENET, V34, P168, DOI 10.1002/ajmg.1320340206; Stewart CB, 1998, CURR BIOL, V8, pR582, DOI 10.1016/S0960-9822(07)00367-3; Stoffman N, 2000, EUR J HUM GENET, V8, P307, DOI 10.1038/sj.ejhg.5200446; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tunca M, 1999, LANCET, V353, P1415, DOI 10.1016/S0140-6736(99)00990-3; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; YANG ZH, 1999, PAML PHYLOGENETIC AN; YUVAL Y, 1995, AM J MED GENET, V57, P455, DOI 10.1002/ajmg.1320570319	24	95	97	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					318	321		10.1038/85893	http://dx.doi.org/10.1038/85893			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242116				2022-12-27	WOS:000167304200026
J	Mavrogiannis, LA; Antonopoulou, I; Baxova, A; Kutilek, S; Kim, CA; Sugayama, SM; Salamanca, A; Wall, SA; Morriss-Kay, GM; Wilkie, AOM				Mavrogiannis, LA; Antonopoulou, I; Baxova, A; Kutilek, S; Kim, CA; Sugayama, SM; Salamanca, A; Wall, SA; Morriss-Kay, GM; Wilkie, AOM			Haploinsufficiency of the human homeobox gene ALX4 causes skull ossification defects	NATURE GENETICS			English	Article							FORAMINA PARIETALIA PERMAGNA; MULTIPLE EXOSTOSES; FAMILY; CLONING	Inherited defects of skull ossification often manifest as symmetric parietal foramina (PFM; MIM 168500). We previously identified mutations of MSX2 in non-syndromic PFM and demonstrated genetic heterogeneity(1). Deletions of 11p11-p12 (proximal 11p deletion syndrome, P11pDS; MIM 601224; ref. 2) are characterized by multiple exostoses, attributable to haploinsufficiency of EXT2 (refs. 3,4) and PFM. Here we identify ALX4, which encodes a paired-related homeodomain transcription factor, as the PFM disease gene in P11pDS.	John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England; Univ Oxford, Dept Human Anat & Genet, Oxford, England; Charles Univ, Fac Med 1, Dept Paediat, Prague, Czech Republic; Charles Univ, Fac Med 1, Dept Med Genet, Prague, Czech Republic; Univ Sao Paulo, Fac Med, Hosp Clin, Inst Crianca, Sao Paulo, Brazil; Univ Granada, Hosp Clin S Cecilio, Dept Obstet & Ginecol, Granada, Spain; Radcliffe Infirm, Craniofacial Unit, Oxford OX2 6HE, England; Dept Clin Genet, Oxford, England	University of Oxford; University of Oxford; Charles University Prague; Charles University Prague; Universidade de Sao Paulo; University of Granada; Radcliffe Infirmary	Wilkie, AOM (corresponding author), John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England.		Baxova, Alice/L-7197-2017; Wilkie, Andrew/AAC-3820-2020	Baxova, Alice/0000-0002-0651-0410; Wilkie, Andrew/0000-0002-2972-5481; Mavrogiannis, Lampros/0000-0002-2869-2067; Kim, Chong/0000-0002-1754-1300				Bartsch O, 1996, AM J HUM GENET, V58, P734; Hudson R, 1998, DEV DYNAM, V213, P159, DOI 10.1002/(SICI)1097-0177(199810)213:2<159::AID-AJA1>3.0.CO;2-F; Iseki S, 1999, DEVELOPMENT, V126, P5611; Kutilek S, 1997, J PAEDIATR CHILD H, V33, P168, DOI 10.1111/j.1440-1754.1997.tb01023.x; MCGAUGHRAN JM, 1995, J MED GENET, V32, P823, DOI 10.1136/jmg.32.10.823; Qu SM, 1997, DEVELOPMENT, V124, P3999; Qu SM, 1997, GENE, V203, P217, DOI 10.1016/S0378-1119(97)00497-6; Qu SM, 1998, DEVELOPMENT, V125, P2711; SALAMANCA A, 1994, PRENATAL DIAG, V14, P766, DOI 10.1002/pd.1970140820; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Takahashi M, 1998, DEVELOPMENT, V125, P4417; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Wu YQ, 2000, AM J HUM GENET, V67, P1327; Wuyts W, 1999, EUR J HUM GENET, V7, P579, DOI 10.1038/sj.ejhg.5200339; Wuyts W, 1996, HUM MOL GENET, V5, P1547, DOI 10.1093/hmg/5.10.1547	15	103	108	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					17	18		10.1038/83703	http://dx.doi.org/10.1038/83703			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137991				2022-12-27	WOS:000166187900008
J	Shemer, R; Hershko, AY; Perk, J; Mostoslavsky, R; Tsuberi, B; Cedar, H; Buiting, K; Razin, A				Shemer, R; Hershko, AY; Perk, J; Mostoslavsky, R; Tsuberi, B; Cedar, H; Buiting, K; Razin, A			The imprinting box of the Prader-Willi/Angelman syndrome domain	NATURE GENETICS			English	Article							IGF2R GENE; SNRPN GENE; METHYLATION; ANTISENSE; MUTATION; PATTERN; WILLI	A subset of mammalian genes is monoallelically expressed in a parent-of-origin manner. These genes are subject to an imprinting process that epigenetically marks alleles according to their parental origin during gametogenesis. Imprinted genes can be organized in clusters as exemplified by the 2-Mb domain on human chromosome 15q11-q13 and its mouse orthologue on chromosome 7c (ref. 1). Loss of this 2-Mb domain on the paternal or maternal allele results in two neurogenetic disorders, Prader-Willi syndrome (PWS) or Angelman syndrome (AS), respectively. Microdeletions on the paternal allele share a 4.3-kb short region of overlap (SRO), which includes the SNRPN promoter/exon1. cause PWS and silence paternally expressed genes(2). Microdeletions on the maternal allele share a 0.88-kb SRO located 35 kb upstream to the SNRPN promoter(3), cause AS and alleviate repression of genes on the maternal allele(4). Individuals carrying both AS and PWS deletions on the paternal allele show a PWS phenotype and genotype. These observations suggest that cis elements within the AS-SRO and PWS-SRO constitute an imprinting box that regulates the entire domain on both chromosomes. Here we show that a minitransgene composed of a 200-bp Snrpn promoter/exon1 and a 1-kb sequence located approximately 35 kb upstream to the SNRPN promoter confer imprinting as judged by differential methylation, parent-of-origin-specific transcription and asynchronous replication.	Hebrew Univ Jerusalem, Sch Med, Dept Cellular Biochem & Human Genet, IL-91010 Jerusalem, Israel; Univ Clin, Inst Human Genet, Essen, Germany	Hebrew University of Jerusalem; University of Duisburg Essen	Razin, A (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Cellular Biochem & Human Genet, IL-91010 Jerusalem, Israel.							Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; Blaydes SM, 1999, MAMM GENOME, V10, P549, DOI 10.1007/s003359901042; Buiting K, 1999, HUM GENET, V105, P665, DOI 10.1007/s004390051160; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; Ohta T, 1999, AM J HUM GENET, V64, P385, DOI 10.1086/302232; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	12	86	87	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					440	443		10.1038/82571	http://dx.doi.org/10.1038/82571			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101841				2022-12-27	WOS:000165671700016
J	Tsai, SC; Valkov, N; Yang, WM; Gump, J; Sullivan, D; Seto, E				Tsai, SC; Valkov, N; Yang, WM; Gump, J; Sullivan, D; Seto, E			Histone deacetylase interacts directly with DNA topoisomerase II	NATURE GENETICS			English	Article							TRANSCRIPTIONAL REPRESSION; ALPHA; BETA; GENE; PHOSPHORYLATION; PROLIFERATION; ACETYLATION; COMPLEX; INVIVO	Histone deacetylases (HDACs) modify nucleosomal histones, have a key role in the regulation of gene transcription(1,2), and may be involved in cell-cycle regulation, differentiation and human cancer(3,4). Purified recombinant human HDAC1 protein was used to screen a cDNA expression library, and one of the clones identified encoded DNA topoisomerase II (Topo II), an enzyme known to have a role in transcriptional regulation and chromatin organization(5,6). Coimmunoprecipitation experiments indicate that HDAC1 and HDAC2 are associated with Topo II in vivo under normal physiological conditions. Complexes containing Topo II possess HDAC activities, and complexes containing HDAC1 or HDAC2 possess Topo II activities. HDAC and Topo II modify each other's activity in vitro and in vivo. Our results indicate the existence of a functionally coupled complex between these two enzymes and offer insights into the potential mechanisms of action of both enzymes.	Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33620 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Seto, E (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33620 USA.			Yang, Wen-Ming/0000-0002-5871-5979	NIGMS NIH HHS [GM58486] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058486] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; BOEGE F, 1995, AM J PATHOL, V146, P1302; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hochhauser D, 1999, J CELL BIOCHEM, V75, P245; JENKINS JR, 1992, NUCLEIC ACIDS RES, V20, P5587, DOI 10.1093/nar/20.21.5587; Kimura K, 1996, J BIOL CHEM, V271, P21439, DOI 10.1074/jbc.271.35.21439; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; SULLIVAN DM, 1989, BIOCHEMISTRY-US, V28, P5680, DOI 10.1021/bi00439a051; SWEDLOW JR, 1993, CELL, V73, P97, DOI 10.1016/0092-8674(93)90163-K; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Valkov NI, 2000, BRIT J HAEMATOL, V108, P331; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Zhang BG, 1997, DYN CONTIN DISCRET I, V3, P89; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	28	130	132	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					349	353		10.1038/81671	http://dx.doi.org/10.1038/81671			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062478				2022-12-27	WOS:000165176500027
J	Inoue, K; Nakada, K; Ogura, A; Isobe, K; Goto, Y; Nonaka, I; Hayashi, JI				Inoue, K; Nakada, K; Ogura, A; Isobe, K; Goto, Y; Nonaka, I; Hayashi, JI			Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes	NATURE GENETICS			English	Article							TRANSMITOCHONDRIAL MICE; PROTEIN-SYNTHESIS; CELL LINES; DNA; DISEASE; MUTATION; MYOPATHY; CHLORAMPHENICOL; MICROINJECTION; HETEROPLASMY	Mice carrying mitochondrial DNA (mtDNA) with pathogenic mutations would provide a system in which to study how mutant mtDNAs are transmitted and distributed in tissues, resulting in expression of mitochondrial diseases. However, no effective procedures are available for the generation of these mice. Isolation of mouse cells without mtDNA (rho(0)) enabled us to trap mutant mtDNA that had accumulated in somatic tissues into rho(0) cells repopulated with mtDNA (cybrids). We isolated respiration-deficient cybrids with mtDNA carrying a deletion and introduced this mtDNA into fertilized eggs. The mutant mtDNA was transmitted maternally, and its accumulation induced mitochondrial dysfunction in various tissues. Moreover, most of these mice died because of venal failure, suggesting the involvement of mtDNA mutations in the pathogeneses of new diseases.	Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 305, Japan; Natl Inst Infect Dis, Dept Vet Sci, Tokyo, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan	University of Tsukuba; University of Tsukuba; National Institute of Infectious Diseases (NIID); National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Hayashi, JI (corresponding author), Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan.		Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988				BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CLAYTON DA, 1967, NATURE, V216, P652, DOI 10.1038/216652a0; DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43; HOLTZWORTHMUNROE A, 1988, CLIN PSYCHOL REV, V8, P331, DOI 10.1016/0272-7358(88)90095-5; Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446; Inoue K, 1997, J BIOL CHEM, V272, P15510, DOI 10.1074/jbc.272.24.15510; Irwin MH, 1999, TRANSGENIC RES, V8, P119, DOI 10.1023/A:1008925419758; Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099; Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955; Marchington DR, 1999, NAT MED, V5, P957, DOI 10.1038/11403; MIYABAYASHI S, 1984, BRAIN DEV-JPN, V6, P362, DOI 10.1016/S0387-7604(84)80112-6; NELSON I, 1993, MAMM GENOME, V4, P680, DOI 10.1007/BF00360907; Pinkert CA, 1997, TRANSGENIC RES, V6, P379, DOI 10.1023/A:1018431316831; POULTON J, 1989, LANCET, V1, P236; ROTIG A, 1992, AM J HUM GENET, V50, P364; Shitara H, 1998, GENETICS, V148, P851; SHITARA H, IN PRESS GENETICS; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181; Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028; TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769; VOLZLINGENHOHL A, 1992, P NATL ACAD SCI USA, V89, P11528, DOI 10.1073/pnas.89.23.11528; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Yamaoka M, 2000, GENETICS, V155, P301; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699	34	303	312	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					176	181		10.1038/82826	http://dx.doi.org/10.1038/82826			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017072				2022-12-27	WOS:000089638800013
J	Irizarry, K; Kustanovich, V; Li, C; Brown, N; Nelson, S; Wong, W; Lee, CJ				Irizarry, K; Kustanovich, V; Li, C; Brown, N; Nelson, S; Wong, W; Lee, CJ			Genome-wide analysis of single-nucleotide polymorphisms in human expressed sequences	NATURE GENETICS			English	Letter							HUMAN GENES; SNPS; IDENTIFICATION; DISCOVERY; DIVERSITY; MAP; DNA	Single-nucleotide polymorphisms (SNPs) have been explored as a high-resolution marker set for accelerating the mapping of disease genes(1-11). Here we report 48,196 candidate SNPs detected by statistical analysis of human expressed sequence tags (ESTs). associated primarily with coding regions of genes. We used Bayesian inference to weigh evidence for true polymorphism versus sequencing error, misalignment or ambiguity, misclustering or chimaeric EST sequences, assessing data such as raw chromatogram height, sharpness, overlap and spacing, sequencing error rates, context-sensitivity and cDNA library origin. Three separate validation-comparison with 54 genes screened for SNPs independently, verification of HLA-A polymorphisms and restriction fragment length polymorphism (RFLP) testing-verified 70%, 89% and 71% of our predicted SNPs, respectively. Our method detects tenfold more true HLA-A SNPs than previous analyses of the EST data. We found SNPs in a large fraction of known disease genes, including some disease-causing mutations (for example, the HbS sickle-cell mutation). Our comprehensive analysis of human coding region polymorphism provides a public resource for mapping of disease genes (available at http://www.bioinformatics.ucla.edu/snp).	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Grad Program Comp Sci, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lee, CJ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.		Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008375] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08375, GM07104] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUR EW, 1965, HUMANGENETIK, V1, P621; BOGUSKI MS, 1994, SCIENCE, V265, P1993, DOI 10.1126/science.8091218; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; INGRAM VM, 1959, BIOCHIM BIOPHYS ACTA, V36, P402, DOI 10.1016/0006-3002(59)90183-0; Jackson AL, 1998, GENETICS, V148, P1483; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; LI WH, 1991, GENETICS, V129, P513; MAEDA M, 1989, TISSUE ANTIGENS, V34, P290, DOI 10.1111/j.1399-0039.1989.tb01745.x; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Masood E, 1999, NATURE, V398, P545, DOI 10.1038/19126; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Pennisi E, 1998, SCIENCE, V281, P1787, DOI 10.1126/science.281.5384.1787; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schuler GD, 1997, J MOL MED, V75, P694, DOI 10.1007/s001090050155; Taillon-Miller P, 1998, GENOME RES, V8, P748, DOI 10.1101/gr.8.7.748; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	22	117	123	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					233	236		10.1038/79981	http://dx.doi.org/10.1038/79981			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017085				2022-12-27	WOS:000089638800026
J	Tillier, ERM; Collins, RA				Tillier, ERM; Collins, RA			Genome rearrangement by replication-directed translocation	NATURE GENETICS			English	Article							PATHOGEN HELICOBACTER-PYLORI; ESCHERICHIA-COLI CHROMOSOME; BACTERIAL GENOMES; SEQUENCE; DNA; ORGANIZATION; TRACHOMATIS; EVOLUTION	Gene order in bacteria is poorly conserved during evolution(1-3). For example, although many homologous genes are shared by the proteobacteria Escherichia coli. Haemophilus influenzae and Helicobacter pylori. their relative positions are very different in each genome, except local functional clusters such as operons(3-6). The complete sequences of the more closely related bacterial genomes, such as pairs of Chlamydia(7-9), H. pylori(10,11) and Mycobacterium species(12), now allow identification of the processes and mechanisms involved in genome evolution. Here we provide evidence that a substantial proportion of rearrangements in gene order results from recombination sites that are determined by the positions of the replication forks. Our observations suggest that replication has a major role in directing genome evolution.	Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada	University of Toronto	Tillier, ERM (corresponding author), Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada.	e.tillier@utoronto.ca		Tillier, Elisabeth/0000-0003-2194-9058				Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Bierne H, 1997, EMBO J, V16, P3332, DOI 10.1093/emboj/16.11.3332; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; CARO LG, 1968, COLD SPRING HARB SYM, V33, P559, DOI 10.1101/SQB.1968.033.01.063; Casjens S, 1998, ANNU REV GENET, V32, P339, DOI 10.1146/annurev.genet.32.1.339; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; IKEDA H, 1980, COLD SPRING HARB SYM, V45, P399; Itaya M, 1997, MICROBIOL-UK, V143, P3723, DOI 10.1099/00221287-143-12-3723; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kolsto AB, 1997, MOL MICROBIOL, V24, P241, DOI 10.1046/j.1365-2958.1997.3501715.x; Kuzminov A, 1999, GENE DEV, V13, P345, DOI 10.1101/gad.13.3.345; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; LIU SL, 1995, P NATL ACAD SCI USA, V92, P1018, DOI 10.1073/pnas.92.4.1018; Lobry JR, 1996, SCIENCE, V272, P745, DOI 10.1126/science.272.5262.745; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Mushegian AR, 1996, TRENDS GENET, V12, P289, DOI 10.1016/0168-9525(96)20006-X; Newport J, 1996, CURR OPIN CELL BIOL, V8, P365, DOI 10.1016/S0955-0674(96)80011-1; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; REBOLLO JE, 1988, P NATL ACAD SCI USA, V85, P9391, DOI 10.1073/pnas.85.24.9391; SCHMID MB, 1987, J BACTERIOL, V169, P2872, DOI 10.1128/jb.169.6.2872-2875.1987; SHAPIRO JA, 1979, P NATL ACAD SCI USA, V76, P1933, DOI 10.1073/pnas.76.4.1933; SHMID MB, 1983, GENETICS, V105, P539; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Tamames J, 1997, J MOL EVOL, V44, P66, DOI 10.1007/PL00006122; Tatusov RL, 1996, CURR BIOL, V6, P279, DOI 10.1016/S0960-9822(02)00478-5; Tillier ERM, 2000, J MOL EVOL, V50, P249, DOI 10.1007/s002399910029; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483	30	156	158	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2000	26	2					195	197		10.1038/79918	http://dx.doi.org/10.1038/79918			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017076				2022-12-27	WOS:000089638800017
J	Kong, A; Gudbjartsson, DF; Sainz, J; Jonsdottir, GM; Gudjonsson, SA; Richardsson, B; Sigurdardottir, S; Barnard, J; Hallbeck, B; Masson, G; Shlien, A; Palsson, ST; Frigge, ML; Thorgeirsson, TE; Gulcher, JR; Stefansson, K				Kong, A; Gudbjartsson, DF; Sainz, J; Jonsdottir, GM; Gudjonsson, SA; Richardsson, B; Sigurdardottir, S; Barnard, J; Hallbeck, B; Masson, G; Shlien, A; Palsson, ST; Frigge, ML; Thorgeirsson, TE; Gulcher, JR; Stefansson, K			A high-resolution recombination map of the human genome	NATURE GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; TETRANUCLEOTIDE-REPEAT MARKERS; PHYSICAL MAPS; SEQUENCE; GENE; TRINUCLEOTIDE; POLYMORPHISMS; INTEGRATION; COLLECTION	Determination of recombination rates across the human genome has been constrained by the limited resolution and accuracy of existing genetic maps and the draft genome sequence. We have genotyped 5,136 microsatellite markers for 146 families, with a total of 1,257 meiotic events, to build a high-resolution genetic map meant to: (i) improve the genetic order of polymorphic markers; (ii) improve the precision of estimates of genetic distances; (iii) correct portions of the sequence assembly and SNP map of the human genome; and (iv) build a map of recombination rates. Recombination rates are significantly correlated with both cytogenetic structures (staining intensity of G bands) and sequence (GC content, CpG motifs and poly(A)/poly(T) stretches). Maternal and paternal chromosomes show many differences in locations of recombination maxima. We detected systematic differences in recombination rates between mothers and between gametes from the same mother, suggesting that there is some underlying component determined by both genetic and environmental factors that affects maternal recombination rates.	deCODE Genet, IS-101 Reykjavik, Iceland		Kong, A (corresponding author), deCODE Genet, Sturlugotu 8, IS-101 Reykjavik, Iceland.	kong@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019	Gudbjartsson, Daniel/0000-0002-5222-9857; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Kong, Augustine/0000-0001-8193-5438				ADAMSON D, 1995, AM J HUM GENET, V57, P619; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Daw EW, 2000, GENET EPIDEMIOL, V19, P366, DOI 10.1002/1098-2272(200012)19:4<366::AID-GEPI8>3.0.CO;2-F; DEMPSTER AP, 1997, J ROYAL STAT SOC B, V39, P1; DeWan AT, 2002, AM J HUM GENET, V70, P101, DOI 10.1086/324774; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Halpern J, 1999, HUM HERED, V49, P194, DOI 10.1159/000022874; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Ji YF, 1999, GENETICS, V151, P821; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; Mohrenweiser HW, 1998, GENOMICS, V47, P153, DOI 10.1006/geno.1997.5097; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Rosenberg M, 1997, GENOME RES, V7, P917, DOI 10.1101/gr.7.9.917; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Sunden SLF, 1996, GENOMICS, V32, P15, DOI 10.1006/geno.1996.0071; THOMPSON EA, 1987, IMA J MATH APPL MED, V4, P93; Venables W.N., 2013, MODERN APPL STAT S; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	26	1333	1368	0	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2002	31	3					241	247		10.1038/ng917	http://dx.doi.org/10.1038/ng917			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12053178				2022-12-27	WOS:000176494100010
J	Pharoah, PDP; Antoniou, A; Bobrow, M; Zimmern, RL; Easton, DF; Ponder, BAJ				Pharoah, PDP; Antoniou, A; Bobrow, M; Zimmern, RL; Easton, DF; Ponder, BAJ			Polygenic susceptibility to breast cancer and implications for prevention	NATURE GENETICS			English	Article							RISK; FAMILY; BRCA1; WOMEN; TWINS	The knowledge of human genetic variation that will come from the human genome sequence makes feasible a polygenic approach to disease prevention, in which it will be possible to identify individuals as susceptible by their genotype profile and to prevent disease by targeting interventions to those at risk. There is doubt, however, regarding the magnitude of these genetic effects and thus the potential to apply them to either individuals or populations. We have therefore examined the potential for prediction of risk based on common genetic variation using data from a population-based series of individuals with breast cancer. The data are compatible with a log-normal distribution of genetic risk in the population that is sufficiently wide to provide useful discrimination of high- and low-risk groups. Assuming all of the susceptibility genes could be identified, the half of the population at highest risk would account for 88% of all affected individuals. By contrast, if currently identified risk factors for breast cancer were used to stratify the population, the half of the population at highest risk would account for only 62% of all cases. These results suggest that the construction and use of genetic-risk profiles may provide significant improvements in the efficacy of population-based programs of intervention for cancers and other diseases.	Strangeways Res Labs, Dept Oncol, Canc Res UK Human Canc Genet Grp, Cambridge CB1 8RN, England; Strangeways Res Labs, Publ Hlth Genet Unit, Cambridge CB1 8RN, England; Strangeways Res Labs, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; Addenbrookes Hosp, Dept Clin Genet, Cambridge CB1 2QQ, England	Cancer Research UK; Cancer Research UK; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Pharoah, PDP (corresponding author), Strangeways Res Labs, Dept Oncol, Canc Res UK Human Canc Genet Grp, Cambridge CB1 8RN, England.	paul.pharoah@srl.cam.ac.uk	Pharoah, Paul/V-6658-2019	Pharoah, Paul/0000-0001-8494-732X				Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; ANTONIOU AC, 2001, IN PRESS BR J CANC; Beaudet AL, 1999, AM J HUM GENET, V64, P1, DOI 10.1086/302217; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; Friend SH, 1999, BRIT MED J, V319, P1306, DOI 10.1136/bmj.319.7220.1306; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; Pharoah PDP, 1998, BREAST, V7, P255, DOI 10.1016/S0960-9776(98)90091-1; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Vaittinen P, 2000, INT J CANCER, V88, P998, DOI 10.1002/1097-0215(20001215)88:6<998::AID-IJC25>3.0.CO;2-0; Vineis P, 2001, LANCET, V357, P709, DOI 10.1016/S0140-6736(00)04136-2	20	596	614	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					33	36		10.1038/ng853	http://dx.doi.org/10.1038/ng853			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11984562	Bronze			2022-12-27	WOS:000175362500011
J	Al-Tassan, N; Chmiel, NH; Maynard, J; Fleming, N; Livingston, AL; Williams, GT; Hodges, AK; Davies, DR; David, SS; Sampson, JR; Cheadle, JR				Al-Tassan, N; Chmiel, NH; Maynard, J; Fleming, N; Livingston, AL; Williams, GT; Hodges, AK; Davies, DR; David, SS; Sampson, JR; Cheadle, JR			Inherited variants of MYH associated with somatic G : C -> T : A mutations in colorectal tumors	NATURE GENETICS			English	Article							ESCHERICHIA-COLI MUTY; DNA-SYNTHESIS; GENE; REPAIR; ENZYME; IDENTIFICATION; EXPRESSION; SUBSTRATE; CLONING; 8-HYDROXYGUANINE	Inherited defects of base excision repair have not been associated with any human genetic disorder, although mutations of the genes mutM and mutY, which function in Escherichia coli base excision repair, lead to increased transversions of G:C to T:A(1-4). We have studied family N, which is affected with multiple colorectal adenomas and carcinoma but lacks an inherited mutation of the adenomatous polyposis coli gene (APC) that is associated with familial adenomatous polyposis(5). Here we show that 11 tumors from 3 affected siblings contain 18 somatic inactivating mutations of APC and that 15 of these mutations are G:C-->T:A transversions-a significantly greater proportion than is found in sporadic tumors or in tumors associated with familial adenomatous polyposis. Analysis of the human homolog of mutY, MYH6, showed that the siblings were compound heterozygotes for the nonconservative missense variants Tyr165Cys and Gly382Asp. These mutations affect residues that are conserved in mutY of E. coli (Tyr82 and Gly253). Tyrosine 82 is located in the pseudo-helix-hairpin-helix (HhH) motif and is predicted to function in mismatch specificity(7). Assays of adenine glycosylase activity of the Tyr82Cys and Gly253Asp mutant proteins with 8-oxoG:A and G:A substrates show that their activity is reduced significantly. Our findings link the inherited variants in MYH to the pattern of somatic APC mutation in family N and implicate defective base excision repair in predisposition to tumors in humans.	Univ Wales Coll Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; Univ Wales Coll Med, Dept Pathol, Cardiff CF14 4XN, S Glam, Wales; Univ Wales Hosp, Dept Gastroenterol, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Utah System of Higher Education; University of Utah; Cardiff University; Cardiff University	Sampson, JR (corresponding author), Univ Wales Coll Med, Inst Med Genet, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.		Hodges, Angela/C-5676-2011; Tassan, Nada Al/K-5605-2019	Tassan, Nada Al/0000-0001-9076-0334; Hodges, Angela/0000-0002-5565-6678				AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Beroud C, 1996, NUCLEIC ACIDS RES, V24, P121, DOI 10.1093/nar/24.1.121; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Chmiel NH, 2001, NUCLEIC ACIDS RES, V29, P553, DOI 10.1093/nar/29.2.553; Dietmaier W, 1997, CANCER RES, V57, P4749; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Ishioka C, 1997, P NATL ACAD SCI USA, V94, P2449, DOI 10.1073/pnas.94.6.2449; Jones AC, 2000, HUM GENET, V106, P663, DOI 10.1007/s004390050040; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LU AL, 1995, J BIOL CHEM, V270, P23582, DOI 10.1074/jbc.270.40.23582; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MORIYA M, 1993, MOL GEN GENET, V239, P72, DOI 10.1007/BF00281603; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Porello SL, 1996, J AM CHEM SOC, V118, P10684, DOI 10.1021/ja9602206; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Slupska MM, 1996, J BACTERIOL, V178, P3885, DOI 10.1128/jb.178.13.3885-3892.1996; SULEKOVA Z, 1995, HUM GENET, V96, P469, DOI 10.1007/BF00191808; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405	29	982	1014	1	44	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					227	232		10.1038/ng828	http://dx.doi.org/10.1038/ng828			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11818965				2022-12-27	WOS:000173708700027
J	Dahlman, I; Eaves, IA; Kosoy, R; Morrison, VA; Heward, J; Gough, SCL; Allahabadia, A; Franklyn, JA; Tuomilehto, J; Tuomilehto-Wolf, E; Cucca, F; Guja, C; Ionescu-Tirgoviste, C; Stevens, H; Carr, P; Nutland, S; McKinney, P; Shield, JP; Wang, W; Cordell, HJ; Walker, N; Todd, JA; Concannon, P				Dahlman, I; Eaves, IA; Kosoy, R; Morrison, VA; Heward, J; Gough, SCL; Allahabadia, A; Franklyn, JA; Tuomilehto, J; Tuomilehto-Wolf, E; Cucca, F; Guja, C; Ionescu-Tirgoviste, C; Stevens, H; Carr, P; Nutland, S; McKinney, P; Shield, JP; Wang, W; Cordell, HJ; Walker, N; Todd, JA; Concannon, P			Parameters for reliable results in genetic association studies in common disease	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY; REGION	It is increasingly apparent that the identification of true genetic associations in common multifactorial disease will require studies comprising thousands rather than the hundreds of individuals employed to date. Using 2,873 families, we were unable to confirm a recently published association of the interleukin 12B gene in 422 type I diabetic families. These results emphasize the need for large datasets, small P values and independent replication if results are to be reliable.	Univ Cambridge, Cambridge Inst Med Res, JDRF WF Diabet & Inflammat Lab, Cambridge CB2 2XY, England; Univ Washington, Sch Med, Virginia Mason Res Ctr, Mol Genet Program, Seattle, WA USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA; Univ Birmingham, Birmingham Heartlands Hosp, Div Med Sci, Birmingham B9 5SS, W Midlands, England; Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B9 5SS, W Midlands, England; Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki 00300, Finland; Univ Cagliari, Dipartimento Sci Biobediche & Biotecnol, Cagliari, Italy; Inst Diabet Nutr & Metab Dis N Paulescu, Diabet Clin, Bucharest, Romania; Paediat Epidemiol Grp, Unit Epidemiol & HSR, Leeds, W Yorkshire, England; Univ Bristol, Royal Hosp Sick Children, Inst Child Hlth, Bristol, Avon, England	University of Cambridge; University of Washington; University of Washington Seattle; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; Heart of England NHS Foundation Trust; University of Birmingham; University of Birmingham; Finland National Institute for Health & Welfare; University of Helsinki; University of Cagliari; University of Leeds; Bristol Royal Hospital For Children; University of Bristol	Todd, JA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, JDRF WF Diabet & Inflammat Lab, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	john.todd@cimr.cam.ac.uk	Wang, William/E-7862-2013; Todd, John A/A-3542-2010; Guja, Cristian/K-2334-2019; Shield, Julian PH/D-6297-2014	Wang, William/0000-0002-5369-5446; Todd, John A/0000-0003-2740-8148; Shield, Julian PH/0000-0003-2601-7575; Concannon, Patrick/0000-0002-5801-1859; Cordell, Heather/0000-0002-1879-5572; CUCCA, Francesco/0000-0002-7414-1995; Dahlman, Ingrid/0000-0003-3819-5977; Walker, Neil/0000-0001-9796-7688				Adorini L, 2001, NAT GENET, V27, P131, DOI 10.1038/84732; Allahabadia A, 2001, LANCET, V358, P984, DOI 10.1016/S0140-6736(01)06125-6; BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Cox NJ, 2001, AM J HUM GENET, V69, P820, DOI 10.1086/323501; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Huang D, 2000, GENES IMMUN, V1, P515, DOI 10.1038/sj.gene.6363720; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; 1999, NATURE GENET, V22, P1	13	181	185	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					149	150		10.1038/ng825	http://dx.doi.org/10.1038/ng825			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11799396				2022-12-27	WOS:000173708700013
J	Fisher, SE; Francks, C; Marlow, AJ; MacPhie, IL; Newbury, DF; Cardon, LR; Ishikawa-Brush, Y; Richardson, AJ; Talcott, JB; Gayan, J; Olson, RK; Pennington, BF; Smith, SD; DeFries, JC; Stein, JF; Monaco, AP				Fisher, SE; Francks, C; Marlow, AJ; MacPhie, IL; Newbury, DF; Cardon, LR; Ishikawa-Brush, Y; Richardson, AJ; Talcott, JB; Gayan, J; Olson, RK; Pennington, BF; Smith, SD; DeFries, JC; Stein, JF; Monaco, AP			Independent genome-wide scans identify a chromosome 18 quantitative-trait locus influencing dyslexia	NATURE GENETICS			English	Article							READING-DISABILITY; DEVELOPMENTAL DYSLEXIA; SPELLING DISABILITY; LARGE-SAMPLE; LINKAGE; COMPONENTS; GENE	Developmental dyslexia is defined as a specific and significant impairment in reading ability that cannot be explained by deficits in intelligence, learning opportunity, motivation or sensory acuity. It is one of the most frequently diagnosed disorders in childhood, representing a major educational and social problem(1). It is well established that dyslexia is a significantly heritable trait(2) with a neurobiological basis(3). The etiological mechanisms remain elusive, however, despite being the focus of intensive multidisciplinary research(3). All attempts to map quantitative-trait loci (QTLs) influencing dyslexia susceptibility have targeted specific chromosomal regions, so that inferences regarding genetic etiology have been made on the basis of very limited information(4). Here we present the first two complete QTL-based genome-wide scans for this trait, in large samples of families from the United Kingdom and United States. Using single-point analysis, linkage to marker D18S53 was independently identified as being one of the most significant results of the genome in each scan (Pless than or equal to0.0004 for single word-reading ability in each family sample). Multipoint analysis gave increased evidence of 18p11.2 linkage for single-word reading, yielding top empirical P values of 0.00001 (UK) and 0,0004 (US). Measures related to phonological and orthographic processing also showed linkage at this locus. We replicated linkage to 18p11.2 in a third independent sample of families (from the UK), in which the strongest evidence came from a phoneme-awareness measure (most significant P value=0.00004). A combined analysis of all UK families confirmed that this newly discovered 18p QTL is probably a general risk factor for dyslexia, influencing several reading-related processes. This is the first report of QTL-based genome-wide scanning for a human cognitive trait.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Dept Physiol, Oxford OX1 3PT, England; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; Univ Denver, Dept Psychol, Denver, CO 80208 USA; Univ Nebraska, Med Ctr, Ctr Human Mol Genet, Omaha, NE 68198 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Colorado System; University of Colorado Boulder; University of Denver; University of Nebraska System; University of Nebraska Medical Center	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	anthony.monaco@well.ox.ac.uk	Monaco, Anthony P/A-4495-2010; Francks, Clyde/AGU-8875-2022; Francks, Clyde/E-1384-2012; Fisher, Simon E./E-9130-2012	Monaco, Anthony P/0000-0001-7480-3197; Francks, Clyde/0000-0002-9098-890X; Fisher, Simon E./0000-0002-3132-1996; Richardson, Alex/0000-0001-5650-4409				Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; AMOS CI, 1994, AM J HUM GENET, V54, P535; BROWN BS, 1978, DYSLEXIA APPRAISAL C, pR5; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; DEFRIES JC, 1987, NATURE, V329, P537, DOI 10.1038/329537a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Fagerheim T, 1999, J MED GENET, V36, P664; Field LL, 1998, AM J HUM GENET, V63, P1448, DOI 10.1086/302107; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 1999, EUR CHILD ADOLES PSY, V8, P47; FISHER SE, 2001, DYSLEXIA THEORY GOOD, P39; Flannery KA, 2000, J INT NEUROPSYCH SOC, V6, P433, DOI 10.1017/S1355617700644016; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Gayan J, 2001, DEV NEUROPSYCHOL, V20, P483, DOI 10.1207/S15326942DN2002_3; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lessem JL, 2001, BIOINFORMATICS, V17, P371, DOI 10.1093/bioinformatics/17.4.371; Marlow AJ, 2001, BEHAV GENET, V31, P219, DOI 10.1023/A:1010209629021; Morris DW, 2000, HUM MOL GENET, V9, P843, DOI 10.1093/hmg/9.5.843; OLSON RK, 1994, VARIETIES ORTHOGRAPH, V1, P27; Pennington BF, 1997, AM J HUM GENET, V60, P13; Posner M.I., 1999, CONVERGING METHODS U; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Schulte-Korne G, 1998, AM J HUM GENET, V63, P279, DOI 10.1086/301919	28	200	208	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					86	91		10.1038/ng792	http://dx.doi.org/10.1038/ng792			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743577	Green Published			2022-12-27	WOS:000173105600019
J	Modrek, B; Lee, C				Modrek, B; Lee, C			A genomic view of alternative splicing	NATURE GENETICS			English	Editorial Material							PRE-MESSENGER-RNA; HUMAN GENES; SEQUENCE; DATABASE; INTRONS; CONSEQUENCES; INFORMATION; ELEGANS; VARIANT	Recent genome-wide analyses of alternative splicing indicate that 40-60% of human genes have alternative splice forms, suggesting that alternative splicing is one of the most significant components of the functional complexity of the human genome. Here we review these recent results from bioinformatics studies, assess their reliability and consider the impact of alternative splicing on biological functions. Although the 'big picture' of alternative splicing that is emerging from genomics is exciting, there are many challenges. High-throughput experimental verification of alternative splice forms, functional characterization, and regulation of alternative splicing are key directions for research. We recommend a community-based effort to discover and characterize alternative splice forms comprehensively throughout the human genome.	Univ Calif Los Angeles, Dept Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lee, C (corresponding author), Univ Calif Los Angeles, Dept Chem, Los Angeles, CA 90095 USA.	leec@mbi.ucla.edu						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Brudno M, 2001, NUCLEIC ACIDS RES, V29, P2338, DOI 10.1093/nar/29.11.2338; Burke J, 1998, GENOME RES, V8, P276, DOI 10.1101/gr.8.3.276; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Dralyuk I, 2000, NUCLEIC ACIDS RES, V28, P296, DOI 10.1093/nar/28.1.296; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hedjran F, 1997, P NATL ACAD SCI USA, V94, P12343, DOI 10.1073/pnas.94.23.12343; Hu GK, 2001, GENOME RES, V11, P1237, DOI 10.1101/gr.165501; HUH GS, 1994, GENE DEV, V8, P1561, DOI 10.1101/gad.8.13.1561; Ji HK, 2001, NUCLEIC ACIDS RES, V29, P260, DOI 10.1093/nar/29.1.260; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Kawamoto S, 1996, J BIOL CHEM, V271, P17613; Kent WJ, 2000, NUCLEIC ACIDS RES, V28, P91, DOI 10.1093/nar/28.1.91; Kent WJ, 2000, GENOME RES, V10, P1115, DOI 10.1101/gr.10.8.1115; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; MODAFFERI EF, 1997, MOL CELL BIOL, V17, P537; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Pennisi E, 2000, SCIENCE, V288, P1146, DOI 10.1126/science.288.5469.1146; ROSENFELD MG, 1982, P NATL ACAD SCI-BIOL, V79, P1717, DOI 10.1073/pnas.79.6.1717; SAMBROOK J, 1977, NATURE, V268, P101, DOI 10.1038/268101a0; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; STAMM S, 1994, NUCLEIC ACIDS RES, V22, P1515, DOI 10.1093/nar/22.9.1515; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10	39	998	1074	7	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					13	19		10.1038/ng0102-13	http://dx.doi.org/10.1038/ng0102-13			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11753382				2022-12-27	WOS:000173105600005
J	Barcellos, LF; Caillier, S; Dragone, L; Elder, M; Vittinghoff, E; Bucher, P; Lincoln, RR; Pericak-Vance, M; Haines, JL; Weiss, A; Hauser, SL; Oksenberg, JR				Barcellos, LF; Caillier, S; Dragone, L; Elder, M; Vittinghoff, E; Bucher, P; Lincoln, RR; Pericak-Vance, M; Haines, JL; Weiss, A; Hauser, SL; Oksenberg, JR			PTPRC (CD45) is not associated with the development of multiple sclerosis in US patients	NATURE GENETICS			English	Article							POLYMORPHISM; MUTATION; LINKAGE	A C-->G nucleotide transition in exon 4 of PTPRC (encoding protein-tyrosine phosphatase receptor-type C, also known as CD45) was recently reported to be genetically associated with the development of multiple sclerosis (MS)(1). We performed an extensive evaluation of this polymorphism using large family-based and case-control comparisons. Overall, we observed no evidence of genetic association between the PTPRC polymorphism and MS susceptibility or disease course.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Duke Univ, Med Ctr, Dept Med, Ctr Human Genet, Durham, NC USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Program Human Genet, Nashville, TN 37232 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Duke University; Vanderbilt University	Oksenberg, JR (corresponding author), Univ Calif San Francisco, Dept Neurol, 513 Parnassus Ave, San Francisco, CA 94143 USA.		Hauser, Stephen L/J-2978-2016; Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, R01NS032830] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32830, NS26799] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARCELLOS LF, IN PRESS BRAIN; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; GOODKIN DE, 1991, ARCH NEUROL-CHICAGO, V48, P805, DOI 10.1001/archneur.1991.00530200041016; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Liao HX, 2000, J IMMUNOL, V165, P148, DOI 10.4049/jimmunol.165.1.148; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; Oksenberg JR, 2001, J NEUROIMMUNOL, V113, P171, DOI 10.1016/S0165-5728(00)00444-6; Templeton AR, 2000, GENETICS, V156, P1259	9	54	54	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					23	24		10.1038/ng722	http://dx.doi.org/10.1038/ng722			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528386				2022-12-27	WOS:000170781300011
J	Zimprich, A; Grabowski, M; Asmus, F; Naumann, M; Berg, D; Bertram, M; Scheidtmann, K; Kern, P; Winkelmann, F; Muller-Myhsok, B; Riedel, L; Bauer, M; Muller, T; Castro, M; Meitinger, T; Strom, TM; Gasser, T				Zimprich, A; Grabowski, M; Asmus, F; Naumann, M; Berg, D; Bertram, M; Scheidtmann, K; Kern, P; Winkelmann, F; Muller-Myhsok, B; Riedel, L; Bauer, M; Muller, T; Castro, M; Meitinger, T; Strom, TM; Gasser, T			Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome	NATURE GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; HEREDITARY ESSENTIAL MYOCLONUS; ONSET TORSION DYSTONIA; D2 DOPAMINE-RECEPTOR; ALPHA-SARCOGLYCAN; COMPLEX; FAMILY; 2D	The dystonias are a common clinically and genetically heterogeneous group of movement disorders. More than ten loci for inherited forms of dystonia have been mapped, but only three mutated genes have been identified so far. These are DYT1, encoding torsin A(1) and mutant in the early-onset generalized form, GCH1 (formerly known as DYT5), encoding GTP-cyclohydrolase I and mutant in dominant dopa-responsive dystonia(2), and TH, encoding tyrosine hydroxylase and mutant in the recessive form of the disease(3). Myoclonus-dystonia syndrome (MDS; DYT11) is an autosomal dominant disorder characterized by bilateral, alcohol-sensitive myoclonic jerks involving mainly the arms and axial muscles(4,5). Dystonia, usually torticollis and/or writer's cramp, occurs in most but not all affected patients and may occasionally be the only symptom of the disease(6,7). In addition, patients often show prominent psychiatric abnormalities, including panic attacks and obsessive-compulsive behavior(8-10). In most MDS families, the disease is linked to a locus on chromosome 7q21 (refs. 11-13). Using a positional cloning approach, we have identified five different heterozygous loss-of-function mutations in the gene for epsilon -sarcoglycan (SGCE), which we mapped to a refined critical region of about 3.2 Mb. SGCE is expressed in all brain regions examined. Pedigree analysis shows a marked difference in penetrance depending on the parental origin of the disease allele, This is indicative of a maternal imprinting mechanism, which has been demonstrated in the mouse epsilon -sarcoglycan gene(14).	Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; GSF Munich, Natl Res Ctr, Inst Human Genet, Munich, Germany; Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; Heidelberg Univ, Dept Neurol, D-6900 Heidelberg, Germany; Neurol Hosp, Bad Aibling, Germany; Klinikum Buch, Dept Neurol, Berlin, Germany; Inst Psychiat, Dept Neurol, Munich, Germany; Bernhard Nocht Inst Trop Med, Hamburg, Germany; LionBiosci AG, Heidelberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Wurzburg; Ruprecht Karls University Heidelberg; Bernhard Nocht Institut fur Tropenmedizin	Gasser, T (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany.	tgasser@brain.nefo.med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013; Gasser, Thomas/GNH-5293-2022; Zimprich, Alexander/A-5232-2017; Berg, Daniela/A-8728-2019; Meitinger, Thomas/O-1318-2015	Gasser, Thomas/0000-0002-1069-1146; Zimprich, Alexander/0000-0002-1668-5177; Berg, Daniela/0000-0001-5796-5442; Meitinger, Thomas/0000-0002-8838-8403; Castro, Mirna/0000-0002-3452-9215; Winkelmann, Juliane/0000-0003-2667-9691; Bauer, Michaela/0000-0001-8717-3278				Asmus F, 2001, ANN NEUROL, V49, P121, DOI 10.1002/1531-8249(200101)49:1<121::AID-ANA20>3.0.CO;2-8; DOHENY D, 2000, MOVEMENT DISORD, V15, pS162; Durr A, 2000, ANN NEUROL, V48, P127; Ettinger AJ, 1997, J BIOL CHEM, V272, P32534, DOI 10.1074/jbc.272.51.32534; FAHN S, 1991, MOVEMENT DISORD, V6, P237, DOI 10.1002/mds.870060308; Gasser T, 1998, Adv Neurol, V78, P325; Gasser T, 1996, MOVEMENT DISORD, V11, P363, DOI 10.1002/mds.870110403; Grimes DA, 2001, MOVEMENT DISORD, V16, P106, DOI 10.1002/1531-8257(200101)16:1<106::AID-MDS1022>3.0.CO;2-7; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Imamura M, 2000, HUM MOL GENET, V9, P3091, DOI 10.1093/hmg/9.20.3091; Klein C, 2000, AM J HUM GENET, V67, P1314; Klein C, 1999, P NATL ACAD SCI USA, V96, P5173, DOI 10.1073/pnas.96.9.5173; Kurlan R, 1988, Adv Neurol, V50, P385; KURLAN R, 1987, MOVEMENT DISORD, V2, P301, DOI 10.1002/mds.870020407; KYLLERMAN M, 1990, MOVEMENT DISORD, V5, P270, DOI 10.1002/mds.870050403; Lim LE, 1998, CURR OPIN NEUROL, V11, P443, DOI 10.1097/00019052-199810000-00006; LUDECKE B, 1995, HUM GENET, V95, P123; LUNDEMO G, 1985, ACTA NEUROL SCAND, V72, P176; McNally EM, 1998, FEBS LETT, V422, P27, DOI 10.1016/S0014-5793(97)01593-7; Nygaard TG, 1999, ANN NEUROL, V46, P794, DOI 10.1002/1531-8249(199911)46:5<794::AID-ANA19>3.0.CO;2-2; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Quinn N P, 1988, Adv Neurol, V50, P391; Scheidtmann K, 2000, NERVENARZT, V71, P839, DOI 10.1007/s001150050673; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Straub V, 1999, J BIOL CHEM, V274, P27989, DOI 10.1074/jbc.274.39.27989	27	331	346	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2001	29	1					66	69		10.1038/ng709	http://dx.doi.org/10.1038/ng709			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528394				2022-12-27	WOS:000170781300019
J	Fukamachi, S; Shimada, A; Shima, A				Fukamachi, S; Shimada, A; Shima, A			Mutations in the gene encoding B, a novel transporter protein, reduce melanin content in medaka	NATURE GENETICS			English	Article							GERM-CELL MUTAGENESIS; ORYZIAS-LATIPES; JAPANESE MEDAKA; TEST SYSTEM; RECEPTOR; DELETION; NEURONS; MODEL; FISH	Pigmentation of the skin is of great social, clinical and cosmetic significance. Several genes that, when mutated, give rise to altered coat color in mice have been identified; their analysis(1-6) has provided some insight into melanogenesis and human pigmentation diseases. Such analyses do not, however, fully inform on the pigmentation of lower vertebrates because mammals have only one kind of chromatophore, the melanocyte. In contrast, the medaka (a small, freshwater teleost) is a suitable model of the lower vertebrates because it has all kinds of chromatophores. The basic molecular genetics of fish are known(7,8) and approximately 70 spontaneous pigmentation mutants have been isolated(9). One of these, an orange-red variant, is a homozygote of a well-known and common allele, b, and has been bred for hundreds of years by the Japanese. Here, we report the first successful positional cloning of a medaka gene (AIM1): one that encodes a transporter that mediates melanin synthesis. The protein is predicted to consist of 12 transmembrane domains and is 55% identical to a human EST of unknown function isolated from melanocytes and melanoma cells. We also isolated a highly homologous gene from the mouse, indicating a conserved function of vertebrate melanogenesis. Intriguingly, these proteins have sequence and structural similarities to plant sucrose transporters, suggesting a relevance of sucrose in melanin synthesis. Analysis of AIM1 orthologs should provide new insights into the regulation of melanogenesis in both teleosts and mammals.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrat Biosci, Kashiwa, Chiba 2770882, Japan; Univ Tokyo, Sch Sci, Dept Biol Sci, Radiat Biol Lab,Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Fukamachi, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrat Biosci, Kashiwa No Ha 5-1-5, Kashiwa, Chiba 2770882, Japan.			Fukamachi, Shoji/0000-0001-7967-1883				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; Branza-Nichita N, 2000, J BIOL CHEM, V275, P8169, DOI 10.1074/jbc.275.11.8169; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; Ferdinandusse S, 2000, NAT GENET, V24, P188, DOI 10.1038/72861; Fukamachi Shoji, 2001, Mutation Research, V458, P19, DOI 10.1016/S1383-5726(01)00009-7; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; Harada M, 2001, CANCER RES, V61, P1089; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HIROSE E, 1993, PIGM CELL RES, V6, P45, DOI 10.1111/j.1600-0749.1993.tb00580.x; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; HYODO-TAGUCHI Y, 1980, Zoological Magazine (Tokyo), V89, P283; Kilty John E., 1992, Current Opinion in Biotechnology, V3, P675, DOI 10.1016/0958-1669(92)90015-B; Koga A, 1999, PIGM CELL RES, V12, P252, DOI 10.1111/j.1600-0749.1999.tb00758.x; Lemoine R, 2000, BBA-BIOMEMBRANES, V1465, P246, DOI 10.1016/S0005-2736(00)00142-5; Matsuda M, 2001, GENES GENET SYST, V76, P61, DOI 10.1266/ggs.76.61; Mount DB, 1998, J EXP BIOL, V201, P2091; NAKAYASU M, 1977, J CELL PHYSIOL, V92, P49, DOI 10.1002/jcp.1040920107; Naruse K, 2000, GENETICS, V154, P1773; SAEKI H, 1978, J CELL PHYSIOL, V94, P139, DOI 10.1002/jcp.1040940203; SHIMA A, 1994, ENVIRON HEALTH PERSP, V102, P33, DOI 10.1289/ehp.94102s1233; SHIMA A, 1991, P NATL ACAD SCI USA, V88, P2545, DOI 10.1073/pnas.88.6.2545; Shimada A, 1998, MUTAT RES-FUND MOL M, V399, P149, DOI 10.1016/S0027-5107(97)00253-4; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Tomita H, 1990, BIOL MEDAKA, P111; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107	28	175	183	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					381	385		10.1038/ng584	http://dx.doi.org/10.1038/ng584			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479596				2022-12-27	WOS:000170174800021
J	McGinnis, RE; Fox, H; Yates, P; Cameron, LA; Barnes, MR; Gray, IC; Spurr, NK; Hurko, O; St Clair, D				McGinnis, RE; Fox, H; Yates, P; Cameron, LA; Barnes, MR; Gray, IC; Spurr, NK; Hurko, O; St Clair, D			Failure to confirm NOTCH4 association with schizophrenia in a large population-based sample from Scotland	NATURE GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; INSULIN GENE; LOCUS; SUSCEPTIBILITY	The NOTCH4 gene was recently reported to be associated with schizophrenia(1) based on TDT analysis of 80 British trios. The strongest evidence for association derived from two microsatellites. We genotyped both loci in a large sample of unrelated Scottish schizophrenics and controls, but failed to replicate the reported association, finding instead that each putative schizophrenia-associated allele had a somewhat lower frequency in schizophrenics than in controls.	SmithKline Beecham Pharmaceut, Harlow CM19 5AD, Essex, England; Univ Aberdeen, Sch Med, Dept Mental Hlth, Aberdeen, Scotland	GlaxoSmithKline; University of Aberdeen	McGinnis, RE (corresponding author), SmithKline Beecham Pharmaceut, New Frontiers Sci Pk, Harlow CM19 5AD, Essex, England.		St Clair, David/AAN-2412-2021	Barnes, Michael/0000-0001-9097-7381; McGinnis, Ralph/0000-0003-4540-9857				BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; McGinnis R, 2000, AM J HUM GENET, V67, P1340; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Wei J, 2000, NAT GENET, V25, P376, DOI 10.1038/78044	6	46	47	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					128	129		10.1038/88839	http://dx.doi.org/10.1038/88839			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381258				2022-12-27	WOS:000169011800013
J	Pravenec, M; Landa, V; Zidek, V; Musilova, A; Kren, V; Kazdova, L; Aitman, TJ; Glazier, AM; Ibrahimi, A; Abumrad, NA; Qi, NN; Wang, JM; St Lezin, EM; Kurtz, TW				Pravenec, M; Landa, V; Zidek, V; Musilova, A; Kren, V; Kazdova, L; Aitman, TJ; Glazier, AM; Ibrahimi, A; Abumrad, NA; Qi, NN; Wang, JM; St Lezin, EM; Kurtz, TW			Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats	NATURE GENETICS			English	Article							FATTY-ACID; METABOLISM; TRANSPORT; MUTATION; GLUCOSE	Spontaneously hypertensive rats (SHR) display several features of the human insulin-resistance syndromes. Cd36 deficiency is genetically linked to insulin resistance in SHR. We show that transgenic expression of Cd36 in SHR ameliorates insulin resistance and lowers serum fatty acids. Our results provide direct evidence that Cd36 deficiency can promote defective insulin action and disordered fatty-acid metabolism in spontaneous hypertension.	Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic; Charles Univ, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; Inst Clin & Expt Med, Prague, Czech Republic; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, MRC Clin Sci Ctr,Mol Med Grp, London, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Div Natl Heart & Lung Inst, London, England; SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	University of California System; University of California San Francisco; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Imperial College London; Imperial College London; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kurtz, TW (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.		Landa, Vladimir/B-8908-2012; Zidek, Vaclav/C-6685-2012; Pravenec, Michal/B-1666-2012	Pravenec, Michal/0000-0001-9197-5871; Aitman, Timothy/0000-0002-7875-4502; Ibrahimi, Azeddine/0000-0003-3226-3836	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056028, P01HL035018, R01HL063709] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL35018, R01 HL56028, R01 HL63709] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Aitman TJ, 1997, NAT GENET, V16, P197, DOI 10.1038/ng0697-197; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Gotoda T, 1999, NAT GENET, V22, P226, DOI 10.1038/10285; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; Pravenec M, 1999, J CLIN INVEST, V103, P1651, DOI 10.1172/JCI6691; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583	9	165	167	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					156	158		10.1038/84777	http://dx.doi.org/10.1038/84777			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175782				2022-12-27	WOS:000166839200015
J	Underhill, PA; Shen, PD; Lin, AA; Jin, L; Passarino, G; Yang, WH; Kauffman, E; Bonne-Tamir, B; Bertranpetit, J; Francalacci, P; Ibrahim, M; Jenkins, T; Kidd, JR; Mehdi, SQ; Seielstad, MT; Wells, RS; Piazza, A; Davis, RW; Feldman, MW; Cavalli-Sforza, LL; Oefner, PJ				Underhill, PA; Shen, PD; Lin, AA; Jin, L; Passarino, G; Yang, WH; Kauffman, E; Bonne-Tamir, B; Bertranpetit, J; Francalacci, P; Ibrahim, M; Jenkins, T; Kidd, JR; Mehdi, SQ; Seielstad, MT; Wells, RS; Piazza, A; Davis, RW; Feldman, MW; Cavalli-Sforza, LL; Oefner, PJ			Y chromosome sequence variation and the history of human populations	NATURE GENETICS			English	Article							GENETIC-EVIDENCE; HAPLOTYPES; AFRICA	Binary polymorphisms associated with the non-recombining region of the human Y chromosome (NRY) preserve the paternal genetic: legacy of our species that has persisted to the present, permitting inference of human evolution, population affinity and demographic history(1). We used denaturing highperformance liquid chromatography (DHPLC; ref. 2) to identify 160 of the 166 bi-allelic and 1 tri-allelic site that formed a parsimonious; genealogy of 116 haplotypes, several of which display distinct population affinities based on the analysis of 1062 globally representative individuals. A minority of contemporary East Africans and Khoisan represent the descendants of the most ancestral patrilineages of anatomically modern humans that left Africa between 35,000 and 89,000 years ago.	Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford DNA Sequencing & Technol Ctr, Palo Alto, CA USA; Univ Texas, Ctr Human Genet, Houston, TX USA; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Univ Pompeu Fabra, Fac Ciencies Salut Vida, Unitat Biol Evolut, Barcelona, Spain; Univ Sassari, Dipartimento Zool & Antropol Biol, I-07100 Sassari, Italy; Univ Khartoum, Inst Endem Dis, Khartoum, Sudan; S African Inst Med Res, Sch Pathol, Dept Human Genet, Johannesburg, South Africa; Univ Witwatersrand, Johannesburg, South Africa; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Biomed & Genet Engn Labs, Dr AQ Khan Res Labs, Islamabad, Pakistan; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; Univ Turin, Dept Genet, Dept Genet Biol & Biochem, Turin, Italy; Stanford Univ, Dept Biol Sci, Herrin Labs, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Texas System; Tel Aviv University; Sackler Faculty of Medicine; Pompeu Fabra University; University of Sassari; University of Khartoum; University of Witwatersrand; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Wellcome Centre for Human Genetics; University of Turin; Stanford University	Underhill, PA (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	under@stanford.edu	Mehdi, Syed Qasim/L-2385-2015; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Seielstad, Mark/T-7841-2019; Bertranpetit, Jaume/F-8550-2012	Jin, Li/0000-0002-4546-2415; Bertranpetit, Jaume/0000-0003-0100-0590; Piazza, Alberto/0000-0002-2355-4183; Seielstad, Mark/0000-0001-5783-1401; FRANCALACCI, Paolo/0000-0001-7912-162X				Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; Cavalli-Sforza L., HIST GEOGRAPHY HUMAN; Diamond J, 1999, GUNS GERMS STEEL; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; Hammer Michael F., 1996, Evolutionary Anthropology, V5, P116, DOI 10.1002/(SICI)1520-6505(1996)5:4<116::AID-EVAN2>3.0.CO;2-E; Jaruzelska J, 1999, MOL BIOL EVOL, V16, P1633, DOI 10.1093/oxfordjournals.molbev.a026076; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Klein R. G., 1999, HUMAN CAREER HUMAN B; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Nachman MW, 1998, MOL BIOL EVOL, V15, P1744, DOI 10.1093/oxfordjournals.molbev.a025900; OEFNER PJ, 1998, CURRENT PROTOCOLS S, V19; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; TAJIMA F, 1989, GENETICS, V123, P585; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zerjal T, 1997, AM J HUM GENET, V60, P1174	26	705	756	1	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					358	361		10.1038/81685	http://dx.doi.org/10.1038/81685			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062480				2022-12-27	WOS:000165176500029
J	Wu, LF; Hughes, TR; Davierwala, AP; Robinson, MD; Stoughton, R; Altschuler, SJ				Wu, LF; Hughes, TR; Davierwala, AP; Robinson, MD; Stoughton, R; Altschuler, SJ			Large-scale prediction of Saccharomyces cerevisiae gene function using overlapping transcriptional clusters	NATURE GENETICS			English	Article							CELL NUCLEAR ANTIGEN; EXPRESSION PROFILES; RIBOSOME BIOGENESIS; PROTEIN FUNCTION; GENOME; YEAST; SEQUENCE; DATABASE; IDENTIFICATION; REPLICATION	Genome sequencing has led to the discovery of tens of thousands of potential new genes. Six years after the sequencing of the well-studied yeast Saccharomyces cerevisiae and the discovery that its genome encodes 6,000 predicted proteins, more than 2,000 have not yet been characterized experimentally, and determining their functions seems far from a trivial task. One crucial constraint is the generation of useful hypotheses about protein function. Using a new approach to interpret microarray data, we assign likely cellular functions with confidence values to these new yeast proteins. We perform extensive genome-wide validations of our predictions and offer visualization methods for exploration of the large numbers of functional predictions. We identify potential new members of many existing functional categories including 285 candidate proteins involved in transcription, processing and transport of non-coding RNA molecules. We present experimental validation confirming the involvement of several of these proteins in ribosomal RNA processing. Our methodology can be applied to a variety of genomics data types and organisms.	Rosetta Inpharmat, Kirkland, WA USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada	Merck & Company; University of Toronto	Altschuler, SJ (corresponding author), Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA.	saltschuler@cgr.harvard.edu	Robinson, Mark D/A-6432-2015; Robinson, Mark D./O-2254-2019	Robinson, Mark D/0000-0002-3048-5518; Robinson, Mark D./0000-0002-3048-5518				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ball CA, 2000, NUCLEIC ACIDS RES, V28, P77, DOI 10.1093/nar/28.1.77; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen C, 1999, MOL CELL BIOL, V19, P7801; CHENG Y, 1995, SCIENCE, V267, P1807, DOI 10.1126/science.7534442; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Goldstein DR, 2002, STAT SINICA, V12, P219; Hartigan J., 1975, CLUSTERING ALGORITHM; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; King RD, 2000, YEAST, V17, P283, DOI 10.1002/1097-0061(200012)17:4<283::AID-YEA52>3.0.CO;2-F; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Prosperi E, 1997, Prog Cell Cycle Res, V3, P193; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shatkay H, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P317; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; 1909, SCIENCE, V282, P2012	41	255	267	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2002	31	3					255	265		10.1038/ng906	http://dx.doi.org/10.1038/ng906			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12089522				2022-12-27	WOS:000176494100012
J	Golling, G; Amsterdam, A; Sun, ZX; Antonelli, M; Maldonado, E; Chen, WB; Burgess, S; Haldi, M; Artzt, K; Farrington, S; Lin, SY; Nissen, RM; Hopkins, N				Golling, G; Amsterdam, A; Sun, ZX; Antonelli, M; Maldonado, E; Chen, WB; Burgess, S; Haldi, M; Artzt, K; Farrington, S; Lin, SY; Nissen, RM; Hopkins, N			Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development	NATURE GENETICS			English	Article							MUTATIONS; SPECIFICATION; MELANOSOMES; PESCADILLO; HINDBRAIN; ORGANIZER; MUTANTS; SEARCH; SCREEN; EMBRYO	To rapidly identify genes required for early vertebrate development, we are carrying out a large-scale, insertional mutagenesis screen in zebrafish, using mouse retroviral vectors as the mutagen. We will obtain mutations in 450 to 500 different genes-roughly 20% of the genes that can be mutated to produce a visible embryonic phenotype in this species-and will clone the majority of the mutated alleles. So far, we have isolated more than 500 insertional mutants. Here we describe the first 75 insertional mutants for which the disrupted genes have been identified. In agreement with chemical mutagenesis screens, approximately one-third of the mutants have developmental defects that affect primarily one or a small number of organs, body shape or swimming behavior; the rest of the mutants show more widespread or pleiotropic abnormalities. Many of the genes we identified have not been previously assigned a biological role in vivo. Roughly 20% of the mutants result from lesions in genes for which the biochemical and cellular function of the proteins they encode cannot be deduced with confidence, if at all, from their predicted amino-acid sequences. All of the genes have either orthologs or clearly related genes in human. These results provide an unbiased view of the genetic construction kit for a vertebrate embryo, reveal the diversity of genes required for vertebrate development and suggest that hundreds of genes of unknown biochemical function essential for vertebrate development have yet to be identified.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Texas, Inst Cellular & Mol Biol, Dept Microbiol, Austin, TX USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin	Hopkins, N (corresponding author), MIT, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Maldonado, Ernesto/I-1032-2016; Maldonado, Ernesto/ABG-9116-2020; Chen, Wenbiao/ABG-1276-2020	Maldonado, Ernesto/0000-0002-9627-967X; Chen, Wenbiao/0000-0002-0750-8275; Burgess, Shawn/0000-0003-1147-0596; Nissen, Robert/0000-0002-0591-1167	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000183, ZIAHG000183] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Becker TS, 1998, DEVELOPMENT, V125, P4369; Belting HG, 2001, DEVELOPMENT, V128, P4165; Bhatnagar V, 1998, MOL CELL BIOCHEM, V189, P99, DOI 10.1023/A:1006876411202; Burgess S, 2002, DEVELOPMENT, V129, P905; Charpentier AH, 2000, CANCER RES, V60, P5977; Chen WB, 2001, DEVELOPMENT, V128, P2385; DIMENT S, 1995, J BIOL CHEM, V270, P4213, DOI 10.1074/jbc.270.9.4213; Driever W, 1996, DEVELOPMENT, V123, P37; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0; Haffter P, 1996, DEVELOPMENT, V123, P1; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Iwasaki N, 1998, DIABETES CARE, V21, P2144, DOI 10.2337/diacare.21.12.2144; Jordan S, 2000, PIGM CELL RES, V13, P70, DOI 10.1034/j.1600-0749.2000.130204.x; Kane DA, 1996, DEVELOPMENT, V123, P57; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Pearson H, 2001, NATURE, V413, P244, DOI 10.1038/35095116; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Schilling TF, 1996, DEVELOPMENT, V123, P329; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670	30	426	466	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					135	140		10.1038/ng896	http://dx.doi.org/10.1038/ng896			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12006978				2022-12-27	WOS:000175903500008
J	Hopyan, S; Gokgoz, N; Poon, R; Gensure, RC; Yu, CY; Cole, WG; Bell, RS; Juppner, H; Andrulis, IL; Wunder, JS; Alman, BA				Hopyan, S; Gokgoz, N; Poon, R; Gensure, RC; Yu, CY; Cole, WG; Bell, RS; Juppner, H; Andrulis, IL; Wunder, JS; Alman, BA			A mutant PTH/PTHrP type I receptor in enchondromatosis	NATURE GENETICS			English	Article							HORMONE-RELATED PEPTIDE; PARATHYROID-HORMONE; INDIAN HEDGEHOG; METAPHYSEAL CHONDRODYSPLASIA; BLOMSTRAND-CHONDRODYSPLASIA; TRANSGENIC MICE; BONE-GROWTH; GENE; DIFFERENTIATION; CHONDROCYTES	Enchondromas are common benign cartilage tumors of bone. They can occur as solitary lesions or as multiple lesions in enchondromatosis (Ollier and Maffucci diseases). Clinical problems caused by enchondromas include skeletal deformity and the potential for malignant change to chondrosarcoma(1-3). The extent of skeletal involvement is variable in enchondromatosis and may include dysplasia that is not directly attributable to enchondromas(4). Enchondromatosis is rare, obvious inheritance of the condition is unusual and no candidate loci have been identified. Enchondromas are usually in close proximity to, or in continuity with, growth-plate cartilage. Consequently, they may result from abnormal regulation of proliferation and terminal differentiation of chondrocytes in the adjoining growth plate. In normal growth plates, differentiation of proliferative chondrocytes to post-mitotic hypertrophic chondrocytes is regulated in part by a tightly coupled signaling relay involving parathyroid hormone related protein (PTHrP) and Indian hedgehog (IHH)(5-9). PTHrP delays the hypertrophic differentiation of proliferating chondrocytes, whereas IHH promotes chondrocyte proliferation. We identified a mutant PTH/PTHrP type I receptor (PTHR1) in human enchondromatosis that signals abnormally in vitro and causes enchondroma-like lesions in transgenic mice. The mutant receptor constitutively activates Hedgehog signaling, and excessive Hedgehog signaling is sufficient to cause formation of enchondroma-like lesions.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Hosp Sick Children, Res Inst, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Surg, Div Orthopaed, Toronto, ON, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Pediat Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Hosp Sick Children, Div Orthopaed, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Mt Sinai Hosp, Univ Musculoskeletal Oncol Unit, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Div Orthopaed, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Wunder, JS (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		Andrulis, Irene L./E-7267-2013					BRUGGEMAN LA, 1991, TERATOLOGY, V44, P203, DOI 10.1002/tera.1420440208; Carter PH, 1999, ENDOCRINOLOGY, V140, P4972, DOI 10.1210/en.140.11.4972; Chung UI, 1998, P NATL ACAD SCI USA, V95, P13030, DOI 10.1073/pnas.95.22.13030; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; GUO J, 2000, J BONE MINER RES, V15, P5152; HALAL F, 1991, AM J MED GENET, V38, P588, DOI 10.1002/ajmg.1320380418; Hopyan S, 1999, J ORTHOPAED RES, V17, P633, DOI 10.1002/jor.1100170503; HUVOS AG, 1991, BONE TUMORS DIAGNOSI, P264; Jaffe HL, 1972, METABOLIC DEGENERATI, P222; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Karaplis AC, 1998, ENDOCRINOLOGY, V139, P5255, DOI 10.1210/en.139.12.5255; Karp SJ, 2000, DEVELOPMENT, V127, P543; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Levesque J., 1998, CLIN GUIDE PRIMARY B, P98; Li C, 1998, AM J PATHOL, V153, P709, DOI 10.1016/S0002-9440(10)65614-3; Mo R, 1997, DEVELOPMENT, V124, P113; OKEEFE RJ, 1994, J BONE MINER RES, V9, P1713; Sasaki H, 1999, DEVELOPMENT, V126, P3915; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; SCHIPANI E, 1995, J CLIN ENDOCR METAB, V80, P1611, DOI 10.1210/jc.80.5.1611; Schipani E, 1996, NEW ENGL J MED, V335, P708, DOI 10.1056/NEJM199609053351004; SCHWARTZ HS, 1987, J BONE JOINT SURG AM, V69A, P269, DOI 10.2106/00004623-198769020-00016; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Xie LY, 1998, ENDOCRINOLOGY, V139, P4563, DOI 10.1210/en.139.11.4563; YAMADA Y, 1990, ANN NY ACAD SCI, V580, P81, DOI 10.1111/j.1749-6632.1990.tb17920.x; ZACK P, 1995, AM J MED GENET, V55, P478, DOI 10.1002/ajmg.1320550417	29	176	194	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					306	310		10.1038/ng844	http://dx.doi.org/10.1038/ng844			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11850620				2022-12-27	WOS:000174157600016
J	Varley, H; Pickett, HA; Foxon, JL; Reddel, RR; Royle, NJ				Varley, H; Pickett, HA; Foxon, JL; Reddel, RR; Royle, NJ			Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells	NATURE GENETICS			English	Article							IMMORTALIZED HUMAN-CELLS; HUMAN XP/YP TELOMERE; HUMAN FIBROBLASTS; LENGTH; MAINTENANCE; RECOMBINATION; MECHANISM; DYNAMICS; CONTAIN; PATHWAY	Telomeres in most immortal cells(1-3) are maintained by the enzyme telomerase(4), allowing cells to divide indefinitely. Some telomerase-negative tumors and immortal cell lines maintain long heterogeneous telomeres by the ALT (alternative lengthening of telomeres) mechanism(5,6); such tumors are expected to be resistant to anti-telomerase drug therapies. Occasionally telomerase-negative Saccharomyces cerevisiae mutants survive, and 10% of them (type II survivors) have unstable telomeres(7,8). As in human ALT+ cells(9), short telomeres in yeast type II survivors lengthen abruptly; in yeast, this is dependent on the recombination proteins Rad52p and Rad50p(10). In human cells, ALT involves copying of sequence from a donor to a recipient telomere(11). We have characterized for the first time a class of complex telomere mutations seen only in ALT+ cells. The mutant telomeres are defined by the replacement of the progenitor telomere at a discrete point (fusion point) with a different telomere repeat array. Among 19 characterized fusion points, one occurred within the first six repeats of the telomere, indicating that these recombination-like events can occur anywhere within the telomere. One mutant telomere may have been involved in a secondary recombination-like mutation event, suggesting that these mutations are sporadic but ongoing in ALT+ cells. We also identified simple intra-allelic mutations at high frequency, which evidently contribute to telomere instability in ALT+ cells.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Childrens Med Res Inst, Canc Res Unit, Sydney, NSW, Australia	University of Leicester; Children's Medical Research Institute - Australia; University of Sydney	Royle, NJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.		Reddel, Roger R/A-6635-2014	Reddel, Roger R/0000-0002-6302-6107; Royle, Nicola/0000-0003-1174-6329				ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; Baird DM, 1997, HUM MOL GENET, V6, P2291, DOI 10.1093/hmg/6.13.2291; Baird DM, 2000, AM J HUM GENET, V66, P235, DOI 10.1086/302721; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; Bryan TM, 1997, EUR J CANCER, V33, P767, DOI 10.1016/S0959-8049(97)00065-8; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Coleman J, 1999, HUM MOL GENET, V8, P1637, DOI 10.1093/hmg/8.9.1637; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; Rizki A, 2001, NATURE, V411, P713, DOI 10.1038/35079641; ROGAN EM, 1995, MOL CELL BIOL, V15, P4745; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; Teng SC, 1999, MOL CELL BIOL, V19, P8083; WARNEFORD SG, 1992, CELL GROWTH DIFFER, V3, P839; Wright WE, 1996, DEV GENET, V18, P173; Yeager TR, 1999, CANCER RES, V59, P4175	28	94	97	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					301	305		10.1038/ng834	http://dx.doi.org/10.1038/ng834			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11919561				2022-12-27	WOS:000174157600015
J	Perrotti, D; Cesi, V; Trotta, R; Guerzoni, C; Santilli, G; Campbell, K; Iervolino, A; Condorelli, F; Gambacorti-Passerini, C; Caligiuri, MA; Calabretta, B				Perrotti, D; Cesi, V; Trotta, R; Guerzoni, C; Santilli, G; Campbell, K; Iervolino, A; Condorelli, F; Gambacorti-Passerini, C; Caligiuri, MA; Calabretta, B			BCR-ABL suppresses C/EBP alpha expression through inhibitory action of hnRNP E2	NATURE GENETICS			English	Article							BINDING PROTEIN-ALPHA; CHRONIC MYELOGENOUS LEUKEMIA; RECEPTOR MESSENGER-RNA; KH-DOMAIN PROTEINS; GRANULOCYTIC DIFFERENTIATION; ERYTHROID-DIFFERENTIATION; RIBONUCLEOPROTEIN-K; PU.1 SPI-1; TRANSCRIPTION; TRANSLATION	The arrest of differentiation is a feature of both chronic myelogenous leukemia cells in myeloid blast crisis and myeloid precursors that ectopically express the p210(BCR-ABL) oncoprotein; however, its underlying mechanisms remain poorly understood. Here we show that expression of BCR-ABL in myeloid precursor cells leads to transcriptional suppression of the granulocyte colony-stimulating factor receptor G-CSF-R (encoded by CSF3R), possibly through down-modulation of C/EBPalpha-the principal regulator of granulocytic differentiation. Expression of C/EBPalpha protein is barely detectable in primary marrow cells taken from individuals affected with chronic myeloid leukemia in blast crisis. In contrast, CEBPA RNA is clearly present. Ectopic expression of C/EBPalpha induces granulocytic differentiation of myeloid precursor cells expressing BCR-ABL. Expression of C/EBPalpha is suppressed at the translational level by interaction of the poly(rC)-binding protein hnRNP E2 with CEBPA mRNA, and ectopic expression of hnRNP E2 in myeloid precursor cells down-regulates both C/EBPalpha. and G-CSF-R and leads to rapid cell death on treatment with G-CSF (encoded by CSF3). Our results indicate that BCR-ABL regulates the expression of C/EBPalpha by inducing hnRNP E2-which inhibits the translation of CEBPA mRNA.	Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Univ Modena, Sect Gen Pathol, Dept Biomed Sci, I-41100 Modena, Italy; NCI, I-20133 Milan, Italy; S Gerardo Hosp, Hematol Sect, I-20052 Monza, Italy; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Canc & Leukemia Grp B, Chicago, IL USA	Jefferson University; Universita di Modena e Reggio Emilia; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Perrotti, D (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	Danilo.Perrotti@mail.tju.edu	Perrotti, Danilo/E-3852-2011; Condorelli, Fabrizio/J-4726-2016	Condorelli, Fabrizio/0000-0002-9943-0857; Trotta, Rossana/0000-0003-4546-2615; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X				Bellon T, 1997, BLOOD, V90, P1828, DOI 10.1182/blood.V90.5.1828; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cambier N, 1998, ONCOGENE, V16, P335, DOI 10.1038/sj.onc.1201490; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Dai ZH, 1998, GENE DEV, V12, P1415, DOI 10.1101/gad.12.10.1415; Elmaagacli AH, 2000, ANN HEMATOL, V79, P424, DOI 10.1007/s002770000169; GAIGER A, 1995, BLOOD, V86, P2371, DOI 10.1182/blood.V86.6.2371.bloodjournal8662371; Gamarnik AV, 1997, RNA, V3, P882; Gordon MY, 1999, J CLIN PATHOL, V52, P719, DOI 10.1136/jcp.52.10.719; Graff J, 1998, J VIROL, V72, P9668, DOI 10.1128/JVI.72.12.9668-9675.1998; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Issaad C, 2000, LEUKEMIA, V14, P662, DOI 10.1038/sj.leu.2401730; KANTARJIAN HM, 1993, BLOOD, V82, P691; KANTARJIAN HM, 1987, AM J MED, V83, P445, DOI 10.1016/0002-9343(87)90754-6; KOZAK M, 1995, P NATL ACAD SCI USA, V92, P2662, DOI 10.1073/pnas.92.7.2662; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; LANEUVILLE P, 1991, ONCOGENE, V6, P275; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Perrotti D, 2000, MOL CELL BIOL, V20, P6159, DOI 10.1128/MCB.20.16.6159-6169.2000; Perrotti D, 1998, EMBO J, V17, P4442, DOI 10.1093/emboj/17.15.4442; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; SCOTT LM, 1992, BLOOD, V80, P1725; Silvera D, 1999, J BIOL CHEM, V274, P38163, DOI 10.1074/jbc.274.53.38163; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; STEINMAN RA, 1994, BLOOD, V83, P119; Thisted T, 2001, J BIOL CHEM, V276, P17484, DOI 10.1074/jbc.M010594200; Thomson AM, 1999, BIOTECHNIQUES, V27, P1032, DOI 10.2144/99275rr03; TKATCH LS, 1995, J LEUKOCYTE BIOL, V57, P964, DOI 10.1002/jlb.57.6.964; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Ward AC, 2000, LEUKEMIA, V14, P973, DOI 10.1038/sj.leu.2401808; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; WONG KK, 1995, MOL CELL BIOL, V15, P6535; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zou XM, 1999, J BIOL CHEM, V274, P18141, DOI 10.1074/jbc.274.26.18141	50	252	268	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					48	58		10.1038/ng791	http://dx.doi.org/10.1038/ng791			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11753385				2022-12-27	WOS:000173105600013
J	Osborne, LR; Li, M; Pober, B; Chitayat, D; Bodurtha, J; Mandel, A; Costa, T; Grebe, T; Cox, S; Tsui, LC; Scherer, SW				Osborne, LR; Li, M; Pober, B; Chitayat, D; Bodurtha, J; Mandel, A; Costa, T; Grebe, T; Cox, S; Tsui, LC; Scherer, SW			A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome	NATURE GENETICS			English	Article							SYNDROME-DELETION; INSITU HYBRIDIZATION; ELASTIN GENE; 7Q11.23; DNA; HEMIZYGOSITY; SEQUENCES; DISORDER; REPEATS; REGION	Williams-Beuren syndrome (WBS) is most often caused by hemizygous deletion of a 1.5-Mb interval encompassing at least 17 genes at 7q11.23 (refs. 1,2). As with many other haploinsufficiency diseases, the mechanism underlying the WBS deletion is thought to be unequal meiotic recombination, probably mediated by the highly homologous DNA that flanks the commonly deleted region(3). Here, we report the use of interphase fluorescence in situ hybridization (FISH) and pulsed-field gel electrophoresis (PFGE) to identify a genomic polymorphism in families with WBS, consisting of an inversion of the WBS region. We have observed that the inversion is hemizygous in 3 of 11 (27%) atypical affected individuals who show a subset of the WBS phenotypic spectrum but do not carry the typical WBS microdeletion. Two of these individuals also have a parent who carries the inversion. In addition, in 4 of 12 (33%) families with a proband carrying the WBS deletion, we observed the inversion exclusively in the parent transmitting the disease-related chromosome. These results suggest the presence of a newly identified genomic variant within the population that may be associated with the disease. It may result in predisposition to primarily WBS-causing microdeletions, but may also cause translocations and inversions.	Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Hosp Sick Children, Dept Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA USA; Atlantic Res Ctr, Dept Pediat, Halifax, NS, Canada; Univ Arizona, Phoenix Genet Program, Phoenix, AZ USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Yale University; Virginia Commonwealth University; University of Arizona	Scherer, SW (corresponding author), Univ Toronto, Dept Mol & Med Genet, 1 Kings Coll Cirle, Toronto, ON, Canada.	steve@genet.sickkids.on.ca	Tsui, Lap-chee/A-1081-2010; Scherer, Stephen W./B-3785-2013	Scherer, Stephen W./0000-0002-8326-1999	Canadian Institutes of Health Research [38103] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; Botta A, 1999, J MED GENET, V36, P478; Chute I, 1997, GENOMICS, V46, P51, DOI 10.1006/geno.1997.5007; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gorlach A, 1997, J CLIN INVEST, V100, P1907, DOI 10.1172/JCI119721; GREEN JE, 1990, AIDS RES HUM RETROV, V6, P85; HENG HHQ, 1993, CHROMOSOMA, V102, P325, DOI 10.1007/BF00661275; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; Kara-Mostefa A, 1999, AM J HUM GENET, V64, P1475, DOI 10.1086/302362; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LOWERY MC, 1995, AM J HUM GENET, V57, P49; MARI A, 1995, HUM GENET, V96, P444; Meng X, 1998, GENOMICS, V52, P130, DOI 10.1006/geno.1998.5412; NICKERSON E, 1995, AM J HUM GENET, V56, P1156; Osborne LR, 1999, MOL GENET METAB, V67, P1, DOI 10.1006/mgme.1999.2844; Osborne LR, 1997, GENOMICS, V45, P402, DOI 10.1006/geno.1997.4923; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Pezzi N, 2000, FASEB J, V14, P581, DOI 10.1096/fasebj.14.3.581; Pober BR, 1996, CHILD ADOL PSYCH CL, V5, P929, DOI 10.1016/S1056-4993(18)30341-9; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; von Dadelszen P, 2000, AM J MED GENET, V90, P270, DOI 10.1002/(SICI)1096-8628(20000214)90:4<270::AID-AJMG2>3.0.CO;2-R	30	223	236	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					321	325		10.1038/ng753	http://dx.doi.org/10.1038/ng753			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11685205	Green Accepted			2022-12-27	WOS:000171911000020
J	Braybrook, C; Doudney, K; Marcano, ACB; Arnason, A; Bjornsson, A; Patton, MA; Goodfellow, PJ; Moore, GE; Stanier, P				Braybrook, C; Doudney, K; Marcano, ACB; Arnason, A; Bjornsson, A; Patton, MA; Goodfellow, PJ; Moore, GE; Stanier, P			The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and ankyloglossia	NATURE GENETICS			English	Article							FAMILY; CPX; EXPRESSION; MUTATIONS; LINKAGE; XQ21.3; LIMB	Formation of the secondary palate is a complex step during craniofacial development. Disturbance of the events affecting palatogenesis results in a failure of the palate to close. As a consequence of deformity, an affected child will have problems with feeding, speech, hearing, dentition and psychological development. Cleft palate occurs frequently, affecting approximately 1 in 1,500 births; it is usually considered a sporadic occurrence(1) resulting from an interaction between genetic and environmental factors(2). Although several susceptibility loci have been implicated, attempts to link genetic variation to functional effects have met with little success(3). Cleft palate with ankyloglossia (CPX; MIM 303400) is inherited as a semidominant X-linked disorder previously described in several large families of different ethnic origins(4-11) and has been the subject of several studies that localized the causative gene to Xq21 (refs. 10-13). Here we show that CPX is caused by mutations in the gene encoding the recently described T-box transcription factor TBX22 (ref. 14). Members of the T-box gene family are known to play essential roles in early vertebrate development, especially in mesoderm specification(15). We demonstrate that TBX22 is a major gene determinant crucial to human palatogenesis. The spectrum of nonsense, splice-site, frameshift and missense mutations we have identified in this study indicates that the cleft phenotype results from a complete loss of TBX22 function.	Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England; Univ Sao Paulo, Hosp Reabilitacao Anomalias Craniofaciais, Dept Genet, Sao Paulo, Brazil; Univ Hosp, Dept Plast Surg, IS-101 Reykjavik, Iceland; Univ London St Georges Hosp, Sch Med, Med Genet Unit, London SW17 0RE, England; Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; Bloodbank, IS-101 Reykjavik, Iceland	Imperial College London; Universidade de Sao Paulo; Landspitali National University Hospital; St Georges University London; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Stanier, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Du Cane Rd,Hammersmith Campus, London W12 0NN, England.		Doudney, Kit/Q-9728-2019; Stanier, Philip/C-1593-2008; Moore, Gudrun/A-2092-2009	Doudney, Kit/0000-0002-0089-1152; Stanier, Philip/0000-0001-9340-8117; Moore, Gudrun/0000-0002-2099-3420				Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; BIXLER D, 1987, AM J MED GENET, V28, P503, DOI 10.1002/ajmg.1320280229; BJORNSSON A, 1989, CLEFT PALATE J, V26, P3; Braybrook C, 2001, HUM GENET, V108, P537, DOI 10.1007/s004390100518; Braybrook C, 2001, GENOMICS, V72, P128, DOI 10.1006/geno.2000.6478; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Dobrovolskaia-Zavadskaia N, 1927, CR SOC BIOL, V97, P114; Forbes SA, 1996, GENOMICS, V31, P36, DOI 10.1006/geno.1996.0006; FRASER FC, 1980, CURRENT RES TRENDS P, P357; GORSKI SM, 1992, AM J HUM GENET, V50, P1129; GORSKI SM, 1994, HUM GENET, V94, P141; HALL B D, 1987, American Journal of Medical Genetics, V26, P239, DOI 10.1002/ajmg.1320260140; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Laugier-Anfossi F, 2000, GENE, V255, P289, DOI 10.1016/S0378-1119(00)00326-7; LECK I, 1984, BRIT MED BULL, V40, P390, DOI 10.1093/oxfordjournals.bmb.a072010; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; LOWRY RB, 1970, PEDIATRICS, V46, P123; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Richardson MP, 1998, GENE, V206, P145, DOI 10.1016/S0378-1119(97)00586-6; ROLLNICK BR, 1986, AM J MED GENET, V24, P465, DOI 10.1002/ajmg.1320240309; RUSHTON AR, 1979, HUM GENET, V48, P179, DOI 10.1007/BF00286901; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; STANIER P, 1993, GENOMICS, V17, P549, DOI 10.1006/geno.1993.1370; Tada M, 2001, DEV GROWTH DIFFER, V43, P1; Wakeling EL, 1998, EUR J HUM GENET, V6, P158, DOI 10.1038/sj.ejhg.5200179; WIKTOP CJ, 1967, HDB CONGENITAL MALFO; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0	32	186	194	2	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					179	183		10.1038/ng730	http://dx.doi.org/10.1038/ng730			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11559848				2022-12-27	WOS:000171374100024
J	Savkur, RS; Philips, AV; Cooper, TA				Savkur, RS; Philips, AV; Cooper, TA			Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy	NATURE GENETICS			English	Article							SKELETAL-MUSCLE CELLS; MESSENGER-RNA; BINDING-PROTEIN; TRIPLET REPEAT; CTG REPEAT; CUG REPEAT; EXPRESSION; EXPANSION; VARIANTS; SENSITIVITY	Myotonic dystrophy type 1 (DM1) is caused by a CTG trinucleotide expansion in the 3' untranslated region of the DM protein kinase gene. People with DM1 have an unusual form of insulin resistance caused by a defect in skeletal muscle. Here we demonstrate that alternative splicing of the insulin receptor (IR) pre-mRNA is aberrantly regulated in DM1 skeletal muscle tissue, resulting in predominant expression of the lower-signaling nonmuscle isoform (IR-A). IR-A also predominates in DM1 skeletal muscle cultures, which exhibit a decreased metabolic response to insulin relative to cultures from normal controls. Steady-state levels of CUG-BP, a regulator of pre-mRNA splicing proposed to mediate some aspects of DM1 pathogenesis, are increased in DM1 skeletal muscle; overexpression of CUG-BP in normal cells induces a switch to IR-A. The CUG-BP protein mediates this switch through an intronic element located upstream of the alternatively spliced exon 11, and specifically binds within this element in vitro. These results support a model in which increased expression of a splicing regulator contributes to insulin resistance in DM1 by affecting IR alternative splicing.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Cooper, TA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.				NIAMS NIH HHS [R01AR45653] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045653] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BENECKE H, 1992, J CLIN INVEST, V89, P2066, DOI 10.1172/JCI115819; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DEPIRRO R, 1982, SCIENCE, V216, P311, DOI 10.1126/science.7063889; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Furling D, 1999, ENDOCRINOLOGY, V140, P4244, DOI 10.1210/en.140.9.4244; KELLERER M, 1993, DIABETOLOGIA, V36, P628, DOI 10.1007/BF00404072; KELLERER M, 1992, BIOCHEMISTRY-US, V31, P4588, DOI 10.1021/bi00134a008; KLIP A, 1990, DIABETES CARE, V13, P696, DOI 10.2337/diacare.13.6.696; Korade-Mirnics Z, 1999, HUM MOL GENET, V8, P1017, DOI 10.1093/hmg/8.6.1017; Kosaki A, 1998, J BIOL CHEM, V273, P10331, DOI 10.1074/jbc.273.17.10331; KOSAKI A, 1993, J BIOL CHEM, V268, P21990; KOSAKI A, 1995, J BIOL CHEM, V270, P20816, DOI 10.1074/jbc.270.35.20816; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; MCCLAIN DA, 1991, MOL ENDOCRINOL, V5, P734, DOI 10.1210/mend-5-5-734; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; Morrone A, 1997, J CLIN INVEST, V99, P1691, DOI 10.1172/JCI119332; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; MOXLEY RT, 1978, J CLIN INVEST, V62, P857, DOI 10.1172/JCI109198; MOXLEY RT, 1984, ANN NEUROL, V15, P157, DOI 10.1002/ana.410150208; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Tapscott SJ, 2000, SCIENCE, V289, P1701, DOI 10.1126/science.289.5485.1701; Timchenko LT, 1999, AM J HUM GENET, V64, P360, DOI 10.1086/302268; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; VIALETTES B, 1986, HORM METAB RES, V18, P395, DOI 10.1055/s-2007-1012325; VOGT B, 1991, BIOCHEM BIOPH RES CO, V177, P1013, DOI 10.1016/0006-291X(91)90639-O; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434	39	573	599	1	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					40	47		10.1038/ng704	http://dx.doi.org/10.1038/ng704			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528389				2022-12-27	WOS:000170781300014
J	Thornsberry, JM; Goodman, MM; Doebley, J; Kresovich, S; Nielsen, D; Buckler, ES				Thornsberry, JM; Goodman, MM; Doebley, J; Kresovich, S; Nielsen, D; Buckler, ES			Dwarf8 polymorphisms associate with variation in flowering time	NATURE GENETICS			English	Letter							MOLECULAR EVOLUTION; MAIZE; GENE	Historically, association tests have been used extensively in medical genetics(1-2), but have had virtually no application in plant genetics. One obstacle to their application is the structured populations often found in crop plants(3), which may lead to nonfunctional. spurious associations(4). In this study. statistical methods to account for population structure(5) were extended for use with quantitative variation and applied to our evaluation of maize flowering time. Mutagenesis and quantitative trait locus (QTL) studies suggested that the maize gene Dwarf8 might affect the quantitative variation of maize flowering time and plant height(6-8). The wheat orthologs of this gene contributed to the increased yields seen in the 'Green Revolution' varieties(6). We used association approaches to evaluate Dwarf8 sequence polymorphisms from 92 maize inbred lines. Population structure was estimated using a Bayesian analysis(4) of 141 simple sequence repeat (SSR) loci. Our results indicate that a suite of polymorphisms associate with differences in flowering time, which include a deletion that may alter a key domain in the coding region. The distribution of nonsynonymous polymorphisms suggests that Dwarf8 has been a target of selection.	N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA; N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; N Carolina State Univ, USDA ARS, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Wisconsin System; University of Wisconsin Madison; Cornell University; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University	Buckler, ES (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	buckler@statgen.ncsu.edu	Peng, Bo/A-6920-2009; Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022	Peng, Bo/0000-0001-8225-2284; Buckler, Edward/0000-0002-3100-371X; Nielsen, Dahlia/0000-0003-0123-6085				Hey J, 1997, GENETICS, V145, P833; Kende H, 2001, PLANT PHYSIOL, V125, P81, DOI 10.1104/pp.125.1.81; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KOESTER RP, 1993, CROP SCI, V33, P1209, DOI 10.2135/cropsci1993.0011183X003300060020x; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Nei M., 1987, MOL EVOLUTIONARY GEN; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SCHON CC, 1994, CROP SCI, V34, P378, DOI 10.2135/cropsci1994.0011183X003400020014x; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1995, GENETICS, V140, P403; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; White SE, 1999, GENETICS, V153, P1455	19	786	955	7	199	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					286	289		10.1038/90135	http://dx.doi.org/10.1038/90135			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431702				2022-12-27	WOS:000169656400024
J	Devriendt, K; Kim, AS; Mathijs, G; Frints, SGM; Schwartz, M; Van den Oord, JJ; Verhoef, GEG; Boogaerts, MA; Fryns, JP; You, DQ; Rosen, MK; Vandenberghe, P				Devriendt, K; Kim, AS; Mathijs, G; Frints, SGM; Schwartz, M; Van den Oord, JJ; Verhoef, GEG; Boogaerts, MA; Fryns, JP; You, DQ; Rosen, MK; Vandenberghe, P			Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia	NATURE GENETICS			English	Letter							WISKOTT-ALDRICH-SYNDROME; SYNDROME PROTEIN WASP; ACTIN NUCLEATION; ARP2/3 COMPLEX; N-WASP; CDC42; EXPRESSION; GENE; BINDING; CELLS	The Wiskott-Aldrich syndrome protein (WASP; encoded by the gene WAS) and its homologs are important regulators of the actin cytoskeleton, mediating communication between Rho-family GTPases and the actin nucleation/crosslinking factor. the Arp2/3 complex(1). Many WAS mutations impair cytoskeletal control in hematopoietic tissues, resulting in functional and developmental defects that define the X-linked Wiskott-Aldrich syndrome (NAS) and the related X-linked thrombocytopenia(2) (XLT), These diseases seem to result from reduced WASP signaling, often through decreased transcription or translation of the gene(3-8). Here we describe a new disease, X-linked severe congenital neutropenia (XLN), caused by a novel L270P mutation in the region of WAS encoding the conserved GTPase binding domain (GBD), In vitro. the mutant protein is constitutively activated through disruption of an autoinhibitory domain in the wild-type protein, indicating that loss of WASP autoinhibition is a key event in XLN. Our findings highlight the importance of precise regulation of WASP in hematopoietic development and function, as impairment versus enhancement of its activity give rise to distinct spectra of cellular defects and clinical phenotypes.	Katholieke Univ Leuven, Lab Expt Hematol, Louvain, Belgium; Katholieke Univ Leuven Hosp, Ctr Human Genet, Louvain, Belgium; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Copenhagen Univ Hosp, Rigshosp, Dept Clin Genet, DK-4062 Copenhagen, Denmark; Katholieke Univ Leuven Hosp, Dept Pathol, Lab Histo & Cytochem, Louvain, Belgium	KU Leuven; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Memorial Sloan Kettering Cancer Center; Rigshospitalet; University of Copenhagen; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Vandenberghe, P (corresponding author), Katholieke Univ Leuven, Lab Expt Hematol, Louvain, Belgium.	rosen@mrnmr1.mskcc.org; peter.vandenberghe@med.kuleuven.ac.be		Vandenberghe, Peter/0000-0003-4719-1935; Frints, Suzanna G.M./0000-0002-5027-8364; Matthijs, Gert/0000-0001-6710-1912				Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Coakley G, 2000, ARTHRITIS RHEUM, V43, P834, DOI 10.1002/1529-0131(200004)43:4<834::AID-ANR14>3.0.CO;2-H; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Devriendt K, 1997, AM J HUM GENET, V60, P581; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; ELSNER J, 1993, EXP HEMATOL, V21, P38; Facchetti F, 1998, J PATHOL, V185, P99, DOI 10.1002/(SICI)1096-9896(199805)185:1<99::AID-PATH48>3.0.CO;2-L; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lemahieu V, 1999, HUM MUTAT, V14, P54, DOI 10.1002/(SICI)1098-1004(1999)14:1<54::AID-HUMU7>3.3.CO;2-5; MacCarthy-Morrogh L, 1998, CLIN IMMUNOL IMMUNOP, V88, P22, DOI 10.1006/clin.1998.4557; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Parolini O, 1997, BLOOD, V90, P70; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Scherbina A, 1999, J IMMUNOL, V163, P6314; Schwartz M, 1996, THROMB HAEMOSTASIS, V75, P546; Snapper SB, 1999, ANNU REV IMMUNOL, V17, P905, DOI 10.1146/annurev.immunol.17.1.905; Stewart DM, 1996, J CLIN INVEST, V97, P2627, DOI 10.1172/JCI118712; Zhu QL, 1997, BLOOD, V90, P2680, DOI 10.1182/blood.V90.7.2680.2680_2680_2689	30	311	323	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					313	317		10.1038/85886	http://dx.doi.org/10.1038/85886			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242115				2022-12-27	WOS:000167304200025
J	Di Cristofano, A; De Acetis, M; Koff, A; Cordon-Cardo, C; Pandolfi, PP				Di Cristofano, A; De Acetis, M; Koff, A; Cordon-Cardo, C; Pandolfi, PP			Pten and p27(KIP1) cooperate in prostate cancer tumor suppression in the mouse	NATURE GENETICS			English	Article							MICE LACKING; HYPERPLASIA; PTEN/MMAC1	The genetic bases underlying prostate tumorigenesis are poorly understood. Inactivation of the tumor-suppressor gene PTEN and lack of p27(KIP1) expression have been detected in most advanced prostate cancers(1,2). But mice deficient for Cdkn1b (encoding p27(KIp1)) do not develop prostate cancer(3-5). PTEN activity leads to the induction of p27(KIP1) expression, which in turn can negatively regulate the transition through the cell cycle(6). Thus, the inactivation of p27(KIP1)may epistatic to PTEN in the control of the cell cycle. Here we show that the concomitant inactivation of one Pten allele and one or both Cdkn1b alleles accelerates spontaneous neoplastic transformation and incidence of tumors of various histological origins. Cell proliferation, but not cell survival, is increased in Pten(+/-)/Cdkn1b(-/-)mice. Moreover, Pten(+/-)/Cdkn1b(-/-) mice develop prostate carcinoma at complete penetrance within three months from birth. These cancers recapitulate the natural history and pathological features of human prostate cancer. Our findings reveal the crucial relevance of the combined tumor-suppressive activity of Pten and p27(Kip1) through the control of cell-cycle progression.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Human Genet, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Human Genet, 1275 York Ave, New York, NY 10021 USA.		di cristofano, antonio/AAJ-3796-2020; Di Cristofano, Antonio/B-4148-2016	di cristofano, antonio/0000-0003-2537-3228; Koff, Andrew/0000-0003-3271-3067				Cairns P, 1997, CANCER RES, V57, P4997; Cordon-Cardo C, 1998, JNCI-J NATL CANCER I, V90, P1284, DOI 10.1093/jnci/90.17.1284; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Green JE, 1998, PROSTATE, V36, P59, DOI 10.1002/(SICI)1097-0045(19980615)36:1<59::AID-PROS11>3.0.CO;2-H; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KURMAN RJ, 1985, CANCER, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Macri E, 1998, CANCER METAST REV, V17, P337, DOI 10.1023/A:1006133620914; MCNEAL JE, 1969, CANCER, V23, P24, DOI 10.1002/1097-0142(196901)23:1<24::AID-CNCR2820230103>3.0.CO;2-1; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Osman I, 1997, CLIN CANCER RES, V3, P531; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; PRICE D, 1963, BIOL PROSTATE RELATE, P1; Verma RS, 1999, CANCER INVEST, V17, P441, DOI 10.3109/07357909909021436	18	386	400	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					222	224		10.1038/84879	http://dx.doi.org/10.1038/84879			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175795				2022-12-27	WOS:000166839200028
J	Maleck, K; Levine, A; Eulgem, T; Morgan, A; Schmid, J; Lawton, KA; Dangl, JL; Dietrich, RA				Maleck, K; Levine, A; Eulgem, T; Morgan, A; Schmid, J; Lawton, KA; Dangl, JL; Dietrich, RA			The transcriptome of Arabidopsis thaliana during systemic acquired resistance	NATURE GENETICS			English	Article							ELICITOR-RESPONSIVE ELEMENT; PLANT-DISEASE RESISTANCE; SALICYLIC-ACID; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; LEAF SENESCENCE; HYDROGEN-PEROXIDE; NUCLEAR EVENTS; CELL-DEATH; PR-1 GENE	Infected plants undergo transcriptional reprogramming during initiation of both local defence and systemic acquired resistance (SAR). We monitored gene-expression changes in Arabidopsis thaliana under 14 different SAR-inducing or SAR-repressing conditions using a DNA microarray representing approximately 25-30% of all A. thaliana genes. We derived groups of genes with common regulation patterns, or regulons. The regulon containing PR-1, a reliable marker gene for SAR in A. thaliana, contains known PR genes and novel genes likely to function during SAR and disease resistance. We identified a common promoter element in genes of this regulon that binds members of a plant-specific transcription factor family. Our results extend expression profiling to definition of regulatory networks and gene discovery in plants.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet, Chapel Hill, NC 27599 USA; Syngenta, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Syngenta	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.		Levine, Aaron/E-6495-2010; Bruening, Stefan/B-8505-2011; Levine, Alex/A-6867-2008					Batz O, 1998, BIOL CHEM, V379, P1127, DOI 10.1515/bchm.1998.379.8-9.1127; BI YM, 1995, PLANT J, V8, P235, DOI 10.1046/j.1365-313X.1995.08020235.x; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Delseny M, 1997, FEBS LETT, V403, P221, DOI 10.1016/S0014-5793(97)00075-6; DEPRES D, 2000, PLANT CELL, V12, P279; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; DrogeLaser W, 1997, EMBO J, V16, P726, DOI 10.1093/emboj/16.4.726; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fukuda Y, 1997, PLANT MOL BIOL, V34, P81, DOI 10.1023/A:1005737128339; Glazebrook J, 1997, ANNU REV GENET, V31, P547, DOI 10.1146/annurev.genet.31.1.547; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; Li X, 1999, CELL, V98, P329, DOI 10.1016/S0092-8674(00)81962-5; Maleck K, 1999, TRENDS PLANT SCI, V4, P215, DOI 10.1016/S1360-1385(99)01415-6; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; NEUENSCHWANDER U, 1995, PLANT J, V8, P227, DOI 10.1046/j.1365-313X.1995.08020227.x; Oh SA, 1996, PLANT MOL BIOL, V30, P739, DOI 10.1007/BF00019008; Park JH, 1998, PLANT MOL BIOL, V37, P445, DOI 10.1023/A:1005958300951; Quirino BF, 1999, PLANT MOL BIOL, V40, P267, DOI 10.1023/A:1006199932265; Ruan Y, 1998, PLANT J, V15, P821, DOI 10.1046/j.1365-313X.1998.00254.x; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHINDLER U, 1992, PLANT CELL, V4, P1309, DOI 10.1105/tpc.4.10.1309; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Somssich IE, 1998, TRENDS PLANT SCI, V3, P86, DOI 10.1016/S1360-1385(98)01199-6; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; UKNES S, 1993, MOL PLANT MICROBE IN, V6, P692, DOI 10.1094/MPMI-6-692; VERNOOIJ B, 1994, PLANT CELL, V6, P959, DOI 10.1105/tpc.6.7.959; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; WOLTER M, 1993, MOL GEN GENET, V239, P122, DOI 10.1007/BF00281610; Yang YO, 1996, P NATL ACAD SCI USA, V93, P14972, DOI 10.1073/pnas.93.25.14972; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191	49	752	825	5	107	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					403	410		10.1038/82521	http://dx.doi.org/10.1038/82521			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101835				2022-12-27	WOS:000165671700010
J	Seri, M; Cusano, R; Gangarossa, S; Caridi, G; Bordo, D; Lo Nigro, C; Ghiggeri, GM; Ravazzolo, R; Savino, M; Del Vecchio, M; d'Apolito, M; Iolascon, A; Zelante, LL; Savoia, A; Balduini, CL; Noris, P; Magrini, U; Belletti, S				Seri, M; Cusano, R; Gangarossa, S; Caridi, G; Bordo, D; Lo Nigro, C; Ghiggeri, GM; Ravazzolo, R; Savino, M; Del Vecchio, M; d'Apolito, M; Iolascon, A; Zelante, LL; Savoia, A; Balduini, CL; Noris, P; Magrini, U; Belletti, S		May-Hegglin Fechtner Syndrome Cors	Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes	NATURE GENETICS			English	Article							MYOSIN HEAVY-CHAINS; LEUKOCYTE INCLUSIONS; NONMUSCLE; MACROTHROMBOCYTOPENIA; VARIANT; PROTEIN; GENE	The autosomal dominant, giant-platelet disorders(1), May-Hegglin anomaly(2,3) (MHA; MIM 155100). Fechtner syndrome(4) (FTNS; MIM 153640) and Sebastian syndrome(5) (SBS), share the triad of thrombocytopenia. large platelets and characteristic leukocyte inclusions ('Dohle-like' bodies). MHA and SBS can be differentiated by subtle ultrastructural leukocyte inclusion features, whereas FTNS is distinguished by the additional Alport-like clinical features of sensorineural deafness, cataracts and nephritis(4). The similarities between these platelet disorders and our recent refinement of the MHA (ref. 6) and FTNS (ref. 7) disease loci to an overlapping region of 480 kb on chromosome 22 suggested that all three disorders are allelic. Among the identified candidate genes is the gene encoding nonmuscle myosin heavy chain 9 (MYH9; refs 8-10). which is expressed in platelets(9) and upregulated during granulocyte differentiation(10). We identified six MYH9 mutations (one nonsense and five missense) in seven unrelated probands from MHA. SBS and FTNS families. On the basis of molecular modelling, the two mutations affecting the myosin head were predicted to impose electrostatic and conformational changes, whereas the truncating mutation deleted the unique carboxyterminal tailpiece. The remaining missense mutations, all affecting highly conserved coiled-coil domain positions, imparted destabilizing electrostatic and polar changes. Thus, our results suggest that mutations in MYH9 result in three megakaryocyte/platelet/leukocyte syndromes and are important in the pathogenesis of sensorineural deafness, cataracts and nephritis.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY USA; Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, Struct Neurobiol & Proteom Lab, New York, NY USA; Osped Civile, Clin Pathol Lab, Venice, Italy; Univ Pavia, IRCCS San Matteo, Dept Internal Med, I-27100 Pavia, Italy; Univ Pavia, IRCCS San Matteo, Dept Pathol, I-27100 Pavia, Italy; Univ Bari, Dept Biomed Evolut Age, Bari, Italy; IRCCS Hosp CSS, Med Genet Serv, Foggia, Italy; Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy; IST, Adv Biotechnol Ctr, Genoa, Italy; Inst G Gaslini, Lab Nephrol, Genoa, Italy; Inst G Gaslini, Genet Mol Lab, Genoa, Italy	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Universita degli Studi di Bari Aldo Moro; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Seri, M (corresponding author), Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA.		Ghiggeri, Gian Marco/N-4712-2015; Savoia, Anna/AIC-4560-2022; Caridi, Gianluca/F-7052-2010; Balduini, Carlo L/D-9299-2015; d'Apolito, Maria/G-5793-2012; Iolascon, Achille/A-4461-2014; Savoia, Anna/B-6463-2014; Heath, K. E./ABG-4658-2020; d'Apolito, Maria/AAQ-9290-2021; Heath, Karen Elise/K-7760-2014; Seri, Marco/A-4339-2014	Ghiggeri, Gian Marco/0000-0003-3659-9062; Savoia, Anna/0000-0002-2407-2696; Caridi, Gianluca/0000-0001-6700-3001; Balduini, Carlo L/0000-0001-6121-9311; Savoia, Anna/0000-0002-2407-2696; Heath, K. E./0000-0002-5816-7044; Heath, Karen Elise/0000-0002-5816-7044; Noris, Patrizia/0000-0002-5035-3707; Cusano, Roberto/0000-0001-5543-7881; Seri, Marco/0000-0003-2425-2176	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034045] Funding Source: NIH RePORTER; NCRR NIH HHS [5 M01 RR00071] Funding Source: Medline; NICHD NIH HHS [5 P30 HD28822] Funding Source: Medline; NIDDK NIH HHS [5 R37 DK34045] Funding Source: Medline; Telethon [E.1313] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Telethon(Fondazione Telethon)		BIZZARO N, 1997, MED LAB, V5, P165; CITI S, 1988, J MUSCLE RES CELL M, V9, P306, DOI 10.1007/BF01773874; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; CUSANO R, IN PRESS EUR J HUM G; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; EPSTEIN CJ, 1972, AM J MED, V52, P299, DOI 10.1016/0002-9343(72)90017-4; GREINACHER A, 1990, BLUT, V61, P282, DOI 10.1007/BF01732878; HARRINGTON WF, 1984, ANNU REV BIOCHEM, V53, P35, DOI 10.1146/annurev.bi.53.070184.000343; HEGGLIN R, 1945, Helv Med Acta, V12, P439; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Kunishima S, 1999, HUM GENET, V105, P379, DOI 10.1007/s004390051119; Lalwani AK, 1999, AM J HUM GENET, V64, P318, DOI 10.1086/302216; LUCAS RC, 1975, PROTIDES BIOL FLUIDS, P465; Martignetti JA, 2000, AM J HUM GENET, V66, P1449, DOI 10.1086/302873; May R, 1909, DTSCH ARCH KLIN MED, V96, P1; Mhawech P, 2000, AM J CLIN PATHOL, V113, P176, DOI 10.1309/FC4H-LM5V-VCW8-DNJU; Moxey-Mims MM, 1999, PEDIATR NEPHROL, V13, P782, DOI 10.1007/s004670050700; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Noris P, 1998, AM J MED, V104, P355, DOI 10.1016/S0002-9343(98)00062-X; PETERSON LC, 1985, BLOOD, V65, P397; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; TOOTHAKER LE, 1991, BLOOD, V78, P1826; Toren A, 1999, AM J HUM GENET, V65, P1711, DOI 10.1086/302654; Urato AC, 1998, AM J OBSTET GYNECOL, V179, P260, DOI 10.1016/S0002-9378(98)70283-2; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506	30	320	331	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2000	26	1					103	105						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973259				2022-12-27	WOS:000089078000028
J	Chano, T; Kontani, K; Teramoto, K; Okabe, H; Ikegawa, S				Chano, T; Kontani, K; Teramoto, K; Okabe, H; Ikegawa, S			Truncating mutations of RB1CC1 in human breast cancer	NATURE GENETICS			English	Article							RETINOBLASTOMA GENE; HETEROZYGOSITY; CHROMOSOME-8; CARCINOMA; SITES	The protein RB1CC1 (retinoblastoma 1 (RB1)-inducible coiled-coil 1) has been identified as a key regulator of the tumor-suppressor gene RB1 (ref. 1). RB1CC1 is localized in the nucleus and has been proposed to be a transcription factor because of its nuclear localization signal, leucine zipper motif and coiled-coil structure(1,2). The gene RB1CC1 is localized to a region of chromosome 8q11 (ref. 2) containing several loci of putative tumor-suppressor genes(3,4); however, its role in human cancers remains to be determined. Here we report that 20% (7 of 35) of primary breast cancers examined contained mutations in RB1CC1, including nine large interstitial deletions predicted to yield markedly truncated RB1CC1 proteins. Wildtype RB1CC1 and RB1 were absent or significantly less abundant than normal in the seven cancers with mutations in RB1CC1, but were abundant in cancers without such mutations. In all seven cancers, both RB1CC1 alleles were inactivated; two showed compound heterozygous deletions. Thus, RB1CC1 is frequently mutated in breast cancer and shows characteristics of a classical tumor-suppressor gene.	Shiga Univ Med Sci, Dept Clin Lab Med, Shiga 5202192, Japan; Shiga Univ Med Sci, Dept Surg 2, Shiga 5202192, Japan; RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Tokyo 1088639, Japan	Shiga University of Medical Science; Shiga University of Medical Science; RIKEN	Chano, T (corresponding author), Shiga Univ Med Sci, Dept Clin Lab Med, Shiga 5202192, Japan.		Chano, Tokuhiro/F-5816-2018; Ikegawa, Shiro/N-6895-2015	Chano, Tokuhiro/0000-0002-9959-1183; Ikegawa, Shiro/0000-0003-0316-2147				Bieche I, 2000, MOL CARCINOGEN, V29, P151, DOI 10.1002/1098-2744(200011)29:3<151::AID-MC4>3.3.CO;2-Y; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; CHANO T, IN PRESS GENE; Dahiya R, 1998, INT J ONCOL, V12, P811; Kaelin WG, 1999, BIOESSAYS, V21, P950, DOI 10.1002/(SICI)1521-1878(199911)21:11<950::AID-BIES7>3.0.CO;2-D; KAMB A, 1995, TRENDS GENET, V11, P136, DOI 10.1016/S0168-9525(00)89027-7; LEMOINE NR, 1994, ANN ONCOL, V4, P31; Perinchery G, 1999, INT J ONCOL, V14, P495; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; Taya Y, 1997, TRENDS BIOCHEM SCI, V22, P14, DOI 10.1016/S0968-0004(96)10070-0; THORLACIUS S, 1991, ANTICANCER RES, V11, P1501; VARLEY JM, 1989, ONCOGENE, V4, P725; WADAYAMA B, 1994, CANCER RES, V54, P3042	13	67	69	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					285	288		10.1038/ng911	http://dx.doi.org/10.1038/ng911			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12068296				2022-12-27	WOS:000176494100017
J	Kikuchi, S; Hata, M; Fukumoto, K; Yamane, Y; Matsui, T; Tamura, A; Yonemura, S; Yamagishi, H; Keppler, D; Tsukita, S; Tsukita, S				Kikuchi, S; Hata, M; Fukumoto, K; Yamane, Y; Matsui, T; Tamura, A; Yonemura, S; Yamagishi, H; Keppler, D; Tsukita, S; Tsukita, S			Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes	NATURE GENETICS			English	Article							MULTIDRUG-RESISTANCE PROTEIN; DUBIN-JOHNSON-SYNDROME; EZRIN/RADIXIN/MOESIN ERM PROTEINS; EXPORT PUMP; CELL-ADHESION; DRUG-RESISTANCE; CDNA CLONING; GENE; MOESIN; FAMILY	The ezrin-radixin-moesin (ERM) family of proteins crosslink actin filaments and integral membrane proteins(1-3). Radixin (encoded by Rdx) is the dominant ERM protein in the liver of wildtype mice(4,5) and is concentrated at bile canalicular membranes (BCMs)(5). Here we show that Rdx(-/-) mice are normal at birth, but their serum concentrations of conjugated bilirubin begin to increase gradually around 4 weeks, and they show mild liver injury after 8 weeks. This phenotype is similar to human conjugated hyperbilirubinemia in Dubin-Johnson syndrome(6,7), which is caused by mutations in the multidrug resistance protein 2 (MRP2, gene symbol ABCC2)(8-11), although this syndrome is not associated with overt liver injury. In wildtype mice, Mrp2 concentrates at BCMs to secrete conjugated bilirubin into bile(8,11,12). In the BCMs of Rdx(-/-) mice, Mrp2 is decreased compared with other BCM proteins such as dipeptidyl peptidase IV (CD26) and P-glycoproteins. In vitro binding studies show that radixin associates directly with the carboxy-terminal cytoplasmic domain of human MRP2. These findings indicate that radixin is required for secretion of conjugated bilirubin through its support of Mrp2 localization at BCMs.	Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Prefectural Univ Med, Dept Surg, Kamigyo Ku, Kyoto 6028566, Japan; KAN Res Inst, Shimogyo Ku, Kyoto 6008815, Japan; RIKEN, Ctr Dev Biol, Lab Cellular Morphogenesis, Chuo Ku, Kobe, Hyogo 6500047, Japan; Deutsch Krebsforschungszentrum, Div Tumor Biochem, D-69120 Heidelberg, Germany; Kyoto Univ, Coll Med Technol, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto Prefectural University of Medicine; KAN Research Institute; RIKEN; Helmholtz Association; German Cancer Research Center (DKFZ); Kyoto University	Tsukita, S (corresponding author), Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.	atsukita@mfour.med.kyoto-u.ac.jp	Keppler, Dietrich/A-5528-2013	Keppler, Dietrich/0000-0003-2964-2333; Kikuchi, Shojiro/0000-0002-6217-8352				Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Buchler M, 1996, J BIOL CHEM, V271, P15091; CHILDS S, 1995, CANCER RES, V55, P2029; Cui YH, 1999, MOL PHARMACOL, V55, P929; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; DUBIN IN, 1954, MEDICINE, V33, P155, DOI 10.1097/00005792-195409000-00001; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Kartenbeck J, 1996, HEPATOLOGY, V23, P1061; Keitel V, 2000, HEPATOLOGY, V32, P1317, DOI 10.1053/jhep.2000.19791; Kocher O, 1999, LAB INVEST, V79, P1161; Kondo T, 1997, J CELL BIOL, V139, P749, DOI 10.1083/jcb.139.3.749; Konig J, 1999, BBA-BIOMEMBRANES, V1461, P377, DOI 10.1016/S0005-2736(99)00169-8; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Nies AT, 2002, EUR J BIOCHEM, V269, P1866, DOI 10.1046/j.1432-1033.2002.02832.x; Nies AT, 1998, HEPATOLOGY, V28, P1332, DOI 10.1002/hep.510280523; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Paulusma CC, 1997, HEPATOLOGY, V25, P1539, DOI 10.1002/hep.510250635; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; SATO N, 1992, J CELL SCI, V103, P131; SPRINZ H, 1954, ANN INTERN MED, V41, P952, DOI 10.7326/0003-4819-41-5-952; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	30	260	269	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					320	325		10.1038/ng905	http://dx.doi.org/10.1038/ng905			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12068294				2022-12-27	WOS:000176494100024
J	Anderson, MG; Smith, RS; Hawes, NL; Zabaleta, A; Chang, B; Wiggs, JL; John, SWM				Anderson, MG; Smith, RS; Hawes, NL; Zabaleta, A; Chang, B; Wiggs, JL; John, SWM			Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice	NATURE GENETICS			English	Article							BROWN LOCUS PROTEIN; OCULOCUTANEOUS ALBINISM; DISPERSION SYNDROME; MOUSE MUTATION; IRIS ATROPHY; TYROSINASE; MELANOCYTES; MELANOMA; TYRP1; GP75	Pigmentary glaucoma is a significant cause of human blindness. Abnormally liberated iris pigment and cell debris enter the ocular drainage structures, leading to increased intraocular pressure (IOP) and glaucoma(1-3). DBA/2J (D2) mice develop a form of pigmentary glaucoma involving iris pigment dispersion (IPD) and iris stromal atrophy (ISA)(4,5). Using high-resolution mapping techniques, sequencing and functional genetic tests, we show that IPD and ISA result from mutations in related genes encoding melanosomal proteins. IPD is caused by a premature stop codon mutation in the Gpnmb (Gpnmb(R150X)) gene, as proved by the occurrence of IPD only in D2 mice that are homozygous with respect to Gpnmb(R150X). otherwise, similar D2 mice that are not homozygous for Gpnmb(R150X) do not develop IPD. ISA is caused by the recessive Tyrp1(b) mutant allele and rescued by the transgenic introduction of wildtype Tyrp1. We hypothesize that IPD and ISA alter melanosomes, allowing toxic intermediates of pigment production to leak from melanosomes, causing iris disease and subsequent pigmentary glaucoma. This is supported by the rescue of IPD and ISA in D2 eyes with substantially decreased pigment production. These data indicate that pigment production and mutant melanosomal protein genes may contribute to human pigmentary glaucoma. The fact that hypopigmentation profoundly alleviates the D2 disease indicates that therapeutic strategies designed to decrease pigment production may be beneficial in human pigmentary glaucoma.	Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Howard Hughes Medical Institute; Jackson Laboratory; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Tufts University	John, SWM (corresponding author), Howard Hughes Med Inst, Bar Harbor, ME 04609 USA.		Anderson, Michael/B-4580-2009	Anderson, Michael/0000-0001-5730-6105; Chang, Bo/0000-0001-8259-7290	NATIONAL EYE INSTITUTE [F32EY007015] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY007015] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andersen JS, 1997, ARCH OPHTHALMOL-CHIC, V115, P384, DOI 10.1001/archopht.1997.01100150386012; Anderson MG, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-1; Boissy RE, 1996, AM J HUM GENET, V58, P1145; Boissy RE, 1998, EXP DERMATOL, V7, P198, DOI 10.1111/j.1600-0625.1998.tb00324.x; CAMPBELL DG, 1996, GLAUCOMAS, V2, P975; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; EPSTEIN DL, 1997, CHANDLER GRANTS GLAU, P220; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; HALABAN R, 1990, P NATL ACAD SCI USA, V87, P4809, DOI 10.1073/pnas.87.12.4809; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; JOHNSON R, 1992, NAT GENET, V1, P226, DOI 10.1038/ng0692-226; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; KOBAYASHI T, 1994, J BIOL CHEM, V269, P29198; Kobayashi T, 1998, J BIOL CHEM, V273, P31801, DOI 10.1074/jbc.273.48.31801; Lalouette A, 1998, GENOMICS, V50, P9, DOI 10.1006/geno.1998.5314; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; MOYER FH, 1966, AM ZOOL, V6, P43; Nylander K, 2000, J PATHOL, V190, P39, DOI 10.1002/(SICI)1096-9896(200001)190:1<39::AID-PATH492>3.0.CO;2-V; RITCH R, 1993, AM J OPHTHALMOL, V115, P707, DOI 10.1016/S0002-9394(14)73635-9; Stjernschantz J, 2000, ACTA OPHTHALMOL SCAN, V78, P618, DOI 10.1034/j.1600-0420.2000.078006618.x; SUGAR HS, 1966, AM J OPHTHALMOL, V62, P499; SWANK RT, 1991, GENET RES, V58, P51, DOI 10.1017/S0016672300029608; TAI T, 1983, CANCER RES, V43, P2773; TAYLOR BA, 1996, GENETIC VARIANTS STR, V2, P1597; Turque N, 1996, EMBO J, V15, P3338, DOI 10.1002/j.1460-2075.1996.tb00699.x; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Wistrand PJ, 1997, SURV OPHTHALMOL, V41, pS129, DOI 10.1016/S0039-6257(97)80020-3; ZDARSKY E, 1990, GENETICS, V126, P443	30	327	343	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					81	85		10.1038/ng794	http://dx.doi.org/10.1038/ng794			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743578				2022-12-27	WOS:000173105600018
J	Anikster, Y; Huizing, M; White, J; Shevchenko, YO; Fitzpatrick, DL; Touchman, JW; Compton, JG; Bale, SJ; Swank, RT; Gahl, WA; Toro, JR				Anikster, Y; Huizing, M; White, J; Shevchenko, YO; Fitzpatrick, DL; Touchman, JW; Compton, JG; Bale, SJ; Swank, RT; Gahl, WA; Toro, JR			Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico	NATURE GENETICS			English	Article							LOCUS HETEROGENEITY; VESICLE FORMATION; AP-3 ADAPTER; PROTEINS; DUPLICATION; ALBINISM; SUBUNIT; COMPLEX; MODELS; MOUSE	Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disorder characterized by oculocutaneous albinism and a storage pool deficiency due to an absence of platelet dense bodies(1-3). Lysosomal ceroid lipofuscinosis, pulmonary fibrosis and granulomatous colitis are occasional manifestations of the disease(4). HPS occurs witha frequency of one in 1800 in northwest Puerto Rico(5) due to a founder effect(6). Several non-Puerto Rican patients also have mutations in HPS1(7,8), which produces a protein of unknown function(9). Another gene, ADTB3A, causes HPS in the pearl mouse(10) and in two brothers with HPS-2 (refs. 11,12). ADTB3A encodes a coat protein involved in vesicle formation(3,13), implicating HPS as a disorder of membrane trafficking. We sought to identify other HPS-causing genes(7,8,14). Using homozygosity mapping on pooled DNA of 6 families from central Puerto Rico, we localized a new HPS susceptibility gene to a 1.6-cM interval on chromosome 3q24. The gene, HPS3, has 17 exons, and a putative 113.7-kD product expected to reveal how new vesicles form in specialized cells. The homozygous, disease-causing mutation is a large deletion and represents the secon example of a founder mutation causing HPS on the small island of Puerto Rico. We also present an allele-specific assay for diagnosing individuals heterozygous or homozygous for this mutation.	NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; Univ Minnesota, Dept Lab Med, Minneapolis, MN 55455 USA; Natl Inst Hlth Intramural Sequencing Ctr, NIH, Gaithersburg, MD USA; NIAMSD, Genet Studies Sect, Skin Biol Lab, NIH, Bethesda, MD 20892 USA; Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Roswell Park Cancer Institute	Gahl, WA (corresponding author), NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA.		Huizing, Marjan/AAR-8860-2020		NCI NIH HHS [CA16506] Funding Source: Medline; NHLBI NIH HHS [HL31698] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031698] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANTONARAKIS SE, 2001, METABOLIC MOL BASES, V1, P359; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; Emr SD, 1997, CURR OPIN CELL BIOL, V9, P475, DOI 10.1016/S0955-0674(97)80021-X; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Gahl WA, 1998, NEW ENGL J MED, V338, P1258, DOI 10.1056/NEJM199804303381803; Hazelwood S, 1997, AM J HUM GENET, V61, P1088, DOI 10.1086/301611; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Huizing M, 2000, TRAFFIC, V1, P823, DOI 10.1034/j.1600-0854.2000.011103.x; Iwata F, 2000, OPHTHALMOLOGY, V107, P783, DOI 10.1016/S0161-6420(99)00150-5; KING RA, 2001, METABOLIC MOL BASES, V4, P5587; Luria SE, 1943, GENETICS, V28, P491; McNew JA, 1996, TRENDS BIOCHEM SCI, V21, P54, DOI 10.1016/S0968-0004(96)80181-2; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Oh J, 1998, AM J HUM GENET, V62, P593, DOI 10.1086/301757; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; Sambrook J., 2002, MOL CLONING LAB MANU; SANTIAGOGONZALE.J, 1985, AIBONITO NOTAS HIST; Shotelersuk V, 2000, AM J MED, V108, P423, DOI 10.1016/S0002-9343(99)00436-2; Shotelersuk V, 1998, MOL GENET METAB, V65, P85, DOI 10.1006/mgme.1998.2729; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Swank RT, 1996, LAB ANIM SCI, V46, P56; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Toro J, 1999, ARCH DERMATOL, V135, P774, DOI 10.1001/archderm.135.7.774; Witkop C J, 1990, Bol Asoc Med P R, V82, P333; WITKOP CJ, 1987, AM J HEMATOL, V26, P305, DOI 10.1002/ajh.2830260403	30	153	155	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					376	380		10.1038/ng576	http://dx.doi.org/10.1038/ng576			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11455388				2022-12-27	WOS:000170174800020
J	Gao, B; Gu, JZ; She, CW; Shu, AL; Yang, MS; Tan, Z; Yang, XP; Guo, SZ; Feng, GY; He, L				Gao, B; Gu, JZ; She, CW; Shu, AL; Yang, MS; Tan, Z; Yang, XP; Guo, SZ; Feng, GY; He, L			Mutations in IHH, encoding Indian hedgehog, cause brachydactyly type A-1	NATURE GENETICS			English	Article							SONIC-HEDGEHOG; RECEPTOR; GENE; VERTEBRATE; PROTEIN; DIFFERENTIATION	Brachyclactyly type A-1 (BDA-1; MIM 112500) is characterized by shortening or missing of the middle phalanges (Fig. 1a)(1). It was first identified by Farabee in 1903 (ref. 2), is the first recorded example of a human anomaly with Mendelian autosomal-dominant inheritance and, as such, is cited in most genetic and biological textbooks. Here we show that mutations in IHH, which encodes Indian hedgehog, cause BDA-1. We have identified three heterozygous missense mutations in the region encoding the amino-terminal signaling domain in all affected members of three large, unrelated families. The three mutant amino acids, which are conserved across all vertebrates and invertebrates studied so far, are predicted to be adjacent on the surface of IHH.	Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, BioX Life Sci Res Ctr, Shanghai 200030, Peoples R China; Guiyang Women & Childrens Hosp, Guiyang, Peoples R China; Huaihua Teachers Coll, Dept Biol, Hunan, Peoples R China; Huaihua Med Jr Coll, Hunan, Peoples R China; Chinese Natl Genome Ctr Shanghai, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	He, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.		Yang, Xinping/HGA-6104-2022; Yang(秧), Maosheng(茂盛)/J-9581-2012; Gao, Bo/F-4688-2013; Pillay, Nischalan/F-9536-2012	Yang(秧), Maosheng(茂盛)/0000-0002-0566-6093; Gao, Bo/0000-0002-8684-5199; Yang, Xinping/0000-0003-4086-4180				Bell J., 1951, TREASURY HUMAN INHER, P1; Bosse K, 2000, AM J HUM GENET, V67, P492, DOI 10.1086/303028; Capdevila J, 2000, CELL MOL LIFE SCI, V57, P1682, DOI 10.1007/PL00000651; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; FARABEE W, 1903, THESIS HARVARD U; FITCH N, 1979, J MED GENET, V16, P36, DOI 10.1136/jmg.16.1.36; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; NAOYUKI F, 1999, P NATL ACAD SCI USA, V96, P10992; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WEINSTEIN LS, 1990, P NATL ACAD SCI USA, V87, P8287, DOI 10.1073/pnas.87.21.8287; Yang XP, 2000, AM J HUM GENET, V66, P892, DOI 10.1086/302806	22	174	202	3	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					386	388		10.1038/ng577	http://dx.doi.org/10.1038/ng577			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11455389				2022-12-27	WOS:000170174800022
J	Magre, J; Delepine, M; Khallouf, E; Gedde-Dahl, T; Van Maldergem, L; Sobel, E; Papp, J; Meier, M; Megarbane, A; Lathrop, M; Capeau, J				Magre, J; Delepine, M; Khallouf, E; Gedde-Dahl, T; Van Maldergem, L; Sobel, E; Papp, J; Meier, M; Megarbane, A; Lathrop, M; Capeau, J		BSCL Working Grp	Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13	NATURE GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; GENERALIZED LIPODYSTROPHY; HUMAN GENOME; GK RAT; MAP; EXPRESSION	Congenital generalized lipodystrophy, or Berardinelli-Seip syndrome (BSCL), is a rare autosomal recessive disease characterized by a near-absence of adipose tissue from birth or early infancy and severe insulin resistance(1-4). Other clinical and biological features include acanthosis nigricans, hyperandrogenism, muscular hypertrophy, hepatomegaly, altered glucose tolerance or diabetes mellitus, and hypertriglyceridemia. A locus (BSCL1) has been mapped to 9q34 with evidence of heterogeneity(5). Here, we report a genome screen of nine BSCL families from two geographical clusters (in Lebanon and Norway). We identified a new disease locus, designated BSCL2, within the 2.5-Mb interval flanked by markers D11S4076 and D11S480 on chromosome 11q13. Analysis of 20 additional families of various ethnic origins led to the identification of 11 families in which the disease cosegregates with the 11q13 locus; the remaining families provide confirmation of linkage to 9q34. Sequence analysis of genes located in the 11q13 interval disclosed mutations in a gene homologous to the murine guanine nucleotide-binding protein (G protein), gamma3-linked gene(6) (Gng3lg) in all BSCL2-linked families. BSCL2 is most highly expressed in brain and testis and encodes a protein (which we have called seipin) of unknown function. Most of the variants are null mutations and probably result in a severe disruption of the protein. These findings are of general importance for understanding the molecular mechanisms underlying regulation of body fat distribution and insulin resistance.	Univ Paris 06, Fac Med St Antoine, INSERM, U402, F-75012 Paris, France; Ctr Natl Genotypage, Paris, France; Hotel Dieu France, Serv Pediat, Beirut, Lebanon; Univ Oslo, Inst Forens Med, Oslo, Norway; Univ Oslo, Dept Dermatol, Oslo, Norway; Univ Oslo, Dept Internal Med, Oslo, Norway; Univ Oslo, Dept Pediat, Oslo, Norway; Univ Oslo, Rikshosp, N-0027 Oslo, Norway; Inst Pathol & Genet, Ctr Genet Humaine, Loveral, Belgium; Univ St Joseph, Fac Med, Unite Genet Med, Beirut, Lebanon	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CEA; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; Saint Joseph University Beirut	Magre, J (corresponding author), Univ Paris 06, Fac Med St Antoine, INSERM, U402, 27 Rue Chaligny, F-75012 Paris, France.	magre@st-antoine.inserm.fr	Van Maldergem, Lionel/O-3242-2019; GRIGORESCU, FLORIN/C-2238-2013; Van Maldergem, Lionel/G-9849-2017; MAGRE, Jocelyne/D-4788-2015; Megarbane, Andre/ABD-5574-2021; VERLOES, Alain/E-7287-2014	Van Maldergem, Lionel/0000-0001-8880-5214; GRIGORESCU, FLORIN/0000-0002-3095-5639; Van Maldergem, Lionel/0000-0001-8880-5214; Medina, Jose Luiz/0000-0001-7229-9679; Stephenson, Terence/0000-0001-8871-7847; VERLOES, Alain/0000-0003-4819-0264; SAVASTA, Salvatore/0000-0001-9238-0749; o'rahilly, stephen/0000-0003-2199-4449; Sobel, Eric/0000-0002-1718-0031; Lacombe, Didier/0000-0002-8956-2207				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BERARDINELLI W, 1954, J CLIN ENDOCR METAB, V14, P193, DOI 10.1210/jcem-14-2-193; CORBIN A, 1974, ACTA ENDOCRINOL-COP, V77, P209, DOI 10.1530/acta.0.0770209; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Downes GB, 1998, GENOMICS, V53, P220, DOI 10.1006/geno.1998.5508; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Garg A, 1999, J CLIN ENDOCR METAB, V84, P3390, DOI 10.1210/jc.84.9.3390; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GeddeDahl T, 1996, ACTA PAEDIATR, V85, P52; HUSEMAN C, 1978, J PEDIATR-US, V93, P221, DOI 10.1016/S0022-3476(78)80500-9; Inoue S, 2000, BIOCHEM BIOPH RES CO, V268, P553, DOI 10.1006/bbrc.2000.2170; KROOK A, 1994, DIABETES, V43, P357, DOI 10.2337/diabetes.43.3.357; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LAWRENCE RD, 1946, LANCET, V250, P724; MABRY CC, 1973, J PEDIATR-US, V82, P625, DOI 10.1016/S0022-3476(73)80588-8; MABRY CC, 1972, J PEDIATR-US, V81, P990, DOI 10.1016/S0022-3476(72)80559-6; Moller David E., 1993, P49; Panz VR, 1997, HUM GENET, V101, P118, DOI 10.1007/s004390050598; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SEIP M, 1959, Acta Paediatr, V48, P555; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; VANDERVORM ER, 1993, DIABETOLOGIA, V36, P172, DOI 10.1007/BF00400701; VanMaldergem L, 1996, AM J MED GENET, V64, P506, DOI 10.1002/(SICI)1096-8628(19960823)64:3<506::AID-AJMG12>3.0.CO;2-P; Vigouroux C, 2000, DIABETES, V49, P1958, DOI 10.2337/diabetes.49.11.1958; Vigouroux C, 1997, J CLIN ENDOCR METAB, V82, P3438, DOI 10.1210/jc.82.10.3438; Watanabe TK, 1999, GENOMICS, V58, P233, DOI 10.1006/geno.1999.5789; Yu W, 1997, GENOME RES, V7, P353, DOI 10.1101/gr.7.4.353	30	511	532	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					365	370		10.1038/ng585	http://dx.doi.org/10.1038/ng585			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479539				2022-12-27	WOS:000170174800018
J	Betz, RC; Schoser, BGH; Kasper, D; Ricker, K; Ramirez, A; Stein, V; Torbergsen, T; Lee, YA; Nothen, MM; Wienker, TF; Malin, JP; Propping, P; Reis, A; Mortier, W; Jentsch, TJ; Vorgerd, M; Kubisch, C				Betz, RC; Schoser, BGH; Kasper, D; Ricker, K; Ramirez, A; Stein, V; Torbergsen, T; Lee, YA; Nothen, MM; Wienker, TF; Malin, JP; Propping, P; Reis, A; Mortier, W; Jentsch, TJ; Vorgerd, M; Kubisch, C			Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease	NATURE GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; CAVEOLIN-3; COMPLEX	Hereditary rippling muscle disease (RMD) is an autosomal dominant human disorder characterized by mechanically triggered contractions of skeletal muscle(1-4). Genome-wide linkage analysis has identified an RMD locus on chromosome 3p25. We found missense mutations in positional candidate CAM (encoding caveolin 3; ref. 5) in all five families analyzed. Mutations in CAM have also been described in limb-girdle muscular dystrophy type 1C (LGMD1C; refs. 6,7), demonstrating the allelism of dystrophic and non-dystrophic muscle diseases.	Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Hamburg, Neurol Klin, Hamburg, Germany; Univ Hamburg, Znetrum Mol Neurobiol, Hamburg, Germany; Univ Wurzburg, Neurol Klin, D-8700 Wurzburg, Germany; Univ Tromso Hosp, Dept Neurol, N-9012 Tromso, Norway; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Univ Bonn, Inst Med Biometrie Informat & Epidemiol, D-53111 Bonn, Germany; Ruhr Univ Bochum, Padiatr Klin, D-4630 Bochum, Germany	University of Bonn; University of Hamburg; University of Hamburg; University of Wurzburg; UiT The Arctic University of Tromso; University Hospital of North Norway; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Bonn; Ruhr University Bochum	Kubisch, C (corresponding author), Univ Bonn, Inst Human Genet, Wilhelmstr 31, D-53111 Bonn, Germany.		Betz, Regina C/E-8591-2011; Vorgerd, Matthias/GRS-7540-2022; Reis, André/D-2309-2009; Ramirez, Alfredo/S-5126-2019; Kubisch, Christian/F-1893-2011; Schoser, Benedikt/AAH-6286-2020; Nöthen, Markus/B-2027-2009	Betz, Regina C/0000-0001-5024-3623; Vorgerd, Matthias/0000-0002-1782-4642; Reis, André/0000-0002-6301-6363; Ramirez, Alfredo/0000-0003-4991-763X; Kubisch, Christian/0000-0003-4220-0978; Nöthen, Markus/0000-0002-8770-2464; Stein, Valentin/0000-0003-1222-4928; Schoser, Benedikt/0000-0002-2757-8131; Jentsch, Thomas/0000-0002-3509-2553				Carbone I, 2000, NEUROLOGY, V54, P1373, DOI 10.1212/WNL.54.6.1373; Galbiati F, 1999, J BIOL CHEM, V274, P25632, DOI 10.1074/jbc.274.36.25632; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Herrmann R, 2000, HUM MOL GENET, V9, P2335, DOI 10.1093/oxfordjournals.hmg.a018926; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; RICKER K, 1989, ARCH NEUROL-CHICAGO, V46, P405, DOI 10.1001/archneur.1989.00520400065020; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; STEPHAN DA, 1994, NEUROLOGY, V44, P1915, DOI 10.1212/WNL.44.10.1915; Sunada Y, 2001, HUM MOL GENET, V10, P173, DOI 10.1093/hmg/10.3.173; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tidball JG, 1998, AM J PHYSIOL-CELL PH, V275, pC260, DOI 10.1152/ajpcell.1998.275.1.C260; TORBERGSEN T, 1975, ACTA NEUROL SCAND, V51, P225, DOI 10.1111/j.1600-0404.1975.tb07603.x; Vorgerd M, 1999, NEUROLOGY, V52, P1453, DOI 10.1212/WNL.52.7.1453; Williams G, 1996, AM J PHYSIOL-REG I, V270, pR145, DOI 10.1152/ajpregu.1996.270.1.R145	15	135	141	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					218	219		10.1038/90050	http://dx.doi.org/10.1038/90050			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431690				2022-12-27	WOS:000169656400012
J	Alagramam, KN; Murcia, CL; Kwon, HY; Pawlowski, KS; Wright, CG; Woychik, RP				Alagramam, KN; Murcia, CL; Kwon, HY; Pawlowski, KS; Wright, CG; Woychik, RP			The mouse Ames waltzer hearing-loss mutant is caused by mutation of Pcdh15, a novel protocadherin gene	NATURE GENETICS			English	Article							DEAFNESS	The neuroepithelia of the inner ear contain hair cells that function as mechanoreceptors to transduce sound and motion signals. Mutations affecting these neuroepithelia cause deafness and vestibular dysfunction in humans(1-3). Ames waltzer (av) is a recessive mutation found in mice that causes deafness and a balance disorder associated with the degeneration of inner ear neuroepithelial. Here we report that the gene that harbours the av mutation encodes a novel protocadherin. Cochlear hair cells in the av mutants show abnormal stereocilia by 10 days after birth (P10). This is the first evidence for the requirement of a protocadherin for normal function of the mammalian inner ear.	Case Western Reserve Univ, Dept Pediat, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Oak Ridge Natl Lab, Div Biol, Oak Ridge, TN 37831 USA; Div Genet Engn, Korean Ind Property Off, Seo Ku, Taejon, South Korea; Univ Texas, SW Med Ctr, Dept Otorhinolaryngol, Dallas, TX USA; Pfizer Global Res & Dev, Alameda, CA USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Pfizer	Woychik, RP (corresponding author), Case Western Reserve Univ, Dept Pediat, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA.		Woychik, Richard P/C-8345-2019	Woychik, Richard P/0000-0001-8196-1732	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003420] Funding Source: NIH RePORTER; NICHD NIH HHS [HD07104] Funding Source: Medline; NIDCD NIH HHS [1RO1-DC03420] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alagramam KN, 1999, GENETICS, V152, P1691; Alagramam KN, 2000, HEARING RES, V148, P181, DOI 10.1016/S0378-5955(00)00152-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; BORK JM, IN PRESS AM J HUM GE; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; COOK S, 1993, MOUSE GENOME, V91, P554; Corwin JT, 1998, P NATL ACAD SCI USA, V95, P12080, DOI 10.1073/pnas.95.21.12080; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Kalatzis V, 1998, HUM MOL GENET, V7, P1589, DOI 10.1093/hmg/7.10.1589; OSAKO S, 1971, ACTA OTO-LARYNGOL, V71, P365, DOI 10.3109/00016487109125376; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; SCHAIBLE RH, 1956, MOUSE NEWS LETT, V15, P29; SCHAIBLE RH, 1961, MOUSE NEWS LETT, V24, P38; Suzuki ST, 1996, J CELL BIOCHEM, V61, P531, DOI 10.1002/(SICI)1097-4644(19960616)61:4<531::AID-JCB6>3.0.CO;2-P; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VandenHeuvel GB, 1996, BIOL REPROD, V55, P731, DOI 10.1095/biolreprod55.4.731; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506; Xu Y, 1994, Genet Eng (N Y), V16, P241	19	242	252	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					99	102		10.1038/83837	http://dx.doi.org/10.1038/83837			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138007				2022-12-27	WOS:000166187900024
J	Bomont, P; Cavalier, L; Blondeau, F; Hamida, CB; Belal, S; Tazir, M; Demir, E; Topaloglu, H; Korinthenberg, R; Tuysuz, B; Landrieu, P; Hentati, F; Koenig, M				Bomont, P; Cavalier, L; Blondeau, F; Hamida, CB; Belal, S; Tazir, M; Demir, E; Topaloglu, H; Korinthenberg, R; Tuysuz, B; Landrieu, P; Hentati, F; Koenig, M			The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy	NATURE GENETICS			English	Article							ACTIN-BINDING PROTEIN; INTERMEDIATE FILAMENTS; GENERALIZED DISORDER; DROSOPHILA; DOMAIN; KELCH; NEUROFILAMENTS; DISEASE; ENC-1; SOD1	Disorganization of the neurofilament network is a prominent feature of several neurodegenerative disorders including amyotrophic lateral sclerosis (ALS), infantile spinal muscular atrophy and axonal Charcot-Marie-Tooth disease(1-4). Giant axonal neuropathy (GAN, MIM 256850), a severe, autosomal recessive sensorimotor neuropathy affecting both the peripheral nerves and the central nervous system, is characterized by neurofilament accumulation, leading to segmental distension of the axons(5,6) GAN corresponds to a generalized disorganization of the cytoskeletal intermediate filaments (IFs), to which neurofilaments belong, as abnormal aggregation of multiple tissue-specific IFs has been reported: vimentin in endothelial cells, Schwann cells and cultured skin fibroblasts, and glial fibrillary acidic protein (GFAP) in astrocytes(7-11) Keratin Ifs also seem to be alterated, as most patients present characteristic curly or kinky hairs(12). We report here identification of the gene GAN, which encodes a novel, ubiquitously expressed protein we have named gigaxonin. We found one frameshift, four nonsense and nine missense mutations in GAN of GAN patients. Gigaxonin is composed of an amino-terminal BTB (for Broad-Complex, Tramtrack and Bric a brac) domain followed by a six kelch repeats, which are predicted to adopt a beta -propeller shape(13). Distantly related proteins sharing a similar domain organization have various functions associated with the cytoskeleton. predicting that gigaxonin is a novel and distinct cytoskeletal protein that may represent a general pathological target for other neurodegenerative disorders with alterations in the neurofilament network.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellularie, F-67404 Illkirch Graffenstaden, France; Inst Biol, Inst Genet Humaine, Lab Genet Mol & Chromosom, Montpellier, France; Inst Natl Neurol, Lab Neuropathol & Neurobiol Mol, Tunis, Tunisia; CHU Mustapha, Neurol Serv, Algiers, Algeria; Hacettepe Univ, Dept Pediat Neurol, Ankara, Turkey; Univ Freiburg, Kinderklin, Abt Neuropadiat & Muskelerkrankungen, D-7800 Freiburg, Germany; Istanbul Univ, Cerrahpasa Tip Fak, Div Genet, Dept Pediat, Istanbul, Turkey; Hop Univ Bicetre, Neurol Serv, Dept Pediat, Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Montpellier; Universite de Tunis-El-Manar; Institut National de Neurologie; Hacettepe University; University of Freiburg; Istanbul University; Istanbul University - Cerrahpasa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Koenig, M (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellularie, BP 163,CU Strasbourg, F-67404 Illkirch Graffenstaden, France.	mkoenig@igbmc.u-strasbg.fr	Tüysüz, Beyhan/AAN-4858-2020; Korinthenberg, Rudolf/A-9796-2009; TOPALOGLU, HALUK AYDIN/I-9318-2013; Demir, Ercan/CAA-1553-2022; Bomont, Pascale/GLS-8721-2022; Bomont, Pascale L/Y-5517-2018	Bomont, Pascale/0000-0001-7216-3261; Bomont, Pascale L/0000-0001-7216-3261; Tuysuz, Beyhan/0000-0002-9620-5021; Korinthenberg, Rudolf/0000-0002-4638-3460				Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; ASBURY AK, 1972, ACTA NEUROPATHOL, V20, P237, DOI 10.1007/BF00686905; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Ben Hamida C, 1997, NEUROGENETICS, V1, P129; BENHAMIDA M, 1990, NEUROLOGY, V40, P245; Bousquet O, 1996, CELL MOTIL CYTOSKEL, V33, P115, DOI 10.1002/(SICI)1097-0169(1996)33:2<115::AID-CM4>3.0.CO;2-B; BUISSONNIERE RF, 1989, REV NEUROL, V145, P355; Cavalier L, 2000, EUR J HUM GENET, V8, P527, DOI 10.1038/sj.ejhg.5200476; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; Hernandez MC, 1998, EXP CELL RES, V242, P470, DOI 10.1006/excr.1998.4109; Hernandez MC, 1997, J NEUROSCI, V17, P3038; ITO N, 1994, J MOL BIOL, V238, P794, DOI 10.1006/jmbi.1994.1335; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Julien JP, 1998, BRAIN PATHOL, V8, P759, DOI 10.1111/j.1750-3639.1998.tb00199.x; KRETZSCHMAR HA, 1987, ACTA NEUROPATHOL, V73, P138, DOI 10.1007/BF00693779; Lupski JR, 2000, AM J HUM GENET, V67, P8, DOI 10.1086/302986; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; PENA SDJ, 1982, MUSCLE NERVE, V5, P166, DOI 10.1002/mus.880050215; PRINEAS JW, 1976, J NEUROPATH EXP NEUR, V35, P458, DOI 10.1097/00005072-197607000-00006; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; TREIBERHELD S, 1994, NEUROPEDIATRICS, V25, P89, DOI 10.1055/s-2008-1071592; Tu PH, 1997, LAB INVEST, V76, P441; VONBULOW M, 1995, EXP CELL RES, V219, P407, DOI 10.1006/excr.1995.1246; XU ZS, 1993, J CELL SCI, P101; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; ZEMMOURI R, IN PRESS NEUROMUSCUL; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	29	286	299	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					370	374		10.1038/81701	http://dx.doi.org/10.1038/81701			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062483				2022-12-27	WOS:000165176500032
J	Niemann, S; Muller, U				Niemann, S; Muller, U			Mutations in SDHC cause autosomal dominant paraganglioma, type 3	NATURE GENETICS			English	Article							CHROMOSOME; TUMORS; 11Q23; GENE		Univ Giessen, Inst Human Genet, Giessen, Germany	Justus Liebig University Giessen	Muller, U (corresponding author), Univ Giessen, Inst Human Genet, Giessen, Germany.							Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 1999, HUM GENET, V104, P219, DOI 10.1007/s004390050939; GRUFFERMAN S, 1980, CANCER, V46, P2116, DOI 10.1002/1097-0142(19801101)46:9<2116::AID-CNCR2820460934>3.0.CO;2-S; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; Hirawake H, 1997, CYTOGENET CELL GENET, V79, P132, DOI 10.1159/000134700; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; Niemann S, 1999, NEUROGENETICS, V2, P167, DOI 10.1007/s100480050078; VANDERMEY AGL, 1989, LANCET, V2, P1291	8	701	719	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					268	270		10.1038/81551	http://dx.doi.org/10.1038/81551			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062460				2022-12-27	WOS:000165176500009
J	Tian, XC; Xu, J; Yang, XZ				Tian, XC; Xu, J; Yang, XZ			Normal telomere lengths found in cloned cattle	NATURE GENETICS			English	Article							CELLS; ADULT; MICE		Univ Connecticut, Dept Anim Sci, Storrs, CT 06268 USA; Univ Connecticut, Ctr Biotechnol, Storrs, CT USA	University of Connecticut; University of Connecticut	Yang, XZ (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06268 USA.		Pillay, Nischalan/F-9536-2012					Betts DH, 1999, DEV GENET, V25, P397, DOI 10.1002/(SICI)1520-6408(1999)25:4&lt;397::AID-DVG13&gt;3.0.CO;2-J; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kozik A, 1998, MOL REPROD DEV, V51, P98, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;98::AID-MRD12&gt;3.0.CO;2-Q; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xu J, 2000, BIOL REPROD, V63, P1124, DOI 10.1095/biolreprod63.4.1124; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648	16	123	140	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					272	273		10.1038/81559	http://dx.doi.org/10.1038/81559			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062462				2022-12-27	WOS:000165176500011
J	Alexander, C; Votruba, M; Pesch, UEA; Thiselton, DL; Mayer, S; Moore, A; Rodriguez, M; Kellner, U; Leo-Kottler, B; Auburger, G; Bhattacharya, SS; Wissinger, B				Alexander, C; Votruba, M; Pesch, UEA; Thiselton, DL; Mayer, S; Moore, A; Rodriguez, M; Kellner, U; Leo-Kottler, B; Auburger, G; Bhattacharya, SS; Wissinger, B			OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28	NATURE GENETICS			English	Letter							MITOCHONDRIAL-DNA MUTATION; CLINICAL-FEATURES; LINKAGE ANALYSIS; YEAST; PROTEIN; REGION; LOCUS; IDENTIFICATION; MAINTENANCE; REFINEMENT	Autosomal dominant optic atrophy (ADOA) is the most prevalent hereditary optic neuropathy resulting in progressive loss of visual acuity. centrocoecal scotoma and bilateral temporal atrophy of the optic nerve with an onset within the first two decades of life(1,2). The predominant locus for this disorder (OPA1; MIM 165500) has been mapped to a 1.4-cM interval on chromosome 3q28-q29 flanked by markers D3S3669 and D3S3562 (ref. 3). We established a PAC contig covering the entire OPA1 candidate region of approximately 1 Mb and a sequence skimming approach allowed us to identify a gene encoding a polypeptide of 960 amino acids with homology to dynamin-related GTPases. The gene comprises 28 coding exons and spans more than 40 kb of genomic sequence. Upon sequence analysis. we identified mutations in seven independent families with ADOA. The mutations include missense and nonsense alterations, deletions and insertions, which all segregate with the disease in these families. Because most mutations probably represent null alleles, dominant inheritance of the disease may result from haploinsufficiency of OPA1. OPA1 is widely expressed and is most abundant in the retina. The presence of consensus signal peptide sequences suggests that the product of the gene OPA1 is targeted to mitochondria and may exert its function in mitochondrial biogenesis and stabilization of mitochondrial membrane integrity.	UCL, Inst Ophthalmol, Dept Mol Genet, London, England; Univ Tubingen Hosp, Mol Genet Lab, Tubingen, Germany; Addenbrookes Hosp, Dept Ophthalmol, Cambridge, England; Ctr Med Genet, Sancti Spiritus, Cuba; Free Univ Berlin, Klinikum Benjamin Franklin, Eye Dept, D-12200 Berlin, Germany; Univ Eye Hosp, Dept Pathophysiol Vis & Neuroophthalmol, Tubingen, Germany; Univ Hosp Dusseldorf, Dept Neurol, Dusseldorf, Germany	University of London; University College London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Bhattacharya, SS (corresponding author), UCL, Inst Ophthalmol, Dept Mol Genet, London, England.	smbcssb@ucl.ac.uk; bernd.wissinger@uni-tuebingen.de	Votruba, Marcela/A-6182-2011; Votruba, Marcela/B-7306-2015; Bhattacharya, Shom/N-2926-2016	Votruba, Marcela/0000-0002-7680-9135; Votruba, Marcela/0000-0002-7680-9135; Bhattacharya, Shom/0000-0002-1601-6344				Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Branda SS, 1999, J BIOL CHEM, V274, P22763, DOI 10.1074/jbc.274.32.22763; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Brown J, 1997, ARCH OPHTHALMOL-CHIC, V115, P95, DOI 10.1001/archopht.1997.01100150097016; EIBERG H, 1994, HUM MOL GENET, V3, P977, DOI 10.1093/hmg/3.6.977; GUAN KL, 1993, CURR GENET, V24, P141, DOI 10.1007/BF00324678; HOYT CS, 1980, OPHTHALMOLOGY, V87, P245; JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8; Johnston RL, 1999, OPHTHALMOLOGY, V106, P123, DOI 10.1016/S0161-6420(99)90013-1; Jonasdottir A, 1997, HUM GENET, V99, P115; Kamimoto T, 1998, J BIOL CHEM, V273, P1044, DOI 10.1074/jbc.273.2.1044; Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805; KIVLIN JD, 1983, AM J HUM GENET, V35, P1190; Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3; KJER P, 1983, ACTA OPHTHALMOL, V61, P300; Kubokawa K, 1998, FEBS LETT, V431, P231, DOI 10.1016/S0014-5793(98)00762-5; LUNKES A, 1995, AM J HUM GENET, V57, P968; Lyle WM., 1990, GENETIC RISKS; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Pelloquin L, 1998, BIOCHEM BIOPH RES CO, V251, P720, DOI 10.1006/bbrc.1998.9539; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Staden R, 2000, Methods Mol Biol, V132, P115; Votruba M, 1998, ARCH OPHTHALMOL-CHIC, V116, P351, DOI 10.1001/archopht.116.3.351; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	28	972	1006	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2000	26	2					211	215		10.1038/79944	http://dx.doi.org/10.1038/79944			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017080				2022-12-27	WOS:000089638800021
J	Meijers-Heijboer, H; van den Ouweland, A; Klijn, J; Wasielewski, M; de Snoo, A; Oldenburg, R; Hollestelle, A; Houben, M; Crepin, E; van Veghel-Plandsoen, M; Elstrodt, F; van Duijn, C; Bartels, C; Meijers, C; Schutte, M; McGuffog, L; Thompson, D; Easton, DF; Sodha, N; Seal, S; Barfoot, R; Mangion, J; Chang-Claude, J; Eccles, D; Eeles, R; Evans, DG; Houlston, R; Murday, V; Narod, S; Peretz, T; Peto, J; Phelan, C; Zhang, HX; Szabo, C; Devilee, P; Goldgar, D; Futreal, PA; Nathanson, KL; Weber, BL; Rahman, N; Stratton, MR				Meijers-Heijboer, H; van den Ouweland, A; Klijn, J; Wasielewski, M; de Snoo, A; Oldenburg, R; Hollestelle, A; Houben, M; Crepin, E; van Veghel-Plandsoen, M; Elstrodt, F; van Duijn, C; Bartels, C; Meijers, C; Schutte, M; McGuffog, L; Thompson, D; Easton, DF; Sodha, N; Seal, S; Barfoot, R; Mangion, J; Chang-Claude, J; Eccles, D; Eeles, R; Evans, DG; Houlston, R; Murday, V; Narod, S; Peretz, T; Peto, J; Phelan, C; Zhang, HX; Szabo, C; Devilee, P; Goldgar, D; Futreal, PA; Nathanson, KL; Weber, BL; Rahman, N; Stratton, MR		CHEK2-Breast Canc Consortium	Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations	NATURE GENETICS			English	Article							LI-FRAUMENI-SYNDROME; DNA-DAMAGE CHECKPOINT; CHK2; GENES; P53; PHOSPHORYLATION; FAMILIES; ATM	Mutations in BRCA1 and BRCA2 confer a high risk of breast and ovarian cancer(1), but account for only a small fraction of breast cancer susceptibility(1,2). To find additional genes conferring susceptibility to breast cancer, we analyzed CHEK2 (also known as CHK2), which encodes a cell-cycle checkpoint kinase that is implicated in DNA repair processes involving BRCA1 and p53 (refs 3-5). We show that CHEK2*1100delC, a truncating variant that abrogates the kinase activity(6), has a frequency of 1.1% in healthy individuals. However, this variant is present in 5.1% of individuals with breast cancer from 718 families that do not carry mutations in BRCA1 or BRCA2 (P=0.00000003), including 13.5% of individuals from families with male breast cancer (P=0.00015). We estimate that the CHEK2*1100delC variant results in an approximately twofold increase of breast cancer risk in women and a tenfold increase of risk in men. By contrast, the variant confers no increased cancer risk in carriers of BRCA1 or BRCA2 mutations. This suggests that the biological mechanisms underlying the elevated risk of breast cancer in CHEK2 mutation carriers are already subverted in carriers of BRCA1 or BRCA2 mutations, which is consistent with participation of the encoded proteins in the same pathway.	Inst Canc Res, Haddow Labs, Canc Genet Sect, Sutton SM2 5NG, Surrey, England; Erasmus Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Med Oncol, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Surg Oncol, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Pathol, Rotterdam, Netherlands; Univ Cambridge, Strangeways Res Labs, Canc Res UK Genet Epidemiol Unit, Cambridge CB2 1TN, England; German Canc Res Ctr, Div Epidemiol, D-6900 Heidelberg, Germany; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; St Georges Med Sch, Med Genet Unit, London, England; Womens Coll Hosp, Ctr Res Womens Hlth, Toronto, ON M5S 1B2, Canada; Hadassah Univ Hosp, Sharett Inst Oncol, IL-91120 Jerusalem, Israel; Inst Canc Res, Haddow Labs, Epidemiol Sect, Surrey, England; London Sch Hyg & Trop Med, London WC1, England; Univ Penn, Med Ctr, Dept Hematol Oncol, Philadelphia, PA 19104 USA; Int Agcy Res Canc, F-69372 Lyon, France; Leiden Univ, Dept Pathol Human Genet, Leiden, Netherlands; Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England	University of London; Institute of Cancer Research - UK; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Cancer Research UK; University of Cambridge; Helmholtz Association; German Cancer Research Center (DKFZ); University of Manchester; St Georges University London; University of Toronto; University Toronto Affiliates; Womens College Hospital; Hebrew University of Jerusalem; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of Pennsylvania; World Health Organization; International Agency for Research on Cancer (IARC); Leiden University; Leiden University - Excl LUMC; Wellcome Trust Sanger Institute	Rahman, N (corresponding author), Inst Canc Res, Haddow Labs, Canc Genet Sect, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.		DEVILEE, PETER/ABR-2140-2022; Evans, D Gareth/AAB-4308-2022; Rahman, Nazneen/B-8890-2012; Eccles, Diana/K-6327-2019; Narod, Steven A/AAA-6112-2022; Rahman, Nazneen/D-2802-2013	Evans, D Gareth/0000-0002-8482-5784; Eccles, Diana/0000-0002-9935-3169; Van Duijn, Cornelia/0000-0002-2374-9204; Hollestelle, Antoinette/0000-0003-1166-1966; Nathanson, Katherine/0000-0002-6740-0901; Houlston, Richard/0000-0002-5268-0242; Eeles, Rosalind/0000-0002-3698-6241; Rahman, Nazneen/0000-0003-4376-0440				Ahn JY, 2000, CANCER RES, V60, P5934; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lee SB, 2001, CANCER RES, V61, P8062; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Shieh SY, 2000, GENE DEV, V14, P289; Sodha N, 2002, HUM MUTAT, V19, P173, DOI 10.1002/humu.10031; Sodha N, 2000, Science, V289, P359; Vahteristo P, 2001, CANCER RES, V61, P5718; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200	19	814	838	0	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2002	31	1					55	59		10.1038/ng879	http://dx.doi.org/10.1038/ng879			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967536	Bronze			2022-12-27	WOS:000175362500014
J	Kazantsev, A; Walker, HA; Slepko, N; Bear, JE; Preisinger, E; Steffan, JS; Zhu, YZ; Gertler, FB; Housman, DE; Marsh, JL; Thompson, LM				Kazantsev, A; Walker, HA; Slepko, N; Bear, JE; Preisinger, E; Steffan, JS; Zhu, YZ; Gertler, FB; Housman, DE; Marsh, JL; Thompson, LM			A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila	NATURE GENETICS			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; TRANSGENIC MOUSE MODEL; NUCLEAR-LOCALIZATION; PROTEIN AGGREGATION; GLUTAMINE REPEATS; MUTANT HUNTINGTIN; CELL-DEATH; DISEASE; RECRUITMENT; CHAPERONES	Huntington disease is caused by the expansion of a polyglutamine repeat in the Huntingtin protein (Htt) that leads to degeneration of neurons in the central nervous system and the appearance of visible aggregates within neurons. We have developed and tested suppressor polypeptides that bind mutant Htt and interfere with the process of aggregation in cell culture. In a Drosophila model, the most potent suppressor inhibits both adult lethality and photoreceptor neuron degeneration. The appearance of aggregates in photoreceptor neurons correlates strongly with the occurrence of pathology, and expression of suppressor polypeptides delays and limits the appearance of aggregates and protects photoreceptor neurons. These results suggest that targeting the protein interactions leading to aggregate formation may be beneficial for the design and development of therapeutic agents for Huntington disease.	Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine; Massachusetts Institute of Technology (MIT); University of California System; University of California Irvine; University of California System; University of California Irvine	Thompson, LM (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	lmthomps@uci.edu						Aebischer P, 2001, TRENDS NEUROSCI, V24, P533, DOI 10.1016/S0166-2236(00)01899-3; Bates GP, 1998, BRAIN PATHOL, V8, P699, DOI 10.1111/j.1750-3639.1998.tb00196.x; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chai YH, 1999, J NEUROSCI, V19, P10338; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000; GUSELLA JF, 1995, SEMIN CELL BIOL, V6, P21, DOI 10.1016/1043-4682(95)90011-X; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Kafri T, 2001, CURR OPIN MOL THER, V3, P316; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li H, 1999, HUM MOL GENET, V8, P1227, DOI 10.1093/hmg/8.7.1227; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McGowan DP, 2000, NEUROSCIENCE, V100, P677, DOI 10.1016/S0306-4522(00)00391-2; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; NUDFORA FC, 2001, SCIENCE, V291, P2423; Parkansky N, 1995, SURF COAT TECH, V76, P197, DOI 10.1016/0257-8972(95)02588-X; Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sigurdsson EM, 2000, J NEUROPATH EXP NEUR, V59, P11, DOI 10.1093/jnen/59.1.11; SKINNER PJ, IN PRESS NEURO MOL M; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TROJANOWSKI JQ, 2000, NY ACAD SCI, V924, P62; TRUMAN JW, 1993, DEV DROSOPHILA MELAN; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	60	137	142	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2002	30	4					367	376		10.1038/ng864	http://dx.doi.org/10.1038/ng864			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11925563	Green Published			2022-12-27	WOS:000174682000013
J	Poy, MN; Yang, Y; Rezaei, K; Fernstrom, MA; Lee, AD; Kido, Y; Erickson, SK; Najjar, SM				Poy, MN; Yang, Y; Rezaei, K; Fernstrom, MA; Lee, AD; Kido, Y; Erickson, SK; Najjar, SM			CEACAM1 regulates insulin clearance in liver	NATURE GENETICS			English	Article							RECEPTOR TYROSINE KINASE; FREE FATTY-ACIDS; CELL-ADHESION MOLECULE; APOLIPOPROTEIN-A-I; ENDOGENOUS SUBSTRATE; ADIPOSE-TISSUE; BILIARY GLYCOPROTEIN; PORTAL-VEIN; RESISTANCE; PP120	We hypothesized that insulin stimulates phosphorylation of CEACAM1 which in turn leads to upregulation of receptor-mediated insulin endocytosis and degradation in the hepatocyte. We have generated transgenic mice over-expressing in liver a dominant-negative, phosphorylation-defective S503A-CEACAM1 mutant. Supporting our hypothesis, we found that S503A-CEACAM1 transgenic mice developed hyperinsulinemia resulting from impaired insulin clearance. The hyperinsulinemia caused secondary insulin resistance with impaired glucose tolerance and random, but not fasting, hyperglycemia. Transgenic mice developed visceral adiposity with increased amounts of plasma free fatty acids and plasma and hepatic triglycerides. These findings suggest a mechanism through which insulin signaling regulates insulin sensitivity by modulating hepatic insulin clearance.	Med Coll Ohio, Dept Pharmacol & Therapeut, Toledo, OH 43614 USA; Med Coll Ohio, Dept Phys Therapy, Toledo, OH 43614 USA; Kobe Univ, Sch Med, Dept Internal Med 2, Chuo Ku, Kobe, Hyogo 650, Japan; Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA	Kobe University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Najjar, SM (corresponding author), Med Coll Ohio, Dept Pharmacol & Therapeut, 3035 Arlington Ave,HSci Bldg Room 270, Toledo, OH 43614 USA.		Poy, Matthew/F-6914-2017; Najjar, Sonia M/GXW-2217-2022	Poy, Matthew/0000-0002-4904-2426; 				BACKER JM, 1992, J BIOL CHEM, V267, P1367; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Bergman RN, 2000, DIABETOLOGIA, V43, P946, DOI 10.1007/s001250051474; BISAHA JG, 1995, J BIOL CHEM, V270, P19979, DOI 10.1074/jbc.270.34.19979; BOSELLO O, 1990, ANN NUTR METAB, V34, P359, DOI 10.1159/000177610; CALZI SL, 1997, AM J PHYSIOL, V273, pE801; Chen XH, 1999, J CLIN INVEST, V103, P365, DOI 10.1172/JCI5479; CHEUNG PH, 1993, J BIOL CHEM, V268, P6139; Choice CV, 1998, J BIOL CHEM, V273, P22194, DOI 10.1074/jbc.273.35.22194; Cinti S, 1998, DIABETOLOGIA, V41, P171, DOI 10.1007/s001250050886; DIEM P, 1990, DIABETES, V39, P534, DOI 10.2337/diabetes.39.5.534; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Escobar O, 1999, AM J MED SCI, V317, P282, DOI 10.1097/00000441-199905000-00003; FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; HENNES MMI, 1990, INT J OBESITY, V14, P831; HSIEH JT, 1995, CANCER RES, V55, P190; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; KISSEBAH AH, 1976, DIABETOLOGIA, V12, P563, DOI 10.1007/BF01220632; Koopmans SJ, 1999, METABOLISM, V48, P330, DOI 10.1016/S0026-0495(99)90081-1; LEE AD, 1995, AM J PHYSIOL-REG I, V268, pR997, DOI 10.1152/ajpregu.1995.268.4.R997; LEE CH, 1993, P NATL ACAD SCI USA, V90, P11713, DOI 10.1073/pnas.90.24.11713; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; Mathews ST, 2000, MOL CELL ENDOCRINOL, V164, P87, DOI 10.1016/S0303-7207(00)00237-9; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MONDON CE, 1975, METABOLISM, V24, P153, DOI 10.1016/0026-0495(75)90016-5; NAJJAR SM, 1995, BIOCHEMISTRY-US, V34, P9341, DOI 10.1021/bi00029a009; Najjar SM, 1998, J BIOL CHEM, V273, P12923, DOI 10.1074/jbc.273.21.12923; NAJJAR SM, 1993, J BIOL CHEM, V268, P1201; Najjar SM, 1996, J BIOL CHEM, V271, P8809, DOI 10.1074/jbc.271.15.8809; NESTEL PJ, 1978, METABOLISM, V27, P589, DOI 10.1016/0026-0495(78)90025-2; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; PEIRIS AN, 1986, J CLIN INVEST, V78, P1648, DOI 10.1172/JCI112758; RANDLE PJ, 1965, ANN NY ACAD SCI, V131, P324, DOI 10.1111/j.1749-6632.1965.tb34800.x; RANDLE PJ, 1994, DIABETOLOGIA, V37, P155; REAVEN GM, 1988, DIABETES METAB REV, V4, P639, DOI 10.1002/dmr.5610040703; Rooney DP, 1996, DIABETES, V45, P134, DOI 10.2337/diabetes.45.2.134; ROSENBERG M, 1993, CANCER RES, V53, P4938; RUCH RJ, 1988, CANCER RES, V48, P2519; Soni P, 2000, MOL CELL BIOL, V20, P3896, DOI 10.1128/MCB.20.11.3896-3905.2000; SVEDBERG J, 1990, DIABETES, V39, P570, DOI 10.2337/diabetes.39.5.570; SVEDBERG J, 1991, J CLIN INVEST, V88, P2054, DOI 10.1172/JCI115534; WALSH A, 1989, J BIOL CHEM, V264, P6488	48	190	193	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					270	276		10.1038/ng840	http://dx.doi.org/10.1038/ng840			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11850617				2022-12-27	WOS:000174157600010
J	Yarden, RI; Pardo-Reoyo, S; Sgagias, M; Cowan, KH; Brody, LC				Yarden, RI; Pardo-Reoyo, S; Sgagias, M; Cowan, KH; Brody, LC			BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage	NATURE GENETICS			English	Article							CELL-CYCLE; PHOSPHORYLATION; PROTEIN; CDC25; SERINE-216; LINKAGE; COMPLEX; LINE; ATM	The breast cancer tumor-suppressor gene, BRCA1, encodes a protein with a BRCT domain-a motif that is found in many proteins that are implicated in DNA damage response and in genome stability(1). Phosphorylation of BRCA1 by the DNA damage-response proteins ATM, ATR and hCds1/Chk2 changes in response to DNA damage and at replication-block checkpoints(2-5). Although cells that lack BRCA1 have an abnormal response to DNA damage, the exact role of BRCA1 in this process has remained unclear. Here we show that BRCA1 is essential for activating the Chk1 kinase that regulates DNA damage-induced G2/M arrest. Thus, BRCA1 controls the expression, phosphorylation and cellular localization of Cdc25C and Cdc2/cyclin B kinase-proteins that are crucial for the G2/M transition. We show that BRCA1 regulates the expression of both Wee1 kinase, an inhibitor of Cdc2/cyclin B kinase, and the 14-3-3 family of proteins that sequesters phosphorylated Cdc25C and Cdc2/cyclin B kinase in the cytoplasm(6). We conclude that BRCA1 regulates key effectors that control the G2/M checkpoint and is therefore involved in regulating the onset of mitosis.	NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Nebraska System; University of Nebraska Medical Center	Brody, LC (corresponding author), NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA.							Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Chen JJ, 2000, CANCER RES, V60, P5037; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Foray N, 1999, ONCOGENE, V18, P7334, DOI 10.1038/sj.onc.1203165; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; LEE MS, 1992, MOL BIOL CELL, V3, P73, DOI 10.1091/mbc.3.1.73; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; OCONNOR PM, 1993, J BIOL CHEM, V268, P8298; OGG S, 1994, J BIOL CHEM, V269, P30461; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Tomlinson GE, 1998, CANCER RES, V58, P3237; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	25	388	416	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					285	289		10.1038/ng837	http://dx.doi.org/10.1038/ng837			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11836499				2022-12-27	WOS:000174157600012
J	Weninger, WJ; Mohun, T				Weninger, WJ; Mohun, T			Phenotyping transgenic embryos: a rapid 3-D screening method based on episcopic fluorescence image capturing	NATURE GENETICS			English	Article							GENE-EXPRESSION; 3-DIMENSIONAL RECONSTRUCTION; ATRIOVENTRICULAR JUNCTION; SERIAL SECTIONS; IN-VIVO; MOUSE; HEART; VISUALIZATION; TRISOMY-16; MORPHOLOGY	We describe a technique suitable for routine three-dimensional (3-D) analysis of mouse embryos that is based on episcopic fluorescence images captured during serial sectioning of wax-embedded specimens. We have used this procedure to describe the cardiac phenotype and associated blood vessels of trisomic 16 (Ts16) and Cited2-null mutant mice, as well as the expression pattern of an Myf5 enhancer/beta-galactosidase transgene. The consistency of the images and their precise alignment are ideally suited for 3-D analysis using video animations, virtual resectioning or commercial 3-D reconstruction software packages. Episcopic fluorescence image capturing (EFIC) provides a simple and powerful tool for analyzing embryo and organ morphology in normal and transgenic embryos.	Univ Vienna, Dept Anat, Integrat Morphol Grp, A-1090 Vienna, Austria; Natl Inst Med Res, Dev Biol Div, London NW7 1AA, England	University of Vienna; MRC National Institute for Medical Research	Weninger, WJ (corresponding author), Univ Vienna, Dept Anat, Integrat Morphol Grp, Waehringerstr 16, A-1090 Vienna, Austria.	Wolfgang.Weninger@univie.ac.at; tmohun@nimr.mrc.ac.uk		Weninger, Wolfgang J/0000-0003-0575-0073				Anderson RH, 1998, CARDIOVASC RES, V39, P155, DOI 10.1016/S0008-6363(98)00037-6; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Gambhir SS, 1999, P NATL ACAD SCI USA, V96, P2333, DOI 10.1073/pnas.96.5.2333; Hecksher-Sorensen J, 2001, MECH DEVELOP, V100, P59, DOI 10.1016/S0925-4773(00)00508-6; LAAN AC, 1989, ANAT RECORD, V224, P443, DOI 10.1002/ar.1092240313; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; MCLEAN MR, 1987, ANAT REC, V219, P434, DOI 10.1002/ar.1092190415; Mohun TJ, 2000, DEV BIOL, V218, P74, DOI 10.1006/dbio.1999.9559; ODGAARD A, 1990, J MICROSC-OXFORD, V159, P335, DOI 10.1111/j.1365-2818.1990.tb03038.x; Scarborough J, 1997, J ANAT, V191, P117, DOI 10.1046/j.1469-7580.1997.19110117.x; Smith BR, 1999, SCI AM, V280, P76, DOI 10.1038/scientificamerican0399-76; Spoor F, 2000, J ANAT, V197, P61, DOI 10.1046/j.1469-7580.2000.19710061.x; Streicher J, 2000, NAT GENET, V25, P147, DOI 10.1038/75989; Streicher J, 1997, ANAT REC, V248, P583; Summerbell D, 2000, DEVELOPMENT, V127, P3745; TJUVAJEV JG, 1995, CANCER RES, V55, P6126; Tjuvajev JG, 1996, CANCER RES, V56, P4087; VERBEEK FJ, 1995, 3 DIMENSIONAL RECONS; Webb S, 1997, CARDIOVASC RES, V34, P515, DOI 10.1016/S0008-6363(97)00064-3; WENINGER W, 1995, COMPUTER ASSISTED 3; Weninger WJ, 1998, ANAT EMBRYOL, V197, P341, DOI 10.1007/s004290050144	21	133	136	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					59	65		10.1038/ng785	http://dx.doi.org/10.1038/ng785			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743576				2022-12-27	WOS:000173105600014
J	Brazma, A; Hingamp, P; Quackenbush, J; Sherlock, G; Spellman, P; Stoeckert, C; Aach, J; Ansorge, W; Ball, CA; Causton, HC; Gaasterland, T; Glenisson, P; Holstege, FCP; Kim, IF; Markowitz, V; Matese, JC; Parkinson, H; Robinson, A; Sarkans, U; Schulze-Kremer, S; Stewart, J; Taylor, R; Vilo, J; Vingron, M				Brazma, A; Hingamp, P; Quackenbush, J; Sherlock, G; Spellman, P; Stoeckert, C; Aach, J; Ansorge, W; Ball, CA; Causton, HC; Gaasterland, T; Glenisson, P; Holstege, FCP; Kim, IF; Markowitz, V; Matese, JC; Parkinson, H; Robinson, A; Sarkans, U; Schulze-Kremer, S; Stewart, J; Taylor, R; Vilo, J; Vingron, M			Minimum information about a microarray experiment (MIAME) - toward standards for microarray data	NATURE GENETICS			English	Editorial Material							GENE-EXPRESSION; DNA ARRAYS	Microarray analysis has become a widely used tool for the generation of gene expression data on a genomic scale. Although many significant results have been derived from microarray studies, one limitation has been the lack of standards for presenting and exchanging such data. Here we present a proposal, the Minimum Information About a Microarray Experiment (MIAME), that describes the minimum information required to ensure that microarray data can be easily interpreted and that results derived from its analysis can be independently verified. The ultimate goal of this work is to establish a standard for recording and reporting microarray-based gene expression data, which will in turn facilitate the establishment of databases and public repositories and enable the development of data analysis tools. With respect to MIAME, we concentrate on defining the content and structure of the necessary information rather than the technical format for capturing it.	European Bioinformat Inst, EMBL Outstn, Cambridge CB10 1SD, England; Univ Mediterranee, Ctr Immunol Marseille Luminy, CIML, TAGC, Marseille, France; Inst Genome Res, TIGR, Rockville, MD USA; Stanford Univ, Palo Alto, CA 94304 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Penn, Philadelphia, PA 19104 USA; Harvard Univ, Sch Med, Dept Genet, Cambridge, MA 02138 USA; European Mol Biol Lab, Heidelberg, Germany; Imperial Coll Sch Med Microarray Ctr, CSC, London, England; Rockefeller Univ, New York, NY 10021 USA; Katholieke Univ Leuven, Louvain, Belgium; Univ Utrecht, Med Ctr, Utrecht, Netherlands; GeneLogic Inc, Gaithersburg, MD USA; German Genome Resource Ctr, RZDP, Berlin, Germany; Open Informat, Albuquerque, NM USA; Univ Colorado, Sch Med, Ctr Computat Pharmacol, Denver, CO USA; Max Planck Inst Mol Genet, Berlin, Germany	European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; J. Craig Venter Institute; Stanford University; University of California System; University of California Berkeley; University of Pennsylvania; Harvard University; European Molecular Biology Laboratory (EMBL); Imperial College London; Rockefeller University; KU Leuven; Utrecht University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Max Planck Society	Brazma, A (corresponding author), European Bioinformat Inst, EMBL Outstn, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.		Holstege, Frank/AAM-9944-2021; Yang, Chen/G-1379-2010; Vilo, Jaak/A-7183-2008; Sherlock, Gavin J/E-9110-2012; Ansorge, Wilhelm/AAN-8780-2020; Hingamp, Pascal/AAO-1382-2020; Sherlock, Gavin J/B-1831-2009; Vilo, Jaak/AAK-2228-2020	Vilo, Jaak/0000-0001-5604-4107; Hingamp, Pascal/0000-0002-7463-2444; Vilo, Jaak/0000-0001-5604-4107; Parkinson, Helen/0000-0003-3035-4195; Taylor, Ronald/0000-0001-9777-9767; Sherlock, Gavin/0000-0002-1692-4983; Matese, John/0000-0002-9432-8909; Quackenbush, John/0000-0002-2702-5879; Brazma, Alvis/0000-0001-5988-7409; Sarkans, Ugis/0000-0001-9227-8488; Causton, Helen/0000-0003-4630-6569				Aach J, 2000, GENOME RES, V10, P431, DOI 10.1101/gr.10.4.431; Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478; Brazma A, 2000, NATURE, V403, P699, DOI 10.1038/35001676; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2; 2001, SCIENCE, V292, P1673; 1999, NATURE GENET, V21, P1; 2001, NATURE, V410, P851	12	2973	3072	2	98	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					365	371		10.1038/ng1201-365	http://dx.doi.org/10.1038/ng1201-365			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726920	Bronze			2022-12-27	WOS:000172507500006
J	Kurahashi, H; Emanuel, BS				Kurahashi, H; Emanuel, BS			Unexpected high rate of de novo constitutional t(11;22) translocations in sperm from normal males	NATURE GENETICS			English	Article							IN-SITU HYBRIDIZATION; DOUBLE-STRAND BREAKS; RECIPROCAL TRANSLOCATION; 22Q11 BREAKPOINTS; CLUSTERED 11Q23; FAMILIES	Junction fragments from the constitutional t(11;22)(q23;q11) translocation have previously been cloned and sequenced. Here we report a high incidence of translocation-specific PCR products in sperm DNA from normal individuals. Somatic DNA from these and other normal individuals or from people with chromosomal breakage syndromes do not yield PCR junction fragments, indicating that this translocation originates during meiosis.	Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Emanuel, BS (corresponding author), Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Abramson Res Ctr Bldg,3516 Civ Ctr Blvd, Philadelphia, PA 19104 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA039926] Funding Source: NIH RePORTER; NCI NIH HHS [CA39926] Funding Source: Medline; NICHD NIH HHS [HD26979] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Armstrong SJ, 2000, AM J HUM GENET, V67, P601, DOI 10.1086/303052; Edelmann L, 1999, AM J HUM GENET, V65, P1608, DOI 10.1086/302689; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Estop AM, 1999, HUM GENET, V104, P412, DOI 10.1007/s004390050977; Kurahashi H, 2000, HUM MOL GENET, V9, P2727, DOI 10.1093/hmg/9.18.2727; Kurahashi H, 2000, AM J HUM GENET, V67, P763, DOI 10.1086/303054; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; KURAHASHI H, IN PRESS HUM MOL GEN; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; Nasar F, 2000, MOL CELL BIOL, V20, P3449, DOI 10.1128/MCB.20.10.3449-3458.2000; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Shaikh TH, 1999, AM J HUM GENET, V65, P1595, DOI 10.1086/302666; Van Assche E, 1999, MOL HUM REPROD, V5, P682, DOI 10.1093/molehr/5.7.682; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412	14	60	65	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					139	140		10.1038/ng1001-139	http://dx.doi.org/10.1038/ng1001-139			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586296				2022-12-27	WOS:000171374100017
J	Le Stunff, C; Fallin, D; Bougneres, P				Le Stunff, C; Fallin, D; Bougneres, P			Paternal transmission of the very common class IINSVNTR alleles predisposes to childhood obesity	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCUS IDDM2; INSULIN GENE; VARIABLE NUMBER; MINISATELLITE; EXPRESSION; FETUS; TDT	To identify some of the genetic factors that contribute to obesity in children of Central European and North African descent, we studied the parental transmission of alleles at the insulin locus to offspring with early-onset obesity. A variable nucleotide tandem repeat (VNTR) polymorphism upstream of the insulin gene (INS) is associated with variations in the expression of INS and the nearby gene encoding insulin-like growth factor 2 (IGF2). We found an excess of paternal transmission of class I VNTR alleles to obese children: children who inherited a class I allele from their father (but not those inheriting it from their mother) had a relative risk of early-onset obesity of 1.8. Due to the frequency of class I alleles in this population, this risk concerns 65-70% of all infants. These results suggest that increased in utero expression of paternal INS or IGF2 due to the class I INS VNTR allele may predispose off spring to postnatal fat deposition.	Hop St Vincent de Paul, Dept Pediat Endocrinol, F-75674 Paris, France; Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Johns Hopkins University	Bougneres, P (corresponding author), Hop St Vincent de Paul, Dept Pediat Endocrinol, F-75674 Paris, France.	pbougneres@mageos.com	LE STUNFF, CATHERINE/Y-3270-2018	LE STUNFF, CATHERINE/0000-0001-8419-0451				Battaglia FC, 1998, DIABETES CARE, V21, pB70; Bennett ST, 1996, J AUTOIMMUN, V9, P415, DOI 10.1006/jaut.1996.0057; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Bundred P, 2001, BMJ-BRIT MED J, V322, P326, DOI 10.1136/bmj.322.7282.326; Catalano PM, 1998, DIABETES CARE, V21, pB85; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, P169; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; DUNGER DB, 1998, NAT GENET, V19, P268; Eaves IA, 1999, NAT GENET, V22, P324, DOI 10.1038/11890; FREEMAN JV, 1995, INT J EPIDEMIOL, V24, P970, DOI 10.1093/ije/24.5.970; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; International Obesity Task Force, 1998, OB PREV MAN GLOB EP; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Le Stunff C, 2000, NAT GENET, V26, P444, DOI 10.1038/82579; Lew A, 2000, P NATL ACAD SCI USA, V97, P12508, DOI 10.1073/pnas.97.23.12508; Moore GE, 2001, DIABETES, V50, P199, DOI 10.2337/diabetes.50.1.199; Paquette J, 1998, J BIOL CHEM, V273, P14158, DOI 10.1074/jbc.273.23.14158; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Schaid DJ, 1999, GENET EPIDEMIOL, V16, P250, DOI 10.1002/(SICI)1098-2272(1999)16:3<250::AID-GEPI2>3.0.CO;2-T; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; TANIGUCHI A, 1986, J LIPID RES, V27, P925; Vafiadis P, 1996, J AUTOIMMUN, V9, P397, DOI 10.1006/jaut.1996.0054; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6	28	88	90	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2001	29	1					96	99		10.1038/ng707	http://dx.doi.org/10.1038/ng707			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528401				2022-12-27	WOS:000170781300026
J	Hiroi, Y; Kudoh, S; Monzen, K; Ikeda, Y; Yazaki, Y; Nagai, R; Komuro, I				Hiroi, Y; Kudoh, S; Monzen, K; Ikeda, Y; Yazaki, Y; Nagai, R; Komuro, I			Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation	NATURE GENETICS			English	Letter							HOLT-ORAM-SYNDROME; T-BOX GENES; TRANSCRIPTION FACTORS CSX/NKX-2.5; CONGENITAL HEART-DISEASE; MUTATIONS; LIMB; TINMAN; EXPRESSION; GATA-4; CELLS	The cardiac homeobox protein Nkx2-5 is essential in cardiac development, and mutations in Csx (which encodes Nkx2-5) cause various congenital heart diseases(1-5). Using the yeast two-hybrid system with Nkx2-5 as the 'bait', we isolated the T-box-containing transcription factor Tbx5; mutations in TBX5 cause heart and limb malformations in Holt-Gram syndrome(6-8) (HOS). Co-transfection of Nkx2-5 and Tbx5 into COS-7 cells showed that they also associate with each other in mammalian cells. Glutathione S-transferase (GST) 'pull-down' assays indicated that the N-terminal domain and N-terminal part of the T-box of Tbx5 and the homeodomain of Nkx2-5 were necessary for their interaction. Tbx5 and Nkx2-5 directly bound to the promoter of the gene for cardiac-specific natriuretic peptide precursor type A (Nppa) in tandem, and both transcription factors showed synergistic activation. Deletion analysis showed that both the N-terminal domain and T-box of Tbx5 were important for this transactivation. A G80R mutation of Tbx5, which causes substantial cardiac defects with minor skeletal abnormalities in HOS, did not activate Nppa or show synergistic activation, whereas R237Q, which causes upper-limb malformations without cardiac abnormalities(8). activated the Nppa promoter to a similar extent to that of wildtype Tbx5. P19CL6 cell lines(9,10) overexpressing wildtype Tbx5 started to beat earlier and expressed cardiac-specific genes more abundantly than did parental P19CL6 cells, whereas cell lines expressing the G80R mutant did not differentiate into beating cardiomyocytes. These results indicate that two different types of cardiac transcription factors synergistically induce cardiac development.	Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba, Japan; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; Kanazawa Med Univ, Dept Cardiovasc Med, Kanazawa, Ishikawa, Japan; Int Med Ctr Japan, Tokyo, Japan	Chiba University; University of Tokyo; Kanazawa Medical University; National Center for Global Health & Medicine - Japan	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba, Japan.		Pillay, Nischalan/F-9536-2012					AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; BODMER R, 1993, DEVELOPMENT, V118, P719; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; HabaraOhkubo A, 1996, CELL STRUCT FUNCT, V21, P101, DOI 10.1247/csf.21.101; Horb ME, 1999, DEVELOPMENT, V126, P1739; Hosoda T, 1999, JPN CIRC J, V63, P425, DOI 10.1253/jcj.63.425; Kasahara H, 2000, J CLIN INVEST, V106, P299, DOI 10.1172/JCI9860; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; Li QY, 1997, NAT GENET, V15, P21; Liberatore CM, 2000, DEV BIOL, V223, P169, DOI 10.1006/dbio.2000.9748; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Shiojima I, 1999, J BIOL CHEM, V274, P8231, DOI 10.1074/jbc.274.12.8231; Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Tanaka M, 1998, DEV GENET, V22, P239, DOI 10.1002/(SICI)1520-6408(1998)22:3<239::AID-DVG6>3.3.CO;2-G; Tanaka M, 1999, DEVELOPMENT, V126, P1269	29	435	449	0	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					276	280		10.1038/90123	http://dx.doi.org/10.1038/90123			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431700				2022-12-27	WOS:000169656400022
J	Hovanes, K; Li, TWH; Munguia, JE; Truong, T; Milovanovic, T; Marsh, JL; Holcombe, RF; Waterman, ML				Hovanes, K; Li, TWH; Munguia, JE; Truong, T; Milovanovic, T; Marsh, JL; Holcombe, RF; Waterman, ML			beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer	NATURE GENETICS			English	Article							COLORECTAL-CANCER; ALPHA-ENHANCER; TRANSCRIPTIONAL ACTIVATION; PROTEIN; GENE; TARGET; APC; LOCALIZATION; CARCINOMA; CONTAINS	Constitutive activation of the Wnt signaling pathway is a root cause of many colon cancers(1-3). Activation of this pathway is caused by genetic mutations that stabilize the beta -catenin protein, allowing it to accumulate in the nucleus and form complexes with any member of the lymphoid enhancer factor (LEF1) and T-cell factor (TCF1, TCF3, TCF4) family of transcription factors (referred to collectively as LEF/TCFs) to activate transcription of target genes(3,4). Target genes such as MYC. CCND1. MMP7 and TCF7 (refs, 5-9) are normally expressed in colon tissue, so it has been proposed that abnormal expression levels or patterns imposed by beta -catenin/TCF complexes have a role in tumor progression. We report here that LEF1 is a new type of target gene ectopically activated in colon cancer. The pattern of this ectopic expression is unusual because it derives from selective activation of a promoter for a full-length LEF1 isoform that binds beta -catenin, but not a second, intronic promoter that drives expression of a dominant-negative isoform. beta -catenin/TCF complexes can activate the promoter for full-length LEF1, indicating that in cancer high levels of these complexes misregulate transcription to favor a positive feedback loop for Wnt signaling by inducing selective expression of full-length, beta -catenin-sensitive forms of LEF/TCFs.	Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA USA; Univ Calif Irvine, Irvine Med Ctr, Div Hematol Oncol, Orange, CA 92668 USA; Univ Calif Irvine, Irvine Med Ctr, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Waterman, ML (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.		truong, therese/A-2837-2013	truong, therese/0000-0002-2943-6786	NCI NIH HHS [R01 CA-83982] Funding Source: Medline; NICHD NIH HHS [R01 HD36049, R01 HD36081] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036081, R01HD036049] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA083982] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hovanes K, 2000, NUCLEIC ACIDS RES, V28, P1994, DOI 10.1093/nar/28.9.1994; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 1999, ADV EXP MED BIOL, V470, P23; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; SPOLSKI R, 1988, EUR J IMMUNOL, V18, P295; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VANDEWETERING M, 1992, J BIOL CHEM, V267, P8530; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656	22	399	419	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					53	57		10.1038/88264	http://dx.doi.org/10.1038/88264			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326276				2022-12-27	WOS:000168413300016
J	Nurnberg, P; Thiele, H; Chandler, D; Hohne, W; Cunningham, ML; Ritter, H; Leschik, G; Uhlmann, K; Mischung, C; Harrop, K; Goldblatt, J; Borochowitz, ZU; Kotzot, D; Westermann, F; Mundlos, S; Braun, HS; Laing, N; Tinschert, S				Nurnberg, P; Thiele, H; Chandler, D; Hohne, W; Cunningham, ML; Ritter, H; Leschik, G; Uhlmann, K; Mischung, C; Harrop, K; Goldblatt, J; Borochowitz, ZU; Kotzot, D; Westermann, F; Mundlos, S; Braun, HS; Laing, N; Tinschert, S			Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia	NATURE GENETICS			English	Article							CHROMOSOME 5P	Craniometaphyseal dysplasia (CMD) is a bone dysplasia characterized by overgrowth and sclerosis of the craniofacial bones and abnormal modeling of the metaphyses of the tubular hones. Hyperostosis and sclerosis of the skull may lead to cranial nerve compressions resulting in hearing loss and facial palsy(1,2). An autosomal dominant form of the disorder (MIM 123000) was linked to chromosome 5p15.2-p14.1 (ref. 3) within a region harboring the human homolog (ANKH) of the mouse progressive ankylosis tank) gene(4). The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate(4) (PPi, a major inhibitor of physiologic and pathologic calcification, bone mineralization and bone resorption(5). Here we carry out mutation analysis of ANKH, revealing six different mutations in eight of nine families. The mutations predict single amino acid substitutions, deletions or insertions. Using a helix prediction program, we propose for the ANK molecule 12 membrane-spanning helices with an alternate inside/out orientation and a central channel permitting the passage of PPi. The mutations occur at highly conserved amino acid residues presumed to be located in the cytosolic portion of the protein. Our results link the PPI channel ANK with bone formation and remodeling.	Humboldt Univ, Univ Klinikum Charite, Inst Med Genet, Berlin, Germany; Humboldt Univ, Univ Klinikum Charite, Inst Biochem, Berlin, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Australian Neuromuscular Res Inst, Queen Elizabeth II Med Ctr, Nedlands, WA 6009, Australia; Univ Washington, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Dept Pediat, Childrens Craniofacial Ctr, Seattle, WA 98195 USA; King Edward Mem Hosp, Hlth Dept Western Australia, Genet Serv, Subiaco, WA, Australia; Technion Israel Inst Technol, Fac Med, Bnai Zion Med Ctr, Simon Winter Inst Human Genet, IL-32000 Haifa, Israel; Univ Zurich, Inst Med Genet, Zurich, Switzerland; Univ Cologne, Kinderklin, Cologne, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Western Australia; University of Washington; University of Washington Seattle; Seattle Children's Hospital; King Edward Memorial Hospital; University of Western Australia; Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Zurich; University of Cologne	Nurnberg, P (corresponding author), Humboldt Univ, Univ Klinikum Charite, Inst Med Genet, Berlin, Germany.		Thiele, Holger/ABE-6792-2020; Mundlos, Stefan/ABH-9585-2020; Westermann, Frank/F-7509-2013	Thiele, Holger/0000-0002-0169-998X; Laing, Nigel/0000-0001-5111-3732; Mundlos, Stefan/0000-0002-9788-3166				Andrew LJ, 1999, AM J HUM GENET, V64, P136, DOI 10.1086/302186; BEIGHTON P, 1995, J MED GENET, V32, P370, DOI 10.1136/jmg.32.5.370; CHANDLER D, IN PRESS HUM GENET; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; FLEISCH H, 1981, METAB BONE DIS RELAT, V3, P279, DOI 10.1016/0221-8747(81)90044-8; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; HUGHES AE, 1995, HUM MOL GENET, V4, P1225, DOI 10.1093/hmg/4.7.1225; Iughetti P., 2000, AM J MED GENET, V95, P482; JACKSON WPU, 1954, ARCH INTERN MED, V94, P871, DOI 10.1001/archinte.1954.00250060005001; Nurnberg P, 1997, AM J HUM GENET, V61, P918, DOI 10.1086/514880; OVERHAUSER J, 1994, HUM MOL GENET, V3, P247, DOI 10.1093/hmg/3.2.247; Schwahn B, 1996, MONATSSCHR KINDERH, V144, P1073, DOI 10.1007/s001120050068; SPRANGER J, 1965, Z Kinderheilkd, V93, P64, DOI 10.1007/BF00438568; TAYLOR D B, 1989, Australasian Radiology, V33, P84, DOI 10.1111/j.1440-1673.1989.tb03242.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tinschert S, 1998, AM J MED GENET, V77, P175, DOI 10.1002/(SICI)1096-8628(19980518)77:3<175::AID-AJMG1>3.0.CO;2-P; [No title captured]	18	167	181	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					37	41		10.1038/ng0501-37	http://dx.doi.org/10.1038/ng0501-37			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326272				2022-12-27	WOS:000168413300012
J	Steel, KP; Kros, CJ				Steel, KP; Kros, CJ			A genetic approach to understanding auditory function	NATURE GENETICS			English	Review							OUTER HAIR-CELLS; SYNDROMIC RECESSIVE DEAFNESS; GUINEA-PIG COCHLEA; MYOSIN-VIIA GENE; INNER-EAR; UNCONVENTIONAL MYOSIN; SENSORINEURAL DEAFNESS; NONSYNDROMIC DEAFNESS; DOMINANT DEAFNESS; POTASSIUM CHANNEL	Little is known of the molecular basis of normal auditory function. in contrast to the visual or olfactory senses, in which reasonable amounts of sensory tissue can be gathered, the auditory system has proven difficult to access through biochemical routes, mainly because such small amounts of tissue are available for analysis. Key molecules, such as the transduction channel, may be present in only a few tens of copies per sensory hair cell, compounding the difficulty. Moreover, fundamental differences in the mechanism of stimulation and, most importantly, the speed of response of audition compared with other senses means that we have no well-understood models to provide good candidate molecules for investigation. For these reasons, a genetic approach is useful for identifying the key components of auditory transduction, as it makes no assumptions about the nature or expression level of molecules essential for hearing. We review here some of the major advances in our understanding of auditory function resulting from the recent rapid progress in identification of genes involved in deafness.	Univ Nottingham, Inst Hearing Res, MRC, Nottingham NG7 2RD, England; Univ Sussex, Sch Biol Sci, Brighton, E Sussex, England	University of Nottingham; University of Sussex	Steel, KP (corresponding author), Univ Nottingham, Inst Hearing Res, MRC, Nottingham NG7 2RD, England.	karen@ihr.mrc.ac.uk						Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Beisel KW, 2000, MOL BRAIN RES, V82, P137; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; COREY DP, 1983, J NEUROSCI, V3, P962; Davis AC, 1995, HEARING IN ADULTS; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Dixon MJ, 1999, HUM MOL GENET, V8, P1579, DOI 10.1093/hmg/8.8.1579; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Geleoc GSG, 1999, NAT NEUROSCI, V2, P713, DOI 10.1038/11174; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOUSLEY GD, 1992, J PHYSIOL-LONDON, V448, P73, DOI 10.1113/jphysiol.1992.sp019030; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; JOHNSTONE BM, 1989, J PHYSIOL-LONDON, V408, P77, DOI 10.1113/jphysiol.1989.sp017448; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; KONISHI T, 1978, ACTA OTO-LARYNGOL, V86, P22, DOI 10.3109/00016487809124717; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Letts VA, 2000, MAMM GENOME, V11, P831, DOI 10.1007/s003350010178; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Richardson GP, 1999, ANN NY ACAD SCI, V884, P110; SCHULTE BA, 1994, HEARING RES, V78, P65, DOI 10.1016/0378-5955(94)90045-0; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Self T, 1998, DEVELOPMENT, V125, P557; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; STEEL KP, 1987, HEARING RES, V27, P11, DOI 10.1016/0378-5955(87)90022-0; STEEL KP, GENETICS AUDITORY DI; STEEL KP, IN PRESS MICE MODELS; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; WADA J, 1979, ARCH OTO-RHINO-LARYN, V225, P79, DOI 10.1007/BF00455206; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WANGEMANN P, 1995, HEARING RES, V90, P149, DOI 10.1016/0378-5955(95)00157-2; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; XIA J, 1998, NAT GENET, V21, P363; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	70	204	217	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2001	27	2					143	149		10.1038/84758	http://dx.doi.org/10.1038/84758			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175778				2022-12-27	WOS:000166839200011
J	Moon, AM; Capecchi, MR				Moon, AM; Capecchi, MR			Fgf8 is required for outgrowth and patterning of the limbs	NATURE GENETICS			English	Article							APICAL ECTODERMAL RIDGE; VERTEBRATE LIMB; SONIC-HEDGEHOG; TRANSGENIC MICE; FEEDBACK LOOP; STEM-CELLS; GROWTH; GENE; BUD; INITIATION	The expression pattern and activity of fibroblast growth factor-8 (FGF8) in experimental assays indicate that it has important roles in limb development(1-3), but early embryonic lethality resulting from mutation of Fgf8 in the germ line of mice has prevented direct assessment of these roles(4). Here we report that conditional disruption of Fgf8 in the forelimb of developing mice bypasses embryonic lethality and reveals a requirement for Fgf8 in the formation of the stylopod, anterior zeugopod and autopod. Lack of Fgf8 in the apical ectodermal ridge (AER) alters expression of other Fgf genes, Shh and Bmp2.	Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Human Mol Biol & Genet, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA.			moon, anne/0000-0002-9090-1093	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001373] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Colvin JS, 1999, DEV DYNAM, V216, P72; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; MAHMOOD R, 1995, CURR BIOL, V5, P797, DOI 10.1016/S0960-9822(95)00157-6; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Moon AM, 2000, DEVELOPMENT, V127, P989; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; OHUCHI H, 1994, BIOCHEM BIOPH RES CO, V204, P882, DOI 10.1006/bbrc.1994.2542; REYNOLDS K, 1991, MECH DEVELOP, V36, P15, DOI 10.1016/0925-4773(91)90068-H; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROGALA EJ, 1974, J MED GENET, V11, P221, DOI 10.1136/jmg.11.3.221; Ros MA, 1996, DEVELOPMENT, V122, P2319; ROWE DA, 1981, J EMBRYOL EXP MORPH, V65, P309; RUBIN L, 1972, DEV BIOL, V28, P94, DOI 10.1016/0012-1606(72)90129-7; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Tabin CJ, 1998, NATURE, V396, P322, DOI 10.1038/24516; TANAKA A, 1992, P NATL ACAD SCI USA, V89, P8928, DOI 10.1073/pnas.89.19.8928; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Vogel A, 1996, DEVELOPMENT, V122, P1737; Wolpert L, 1975, Ciba Found Symp, V0, P95; Xu XL, 1998, DEVELOPMENT, V125, P753	30	255	262	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					455	459		10.1038/82601	http://dx.doi.org/10.1038/82601			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101845	Green Accepted			2022-12-27	WOS:000165671700020
J	Fruman, DA; Mauvais-Jarvis, F; Pollard, DA; Yballe, CM; Brazil, D; Bronson, RT; Kahn, CR; Cantley, LC				Fruman, DA; Mauvais-Jarvis, F; Pollard, DA; Yballe, CM; Brazil, D; Bronson, RT; Kahn, CR; Cantley, LC			Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha	NATURE GENETICS			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATORY SUBUNIT; DIFFERENTIAL REGULATION; SKELETAL-MUSCLE; RAT-LIVER; IRS-1; STIMULATION; RESISTANCE; TRANSPORT	Phosphoinositide 3-kinases produce 3'-phosphorylated phosphoinositides that act as second messengers to recruit other signalling proteins to the membrane(1). Pi3ks are activated by many extracellular stimuli and have been implicated in a variety of cellular responses(1). The Pi3k gene family is complex and the physiological roles of different classes and isoforms are not clear. The gene Pik3r1 encodes three proteins (p85 alpha, p55 alpha and p50 alpha) that serve as regulatory subunits of class I-A Pi3ks (ref. 2). Mice lacking only the p85a isoform are viable but display hypoglycaemia and increased insulin sensitivity correlating with upregulation of the p55 alpha and p50 alpha variants(3). Here we report that loss of all protein products of Pik3r1 results in perinatal lethality. We observed, among other abnormalities, extensive hepatocyte necrosis and chylous ascites, We also noted enlarged skeletal muscle fibres, brown fat necrosis and calcification of cardiac tissue. In liver and muscle, loss of the major regulatory isoform caused a great decrease in expression and activity of class I-A Pi3k catalytic subunits: nevertheless, homozygous mice still displayed hypoglycaemia, lower insulin levels and increased glucose tolerance. Our findings reveal that p55 alpha and/or p50 alpha are required for survival, but not for development of hypoglycaemia, in mice lacking p85 alpha.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Signal Transduct, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Tufts Sch Vet Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Cantley, LC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Signal Transduct, Boston, MA 02215 USA.		Kahn, Ronald/AAY-2435-2021; Cantley, Lewis C/D-1800-2014	Kahn, Ronald/0000-0002-7583-9228; Cantley, Lewis C/0000-0002-1298-7653	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890, R37GM041890] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK55545] Funding Source: Medline; NIGMS NIH HHS [R01 GM041890, GM41890] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Egawa K, 1999, J BIOL CHEM, V274, P14306, DOI 10.1074/jbc.274.20.14306; Folli F, 1997, GASTROENTEROLOGY, V113, P954, DOI 10.1016/S0016-5085(97)70192-6; FRANK J, 1997, RETINOIDS, V13, P88; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Inukai K, 1997, J BIOL CHEM, V272, P7873, DOI 10.1074/jbc.272.12.7873; Jiang BH, 1998, P NATL ACAD SCI USA, V95, P14179, DOI 10.1073/pnas.95.24.14179; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kim YB, 1999, DIABETES, V48, P310, DOI 10.2337/diabetes.48.2.310; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Misra S, 1999, P NATL ACAD SCI USA, V96, P5814, DOI 10.1073/pnas.96.10.5814; Misra S, 1998, J BIOL CHEM, V273, P26638, DOI 10.1074/jbc.273.41.26638; PONS S, 1995, MOL CELL BIOL, V15, P4453; PRESS OW, 1982, ANN INTERN MED, V96, P358, DOI 10.7326/0003-4819-96-3-358; Sharma PM, 1997, MOL CELL BIOL, V17, P7386, DOI 10.1128/MCB.17.12.7386; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Shepherd PR, 1997, J BIOL CHEM, V272, P19000, DOI 10.1074/jbc.272.30.19000; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	28	228	237	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					379	382		10.1038/81715	http://dx.doi.org/10.1038/81715			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062485				2022-12-27	WOS:000165176500034
J	Gilad, Y; Segre, D; Skorecki, K; Nachman, MW; Lancet, D; Sharon, D				Gilad, Y; Segre, D; Skorecki, K; Nachman, MW; Lancet, D; Sharon, D			Dichotomy of single-nucleotide polymorphism haplotypes in olfactory receptor genes and pseudogenes	NATURE GENETICS			English	Letter							HUMAN LIPOPROTEIN-LIPASE; STATISTICAL TESTS; DNA POLYMORPHISM; DIVERSITY; EVOLUTION; CLUSTER; HUMAN-CHROMOSOME-17; RECOMBINATION; NEUTRALITY; ANCESTRY	Substantial efforts are focused on identifying single-nucleotide polymorphisms (SNPs) throughout the human genome, particularly in coding regions (cSNPs), for both linkage disequilibrium and association studies(1,2). Less attention, however, has been directed to the clarification of evolutionary processes that are responsible for the variability in nucleotide diversity among different regions of the genome(3). We report here the population sequence diversity of genomic segments within a 450-kb cluster(4,5) of olfactory receptor (OR) genes(6,7) on human chromosome 17. We found a dichotomy in the pattern of nucleotide diversity between OR pseudogenes and introns on the one hand and the closely interspersed intact genes on the other. We suggest that weak positive selection is responsible for the observed patterns of genetic variation. This is inferred from a lower ratio of polymorphism to divergence in genes compared with pseudogenes or introns, high non-synonymous substitution rates in OR genes. and a small but significant overall reduction in variability in the entire OR gene cluster compared with other genomic regions. The dichotomy among functionally different segments within a short genomic distance requires high recombination rates within this OR cluster. Our work demonstrates the impact of weak positive selection on human nucleotide diversity, and has implications for the evolution of the olfactory repertoire.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Crown Human Genome Ctr, IL-76100 Rehovot, Israel; Technion Israel Inst Technol, Fac Med, Mol Med Lab, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Dept Nephrol, Haifa, Israel; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Weizmann Institute of Science; Weizmann Institute of Science; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Arizona	Lancet, D (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.		Sharon, Dror/P-4539-2015; Segrè, Daniel/A-1993-2009	Sharon, Dror/0000-0002-1789-5811; Segrè, Daniel/0000-0003-4859-1914	NIDCD NIH HHS [DC00305] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; FU YX, 1993, GENETICS, V133, P693; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; HUDSON RR, 1987, GENETICS, V116, P153; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; LI WH, 1991, GENETICS, V129, P513; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MIYAMOTO MM, 1987, SCIENCE, V238, P369, DOI 10.1126/science.3116671; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Nachman MW, 1998, GENETICS, V150, P1133; NACHMAN MW, IN PRESS GENETICS; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; OHTA T, 1995, J MOL EVOL, V40, P56, DOI 10.1007/BF00166595; PAYSEUR BA, IN PRESS GENETICS; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; Sherry ST, 1999, GENOME RES, V9, P677; SIMONSEN KL, 1995, GENETICS, V141, P413; TAJIMA F, 1989, GENETICS, V123, P585; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	30	72	76	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					221	224		10.1038/79957	http://dx.doi.org/10.1038/79957			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017082				2022-12-27	WOS:000089638800023
J	Gonzalez-Suarez, E; Samper, E; Flores, JM; Blasco, MA				Gonzalez-Suarez, E; Samper, E; Flores, JM; Blasco, MA			Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis	NATURE GENETICS			English	Article							IMMORTAL HUMAN-CELLS; HUMAN TUMOR-CELLS; MOUSE TELOMERASE; CANCER; RAS; CARCINOGENESIS; PAPILLOMAS; INHIBITION; EXPRESSION; SUBUNIT	Inhibition of telomerase is proposed to limit the growth of cancer cells by triggering telomere shortening and cell death(1-9). Telomere maintenance by telomerase is sufficient, in some cell types, to allow immortal growth(1-5). Telomerase has been shown to cooperate with oncogenes in transforming cultured primary human cells into neoplastic cells, suggesting that telomerase activation contributes to malignant transformation(6). Moreover. telomerase inhibition in human tumour cell lines using dominant-negative versions of TERT leads to telomere shortening and cell death(7,8). These findings have led to the proposition that telomerase inhibition may result in cessation of tumour growth(9). The absence of telomerase from most normal cells supports the potential efficacy of anti-telomerase drugs for tumour therapy, as its inhibition is unlikely to have toxic effects. Mice deficient for Terc RNA (encoding telomerase) lack telomerase activity, and constitute a model for evaluating the role of telomerase and telomeres in tumourigenesis(10). Late-generation Terc(-/-) mice show defects in proliferative tissues(10-15) and a moderate increase in the incidence of spontaneous tumours in highly proliferative cell types (lymphomas, teratocarcinomas(12)). The appearance of these tumours is thought to be a consequence of chromosomal instability in these mice(10,12,16,17). These observations have challenged the expected effectiveness of anti-telomerase-based cancer therapies(18). Different cell types may nonetheless vary in their sensitivity to the chromosomal instability produced by telomere lost; or to the activation of telomere-rescue mechanisms. Here we show that late-generation Terc(-/-) mice, which have short telomeres and are telomerase-deficient(10), are resistant to tumour development in multi-stage skin carcinogenesis. Our results predict that an anti-telomerase-based tumour therapy may be effective in epithelial tumours.	Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid, Spain; Univ Complutense Madrid, Fac Vet, Dept Anim Pathol 2, Madrid, Spain	Complutense University of Madrid	Blasco, MA (corresponding author), Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid, Spain.	mblasco@cnb.uam.es	Gonzalez-Suarez, Eva/L-6298-2014; Blasco, Maria A./M-1694-2014	Gonzalez-Suarez, Eva/0000-0003-0858-8171; Blasco, Maria A./0000-0002-4211-233X				BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BALMAIN A, 1992, PRINCESS TAKAMATSU S, V22, P97; Bednarek AK, 1997, MOL CARCINOGEN, V20, P329, DOI 10.1002/(SICI)1098-2744(199712)20:4<329::AID-MC1>3.0.CO;2-E; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; de Lange T, 1999, CELL, V98, P273, DOI 10.1016/S0092-8674(00)81955-8; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HECKNER E, 1982, CARCINOGENESIS COMPR; HENNINGS H, 1994, KERATINOCYTE METHODS, P21; Herrera E, 2000, EMBO J, V19, P472, DOI 10.1093/emboj/19.3.472; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423; Zumstein LA, 1999, NAT MED, V5, P1129, DOI 10.1038/13451	30	269	286	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					114	117		10.1038/79089	http://dx.doi.org/10.1038/79089			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973262				2022-12-27	WOS:000089078000031
J	Hong, SE; Shugart, YY; Huang, DT; Shahwan, SA; Grant, PE; Hourihane, JOB; Martin, NDT; Walsh, CA				Hong, SE; Shugart, YY; Huang, DT; Shahwan, SA; Grant, PE; Hourihane, JOB; Martin, NDT; Walsh, CA			Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations	NATURE GENETICS			English	Article							NEURONAL MIGRATION; CORTICAL DEVELOPMENT; VLDL RECEPTOR; REELIN GENE; PROTEIN; EXPRESSION; SEQUENCE; ENCODES; CORTEX; MICE	Normal development of the cerebral cortex requires long-range migration of cortical neurons from proliferative regions deep in the brain. Lissencephaly ("smooth brain." from "lissos," meaning smooth, and "encephalos," meaning brain) is a severe developmental disorder in which neuronal migration is impaired, leading to a thickened cerebral cortex whose normally folded contour is simplified and smooth. Two identified lissencephaly genes(1-3) do not account for all known cases(4), and additional lissencephaly syndromes have been described(5). An autosomal recessive form of lissencephaly (LCH) associated with severe abnormalities of the cerebellum, hippocampus and brainstem maps to chromosome 7q22, and is associated with two independent mutations in the human gene encoding reelin (RELN). The mutations disrupt splicing of RELN cDNA, resulting in low or undetectable amounts of reelin protein. LCH parallels the reeler mouse mutant (Reln(rl)). in which Rein mutations cause cerebellar hypoplasia, abnormal cerebral cortical neuronal migration and abnormal axonal connectivity(6,7). RELN encodes a large (388 kD) secreted proteins that acts on migrating cortical neurons by binding to the very low density lipoprotein receptor (VLDLR), the apolipoprotein E receptor 2 (ApoER2; refs 9-11), alpha 3 beta 1 integrin(12) and protocadherins(13). Although reelin was previously thought to function exclusively in brain, some humans with RELN mutations show abnormal neuromuscular connectivity and congenital lymphoedema, suggesting previously unsuspected functions for reelin in and outside of the brain.	Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Neurogenet, Boston, MA 02115 USA; Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD USA; Riyadh Armed Forces Hosp, Dept Pediat, Riyadh, Saudi Arabia; Riyadh Armed Forces Hosp, Dept Neurosci, Riyadh, Saudi Arabia; Massachusetts Gen Hosp, Dept Radiol, Serv Neuroradiol, Boston, MA 02114 USA; Kent & Canterbury Hosp, Dept Pediat, Canterbury, Kent, England	Harvard University; Beth Israel Deaconess Medical Center; Johns Hopkins University; Prince Sultan Military Medical City; Prince Sultan Military Medical City; Harvard University; Massachusetts General Hospital; University of Kent	Walsh, CA (corresponding author), Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Neurogenet, Boston, MA 02115 USA.		Grant, Peter/HIR-3733-2022	Grant, Patricia/0000-0003-1005-4013; Walsh, Christopher/0000-0002-0156-2238	NINDS NIH HHS [P01 NS39404, R01 NS38097, R01 NS35129] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039404, R01NS038097, R01NS035129] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Rouvroit CL, 1999, EXP NEUROL, V156, P229, DOI 10.1006/exnr.1999.7019; de Rouvroit CL, 1998, GENOMICS, V53, P246, DOI 10.1006/geno.1998.5523; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; des Portes V, 1998, CELL, V92, P51; DeSilva U, 1997, GENOME RES, V7, P157, DOI 10.1101/gr.7.2.157; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gonzalez JL, 1997, J NEUROSCI, V17, P9204; GUYER M, 1992, SCIENCE, V258, P67; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; HOURIHANE JO, 1993, NEUROPEDIATRICS, V24, P43, DOI 10.1055/s-2008-1071511; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Royaux I, 1997, GENOMICS, V42, P479, DOI 10.1006/geno.1997.4772; Royaux I, 1997, GENOMICS, V46, P240, DOI 10.1006/geno.1997.4983; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Smalheiser NR, 2000, P NATL ACAD SCI USA, V97, P1281, DOI 10.1073/pnas.97.3.1281; Takahara T, 1996, HUM MOL GENET, V5, P989, DOI 10.1093/hmg/5.7.989; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7	28	609	635	1	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					93	96		10.1038/79246	http://dx.doi.org/10.1038/79246			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973257				2022-12-27	WOS:000089078000026
J	Kurdistani, SK; Robyr, D; Tavazoie, S; Grunstein, M				Kurdistani, SK; Robyr, D; Tavazoie, S; Grunstein, M			Genome-wide binding map of the histone deacetylase Rpd3 in yeast	NATURE GENETICS			English	Article							CHROMATIN REMODELING COMPLEX; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; TRANSCRIPTIONAL REPRESSION; TARGETED RECRUITMENT; COREPRESSOR; ACETYLATION; COMPONENT; PROTEINS; UME6	We describe the genome-wide distribution of the histone deacetylase and repressor Rpd3 and its associated proteins Ume1 and Ume6 in Saccharomyces cerevisiae. Using a new cross-linking protocol, we found that Rpd3 binds upstream of many individual genes and upstream of members of gene classes with similar functions in anabolic processes. In addition, Rpd3 is preferentially associated with promoters that direct high transcriptional activity. We also found that Rpd3 was absent from large sub-telomeric domains. We show by co-immunoprecipitation and by the high similarity of their binding maps that Ume1 interacts with Rpd3. In contrast, despite the known role of Ume6 in Rpd3 recruitment, only a limited number of the genes targeted by Rpd3 are also enriched for (or targeted by) Ume6. This suggests that Rpd3 is brought to many promoters by alternative recruiters, some of which may bind the putative cis-regulatory DNA elements that we have identified in sets of Rpd3 target genes. Finally, we show that comparing the genome-wide pattern of Rpd3 binding with gene expression and histone acetylation in the rpd3Delta mutant strain reveals new sites of Rpd3 function.	Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Princeton Univ, Lewis Thomas Labs, Dept Mol Biol, Princeton, NJ USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Princeton University	Grunstein, M (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.			Kurdistani, Siavash/0000-0003-3295-3511				Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Loewith R, 2001, J BIOL CHEM, V276, P24068, DOI 10.1074/jbc.M102176200; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Pemberton LF, 1997, MOL CELL BIOL, V17, P4830, DOI 10.1128/MCB.17.8.4830; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Waterborg JH, 2001, BIOCHEMISTRY-US, V40, P2599, DOI 10.1021/bi002480c; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	30	226	230	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					248	254		10.1038/ng907	http://dx.doi.org/10.1038/ng907			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12089521				2022-12-27	WOS:000176494100011
J	Morrish, TA; Gilbert, N; Myers, JS; Vincent, BJ; Stamato, TD; Taccioli, GE; Batzer, MA; Moran, JV				Morrish, TA; Gilbert, N; Myers, JS; Vincent, BJ; Stamato, TD; Taccioli, GE; Batzer, MA; Moran, JV			DNA repair mediated by endonuclease-independent LINE-1 retrotransposition	NATURE GENETICS			English	Article							STRAND BREAK-REPAIR; HAMSTER OVARY CELL; REVERSE-TRANSCRIPTASE; V(D)J RECOMBINATION; MUSCULAR-DYSTROPHY; GENE; INSERTION; ELEMENT; ENCODES; RNA	Long interspersed elements (LINE-1s) are abundant retrotransposons in mammalian genomes that probably retrotranspose by target site-primed reverse transcription (TPRT)(1,2). During TPRT, the LINE-1 endonuclease cleaves genomic DNA 3, freeing a 3 hydroxyl that serves as a primer for reverse transcription of LINE-1 RNA by LINE-1 reverse transcriptase. The nascent LINE-1 cDNA joins to genomic DNA, generating LINE-1 structural hallmarks such as frequent 5' truncations, a 3' poly( A)(+) tail and variable-length target site duplications (TSDs)(2). Here we describe a pathway for LINE-1 retrotransposition in Chinese hamster ovary (CHO) cells that acts independently of endonuclease but is dependent upon reverse transcriptase. We show that endonuclease-independent LINE-1 retrotransposition occurs at near-wildtype levels in two mutant cell lines that are deficient in nonhomologous end-joining (NHEJ). Analysis of the pre- and post-integration sites revealed that endonuclease-independent retrotransposition results in unusual structures because the LINE-1s integrate at atypical target sequences, are truncated predominantly at their 3 ends and lack TSDs. Moreover, two of nine endonuclease-independent retrotranspositions contained cDNA fragments at their 3 ends that are probably derived from the reverse transcription of endogenous mRNA. Thus, our results suggest that LINE-1s can integrate into DNA lesions, resulting in retrotransposon-mediated DNA repair in mammalian cells.	Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48105 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48105 USA; Louisiana State Univ, Biol Computat & Visualizat Ctr, Dept Biol Sci, Baton Rouge, LA USA; Lankenau Inst Med Res, Wynnewood, PA USA; Boston Univ, Sch Med, Dept Microbiol, Boston, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University; Lankenau Medical Center; Lankenau Institute for Medical Research; Boston University	Moran, JV (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, 1241 E Catherine St, Ann Arbor, MI 48105 USA.		Gilbert, Nicolas/M-9568-2018	Gilbert, Nicolas/0000-0003-3311-7494; Morrish, Tammy/0000-0002-6725-0253				BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Carroll ML, 2001, J MOL BIOL, V311, P17, DOI 10.1006/jmbi.2001.4847; CHAMBEYRON S, 2002, J BIOL CHEM     0306; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FULLER LF, 1988, MUTAT RES, V193, P109, DOI 10.1016/0167-8817(88)90041-7; GIACCIA AJ, 1990, AM J HUM GENET, V47, P459; Higashiyama T, 1997, EMBO J, V16, P3715, DOI 10.1093/emboj/16.12.3715; Kojima T, 2000, MOL BRAIN RES, V75, P121, DOI 10.1016/S0169-328X(99)00313-7; Kondo-Iida E, 1999, HUM MOL GENET, V8, P2303, DOI 10.1093/hmg/8.12.2303; Levin HL, 1997, CELL, V88, P5, DOI 10.1016/S0092-8674(00)81851-6; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; MAGER DL, 1985, NUCLEIC ACIDS RES, V13, P6559, DOI 10.1093/nar/13.18.6559; Moran J.V., 2002, MOBILE DNA, P836; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Pardue ML, 1997, GENETICA, V100, P73, DOI 10.1023/A:1018352706024; Priestley A, 1998, NUCLEIC ACIDS RES, V26, P1965, DOI 10.1093/nar/26.8.1965; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; STAMATO TD, 1983, SOMAT CELL GENET, V9, P165, DOI 10.1007/BF01543175; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; VOLIVA CF, 1984, J MOL BIOL, V178, P795, DOI 10.1016/0022-2836(84)90312-7; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001	30	332	342	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					159	165		10.1038/ng898	http://dx.doi.org/10.1038/ng898			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12006980				2022-12-27	WOS:000175903500011
J	Hearn, T; Renforth, GL; Spalluto, C; Hanley, NA; Piper, K; Brickwood, S; White, C; Connolly, V; Taylor, JFN; Russell-Eggitt, I; Bonneau, D; Walker, M; Wilson, DI				Hearn, T; Renforth, GL; Spalluto, C; Hanley, NA; Piper, K; Brickwood, S; White, C; Connolly, V; Taylor, JFN; Russell-Eggitt, I; Bonneau, D; Walker, M; Wilson, DI			Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; CANDIDATE; LINKAGE	Alstrom syndrome (OMIM 203800) is an autosomal recessive disease, characterized by cone-rod retinal dystrophy, cardiomyopathy and type 2 diabetes mellitus, that has been mapped to chromosome 2p13 (refs 1-5). We have studied an individual with Alstrom syndrome carrying a familial balanced reciprocal chromosome translocation (46, XY, t(2;11)(p13; q21)mat) involving the previously implicated critical region. We postulated that this individual was a compound heterozygote, carrying one copy of a gene disrupted by the translocation and the other copy disrupted by an intragenic mutation. We mapped the 2p13 breakpoint on the maternal allele to a genomic fragment of 1.7 kb which contains exon 4 and the start of exon 5 of a newly discovered gene (ALMS1); we detected a frameshift mutation in the paternal copy of the gene. The 12.9-kb transcript of ALMS1 encodes a protein of 4,169 amino acids whose function is unknown. The protein contains a large tandem-repeat domain comprising 34 imperfect repetitions of 47 amino acids. We have detected six different mutations (two nonsense and four frameshift mutations causing premature stop codons) in seven families, confirming that ALMS1 is the gene underlying Alstrom syndrome. We believe that ALMS1 is the first human disease gene characterized by autosomal recessive inheritance to be identified as a result of a balanced reciprocal translocation.	Univ Southampton, Southampton Gen Hosp, Div Human Genet, Southampton SO16 6YD, Hants, England; Newcastle Univ, Sch Med, Dept Diabet & Metab, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; S Cleveland Hosp, Middlesbrough, Cleveland, England; Hosp Sick Children, London WC1N 3JH, England; CHU Angers, Dept Med Genet, Angers, France	University of Southampton; Newcastle University - UK; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Walker, M (corresponding author), Univ Southampton, Southampton Gen Hosp, Div Human Genet, Duthie Bldg,Tremona Rd, Southampton SO16 6YD, Hants, England.	mark.walker@ncl.ac.uk; d.i.wilson@soton.ac.uk	Wilson, David/A-6264-2010; Bonneau, Dominique/K-6110-2015; Hearn, Tom/O-7217-2019; Piper Hanley, Karen/O-8676-2015; Hearn, Tom/G-8846-2013	Wilson, David/0000-0001-8779-2060; Hearn, Tom/0000-0002-8670-6236; Piper Hanley, Karen/0000-0001-9473-9647; Hearn, Tom/0000-0002-8670-6236; Hanley, Neil/0000-0003-3234-4038				Chen FB, 2001, GENOMICS, V74, P219, DOI 10.1006/geno.2001.6539; Collin GB, 1999, HUM GENET, V105, P474, DOI 10.1007/s004390051133; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; Collin GB, 1998, GENOMICS, V53, P359, DOI 10.1006/geno.1998.5542; Collin GB, 1997, HUM MOL GENET, V6, P213, DOI 10.1093/hmg/6.2.213; Collin GB, 1999, CLIN GENET, V55, P61, DOI 10.1034/j.1399-0004.1999.550111.x; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; Macari F, 1998, HUM GENET, V103, P658, DOI 10.1007/s004390050887; Marshall JD, 1997, AM J MED GENET, V73, P150, DOI 10.1002/(SICI)1096-8628(19971212)73:2<150::AID-AJMG9>3.0.CO;2-Y; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Moniaux N, 2001, FRONT BIOSCI-LANDMRK, V6, pD1192, DOI 10.2741/Moniaux; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; Ozaki K, 1998, J HUM GENET, V43, P255, DOI 10.1007/s100380050084; Russell-Eggitt IM, 1998, OPHTHALMOLOGY, V105, P1274, DOI 10.1016/S0161-6420(98)97033-6; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116	16	208	213	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					79	83		10.1038/ng874	http://dx.doi.org/10.1038/ng874			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11941370	Bronze			2022-12-27	WOS:000175362500019
J	Klose, J; Nock, C; Herrmann, M; Stuhler, K; Marcus, K; Bluggel, M; Krause, E; Schalkwyk, LC; Rastan, S; Brown, SDM; Bussow, K; Himmelbauer, H; Lehrach, H				Klose, J; Nock, C; Herrmann, M; Stuhler, K; Marcus, K; Bluggel, M; Krause, E; Schalkwyk, LC; Rastan, S; Brown, SDM; Bussow, K; Himmelbauer, H; Lehrach, H			Genetic analysis of the mouse brain proteome	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; 2-DIMENSIONAL ELECTROPHORESIS; MASS-SPECTROMETRY; PROTEINS; GENOME; MAP; IDENTIFICATION; RESOLUTION; SEPARATION	Proteome analysis is a fundamental step in systematic functional genomics. Here we have resolved 8,767 proteins from the mouse brain proteome by large-gel two-dimensional electrophoresis. We detected 1,324 polymorphic proteins from the European collaborative interspecific backcross. Of these, we mapped 665 proteins genetically and identified 466 proteins by mass spectrometry. Qualitatively polymorphic proteins, to 96%, reflect changes in conformation and/or mass. Quantitatively polymorphic proteins show a high frequency (73%) of allele-specific transmission in codominant heterozygotes. Variations in protein isoforms and protein quantity often mapped to chromosomal positions different from that of the structural gene, indicating that single proteins may act as polygenic traits. Genetic analysis of proteomes may detect the types of polymorphism that are most relevant in disease-association studies.	Humboldt Univ, Charite, Inst Humangenet, D-13353 Berlin, Germany; Free Univ Berlin, Fachbereich Biol, D-14195 Berlin, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Ruhr Univ Bochum, Inst Physiol Chem, D-44780 Bochum, Germany; Protagen AG, D-44801 Bochum, Germany; Inst Mol Pharmakol, D-13125 Berlin, Germany; Inst Psychiat, SGDP Res Ctr, London SE5 8AF, England; MWB Business Exchange, Cambridge CB1 1BH, England; MRC, Mammalian Genet Unit, Oxford OX11 0RD, England; UK Mouse Genome Ctr, Oxford OX11 0RD, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Max Planck Society; Ruhr University Bochum; Protagen Protein Services (PPS); University of London; King's College London	Klose, J (corresponding author), Humboldt Univ, Charite, Inst Humangenet, Campus Virchow Klinikum,Augustenburger Pl 1, D-13353 Berlin, Germany.		Schalkwyk, Leonard C/A-2150-2010	Schalkwyk, Leonard C/0000-0001-7030-5756; Himmelbauer, Heinz/0000-0001-8897-2928				ANDERSON NG, 2002, PROTEOMICS, V2, pP; AVNER P, 1988, TRENDS GENET, V4, P18, DOI 10.1016/0168-9525(88)90123-0; BREEN M, 1994, HUM MOL GENET, V3, P621, DOI 10.1093/hmg/3.4.621; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Church G M, 1985, Prog Clin Biol Res, V177, P17; DAMERVAL C, 1994, GENETICS, V137, P289; DIETRICH W, 1992, GENETICS, V131, P423; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRIS SD, 1983, GENETICS, V105, P681; Gauss C, 1999, ELECTROPHORESIS, V20, P575, DOI 10.1002/(SICI)1522-2683(19990301)20:3<575::AID-ELPS575>3.0.CO;2-3; Gerstner A, 2000, ELECTROPHORESIS, V21, P834, DOI 10.1002/(SICI)1522-2683(20000301)21:5<834::AID-ELPS834>3.0.CO;2-X; GOOLEY AA, 2001, PROTEOME RES NEW FRO, P65; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HERMEL E, 1993, IMMUNOGENETICS, V38, P106; Janke C, 1996, FEBS LETT, V379, P222, DOI 10.1016/0014-5793(95)01522-1; Kato GJ, 1999, HUM MUTAT, V13, P87, DOI 10.1002/(SICI)1098-1004(1999)13:2<87::AID-HUMU1>3.0.CO;2-K; Klose J, 1999, METH MOL B, V112, P147; KLOSE J, 1975, HUMANGENETIK, V26, P231; Klose J, 1999, METH MOL B, V112, P67; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Klose J, 1999, ELECTROPHORESIS, V20, P643; LACOMBE C, 1985, PROTIDES BIOL FLUIDS, V32, P1001; Lai K, 1998, HUM MUTAT, V11, P28; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Le Stunff C, 2000, NAT GENET, V26, P444, DOI 10.1038/82579; LEHMANN WD, 1996, MASSENSPEKTROMETRIE, P410; LITERSKY JM, 1993, BRAIN RES, V604, P32, DOI 10.1016/0006-8993(93)90349-R; Marcus K, 2000, ELECTROPHORESIS, V21, P2622, DOI 10.1002/1522-2683(20000701)21:13<2622::AID-ELPS2622>3.0.CO;2-3; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NOEL D, 1979, BIOCHEMISTRY-US, V18, P4159, DOI 10.1021/bi00586a017; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Pesole G, 2000, NUCLEIC ACIDS RES, V28, P193, DOI 10.1093/nar/28.1.193; Phillips PC, 1999, TRENDS GENET, V15, P6, DOI 10.1016/S0168-9525(98)01622-9; Rhodes M, 1998, GENOME RES, V8, P531, DOI 10.1101/gr.8.5.531; Schalkwyk LC, 2001, GENOME RES, V11, P2142, DOI 10.1101/gr.176201; Schalkwyk LC, 1999, GENOME RES, V9, P878, DOI 10.1101/gr.9.9.878; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6; STRUPAT K, 1994, ANAL CHEM, V66, P464, DOI 10.1021/ac00076a008; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Thiellement H, 1999, ELECTROPHORESIS, V20, P2013, DOI 10.1002/(SICI)1522-2683(19990701)20:10&lt;2013::AID-ELPS2013&gt;3.0.CO;2-#; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; WHITNEY JB, 1985, P NATL ACAD SCI USA, V82, P7646, DOI 10.1073/pnas.82.22.7646; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	47	197	205	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					385	393		10.1038/ng861	http://dx.doi.org/10.1038/ng861			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11912495				2022-12-27	WOS:000174682000015
J	Stock, M; Lamatsch, DK; Steinlein, C; Epplen, JT; Grosse, WR; Hock, R; Klapperstuck, T; Lampert, KP; Scheer, U; Schmid, M; Schartl, M				Stock, M; Lamatsch, DK; Steinlein, C; Epplen, JT; Grosse, WR; Hock, R; Klapperstuck, T; Lampert, KP; Scheer, U; Schmid, M; Schartl, M			A bisexually reproducing all-triploid vertebrate	NATURE GENETICS			English	Article							POLYMORPHIC MICROSATELLITE LOCI; LAMPBRUSH CHROMOSOMES; ALBURNOIDES COMPLEX; FLOW-CYTOMETRY; BUFO; DIVERSITY; DNA; ELIMINATION; SEQUENCES; AMPHIBIA	Green toads are common in the Palaearctic region, where they have differentiated into several taxa(1,2). The toads exist with variable amounts of ploidy, similar to other anuran species(3) or reptiles(4). In vertebrate biology, the very rare occurrence of triploidy is coupled with infertility or unisexuality, or requires the coexistence of individuals of different ploidy in a reproductive community. The reproduction of naturally occurring triploids has been reported to occur only through parthenogenesis, gynogenesis or hybridogenesis. The bisexual reproduction of pure triploids has been considered to be impossible because of the problem of equally distributing three chromosome sets in meiosis. Here we report geographically isolated populations of green toads (Bufo viridis complex) that are all-triploid and reproduce bisexually.	Theodor Boveri Inst, Lehrstuhl Phyziol Chem 1, D-97074 Wurzburg, Germany; Univ Halle Wittenberg, Inst Zool, D-06099 Halle Saale, Saale, Germany; Biozentrum, Theodor Boveri Inst, Inst Humangenet, D-97074 Wurzburg, Germany; Biozentrum, Theodor Boveri Inst, Lehrstuhl Zool 1, D-97074 Wurzburg, Germany; Ruhr Univ Bochum, Abt Mol Humangenet, D-44780 Bochum, Germany; Univ Halle Wittenberg, Klin Dermatol & Venerol, D-06097 Halle Saale, Saale, Germany	University of Wurzburg; Martin Luther University Halle Wittenberg; University of Wurzburg; University of Wurzburg; Ruhr University Bochum; Martin Luther University Halle Wittenberg	Schartl, M (corresponding author), Theodor Boveri Inst, Lehrstuhl Phyziol Chem 1, D-97074 Wurzburg, Germany.		Stöck, Matthias/E-7245-2014	Stöck, Matthias/0000-0003-4888-8371; Schartl, Manfred/0000-0001-9882-5948; Epplen, Joerg T./0000-0002-6087-3327				Alves MJ, 1998, MOL BIOL EVOL, V15, P1233, DOI 10.1093/oxfordjournals.molbev.a025852; Beukeboom LW, 1998, J EVOLUTION BIOL, V11, P755, DOI 10.1007/s000360050117; BICKHAM JW, 1993, COPEIA, P723; Borkin Leo J., 2001, Russian Journal of Herpetology, V8, P45; Borkin LJ, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P329; CALLAN HG, 1987, CHROMOSOMA, V95, P236, DOI 10.1007/BF00294780; Carmona JA, 1997, GENETICS, V146, P983; Castellano S, 1998, BIOL J LINN SOC, V63, P257, DOI 10.1006/bijl.1997.0189; CHEN H, 1995, BIOCHEM GENET, V33, P297, DOI 10.1007/BF02399929; GALL JG, 1991, METHOD CELL BIOL, V36, P149; Green D.M., 1991, AMPHIBIAN CYTOGENETI; Gunther R., 1979, Mitteilungen aus dem Zoologischen Museum in Berlin, V55, P35; Klapperstuck T, 1996, CYTOMETRY, V25, P82, DOI 10.1002/(SICI)1097-0320(19960901)25:1<82::AID-CYTO9>3.0.CO;2-G; MEZHZHERIN SV, 1995, GENETIKA+, V31, P43; MORGAN GT, 1980, CHROMOSOMA, V80, P309, DOI 10.1007/BF00292687; OHTANI H, 1993, CHROMOSOMA, V102, P158, DOI 10.1007/BF00387730; PISANETS EM, 1978, DOKLADY AKAD NAUK B, V3, P280; Roth P., 1987, P335; Rowe G, 1997, MOL ECOL, V6, P401, DOI 10.1046/j.1365-294X.1997.00197.x; SCHARTL M, 1991, P NATL ACAD SCI USA, V88, P8759, DOI 10.1073/pnas.88.19.8759; SCHMID M, 1978, CHROMOSOMA, V66, P361, DOI 10.1007/BF00328536; SCRIBNER KT, 1994, MOL BIOL EVOL, V11, P737; Stock M, 1999, ITAL J ZOOL, V66, P215; Stock M., 2001, ZOOLOGICAL ABHANDLUN, V51, P253; STOCK M, 2001, THESIS M LUTHER U HA; Stock Matthias, 1997, Alytes (Paris), V15, P72; Sumida Masayuki, 1993, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V12, P133; Tikel D, 2000, MOL ECOL, V9, P1927, DOI 10.1046/j.1365-294x.2000.01074-6.x; UZZELL T, 1970, AM NAT, V104, P433, DOI 10.1086/282678; VINOGRADOV AE, 1990, GENOME, V33, P619, DOI 10.1139/g90-092	30	93	100	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					325	328		10.1038/ng839	http://dx.doi.org/10.1038/ng839			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11836500				2022-12-27	WOS:000174157600020
J	Suzuki, T; Li, W; Zhang, Q; Karim, A; Novak, EK; Sviderskaya, EV; Hill, SP; Bennett, DC; Levin, AV; Nieuwenhuis, HK; Fong, CT; Castellan, C; Miterski, B; Swank, RT; Spritz, A				Suzuki, T; Li, W; Zhang, Q; Karim, A; Novak, EK; Sviderskaya, EV; Hill, SP; Bennett, DC; Levin, AV; Nieuwenhuis, HK; Fong, CT; Castellan, C; Miterski, B; Swank, RT; Spritz, A			Hermansky-Pudlak syndrome is caused by mutations in HPS4, the human homolog of the mouse light-ear gene	NATURE GENETICS			English	Article							MULTI-ORGANELLAR DISORDERS; PALE EAR; PIGMENTATION; PROTEIN; EP	Hermansky-Pudlak syndrome (HPS) is a disorder of organelle biogenesis in which oculocutaneous albinism, bleeding and pulmonary fibrosis result from defects of melanosomes, platelet dense granules and lysosomes(1-4). HPS is common in Puerto Rico 5,6, where it is caused by mutations in the genes HPS1(7) and, less often, HPS3 (ref. 8). In contrast, only half of non-Puerto Rican individuals with HPS have mutations in HPS1 (ref. 9), and very few in HPS3 (ref. 10). In the mouse, more than 15 loci manifest mutant phenotypes similar to human HPS 11,12, including pale ear (ep), the mouse homolog of HPS1 (refs 13,14). Mouse ep has a phenotype identical to another mutant, light ear (le)(15-18), which suggests that the human homolog of le is a possible human HPS locus. We have identified and found mutations of the human le homolog, HPS4, in a number of non-Puerto Rican individuals with HPS, establishing HPS4 as an important HPS locus in humans. In addition to their identical phenotypes, le and ep mutant mice have identical abnormalities of melanosomes, and in transfected melanoma cells the HPS4 and HPS1 proteins partially co-localize in vesicles of the cell body. In addition, the HPS1 protein is absent in tissues of le mutant mice. These results suggest that the HPS4 and HPS1 proteins may function in the same pathway of organelle biogenesis.	Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA; Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ London St Georges Hosp, Sch Med, Dept Anat & Cell Biol, London SW17 0RE, England; Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Univ Utrecht Hosp, Dept Hematol, Utrecht, Netherlands; Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; Genet Beratungsstelle, Bolzano, Italy; Ruhr Univ Bochum, Abt Mol Humangenet, D-4630 Bochum, Germany	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Roswell Park Cancer Institute; St Georges University London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Utrecht University; Utrecht University Medical Center; University of Rochester; Ruhr University Bochum	Spritz, A (corresponding author), Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, 4200 E 9th Ave, Denver, CO 80262 USA.		Sviderskaya, Elena V/D-2419-2009; Bennett, Dorothy C/C-2418-2008	Bennett, Dorothy C/0000-0002-3639-7527				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; BENNETT DC, 1993, INT REV CYTOL, V146, P191, DOI 10.1016/S0074-7696(08)60383-6; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CHAPMAN VM, 1975, MOUSE NEWS LETT, V53, P61; CUOMO M, 1991, J INVEST DERMATOL, V96, P446, DOI 10.1111/1523-1747.ep12470092; DELLANGELICA EC, 1999, MOL CELL, V3, P1; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Feng GH, 1997, HUM MOL GENET, V6, P793, DOI 10.1093/hmg/6.5.793; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; LANE PW, 1967, J HERED, V58, P17, DOI 10.1093/oxfordjournals.jhered.a107529; LANE PW, 1967, J HERED, V58, P21, DOI 10.1093/oxfordjournals.jhered.a107531; Lee ST, 1995, MOL CELLS, V5, P668; MEISLER M, 1980, AM J PATHOL, V101, P581; MEISLER MH, 1984, J HERED, V75, P103, DOI 10.1093/oxfordjournals.jhered.a109881; NOVAK EK, 1984, BLOOD, V63, P536; Oh J, 2000, HUM MOL GENET, V9, P375, DOI 10.1093/hmg/9.3.375; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Oh J, 1998, AM J HUM GENET, V62, P593, DOI 10.1086/301757; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Spritz RA, 2000, PIGM CELL RES, V13, P15, DOI 10.1034/j.1600-0749.2000.130104.x; Spritz RA, 1999, TRENDS GENET, V15, P337, DOI 10.1016/S0168-9525(99)01785-0; Spritz RA, 1999, CLIN GENET, V55, P309, DOI 10.1034/j.1399-0004.1999.550503.x; Spritz RA, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P389; SUZUKI T, 2001, GENOMICS, V78, P1; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Witkop C J, 1990, Bol Asoc Med P R, V82, P333; WITKOP CJ, 1990, OPHTHALMIC PAED GEN, V11, P245, DOI 10.3109/13816819009020986	30	142	146	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					321	324		10.1038/ng835	http://dx.doi.org/10.1038/ng835			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11836498				2022-12-27	WOS:000174157600019
J	Yan, H; Dobbie, Z; Gruber, SB; Markowitz, S; Romans, K; Giardiello, FM; Kinzler, KW; Vogelstein, B				Yan, H; Dobbie, Z; Gruber, SB; Markowitz, S; Romans, K; Giardiello, FM; Kinzler, KW; Vogelstein, B			Small changes in expression affect predisposition to tumorigenesis	NATURE GENETICS			English	Article								We have used quantitative measures of gene expression to show that constitutional 50% decreases in expression of one adenomatous polyposis coli tumor suppressor gene (APC) allele can lead to the development of familial adenop polyposis.	Johns Hopkins Med Inst, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Med Inst, Ctr Oncol, Baltimore, MD 21231 USA; Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21231 USA; Univ Basel Hosp, Res Dept, Res Grp Human Genet, CH-4031 Basel, Switzerland; Univ Michigan, Sch Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Howard Hughes Med Inst, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Ireland Canc Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Basel; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Case Western Reserve University; Case Western Reserve University Hospital; Howard Hughes Medical Institute; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Vogelstein, B (corresponding author), Johns Hopkins Med Inst, Howard Hughes Med Inst, Baltimore, MD 21231 USA.			Edsall, Lee Elizabeth/0000-0002-0326-2829	NATIONAL CANCER INSTITUTE [R01CA140316] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTONARAKIS SE, 2001, METABOLIC MOL BASES, P356; Jaiswal AS, 2001, J CELL BIOCHEM, V81, P262, DOI 10.1002/1097-4644(20010501)81:2<262::AID-JCB1041>3.0.CO;2-R; Johnson NA, 2000, J THEOR BIOL, V205, P527, DOI 10.1006/jtbi.2000.2070; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Laken SJ, 1999, P NATL ACAD SCI USA, V96, P2322, DOI 10.1073/pnas.96.5.2322; Royall R., 1997, STAT EVIDENCE LIKELI; Shih IM, 2001, CANCER RES, V61, P818; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Zhou W, 2001, NAT BIOTECHNOL, V19, P78, DOI 10.1038/83572	10	188	192	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					25	26		10.1038/ng799	http://dx.doi.org/10.1038/ng799			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743581				2022-12-27	WOS:000173105600008
J	Fraser, CM; Dando, MR				Fraser, CM; Dando, MR			Genomics and future biological weapons: The need for preventive action by the biomedical community	NATURE GENETICS			English	Editorial Material							MICROARRAY ANALYSIS; STREPTOCOCCUS-PNEUMONIAE; GENETIC DIVERSITY; SUSCEPTIBILITY; RESISTANCE; DNA	There is an increasing concern within both the scientific and security communities that the ongoing revolution in biology has great potential to be misused in offensive biological weapons programs. In light of the 11 September tragedy, we can no longer afford to be complacent about the possibility of biological terrorism. Here we review the major relevant trends in genomics research and development, and discuss how these capabilities might be misused in the design of new bioweapons. We also discuss how the breakthroughs that have come from the genomics revolution may be used to enhance detection, protection and treatment so that biological warfare agents are never used.	Inst Genom Res, Rockville, MD 20850 USA; Univ Bradford, Dept Peace Studies, Bradford BD7 1DP, W Yorkshire, England	J. Craig Venter Institute; University of Bradford	Fraser, CM (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	cmfraser@tigr.org		Fraser, Claire/0000-0003-1462-2428				Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Block SM, 1999, HOOVER NATL SECUR FO, P39; BLOOM BR, 1995, NATURE, V378, P236, DOI 10.1038/378236a0; British Medical Association, 1999, BIOT WEAP HUM; Chizhikov V, 2001, APPL ENVIRON MICROB, V67, P3258, DOI 10.1128/AEM.67.7.3258-3263.2001; COHEN W, 1997, PROLIFERATION THREAT; Cummings CA, 2000, EMERG INFECT DIS, V6, P513, DOI 10.3201/eid0605.000511; Dando M., 1999, DEFENSE ANAL, V15, P43, DOI DOI 10.1080/713604665; DANDO M, 2001, NEW BIOL WEAPONS THR; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; Hill AVS, 1999, BRIT MED BULL, V55, P401, DOI 10.1258/0007142991902457; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; KELLE A, 2001, NAT SCI SERIES, V1; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Kuwabara PE, 2000, PARASITOL TODAY, V16, P347, DOI 10.1016/S0169-4758(00)01677-X; LEDERBERG J, 1999, BIOL WEAPONS LIMITIN; LI WH, 1991, GENETICS, V129, P513; Mark Wheelis, 2000, DISARMAMENT FORUM, V4, P43; Marshall E, 1998, SCIENCE, V282, P654, DOI 10.1126/science.282.5389.654; NIXDORF K, 2000, NATO ASI SER, V1, P77; NOWAK R, 2001, NEW SCIENTIST   0119; PEARSON GS, 2001, 5 REV C; PEARSON GS, 2001, 22 U BRADF DEP PEAC; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Schmid MB, 1998, CURR OPIN CHEM BIOL, V2, P529, DOI 10.1016/S1367-5931(98)80130-0; SIMS NA, 2001, DISARMAMENT DIPLOMAC; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thursz M, 2000, BIOTECHNOL GENET ENG, V17, P253; *UN, 1996, 4 REV C PART CONV PR; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; ZILINSKAS RA, 2000, BIOL WARFARE MODERN; ZILINSKAS RA, 2000, BIOL WARFARE MODERN, P247	34	45	48	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					253	256		10.1038/ng763	http://dx.doi.org/10.1038/ng763			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687792				2022-12-27	WOS:000171911000007
J	Kawaguchi, TK; Skaletsky, H; Brown, LG; Minx, PJ; Cordum, HS; Waterston, RH; Wilson, RK; Silber, S; Oates, R; Rozen, S; Page, DC				Kawaguchi, TK; Skaletsky, H; Brown, LG; Minx, PJ; Cordum, HS; Waterston, RH; Wilson, RK; Silber, S; Oates, R; Rozen, S; Page, DC			The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men	NATURE GENETICS			English	Article							INTRACYTOPLASMIC SPERM INJECTION; DAZ GENE-CLUSTER; INTRACHROMOSOMAL RECOMBINATION; AZOOSPERMIC MEN; MICRODELETIONS; SEQUENCE; INTERVAL; GENOME; FAMILY; LOCUS	Deletions of the AZFc (azoospermia factor c) region of the Y chromosome are the most common known cause of spermatogenic failure. We determined the complete nucleotide sequence of AZFc by identifying and distinguishing between near-identical amplicons (massive repeat units) using an iterative mapping-sequencing process. A complex of three palindromes, the largest spanning 3 Mb with 99.97% identity between its arms, encompasses the AZFc region. The palindromes are constructed from six distinct families of amplicons, with unit lengths of 115-678 kb, and may have resulted from tandem duplication and inversion during primate evolution. The palindromic complex contains 11 families of transcription units, all expressed in testis. Deletions of AZFc that cause infertility are remarkably uniform, spanning a 3.5-Mb segment and bounded by 229-kb direct repeats that probably served as substrates for homologous recombination.	MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; St Lukes Hosp, Infertil Ctr St Louis, St Louis, MO 63107 USA; Boston Univ, Sch Med, Dept Urol, Boston, MA 02228 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Saint Luke's Hospital - Missouri; Boston University	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	page_admin@wi.mit.edu	Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	Wilson, Richard K./0000-0002-1992-1358; Rozen, Steven G./0000-0002-4288-0056; Oates, Robert/0000-0003-2330-6697				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chai NN, 1998, GENOMICS, V49, P283, DOI 10.1006/geno.1998.5255; Delbridge ML, 1999, NAT GENET, V22, P223, DOI 10.1038/10279; DRWINGA HL, 1993, GENOMICS, V16, P311, DOI 10.1006/geno.1993.1190; Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; Girardi SK, 1997, HUM REPROD, V12, P1635, DOI 10.1093/humrep/12.8.1635; Glaser B, 1998, CHROMOSOME RES, V6, P481, DOI 10.1023/A:1009256613348; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kleiman SE, 1999, HUM REPROD, V14, P33, DOI 10.1093/humrep/14.1.33; KOBAYASHI K, 1994, HUM MOL GENET, V3, P1965, DOI 10.1093/hmg/3.11.1965; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LEWIN B, 1995, CELL, V80, P1, DOI 10.1016/0092-8674(95)90442-5; LIU L, 1987, NUCLEIC ACIDS RES, V15, P9461, DOI 10.1093/nar/15.22.9461; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; McMurray AA, 1998, GENOME RES, V8, P562, DOI 10.1101/gr.8.5.562; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Mulhall JP, 1997, HUM REPROD, V12, P503; Nakahori Y, 1996, HORM RES, V46, P20, DOI 10.1159/000185175; Ohno S., 1967, SEX CHROMOSOMES SEX; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; Page DC, 1999, HUM REPROD, V14, P1722, DOI 10.1093/humrep/14.7.1722; Pearson W R, 2000, Methods Mol Biol, V132, P185; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Rozen S, 2000, Methods Mol Biol, V132, P365; Sargent CA, 1999, J MED GENET, V36, P670; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Silber SJ, 1998, HUM REPROD, V13, P3332, DOI 10.1093/humrep/13.12.3332; Simoni M, 1997, FERTIL STERIL, V67, P542, DOI 10.1016/S0015-0282(97)80083-0; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Vogel T, 1999, HUM REPROD, V14, P3023, DOI 10.1093/humrep/14.12.3023; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Yen PH, 1998, GENOMICS, V54, P5, DOI 10.1006/geno.1998.5526	49	457	497	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					279	286		10.1038/ng757	http://dx.doi.org/10.1038/ng757			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687796				2022-12-27	WOS:000171911000013
J	Mazeyrat, S; Saut, N; Grigoriev, V; Mahadevaiah, SK; Ojarikre, OA; Rattigan, A; Bishop, C; Eicher, EM; Mitchell, MJ; Burgoyne, PS				Mazeyrat, S; Saut, N; Grigoriev, V; Mahadevaiah, SK; Ojarikre, OA; Rattigan, A; Bishop, C; Eicher, EM; Mitchell, MJ; Burgoyne, PS			A Y-encoded subunit of the translation initiation factor Eif2 is essential for mouse spermatogenesis	NATURE GENETICS			English	Article							UBIQUITIN-ACTIVATING ENZYME-E1; EXPRESSION ANALYSIS; MALE-INFERTILITY; CHROMOSOME GENE; INTERVAL; REGION; MICE; SPERMATOCYTES; SPERMATOGONIA; TRANSCRIPT	In mouse and man, deletions of specific regions of the Y chromosome have been linked to early failure of spermatogenesis and consequent sterility; the Y chromosomal gene(s) with this essential early role in spermatogenesis have not been identified. The partial deletion of the mouse Y short arm (the Sxr(b) deletion) that occurred when Tp(Y)1Ct(Sxr-b) (hereafter Sxr(b)) arose from Tp(Y)1CT(Sxr-b) (hereafter Sxr(a)) defines Spy, a Y chromosomal factor essential for normal spermatogonial proliferation(1-3). Molecular analysis has identified six genes that lie within the deletion: Ube1y1 (refs. 4,5), Smcy(6), Uty(7), Usp9y (also known as Dffry)(8), Eif2s3y (also known as Eif-2 gammaY)(9) and Dby(10); all have closely similar X-encoded homologs. of the Y-encoded genes, Ube1y1 and Dby have been considered strong candidates for mouse Spy function(4,5,10,11), whereas Smcy has been effectively ruled out as a candidate(12). There is no Ube1y1 homolog in man, and DBY, either alone or in conjunction with USP9Y, is the favored candidate for an early spermatogenic role(10,13-15). Here we show that introduction of Ube1y1 and Dby as transgenes. into Sxr(b)-deletion mice fails to overcome the spermatogenic block. However, the introduction of Eif2s3y restores normal spermatogonial proliferation and progression through meiotic prophase. Therefore, Eif2s3y, which encodes a subunit of the eukaryotic translation initiation factor Eif2, is Spy.	Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; Fac Med Marseille, INSERM, U491, F-13385 Marseille 5, France; Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Jackson Lab, Bar Harbor, ME 04609 USA	MRC National Institute for Medical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Baylor College of Medicine; Jackson Laboratory	Burgoyne, PS (corresponding author), Natl Inst Med Res, MRC, Div Dev Genet, Mill Hill, London NW7 1AA, England.		Mitchell, Michael/I-3987-2016	Mitchell, Michael/0000-0003-2052-7347	NCI NIH HHS [CA34196] Funding Source: Medline; NIGMS NIH HHS [GM20919] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020919, R37GM020919] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agulnik AI, 1999, MAMM GENOME, V10, P926, DOI 10.1007/s003359901116; AGULNIK AI, 1994, HUM MOL GENET, V3, P873, DOI 10.1093/hmg/3.6.873; Agulnik AI, 2001, MAMM GENOME, V12, P112, DOI 10.1007/s003350010249; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; BURGOYNE PS, 1986, NATURE, V320, P170, DOI 10.1038/320170a0; Burgoyne PS, 2000, CYTOGENET CELL GENET, V91, P57, DOI 10.1159/000056819; DRESSER DW, 1995, HUM MOL GENET, V4, P1613, DOI 10.1093/hmg/4.9.1613; Ehrmann IE, 1998, HUM MOL GENET, V7, P1725, DOI 10.1093/hmg/7.11.1725; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; HANNIG EM, 1993, MOL CELL BIOL, V13, P506, DOI 10.1128/MCB.13.1.506; KAY GF, 1991, NATURE, V354, P486, DOI 10.1038/354486a0; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; LEVY ER, 1986, CYTOGENET CELL GENET, V42, P208, DOI 10.1159/000132280; Levy N, 2000, MAMM GENOME, V11, P164, DOI 10.1007/s003350010031; Mahaffey CL, 1997, GENOMICS, V41, P123, DOI 10.1006/geno.1997.4611; Mazeyrat S, 1998, HUM MOL GENET, V7, P1713, DOI 10.1093/hmg/7.11.1713; MELTON DW, 1984, P NATL ACAD SCI-BIOL, V81, P2147, DOI 10.1073/pnas.81.7.2147; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MITCHELL MJ, 1991, NATURE, V354, P483, DOI 10.1038/354483a0; MITCHELL MJ, 2000, GENETIC BASIS MALE I, P233; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Odorisio T, 1996, DEV BIOL, V180, P336, DOI 10.1006/dbio.1996.0305; Sargent CA, 1999, J MED GENET, V36, P670; SIMPSON EM, 1991, GENOMICS, V11, P601, DOI 10.1016/0888-7543(91)90067-O; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; SUTCLIFFE MJ, 1991, MOL REPROD DEV, V30, P81, DOI 10.1002/mrd.1080300202; SUTCLIFFE MJ, 1989, DEVELOPMENT, V107, P373; VOGT PH, 1996, ADV DEV BIO, V4, P191	30	124	128	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					49	53		10.1038/ng717	http://dx.doi.org/10.1038/ng717			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528390				2022-12-27	WOS:000170781300015
J	Parant, J; Chavez-Reyes, A; Little, NA; Yan, W; Reinke, V; Jochemsen, AG; Lozano, G				Parant, J; Chavez-Reyes, A; Little, NA; Yan, W; Reinke, V; Jochemsen, AG; Lozano, G			Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53	NATURE GENETICS			English	Article							MDM2-DEFICIENT MICE; ONCOPROTEIN MDM2; DEGRADATION; APOPTOSIS; REGION	The p53 protein can inhibit cell cycling or induce apoptosis, and is thus a critical regulator of tumorigenesis'. This protein is negatively regulated by a physical interaction with MDM2, an E3 ubiquitin ligase(2-4). This interaction is critical for cell viability; loss of Mdm2 causes cell death in vitro and in vivo in a p53-dependent manner(5-7). The recently discovered(8) MDM2-related protein MDM4 (also known as MDMX) has some of the same properties as MDM2. MDM4 binds and inhibits p53 transcriptional activity in vitro. Unlike MDM2, however, MDM4 does not cause nuclear export or degradation of p53 (refs. 9,10). To study MDM4 function in vivo, we deleted Mdm4 in mice. Mdm4-null mice died at 7.5-8.5 dpc, owing to loss of cell proliferation and not induction of apoptosis. To assess the importance of p53 in the death of Mdm4(-/-) embryos, we crossed in the Trp53-null allele. The loss of Trp53 completely rescued the Mdm4(-/-) embryonic lethality. Thus, MDM2 and MDM4 are nonoverlapping critical regulators of p53 in vivo. These data define a new pathway of p53 regulation and raise the possibility that increased MDM4 levels and the resulting inactivation of p53 contribute to the development of human tumors.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA; Univ Autonoma Nuevo Leon, Sch Biol Sci, Dept Microbiol & Immunol, Monterrey, NL, Mexico; Leiden Univ, Med Ctr, Dept Mol & Cell Biol, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RA Leiden, Netherlands	University of Texas System; UTMD Anderson Cancer Center; Universidad Autonoma de Nuevo Leon; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lozano, G (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Box 11,1515 Holcombe Blvd, Houston, TX 77030 USA.		Chavez-Reyes, Arturo/ABG-1231-2020	Chavez-Reyes, Arturo/0000-0002-6655-815X				de Rozieres S, 2000, ONCOGENE, V19, P1691, DOI 10.1038/sj.onc.1203468; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LUNA RMD, 1995, NATURE, V378, P203; Manova K, 1998, DEV DYNAM, V213, P293, DOI 10.1002/(SICI)1097-0177(199811)213:3<293::AID-AJA6>3.0.CO;2-D; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Parant JM, 2001, GENE, V270, P277, DOI 10.1016/S0378-1119(01)00432-2; Ramos YFM, 2001, CANCER RES, V61, P1839; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Stad R, 2000, J BIOL CHEM, V275, P28039; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WILKINSON DG, 1998, IN SITU HYBRIDIZATIO	18	403	408	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					92	95		10.1038/ng714	http://dx.doi.org/10.1038/ng714			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528400				2022-12-27	WOS:000170781300025
J	Ma, ZG; Morris, SW; Valentine, V; Li, M; Herbrick, JA; Cui, XL; Bouman, D; Li, Y; Mehta, PK; Nizetic, D; Kaneko, Y; Chan, GCF; Chan, LC; Squire, J; Scherer, SW; Hitzler, JK				Ma, ZG; Morris, SW; Valentine, V; Li, M; Herbrick, JA; Cui, XL; Bouman, D; Li, Y; Mehta, PK; Nizetic, D; Kaneko, Y; Chan, GCF; Chan, LC; Squire, J; Scherer, SW; Hitzler, JK			Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia	NATURE GENETICS			English	Article							SPLIT ENDS; PROTEIN; NONRANDOM; PATHWAY; ENCODES	t(1;22) is the principal translocation of acute megakaryoblastic leukemias. Here we show this chromosomal rearrangement to result in the fusion of two novel genes. RNA-binding motif protein-15 (RBM15). an RNA recognition motif-encoding gene with homology to Drosophila spen. and Megakaryoblastic Leukemia-1 (MKL1), a gene encoding an SAP (SAF-A/B. Acinus and PIAS) DNA-binding domain.	Univ Toronto, Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Canc & Blood, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN 38163 USA; Univ London, Sch Pharm, Ctr Appl Mol Biol, London WC1N 1AX, England; Saitama Canc Ctr Hosp, Dept Canc Chemotherapy, Ina, Saitama 3630806, Japan; Univ Hong Kong, Queen Mary Hosp, Dept Paediat, Div Haematol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Div Haematol, Hong Kong, Hong Kong, Peoples R China; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of London; University College London; University of London School of Pharmacy; University of Hong Kong; University of Hong Kong; University of Toronto; University of Toronto; University of Toronto	Hitzler, JK (corresponding author), Univ Toronto, Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada.		Squire, Jeremy A/A-9352-2012; Scherer, Stephen W./B-3785-2013; Nizetic, Dean/F-9509-2015	Squire, Jeremy A/0000-0002-9863-468X; Scherer, Stephen W./0000-0002-8326-1999; Nizetic, Dean/0000-0001-5486-5761	NATIONAL CANCER INSTITUTE [R01CA087064] Funding Source: NIH RePORTER; NCI NIH HHS [CA-87064, CA-27165] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bernstein J, 2000, LEUKEMIA, V14, P216, DOI 10.1038/sj.leu.2401639; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CARROLL A, 1991, BLOOD, V78, P748; Chen FL, 2000, CURR BIOL, V10, P943, DOI 10.1016/S0960-9822(00)00625-4; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Kuang B, 2000, DEVELOPMENT, V127, P1517; LION T, 1992, BLOOD, V79, P3325; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MITCHEL PJ, 1989, SCIENCE, V245, P372; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Rebay I, 2000, GENETICS, V154, P695; Wiellette EL, 1999, DEVELOPMENT, V126, P5373	15	228	239	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					220	221		10.1038/90054	http://dx.doi.org/10.1038/90054			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431691				2022-12-27	WOS:000169656400013
J	Njajou, OT; Vaessen, N; Joosse, M; Berghuis, B; van Dongen, JWF; Breuning, MH; Snijders, PJLM; Rutten, WPF; Sandkuijl, LA; Oostra, BA; van Duijn, CM; Heutink, P				Njajou, OT; Vaessen, N; Joosse, M; Berghuis, B; van Dongen, JWF; Breuning, MH; Snijders, PJLM; Rutten, WPF; Sandkuijl, LA; Oostra, BA; van Duijn, CM; Heutink, P			A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis	NATURE GENETICS			English	Article							HEREDITARY HEMOCHROMATOSIS; IRON; GENE; TRANSPORTER; NRAMP2	Hereditary hemochromatosis (HH) is a very common disorder characterized by iron overload and multi-organ damage. Several genes involved in iron metabolism have been implicated in the pathology of HH (refs. 1-4). We report that a mutation in the gene encoding Solute Carrier family 11, member A3 (SLC11A3). also known as ferroportin. is associated with autosomal dominant hemochromatosis.	Erasmus Univ, Dept Epidemiol & Biostat, Genet Epidemiol Unit, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Leiden Univ, Med Ctr, Dept Anthropogenet, NL-2300 RA Leiden, Netherlands; Stichting Huisarts Lab, Breda, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Njajou, OT (corresponding author), Erasmus Univ, Dept Epidemiol & Biostat, Genet Epidemiol Unit, NL-3000 DR Rotterdam, Netherlands.		Breuning, Martijn H/E-3429-2010	Heutink, Peter/0000-0001-5218-1737				Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Cairo G, 2000, BIOCHEM J, V352, P241, DOI 10.1042/0264-6021:3520241; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; EASON RJ, 1990, AUST NZ J MED, V20, P226, DOI 10.1111/j.1445-5994.1990.tb01024.x; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; GOOSSENS JP, 1977, LANCET, P1106; Haile DJ, 2000, CYTOGENET CELL GENET, V88, P328, DOI 10.1159/000015522; Kaplan J, 2000, NATURE, V403, P711, DOI 10.1038/35001691; KATO J, IN PRESS AM J HUM GE; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Pietrangelo A, 1999, NEW ENGL J MED, V341, P725, DOI 10.1056/NEJM199909023411003; Roetto A, 1999, AM J HUM GENET, V64, P1388, DOI 10.1086/302379	15	368	380	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					213	214		10.1038/90038	http://dx.doi.org/10.1038/90038			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431687				2022-12-27	WOS:000169656400009
J	Grewal, PK; Holzfeind, PJ; Bittner, RE; Hewitt, JE				Grewal, PK; Holzfeind, PJ; Bittner, RE; Hewitt, JE			Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse	NATURE GENETICS			English	Letter							MUSCULAR-DYSTROPHY; GENE; CHROMOSOME-8; MICE; GLYCOPROTEIN; MEMBRANE; PROTEIN; COMPLEX; LAMININ; FAMILY	Spontaneous and engineered mouse mutants have facilitated our understanding of the pathogenesis of muscular dystrophy and they provide models for the development of therapeutic approaches'. The mouse myodystrophy (myd) mutation produces an autosomal recessive, neuromuscular phenotype(2). Homozygotes have an abnormal gait, show abnormal posturing when suspended by the tail and are smaller than littermate controls. Serum creatine kinase is elevated and muscle histology is typical of a progressive myopathy with focal areas of acute necrosis and clusters of regenerating fibers(3). Additional aspects of the phenotype include sensorineural deafness, reduced lifespan and decreased reproductive fitness(2,3). The myd mutation maps to mouse chromosome 8 at approximately 33 centimorgans (cM) (refs. 2,4-7). Here we show that the gene mutated in myd encodes a glycosyltransferase. Large. The human homolog of this gene (LARGE) maps to chromosome 22q, In myd, an intragenic deletion of exons 4-7 causes a frameshift in the resultant mRNA and a premature termination codon before the first of the two catalytic domains. On immunoblots, a monoclonal antibody to alpha -dystroglycan (a component of the dystrophin-associated glycoprotein complex) shows reduced binding in myd,which we attribute to altered glycosylation of this protein. We speculate that abnormal posttranslational modification of alpha -dystroglycan may contribute to the myd phenotype.	Univ Nottingham, Queens Med Ctr, Genet Inst, Nottingham NG7 2UH, England; Univ Vienna, Neuromuscular Res Dept, Inst Anat, A-1010 Vienna, Austria	University of Nottingham; University of Vienna	Hewitt, JE (corresponding author), Univ Nottingham, Queens Med Ctr, Genet Inst, Nottingham NG7 2UH, England.	jane.hewitt@nottingham.ac.uk						Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459; Aravind L, 1999, CURR BIOL, V9, pR836, DOI 10.1016/S0960-9822(00)80039-1; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Durbeej M, 1998, CURR OPIN CELL BIOL, V10, P594, DOI 10.1016/S0955-0674(98)80034-3; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; GEE SH, 1993, J BIOL CHEM, V268, P14972; Grewal PK, 1997, MAMM GENOME, V8, P394, DOI 10.1007/s003359900454; Grewal PK, 1998, MAMM GENOME, V9, P603, DOI 10.1007/s003359900829; Grewal PK, 1998, GENE, V216, P13, DOI 10.1016/S0378-1119(98)00334-5; Grewal PK, 1999, GENE, V240, P389, DOI 10.1016/S0378-1119(99)00459-X; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; Herrmann R, 2000, HUM MOL GENET, V9, P2335, DOI 10.1093/oxfordjournals.hmg.a018926; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KIM J, IN PRESS GENOMICS; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; LANE PW, 1976, J HERED, V67, P135, DOI 10.1093/oxfordjournals.jhered.a108687; MATHEWS KD, 1995, J NEUROPATH EXP NEUR, V54, P601, DOI 10.1093/whq/54.4.601; MATHEWS KD, 1995, MUSCLE NERVE, pS98; Matthews KD, 1996, CURR OPIN NEUROL, V9, P394; MILLS KA, 1995, MAMM GENOME, V6, P278, DOI 10.1007/BF00352416; NUTTING DF, 1980, J HERED, V71, P15, DOI 10.1093/oxfordjournals.jhered.a109302; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Sasaki K, 1997, P NATL ACAD SCI USA, V94, P14294, DOI 10.1073/pnas.94.26.14294; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; YAMADA H, 1994, FEBS LETT, V352, P49, DOI 10.1016/0014-5793(94)00917-1	27	249	252	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2001	28	2					151	154		10.1038/88865	http://dx.doi.org/10.1038/88865			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381262				2022-12-27	WOS:000169011800017
J	Howe, JR; Bair, JL; Sayed, MG; Anderson, ME; Mitros, FA; Petersen, GM; Velculescu, VE; Traverso, G; Vogelstein, B				Howe, JR; Bair, JL; Sayed, MG; Anderson, ME; Mitros, FA; Petersen, GM; Velculescu, VE; Traverso, G; Vogelstein, B			Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis	NATURE GENETICS			English	Letter							COWDEN-DISEASE; SIGNALING PATHWAYS; SMAD PROTEINS; CANCER; CELLS; PTEN; SMAD4/DPC4; CARCINOMA; KINASE; BREAST	Juvenile polyposis (JP; OMIM 174900) is an autosomal dominant gastrointestinal hamartomatous polyposis syndrome in which patients are at risk for developing gastrointestinal cancers(1,2). Previous studies have demonstrated a locus for JP mapping to 18q21.1 (ref. 3) and germline mutations in the homolog of the gene for mothers against decapentaplegic. Drosophila. (MADH4. also known as SMAD4) in several JP families(4). However, mutations in MADH4 are only present in a subset of JP cases'. and although mutations in the gene for phosphatase and tensin homolog (PTEN) have been described in a few families(6,7), undefined genetic heterogeneity remains. Using a genome-wide screen in four JP kindreds without germline mutations in MADH4 or PTEN, we identified linkage with markers from chromosome 10q22-23 (maximum lod score of 4.74, theta =0.00). We found no recombinants using markers developed from the vicinity of the gene for bone morphogenetic protein receptor 1A (BMPR1A), a serine-threonine kinase type I receptor involved in bone morphogenetic protein (BMP) signaling(8). Genomic sequencing of BMPR1A in each of these JP kindreds disclosed germline nonsense mutations in all affected kindred members but not in normal control individuals. These findings indicate involvement of an additional gene in the transforming growth factor-beta (TGF-beta) superfamily in the genesis of JP, and document an unanticipated function for BMP in colonic epithelial growth control.	Univ Iowa, Coll Med, Dept Surg, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA; Mayo Clin & Mayo Fdn, Clin Epidemiol Sect, Rochester, MN 55905 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Oncol Ctr, Baltimore, MD USA	University of Iowa; University of Iowa; Mayo Clinic; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Howe, JR (corresponding author), Univ Iowa, Coll Med, Dept Surg, Iowa City, IA 52242 USA.		Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X; Howe, James/0000-0001-5312-5972	NATIONAL CANCER INSTITUTE [R01CA043460, P50CA062924, R37CA043460] Funding Source: NIH RePORTER; NCI NIH HHS [CA43460, CA62924] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dai JL, 1999, P NATL ACAD SCI USA, V96, P1427, DOI 10.1073/pnas.96.4.1427; Eng C, 1998, AM J HUM GENET, V62, P1020, DOI 10.1086/301847; Fink SP, 2001, CANCER RES, V61, P256; GENTRY WC, 1974, ARCH DERMATOL, V109, P521, DOI 10.1001/archderm.109.4.521; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Henningfeld KA, 2000, J BIOL CHEM, V275, P21827, DOI 10.1074/jbc.M000978200; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Houlston R, 1998, HUM MOL GENET, V7, P1907, DOI 10.1093/hmg/7.12.1907; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 1998, ANN SURG ONCOL, V5, P751, DOI 10.1007/BF02303487; Howe JR, 1998, AM J HUM GENET, V62, P1129, DOI 10.1086/301840; IWASAKI S, 1995, J BIOL CHEM, V270, P5476, DOI 10.1074/jbc.270.10.5476; Jacoby RF, 1997, GASTROENTEROLOGY, V112, P1398, DOI 10.1016/S0016-5085(97)70156-2; JARVINEN H, 1984, GUT, V25, P792, DOI 10.1136/gut.25.7.792; Kleeff J, 1999, GASTROENTEROLOGY, V116, P1202, DOI 10.1016/S0016-5085(99)70024-7; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Olschwang S, 1998, NAT GENET, V18, P12, DOI 10.1038/ng0198-12; Raida M, 1999, INT J CANCER, V83, P38, DOI 10.1002/(SICI)1097-0215(19990924)83:1<38::AID-IJC8>3.3.CO;2-2; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; TENDIJKE P, 1993, ONCOGENE, V8, P2879; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; Woodford-Richens K, 2000, CANCER RES, V60, P2477	30	454	484	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					184	187		10.1038/88919	http://dx.doi.org/10.1038/88919			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381269				2022-12-27	WOS:000169011800024
J	Guris, DL; Fantes, J; Tara, D; Druker, BJ; Imamoto, A				Guris, DL; Fantes, J; Tara, D; Druker, BJ; Imamoto, A			Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome	NATURE GENETICS			English	Letter							CARDIAC NEURAL CREST; CRITICAL REGIONS; STEM-CELL; DELETION; MUTANT; MOUSE; INDUCTION; SIGNAL; TWIST; PAX3	Heterozygous deletions within human chromosome 22q11 are the genetic basis of DiGeorge/velocardiofacial syndrome (DGS/VCFS), the most common deletion syndrome (1 in 4,000 live births) in humans(1). CRKL maps within the common deletion region for DCS/VCFS (ref. 2) and encodes an SH2-SH3-SH3 adapter protein closely related to the Crk gene products(3). Here we report that mice homozygous for a targeted null mutation at the CrkL locus (gene symbol Crkol for mice) exhibit defects in multiple cranial and cardiac neural crest derivatives including the cranial ganglia, aortic arch arteries, cardiac outflow tract, thymus, parathyroid glands and craniofacial structures, We show that the migration and early expansion of neural crest cells is unaffected in Crkol(-/-) embryos, These results therefore indicate an essential stage- and tissue-specific role for Crkol in the function, differentiation, and/or survival of neural crest cells during development. The similarity between the Crkol(-/-) phenotype and the clinical manifestations of DCS/VCFS implicate defects in CRKL-mediated signaling pathways as part of the molecular mechanism underlying this syndrome.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Ctr Mol Oncol, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA	University of Chicago; University of Chicago; University of Chicago; Oregon Health & Science University	Imamoto, A (corresponding author), Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA.	aimamoto@midway.uchicago.edu		Druker, Brian/0000-0001-8331-8206				Amati F, 1999, EUR J HUM GENET, V7, P903, DOI 10.1038/sj.ejhg.5200399; Begbie J, 1999, DEVELOPMENT, V126, P895; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; Conway SJ, 1997, CARDIOVASC RES, V36, P163, DOI 10.1016/S0008-6363(97)00172-7; Conway SJ, 1997, DEVELOPMENT, V124, P505; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Eicher PS, 2000, J PEDIATR-US, V137, P158, DOI 10.1067/mpd.2000.105356; EMANUEL BS, 1999, HEART DEV, P463; Farrell M, 1999, TRENDS CARDIOVAS MED, V9, P214, DOI 10.1016/S1050-1738(00)00023-2; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Gripp KW, 2000, HUM MUTAT, V15, P150, DOI 10.1002/(SICI)1098-1004(200002)15:2<150::AID-HUMU3>3.0.CO;2-D; Kimber WL, 1999, HUM MOL GENET, V8, P2229, DOI 10.1093/hmg/8.12.2229; Kirby M. L., 1999, HEART DEV, P179; Kurahashi H, 1997, AM J MED GENET, V72, P180, DOI 10.1002/(SICI)1096-8628(19971017)72:2<180::AID-AJMG10>3.0.CO;2-J; LaBonne C, 1998, J NEUROBIOL, V36, P175, DOI 10.1002/(SICI)1097-4695(199808)36:2<175::AID-NEU6>3.0.CO;2-Z; LEDOUARIN NM, 1988, ANNU REV CELL BIOL, V4, P375, DOI 10.1146/annurev.cellbio.4.1.375; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; MARK M, 1993, DEVELOPMENT, V119, P319; McDonaldMcGinn DM, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e9; Sattler M, 1998, LEUKEMIA, V12, P637, DOI 10.1038/sj.leu.2401010; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Waldo KL, 1996, DEV DYNAM, V205, P281, DOI 10.1002/(SICI)1097-0177(199603)205:3<281::AID-AJA8>3.0.CO;2-E	30	222	231	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					293	298		10.1038/85855	http://dx.doi.org/10.1038/85855			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242111				2022-12-27	WOS:000167304200021
J	Musaro, A; McCullagh, K; Paul, A; Houghton, L; Dobrowolny, G; Molinaro, M; Barton, ER; Sweeney, HL; Rosenthal, N				Musaro, A; McCullagh, K; Paul, A; Houghton, L; Dobrowolny, G; Molinaro, M; Barton, ER; Sweeney, HL; Rosenthal, N			Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle	NATURE GENETICS			English	Article							GROWTH-FACTOR-I; DEPENDENT TRANSCRIPTIONAL PATHWAY; CARDIAC-HYPERTROPHY; MICE; DIFFERENTIATION; CALCINEURIN; PROLIFERATION; MYOGENESIS; GENES	Aging skeletal muscles suffer a steady decline in mass and functional performance, and compromised muscle integrity as fibrotic invasions replace contractile tissue, accompanied by a characteristic loss in the fastest, most powerful muscle fibers(1,2). The same programmed deficits in muscle structure and function are found in numerous neurodegenerative syndromes and disease-related cachexia(3). We have generated a model of persistent, functional myocyte hypertrophy using a tissue-restricted transgene encoding a locally acting isoform of insulin-like growth factor-1 that is expressed in skeletal muscle (mlgf-1), Transgenic embryos developed normally, and postnatal increases in muscle mass and strength were not accompanied by the additional pathological changes seen in other Igf-l transgenic models. Expression of CATA-2, a transcription factor normally undetected in skeletal muscle, marked hypertrophic myocytes that escaped age-related muscle atrophy and retained the proliferative response to muscle injury characteristic: of younger animals. The preservation of muscle architecture and age-independent regenerative capacity through localized mlgf-1 transgene expression suggests clinical strategies for the treatment of age or disease-related muscle frailty.	Massachusetts Gen Hosp E, Cardiovasc Res Ctr, Charlestown, MA USA; Univ Rome La Sapienza, Dept Histol & Med Embryol, Rome, Italy; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	Sapienza University Rome; University of Pennsylvania	Rosenthal, N (corresponding author), Massachusetts Gen Hosp E, Cardiovasc Res Ctr, Charlestown, MA USA.		Sweeney, H Lee/F-1862-2010; Musarò, Antonio/K-9598-2016; Musaro, Antonio/P-2953-2019	Musarò, Antonio/0000-0002-2944-9739; Musaro, Antonio/0000-0002-2944-9739; Dobrowolny, Gabriella/0000-0001-8693-0724; Rosenthal, Nadia/0000-0002-7599-7365				Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; ADAMO ML, 1993, ADV EXP MED BIOL, V343, P1; Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Bigard X, 2000, J BIOL CHEM, V275, P19653, DOI 10.1074/jbc.M000430200; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Delaughter MC, 1999, FASEB J, V13, P1923, DOI 10.1096/fasebj.13.14.1923; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; GRIESHAMMER U, 1992, CELL, V69, P79, DOI 10.1016/0092-8674(92)90120-2; LEROITH D, 1991, MOL CELL ENDOCRINOL, V77, pC57, DOI 10.1016/0303-7207(91)90054-V; Lescaudron L, 1997, J MUSCLE RES CELL M, V18, P631, DOI 10.1023/A:1018679722112; Lim HW, 2000, J MOL CELL CARDIOL, V32, P697, DOI 10.1006/jmcc.2000.1113; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; McKoy G, 1999, J PHYSIOL-LONDON, V516, P583, DOI 10.1111/j.1469-7793.1999.0583v.x; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MUSARO A, 1995, EXP CELL RES, V221, P241, DOI 10.1006/excr.1995.1372; Musaro A, 1999, MOL CELL BIOL, V19, P3115; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Nelson KA, 2000, SEMIN ONCOL, V27, P64; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; ROSENTHAL SM, 1995, P NATL ACAD SCI USA, V92, P10307, DOI 10.1073/pnas.92.22.10307; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005	29	808	847	1	52	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					195	200		10.1038/84839	http://dx.doi.org/10.1038/84839			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175789				2022-12-27	WOS:000166839200022
J	Cho, RJ; Huang, MX; Campbell, MJ; Dong, HL; Steinmetz, L; Sapinoso, L; Hampton, G; Elledge, SJ; Davis, RW; Lockhart, DJ				Cho, RJ; Huang, MX; Campbell, MJ; Dong, HL; Steinmetz, L; Sapinoso, L; Hampton, G; Elledge, SJ; Davis, RW; Lockhart, DJ			Transcriptional regulation and function during the human cell cycle	NATURE GENETICS			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; THYMOCYTE APOPTOSIS; BINDING; EXPRESSION; PROTEIN; GENE; FAMILY; KINASE; DEATH; RHO	We report here the transcriptional profiling of the cell cycle on a genome-wide scale in human fibroblasts. We identified approximately 700 genes that display transcriptional fluctuation with a periodicity consistent with that of the cell cycle. Systematic analysis of these genes revealed functional organization within groups of coregulated transcripts. A diverse set of cytoskeletal reorganization genes exhibit cell-cycle-dependent regulation, indicating that biological pathways are redirected for the execution of cell division. Many genes involved in cell motility and remodeling of the extracellular matrix are expressed predominantly in M phase, indicating a mechanism for balancing proliferative and invasive cellular behavior. Transcripts upregulated during S phase displayed extensive overlap with genes induced by DNA damage; cell-cycle-regulated transcripts may therefore constitute coherent programs used in response to external stimuli. Our data also provide clues to biological function for hundreds of previously uncharacterized human genes.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Biochem & Mol Biol, Dept Mol & Human Genet, Houston, TX 77030 USA; Affymetrix Inc, Santa Clara, CA USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA USA; Mol Applicat Grp, Palo Alto, CA USA; Novartis Res Fdn, Genomics Inst, San Diego, CA USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Stanford University; Baylor College of Medicine; Howard Hughes Medical Institute; Affymetrix; Stanford University; Novartis; Salk Institute	Campbell, MJ (corresponding author), Celera Genomics, Foster City, CA USA.	michael.campbell@fc.celera.com	Cho, Raymond/AAO-8125-2020	Cho, Raymond/0000-0001-6090-6603; Steinmetz, Lars/0000-0002-3962-2865				Arai M, 1999, DEV DYNAM, V215, P297, DOI 10.1002/(SICI)1097-0177(199908)215:4<297::AID-AJA2>3.3.CO;2-9; Assmann V, 1999, J CELL SCI, V112, P3943; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P1421; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; Farrance IKG, 1996, J BIOL CHEM, V271, P8266, DOI 10.1074/jbc.271.14.8266; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gil-Gomez G, 1998, EMBO J, V17, P7209, DOI 10.1093/emboj/17.24.7209; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Hakem A, 1999, J EXP MED, V189, P957, DOI 10.1084/jem.189.6.957; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; Kosaki R, 1999, CANCER RES, V59, P1141; Law SF, 2000, MOL CELL BIOL, V20, P5184, DOI 10.1128/MCB.20.14.5184-5195.2000; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Lind EF, 1999, J IMMUNOL, V162, P5374; Liu KY, 1999, MOL CELL BIOL, V19, P3696; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Martin LG, 1998, J VIROL, V72, P975, DOI 10.1128/JVI.72.2.975-985.1998; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; Moorman JP, 1996, J IMMUNOL, V156, P4146; Nasmyth K, 1996, SCIENCE, V274, P1643, DOI 10.1126/science.274.5293.1643; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; North AJ, 1999, J CELL SCI, V112, P4325; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Radhakrishna H, 1999, J CELL SCI, V112, P855; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Sanchez I, 1996, CURR OPIN CELL BIOL, V8, P318, DOI 10.1016/S0955-0674(96)80004-4; SATO N, 1992, J CELL SCI, V103, P131; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wei MC, 2000, GENE DEV, V14, P2060; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469	51	353	365	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					48	54		10.1038/83751	http://dx.doi.org/10.1038/83751			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137997				2022-12-27	WOS:000166187900014
J	Jackson-Grusby, L; Beard, C; Possemato, R; Tudor, M; Fambrough, D; Csankovszki, G; Dausman, T; Lee, P; Wilson, C; Lander, E; Jaenisch, R				Jackson-Grusby, L; Beard, C; Possemato, R; Tudor, M; Fambrough, D; Csankovszki, G; Dausman, T; Lee, P; Wilson, C; Lander, E; Jaenisch, R			Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation	NATURE GENETICS			English	Article							DNA METHYLTRANSFERASE GENE; EMBRYONIC STEM-CELLS; CYTOSINE METHYLATION; IMMUNODEFICIENCY SYNDROME; MAMMALIAN DEVELOPMENT; CRE RECOMBINASE; P53; EXPRESSION; MUTATION; MICE	Cytosine methylation of mammalian DNA is essential for the proper epigenetic regulation of gene expression and maintenance of genomic integrity. To define the mechanism through which demethylated cells die, and to establish a paradigm for identifying genes regulated by DNA methylation, we have generated mice with a conditional allele for the maintenance DNA methyltransferase gene Dnmt1. Cre-mediated deletion of Dnmt1 causes demethylation of cultured fibroblasts and a uniform p53-dependent cell death. Mutational inactivation of Trp53 partially rescues the demethylated fibroblasts for up to five population doublings in culture. Oligonucleotide microarray analysis showed that up to 10% of genes are aberrantly expressed in demethylated fibroblasts. Our results demonstrate that loss of Dnmt1 causes cell-type-specific changes in gene expression that impinge on several pathways, including expression of imprinted genes, cell-cycle control, growth factor/receptor signal transduction and mobilization of retroelements.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA.	jaenisch@wi.mit.edu		Csankovszki, Gyorgyi/0000-0001-5918-034X; Tudor, Matthew/0000-0001-8766-195X	NCI NIH HHS [R-35-CA44339] Funding Source: Medline; NICHD NIH HHS [HD18184] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD018184, R01HD018184] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R35CA044339] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BEARD C, 1995, GENE DEV, V9, P2325, DOI 10.1101/gad.9.19.2325; BIRD A, 1995, PHILOS T ROY SOC B, V349, P249, DOI 10.1098/rstb.1995.0109; Bird A, 1997, TRENDS GENET, V13, P469, DOI 10.1016/S0168-9525(97)01310-3; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLOSI P, 1987, MOL ENDOCRINOL, V1, P767, DOI 10.1210/mend-1-11-767; Cormier RT, 2000, CANCER RES, V60, P3965; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; EMERMAN M, 1984, CELL, V39, P459, DOI 10.1016/0092-8674(84)90453-7; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; FAN GP, IN PRESS J NEUROSCI; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gaudet F, 1998, J BIOL CHEM, V273, P32725, DOI 10.1074/jbc.273.49.32725; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Knox JD, 2000, J BIOL CHEM, V275, P17986, DOI 10.1074/jbc.C900894199; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Margot JB, 2000, J MOL BIOL, V297, P293, DOI 10.1006/jmbi.2000.3588; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Onishi M, 1996, EXP HEMATOL, V24, P324; Panning B, 1996, GENE DEV, V10, P1991, DOI 10.1101/gad.10.16.1991; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Stancheva I, 2000, GENE DEV, V14, P313; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	52	537	557	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					31	39		10.1038/83730	http://dx.doi.org/10.1038/83730			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137995				2022-12-27	WOS:000166187900012
J	Peterfy, M; Phan, J; Xu, P; Reue, K				Peterfy, M; Phan, J; Xu, P; Reue, K			Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; SERUM LEPTIN LEVELS; MUTANT MOUSE; INSULIN-RESISTANCE; DIABETES-MELLITUS; ADIPOSE-TISSUE; MICE; REVEALS; GENOME; MAP	Mice carrying mutations in the fatty liver dystrophy (fld) gene have features of human lipodystrophy(1), a genetically heterogeneous group of disorders characterized by loss of body fat, fatty liver hypertriglyceridemia and insulin resistance(2-4). Through positional cloning, we have isolated the gene responsible and characterized two independent mutant alleles, fld and fld(2J). The gene (Lpin1) encodes a novel nuclear protein which we have named lipin. Consistent with the observed reduction of adipose tissue mass in fld and fld(2J) mice, wild-type Lpin1 mRNA is expressed at high levels in adipose tissue and is induced during differentiation of 3T3-L1 pre-adipocytes. Our results indicate that lipin is required for normal adipose tissue development, and provide a candidate gene for human lipodystrophy. Lipin defines a novel family of nuclear proteins containing at least three members in mammalian species, and homologs in distantly related organisms from human to yeast.	Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Reue, K (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.	Reuek@ucla.edu		Phan, Jack/0000-0001-5977-6004	NHLBI NIH HHS [HL24841] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; DORFLER H, 1993, CLIN INVESTIGATOR, V71, P264; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hegele RA, 2000, J CLIN ENDOCR METAB, V85, P3089, DOI 10.1210/jc.85.9.3089; Klingenspor M, 1999, J BIOL CHEM, V274, P23078, DOI 10.1074/jbc.274.33.23078; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; OKANO H, 1991, J NEUROCHEM, V56, P560, DOI 10.1111/j.1471-4159.1991.tb08186.x; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Peterfy M, 1999, GENOMICS, V62, P436, DOI 10.1006/geno.1999.6023; Rehnmark S, 1998, J LIPID RES, V39, P2209; Reue K, 2000, J LIPID RES, V41, P1067; Rotimi CN, 1999, DIABETES, V48, P643, DOI 10.2337/diabetes.48.3.643; Rowe LB, 1996, MAMM GENOME, V7, P555, DOI 10.1007/s003359900166; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; SENIOR B, 1964, PEDIATRICS, V33, P593; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	26	446	469	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					121	124		10.1038/83685	http://dx.doi.org/10.1038/83685			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138012				2022-12-27	WOS:000166187900029
J	Scott, HS; Kudoh, J; Wattenhofer, M; Shibuya, K; Berry, A; Chrast, R; Guipponi, M; Wang, J; Kawasaki, K; Asakawa, S; Minoshima, S; Younus, F; Mehdi, SQ; Radhakrishna, U; Papasavvas, MP; Gehrig, C; Rossier, C; Korostishevsky, M; Gal, A; Shimizu, N; Bonne-Tamir, B; Antonarakis, SE				Scott, HS; Kudoh, J; Wattenhofer, M; Shibuya, K; Berry, A; Chrast, R; Guipponi, M; Wang, J; Kawasaki, K; Asakawa, S; Minoshima, S; Younus, F; Mehdi, SQ; Radhakrishna, U; Papasavvas, MP; Gehrig, C; Rossier, C; Korostishevsky, M; Gal, A; Shimizu, N; Bonne-Tamir, B; Antonarakis, SE			Insertion of beta-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness	NATURE GENETICS			English	Article							LOCUS DFNB8; GENE; CLONING; TRANSLOCATIONS; LOCALIZATION; SEQUENCE; 21Q22.3; DOMAIN; HEPSIN; MAPS	Approximately 50% of childhood deafness is caused by mutations in specific genes. Autosomal recessive loci account for approximately 80% of nonsyndromic genetic deafness(1). Here Ne report the identification of a new transmembrane serine protease (TMPRSS3; also known as ECHOS1) expressed in many tissues, including fetal cochlea, which is mutated in the families used to describe both the DFNB10 and DFNB8 loci. An 8-bp deletion and insertion of 18 monomeric (similar to 68-bp) beta -satellite repeat units, normally present in tandem arrays of up to several hundred kilobases on the short arms of acrocentric chromosomes, causes congenital deafness (DFNB10), A mutation in a splice-acceptor site, resulting in a 4-bp insertion in the mRNA and a frameshift, was detected in childhood onset deafness (DFNB8). This is the first description of beta -satellite insertion into an active gene resulting in a pathogenic state, and the first description of a protease involved in hearing loss.	Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva, Switzerland; Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo, Japan; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, Ramat Aviv, Israel; Khan Res Labs, Biomed & Genet Engn Div, Islamabad, Pakistan; Univ Hamburg, Krankenhaus Eppendorf, Inst Humangenet, D-2000 Hamburg, Germany	University of Geneva; Keio University; Tel Aviv University; Sackler Faculty of Medicine; University of Hamburg	Antonarakis, SE (corresponding author), Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva, Switzerland.	Stylianos.Antonarakis@medecine.unige.ch	Antonarakis, Stylianos E/N-8866-2014; Mehdi, Syed Qasim/L-2385-2015; Scott, Hamish/B-2122-2009	Antonarakis, Stylianos E/0000-0001-8907-5823; Scott, Hamish/0000-0002-5813-631X; Chrast, Roman/0000-0003-4189-3514				ASSUM G, 1993, HUM GENET, V91, P489; Bartoloni L, 2000, GENOMICS, V70, P190, DOI 10.1006/geno.2000.6395; Berry A, 2000, GENOMICS, V68, P22, DOI 10.1006/geno.2000.6253; BonneTamir B, 1996, AM J HUM GENET, V58, P1254; Chen H, 1996, GENOME RES, V6, P747, DOI 10.1101/gr.6.8.747; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Eichler EE, 1998, GENOME RES, V8, P791, DOI 10.1101/gr.8.8.791; FARRELL SA, 1993, AM J MED GENET, V46, P715, DOI 10.1002/ajmg.1320460624; GAUBATZ JW, 1990, MUTAT RES, V237, P271, DOI 10.1016/0921-8734(90)90009-G; GREIG GM, 1992, GENOMICS, V12, P573, DOI 10.1016/0888-7543(92)90450-7; Handt O, 2000, MOL GENET METAB, V70, P99, DOI 10.1006/mgme.2000.2996; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Kalatzis V, 1998, HUM MOL GENET, V7, P1589, DOI 10.1093/hmg/7.10.1589; Kawamura S, 1999, EUR J BIOCHEM, V262, P755, DOI 10.1046/j.1432-1327.1999.00431.x; Michaud J, 2000, GENOMICS, V68, P71, DOI 10.1006/geno.2000.6258; PaoloniGiacobino A, 1997, GENOMICS, V44, P309, DOI 10.1006/geno.1997.4845; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Samonte RV, 1996, HUM GENET, V98, P576, DOI 10.1007/s004390050262; Scott HS, 2000, ADV OTO-RHINO-LARYNG, V56, P158; SCOTT HS, 1993, AM J HUM GENET, V53, P973; Shiels C, 1997, GENOMICS, V44, P35, DOI 10.1006/geno.1997.4817; Thalmann R, 1999, ACTA OTO-LARYNGOL, V119, P293, DOI 10.1080/00016489950181260; TSUJI A, 1991, J BIOL CHEM, V266, P16948; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Veske A, 1996, HUM MOL GENET, V5, P165, DOI 10.1093/hmg/5.1.165; WATTENHOFER M, IN PRESS HUM GENET; WOLFF DJ, 1992, AM J HUM GENET, V50, P174	28	170	186	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					59	63		10.1038/83768	http://dx.doi.org/10.1038/83768			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137999	Green Published, Bronze			2022-12-27	WOS:000166187900016
J	Wei, XY; Malicki, J				Wei, XY; Malicki, J			nagie oko, encoding a MAGUK-family protein, is essential for cellular patterning of the retina	NATURE GENETICS			English	Article							ELECTRON-MICROSCOPIC ANALYSIS; ZEBRAFISH DANIO-RERIO; TUMOR-SUPPRESSOR GENE; NEURAL RETINA; DROSOPHILA STARDUST; MOUSE RETINA; POLARITY; KINASE; CELLS; DIFFERENTIATION	A layered organization of cells is a common architectural feature of many neuronal formations. Mutations of the zebrafish gene nagie oko (nok) produce a severe disruption of retinal architecture, indicating a key role for this locus in neuronal patterning. We show that nok encodes a membrane-associated guanylate kinase-family scaffolding protein. Nok localizes to the vicinity of junctional complexes in retinal neuroepithelium and in the photoreceptor cell layer. Mosaic analysis indicates that the nok retinal patterning phenotype is not cell-autonomous. We propose that nok function in patterning of postmitotic neurons is mediated through neuroepithelial cells and is necessary for guiding neurons to their proper destinations in retinal laminae.	Harvard Univ, Sch Med, MEEI, Dept Ophthalmol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Malicki, J (corresponding author), Harvard Univ, Sch Med, MEEI, Dept Ophthalmol, 243 Chrales St, Boston, MA 02114 USA.		malicki, jarema/G-8611-2014	malicki, jarema/0000-0002-5947-8805				Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Dowling J. E., 1987, RETINA; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; FUJISAWA H, 1971, DEV GROWTH DIFFER, V13, P25; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; HINDS JW, 1979, J COMP NEUROL, V187, P495, DOI 10.1002/cne.901870303; HINDS JW, 1974, DEV BIOL, V37, P381, DOI 10.1016/0012-1606(74)90156-0; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; Jensen AM, 2001, DEVELOPMENT, V128, P95; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Knapik EW, 1996, DEVELOPMENT, V123, P451; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Malicki J, 1999, DEVELOPMENT, V126, P1235; Malicki J, 1999, METHODS CELL BIOL, V59, P273; Malicki J, 1996, DEVELOPMENT, V123, P263; Marfatia SM, 1997, J BIOL CHEM, V272, P24191, DOI 10.1074/jbc.272.39.24191; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; Muller HAJ, 2000, DEV DYNAM, V218, P52; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Pujic Z, 2001, DEV BIOL, V234, P454, DOI 10.1006/dbio.2001.0251; SHEFFIELD JB, 1970, DEV BIOL, V23, P36, DOI 10.1016/S0012-1606(70)80006-9; STREISINGER G, 1986, GENETICS, V112, P311; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	42	155	157	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					150	157		10.1038/ng883	http://dx.doi.org/10.1038/ng883			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	11992120				2022-12-27	WOS:000175903500010
J	Kulkarni, RN; Holzenberger, M; Shih, DQ; Ozcan, U; Stoffel, M; Magnuson, MA; Kahn, CR				Kulkarni, RN; Holzenberger, M; Shih, DQ; Ozcan, U; Stoffel, M; Magnuson, MA; Kahn, CR			beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass	NATURE GENETICS			English	Article							GROWTH-FACTOR-I; INSULIN-RECEPTOR; GENE-EXPRESSION; MICE CAUSES; DIFFERENTIATION; TRANSCRIPTION; EXOCYTOSIS; SECRETION; KNOCKOUT; HORMONE	Regulation of glucose homeostasis by insulin depends on the maintenance of normal beta-cell mass and function. Insulin-like growth factor 1 (Igf1) has been implicated in islet development and differentiated function(1,2), but the factors controlling this process are poorly understood. Pancreatic islets produce Igf1 and Igf2, which bind to specific receptors on beta-cells(3-6). Igf1 has been shown to influence beta-cell apoptosis(7), and both Igf1 and Igf2 increase islet growth(8,9); Igf2 does so in a manner additive with fibroblast growth factor 2 (ref. 10). When mice deficient for the Igf1 receptor (Igf1r(+/-)) are bred with mice lacking insulin receptor substrate 2 (Irs2(-/-)), the resulting compound knockout mice show a reduction in mass of beta-cells(11) similar to that observed in pancreas of Igf1r(-/-) mice (ref. 11), suggesting a role for Igf1r in growth of beta-cells. It is possible, however, that the effects in these mice occur secondary to changes in vascular endothelium(12) or in the pancreatic ductal cells, or because of a decrease in the effects of other hormones implicated in islet growth. To directly define the role of Igf1, we have created a mouse with a beta-cell-specific knockout of Igf1r (Igf1r(-/-)). These mice show normal growth and development of beta-cells, but have reduced expression of Slc2a2 (also known as Glut2) and Gck (encoding glucokinase) in beta-cells, which results in defective glucose-stimulated insulin secretion and impaired glucose tolerance. Thus, Igf1r is not crucial for islet beta-cell development, but participates in control of differentiated function.	Harvard Univ, Sch Med, Dept Med, Joslin Diabet Ctr,Res Div, Boston, MA 02215 USA; Hop St Antoine, INSERM, U515, F-75571 Paris, France; Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Rockefeller University; Vanderbilt University	Kulkarni, RN (corresponding author), Harvard Univ, Sch Med, Dept Med, Joslin Diabet Ctr,Res Div, 1 Joslin Pl, Boston, MA 02215 USA.	rohit.kulkarni@joslin.harvard.edu	Holzenberger, Martin/N-9732-2018; Kahn, Ronald/AAY-2435-2021; Magnuson, Mark A/B-1335-2009; Magnuson, Mark/AAY-7172-2021	Kahn, Ronald/0000-0002-7583-9228; Magnuson, Mark A/0000-0002-8824-6499; Magnuson, Mark/0000-0002-8824-6499; Stoffel, Markus/0000-0003-1304-5817; Holzenberger, Martin/0000-0003-4869-725X				Arany E, 2000, PEDIATR RES, V48, P389, DOI 10.1203/00006450-200009000-00023; Argetsinger LS, 1996, J BIOL CHEM, V271, P29415, DOI 10.1074/jbc.271.46.29415; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Blakesley VA, 1999, CONT ENDOCRINOL, V17, P143; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BONNERWEIR S, 1994, TRENDS ENDOCRIN MET, V5, P60, DOI 10.1016/1043-2760(94)90003-5; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Holzenberger M, 2000, ENDOCRINOLOGY, V141, P2557, DOI 10.1210/en.141.7.2557; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; KULKARNI RN, 2001, MOL BASIS PANCREAS D, P299; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; LEAHY JL, 1990, ENDOCRINOLOGY, V126, P1593, DOI 10.1210/endo-126-3-1593; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Nguyen HQ, 1996, ONCOGENE, V12, P2109; OTONKOSKI T, 1988, DIABETES, V37, P1678, DOI 10.2337/diabetes.37.12.1678; RABINOVITCH A, 1982, DIABETES, V31, P160, DOI 10.2337/diabetes.31.2.160; Rhodes CJ, 2000, J MOL ENDOCRINOL, V24, P303, DOI 10.1677/jme.0.0240303; SANFORD LP, 2001, GENE KNOCKOUT PROTOC, P217; SMITH FE, 1991, P NATL ACAD SCI USA, V88, P6152, DOI 10.1073/pnas.88.14.6152; SWENNE I, 1992, DIABETOLOGIA, V35, P193, DOI 10.1007/BF00400917; VANSCHRAVENDIJK CFH, 1987, ENDOCRINOLOGY, V121, P1784, DOI 10.1210/endo-121-5-1784; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Xavier GD, 2000, J BIOL CHEM, V275, P36269, DOI 10.1074/jbc.M006597200; Zhang QM, 1997, P NATL ACAD SCI USA, V94, P6232, DOI 10.1073/pnas.94.12.6232	29	286	297	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					111	115		10.1038/ng872	http://dx.doi.org/10.1038/ng872			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11923875	Bronze			2022-12-27	WOS:000175362500025
J	Mantamadiotis, T; Lemberger, T; Bleckmann, SC; Kern, H; Kretz, O; Villalba, AM; Tronche, F; Kellendonk, C; Gau, D; Kapfhammer, J; Otto, C; Schmid, W; Schutz, G				Mantamadiotis, T; Lemberger, T; Bleckmann, SC; Kern, H; Kretz, O; Villalba, AM; Tronche, F; Kellendonk, C; Gau, D; Kapfhammer, J; Otto, C; Schmid, W; Schutz, G			Disruption of CREB function in brain leads to neurodegeneration	NATURE GENETICS			English	Article							ELEMENT-BINDING PROTEIN; HUNTINGTONS-DISEASE; MICE LACKING; EXPANDED POLYGLUTAMINE; MEDIATED TRANSCRIPTION; BCL-2 EXPRESSION; MUTANT MICE; CELL-DEATH; SURVIVAL; GENE	Control of cellular survival and proliferation is dependent on extracellular signals and is a prerequisite for ordered tissue development and maintenance. Activation of the cAMP responsive element binding protein (CREB) by phosphorylation has been implicated in the survival of mammalian cells. To define its roles in the mouse central nervous system, we disrupted Creb1 in brain of developing and adult mice using the Cre/loxP system. Mice with a Crem(-/-) background and lacking Creb in the central nervous system during development show extensive apoptosis of postmitotic neurons. By contrast, mice in which both Creb1 and Crem are disrupted in the postnatal fore-brain show progressive neurodegeneration in the hippocampus and in the dorsolateral striatum. The striatal phenotype is reminiscent of Huntington disease and is consistent with the postulated role of CREB-mediated signaling in polyglutamine-triggered diseases.	Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Univ Basel, Inst Anat, CH-4003 Basel, Switzerland	Helmholtz Association; German Cancer Research Center (DKFZ); University of Basel	Schutz, G (corresponding author), Deutsch Krebsforschungszentrum, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Mantamadiotis, Theo/W-9010-2019; Kellendonk, Christoph/O-7229-2018; TRONCHE, François/F-3895-2011; Mantamadiotis, Theo/AAM-1346-2020; Lemberger, Thomas/A-7301-2008	Mantamadiotis, Theo/0000-0003-3971-5380; Kellendonk, Christoph/0000-0003-3302-2188; Lemberger, Thomas/0000-0002-2499-4025; Martin-Villalba, Ana/0000-0002-9405-8910; Kretz, Oliver/0000-0003-1152-5956				BIRREN B, 1997, ANAL DNA; BLECKMANN SC, 1908, MOL CELL BIOL, V22, P1919; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; LALONDE R, 1987, EXP BRAIN RES, V65, P479; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mantamadiotis T, 1998, BIOTECHNIQUES, V25, P968, DOI 10.2144/98256bm07; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; ROSSI JM, 1992, P NATL ACAD SCI USA, V89, P2456, DOI 10.1073/pnas.89.6.2456; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; SIKORSKI RS, 1989, GENETICS, V122, P19; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Somers JP, 1999, MOL ENDOCRINOL, V13, P1364, DOI 10.1210/me.13.8.1364; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van den Akker E, 1999, MECH DEVELOP, V89, P103, DOI 10.1016/S0925-4773(99)00212-9; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yamada M, 2001, MOL CELL BIOL, V21, P3807, DOI 10.1128/MCB.21.11.3807-3819.2001	37	544	554	2	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2002	31	1					47	54		10.1038/ng882	http://dx.doi.org/10.1038/ng882			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967539				2022-12-27	WOS:000175362500013
J	Kurima, K; Peters, LM; Yang, YD; Riazuddin, S; Ahmed, ZM; Naz, S; Arnaud, D; Drury, S; Mo, JH; Makishima, T; Ghosh, M; Menon, PSN; Deshmukh, D; Oddoux, C; Ostrer, H; Khan, S; Riazuddin, S; Deininger, PL; Hampton, LL; Sullivan, SL; Battey, JF; Keats, BJB; Wilcox, ER; Friedman, TB; Griffith, AJ				Kurima, K; Peters, LM; Yang, YD; Riazuddin, S; Ahmed, ZM; Naz, S; Arnaud, D; Drury, S; Mo, JH; Makishima, T; Ghosh, M; Menon, PSN; Deshmukh, D; Oddoux, C; Ostrer, H; Khan, S; Riazuddin, S; Deininger, PL; Hampton, LL; Sullivan, SL; Battey, JF; Keats, BJB; Wilcox, ER; Friedman, TB; Griffith, AJ			Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function	NATURE GENETICS			English	Article							INNER-EAR; LOCUS DN; MOUSE; CHROMOSOME-19; SENSITIVITY; DFNB3; MICE	Positional cloning of hereditary deafness genes is a direct approach to identify molecules and mechanisms underlying auditory function. Here we report a locus for dominant deafness, DFNA36, which maps to human chromosome 9q13-21 in a region overlapping the DFNB7/B11 locus for recessive deafness. We identified eight mutations in a new gene, transmembrane cochlear-expressed gene 1 (TMC1), in a DFNA36 family and eleven DFNB7/B11 families. We detected a 1.6-kb genomic deletion encompassing exon 14 of Tmc1 in the recessive deafness (dn) mouse mutant, which lacks auditory responses and has hair-cell degeneration(1,2). TMC1 and TMC2 on chromosome 20p13 are members of a gene family predicted to encode transmembrane proteins. Tmc1 mRNA is expressed in hair cells of the postnatal mouse cochlea and vestibular end organs and is required for normal function of cochlear hair cells.	Natl Inst Deafness & Other Commun Disorders, Sect Gene Struct & Funct, Mol Genet Lab, NIH, Rockville, MD 20850 USA; Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD 20850 USA; Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan; Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; All India Inst Med Sci, Dept Pediat, Genet Unit, New Delhi, India; Rotary Deaf Sch, Ichalkaranji Tilawani, Maharashtra, India; NYU, Sch Med, Dept Pediat, Human Genet Program, New York, NY USA; Tulane Univ, Med Ctr, Dept Environm Hlth Sci, New Orleans, LA USA; NINCDS, G Prot Coupled Receptors Sect, NIH, Bethesda, MD 20892 USA; Natl Inst Deafness & Other Commun Disorders, Mol Neurosci Sect, NIH, Rockville, MD 20850 USA; Natl Inst Deafness & Other Commun Disorders, Hearing Sect, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Punjab; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; All India Institute of Medical Sciences (AIIMS) New Delhi; New York University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Griffith, AJ (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Gene Struct & Funct, Mol Genet Lab, NIH, 5 Res Court, Rockville, MD 20850 USA.		Makishima, Tomoko/L-2439-2019; Drury, Stacy/O-9181-2017; Naz, Sadaf/C-3911-2019; naz, sadaf/F-4406-2015; Peters, Linda/P-5370-2018	Makishima, Tomoko/0000-0003-3397-6395; Drury, Stacy/0000-0001-5950-0091; Naz, Sadaf/0000-0002-1912-0235; Peters, Linda/0000-0002-9961-4293; Deininger, Prescott/0000-0002-1067-3028	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000048, ZIADC000039, Z01DC000039, ZIADC000060, Z01DC000048, Z01DC000035, Z01DC000060] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Ashmore JF, 2001, CURR OPIN NEUROBIOL, V11, P449, DOI 10.1016/S0959-4388(00)00233-6; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BOCK GR, 1983, ACTA OTO-LARYNGOL, V96, P39, DOI 10.3109/00016488309132873; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; DEOL M. S., 1958, HEREDITY, V12, P463, DOI 10.1038/hdy.1958.46; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Griffith AJ, 1999, NAT GENET, V21, P347, DOI 10.1038/7668; Huang JM, 1998, HEARING RES, V117, P24, DOI 10.1016/S0378-5955(98)00005-7; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; JAIN PK, 1995, HUM MOL GENET, V4, P2391, DOI 10.1093/hmg/4.12.2391; KEATS BJB, 1995, MAMM GENOME, V6, P8, DOI 10.1007/BF00350886; Kiernan AE, 1999, J NEUROCYTOL, V28, P969, DOI 10.1023/A:1007090626294; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Liang Y, 1999, GENOMICS, V61, P243, DOI 10.1006/geno.1999.5976; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PUJOL R, 1983, HEARING RES, V12, P57, DOI 10.1016/0378-5955(83)90118-1; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rivolta MN, 1998, P ROY SOC B-BIOL SCI, V265, P1595, DOI 10.1098/rspb.1998.0477; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SASSOON DA, 1988, DEVELOPMENT, V104, P155; Scott DA, 2000, GENE, V246, P265, DOI 10.1016/S0378-1119(00)00090-1; Scott DA, 1996, AM J HUM GENET, V59, P385; STEEL KP, 1980, NATURE, V288, P159, DOI 10.1038/288159a0; Suzuki Y, 2000, GENOMICS, V64, P286, DOI 10.1006/geno.2000.6076; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726; Vinas AM, 1998, BBA-MOL BASIS DIS, V1407, P257, DOI 10.1016/S0925-4439(98)00050-7; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8	36	299	320	2	32	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					277	284		10.1038/ng842	http://dx.doi.org/10.1038/ng842			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11850618	Green Published			2022-12-27	WOS:000174157600011
J	Weber, G; Shendure, J; Tanenbaum, DM; Church, GM; Meyerson, M				Weber, G; Shendure, J; Tanenbaum, DM; Church, GM; Meyerson, M			Identification of foreign gene sequences by transcript filtering against the human genome	NATURE GENETICS			English	Article							DNA-SEQUENCES; PATHOGENS; SEARCH; TAGS	We have developed a computational subtraction approach to detect microbial causes for putative infectious diseases by filtering a set of human tissue-derived sequences against the human genome. We demonstrate the potential of this method by identifying sequences from known pathogens in established expressed-sequence tag libraries.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Decis Syst Grp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012	church, george/0000-0001-6232-9969; Weber, Griffin/0000-0002-2597-881X; Shendure, Jay/0000-0002-1516-1865				ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Befeler AS, 2000, INFECT DIS CLIN N AM, V14, P617, DOI 10.1016/S0891-5520(05)70124-0; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; BURGER RA, 1996, J NATL CANCER I, V88, P1360; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Relman DA, 1999, SCIENCE, V284, P1308, DOI 10.1126/science.284.5418.1308; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	14	55	58	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					141	142		10.1038/ng818	http://dx.doi.org/10.1038/ng818			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11788827				2022-12-27	WOS:000173708700009
J	Zou, YR; Sunshine, MJ; Taniuchi, I; Hatam, F; Killeen, N; Littman, DR				Zou, YR; Sunshine, MJ; Taniuchi, I; Hatam, F; Killeen, N; Littman, DR			Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage	NATURE GENETICS			English	Article							HISTONE DEACETYLASE; GENE-EXPRESSION; METHYLATION; REPRESSION; SELECTION; PROLIFERATION; TRANSCRIPTION; INACTIVATION; INHERITANCE; THYMOCYTES	The process of thymocyte development culminates in the maturation of helper (CD4(+)) and cytotoxic (CD8(+)) T cells from their common precursors, the CD4(+)CD8(+) double-positive cells(1,2). A crucial step during lineage specification is the termination of expression of either the CD4 or the CD8 coreceptor(3,4). A silencer element within the first intron of the CD4 gene is sufficient for CD4 transcriptional repression in cells of the cytotoxic lineage, as well as in thymocytes at earlier stages of differentiation(5,6). Here we show that the function of the CD4 silencer is required only at distinct stages of development. Its deletion before the initiation of lineage specification resulted in CD4 derepression throughout thymocyte differentiation. By contrast, once cells committed to the cytotoxic CD8(+) lineage, the CD4 locus remained silent through subsequent mitoses, even when the silencer element was excised. The epigenetic inheritance of the silenced CD4 locus was not affected by the inhibition of DNA methylation or histone deacetylation, and may thus involve other mechanisms that ensure a stable state of gene expression.	NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	New York University; Howard Hughes Medical Institute; New York University; University of California System; University of California San Francisco	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA.	yz2001@columbia.edu; littman@saturn.med.nyu.edu	Taniuchi, Ichiro/N-6399-2015	Taniuchi, Ichiro/0000-0002-9853-9068; Sunshine, Mary Jean/0000-0002-2188-7881				Basson MA, 2000, IMMUNOL TODAY, V21, P509, DOI 10.1016/S0167-5699(00)01711-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Berg LJ, 2001, CURR OPIN IMMUNOL, V13, P232, DOI 10.1016/S0952-7915(00)00209-0; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Clerc P, 2000, SCIENCE, V290, P1518, DOI 10.1126/science.290.5496.1518; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; von Boehmer H, 2000, CURR BIOL, V10, pR642, DOI 10.1016/S0960-9822(00)00665-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481	33	148	155	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					332	336		10.1038/ng750	http://dx.doi.org/10.1038/ng750			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687799				2022-12-27	WOS:000171911000022
J	Date, H; Onodera, O; Tanaka, H; Iwabuchi, K; Uekawa, K; Igarashi, S; Koike, R; Hiroi, T; Yuasa, T; Awaya, Y; Sakai, T; Takahashi, T; Nagatomo, H; Sekijima, Y; Kawachi, I; Takiyama, Y; Nishizawa, M; Fukuhara, N; Saito, K; Sugano, S; Tsuji, S				Date, H; Onodera, O; Tanaka, H; Iwabuchi, K; Uekawa, K; Igarashi, S; Koike, R; Hiroi, T; Yuasa, T; Awaya, Y; Sakai, T; Takahashi, T; Nagatomo, H; Sekijima, Y; Kawachi, I; Takiyama, Y; Nishizawa, M; Fukuhara, N; Saito, K; Sugano, S; Tsuji, S			Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene	NATURE GENETICS			English	Article							CEREBELLAR ATROPHY HMSNCA; HEREDITARY MOTOR; LINKAGE ANALYSIS; PROTEINS; FEATURES; FAMILY	Friedreich ataxia (FRDA), the most common autosomal recessive neurodegenerative disease among Europeans and people of European descent, is characterized by an early onset (usually before the age of 25), progressive ataxia, sensory loss, absence of tendon reflexes and pyramidal weakness of the legs(1-4). We have recently identified a unique group of patients whose clinical presentations are characterized by autosomal recessive inheritance, early age of onset, FRDA-like clinical presentations and hypoalbuminemia. Linkage to the FRDA locus, however, was excluded. Given the similarities of the clinical presentations to those of the recently described ataxia with oculomotor apraxia (AOA) linked to chromosome 9p13, we confirmed that the disorder of our patients is also linked to the same locus(5). We narrowed the candidate region and have identified a new gene encoding a member of the histidine triad (HIT) superfamily as the 'causative' gene. We have called its product aprataxin; the gene symbol is APTX. Although many HIT proteins have been identified, aprataxin is the first to be linked to a distinct phenotype.	Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; Kanagawa Rehabil Ctr, Dept Neurol & Psychiat, Kanagawa, Japan; Natl Kumamoto Minami Hosp, Dept Neurol, Kumamoto, Japan; Hosoki Hosp, Kouchi, Japan; Kohnodai Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo, Japan; Seibo Hosp, Dept Pediat, Tokyo, Japan; Natl Chikugo Hosp, Fukuoka, Japan; Yokohama City Univ, Med Ctr, Dept Psychiat, Kanagawa, Japan; Shinshu Univ, Sch Med, Dept Med 3, Nagano, Japan; Jichi Med Sch, Dept Neurol, Minami Kawachi, Tochigi 32904, Japan; Natl Saigata Hosp, Dept Neurol, Niigata, Japan; Tokyo Womens Med Univ, Sch Med, Dept Pediat, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Virol, Tokyo, Japan	Niigata University; National Center for Neurology & Psychiatry - Japan; Yokohama City University; Shinshu University; Jichi Medical University; Tokyo Women's Medical University; University of Tokyo	Tsuji, S (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, 1 Asahimachi, Niigata 951, Japan.		Kawachi, Izumi/AFE-8189-2022; Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472; Saito, Kayoko/0000-0003-2632-0873				AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; ARAIE M, 1977, JPN J OPHTHALMOL, V21, P355; Barbot C, 2001, ARCH NEUROL-CHICAGO, V58, P201, DOI 10.1001/archneur.58.2.201; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; COGAN DG, 1953, AM J OPHTHALMOL, V36, P433, DOI 10.1016/0002-9394(53)90553-4; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Friedreich N., 1876, VIRCHOWS ARCH PATHOL, V68, P145, DOI 10.1007/BF01879049; Friedreich N., 1877, VIRCHOWS ARCH PATHOL, V70, P140, DOI 10.1007/BF01936635; FUKUHARA N, 1995, J NEUROL SCI, V133, P140, DOI 10.1016/0022-510X(95)00176-3; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; INOUE N, 1971, CLIN NEUROL TOKYO, V11, P855; KAWASAKI S, 1982, CLIN NEUROL, V22, P15; KOIKE R, 1998, NEUROL MED, V48, P237; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kubota Hiroshi, 1995, Brain and Nerve (Tokyo), V47, P289; KURITATAKAHASHI S, NEUROOPHTHALMOL, V12, P41; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Lima CD, 1996, P NATL ACAD SCI USA, V93, P5357, DOI 10.1073/pnas.93.11.5357; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Moreira MD, 2001, AM J HUM GENET, V68, P501, DOI 10.1086/318191; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMBROOK J, 2001, MOL CLONING LAB MANU, V1; Sekijima Y, 1998, J NEUROL SCI, V158, P30, DOI 10.1016/S0022-510X(98)00103-8; Seraphin B., 1992, DNA Sequence, V3, P177, DOI 10.3109/10425179209034013; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UEKAWA K, 1992, CLIN NEUROL, V32, P1067	28	274	286	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					184	188		10.1038/ng1001-184	http://dx.doi.org/10.1038/ng1001-184			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586299				2022-12-27	WOS:000171374100025
J	Robertson, JA				Robertson, JA			Consent and privacy in pharmacogenetic testing	NATURE GENETICS			English	Editorial Material								The clinical use of pharmacogenetic drugs will require that a sample of a patient's DNA be tested before a drug is prescribed. Although pharmacogenetic tests pose fewer risks than genetic tests for disease mutations, they might still reveal personal information that could be used adversely to a patient's interests. Informed consent and privacy of pharmacogenetic test results may be essential in most clinical uses of pharmacogenetic drugs.	Univ Texas, Sch Law, Austin, TX 78705 USA	University of Texas System; University of Texas Austin	Robertson, JA (corresponding author), Univ Texas, Sch Law, Austin, TX 78705 USA.	jrobertson@mail.law.utexas.edu						Bernstein T, 1994, RADON RENTAL HOUSING; Department of Health and Human Services, 2000, FED REG, V65, P82462; HOLTZMAN NA, 1997, PROMOTING SAFE EFFEC, P180; *I HLTH CAR RES PO, 1999, HLTH POL PROJ STAT H; Marshall E, 2001, SCIENCE, V291, P575; Pear R, 2001, N Y Times Web, pA12; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; *SECR ADV COMM GEN, 2000, FIN REP ENH OV GEN T; TORRES A, 1994, ARCH DERMATOL, V130, P32, DOI 10.1001/archderm.130.1.32; 2001, NATURE GENET, V28, P195	10	56	57	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					207	209		10.1038/90032	http://dx.doi.org/10.1038/90032			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431685				2022-12-27	WOS:000169656400007
J	Charlier, C; Segers, K; Karim, L; Shay, T; Gyapay, G; Cockett, N; Georges, M				Charlier, C; Segers, K; Karim, L; Shay, T; Gyapay, G; Cockett, N; Georges, M			The callipyge mutation enhances the expression of coregulated imprinted genes in cis without affecting their imprinting status	NATURE GENETICS			English	Article							GTL2	The callipyge (CLPG) phenotype (from kappa alpha lambda iota, "beautiful," and pi iota gamma epsilon, "buttocks") described in sheep is an inherited muscular hypertrophy that is subject to unusual parent-of-origin effect referred to as polar overdominance:only heterozygous individuals having inherited the CLPG mutation from their sire exhibit muscular hypertrophy(1). The callipyge (clpg) locus was mapped to a segment of approximately 400 kb (refs, 2-4), which was shown to contain genes (DLK1, GTL2, PEG11 and MEG8) that are preferentially expressed in skeletal muscle and subject to parental imprinting in this tissue(5-9). Here we describe effect of the CLPG mutation on the expression of these four genes, and demonstrate that callipyge individuals have a unique expression profile that may for the observed polar overdominance. for the observed polar overdominance.	Univ Liege B43, Fac Med Vet, Dept Genet, Liege, Belgium; Ctr Natl Sequencage, Genoscope, Evry, France; Utah State Univ, Coll Agr, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA	University of Liege; Utah System of Higher Education; Utah State University	Georges, M (corresponding author), Univ Liege B43, Fac Med Vet, Dept Genet, Liege, Belgium.	michel.georges@ulg.ac.be		Charlier, Carole/0000-0002-9694-094X; Georges, Michel/0000-0003-4124-2375				Berghmans S, 2001, MAMM GENOME, V12, P183, DOI 10.1007/s003350010246; CHARLIER C, IN PRESS GENOME RES; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Schmidt JV, 2000, GENE DEV, V14, P1997; Segers K, 2000, ANIM GENET, V31, P352, DOI 10.1046/j.1365-2052.2000.00676.x; Shay TL, 2001, MAMM GENOME, V12, P141, DOI 10.1007/s003350010248; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600	9	136	146	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2001	27	4					367	369		10.1038/86856	http://dx.doi.org/10.1038/86856			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279514				2022-12-27	WOS:000167811200007
J	Kovtun, IV; McMurray, CT				Kovtun, IV; McMurray, CT			Trinucleotide expansion in haploid germ cells by gap repair	NATURE GENETICS			English	Article							DNA SECONDARY STRUCTURE; CAG REPEAT; CTG REPEATS; HUNTINGTON-DISEASE; INSTABILITY; YEAST; LENGTH; REPLICATION; ORIENTATION; DELETION	Huntington disease (HD) is one of eight progressive neurodegenerative disorders in which the underlying mutation is a CAG expansion encoding a polyglutamine tract(1). The mechanism of trinucleotide expansion is poorly understood. Expansion is mediated by misaligned pairing of repeats and the inappropriate formation of DNA secondary structure as the duplex unpairs(2-7). It has never been clear, however, whether duplex unpairing occurs during mitotic replication or during strand-break repair. In simple organisms, trinucleotide expansion arises by replication slippage on either the leadings or the lagging strand(9-12), homologous recombination(13,14), gene conversion(15,16), double-strand break repair(13-17) and base excision repair(18); it is not clear which of these mechanisms is used in mammalian cells in vivo. We have followed heritable changes in CAG length in male transgenic mice. In germ cells, expansion is limited to the post-meiotic, haploid cell and therefore cannot involve mitotic replication or recombination between a homologous chromosome or a sister chromatid. Our data support a model in which expansion in the germ cells arises by gap repair and depends on a complex containing Msh2. Expansion occurs during gap-filling synthesis when DNA loops comprising the CAG trinucleotide repeats are sealed into the DNA strand.	Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mol Neurosci Program, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	McMurray, CT (corresponding author), Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, 200 1st St SW, Rochester, MN 55905 USA.	mcmurray.cynthia@mayo.edu	Kovtun, Irina/ABA-8484-2020		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056207] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 43694] Funding Source: Medline; NIMH NIH HHS [MH56207] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cemal CK, 1999, GENE, V236, P53, DOI 10.1016/S0378-1119(99)00273-5; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Freudenreich CH, 1997, MOL CELL BIOL, V17, P2090, DOI 10.1128/MCB.17.4.2090; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; GACY AM, 1995, CELL, V81, P533; Goellner GM, 1997, AM J HUM GENET, V60, P879; Iyer RR, 1999, J BIOL CHEM, V274, P3865, DOI 10.1074/jbc.274.6.3865; Jakupciak JP, 1999, J BIOL CHEM, V274, P23468, DOI 10.1074/jbc.274.33.23468; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; Kovtun IV, 2000, HUM MOL GENET, V9, P2767, DOI 10.1093/hmg/9.18.2767; Leeflang EP, 1999, HUM MOL GENET, V8, P173, DOI 10.1093/hmg/8.2.173; Lyons-Darden T, 1999, J BIOL CHEM, V274, P25975, DOI 10.1074/jbc.274.37.25975; MACDONALD ME, 1993, J MED GENET, V30, P982, DOI 10.1136/jmg.30.12.982; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; MAYSHOOPES LL, 1995, BIOL REPROD, V53, P1003, DOI 10.1095/biolreprod53.5.1003; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; MCPHERSON SMG, 1993, DEV BIOL, V158, P122, DOI 10.1006/dbio.1993.1173; Miret JJ, 1998, P NATL ACAD SCI USA, V95, P12438, DOI 10.1073/pnas.95.21.12438; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; NORREMOLLE A, 1995, CLIN GENET, V47, P113; Petersen A, 1999, EXP NEUROL, V157, P1; RANEN NG, 1995, AM J HUM GENET, V57, P593; Richard GF, 2000, EMBO J, V19, P2381, DOI 10.1093/emboj/19.10.2381; Sarkar PS, 1998, CELL, V95, P531, DOI 10.1016/S0092-8674(00)81620-7; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; Smith A, 1998, BIOTECHNIQUES, V25, P496, DOI 10.2144/98253rr05; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1	30	213	216	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2001	27	4					407	411		10.1038/86906	http://dx.doi.org/10.1038/86906			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279522				2022-12-27	WOS:000167811200015
J	Wang, PJ; McCarrey, JR; Yang, F; Page, DC				Wang, PJ; McCarrey, JR; Yang, F; Page, DC			An abundance of X-linked genes expressed in spermatogonia	NATURE GENETICS			English	Article							RADIATION HYBRID MAP; MOUSE Y-CHROMOSOME; GERM-CELLS; SEX-CHROMOSOMES; MEIOTIC DRIVE; DAZ GENE; STERILITY; EVOLUTION; HOMOLOG; EXPLANATION	Spermatogonia are the self-renewing, mitotic germ cells of the testis from which sperm arise by means of the differentiation pathway known as spermatogenesis'. By contrast with hematopoietic and other mammalian stem-cell populations. which have been subjects of intense molecular genetic investigation, spermatogonia have remained largely unexplored at the molecular level. Here we describe a systematic search for genes expressed in mouse spermatogonia, but not in somatic tissues. We identified 25 genes (19 of which are novel) that are expressed in only mate germ cells. Of the 25 genes, 3 are Y-linked and 10 are X-linked. If these genes had been distributed randomly in the genome, one would have expected zero to two of the genes to be X-linked. Our findings indicate that the X chromosome has a predominant role in pre-meiotic stages of mammalian spermatogenesis. We hypothesize that the X chromosome acquired this prominent role in male germ-cell development as it evolved from an ordinary, unspecialized autosome.	MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Whitehead Inst, Cambridge, MA USA; MIT, Dept Biol, Cambridge, MA USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Texas Biomedical Research Institute	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.		Yang, Fan/GYU-4249-2022	Yang, Fengtang/0000-0002-3573-2354				BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Bergstrom DE, 1998, GENOMICS, V48, P304, DOI 10.1006/geno.1997.5176; Brooks R, 2000, NATURE, V406, P67, DOI 10.1038/35017552; CHARLESWORTH B, 1993, GENETICS, V133, P421; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Elliott DJ, 1996, HUM MOL GENET, V5, P869, DOI 10.1093/hmg/5.7.869; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; FOSTER JW, 1994, P NATL ACAD SCI USA, V91, P1927, DOI 10.1073/pnas.91.5.1927; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; Graves JAM, 1998, CYTOGENET CELL GENET, V80, P94, DOI 10.1159/000014963; Herrmann BG, 1999, NATURE, V402, P141, DOI 10.1038/45970; Hurst LD, 1999, TRENDS GENET, V15, P383, DOI 10.1016/S0168-9525(99)01809-0; HURST LD, 1991, GENETICS, V128, P841; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lavery DJ, 1997, P NATL ACAD SCI USA, V94, P6831, DOI 10.1073/pnas.94.13.6831; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; MORRISONGRAHAM K, 1993, BIOESSAYS, V15, P77, DOI 10.1002/bies.950150202; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Rongo C, 1996, TRENDS GENET, V12, P102, DOI 10.1016/0168-9525(96)81421-1; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Van Etten WJ, 1999, NAT GENET, V22, P384, DOI 10.1038/11962	30	613	673	1	35	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					422	426		10.1038/86927	http://dx.doi.org/10.1038/86927			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279525				2022-12-27	WOS:000167811200018
J	Whitelaw, E; Martin, DIK				Whitelaw, E; Martin, DIK			Retrotransposons as epigenetic mediators of phenotypic variation in mammals	NATURE GENETICS			English	Editorial Material							DNA METHYLATION; TRANSPOSABLE ELEMENTS; TRANSCRIPTIONAL INTERFERENCE; DROSOPHILA-MELANOGASTER; RNA INTERFERENCE; MOUSE EMBRYO; C-ELEGANS; GENE; INHERITANCE; EXPRESSION	Phenotypic variation in mammals is frequently attributed to the action of quantitative trait loci (QTL) or the environment, but may also be epigenetic in origin. Here we consider a mechanism for phenotypic variation based on interference of transcription by somatically active retrotransposons. Transcriptionally competent retrotransposons may number in the tens of thousands in mammalian genomes. We propose that silencing of retrotransposons occurs by cosuppression during early embryogenesis, but that this process is imperfect and produces a mosaic pattern of retrotransposon expression in somatic cells. Transcriptional interference by active retrotransposons perturbs expression of neighboring genes in somatic cells, in a mosaic pattern corresponding to activity of each retrotransposon. The epigenotype of retrotransposon activity is reset in each generation, but incomplete resetting can lead to heritable epigenetic effects. The stochastic nature of retrotransposon activity, and the very large number of genes that may be affected, produce subtle phenotypic variations even between genetically identical individuals, which may affect disease risk and be heritable in a non-mendelian fashion.	Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; Univ Sydney, Dept Biochem, Sydney, NSW 2006, Australia	Victor Chang Cardiac Research Institute; University of Sydney	Martin, DIK (corresponding author), Victor Chang Cardiac Res Inst, Sydney, NSW, Australia.	d.martin@victorchang.unsw.edu.au						Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Chaboissier MC, 1998, P NATL ACAD SCI USA, V95, P11781, DOI 10.1073/pnas.95.20.11781; CORBIN V, 1989, NATURE, V337, P279, DOI 10.1038/337279a0; EMERMAN M, 1984, CELL, V39, P459, DOI 10.1016/0092-8674(84)90453-7; ESSIEN FB, 1990, TERATOLOGY, V42, P183, DOI 10.1002/tera.1420420209; Falconer, 1989, INTRO QUANTITATIVE G, P438; FERRANTE F, 1994, CLIN EXP HYPERTENS, V16, P1, DOI 10.3109/10641969409068580; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; FINCHAM JRS, 1974, ANNU REV GENET, V8, P15, DOI 10.1146/annurev.ge.08.120174.000311; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; GARTNER K, 1981, NATURE, V292, P646, DOI 10.1038/292646a0; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; GRUNEBERG H, 1970, NATURE, V225, P39, DOI 10.1038/225039a0; Hollick JB, 1997, TRENDS GENET, V13, P302, DOI 10.1016/S0168-9525(97)01184-0; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; HUMMEL KP, 1958, J EXP ZOOL, V137, P389, DOI 10.1002/jez.1401370303; JABLONKA E, 1995, EPIGENETIC INHERITAN, P46; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; KRIEG AM, 1992, FASEB J, V6, P2537, DOI 10.1096/fasebj.6.8.1592206; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Machin GA, 1996, AM J MED GENET, V61, P216, DOI 10.1002/(SICI)1096-8628(19960122)61:3<216::AID-AJMG5>3.0.CO;2-S; MARTIENSSEN R, 1994, GENETICS, V136, P1157; MARTIENSSEN RA, 1995, CURR OPIN GENET DEV, V5, P234, DOI 10.1016/0959-437X(95)80014-X; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; McClintock B, 1968, CARNEGIE I WASHINGTO, V66, P20; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MONK M, 1987, DEVELOPMENT, V99, P371; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PACKER AI, 1993, DEV BIOL, V157, P281, DOI 10.1006/dbio.1993.1133; PARKHURST SM, 1986, MOL CELL BIOL, V6, P47, DOI 10.1128/MCB.6.1.47; PIKO L, 1984, P NATL ACAD SCI-BIOL, V81, P488, DOI 10.1073/pnas.81.2.488; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roemer I, 1997, CURR BIOL, V7, P277, DOI 10.1016/S0960-9822(06)00124-2; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Vasicek TJ, 1997, GENETICS, V147, P777; WLKINSON DA, 1994, RETROVIRIDAE, P465; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	52	273	284	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2001	27	4					361	365		10.1038/86850	http://dx.doi.org/10.1038/86850			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279513				2022-12-27	WOS:000167811200006
J	Zenklusen, JC; Conti, CJ; Green, ED				Zenklusen, JC; Conti, CJ; Green, ED			Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31	NATURE GENETICS			English	Article							PRIMARY BREAST-CANCER; COMMONLY DELETED REGION; LONG ARM; PHYSICAL MAP; OVARIAN-CANCER; SQUAMOUS-CELL; FREQUENT LOSS; HETEROZYGOSITY; HUMAN-CHROMOSOME-7; CARCINOMAS	Loss of heterozygosity (LOH) of markers on human chromosome 7q31 is frequently encountered in a variety of human neoplasias, indicating the presence of a tumor-suppressor gene (TSC). By a combination of microcell-fusion and deletion-mapping studies, we previously established that this TSG resides within a critical region flanked by the genetic markers D7S522 and D7S677. Using a positional cloning strategy and aided by the availability of near-complete sequence of this genomic interval, we have identified a TSG within 7q31, named ST7 (for suppression of tumorigenicity 7; this same gene was recently reported in another context and called RAY1). ST7 is ubiquitously expressed in human tissues. Analysis of a series of cell lines derived from breast tumors and primary colon carcinomas revealed the presence of mutations in ST7. Introduction of the ST7 cDNA into the prostate-cancer-derived cell line PC3 had no effect on the in vitro proliferation of the cells, but abrogated their in vivo tumorigenicity. Our data indicate that ST7 is a TSG within chromosome 7q31 and may have an important role in the development of some types of human cancer.	NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Texas System; UTMD Anderson Cancer Center	Zenklusen, JC (corresponding author), NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA.							ABRAHAMSON GM, 1993, AM J HEMATOL, V42, P171, DOI 10.1002/ajh.2830420206; Achille A, 1996, CANCER RES, V56, P3808; BIECHE I, 1992, LANCET, V339, P139, DOI 10.1016/0140-6736(92)90208-K; Bieche I, 1997, CLIN CANCER RES, V3, P1009; Black DM, 1999, BRIT J CANCER, V80, P42; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; Cunningham JM, 1996, CANCER RES, V56, P4475; Dale TC, 1996, CANCER RES, V56, P4320; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; ElNaggar AK, 1997, AM J PATHOL, V151, P1767; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8449; Gupta PK, 1997, CANCER RES, V57, P1188; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang HJ, 1999, GENE CHROMOSOME CANC, V24, P48, DOI 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.0.CO;2-V; Hurlstone AFL, 1999, ONCOGENE, V18, P1881, DOI 10.1038/sj.onc.1202491; Kaighn M E, 1978, Natl Cancer Inst Monogr, P17; KIBBELAAR RE, 1993, BLOOD, V82, P904; Koike M, 1999, LEUKEMIA RES, V23, P307, DOI 10.1016/S0145-2126(98)00159-3; Koike M, 1997, GENE CHROMOSOME CANC, V19, P1, DOI 10.1002/(SICI)1098-2264(199705)19:1<1::AID-GCC1>3.0.CO;2-3; Lin JC, 1996, ONCOGENE, V13, P2001; Matsuda T, 1997, ONCOGENE, V15, P2773, DOI 10.1038/sj.onc.1201461; Michaels JEA, 1996, P NATL ACAD SCI USA, V93, P14452, DOI 10.1073/pnas.93.25.14452; MOORE D, 1992, CURRENT PROTOCOLS MO; Myohanen SK, 1998, CANCER RES, V58, P591; NEUMAN WL, 1992, BLOOD, V79, P1501; Nishizuka S, 1997, BRIT J CANCER, V76, P1567, DOI 10.1038/bjc.1997.598; OGATA T, 1993, MOL CELL BIOL, V13, P6036, DOI 10.1128/MCB.13.10.6036; OGATA T, 1995, JPN J CANCER RES, V86, P35, DOI 10.1111/j.1349-7006.1995.tb02985.x; Seibert FS, 1997, J BIOENERG BIOMEMBR, V29, P429, DOI 10.1023/A:1022478822214; Shridhar V, 1997, ONCOGENE, V15, P2727, DOI 10.1038/sj.onc.1201448; Sprenger CC, 1999, CANCER RES, V59, P2370; Tatarelli C, 2000, GENOMICS, V68, P1, DOI 10.1006/geno.2000.6272; Trovato M, 1999, J CLIN ENDOCR METAB, V84, P3235, DOI 10.1210/jcem.84.9.5986; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; Vande Woude GF, 1997, CIBA F SYMP, V212, P119; Vincent JB, 2000, AM J HUM GENET, V67, P510, DOI 10.1086/303005; XU Y, 1994, ISMB, V2, P376; ZENKLUSEN JC, 1994, ONCOGENE, V9, P2817; Zenklusen JC, 1996, MOL CARCINOGEN, V15, P167; ZENKLUSEN JC, 1995, ONCOGENE, V11, P359; ZENKLUSEN JC, 1994, CANCER RES, V54, P6370; ZENKLUSEN JC, 1994, P NATL ACAD SCI USA, V91, P12155, DOI 10.1073/pnas.91.25.12155; ZENKLUSEN JC, 1995, CANCER RES, V55, P1347; Zenklusen JC, 2000, ONCOGENE, V19, P1729, DOI 10.1038/sj.onc.1203488; Zenklusen Jean C., 1999, Neoplasia (New York), V1, P16, DOI 10.1038/sj.neo.7900011; Zhang JH, 1997, GENOME RES, V7, P649, DOI 10.1101/gr.7.6.649	50	79	86	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					392	398		10.1038/86891	http://dx.doi.org/10.1038/86891			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279520				2022-12-27	WOS:000167811200013
J	Patel, PI				Patel, PI			Soundbites	NATURE GENETICS			English	Editorial Material							DENTINOGENESIS-IMPERFECTA; DENTIN PHOSPHOPROTEIN; II LOCUS; SIALOPROTEIN	Dentinogenesis imperfecta (DGI) is characterized by discolored teeth with an opalescent sheen and dentin that fails to support enamel, causing it to easily chip. Two new studies show that DGI is associated with mutations in DSPP. a gene encoding dentin sialophospho-protein that is processed into two proteins: dentin sialoprotein (DSP) and dentin phosphoprotein (DPP). These are key components of the dentin extracellular matrix (DECM). Notably, missense mutations in DSPP are also associated with progressive hearing loss.	Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Patel, PI (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.							Aplin HM, 1999, J DENT RES, V78, P1270, DOI 10.1177/00220345990780061201; BALL SP, 1982, ANN HUM GENET, V46, P35, DOI 10.1111/j.1469-1809.1982.tb00693.x; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; BIXLER D, 1969, J DENT RES, V48, P1196, DOI 10.1177/00220345690480061701; Butler WT, 1998, EUR J ORAL SCI, V106, P204, DOI 10.1111/j.1600-0722.1998.tb02177.x; CROSBY AH, 1995, AM J HUM GENET, V57, P832; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; MACDOUGALL M, 1992, AM J HUM GENET, V50, P109; MARS M, 1976, BRIT DENT J, V140, P206, DOI 10.1038/sj.bdj.4803733; QIN C, IN PRESS J BIOL CHEM; Roberts E., 1939, AM J ORTHOD ORAL SUR, V25, P267, DOI [10.1016/S0096-6347(39)90098-0, DOI 10.1016/S0096-6347(39)90098-0]; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; TAKAGI Y, 1986, J ORAL PATHOL, V15, P464; WITKOP C J, 1957, Acta Genet Stat Med, V7, P236; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	16	7	10	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					129	130		10.1038/84728	http://dx.doi.org/10.1038/84728			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175770				2022-12-27	WOS:000166839200002
J	Myung, K; Datta, A; Chen, C; Kolodner, RD				Myung, K; Datta, A; Chen, C; Kolodner, RD			SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination	NATURE GENETICS			English	Article							WERNERS-SYNDROME GENES; DNA HELICASE; BLOOMS-SYNDROME; REPLICATION; INTERACTS; PROTEINS; PRODUCT	The Escherichia coli gene recQ was identified as a RecF recombination pathway gene(1). The gene SGS1, encoding the only RecQ-like DNA helicase in Saccharomyces cerevisiae, was identified by mutations that suppress the top3 slow-growth phenotype(2,3). Relatively little is known about the function of Sgs1p because single mutations in SCSI do not generally cause strong phenotypes. Mutations in genes encoding RecQ-like DNA helicases such as the Bloom and Werner syndrome genes, BLM and WRN, have been suggested to cause increased genome instability(4,5). But the exact DNA metabolic defect that might underlie such genome instability has remained unclear. To better understand the cellular role of the RecQ-like DNA helicases, sgs1 mutations were analyzed for their effect on genome rearrangements(6,7). Mutations in SGS1 increased the rate of accumulating gross chromosomal rearrangements (GCRs), including translocations and deletions containing extended regions of imperfect homology at their breakpoints. sgs1 mutations also increased the rate of recombination between DNA sequences that had 91% sequence homology. Epistasis analysis showed that Sgs1p is redundant with DNA mismatch repair (MMR) for suppressing GCRs and for suppressing recombination between divergent DNA sequences. This suggests that defects in the suppression of rearrangements involving divergent, repeated sequences may underlie the genome instability seen in BLM and WRN patients and in cancer cases associated with defects in these genes.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA.		Chen, Clark C/C-8714-2013	Chen, Clark C/0000-0001-6258-9277	NIGMS NIH HHS [GM50006, GM26017] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026017, R01GM026017, R01GM050006] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bennett RJ, 1998, J BIOL CHEM, V273, P9644, DOI 10.1074/jbc.273.16.9644; Blander G, 1999, J BIOL CHEM, V274, P29463, DOI 10.1074/jbc.274.41.29463; Calin G, 1998, CANCER RES, V58, P3777; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen YL, 1998, T NONFERR METAL SOC, V8, P5; Datta A, 1996, MOL CELL BIOL, V16, P1085; Davey S, 1998, MOL CELL BIOL, V18, P2721, DOI 10.1128/MCB.18.5.2721; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Frei C, 2000, GENE DEV, V14, P81; FUKUCHI K, 1990, HUM GENET, V84, P249; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; German J, 1998, GENETIC BASIS HUMAN, P301; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; LANGLOIS RG, 1989, P NATL ACAD SCI USA, V86, P670, DOI 10.1073/pnas.86.2.670; MATIC I, 1995, CELL, V80, P507, DOI 10.1016/0092-8674(95)90501-4; MONNAT RJ, 1992, GENOMICS, V13, P777, DOI 10.1016/0888-7543(92)90153-J; Moser MJ, 1999, HUM MUTAT, V13, P271, DOI 10.1002/(SICI)1098-1004(1999)13:4<271::AID-HUMU2>3.0.CO;2-Q; NAKAYAMA H, 1984, MOL GEN GENET, V195, P475; Ng SW, 1999, NUCLEIC ACIDS RES, V27, P993, DOI 10.1093/nar/27.4.993; Nicholson A, 2000, GENETICS, V154, P133; SALK D, 1985, ADV EXP MED BIOL, V190, P541; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SHIRAISHI Y, 1983, CANCER GENET CYTOGEN, V9, P129, DOI 10.1016/0165-4608(83)90033-X; Watt PM, 1996, GENETICS, V144, P935; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	30	262	266	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					113	116		10.1038/83673	http://dx.doi.org/10.1038/83673			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138010				2022-12-27	WOS:000166187900027
J	Wasserman, WW; Palumbo, M; Thompson, W; Fickett, JW; Lawrence, CE				Wasserman, WW; Palumbo, M; Thompson, W; Fickett, JW; Lawrence, CE			Human-mouse genome comparisons to locate regulatory sites	NATURE GENETICS			English	Letter							SEQUENCE ALIGNMENT; GENE-EXPRESSION; REGIONS; MODELS; IDENTIFICATION; TRANSCRIPTION; RECOGNITION; EVOLUTION; NETWORK	Elucidating the human transcriptional regulatory network(1) is a challenge of the post-genomic era. Technical progress so far is impressive, including detailed understanding of regulatory mechanisms for at least a few genes in multicellular organisms(2-4), rapid and precise localization of regulatory regions within extensive regions of DNA by means of cross-species comparison(5-7), and de novo determination of transcription-factor binding specificities from large-scale yeast expression datas. Here we address two problems involved in extending these results to the human genome: first, it has been unclear how many model organism genomes will be needed to delineate most regulatory regions: and second, the discovery of transcription-factor binding sites (response elements) from expression data has not yet been generalized from single-celled organisms to multicellular organisms. We found that 98% (74/75) of experimentally defined sequence-specific binding sites of skeletal-muscle-specific transcription factors are confined to the 19% of human sequences that are most conserved in the orthologous rodent sequences. Also we found that in using this restriction, the binding specificities of all three major muscle-specific transcription factors (MYF. SRF and MEF2) can be computationally identified.	New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA; SmithKline Beecham Pharmaceut, Bioinformat Grp, King Of Prussia, PA 19406 USA	State University of New York (SUNY) System; Wadsworth Center; GlaxoSmithKline	Lawrence, CE (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Empire State Plaza,POB 509, Albany, NY 12237 USA.		Wasserman, Wyeth/I-4866-2015	Wasserman, Wyeth/0000-0001-6098-6412	NHGRI NIH HHS [R01 HG00981-03, R01 HG01257] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000981, R01HG001257] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Agarwal P, 1996, J COMPUT BIOL, V3, P1, DOI 10.1089/cmb.1996.3.1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aparicio S, 1997, NAT GENET, V16, P79, DOI 10.1038/ng0597-79; Battey J, 1999, NAT GENET, V21, P73, DOI 10.1038/5012; Brickner AG, 1999, MAMM GENOME, V10, P95, DOI 10.1007/s003359900951; Duret L, 1997, CURR OPIN STRUC BIOL, V7, P399, DOI 10.1016/S0959-440X(97)80058-9; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861; Fickett JW, 2000, CURR OPIN BIOTECH, V11, P19, DOI 10.1016/S0958-1669(99)00049-X; Harding K, 1997, AGRO FOOD IND HI TEC, V8, P8; HUANG XQ, 1990, COMPUT APPL BIOSCI, V6, P373; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KOOP BF, 1995, TRENDS GENET, V11, P367, DOI 10.1016/S0168-9525(00)89108-8; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liu JS, 1995, J AM STAT ASSOC, V90, P1156, DOI 10.2307/2291508; Liu JS, 1999, BIOINFORMATICS, V15, P38, DOI 10.1093/bioinformatics/15.1.38; ORKIN SH, 1995, EUR J BIOCHEM, V231, P271, DOI 10.1111/j.1432-1033.1995.tb20697.x; Qin WN, 1998, MOL CELL BIOCHEM, V184, P153, DOI 10.1023/A:1006807515892; Sankoff D, 1973, J Mol Biol, V77, P169; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tronche F, 1997, J MOL BIOL, V266, P231, DOI 10.1006/jmbi.1996.0760; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Werner T, 1999, MAMM GENOME, V10, P168, DOI 10.1007/s003359900963; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Zhu J, 1998, BIOINFORMATICS, V14, P25, DOI 10.1093/bioinformatics/14.1.25	30	354	373	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					225	228		10.1038/79965	http://dx.doi.org/10.1038/79965			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017083				2022-12-27	WOS:000089638800024
J	Guelzim, N; Bottani, S; Bourgine, P; Kepes, F				Guelzim, N; Bottani, S; Bourgine, P; Kepes, F			Topological and causal structure of the yeast transcriptional regulatory network	NATURE GENETICS			English	Article							SMALL-WORLD; BINDING	Interpretation of high-throughput biological data requires a knowledge of the design principles underlying the networks that sustain cellular functions. Of particular importance is the genetic network, a set of genes that interact through directed transcriptional regulation. Genes that exert a regulatory role encode dedicated transcription factors (hereafter referred to as regulating proteins) that can bind to specific DNA control regions of regulated genes to activate or inhibit their transcription. Regulated genes may themselves act in a regulatory manner, in which case they participate in a causal pathway. Looping pathways form feedback circuits. Because a gene can have several connections, circuits and pathways may crosslink and thus represent connected components. We have created a graph of 909 genetically or biochemically established interactions among 491 yeast genes. The number of regulating proteins per regulated gene has a narrow distribution with an exponential decay. The number of regulated genes per regulating protein has a broader distribution with a decay resembling a power law. Assuming in computer-generated graphs that gene connections fulfill these distributions but are otherwise random, the local clustering of connections and the number of short feedback circuits are largely underestimated. This deviation from randomness probably reflects functional constraints that include biosynthetic cost, response delay and differentiative and homeostatic regulation.	ATelier Genom Cognit, CNRS, ESA 8071, Genopole, F-91000 Evry, France; Ecole Polytech, Ctr Rech Epistemol Appl, F-75230 Paris, France; Univ Paris 07, UFR Phys, Grp Modelisat Phys Interfaces Biol, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Kepes, F (corresponding author), ATelier Genom Cognit, CNRS, ESA 8071, Genopole, 523 Terrasses Agora, F-91000 Evry, France.	Francois.Kepes@genopole.cnrs.fr						Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Karp PD, 2001, SCIENCE, V293, P2040, DOI 10.1126/science.1064621; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; RAINE DJ, 2000, INTERJOURNAL COMPLEX; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Svetlov VV, 1995, YEAST, V11, P1439, DOI 10.1002/yea.320111502; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Thomas R., 1990, BIOL FEEDBACK; Vershon AK, 2000, CURR OPIN CELL BIOL, V12, P334, DOI 10.1016/S0955-0674(00)00104-6; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442	23	428	441	2	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					60	63		10.1038/ng873	http://dx.doi.org/10.1038/ng873			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967534	Bronze			2022-12-27	WOS:000175362500015
J	Sehnert, AJ; Huq, A; Weinstein, BM; Walker, C; Fishman, M; Stainier, DYR				Sehnert, AJ; Huq, A; Weinstein, BM; Walker, C; Fishman, M; Stainier, DYR			Cardiac troponin T is essential in sarcomere assembly and cardiac contractility	NATURE GENETICS			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; SUDDEN-DEATH; CARDIOVASCULAR-SYSTEM; MUTATIONS; ZEBRAFISH; TROPOMYOSIN; DISEASE; CHAIN; GENES	Mutations of the gene (TNNT2) encoding the thin-filament contractile protein cardiac troponin T are responsible for 15% of all cases of familial hypertrophic cardiomyopathy, the leading cause of sudden death in young athletes(1,2). Mutant proteins are thought to act through a dominant-negative mode that impairs function of heart muscle(3). TNNT2 mutations can also lead to dilated cardiomyopathy, a leading cause of heart failure(4). Despite the importance of cardiac troponin T in human disease, its loss-of-function phenotype has not been described. We show that the zebrafish silent heart (sih) mutation affects the gene tnnt2. We characterize two mutated alleles of sih that severely reduce tnnt2 expression: one affects mRNA splicing, and the other affects gene transcription. Tnnt2, together with alpha-tropomyosin (Tpma) and cardiac troponins C and I (Tnni3), forms a calcium-sensitive regulatory complex within sarcomeres(5). Unexpectedly, in addition to loss of Tnnt2 expression in sih mutant hearts, we observed a significant reduction in Tpma and Tnni3, and consequently, severe sarcomere defects. This interdependence of thin-filament protein expression led us to postulate that some mutations in tnnt2 may trigger misregulation of thin-filament protein expression, resulting in sarcomere loss and myocyte disarray, the life-threatening hallmarks of TNNT2 mutations in mice and humans(6,7).	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Oregon; Harvard University; Massachusetts General Hospital	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, 513 Parnassus Ave,Box 0448, San Francisco, CA 94143 USA.			Stainier, Didier/0000-0002-0382-0026				Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Amemiya CT, 1999, METHOD CELL BIOL, V60, P235; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; BURGGREN WW, 1991, ANNU REV PHYSIOL, V53, P107, DOI 10.1146/annurev.physiol.53.1.107; Chen JN, 1996, DEVELOPMENT, V123, P293; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; FYRBERG E, 1990, J MOL BIOL, V216, P657, DOI 10.1016/0022-2836(90)90390-8; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; LIN JJC, 1985, HYBRIDOMA, V4, P223, DOI 10.1089/hyb.1985.4.223; MALOUF NN, 1992, J BIOL CHEM, V267, P9269; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; OHARA O, 1989, P NATL ACAD SCI USA, V86, P5673, DOI 10.1073/pnas.86.15.5673; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Tardiff JC, 1998, J CLIN INVEST, V101, P2800, DOI 10.1172/JCI2389; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Varnava AM, 2001, CIRCULATION, V104, P1380, DOI 10.1161/hc3701.095952; Westerfield M, 1995, ZEBRAFISH BOOK; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406	25	450	460	1	41	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2002	31	1					106	110		10.1038/ng875	http://dx.doi.org/10.1038/ng875			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967535				2022-12-27	WOS:000175362500024
J	Kurotaki, N; Imaizumi, K; Harada, N; Masuno, M; Kondoh, T; Nagai, T; Ohashi, H; Naritomi, K; Tsukahara, M; Makita, Y; Sugimoto, T; Sonoda, T; Hasegawa, T; Chinen, Y; Tomita, H; Kinoshita, A; Mizuguchi, T; Yoshiura, K; Ohta, T; Kishino, T; Fukushima, Y; Niikawa, N; Matsumoto, N				Kurotaki, N; Imaizumi, K; Harada, N; Masuno, M; Kondoh, T; Nagai, T; Ohashi, H; Naritomi, K; Tsukahara, M; Makita, Y; Sugimoto, T; Sonoda, T; Hasegawa, T; Chinen, Y; Tomita, H; Kinoshita, A; Mizuguchi, T; Yoshiura, K; Ohta, T; Kishino, T; Fukushima, Y; Niikawa, N; Matsumoto, N			Haploinsufficiency of NSD1 causes Sotos syndrome	NATURE GENETICS			English	Article							CEREBRAL GIGANTISM; CHROMATIN; DOMAINS; PROTEIN	We isolated NSD1 from the 5q35 breakpoint in an individual with Sotos syndrome harboring a chromosomal translocation. We identified 1 nonsense, 3 frameshift and 20 submicroscopic deletion mutations of NSD1 among 42 individuals with sporadic cases of Sotos syndrome. The results indicate that haploinsufficiency of NSD1 is the major cause of Sotos syndrome.	Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Japan; Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa, Japan; Kyushu Med Sci Nagasaki Lab, Nagasaki, Japan; Nagasaki Univ, Sch Med, Dept Pediat, Nagasaki 852, Japan; Dokkyo Univ, Sch Med, Koshigaya Hosp, Dept Pediat, Koshigaya, Japan; Saitama Childrens Med Ctr, Div Med Genet, Kawagoe, Saitama, Japan; Univ Ryukyus, Sch Med, Dept Med Genet, Okinawa, Japan; Yamaguchi Univ, Sch Med, Fac Hlth Sci, Ube, Yamaguchi 755, Japan; Asahikawa Med Coll, Dept Publ Hlth, Asahikawa, Hokkaido 078, Japan; Kansai Med Univ, Otokoyama Hosp, Dept Pediat, Yawata, Japan; Miyazaki Med Coll, Dept Pediat, Miyazaki 88916, Japan; Shizuoka Childrens Med Ctr, Div Clin Genet & Cytogenet, Shizuoka, Japan; Univ Ryukyus, Sch Med, Dept Pediat, Okinawa, Japan; Nagasaki Univ, Ctr Gene Res, Nagasaki 852, Japan; Shinshu Univ, Sch Med, Dept Hyg & Med Genet, Matsumoto, Nagano 390, Japan	Nagasaki University; Japan Science & Technology Agency (JST); Nagasaki University; Dokkyo Medical University; Saitama Children's Medical Center; University of the Ryukyus; Yamaguchi University; Asahikawa Medical College; Kansai Medical University; University of Miyazaki; University of the Ryukyus; Nagasaki University; Shinshu University	Matsumoto, N (corresponding author), Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan.			Tomita, Hiroaki/0000-0003-2628-880X				AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; BALE AE, 1985, AM J MED GENET, V20, P613, DOI 10.1002/ajmg.1320200407; BOMAN H, 1980, CLIN GENET, V18, P421; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Imaizumi K, 2002, AM J MED GENET, V107, P58, DOI 10.1002/ajmg.10080; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Kurotaki N, 2001, GENE, V279, P197, DOI 10.1016/S0378-1119(01)00750-8; Opitz JM, 1998, AM J MED GENET, V79, P294, DOI 10.1002/(SICI)1096-8628(19981002)79:4<294::AID-AJMG12>3.0.CO;2-M; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; TOWNES PL, 1976, J MED GENET, V13, P80, DOI 10.1136/jmg.13.1.80	10	410	425	1	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					365	366		10.1038/ng863	http://dx.doi.org/10.1038/ng863			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11896389				2022-12-27	WOS:000174682000012
J	Passegue, E; Jochum, W; Behrens, A; Ricci, R; Wagner, EF				Passegue, E; Jochum, W; Behrens, A; Ricci, R; Wagner, EF			JunB can substitute for Jun in mouse development and cell proliferation	NATURE GENETICS			English	Article							D1 MESSENGER-RNA; C-JUN; TRANSCRIPTIONAL ACTIVATION; CYCLE PROGRESSION; EXPRESSION; FOS; APOPTOSIS; GROWTH; AP-1; PHOSPHORYLATION	The Jun and JunB components of the AP-1 transcription factor are known to have antagonistic functions. Here we show, by a knock-in strategy and a transgenic complementation approach, that Junb can substitute for absence of Jun during mouse development. Junb can rescue both liver and cardiac defects in Jun-null mice in a manner dependent on gene dosage. JunB restores the expression of genes regulated by Jun/Fos, but not those regulated by Jun/ATF, thereby rescuing Jun-dependent defects in vivo as well as in primary fibroblasts and fetal hepatoblasts in vitro. Thus, the transcriptionally less active JunB has the potential to substitute for Jun, indicating that the spatial and temporal regulation of expression of the transcription factor AP-1 may be more important than the coding sequence of its components.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	wagner@nt.imp.univie.ac.at	Ricci, Romeo/K-3009-2013	Ricci, Romeo/0000-0002-9766-4369; Wagner, Erwin F/0000-0001-7872-0196; Behrens, Axel/0000-0002-1557-1143; Passegue, Emmanuelle/0000-0002-3516-297X				Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BENBROOK DM, 1990, ONCOGENE, V5, P295; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; Cirillo G, 1999, MOL CELL BIOL, V19, P6240; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HSU JC, 1993, CANCER RES, V53, P3789; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; KITABAYASHI I, 1993, J BIOL CHEM, V268, P14482; Kockel L, 2001, ONCOGENE, V20, P2347, DOI 10.1038/sj.onc.1204300; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; van Dam H, 1998, GENE DEV, V12, P1227, DOI 10.1101/gad.12.8.1227; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188	41	121	122	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					158	166		10.1038/ng790	http://dx.doi.org/10.1038/ng790			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11818961				2022-12-27	WOS:000173708700015
J	Wutz, A; Rasmussen, TP; Jaenisch, R				Wutz, A; Rasmussen, TP; Jaenisch, R			Chromosomal silencing and localization are mediated by different domains of Xist RNA	NATURE GENETICS			English	Article							X-INACTIVATION CENTER; DOSAGE COMPENSATION; HISTONE MACROH2A1; MAMMALIAN-CELLS; GENE; EXPRESSION; TETRACYCLINE; INTEGRATION; NUCLEUS; STRAIN	The gene Xist initiates the chromosomal silencing process of X inactivation in mammals. Its product, a noncoding RNA, is expressed from and specifically associates with the inactive X chromosome in female cells. Here we use an inducible Xist expression system in mouse embryonic stem cells that recapitulates long-range chromosomal silencing to elucidate which Xist RNA sequences are necessary for chromosomal association and silencing. We show that chromosomal association and spreading of Xist RNA can be functionally separated from silencing by specific mutations. Silencing requires a conserved repeat sequence located at the 5' end of Xist. Deletion of this element results in Xist RNA that still associates with chromatin and spreads over the chromosome but does not effect transcriptional repression. Association of Xist RNA with chromatin is mediated by functionally redundant sequences that act cooperatively and are dispersed throughout the remainder of Xist but show little or no homology.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.			Rasmussen, Theodore/0000-0001-9450-3394				Allaman-Pillet N, 2000, GENE EXPRESSION, V9, P93; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; Beletskii A, 2001, P NATL ACAD SCI USA, V98, P9215, DOI 10.1073/pnas.161173098; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; BROWN CJ, 1989, CYTOGENET CELL GENET, V51, P971; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; FUKUSHIGE S, 1992, P NATL ACAD SCI USA, V89, P7905, DOI 10.1073/pnas.89.17.7905; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; KARN J, 1994, RNA PROTEIN INTERACT, P192; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1998, CELL, V92, P657, DOI 10.1016/S0092-8674(00)81133-2; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Rasmussen TP, 2000, J CELL BIOL, V150, P1189, DOI 10.1083/jcb.150.5.1189; Rasmussen TP, 2001, CHROMOSOMA, V110, P411, DOI 10.1007/s004120100158; RUSSELL LB, 1961, SCIENCE, V133, P1795, DOI 10.1126/science.133.3467.1795; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tinker AV, 1998, NUCLEIC ACIDS RES, V26, P2935, DOI 10.1093/nar/26.12.2935; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2001, DEVELOPMENT, V128, P1881; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	34	550	585	1	48	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					167	174		10.1038/ng820	http://dx.doi.org/10.1038/ng820			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11780141				2022-12-27	WOS:000173708700016
J	Yamauchi, T; Oike, Y; Kamon, J; Waki, H; Komeda, K; Tsuchida, A; Date, Y; Li, MX; Miki, H; Akanuma, Y; Nagai, R; Kimura, S; Saheki, T; Nakazato, M; Naitoh, T; Yamamura, K; Kadowaki, T				Yamauchi, T; Oike, Y; Kamon, J; Waki, H; Komeda, K; Tsuchida, A; Date, Y; Li, MX; Miki, H; Akanuma, Y; Nagai, R; Kimura, S; Saheki, T; Nakazato, M; Naitoh, T; Yamamura, K; Kadowaki, T			Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice	NATURE GENETICS			English	Article							PPAR-GAMMA; ADIPOSE-TISSUE; PROTEIN; ACTIVATION; MECHANISMS; RECEPTORS; OBESITY; LACKING; ALPHA	The CBP protein (cAMP response element binding protein (CREB) binding protein)(1) is a co-activator(2) for several transcription factors with a wide range of important biological functions, such as sterol regulatory element binding proteins (SREBPs)(3), CCAAT/enhancer-binding proteins (C/EBPs)(4), nuclear receptors(5,6) (including peroxisome proliferator-activated receptors, PPARS)(7), and signal transducers and activators of transcription (STATs)(8). In contrast to these individual transcription factors, the biological roles of CBP are poorly understood. CBP enhances transcriptional activities via histone acetylation and the recruitment of additional co-activators such as SRC (steroid coactivator)-1 (ref. 9). To identify its physiological functions using a loss-of-function mutant, we analyzed CBP-deficient mice(10-12). As Crebbp null mice (Crebbp(-/-)) died during embryogenesis(10-12), we used Crebbp(+/-) mice(12). Unexpectedly, Crebbp(+/-) mice showed markedly reduced weight of white adipose tissue (WAT) but not of other tissues. Despite this lipodystrophy, Crebbp(+/-) mice showed increased insulin sensitivity and glucose tolerance and were completely protected from body weight gain induced by a high-fat (HF) diet. We observed increased leptin sensitivity and increased serum adiponectin levels in Crebbp(+/-) mice. These increased effects of insulin-sensitizing hormones secreted from WAT may explain, at least in part, the phenotypes of Crebbp(+/-) mice. This study demonstrates that CBP may function as a 'master-switch' between energy storage and expenditure.	Univ Tokyo, Dept Internal Med, Grad Sch Med, Tokyo 1138655, Japan; Kumamoto Univ, Dept Cell Differentiat, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; Nissan Chem Ind Co Ltd, Biol Res Labs, Saito 3490294, Japan; Tokyo Med & Dent Univ, Div Lab Anim Sci, Anim Res Ctr, Tokyo 1608402, Japan; Miyazaki Med Coll, Dept Internal Med 3, Miyazaki 8891692, Japan; Kagoshima Univ, Fac Med, Dept Biochem, Kagoshima 8908520, Japan; Asahi Life Fdn, Inst Diabet Care & Res, Tokyo 1000005, Japan; Kumamoto Univ, Dept Dev Genet, Inst Mol Embryol & Genet, Kumamoto 8620976, Japan	University of Tokyo; Kumamoto University; Nissan Chemical Corporation; Tokyo Medical & Dental University (TMDU); University of Miyazaki; Kagoshima University; Asahi Life Foundation; Kumamoto University	Kadowaki, T (corresponding author), Univ Tokyo, Dept Internal Med, Grad Sch Med, Tokyo 1138655, Japan.	kadowaki-3im@h.u-tokyo.ac.jp	Waki, Hironori/AAE-3942-2020	Waki, Hironori/0000-0002-5302-9793				AILAUD G, 1998, HDB OBESITY, P359; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Goodman RH, 2000, GENE DEV, V14, P1553; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; HOUSTEK J, 1988, BIOCHIM BIOPHYS ACTA, V935, P19, DOI 10.1016/0005-2728(88)90103-X; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KIM JB, 1995, MOL CELL BIOL, V15, P2582; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Mark M, 1999, P NUTR SOC, V58, P609, DOI 10.1017/S0029665199000798; MCKENNA NJ, 2000, J STEROID BIOCHEM, V74, P255; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Murakami K, 1998, DIABETES, V47, P1841, DOI 10.2337/diabetes.47.12.1841; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Perlmann T, 1997, CELL, V90, P391, DOI 10.1016/S0092-8674(00)80498-5; Rosen ED, 2000, GENE DEV, V14, P1293; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Westin S, 2000, ADV PHARMACOL, V47, P89; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; YAMAUCHI T, 2001, NAT MED, V7, P641; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	30	130	138	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					221	226		10.1038/ng829	http://dx.doi.org/10.1038/ng829			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11818964				2022-12-27	WOS:000173708700026
J	Armstrong, SA; Staunton, JE; Silverman, LB; Pieters, R; de Boer, ML; Minden, MD; Sallan, SE; Lander, ES; Golub, TR; Korsmeyer, SJ				Armstrong, SA; Staunton, JE; Silverman, LB; Pieters, R; de Boer, ML; Minden, MD; Sallan, SE; Lander, ES; Golub, TR; Korsmeyer, SJ			MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC-CELLS; CHROMOSOME-TRANSLOCATION; CLINICAL CHARACTERISTICS; DROSOPHILA-TRITHORAX; T(4-11)(Q21-Q23); FUSION; T(7-11)(P15-P15); REARRANGEMENTS	Acute lymphoblastic leukemias carrying a chromosomal translocation involving the mixed-lineage leukemia gene (MLL, ALL1, HRX) have a particularly poor prognosis. Here we show that they have a characteristic, highly distinct gene expression profile that is consistent with an early hematopoietic progenitor expressing select multilineage markers and individual HOX genes. Clustering algorithms reveal that lymphoblastic leukemias with MLL translocations can clearly be separated from conventional acute lymphoblastic and acute myelogenous leukemias. We propose that they constitute a distinct disease, denoted here as MLL, and show that the differences in gene expression are robust enough to classify leukemias correctly as MLL, acute lymphoblastic leukemia or acute myelogenous leukemia. Establishing that MLL is a unique entity is critical, as it mandates the examination of selectively expressed genes for urgently needed molecular targets.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02142 USA; Univ Rotterdam, Sophia Childrens Hosp, Div Pediat Hematol Oncol, Rotterdam, Netherlands; Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Korsmeyer, SJ (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.			den Boer, Monique/0000-0002-5795-2921				Behm FG, 1996, BLOOD, V87, P1134, DOI 10.1182/blood.V87.3.1134.bloodjournal8731134; Borrello MA, 1996, IMMUNOL TODAY, V17, P471, DOI 10.1016/0167-5699(96)20031-B; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; Buske C, 2000, INT J HEMATOL, V71, P301; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Cuthbert G, 2000, GENE CHROMOSOME CANC, V29, P180, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1016>3.0.CO;2-K; DASARATHY V, 1991, NEAREST NEIGHBOR NOR; DiMartino JF, 1999, BRIT J HAEMATOL, V106, P614, DOI 10.1046/j.1365-2141.1999.01439.x; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; Dong WF, 1996, BRIT J HAEMATOL, V93, P280, DOI 10.1046/j.1365-2141.1996.5001044.x; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LeBien TW, 2000, BLOOD, V96, P9, DOI 10.1182/blood.V96.1.9; Loh ML, 1998, BLOOD, V92, P4792, DOI 10.1182/blood.V92.12.4792.424k30_4792_4797; Ludwig WD, 1998, BLOOD, V92, P1898; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Murre C, 1999, COLD SPRING HARB SYM, V64, P39, DOI 10.1101/sqb.1999.64.39; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Nakao M, 1996, LEUKEMIA, V10, P1911; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pieters R, 1998, LEUKEMIA, V12, P1344, DOI 10.1038/sj.leu.2401129; PUI CH, 1991, BLOOD, V77, P440; REMOLDODONNELL E, 1992, P NATL ACAD SCI USA, V89, P5635, DOI 10.1073/pnas.89.12.5635; ROSENBERG HF, 1989, J EXP MED, V170, P163, DOI 10.1084/jem.170.1.163; ROSNET O, 1993, BLOOD, V82, P1110, DOI 10.1182/blood.V82.4.1110.bloodjournal8241110; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Rozovskaia T, 2001, ONCOGENE, V20, P874, DOI 10.1038/sj.onc.1204174; SCHUSTER RM, 1969, HEPATICAE ANTHOCEROT, V2, P1; Silverman LB, 1997, CANCER-AM CANCER SOC, V80, P2285; Tallman MS, 1997, NEW ENGL J MED, V337, P1021, DOI 10.1056/NEJM199710093371501; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Tse KF, 2000, LEUKEMIA, V14, P1766, DOI 10.1038/sj.leu.2401905; Venables W.N., 2013, MODERN APPL STAT S; Yang R, 1999, BLOOD, V93, P2067; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhao M, 2000, LEUKEMIA, V14, P374, DOI 10.1038/sj.leu.2401680	47	1451	1517	4	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					41	47		10.1038/ng765	http://dx.doi.org/10.1038/ng765			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11731795				2022-12-27	WOS:000173105600012
J	Colmenares, C; Heilstedt, HA; Shaffer, LG; Schwartz, S; Berk, M; Murray, JC; Stavnezer, E				Colmenares, C; Heilstedt, HA; Shaffer, LG; Schwartz, S; Berk, M; Murray, JC; Stavnezer, E			Loss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski(-/-) mice	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR AP-2; PEROXISOME-BIOGENESIS DISORDERS; C-SKI; NEURAL-TUBE; MOLECULAR CHARACTERIZATION; ECTOPIC EXPRESSION; SKELETAL-MUSCLE; TRANSGENIC MICE; RETINOIC ACID; LACKING	Experiments involving overexpression of Ski have suggested that this gene is involved in neural tube development and muscle differentiation(1-4). in agreement with these findings, Ski(-/-) mice display a cranial neural tube defect that results in exencephaly and a marked reduction in skeletal muscle mass(5). Here we show that the penetrance and expressivity of the phenotype changes when the null mutation is backcrossed into the C57BL6/J background, with the principal change involving a switch from a neural tube defect to midline facial clefting. Other defects, including depressed nasal bridge, eye abnormalities, skeletal muscle defects and digit abnormalities, show increased penetrance in the C57BL6/J background. These phenotypes are interesting because they resemble some of the features observed in individuals diagnosed with 1p36 deletion syndrome, a disorder caused by monosomy of the short arm of human chromosome 1p (refs. 6-9). These similarities prompted us to re-examine the chromosomal location of human SKI and to determine whether SKI is included in the deletions of 1p36. We found that human SKI is located at distal 1p36.3 and is deleted in all of the individuals tested so far who have this syndrome. Thus, SKI may contribute to some of the phenotypes common in 1p36 deletion syndrome, and particularly to facial clefting.	Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Res Inst, Dept Human Genet, Cleveland, OH 44106 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Baylor College of Medicine; Case Western Reserve University; University Hospitals of Cleveland; University of Iowa; Case Western Reserve University; Case Western Reserve University	Colmenares, C (corresponding author), Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	colmenc@ccf.org	Berk, Michael/M-7891-2013; Berk, Michael/M-3585-2019	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946				Amaravadi LS, 1997, DEV BIOL, V192, P392, DOI 10.1006/dbio.1997.8780; Barlow AJ, 1997, DEVELOPMENT, V124, P391; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; CHAGANTI RSK, 1986, CYTOGENET CELL GENET, V43, P181, DOI 10.1159/000132318; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; Dahl R, 1998, P NATL ACAD SCI USA, V95, P11187, DOI 10.1073/pnas.95.19.11187; Favire L, 1999, PRENATAL DIAG, V19, P49; GOODFELLOW P N, 1991, Current Biology, V1, P11, DOI 10.1016/0960-9822(91)90111-9; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; GRIMES HL, 1992, NUCLEIC ACIDS RES, V20, P1511, DOI 10.1093/nar/20.7.1511; Harris MJ, 1999, TERATOLOGY, V60, P292, DOI 10.1002/(SICI)1096-9926(199911)60:5<292::AID-TERA10>3.3.CO;2-Y; Kaufman CD, 2000, MECH DEVELOP, V95, P147, DOI 10.1016/S0925-4773(00)00351-8; KEPPLERNOREUIL KM, 1995, J MED GENET, V32, P619, DOI 10.1136/jmg.32.8.619; LOHNES D, 1994, DEVELOPMENT, V120, P2723; LUSCHER B, 1989, GENE DEV, V3, P1507, DOI 10.1101/gad.3.10.1507; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; REISH O, 1995, AM J MED GENET, V59, P467, DOI 10.1002/ajmg.1320590413; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; Shapria SK, 1997, AM J HUM GENET, V61, P642, DOI 10.1086/515520; Slavotinek A, 1999, J MED GENET, V36, P657; STAVNEZER E, 1989, MOL CELL BIOL, V9, P4038, DOI 10.1128/MCB.9.9.4038; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Wang W, 2000, P NATL ACAD SCI USA, V97, P14394, DOI 10.1073/pnas.97.26.14394; Warren DS, 1998, AM J HUM GENET, V63, P347, DOI 10.1086/301963; Winograd J, 1997, HUM MOL GENET, V6, P369, DOI 10.1093/hmg/6.3.369; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	30	105	115	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					106	109		10.1038/ng770	http://dx.doi.org/10.1038/ng770			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11731796				2022-12-27	WOS:000173105600023
J	Gouya, L; Puy, H; Robreau, AM; Bourgeois, M; Lamoril, J; Da Silva, V; Grandchamp, B; Deybach, JC				Gouya, L; Puy, H; Robreau, AM; Bourgeois, M; Lamoril, J; Da Silva, V; Grandchamp, B; Deybach, JC			The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH	NATURE GENETICS			English	Article							HIRSCHSPRUNG-DISEASE	Erythropoietic protoporphyria (EPP) is an inherited disorder of heme biosynthesis caused by a partial deficiency of ferrochelatase (FECH, EC 4.99.1.1)(1,2). EPP is transmitted as an autosomal dominant disorder(3) with an incomplete penetrance(1). Using haplotype segregation analysis, we have identified an intronic single nucleotide polymorphism (SNP), IVS3-48T/C, that modulates the use of a constitutive aberrant acceptor splice site. The aberrantly spliced mRNA is degraded by a nonsense-mediated decay mechanism (NMD), producing a decreased steady-state level of mRNA and the additional FECH enzyme deficiency necessary for EPP phenotypic expression.	Hop Louis Mourier, Fac Xavier Bichat, INSERM, U 409, F-92701 Colombes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Deybach, JC (corresponding author), Hop Louis Mourier, Fac Xavier Bichat, INSERM, U 409, F-92701 Colombes, France.		PUY, HERVE/O-1785-2017	PUY, HERVE/0000-0003-3362-2634; Gouya, Laurent/0000-0002-1326-7025				ANDERSON KE, 2001, METABOLIC MOL BASES, P2991; Borrego S, 1999, J MED GENET, V36, P771, DOI 10.1136/jmg.36.10.771; Borrego S, 2000, J MED GENET, V37, P572, DOI 10.1136/jmg.37.8.572; Gouya L, 1996, AM J HUM GENET, V58, P292; Gouya L, 1999, BLOOD, V93, P2105, DOI 10.1182/blood.V93.6.2105.406k28_2105_2110; LAMORIL J, 1991, BIOCHEM BIOPH RES CO, V181, P594, DOI 10.1016/0006-291X(91)91231-Z; Li F M, 1987, Biomed Chromatogr, V2, P164, DOI 10.1002/bmc.1130020408; SARKANY RP, 1994, LANCET, V8910, P1394; TODD DJ, 1994, BRIT J DERMATOL, V131, P751, DOI 10.1111/j.1365-2133.1994.tb08577.x; WENT LN, 1984, ANN HUM GENET, V48, P105, DOI 10.1111/j.1469-1809.1984.tb01006.x	10	185	193	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					27	28		10.1038/ng809	http://dx.doi.org/10.1038/ng809			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11753383				2022-12-27	WOS:000173105600009
J	Hogema, BM; Gupta, M; Senephansiri, H; Burlingame, TG; Taylor, M; Jakobs, C; Schutgens, RBH; Froestl, W; Snead, OC; Diaz-Arrastia, R; Bottiglieri, T; Grompe, M; Gibson, KM				Hogema, BM; Gupta, M; Senephansiri, H; Burlingame, TG; Taylor, M; Jakobs, C; Schutgens, RBH; Froestl, W; Snead, OC; Diaz-Arrastia, R; Bottiglieri, T; Grompe, M; Gibson, KM			Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase	NATURE GENETICS			English	Article							GAMMA-HYDROXYBUTYRIC ACID; GABA(B) RECEPTORS; RAT HIPPOCAMPUS; TAURINE RELEASE; BINDING-SITES; FIRING RATE; BRAIN; ACTIVATION; CELLS; NEURONS	Succinate semialdehyde dehydrogenase (ALDH5A1, encoding SSADH deficiency is a defect of 4-aminobutyric acid (GABA) degradation that manifests in humans as 4-hydroxybutyric (gamma-hydroxybutyric, GHB) aciduria. It is characterized by a non-specific neurological disorder including psychomotor retardation, language delay, seizures, hypotonia and ataxia. The current therapy, vigabatrin (VGB), is not uniformly successful(1). Here we report the development of Aldh5a1-deficient mice. At postnatal day 16-22 Aldh5a1(-/-) mice display ataxia and develop generalized seizures leading to rapid death. We observed increased amounts of GHB and total GABA in urine, brain and liver homogenates and detected significant gliosis in the hippocampus of Aldh5a1(-/-) mice. We found therapeutic intervention with phenobarbital or pherytoin ineffective, whereas intervention with vigabatrin or the GABA(B) receptor antagonist CGP 35348 (ref. 2) prevented tonic-clonic convulsions and significantly enhanced survival of the mutant mice. Because neurologic deterioration coincided with weaning, we hypothesized the presence of a protective compound in breast milk. Indeed, treatment of mutant mice with the amino acid taurine rescued Aldh5a1(-/-) mice. These findings provide insight into pathomechanisms and may have therapeutic relevance for the human SSADH deficiency disease and GHB overdose and toxicity.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Metab Unit, Amsterdam, Netherlands; Erasmus Univ, Fac Med, Cardiovasc Res Inst COEUR, Dept Biochem, NL-3000 DR Rotterdam, Netherlands; Oregon Hlth Sci Univ, Dept Pediat, Portland, OR 97201 USA; Novartis Pharma Inc, CH-4002 Basel, Switzerland; Hosp Sick Children, Fac Med, Dept Pediat, Div Neurol, Toronto, ON, Canada; Hosp Sick Children, Fac Med, Program Brain & Behav, Toronto, ON, Canada; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA; Baylor Univ, Med Ctr, Inst Metab Dis, Dallas, TX USA	Oregon Health & Science University; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Oregon Health & Science University; Novartis; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Baylor University; Baylor University Medical Center	Gibson, KM (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, 2525 SW 3rd Ave, Portland, OR 97201 USA.		Gupta, Maneesh/GSE-3631-2022	Grompe, Markus/0000-0002-6616-4345; Diaz-Arrastia, Ramon/0000-0001-6051-3594	NIA NIH HHS [R03 AG16450, P30 AG12300] Funding Source: Medline; NINDS NIH HHS [NS 40270] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG016450, P30AG012300] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENAVIDES J, 1982, LIFE SCI, V30, P953, DOI 10.1016/0024-3205(82)90624-5; CLEMENTS JR, 1989, SYNAPSE, V4, P70, DOI 10.1002/syn.890040108; del Olmo N, 2000, BRAIN RES, V864, P298, DOI 10.1016/S0006-8993(00)02211-3; DIANA M, 1991, BRAIN RES, V566, P208, DOI 10.1016/0006-8993(91)91700-B; ENG LF, 1992, PROG BRAIN RES, V94, P353; Erhardt S, 1998, N-S ARCH PHARMACOL, V357, P611, DOI 10.1007/PL00005215; Fernandes MJD, 1999, J CEREBR BLOOD F MET, V19, P195; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; GIBSON KM, 1990, BIOMED ENVIRON MASS, V19, P89, DOI 10.1002/bms.1200190207; GIBSON KM, 1995, J INHERIT METAB DIS, V18, P143, DOI 10.1007/BF00711750; GIBSON KM, 2001, METABOLIC MOL BASES, P2079; Hardus P, 2001, EPILEPSIA, V42, P262, DOI 10.1046/j.1528-1157.2001.4220262.x; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; LANDIS DMD, 1994, ANNU REV NEUROSCI, V17, P133, DOI 10.1146/annurev.ne.17.030194.001025; Lingenhoehl K, 1999, NEUROPHARMACOLOGY, V38, P1667, DOI 10.1016/S0028-3908(99)00131-8; Mathivet P, 1997, EUR J PHARMACOL, V321, P67, DOI 10.1016/S0014-2999(96)00916-8; MILLER DB, 1995, EXP GERONTOL, V30, P383, DOI 10.1016/0531-5565(94)00064-A; Minn A, 1998, GLIA, V22, P338, DOI 10.1002/(SICI)1098-1136(199804)22:4<338::AID-GLIA3>3.0.CO;2-#; Motalli R, 1999, J NEUROPHYSIOL, V82, P638, DOI 10.1152/jn.1999.82.2.638; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; Oja SS, 2000, PROG NEUROBIOL, V62, P407, DOI 10.1016/S0301-0082(00)00005-8; OLPE HR, 1990, EUR J PHARMACOL, V187, P27, DOI 10.1016/0014-2999(90)90337-6; Rizvi TA, 1999, BRAIN RES, V816, P111, DOI 10.1016/S0006-8993(98)01133-0; Saransaari P, 2000, AMINO ACIDS, V18, P17, DOI 10.1007/s007260050002; Sarwar G, 1998, BRIT J NUTR, V79, P129, DOI 10.1079/BJN19980023; SMITH SS, 1991, NEUROSCI LETT, V132, P59, DOI 10.1016/0304-3940(91)90433-T; SNEAD OC, 1994, BRAIN RES, V659, P147, DOI 10.1016/0006-8993(94)90874-5; SNEAD OC, 1984, BIOCHEM PHARMACOL, V33, P2587; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Timby N, 2000, AM J MED, V108, P518, DOI 10.1016/S0002-9343(99)00468-4	31	127	137	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					212	216		10.1038/ng727	http://dx.doi.org/10.1038/ng727			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11544478				2022-12-27	WOS:000171374100030
J	Mykytyn, K; Braun, T; Carmi, R; Haider, NB; Searby, CC; Shastri, M; Beck, G; Wright, AF; Iannaccone, A; Elbedour, K; Riise, R; Baldi, A; Raas-Rothschild, A; Gorman, SW; Duhl, DM; Jacobson, SG; Casavant, T; Stone, EM; Sheffield, VC				Mykytyn, K; Braun, T; Carmi, R; Haider, NB; Searby, CC; Shastri, M; Beck, G; Wright, AF; Iannaccone, A; Elbedour, K; Riise, R; Baldi, A; Raas-Rothschild, A; Gorman, SW; Duhl, DM; Jacobson, SG; Casavant, T; Stone, EM; Sheffield, VC			Identification of the gene that, when mutated, causes the human obesity syndrome BBS4	NATURE GENETICS			English	Letter							BARDET-BIEDL-SYNDROME; TETRATRICOPEPTIDE REPEAT; CHROMOSOME 16Q; SYNDROME LOCUS; PROTEIN; DNA; MUTATIONS; LINKAGE	Bardet-Biedl syndrome (BBS. MIM 209900) is a heterogeneous autosomal recessive disorder characterized by obesity, pigmentary retinopathy. polydactyly, renal malformations, mental retardation, and hypogenitalism(1-4). The disorder is also associated with diabetes mellitus, hypertension, and congenital heart disease(4-6). Six distinct BBS loci map to 11q13 (BBS1), 16q21 (BBS2). 3p13-p12 (BBS3). 15q22,3-q23 (BBS4), 2q31 (BBS5). and 20p12 (BBS6)(7-13). Although BBS is rare in the general population (<1/100,000). there is considerable interest in identifying the genes causing BBS because components of the phenotype. such as obesity and diabetes, are common. We and others have demonstrated that BBS6 is caused by mutations in the gene MKKS (refs. 12,13). mutation of which also causes McKusick-Kaufman syndrome (hydrometrocolpos. post-axial polydactyly, and congenital heart defects)(14,15). MKKS has sequence homology to the alpha subunit of a prokaryotic chaperonin in the thermosome Thermoplasma acidophilum(15). We recently identified a novel gene that causes BBS2(16). The BBS2 protein has no significant similarity to other chaperonins or known proteins. Here we report the positional cloning and identification of mutations in BBS patients in a novel gene designated BBS4.	Univ Iowa, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Ben Gurion Univ Negev, Soroka Med Ctr, Inst Genet, IL-84105 Beer Sheva, Israel; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38103 USA; Cent Hosp Hedmark, Dept Ophthalmol, Hamar, Norway; Ist Regina Elena, I-00161 Rome, Italy; Hadassah Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel; Chiron Corp, Emeryville, CA 94608 USA; Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; Univ Iowa, Dept Elect Engn, Iowa City, IA 52242 USA; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA	University of Iowa; Howard Hughes Medical Institute; University of Iowa; Ben Gurion University; Soroka Medical Center; University of Edinburgh; University of Tennessee System; University of Tennessee Health Science Center; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Hebrew University of Jerusalem; Novartis; University of Pennsylvania; Pennsylvania Medicine; University of Iowa; University of Iowa	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu	Mykytyn, Kirk/E-3723-2011; Baldi, Alfonso/ABG-2397-2021	Mykytyn, Kirk/0000-0002-0158-4592; Iannaccone, Alessandro/0000-0001-5737-8424; Baldi, Alfonso/0000-0002-8693-3842; Stone, Edwin M./0000-0003-3343-4414; Jacobson, Samuel/0000-0003-2122-169X; Sheffield, Val/0000-0002-6282-0835	NEI NIH HHS [R01-EY-11298] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011298] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARDET G, 1920, THESIS PARIS; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Biedl A., 1922, DEUT MED WOCHENSCHR, V48, P1630; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; CARMI R, 1995, AM J MED GENET, V59, P199, DOI 10.1002/ajmg.1320590216; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; ELBEDOUR K, 1994, AM J MED GENET, V52, P164, DOI 10.1002/ajmg.1320520208; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; HARNETT JD, 1988, NEW ENGL J MED, V319, P615, DOI 10.1056/NEJM198809083191005; HENIKOFF S, 1994, GENOMICS, V19, P97, DOI 10.1006/geno.1994.1018; IANNACCONE A, 1999, BARDET BIEDL SYNDROM, P187; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; ROBINOW M, 1979, J PEDIATR-US, V94, P776, DOI 10.1016/S0022-3476(79)80155-9; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; SOLISCOHEN S, 1924, T ASSOC AM PHYSICIAN, V39, P356; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301	27	203	211	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2001	28	2					188	191		10.1038/88925	http://dx.doi.org/10.1038/88925			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381270				2022-12-27	WOS:000169011800025
J	Khanna, KK; Jackson, SP				Khanna, KK; Jackson, SP			DNA double-strand breaks: signaling, repair and the cancer connection	NATURE GENETICS			English	Article							CELL-CYCLE CHECKPOINT; INTRACHROMOSOMAL HOMOLOGOUS RECOMBINATION; EARLY EMBRYONIC LETHALITY; LIGASE IV DEFICIENCY; ATAXIA-TELANGIECTASIA; DEFECTIVE NEUROGENESIS; TARGETED DISRUPTION; DAMAGE; ATM; GENE	To ensure the high-fidelity transmission of genetic information, cells have evolved mechanisms to monitor genome integrity. Cells respond to DNA damage by activating a complex DNA-damage-response pathway that includes cell-cycle arrest, the transcriptional and post-transcriptional activation of a subset of genes including those associated with DNA repair, and, under some circumstances, the triggering of programmed cell death. An inability to respond properly to, or to repair, DNA damage leads to genetic instability, which in turn may enhance the rate of cancer development. Indeed, it is becoming increasingly clear that deficiencies in DNA-damage signaling and repair pathways are fundamental to the etiology of most, if not all, human cancers. Here we describe recent progress in our understanding of how cells detect and signal the presence and repair of one particularly important form of DNA damage induced by ionizing radiation-the DNA double-strand break (DSB). Moreover, we discuss how tumor suppressor proteins such as p53, ATM, Brca1 and Brca2 have been linked to such pathways, and how accumulating evidence is connecting deficiencies in cellular responses to DNA DSBs with tumorigenesis.	Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia; Univ Queensland, Dept Pathol, Brisbane, Qld, Australia; Wellcome Trust & Canc Res Campaign Inst Canc & De, Cambridge, England; Univ Cambridge, Dept Zool, Cambridge, England	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; University of Cambridge	Khanna, KK (corresponding author), Univ Queensland, Queensland Inst Med Res, PO Royal Brisbane Hosp, Brisbane, Qld, Australia.	kumkumK@qimr.edu.au	Jackson, Stephen Philip/R-4548-2019; Khanna, Kum Kum/I-1747-2013; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; Khanna, Kum Kum/0000-0001-8650-5381				Barlow C, 1998, DEVELOPMENT, V125, P4007; Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Bishop AJR, 2000, CANCER RES, V60, P395; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brown EJ, 2000, GENE DEV, V14, P397; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Caspari T, 2000, CURR BIOL, V10, pR315, DOI 10.1016/S0960-9822(00)00439-5; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Gu YS, 2000, P NATL ACAD SCI USA, V97, P2668, DOI 10.1073/pnas.97.6.2668; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Haber JE, 1999, NATURE, V398, P665, DOI 10.1038/19423; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hiramoto T, 1999, ONCOGENE, V18, P3422, DOI 10.1038/sj.onc.1202691; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jeggo PA, 1998, TRENDS GENET, V14, P312, DOI 10.1016/S0168-9525(98)01511-X; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Khanna KK, 2000, JNCI-J NATL CANCER I, V92, P795, DOI 10.1093/jnci/92.10.795; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lee Y, 2000, GENE DEV, V14, P2576, DOI 10.1101/gad.837100; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Liu QH, 2000, GENE DEV, V14, P1448; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; Matsuda M, 1999, ONCOGENE, V18, P3427, DOI 10.1038/sj.onc.1202692; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Oka A, 1998, NEUROSCI LETT, V252, P195, DOI 10.1016/S0304-3940(98)00576-X; Passalaris TM, 1999, MOL CELL BIOL, V19, P5872, DOI 10.1128/mcb.19.9.5872; Petiniot LK, 2000, P NATL ACAD SCI USA, V97, P6664, DOI 10.1073/pnas.97.12.6664; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Phillips KA, 1999, J NATL CANCER I, V91, P469, DOI 10.1093/jnci/91.5.469; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Saintigny Y, 1999, ONCOGENE, V18, P3553, DOI 10.1038/sj.onc.1202941; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Smilenov LB, 1999, MOL CELL BIOL, V19, P6963; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; TAKAL H, 2000, GENE DEV, V12, P1439; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Vamvakas S, 1997, CRIT REV TOXICOL, V27, P155, DOI 10.3109/10408449709021617; Vanasse GJ, 1999, J CLIN INVEST, V103, P1669, DOI 10.1172/JCI6658; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Wang Y, 2000, GENE DEV, V14, P927; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	76	1795	1904	8	383	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					247	254		10.1038/85798	http://dx.doi.org/10.1038/85798			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242102				2022-12-27	WOS:000167304200012
J	LaVaute, T; Smith, S; Cooperman, S; Iwai, K; Land, W; Meyron-Holtz, E; Drake, SK; Miller, G; Abu-Asab, M; Tsokos, M; Switzer, R; Grinberg, A; Love, P; Tresser, N; Rouault, TA				LaVaute, T; Smith, S; Cooperman, S; Iwai, K; Land, W; Meyron-Holtz, E; Drake, SK; Miller, G; Abu-Asab, M; Tsokos, M; Switzer, R; Grinberg, A; Love, P; Tresser, N; Rouault, TA			Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice	NATURE GENETICS			English	Article							RESPONSIVE ELEMENT; CEREBRAL-CORTEX; RNA-BINDING; SYSTEM; DEGRADATION; EXPRESSION; MEMBRANES; ACONITASE; FEATURES; FERRITIN	In mammalian cells, regulation of the expression of proteins involved in iron metabolism is achieved through interactions of iron-sensing proteins known as iron regulatory proteins (IRPs), with transcripts that contain RNA stem-loop structures referred to as iron responsive elements (IREs). Two distinct but highly homologous proteins, IRP1 and IRP2, bind IREs with high affinity when cells are depleted of iron, inhibiting translation of some transcripts, such as ferritin, or turnover of others, such as the transferrin receptor (TFRC). IRPs sense cytosolic iron levels and modify expression of proteins involved in iron uptake, export and sequestration according to the needs of individual cells(1,2). Here we generate mice with a targeted disruption of the gene encoding Irp2 (Ireb2). These mutant mice misregulate iron metabolism in the intestinal mucosa and the central nervous system. In adulthood, Ireb2(-/-) mice develop a movement disorder characterized by ataxia, bradykinesia and tremor. Significant accumulations of iron in white matter tracts and nuclei throughout the brain precede the onset of neurodegeneration and movement disorder symptoms by many months. Ferric iron accumulates in the cytosol of neurons and oligodendrocytes in distinctive regions of the brain. Abnormal accumulations of ferritin colocalize with iron accumulations in populations of neurons that degenerate, and iron-laden oligodendrocytes accumulate ubiquitin-positive inclusions. Thus, misregulation of iron metabolism leads to neurodegenerative disease in Ire62(-/-) mice and may contribute to the pathogenesis of comparable human neurodegenerative diseases.	NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA; NIH, Vet Resources Program, Off Director, Bethesda, MD USA; NCI, Div Clin Sci, Bethesda, MD 20892 USA; NeuroSci Associates, Knoxville, TN USA; NICHHD, Lab Mammalian Genet & Dev, Bethesda, MD 20892 USA; NINDS, Neuroimmunol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Rouault, TA (corresponding author), NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA.		Meyron-Holtz, Esther/B-5991-2013; IWAI, KAZUHIRO/GSN-7385-2022	Abu-Asab, Mones/0000-0002-4047-1232; Iwai, Kazuhiro/0000-0001-5620-5951; Lipko, Nancy/0000-0001-9267-4587	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001602, ZIAHD001803] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001602, Z01HD001803] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Allerson CR, 1999, J BIOL CHEM, V274, P26439, DOI 10.1074/jbc.274.37.26439; Andrews NC, 1999, NUTR REV, V57, P114, DOI 10.1111/j.1753-4887.1999.tb06934.x; ARAI N, 1994, NEUROSCI LETT, V182, P197, DOI 10.1016/0304-3940(94)90796-X; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; DERUSSO PA, 1995, J BIOL CHEM, V270, P15451, DOI 10.1074/jbc.270.26.15451; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Fix AS, 2000, TOXICOL PATHOL, V28, P122, DOI 10.1177/019262330002800115; Fix AS, 1996, TOXICOL PATHOL, V24, P291, DOI 10.1177/019262339602400305; FRANCOIS C, 1981, BRAIN RES, V215, P317, DOI 10.1016/0006-8993(81)90510-2; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; HENDERSON BR, 1993, J BIOL CHEM, V268, P27327; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Ishino K, 2000, J CELL BIOCHEM, V76, P411, DOI 10.1002/(SICI)1097-4644(20000301)76:3<411::AID-JCB9>3.0.CO;2-J; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; Katz RL, 1997, HUM PATHOL, V28, P502, DOI 10.1016/S0046-8177(97)90042-3; KIM HY, 1995, J BIOL CHEM, V270, P4983, DOI 10.1074/jbc.270.10.4983; Kim HY, 1996, J BIOL CHEM, V271, P24226, DOI 10.1074/jbc.271.39.24226; KONIJN AM, 1982, J IMMUNOL METHODS, V54, P297, DOI 10.1016/0022-1759(82)90314-3; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Yin X, 1997, J NEUROSCI RES, V50, P238, DOI 10.1002/(SICI)1097-4547(19971015)50:2<238::AID-JNR12>3.0.CO;2-4	30	395	406	2	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					209	214		10.1038/84859	http://dx.doi.org/10.1038/84859			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175792				2022-12-27	WOS:000166839200025
J	Jacobsen, M; Schweer, D; Ziegler, A; Gaber, R; Schock, S; Schwinzer, R; Wonigeit, K; Lindert, RB; Kantarci, O; Schaefer-Klein, J; Schipper, HI; Oertel, WH; Heidenreich, F; Weinshenker, BG; Sommer, N; Hemmer, B				Jacobsen, M; Schweer, D; Ziegler, A; Gaber, R; Schock, S; Schwinzer, R; Wonigeit, K; Lindert, RB; Kantarci, O; Schaefer-Klein, J; Schipper, HI; Oertel, WH; Heidenreich, F; Weinshenker, BG; Sommer, N; Hemmer, B			A point mutation in PTPRC is associated with the development of multiple sclerosis	NATURE GENETICS			English	Article							TYROSINE-PHOSPHATASE CD45; RECEPTOR COMPLEX; EXON-A; ACTIVATION; SCREEN; MYELIN; FAMILY	Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. It is widely accepted that a dysregulated immune response against brain resident antigens is central to its yet unknown pathogenesis(1-4). Although there is evidence that the development of MS has a genetic component, specific genetic factors are largely unknown(5-7). Here we investigated the role of a point mutation in the gene (PTPRC) encoding protein-tyrosine phosphatase, receptor-type C (also known as CD45) in the heterozygous state in the development of MS. The nucleotide transition in exon 4 of the gene locus interferes with mRNA splicing and results in altered expression of CD45 isoforms on immune cells. In three of four independent case-control studies, we demonstrated an association of the mutation with MS. We found the PTPRC mutation to be linked to and associated with the disease in three MS nuclear families. In one additional family, we found the same variant CD45 phenotype, with an as-yet-unknown origin, among the members affected with MS. Our findings suggest an association of the mutation in PTPRC with the development of MS in some families.	Univ Marburg, Dept Neurol, Marburg, Germany; Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; Hannover Med Sch, Viszeral & Transplantat Chirurg Klin, Transplantat Lab, D-3000 Hannover, Germany; Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; Schlossbergklin Wittgenstein, Bad Laasphe, Germany	Philipps University Marburg; Philipps University Marburg; Hannover Medical School; Hannover Medical School; Mayo Clinic	Hemmer, B (corresponding author), Univ Marburg, Dept Neurol, Marburg, Germany.	hemmer@mailer.uni-marburg.de	Weinshenker, Brian G/ABH-6146-2020; Hemmer, Bernhard/GPX-8451-2022; Hemmer, Bernhard/AAT-8388-2021; Ziegler, Andreas/G-4246-2012	Weinshenker, Brian G/0000-0001-5806-6203; Hemmer, Bernhard/0000-0001-5985-6784; Jacobsen, Marc/0000-0002-4703-5652; Ziegler, Andreas/0000-0002-8386-5397				Ebers GC, 1998, SEMIN NEUROL, V18, P295, DOI 10.1055/s-2008-1040880; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; HAFLER DA, 1995, IMMUNOL REV, V144, P75, DOI 10.1111/j.1600-065X.1995.tb00066.x; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Kantarci OH, 2000, J NEUROIMMUNOL, V106, P220, DOI 10.1016/S0165-5728(00)00202-2; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Kung C, 2000, NAT MED, V6, P343; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; Leitenberg D, 1999, IMMUNITY, V10, P701, DOI 10.1016/S1074-7613(00)80069-2; Martin MU, 1997, EUR CYTOKINE NETW, V8, P5; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; Noseworthy JH, 1999, NATURE, V399, pA40, DOI 10.1038/399a040; NOVAK TJ, 1994, IMMUNITY, V1, P109, DOI 10.1016/1074-7613(94)90104-X; Oksenberg JR, 1997, CURR OPIN NEUROL, V10, P181, DOI 10.1097/00019052-199706000-00003; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Sawcer S, 1997, TRENDS GENET, V13, P234, DOI 10.1016/S0168-9525(97)01140-2; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SCHWINZER R, 1990, J EXP MED, V171, P1803, DOI 10.1084/jem.171.5.1803; Shenoi H, 1999, J IMMUNOL, V162, P7120; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; THUDE H, 1995, EUR J IMMUNOL, V25, P2101, DOI 10.1002/eji.1830250745; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Vergelli M, 1996, EUR J IMMUNOL, V26, P2624, DOI 10.1002/eji.1830261113; Zilch CF, 1998, EUR J IMMUNOL, V28, P22, DOI 10.1002/(SICI)1521-4141(199801)28:01<22::AID-IMMU22>3.0.CO;2-7	26	161	166	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2000	26	4					495	499		10.1038/82659	http://dx.doi.org/10.1038/82659			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101853				2022-12-27	WOS:000165671700028
J	White, KE; Evans, WE; O'Riordan, JLH; Speer, MC; Econs, MJ; Lorenz-Depiereux, B; Grabowski, M; Meitinger, T; Strom, TM				White, KE; Evans, WE; O'Riordan, JLH; Speer, MC; Econs, MJ; Lorenz-Depiereux, B; Grabowski, M; Meitinger, T; Strom, TM		ADHR Consortium	Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23	NATURE GENETICS			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR-3; BONE-GROWTH; OSTEOMALACIA; DOMAIN; DNA	Proper serum phosphate concentrations are maintained by a complex and poorly understood process. Identification of genes responsible for inherited disorders involving disturbances in phosphate homeostasis may provide insight into the pathways that regulate phosphate balance. Several hereditary disorders of isolated phosphate wasting have been described, including X-linked hypophosphataemic rickets(1) (XLH), hypophosphataemic bone disease(2) (HBD), hereditary hypophosphataemic rickets with hypercalciuria(3) (HHRH) and autosomal dominant hypophosphataemic rickets(4,5) (ADHR). Inactivating mutations of the gene PHEX, encoding a member of the neutral endopeptidase family of proteins, are responsible for XLH (refs 6,7), ADHR (MIM 193100) is characterized by low serum phosphorus concentrations, rickets, osteomalacia, lower extremity deformities, short stature, bone pain and dental abscesses(4,5). Here we describe a positional cloning approach used to identify the ADHR gene which included the annotation of 37 genes within 4 Mb of genomic sequence. We identified missense mutations in a gene encoding a new member of the fibroblast growth factor (FGF) family, FGF23, These mutations in patients with ADHR represent the first mutations found in a human FGF gene.	Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN USA; UCL, Dept Med, Middlesex Hosp, London, England; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA; Univ Munich, Klinikum Innenstadt, Abt Med Genet, D-8000 Munich, Germany	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of London; University College London; Duke University; University of Munich	Econs, MJ (corresponding author), Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA.	mecons@iupui.edu; TimStrom@pedgen.med.uni-muenchen.de	Evans, William E./C-2069-2012; Meitinger, Thomas/O-1318-2015	Evans, William E./0000-0002-9333-5322; Meitinger, Thomas/0000-0002-8838-8403	NIAMS NIH HHS [AR42228] Funding Source: Medline; NIA NIH HHS [AG05793] Funding Source: Medline; NINDS NIH HHS [NS26630] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR042228, R01AR042228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; Bianchine J W, 1971, Birth Defects Orig Artic Ser, V7, P287; BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CAI Q, 1994, NEW ENGL J MED, V330, P1645, DOI 10.1056/NEJM199406093302304; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; ECONS MJ, 1994, NEW ENGL J MED, V330, P1679, DOI 10.1056/NEJM199406093302310; Econs MJ, 1997, J CLIN ENDOCR METAB, V82, P674, DOI 10.1210/jc.82.2.674; Econs MJ, 1997, J CLIN INVEST, V100, P2653, DOI 10.1172/JCI119809; Francis F, 1997, GENOME RES, V7, P573, DOI 10.1101/gr.7.6.573; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Ikemoto M, 1999, CLIN CHIM ACTA, V283, P171, DOI 10.1016/S0009-8981(99)00045-5; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; ROWE PSN, 1992, HUM GENET, V89, P539; SCRIVER CR, 1977, AM J MED GENET, V1, P101, DOI 10.1002/ajmg.1320010111; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; WINTERS RW, 1958, MEDICINE, V37, P97, DOI 10.1097/00005792-195805000-00001; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565	24	1081	1163	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					345	348		10.1038/81664	http://dx.doi.org/10.1038/81664			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062477				2022-12-27	WOS:000165176500026
J	Cohen, BA; Mitra, RD; Hughes, JD; Church, GM				Cohen, BA; Mitra, RD; Hughes, JD; Church, GM			A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; PROMOTER REGION; YEAST; TRANSCRIPTION; SEQUENCES; LOCATION; START	Chromosome correlation maps display correlations between the expression patterns of genes on the same chromosome. Using these maps, we show here that adjacent pairs of genes, as well as nearby non-adjacent pairs of genes, show correlated expression independent of their orientation. We present specific examples of adjacent pairs with highly correlated expression patterns, in which the promoter of only one of the two genes contains an upstream activating sequence (UAS) known to be associated with that expression pattern. Finally, we show that genes with similar functions tend to occur in adjacent positions along the chromosomes. Our results suggest that, in certain chromosomal expression domains, an UAS can affect the transcription of genes that are not immediately downstream from it.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.			Mitra, Robi/0000-0002-2680-4264; church, george/0000-0001-6232-9969				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Felsenfeld G, 1996, CELL, V86, P13, DOI 10.1016/S0092-8674(00)80073-2; Graber JH, 1999, P NATL ACAD SCI USA, V96, P14055, DOI 10.1073/pnas.96.24.14055; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; KRAAKMAN LS, 1989, NUCLEIC ACIDS RES, V17, P9693, DOI 10.1093/nar/17.23.9693; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Moore D., 1998, INTRO PRACTICE STAT; NAKAO J, 1986, MOL CELL BIOL, V6, P2613, DOI 10.1128/MCB.6.7.2613; NASMYTH K, 1985, CELL, V42, P225, DOI 10.1016/S0092-8674(85)80118-5; OSLEY MA, 1986, CELL, V45, P537, DOI 10.1016/0092-8674(86)90285-0; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	17	410	426	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					183	186		10.1038/79896	http://dx.doi.org/10.1038/79896			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017073				2022-12-27	WOS:000089638800014
